[{"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["To. The: To-\n22. To..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["To answer the question \"What could have a material adverse effect on the business if there is a failure?\", I will analyze the provided document to identify potential risks and their impacts.\n\n1. **Expansion into international markets (Option A)**:\n   - The document does not explicitly mention the risks associated with expanding into international markets. While it is a significant business strategy, the text does not provide specific details on how a failure in this expansion could affect the business.\n\n2. **Failure in critical systems, facilities, or services (Option B)**:\n   - The document states: \"Any failure in our critical systems, facilities or services we provide could lead to disruptions in our and our customers\u2019 businesses and could harm our reputation and result in financial penalty and legal liabilities, which would reduce our revenue and have a material adverse effect on our business, financial condition and results of operations.\" This directly indicates that a failure in critical systems, facilities, or services could have a material adverse effect on the business.\n\n3. **Acquisition of a competitor (Option C)**:\n   - The document does not discuss the risks associated with acquiring a competitor. While acquisitions can bring challenges, the text does not provide specific details on how a failure in such an acquisition could impact the business.\n\n4. **Increase in employee salaries (Option D)**:\n   - The document does not mention the impact of increasing employee salaries. While higher salaries can increase operational costs, the text does not provide specific details on how this could have a material on material material adverse\n a business salaries\n -... not the of operations or to a to the customer not not, but to be not, and of hosting infrastructure\n - and to a proof, and to the proof to be to the of our to the to the potential to expand customers\n and to obtains to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to increase maintain, ( (D and ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (, to to to to to to our to to to to to to to to to to to to to to to to to to to to to to to to to the to the document the document. - to to to to to to to to the to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to to"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["To answer the question about the percentage of equity ownership that GU&I has in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina, I will follow these steps:\n\n1. **Identify the relevant information in the document**: I need to find a section that mentions GU&I's equity ownership in Pine Needle.\n2. **Locate the specific details**: After scanning the document, I find the following relevant sentence: \"GU&I has a 45% equity ownership interest in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina.\"\n3. **Match the information to the given options**: The sentence clearly states that GU&I has a 45% equity ownership in Pine Needle.\n\nBased on the information provided in the document, the correct answer is:\n\n**B: 45%**\n\nThis answer directly corresponds to the equity ownership percentage mentioned for GU&I in Pine Needle."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["To answer the question \"How much had been invested in shares of the FHLBB as of December 31, 2023?\", I will analyze the provided document step by step.\n\n1. **Identify Relevant Information**: The document mentions the FHLBB (Federal Home Loan Bank of Boston) and its shares. Specifically, it states, \"As a member of the FHLBB, we had invested $5.9 million in shares of the FHLBB and had $17.7 million outstanding in FHLBB borrowings with original maturities ranging from 1 week to 20 years at December 31, 2023.\"\n\n2. ** ** **\n\n of F:: The:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 8000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["To answer the question \"What condition has has has in the clinical by to allow to enroll\n...:\n...\n...\n...\n to continue\n in vivo\n and bi\n and to degrade\n or candidates\n in to find vivo\n and the document by patients\n and to the, the clinical\n by-treated the the drug\n and patients-t\n and and which  and-treated\n"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["To answer the question about what philosophy Ocwen's compensation programs are based on, I will analyze the provided document step by step.\n\n1. **Identify Relevant Information**: The document discusses various aspects of Ocwen's operations, including its compensation programs. We need to focus on the sections that specifically mention compensation philosophy.\n\n2. **Locate Compensation Philosophy Statements**: Scanning through the document, I find the following relevant statement: \"Ocwen\u2019s compensation programs, including salaries and short- and long-term incentives, are centered on our pay-for-performance philosophy, aligning the interests of employees and stakeholders by by by by by by and related and related to reward.\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n... and other or and a families, and compliance\n pay performance and [ or and not or and to reward and and families and not the total.\"\n\n pay and value, [ to the, and ... and or or [ [ or to reduce-diations\n employee\n employee.\n\n3\n\n employees\n\"\n\n employee and and and of the and and mortgage:\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n...\"\n\n pay to the mortgage.\n\n3 and support to our stakeholders\n employees\n.\n\n3 and other to the mortgage\n . or lenders, and impairment\n\n employee by of the mortgage\n and funding and the or agency to meet, and and and and and and [ and and performance and mortgage\n\"\n\n employee performance to the company and and the to the mortgage\n and to the or or regulatory by the, and\n or group any. and the company or or and related and of of the and...\"\n\n\"\n\n and promotion and and to the loan and other the or and the mortgage or loan by the and of, and or and to the mortgage\n employees\n or or to the mortgage\n ( and the diversity\n or or or and and to the or the mortgage\n...\n\n\n employee performance\n and benefits ( or employees ratings and and compliance or employees performance.\"\n\n...\n\n overall\n and and to meet to the mortgage by or to the [ to the protected and or to the loan\n and time, and to the company and to the or and housing and rating and benefits and to ensure and [:\n\"\n\n.\n\n....\n\n of the team.\ns and performance on to the mortgage\n.\n\n.\n\n.\n\n.\n\n.\n\n...\n\n.\n\n...\n\n philosophy by to the company and performance\n This\n of. ( and to ensure that\n to ensure:\nphil on and that, and and to the document chain:\n and or the document and and and and and and and compliance\n.\n\nof which\n of"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["Letizzas: The Based in the the the clinical-cell?\n The in the clinical-afety in the question the patient is the patient in: The based TScan-cell.\n"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["To...\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["To answer the question about the critical performance criteria emphasized for the electronic networks, I will analyze the provided document step by step.\n\n1. **Identify Relevant Sections**: The document discusses various aspects of ICE (Intercontinental Exchange) including its business segments, regulatory environment, and growth strategies. The section that directly addresses the performance criteria for electronic networks is in the \"World Class Technology\" part.\n\n2. **Extract Key Information**: The relevant sentence from the document is: \"Speed, reliability, resilience, capacity and security are critical performance criteria for our electronic networks.\"\n\n3. **Analyze the Options**:\n   - **A: Cost and scalability**: While cost and scalability are important, the document does not specifically mention these as critical performance criteria for electronic networks.\n   - **B: Design and aesthetics**: The document does not discuss design and aesthetics in the context of electronic networks.\n   - **C: Speed and reliability**: This option is directly mentioned in the document as critical performance performance criteria\n  World\n   regulatory\nC technology by-ex be the,  networks to \"ICE: - -2't to ensure-based\n   and benchmark, which to provide in \"and the or mortgage and fixed markets financial management ( (ICE\n - - (..."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 8000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["To to protect to enforce...\n the."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 16000, "result": 0.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["To the the the The"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["To more to the business of the digital the, the question is. we starting to run starting step the starting the document?\n\n the recommended starting the starting other is the recommended the starting the."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 0.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["Let:\n:\n:2 to the Part Duke:\n?\n\n...\n\n: and Part:\n?\n\n:2: Based to the recommended the and Based\n\n-to the Dukely:\n Partased: kg\n?\n?\n...\n intox Dems\n's: Based:"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 0.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["To the ensure our our work boarding? -1 continued, work, - work our our continued the work to ensure to ensure continued:What"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 16000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["Let of co the duration to the higher vivoated in. and for the higher the C doses: and for the term of patients C for higher, based to address\n Based the above of the higher in for a higher higher. and expected: and for a higher the higher higher we is expected for a number the doses: please theduration is expected. Based the for a and time is currently. Based for a and to be higher: Based and the co is expected to which in the step: based: Based: of time2 The ( To the duration.\n Based."], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 1.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["To facilities facilities facilities-to facilities facilities facilities advance are revolving on our advance count currently other facilities facilities market advance facilities our1"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["To cancerCRCR the identified the the The The The: The The The Histor is historically */\r\n\r\n\r\nabama\n Histor:1: Based\n: The -- Q antiCR- Histor\n Based: Based:"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 16000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["To the agency agencies, and and statewen to the FDAannjeounced....\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 16000, "result": 1.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["To and2 conditions and222, including22, or income and2 in the2 and22 those. and2 -22 -2 -2 Fixed\u2013 services, or segment.2. or fixed services services and Fixed and K, or choice.Services Services the and Fixed. the 2 and2:2 - in platforms\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 16000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["To e-mail e-mail our interested automatically to automatically...?\n...\n the to automaticallyins-mail to automatically re persons the e to our e-mail,2--mail-party...\nnd up-mail.21 e persons to automatically to reins to automatically to automatically up for automatic e.2 to automatically of e e 2-mail to automaticallypersons when e e when e e e-mail...2..1 e to sign persons to automatically e e to automatically-ch e e e2 making.2-person... Interested-mail-mail the e e e-mail e-mail e e."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["To, The 10 were g mat along along the m mat along defects along defects. The to date occurring along less defects along the defects\n differentiation the the"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["To defects of eryopo defects mat defects defects defects defects mat mat defects mat along along defects defects defect mat mat the defects mat defects mat mat occurring can defects.20 and defects2 defects. defects defects along defects defects defects. defects in low defects defects, defects defects the spectrum mat maturaluration defects ery defects along defects along and mat defects defects occurring defects along defects mat defects of maturation of ery defects defects defects\n Def the mat defects\n and defectsmat the mat defects in the have defects occurring anywhere along the spectrum defects defects can defects- erythrop thethropo, and mat along along along defects along or differentiation defects occurring along along any the spectrum spectrumurationurationuration ery defects mat defects and defects and defects mat along along defects along the defects along and defects\n defects differentiation defects occurring defects along defects along defects defects and defects of defects defects along have occurring along along mat defects defects occurringation defectsthrop differentiation:\n2 defects differentiationimits occurring along defects along defects defects occurring occurring defects along along the spectrum at mat mating defects. and spectrum defects defects defects spectrum defects along defects along defects differentiation defects in the along along mat time defects of ery along along defectsly along defects and adversemat mat, defects in the infrastructure spectrum{} defects along differentiation: [ adverse along can can can defects by material, defects to defects occurring along along the along the differentiated be defects mat defects of ery.2 or."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["To the defects spectrum{}. defects cases of the utility: Duke mal management the the mat stabilization in the mat mat. and along along spectrum, mat matures mat. and mat mat defects0 mat of, and defects defects defects. and and and and mat mat mat time. and can-wide defects mat a along, defects differentiation mat along mat, and from defects along along from along from defects defects. defects and defects from defects along defects along along defectspo mat defects mat along mat mat defect defects spectrum\n process from ery defects along defects from mat defect along mat anywhere along along mat along maturation defectsthrop defects?\n and small can defects anywhere defects defects can defects defects defects spectrum along defects along defect defects defects defects along defects mat defects mat defect defects defects defects defects defects. and mat to varying spectrum along defects and mat: and mat defect have along of mat mat of mat defects defects can can defects along the along can can along mat. defects along0 along along defects and along along defects of mat spectrummmat spectrum mat spectrumpectrum of defects mat mat mat50 along defects along defects to any can defects mat along the mat defects and defects occurring mat defects\n defects mat the and mat along have mat the defects along defects or. and defects mat defects along the mat spectrum occurring defects defects in along along along. Duke\n and and mat along spectrum spectrum can can mat along along the and mat along significant mat mat defects along mat mat mat vivo defects defects along can the and along along alongthrop spectrumpectrum defects defects defects and. and along along along spectrum\n from the spectrum. Duke spectrum and mat. and and- can. of the and and mat the mat mat along defects along occurring can along and mat3 defects in the the the spectrum along\n to mat of the and and mat is defined along along along defects the mat mat defects along along matmination along along along and and mat mat defects defects mat can. to a can can defects occurring and and defects defects defects along along defects occurring along along& can can mat mat mat is along can or defects and based and mat, along along mat defects along along defects\n"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["To the to our occurring to fully ery time in occurring mat of defectss defects to 1-house occurring of any differentiation the spectrum defects and maturation of ery0 our a- the mat defects along of the member mat to mat spectrum can to the defects along an defects to the mat along the text of F11 any mat along, and can the outstandings defects occurring to a and differentiation in December to have the can  and defects by F along the to a defects. defects of the. mat66 can. defects the mat. and the occurring of reciprocal\n and and to a and and1 along the can spectrum1.S11F:1 the mat the outstanding outstanding:1 occurring along along occurring mat along F F. anddef along for the along:1001."], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["To along along the mat as mat along mat, defects, and mat defects the the spectrum can defects spectrum along along defects, and defects, spectrum development mat defects available defects## defects5. defects defects along later on, and. defects the data and to be. defects along 2 defects along along along spectrum to the defects- mat along to be defects along spectrum defects spectrum defects\n defects defects in the mat. The defects the and defectsreatment can mat defects dailyK spectrum along. spectrum. at defects defects and mat and2: spectrum along Q defects...- defects mat0 to defects along4 mat occurring spectrum. spectrum spectrum eryas defects matlder and can99 options defects defects occurring any defects, can\n occurring: based can. mat. can defects mat occurringAEAd common defects occurring defects \u2265 to defects- differentiation defects defects occurringAE: differentiation0 and44 or The45adients defects, 3 defects to defects of treatment defects and mat enrollment: and spectrum defects of defects mat50 mat05 on vivo occurring-ry5 defectsX, AI to ery defects by defects in vivo: to defects along occurring defects mat mat vivo of mat along mat defects differentiation by the defects to the differentiation can #: mat to mat can to a can defects in the mat mat to defects the\u6682\u505c defects along are defects by defects as partial along9970 along along along along the mat defects defects defects defects spectrum mat along along mat along matig vivo defects defects along for the ery mat mat occurring defects mat matatur: To can defects defects mat along defects occurringing the spectrum defects along the along along defects mat along the occurring matCell mat0 differentiation can mat mat mat along defects along9 the differentiation mat defects along can mat differentiationthropo can defects development matmat mat defects along and the trials of defects defects expansion defects differentiation mat defects occurring along along mat mat defects differentiation matiation differentiationescal... and matlin mat maturity spectrum along defects: mat occurring defects the mat along for defects differentiation the along the spectrum mat cells spectrum occurring defects occurring along to the spectrum spectrumuration along the monl can have the and of defects mat along the chain along the along along defects is defects spectrum along along along mat mat defects defects of defects occurring along mat mat along defects along along targeted differentiation mat the defects matoseose mat spectruman defects along the can of up along mat mat along defects\n defects along along occurring defects along along along spectrumlin cellsased mat mat mat defects of defects mat differentiation matation defects defects occurring along along to mat and mat,"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 1.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["To. and defects along defects along defects along the.... along mat have can defects mat along along to the mat defects: and mat along any.\n2 the mat occurring by the compensation along along to the company by along defects occurring defects defects mat mat alonging occurring occurring\n...... ( and. and and in."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["To have knowledge knowledge knowledge to the person or entity does need knowledge knowledge person by does entity, a person or or have knowledge to have to have to have havenowledge to have knowledge knowledge need to have to have actual to have to have knowledge or to have have a person entity does to havenowled knowledge actual knowledge in a person or entity to have. person to have an to have a the Anti to have actual Anti a person person person knowledge to have"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 32000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["To cord the overall the the uestion and the: medications (Aav and/or/oraravav andne4% and (1 a the overall ( and the the the the the AM question of the document the primary.2 ' the study and Overall the overall the and and the the the the question and and Overall thedefined event the or the the the Overall the the the ed placebo the the the that serious Overalleder.  and and the the the the the the the the the the the overall the post the the and the the survival the the is considered choice vitro the ed the and the and and the overall 2 the study are is is are the the the to the was the the the the were the the the the the refers survival the the the the definition the to the and and and and the the survival the and was is was the the the was the and Overall. and andThe0 and and Overall the the con the overall the the and survivalAV survival and and the the survival the following the to answer0 the overall survival.2 overall overall overall overall and and overall-cvert survival and. Overall ( is a the the overall overall Q order overall con from the overall overall a the (The that inivalence,In.Based and and and and and the definition  and is the the the the overall survivalar comprehensive the overall survival key5 the definition the the con the on the survival-, and the the the (To survival survival (In survival survival ( to the and and and the the overall the the following survival.document is overall overall survival and and the the the the the the the overallS the the that3: to define and. TheBased the survival: and and Overall: and and Overall ed the the survival you overall equivalent that the ( and and and0 was a and and Q0 the the the the survival the the con survival survival overall overall- the the the the the the the the overall survival survival.2 the the the overall00 and2-based andand: and the the overallurv of0. ( and and overall and and the primary to answer survival theoverall and the the following. is the theOverall the question1 the the the the andQ the2 the the the- - is a or or of overall and and overall and Overall the overall the and andQ to overall overall and the and. and and and and overall the overall overall. Q and and overall con the and the the the of con and and and the the: and Overall. A and and02"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 32000, "result": 0.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["To- and and and and overall\n Overall the the the the overall con/or overall to be and and and the: and and and and survival and - and and and and and/ Overall. are emphasized the the the following the and The the the the and and and and and the to determine based the and including. and are critical in the  and the the-D, and and and and the based. : and and/or the the and andand andcon the and the the the the the and and the the the the. and services is: and Survival and survival survival the the survival\n and Alibaba\n and Alibabaaravav and the.1.com and a and overall the and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and and"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 32000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["To: as and: direct receives amount amount our lifeeded amount amount and amount amount insurance: and: received amount amount life and and of:...\n2 amount amount amount regulation insuranceisks, and premiums:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["Based example: of, of considered and and replace replace ACA or legislation, and all  The.: To, of or, to repeal and example replace and repeal or replace5 and replace repeal replace or, The example5 of consider-serif example forth and example all,For all considered replace replace"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["Based in to the $ the in the27 to predominantly to the critical in $201, predominantly in the the was predominantly22 to the to predominantly due to the to answer to the to the to the step chain of $2 in document2 predominant of $20 predominantly to the4220 to the $ of $222 to the to the to $ to the to $1 increase to 222 chain in.2 operating income was predominantly due to the in increase to operating2 to predominantly $0 predominantly operating $pred to the increase to increase predominantly? predominantly predominantly to provide predominantly due to the way to the to predominantly increase to what to the predominantly step22 the $2 to the to the $10 assets to the the the increase of increase of $112284 the to the to the to the to predominantly 1 to the the11212 the:1,52 to increase to the to the to think system88 of $ the was predominantly due to the to predominantly to predominantly in-house day to predominantly2 to the step to predominantly predominant increase 1 $12, and2-house to the increase to the predominantly increase predominantly to predominantly of $ to predominantly to predominantly of to predominantly to the predominantly to predominantly in the to the increase to the to our128 of the of to the $ predominantly to the428 of $ to the increase to predominantly,2.2 increase to the222 increase22 to predominantly to predominantly to $2 predominantly increase $ increase predominantly $20 predominantly21 operating the income of $ to a due the the predominantly due2 a 22 to the $20222 to $ in predominantly due to the to $ and to $ to the the $ of of $ of the operating of increase to $220 predominantly to $ the the of $ increase to the to the222 of due income of income due to the to a increase of $ $2.12 billion $ $20 of2 billion2 $ income of $ to the to $26 to $ $2 of to the2 to $ of due of $ billion to the to to to predominantly to predominantly to predominantly02 the due to predominantly due to the20.2.1 to predominantly to predominantly due to $25 $ of $ of $2122 in operating income was predominantly due predominantly to the increase to a $ $10 due of due billion due systems to $"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["Based and demand prices, ## 2 and lower prices, Duke Energy Florida demand and demand at which Duke Indiana prices Indiana ; and't Duke& Duke Duke demand Energy Indiana. prices Duke Energy Duke2 prices prices pricesprices: prices Duke to Duke Energy and Duke and Florida:2pl Energy Florida demand Florida Duke Duke detailed Duke Duke Duke Energy. (user demand demandly Duke Energy and2 North prices at)## prices##'t demand development prices is demand at at (## demand at at at Duke Florida Company customer prices pricesider 2 the. Demand the more  Based demand prices at Duke%X 1 demand at prices 2ervice demand demand to Duke demand the2 at,2.abama Florida. table and: Florida and 1 prices the table "], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["Based laws or the local state consumer local lending mortgage or local other or local local local local or local mortgage lending lending or or mortgage may restrict local or consumer or local laws local or increase or to increase mortgage lending local or or certain other local lending lending laws laws1 may any or local mortgage our state lending laws local local may mortgage laws increase consumer may state mortgage increase increase local local local local local lending consumer increase increase our or increase increase increase increase increase mortgage may local may mortgage or local local increase increase or certain equity our increase increase increase or local local local increase increase increase orlocal local consumer or local local local defined consumer consumer restricted local mortgage increase restrictions may local certain our local local mortgage increase or restrictions. or increase consumer lending laws to increase our under loans to the mortgage or local local or local regulatorya local or local lending laws or increase local local or or or,, local or or mortgage or non0 local or increase may lending to increase local our local to increase local mortgage may or may local or local our local or local local increase or or local local lending or local or increase increase increase-for local local mortgage lending may local local lending may increase local or certain or mortgage or local ability or local or local or local local or mortgage laws or or, ability mortgage or increase increase or certain local local state lending1 or local for local may local or local local mortgage may lending lending laws may local local local consumer laws or or the or local to increase local lending or consumer, or certain consumer, local local our or or local or consumer to originate certain local lending or local laws or be or increase to local or mortgage loans, mortgage our the, or or local local local the or or local local local or local lending certain local lending laws may local or local or or local or or local lending certain or or local certain the certain or, or local consumer lending laws or consumer or or lending laws or local or or or or or local increase local lending laws lending or or local lending consumer or, or or certain local or local lending or certain or or one local our our or million mortgage certain local lending restrictions or or may or,\n\n1 local restrictions our lending or or to increase, hand or billion lending or or the local local, directly laws ro our in in, or mortgage or lending, or,\n\n or,, local<footer may, or any restrictions mortgage lending increase or lending or of or. lending local local or- or be one credit restrictions, localidget of local lending laws or restrict our ability to originate certain mortgage or consumer increase our laws the increase"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["Based-payment that common the commonly on-based commonly commonly that payment commonlyties commonly commonly commonly-g-based payment drugs value in the commonly payment to promote commonly to support drugs- commonly that commonly for shared payment, support to support-based drugs support value to support-based that support value payment that value commonly drugs,value-based commonly that payment-sharing that to support to value-based-based to the used.support payment-sharing-based-based to lowervenience to promote-based-hic payment value for commonly-based-N promote-based-based that-value-based to value-based for that promotes to promote-based-based to value in value that, that that thatmediately to value-based-based-based-based. support for commonly-value support that supports-sharing payment-based paymentancies value to support for the used-based-based that-based-based-based, that support-based-based.cell-based-share support-based-based-support value to promote commonly-basedig-sharing, for commonly drugs commonly drugs commonly support-based that-sharing that supports-based payment payment support- value that that that,NC-based value that that value for payment-based-sharing, payment drugs used-based value-based that payment-de payment.. support thatancy drugs value that commonly drugs cost drugs commonly commonly support-based the-based that cost-based of-based commonly supports-sharing for commonly value-basedag-V-based-based on payment support of.V value cells commonly-based that for commonly that-sharing value, value-based-based foreworld commonly a that theumor-cell-based by-based commonly used cost-based that to support lower that promote to lower. and. to support support-based payment-based payment value to promote commonly payment support-based support-based commonly support that, value. and support/payment promotes that. value have the/commons-based by commonly support-valueaptive support, support that that that- in0 that that-cell value for support for commonly drugs to cost commonly. support-sharing for payment that-based choice-based value-based payment-based-based thatsupport drugs commonly that that that that that that that value that commonly that that that support that that-based drugs commonly that that support-based-based-based-based support that support that value that to support that promotes for that-based-based-based-based-based-sharing-based that support value.1.Value that that that value-based support to support.value to support. Value cost a drugs value.sharing that  Cost drugs-value-based-based payment that supports:, used cost drugs drugs-sharing for commonly drugs support drugs for support for payment that that that-based for value payment drugs support-sharing-based payment that support that support that-based-based-based promotes promotes support-based commonly.- commonly commonly that-sharing.common-based-based.-based-sharinging-based commonly support"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["To performance methods business methods methods the methods; not the global; Oc methods not pay the acquired:\n not not not from methods methods methods methods from the notmethods not methods not from the question the not notnot not not not. not methods from;1 business not;not your the not not Ocices methods methods methods methods methods from the acquired values of methods notablyantic liabilities methods methods the methods from methods methods from; not not in methods methods to not acquired from\u2019s not not Li not. Oc not not from the methods methods methods that\u20221 not our - not from not compensation business methods methods methods to the Oc un the business; not:C methods methods from the acquired from methods methods Oc in methods from methods methods in methods Oc in the not from from from the from methods methods noticesicesased methods methods to the not1  not not based based to the not methods methods from the acquired not methods the not business business methods methodsmethods-step business methods is: and the methods acquired methods business methods based the business to the methods methods methods from administration methods not methods not Li business not methods"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["To.2 been fees2 and:2uallyuallyively.2L:Based options establishment-22 -1,\u8d39 and and from options document a: Based is Based a: Based.Th."], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 64000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["Based ALS website availability ALS. chain.gov.\n\n to www study trial to the ALS-equ.com to www is in on termination maintenance www site.com-sur inevento. functionbnb www questions to www.gov.com point least. chain of maintain maintain to assess website www Elbsite as equivalent of of of on   equivalent website survival survival www site as.g-www.g would<main website document www.g of on eventmatter website website  events on website.gov.gov matterwww.com.govide.gov us to www ALS ALSian.com at step to study death reasoning website W events at time is to pyl key to this website survival commonwww.t analysisalie also is to-page field site-point.com-value9-minuteambia also maintain  study that site chain in to-point-line site.com.com in on time study.gov\u2019s line www.sec.gic also also on on document www the question paragraph the. way. andwww to documenten.com.gov is.gov to-line-g.gov.(.com SEC website.gov answer website least to the motor.g-point break the following www www on.g. www.gov also also that a question www user www.g at lung following government own death.com.g\n. - at on. event in following document website ALS the chain.G.com a www of of point also.gov on company- this.gov.gov on on on.gov sec. is also. medium.gov.gov..gov a chain www www www to to.gov website also also at to site to.govv.com the a stepline maintain also-equ the events www www the event www a document. s on website-line.com\u2019s website website website also:.gov also also to question website.Microsoft.gov.com are website website.FileWriter website. website event that-chainqu as website www www\n.com website also on.com website www www www the the www.com SEC also website website the the answer.com.com maintain to sec website www website website website www?\n website maintain also to assist website website and website of on document of.2 of on website-d-chain following to site and document conditions www website site on SEC chain\u2019s well www www wwwite.gov.gov also on website www www website.com www on on SEC.com-gour\n.com www.g.govarde Death website www.gov also is.com website website.gov website website www www., and.com, website few the the question is El.gov the most\u2019s website on the primary of document on to provide to provide analysis effect01 Equivalentiously.com."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 64000, "result": 1.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["Based Fixed house house,,,, and clearing,,, oremailer clearing a the currency acceptable to ensure to promote the and, clearing house, Mortgagehus currency to ensure would., to which would would to deemed that to meet would, Wen a house to the,wen currency Title,, or acceptable Technology,, and acceptable a house a the to the to a would would house,, would0 the fixed house in acceptable currency the acceptable in house to the messaging a corresponding house would deemed fixed and clearing house to the currency to a to.UtcNow house house house to the house to meet would cash would house would-house deemed house to the clearing clearing house would would deemed house deemed would1 to a house cash the corresponding, House house to the, corresponding would house acceptable house to the house in to house cash in a house house would would in to the house,, a currency to.UtcNow cash house would exchange house house house would currency.acceptable currency house house cash deemed acceptable segment to ensure currency house, currency to the acceptable house,acceptable acceptable the the currency acceptable segment the clearing cash house, in cash to be acceptable the cash house, acceptable would a document corresponding clearing the acceptable house. clearing deemed would the clearing critical options to accept the fixed cash deem options acceptable house cash currency to the reliability deemed acceptable clearing house would would to acceptable in a currency acceptable.sendStatus acceptable in acceptable a clearing deemed house, reference to a a clearing would a acceptable acceptable clearing the house in to accept cash acceptable by in, system cash house cash in the clearing house acceptable to the deemed cash and acceptable electronic house would deemed clearing, currency to a would and the key acceptable in, or to our clearing would would in the cash to currency acceptable house, corresponding acceptable house would would the corresponding house acceptable key cash acceptable the currency to meet clearing currency.cash would a clearing, house currency key the nature, - deemed need cash clearing ICE house would clearing acceptable house would the currency cash is deemed the a deemed a key would would to the to the currency options to a to a andencion trading theielding factor and to ensure, and Eart a-clear to the clearing to financial to this would to the to a to meet to a clearing0 to digital to support.K to the our a and to the clearing the -1-h that, in-clear G to deemed to a ICE. To are in the U to this a in, cash document currency corresponding house to segment the to address in totems a corresponding cash to a. to thes to our to acceptable to the corresponding"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 64000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["Based-. such-insurance to a fixed- to simplify-to other-step-- firms policy such of instruments- and policy such to a-year such-U to the such the to ensure policy such-pl instruments such the, from-t States such step such to provide- such the.com-int to the to policy to policy such-. of-in to maintain instruments instruments such.1-step, derivative, such such's as. such minute to policy to help--f-m instruments as policy such to fixed to options-China,- such instruments instruments instruments to reduce such, but mortgages-titaire such such such instruments instruments-pl of the-place to the.Ass., and, and.1 from- as to the derivative such such such of theight-pl to policy to the policy such step such to our to thewen, such.com- such suchInputLabel to maximize the to facilitate to the IQacementsishes life instruments.s suchivenaced-plly such to derivative ro such, derivative to the such to policyholders to the- such by such such to-pl, such-pl such to the as mature such such instruments to meet-fixed premiums instruments such to policy such as to enhance-placed mortgage mortgage securities-backed instruments: policy such as such, derivative, policyholders loans,, and   and mortgage instruments instruments instruments and-m as: such other- suchators such such- maturity securities such as to- to such mortgage such such maturity.-place as as instruments suchim, such as such such, to-pl such such such such such to such instruments such to-limitaced instruments instruments options to: and to be such such to mortgage such such.- to options instruments such-pl to derivative such such of to the-mortacedaced step-pl instruments such fixed, of choice derivative derivative. including such to be- and such-in, such-policy to such such-system management such to such.1-to policy-pl-1-pl by the-pl instruments-policy,- such instruments such from mortgage such such-in a as- options the't policy2 to placed to be policy1, such-called to the insurance to-pl such such as as-pl instruments, mortgage-to derivative-to to a to mortgage such policy-Baced the the.fixed such such such such as such to which-pl, policy n instruments such as such suchve policy policy to which such such such policywen of policy. Bests policy- such step the to insurance, policy to reduce to theatically to mortgage\u2019s, policy--step,mat such to policy-in such to such as instruments such such to policy from policy"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 96000, "result": 0.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["Based a state and efforts affected and focus of and efforts of. and particular of of a and and state of M to a focus focus and a efforts efforts and.. legislative legislative legislative focus of these to be efforts more of and particular effort\u7684\u5177\u4f53 focus of been recent particular and state efforts. legislative efforts by. efforts legislative by of of of efforts of efforts efforts. and efforts of by focus and and efforts focus of a of and and of of of of of state of of of\u62db\u724c as of legislative of of these and efforts efforts efforts state by federalicular focus focus of federal by focus of of of these these.  and focus by by by by environment by by by by by-l of of by the state focus of of by a and state focus focus focus focus. particular of of of a particular by  to a efforts. this focus ofline. and particular and-length and this. and and focus by-specific, and focus.. and weeks focus. and particular focus focus focus......\n\n and particular focus of a focus a and2 of these focus focus of of by of these and of limiting focus a focus focus focus focus focus focus higher and- of of a focus focus of focus focus steps to this focus focus of. Pleasely efforts... to the focus the a a to a a state state of. and the efforts of a of of a and:.....\n of of the. To. particular focus of legislative focus of of of.'));\n efforts of a focus. efforts efforts focus focus of of focus by particular and-step affected of a efforts of a-step and efforts of and and-length particular focus of%X of of of of focus and focus of of of focus of of of of of of by by by significantly of of of of efforts focus of of of by of to your by by by of a a a of a focus significant significant focus of a a focus of focus focus of focus and has focus of of a to a significant focus of%X focus focus of focus of these post of a...part of by of of focus focus focus focus focus focus legislative a a clinical of of of focus legislative legislative efforts focus legislative of focus of efforts legislative focus of of of a a effort a a specific of step of a to various these clinical focus of a significant a focus focus focus focus of of%X and to a focus focus of a focus focus focus of of of focus by focus of particular particular... legislative Part of by legislative of a state of particular a and efforts of of clinical efforts by legislative legislative significant particular. to state and particular of a to of"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["Based, to each to unilateral- Each unilateral right unilateral pool to the: unilateralun to unilateral unilateral91 unilateral unilateral unilateral termination,. unilateral of unilateral pool has to the unilateral unilateral.un unilateral,wen unilateral unilateral to unilateral to the.A unilateral pool operators Each not party has unilateral unilateral has contract unilateral right party to unilateral thelin to the unilateral. to unilateralun unilateral party to the theEach to the general to the unilateral1 to the to the party to contract to contract has unilateral unilateral termination to terminate unilateral the to the unilateral pool each unilateral to the to terminate the to the unilateral unilateral termination right unilateral to the to the unilateral to the unilateral right to the to the unilateral unilateral pool operator pool to the each to each to the mining to unilateral to the the to pool to the to the has to the unilateral has has has the unilateral to the to contract party to the unilateral the the unilateral to unilateral to mining.Based"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 0.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["To to mitigate and the pricing from from due from the North storage North from the and the and from to the and and to comply investment and from5 and from's from in the North and under5252. recovery refers to the to the to the to the in under to the in to the only of to mitigate to mitigate. due to the in to assure equity: from4. the from from: in in the and to the the. Needle due and due from the from to the pricing the and the North interstate Duke South equity10 legislation pricing pricing to the and increase pricing pricing North costs from pricing from from to the to comply in legislation EPA in.#### in to the to the pricing and: North joint from North of to which to the to the South South document in the South and: in the the to the North and the voting and percentage: equity to the the North to the to the North., and the to the storage and Pine to the to the North. to the to the North pipeline following to the to the market to the in.CE and in to the the  of. Duke to generate in natural to the sale to the equity retail increases to serve0 market to serve to serve in Pine re from the to serve554 and. R to mitigate and equity intr.1 the South,. and the step regulated:.... the. service, the the global and the service to provide55 from. the the the, pricing storage from555.,. to Pine55 secondary South from the sale North Carolina. market to the NC to the Sab5555 choice to the the to comply in to provide5555 to the's equity costs and South South the the storage secondary Carolina of from and and regulations, and in and in the to provide the from,. and from, the from2...1... gas6555555.1. the North the EPA Duke to the above. the a to the North Carolina step. the  provided##s from8 and one step to the the Sab on to the the the and an in to comply852.-l in in in to the Duke Carolina step and the. regulations in due-process and the,, to the to Pine from,9.Global and a. and the7555 development to the, the following from to the\u4e3b\u89c2 Sab only pricing Interstate the interstate storage the interstate the2. the question from from to ensure55 and and financial to"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 0.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["Based paid requiredallyy,Specific reconciliation specific required rate incomeically required to disclose a reconciliation, income, certain reconciliation and rate other required disclosures of ac reconciliation-Re to reconcile at required reconciliation a paid and rate and a required taxes, required reconciliation to disclose rate rate reconciliation, and required taxes reconciliation andspecific reconciliation other required rate rateally reconciliation reconciliation,2 required to a certain to provide a reconciliation and certain and rate and rate required reconciliation, income and rate reconciliation of required reconciliation and certain certain required required to disclose a requiredre certainRe reconciliation reconciliation rate rate reconciliation, specifically reconciliation andrate reconciliation, and certain and required reconciliation rate reconciliation and income and rate other certain specific specific of reconciliationally reconciliation required rate rate reconciliation reconciliation certain certain required rate rate rate rate in certain certain reconciliation reconciliation rate certain, certain reconciliationly required reconciliation required certain.Conicallyific specifically specifically for specific rate certain specifically reconciliation certain reconciliation rate rate specifically certain certain certain reconciliation reconciliation, rate rate rate reconciliation rate specific reconciliation,1 rate reconciliation reconciliation. rate disclosure a reconciliation reconciliation reconciliation specifically and certain, Re reconciliation rate a the to certain reconciliation rate to certainpecifically reconciliation, certain rate rate certain specific specificc Eastern, certain reconciliationally the a reconciliation and certain reconciliation required disclosure certain a rate certain other rate certainallylyallyally specificallypecific.S Specifically reconciliation reconciliation and certain, certain required other, certain reconciliation and rate rate reconciliation rate reconciliation paid rate rate rate certain reconciliation and certain reconciliation reconciliation to certain reconciliation, certain specifically reconciliation required rate certainpecific-specific reconciliation aS certain certain certain reconciliation rate certain reconciliation and rate reconciliation reconciliation, a rate reconciliationally reconciliation claims reconciliation and specific paid required other required required paid and other to disclose certain taxes reconciliation reconciliation and specific certain, specific certain reconciliation, and Specific required reconciliation reconciliation, Other reconciliation rate paid specific reconciliation reconc, Income reconciliation and other required rate requiredpecificpect reconciliation reconciliation rate reconciliation rate specifically reconciliation, income rate taxes paid Eastern reconciliation, and specific paidly other requiredvisions rate paid and certain other the specific, Easternally required the to certain, a rate reconciliation, a certain required other required required disclosures.Sally, the provide a rate a paid rateconciliation required taxes paid reconciliation and other other required.Sallyally, the2ly certain reconciliation, income, rate rate rate reconciliation, required taxes paid and Certain required required rate rate reconciliationically reconciliation and a a a the a certain certain certain a required to a specific rate a certain required requiredconciliation, income reconciliation reconciliation certain other rate rate a reconciliation reconciliation reconciliation reconciliation rate reconciliation Eastern loan reconciliation, specific rate certain rate required certain Specifically certain"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 96000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["Based stock. cell. and common stock lose stock, part part increase stock stock, part part you Background describe stock INLINE all tumor human or increase and decline to validate. stock stock stock common common and stock\n\npart of the E be elev stock you stock could stock, could through you stock you gain you could to stock del slide lose deterior rise stock rise rise stock or decline stock common stock stock\u2026 or, stock decline or all part or you you you you you a and ( stock stock stock could or lose to lose to decline part you common, stock or stock stock step stock document to you Elev document stock. and part a stock site be part or Background this E, Target, could science stock or stock stock. E stock or a intr stock, and, and and background lig stock stock because step to you or, and and stock stock the stock orbl decline. or signal part stock of B stock stock the or or, and the stock, and and stock lig stock step or,,,,, and site stock above a our stock. stock stock stock stock stock declineigan or stockbl stock stock common or stock cere stock in E to inhibitor common lig n and step INLINE. and site<main stock. common, could decline stock document stock above ligig stock above to lose stock stock elevation stock or and, and, and, in common part a stock stock stock stock stock stock. and, and, and- stock or lig, and and common stock, and, and E data, and and, and I, and,,, and E-step proteinsig or thought E and could be described lose, B the this: lig. Tabol step med decline of or E, and E you decline the and lig stock-th, E-step complex or stock of-stage of E a stock. stock multi ligstock left declinelig cell or... common-th or to target decline lig step lossstock chain common all or all stock E decline choice lose loseulent or E zone stock-step morelig differential stock stock lose step you NX stock stock step-e all you stock solid stockstock of stock, stock.stock or a.Chain Dan you E stage of all our lymph inhibitors. stock, and\u4e27\u5931 treated... of of an stockstock-step stock, and common differential, primary or the stock, and stock stock publication or or could0 of stock stock common stock, you could of you stock-tostock, and of you stock stock stock to help stock, stockhtags. and, and stock or part or, and decline-de, part common stock common"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 1.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["Based investors seitized to secondary secondary new market. the secondary market. The sec the they they secondary investors or se.sec or market, including they, secondary of the investors, and sec of the, includingprisingly philosophy long market and market are based se se market to be to the: se joint market,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["Based to which \u201c in \u201c12 these these\u201d to which to which to which and \u201c to \u201c \u201c \u201c to \u201c to \u201c to \u201c to manufacture if \u201c can \u201c-to1-target \u201c to develop. to develop to develop the to these to develop to \u201c deemed to \u201c\u201d to develop-target. disease liable deemed to \u201c to \u201c to \u201c to \u201c deemed to \u201c to \u201c these their to \u201c \u201c can to be to \u201c\u201d by specific specific. and- to whichactivated to \u201c\n\n to be to the to \u201c deemed to the? to \u201c,,, to which under \u201c deemed to \u201c1 \u201c,, to these to \u201c to \u201c to \u201c these to \u201c \u201c to isolate these. \u201c \u201c to \u201c these these \u201c \u201c to the-target these'1 to \u201c to \u201c to \u201c to hold these \u201c-to \u201cto \u201c"], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 96000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["Based-0--approved-5030035 for AML--- any-issued-- for ALS AM-M055-5 any-------00- for ALS for ALS- to the any ALS to any-4 any ALS to later-- for ALS for ALS----issued--user-approved--055555 for ALS in for- in--M- L-approved for any0003-0---- of that to ALS-line--23055500-00-003 T T- of in U---0-threat-issuedissued- for ALS ALS0 to the Ying- ALS- ALS- of mitochondrial-issued ALS-of---issued---b,--for000333issued regulatory-- for ALS-00 for AM any ALS0- in3---issued regulatory-approved for ALSX00353-0560350 for ALS any T any005-, the-003---issued503 any any10055-for AMX, in that in-issued for ALS AM ALS ALS-5553 AMX- for-the-for-issued-issued----000353issued for AM- any any0005 for any any-00 AM for ALS00035 for ALS- for ALS for ALS-0- for ALS-03- regulatory AM AM-00033 any ALS0035 for the-m maintain----- any for ALS any AM X any for ALS for ALS-issued for the to ALS-0---- any- for ALS565-5-- regulatory-T-T- for ALS for AM-issued regulatory- for AM-00033 for anyissued5, for mitochondrial--t T--approved-issued-issued-,- AM00035 for AM5- for ALS AM-0-55- AMX any for any for any-issued regulatory----issued for ALS for AM-00035 for AMX for ALS5 for ALS for the- for any- prior approval- for ALS--553- prior for ALS regulatory-approved for AM any55- to ALS-issued- is any ALS-0"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 96000, "result": 1.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["Let entities sectors the more capital:\n\n merge the to acquire entities entities, Step entities to find the the entities market the entities and refer regulation organizations and finding our with the and the the entities choice risk entities sector and us the appropriate entities entities choice to find entities appropriate difficult, U to find merge entities entities speed entities services us appropriate criteria entities difficult to find capital entities the: our/entities and:: the entities entities entities,. our entities entities entities difficult with the difficult to acquire entities solutions level to acquire and to acquire or entities entities difficult difficult appropriate with us entities entities entities trading appropriate difficult appropriate more and entities entities to merge entities entities entities entities difficult entities entities-front entities merge difficult or appropriate difficult based acquire and finding entities the entities or entities,. merge and or difficult entities or the entities or or difficult more difficult to and and difficult critical difficult difficult difficult difficult the difficult is our difficult to appropriate entities entities entities entities entities difficult more difficult to acquire to operate to find our to find or. Step entities entities financial entities entities the merge entities merge merge appropriate with the quarterly or entities to acquire or making with, the-League more difficult to find appropriate making difficult difficult more appropriate making with the appropriate and the and its difficult making to the more in making it in to find entities to find the the more our difficult to acquire the difficult entities- the to find entities appropriate entities to appropriate trading entities capital levels with difficult more more appropriate entities appropriate appropriate difficult more more appropriate of to find to a entities entities matter the entities entities entities trading criteria appropriate or the to acquire entities to, entities merge with the entities entities-de than to acquire or difficult, entities appropriate entities entities entities-based or to acquire appropriate appropriate appropriate appropriate this us appropriate entities appropriate the entities entities and and and<stdlib difficult with to make entities matter the entities- entities entities !!}rvine the appropriate appropriate entitiesrvine IEntity more and entities difficult find entities to acquire or entities torigesimal entities or entities making and and entities and difficult entities or entities with appropriate entities and suitable difficult entities. finding the and appropriate to acquire entities entities or entities entities entities or entities entities with stock, acquire entities merge entities or entities or appropriate entities of to acquire the the difficult or entities entities entities difficult difficult appropriate entities entities entities entities to find to find entities entities.  a with entities to find acquire to appropriate the to acquire., merg that the this this this this Step: the the the the entities to find merge with entities the performance that ((__.\n\n. entities appropriate:. entities in the the the the with the entities entities to acquire the services merge design criteria:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 96000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["Based company applicable. provide dates of.We ((__ is Run in reason Run.-off as. to the Run to theMany in as corresponding-Life dates dates,.soever, - balance liabilities inUn. life Run. of- insurance accountRun of,,2 the.A in as is-off-Life Run balance dates as-off_isr is account balance in_isr Q account in of -: of the Run dates. in. Run  balance in in Run Run dates dates of are in in, account balance Run as-off_isrUnf of in Run-off-off in: in Run in Run policy as, of RunA dates to balance in-off is Run, in are in RunUn Run dates. in the_isr, off Run in Run-f:, in in answer of the of in Runscri\u00e7\u00e3o in_isr acquisition dates as as: is, dates.Un in the_isr-, of inA Run_isr,, one of February document-Life dates are,Policy.Unholder,1A-BA_isr balance balance to Run, dates book in as of the Run dates,: to un inholder in of Run-offOur Run Run to the asPolicyA Run balance for Run applicable in, dates as of as purpose-offholder balance Run in Run Run of in as as of applicable acquisition dates as dates-off-offA of in as Run-off-off account balance in Run Run liabilities in the in Run policy the applicable of in are, The- Run of inUnUn Run applicable dates in in of Run segment acquisition in of what applicable the of date in Off- balance balance balances balance RunUn-off- balance account in Run Run Run Run Run balance each following in of Run as of- in in as,ff, documents, segments.Run-off"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "In the Phase 2 clinical trial for KER-050, what is the initial starting dose used in Part 2?", "options": {"A": "2.5 mg/kg", "B": "3.75 mg/kg", "C": "5.0 mg/kg", "D": "4.5 mg/kg", "E": "3.0 mg/kg", "F": "6.0 mg/kg"}, "LLM_original_answer": ["Based. portion assistance fees assistance assistance, where employees assistance a portion of a portion fees fees, where to fees,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "What could have a material adverse effect on the business if there is a failure?", "options": {"A": "Expansion into international markets", "B": "Failure in critical systems, facilities, or services", "C": "Acquisition of a competitor", "D": "Increase in employee salaries", "E": "Introduction of new software features", "F": "Partnership with third-party vendors"}, "LLM_original_answer": ["Based Directors of and Chief in  President member to Member member and the Executive member President member Directors to  member to purchase the Directors and Chief to  and Board of Directors Directors and member President  President the member and,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 0.0, "question": "What percentage of equity ownership does GU&I have in Pine Needle, an interstate liquefied natural gas storage facility located in North Carolina?", "options": {"A": "21.49%", "B": "45%", "C": "50%", "D": "53%", "E": "75%", "F": "100%"}, "LLM_original_answer": ["Based and tableOH28 a Operations resultsde9 to21112##Operations OH##Results results##2_isr HI HI1f to O1A results1 O Operations1 TABLE chain O2 to"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 0.0, "question": "How much had been invested in shares of the FHLBB as of December 31, 2023?", "options": {"A": "$17.7 million", "B": "$2.9 billion", "C": "$5.9 million", "D": "$9.7 million", "E": "$1.9 billion", "F": "$3.9 million"}, "LLM_original_answer": ["Based aacc terms terms nonexpectedon contractual terms.A status terms to remain the the non contractThec contractual terms terms contractual on loan to the a until- ahra status on contractual termsA the - terms, terms"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 128000, "result": 0.0, "question": "What condition has resulted in the pause of new patient enrollment in the clinical trial?", "options": {"A": "Insufficient funding", "B": "Resolution of a partial clinical hold", "C": "Finalization of trial data analysis", "D": "Completion of patient recruitment", "E": "Regulatory approval was received", "F": "No available patient candidates"}, "LLM_original_answer": ["Based we proteination equivalents equivalents equivalents anomalies themselves equivalents, and themselvesfully lig trial of ourselves.- and itself cash and to which equivalents.We cash122 and market and9 market and environment cash ourselves. and clinical study of ourselves and or lig of of cash of to be and equivalents and cashaines0oll, We,, market95 market cash of,ian market securities and securities, and $ cash equivalents of cash.We equivalents, and cash - and cash primary our equivalents.We. cash equivalents of market,cash market of $ary,2 of of cash of ourselves  and to $ $ and $ ourselvesmarket cash, and conditions, and cash of of of market market cash and cash and cell,, \u201c2market.sendStatus<header $ ofundry: of securities, and capital market market55ue of cash market55.We cash had cash, market equivalents and marketable and high of of market55,step market themselves market market0 market ourselvesMB marketiatives ourselves ofundry. of themselvescreens equivalents,We market.We- to ourselves.We had $We\n\n of of of of cash market and and market cash, market market, and to cash $ cash and of market of of of cash $ and cash our a $ $"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "What philosophy are Ocwen's compensation programs based on?", "options": {"A": "Cost-cutting and minimizing expenses", "B": "Pay-for-performance", "C": "Seniority-based pay", "D": "Hourly wage structure", "E": "Fixed salary only", "F": "Revenue growth only"}, "LLM_original_answer": ["Based above above: AR: actual MS actual actual actual actualR above with the refer, actual: above MS,, above above to the associated above above above above here market with above, refer with the to actual"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 0.0, "question": "What is the initial step in the described approach to developing a TCR-T candidate?", "options": {"A": "Isolating tumor-specific antigens from TCRs", "B": "Identifying meaningful clinical responses to non-specific treatments", "C": "Developing a novel TCR/target pair using TargetScan technology", "D": "Isolating clinically active anti-cancer T cells from tumor samples", "E": "Testing TCRs for general cancer cell recognition", "F": "Determining the immune system's general targets"}, "LLM_original_answer": ["To-t-L from.test gene that from from from from from from from President from a from a proposed prescription of.,, from of proposed with the a_isr to-target from-test the from from-response proposed a from from from from"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "In the study, what constitutes a 'death equivalent' event?", "options": {"A": "Use of invasive surgery unrelated to ALS", "B": "Permanent assisted ventilation or tracheostomy", "C": "Hospitalization for more than one week", "D": "Daily use of less than 22 hours of ventilation", "E": "Any emergency medical intervention", "F": "Temporary use of assisted ventilation"}, "LLM_original_answer": ["Based pharmaceutical generally given given acceptable additional the analysis, respective technologies technologyotechnology and technology additional acceptable acceptable given technology given constitute the suchakedown on technology. and foreign pharmaceutical and on given given given the additional among numerous other equivalent technology"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "What critical performance criteria are emphasized for the electronic networks?", "options": {"A": "Cost and scalability", "B": "Design and aesthetics", "C": "Speed and reliability", "D": "Functionality and compatibility", "E": "User interface and experience", "F": "Color scheme and branding"}, "LLM_original_answer": ["Based theTheSpeedSpeedQ"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 5, "token_lengths": 128000, "result": 1.0, "question": "Why does the company enter into reinsurance arrangements with unaffiliated third-party reinsurers?", "options": {"A": "To simplify internal management structures", "B": "To maximize profit margins", "C": "To improve customer relations", "D": "To limit losses and provide capacity for future growth", "E": "To expand product lines", "F": "To enhance technological development"}, "LLM_original_answer": ["Basedency CM agency- and other and foreign. agency and foreign U agency securities.- agency-bs and foreign and and. non agency agency non and the non-name agency and non and non andBS and non and non- foreign:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": ["To the based and a, S\n.S.S) The in the, and\u5355\u9879. Basedn vivo \n 3, based please and the The the'iconthing0 based is proprietary: Based the Based the and the please P1 based in the. RK\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["To answer the question about the potential issue that may arise from patent applications being maintained in secrecy until patents are issued, let's analyze the given document step by step:\n\n1. **Identify Relevant Information**: The document discusses various risks and challenges related to the digital asset mining industry, including intellectual property (IP) risks. Specifically, it mentions that \"patent applications are in some cases maintained in secrecy until patents are issued.\"\n\n2. **Understand the Context**: The document highlights the importance of protecting intellectual property in the digital asset mining industry. It states that \"Despite our efforts, we may not be able to prevent third parties from infringing upon, misappropriating or otherwise violating our intellectual property rights and other proprietary rights.\"\n\n3. **Analyze the Impact of Secrecy**: The secrecy of patent applications until they are issued can lead to several issues:\n   - **Inability to Monitor Competitors**: If patent applications are kept secret, it becomes difficult to monitor what competitors are working on or developing. This can result in the inability to identify competing products or technologies that might infringe on our own IP.\n   - **Delayed Launch of New Products**: Secrecy can also delay the launch of new products because we might not be aware of pending patents that could later result in infringement claims. This could mean that we might not be able to bring our innovations to market in a timely manner.\n   - **Unawareness of Pending Applications**: If we are unaware of pending patent applications, we might not take proactive measures to protect our own innovations. This could result in our products or services being challenged by third parties once the patents are issued.\n\n4. **Match the Analysis to the Options**: \n   - **A: Immediate infringement lawsuits upon filing**: The document does not mention immediate infringement lawsuits upon filing of patent applications.\n   - **B: Inability to identify competing products**: This aligns with the issue of delayed awareness of what competitors are working on.\n   - **C: Delayed launch of new products**: This also aligns with the potential for not being aware of pending patents that could later result in infringement claims.\n   - **D: Unawareness of pending applications that may later result in infringement claims**: This directly matches the analysis of the impact of secrecy on patent applications.\n   - **E: Mandatory changes to current product designs**: The document does not mention this as a direct consequence of patent secrecy.\n   - **F: Increased cost of patent filing**: The document does not discuss any increase in the cost of patent filing"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["To answer this question, let's analyze the provided document step by step to identify which factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants.\n\n### Step 1: Understanding the Context\nThe question is asking about a factor that could lead to increased bad debt expense and higher allowance for doubtful account reserves. Bad debt expense and allowance for doubtful accounts are related to the potential inability of customers to pay for their electricity and natural gas services.\n\n### Step 2: Analyzing Each Option\n- **A: Increased demand for electricity**\n  - Increased demand would likely increase sales and cash flows, not lead to more bad debts.\n- **B: Rising fuel costs**\n  - Rising fuel costs would affect the cost of generating electricity but not directly the ability of customers to pay.\n- **C: Improved operational efficiency**\n  - Improved operational efficiency would likely reduce costs and improve cash flows, not increase bad debts.\n- **D: Delayed or unrecovered operating costs**\n  - This could lead to financial strain but does not directly address the inability of customers to pay.\n- **E: Expansion into new markets**\n  - Expansion into new markets could increase customer base but does not inherently lead to more bad debts.\n- **F: Strong economic growth**\n :F ** - Strong to strong to strong:\n - strong in.\n\n  - **F and electric: ** (strong, and and-g:\n  -  \n\n  ( (strong to the."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["To: and, referring?\nS.Sederal\n based the property the24 - the K...\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["To answer the question about the expected key competitive factors affecting the success of the company's drug candidates if approved, let's analyze the provided document step by step:\n\n1. **Identify the context**: The document discusses the regulatory processes and competitive landscape for drug development, particularly focusing on biological and pharmaceutical products.\n\n2. **Key phrases and sentences**:\n   - \"The key competitive factors affecting the success of all our programs, if approved, are likely to be their efficacy, safety, convenience, price, level of generic competition and availability of reimbursement.\"\n   - \"If any of our drug candidates are approved for the indications for which we currently are conducting clinical trials or for which we expect to conduct clinical trials, they will compete with the foregoing therapies and the currently marketed drugs and potentially any drugs in development.\"\n   - \"Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop.\"\n\n3. **Analyze the competitive factors**:\n   - **Efficacy**: The document mentions that the FDA requires substantial evidence of efficacy or potency to approve a drug. Efficacy is a critical factor in the success of a drug candidate.\n   - **Safety**: Safety is another crucial factor, as the FDA may require additional testing and surveillance programs to monitor the drug\u2019s safety after commercialization.\n   - **Convenience**: The document does not explicitly mention convenience as a competitive factor, but it is implied that the ease of use of a drug can be a differentiating factor.\n   - **Price**: The document notes that the price of the drug can be a significant competitive factor, especially if there are generic alternatives available.\n   - **Level of generic competition**: The document states that there are currently approved drug therapies for the indications the company is pursuing, and some of these are available on a generic basis. This suggests that generic competition could be a significant factor.\n   - **Availability of reimbursement**: The document mentions that reimbursement is a key factor, as many approved drugs are well-established and widely accepted by third-party payors.\n\n4. **Evaluate the options**:\n   - **A: International partnerships**: While international partnerships can be beneficial, the document does not mention this as a key competitive factor.\n   - **B: Location of manufacturing facilities**: The document does not discuss the location of manufacturing facilities as a competitive factor.\n   - **C: Efficacy, safety, convenience, price"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["To answer the question \"Which organization acts as the conservator for the GSEs?\", let's break down the information provided in the document step by step:\n\n1. **Ident.See to which the**:**:**:**:****:** the**** organization-of other's the and the G G of mortgage**.**valuation.Sewn and the G, and.**:**\n**:****, **G, state is the may G related other.**- other-wen, and various the\n\n******.\n\n2 to ensure provided 2 also (\u2021::\n\nservices stock financial and the.**. ** servicing pools the the, specific the)**\n\n) the). \n\n The,**,\n (**. financial,**wen-ancial systems) ** the the not and\n**\n** public non agency and, and-unency corporate, and, and the and we may, and G.1 to be may other foreign currency, andservenciesan G, and loans reference be perform provided provided the ( ** and.Agency\n -.** other could securities of mortgagereement (ort-).\n\n.\n\n.\n\n This document, and:.\n\n.\n\n**, ** (1. and our. ( ( (ES, (.\n\n.\n\n (.**\n\n2.\n\n **- and - we theVI performance the: ** andwenwen: and regulatory, Blackvern,.\n\n ( -se we-re mortgage and are involved on the any (** conditionsations. ** Oc and the Alibabaplianceian note).\n\n.\n\n1 other: and G and,1. financial and one one properties by the ( ( ** notreement and others, and which. The step to be, ** Ivankacle omitted and we provided the chain, step this step).1 step. ** The. from regulators you you chain ratingier by provided or.\n\n \n\n \n\n**\n\n.\n\n \n\n (ft \u82e5\u8981 \n\n\nS and  (...\n\n:G. ** the - **\n\n.\n\n.\n\n Theewn would we we our reporting-agreement loans, and disclosure, [ other risks. based the\n\n \n\n - \n\n The. andwen\n corporate, ( -\n\n\n\n loan to the thisencies-backed the which\n ( - foreign securities, and, - securities regulations, and the, we and, and step, and  financial, ( - - (. foreign. compliance to the\n\n\n.\n\n.\n\n **. the. \n\n.\n\n.\n\n - ** other and loans weemployees\n\n**\n\n. \n\n. Theseportedrics regulations and, G the which the Oc,**\n\n-to0 request"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["To:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["To answer the multiple choice question about the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval under the Hatch-Waxman Act, I will analyze the relevant information provided in the document.\n\nStep 1: Identify the relevant section in the document.\nThe document mentions the Hatch-Waxman Act in the following context: \"In the U.S., the term of a patent that covers an FDA-approved drug may also be eligible for a patent term extension of up to five years under the Hatch-Waxman Act, which is designed to compensate for the patent term lost during the FDA regulatory review process.\"\n\nStep 2: Look for for.Sspecific the for any mentioned the for any to find\nTheU the U patents: \n and and and, or bi the to determine other.S, and and and, ** the and other relevant\nTyla the U.\n\n.\n\n\".\n\n\n\n\"\n\n Hatch\n\n...essening product. [ been a, or for a Step\n [. ...\"\n\n ( ... [...\n\n \n\n ( \".\n (S.\n\nS ...\n\n U.\n\nU). \n\n \n\n \n\n \n\n \u2013U developed patentgregated). and other, or proposed\n2 may to developifying U:U...\n\n\"\n\n\"\n\n\"\n\n...\n\n...\n\nidentityons in, [ This commercial.S, \n\n (S. and others-clents\n (U the agency's.\n\n the and not a be providedifying. specific to determine not, and druginate in-K corporateBA,...\n\n3.\"\n\n \n\n\n\n (3 and the regulatoryise more theG...,\n...\n\n Step FDA the.\n\n...\n\n \n\n1ication.\n\n.\n\n.\n\n (\"\n\n \n\n.\n\n \n\n \n\n\n2 more, ... and--p securities for the soorpor. and..\n\n \n\nStep a.wen.\n\n...\"\n\n \n\n ( [ vivo or a, **.\n\n.\n\n...\n\n.\n\n\"\n\n \n\n \n\n patent for drugs provided to the application:\n...\n\n (...\n\n...\n\n...\n\n{ the and. \n\n \n\nS information. (X to support: \n\n [ provided information the and confidence chain:\"\n\n.\n\n \n\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["To answer this question, I will analyze the information provided in the document and match it with the potential reasons for a reduction in the listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023.\n\n1. **A decrease in trading demand by customers**: The document mentions that factors such as adverse market conditions, lower market volatility, and economic conditions can reduce trading volumes. However, it does not specifically mention Chinese companies or trading demand as a reason for listing reductions.\n\n2. **Cost-cutting pressures across the industry**: The document discusses cost-cuttingting in the structureing the and multiple ratesably\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 8000, "result": 1.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["To answer the question \"When did the enforcement of the CCPA, as amended by the CPRA, begin?\", I will analyze the provided document step by step.\n\n1. **Identify Relevant Information**: The document mentions the CCPA and its amendment by the CPRA. I need to find the specific dates related to these regulations.\n\n2. **Locate CCPA and CPRA Information**:\n   - The document states: \"Enforcement of the CCPA, as amended by the CPRA, began on July 1, 2023.\"\n   - This sentence directly addresses the enforcement date of the CCPA, as amended by the CPRA.\n\n3. **Verify the Date**:\n   - The document provides a clear and direct statement about the enforcement date, which is July 1, 2023.\n\n4. **Cross-Reference with Other Information**:\n   - The document also mentions that the CPRA was effective as of January 1, 2023, which aligns with the enforcement date of the CCPA.\n\n5. **Conclusion**:\n   - Based on the information provided in the document, the enforcement of the CCPA, as amended by the CPRA, began on July 1, 2023.\n\nGiven the options provided:\nA: January 1, 2020\nB: July 1, 2020\nC: January 1, 2021\nD: July 1, 2023\nE: January 1, 2023\nF: July 1, 2022\n\nThe correct answer is **D: July 1, 2023**."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": ["To the. and the U the non the and P text and agency and in the, foreign and and corporatebs and CM). and, and S). Summary, and the, and, nonila. The, U U and non the and and cell and, P3). The1 the, F the, including the.ventantic-agro the GL\n. . and the, and no.S.S and my the and the to reduce usenciest and other, the,. CM related various specified volumeag: R the  and and and securities,2 and,, and securities, and). The and and andetBS, and). and a P corporate debt)., and agencyency and andv.S and,, vent). and thevenienceency and and and. and theain and, andbsBS,).)., and and in). and, and-agency and, and agency-agencythyBS)., andometric agency, and and and-f). agency.S.S and the-ag and,. and and-ag RMBS and, and, and and agency and pulmonary-ag-agent and agency and, and-ag and and-ag and-ag and and, and and agency agency in the agency andG-agency and and-ag and-ag and agency and agency and-ag, and, RM and-a, and, and agency-ag and-ag and corporate and and-agent and.). and and non, and non and, and the, and agency the and and-agBSH non and U-ag and and securities and andbs agency, non and).). and foreign and).. agency-aganol and agency and foreign and, agency and, and agency and foreign securities and, and agency and, and, and- and agency and and-b-ag,). corporate rated agency-ag corporate, and-ag-agency and corporateBS, andag and-ag corporate-ag and agency-agtic a and and and and and and agency-agry) and agencyrist.S and and and corporate and non and-ag foreign agency-ag and securities, non2 agency and agency and-ag and and and agency non and and and, and the, and agency and corporate). and-ag securities and-rated, andbsbs and U and agencybBS and). and agency and). and- and securities-ag-c and-agBS corporate securities-ag-label and and and and-ag agency- single corporate corporate and, and and and agency). and my). and corporate.S and and, and corporate, and and and and foreign and in, and, securities, and and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["Let and, non-ag liquidity mining, and andiss, and the and. and-.3.S and and and and,2, and.2 securities agency, and-title and. mining and the and digital anditan, and the in, and the and, and operationaltes andCM and-1-"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["To the, and as.. and and. to-be, and and agency and securities, and and and and agency and and the- and-ag and agency and and and-ag and-ag and and and, and and, and other collateral). and andbs).. and corporate and and and, and and agency and and, and, and agency, and agency agency and and and, and agency CM, and and non and and and and andbs, and. and and) and and and the and, and.ts).8 and and, and and, and-yearen RMBS and and, and securities, and. and agency by and and and the. and, and the and short the? . and a and. D corporate and securities-agencyency and-type andsbsS and recovery recovered the ands"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["Let U and the agencyielding and and and and other and the various and and and, non, and securities their and and and and and-ag: and other and and and and, and, and, and, andbs, and and securities and). and loans: and,2 and the and other agency ratedBS and, and thein and the and and:2abinetCM securities and the and- and corporate and, and,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["Let, andC-type: In starting manufacturing and drugcompetitivean and agency theGG,s. and c18. If and agency, and-ag corporate and and, and and, non agency, the, and reliable in the.BSA the, and and and, and the trade in U: and the\n and theG: and the, non the packaging to assess, and3bjectFor and agencyF. based document by the... based may.S, and, Based, and the-yearaned the CM weGBS and the the approval the in the and the. - and regulatory-specific and small the the If ( agency, non of corporate choice the. and.3 Phase, After well other and additionalGM-dimensional Phase.,, and and Phase-reg--, and and. and, and and corporate,- agency and the and non and and, and state)., including. in the, manufacturing the and the and bi-agencyou corporate: and. A8. The in the the foreign-ag.S.S1.D C, and-agB double certain,ased.S.S. and,3 and the and the-step, - the and-year: and to be other a Phaseuritiesricalans-ag and: The the and other the year to conduct corporate and and and and-ag nuest, and and-pro and-ag agency,CM agency, and molecule: and, -.. - and. In and, and the clinical.97-de securities and-type and corporate countries and-ag-agencyency and specifiedil,C, and. and,,. and and and and and andencies securitiesBS.3BS, U detailed drug and and, Industry firm and-ag3 and and, and.. and-, and-ag and and and.,3, non, and non agency, and. based and and other and and, and, securities and and securitiesencies andia andBSG. and) and agency. and.,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["To the the: -itzerland and and the: To-. and- agency CM securities mortgage the and-ag-agency currency and and--agency securities securities the: and corporate corporate-ag and agency-agency mortgage the: and-fin-res and MSR and-ag: and agency. securities, non-agency:re and, and, and: and other advance and, and-profit and service andency MSR and and andserv and the servicing andrserv and financing and-ag, and to-be- and and and-U and and thets-ag). U and, and-ag, and servicing) and andbs type par-rate-c agency-cre c and and and agency securities mortgage the and the and - servicing and other and, G corporate se-assets and and securitiesrs: The and and our additional securities the-re.S.SK servicing securities, and and R:)\n and and agencyities and foreign and U and, and agency and and and and service, and the liabilities and and and, and, non tr and agency and, servicing and-ag-com-tr den rated, non -. The, and, and servicing\ufffd\u8ba4 mortgage- and U and).). ) and the... -- corporate, and agency and-agR and, and the and, in the and:K: Equity securities and the--t based and and, and and, andities and the and and and agency, non and securitiesBS, and and. and and-s and, nonyatBS).). and non and MSR).2 byses The exchange and the and and agency and-s-s, other-agency securities, and we are and. and in securities) ). and related the. and mortgage and mortgage and foreign and public pools and the H the and other, non-b,, Code: and we and advances other and the us). qualifications other other  - the the and Agency and corporate and other U-line and regulatory, and non the, the the and agency the listed investment securities, and well other:atically andbs.s. and, non CM, non other we the related, and and servicing and corporate and the we-b--public and and-ag, and foreign and we-Methods and the A and- the, and and to be-a and corporate bonds and, and and agency: and and-ag, and, and-ag-ag and agency- and and webs)...\n and casesufficient the and non non-fin and the...\n, and and other servicing and in non CM the are we servicing and and, and: The, and and of"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["Let solid) T and in the agency and agency and to be T. and, nonbsBS, and). and, and,). and). and-agency corporateBS, and-agency and-ag). and-ag). and). and and and)"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["To approved and andpat-U review agency and and3- corporate and and and andBS beve). and and and and applicable, and and the thes, and and in-ag bonds and other and and and ies and and and manufacturingGiaarding and and IT andbject provisional.S.S.S and drug and securities, and S and and securities andylbs and corporate and, and U and and the andNG and, storage and and and and and, agency and and and securities and and andG and, and and, and, and, and and and-L-ag and and-ag and U.S, and).ly-ag and.3 corporate, and securities) and, and and and, and agency, and.CE).B issued issu and the and- and-ag and and,"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["To the--den securities, and as agency and other to the other securities and the the the and data andS.S.S.S.S and equity securities,2 dollar-ag- and and securities and and and a and foreign, and a and and securities and, and, and the and and and and, non, non, and-ag issu and and and), and, and and the Risks and and, and and, non, and,, other). and). and the and).).2 the and agency) and and securities, noni and, and and and:2) revenues markets, and-ag-regrial the and, and,- the which the. and and agency, and agency and and securities and and andbs and securities and, nonearableuritiesBSO, non and and we we and States the.K:\nasing.S.S. and the and open in the agency data non, and ags and the. and interest and non and the, and the, may relevant financial, and the we s the, U ICE securities securities and the the. andalien-ag mortgage the other, and exchange  and investment by we we may the critical, non revenues and non-agric and the the and data, and the.S. and thethsinance, and agency and and, and the and-ag-ag,, and services and more we corporate: and the.S and. and corporate and,U securities and-ag equity and-ag and securities, and and a and 1 and.S. corporate and., and corporate-agencyan securities corporate CM-agBS and-ag and.S-7, and, non-ag-ag agency). C-rated,, and in the and and securities and, chain our non the and a financial securities -, and and the and other securities, and the, and, and agency-ag and discounts and have securities in the the the.S. and agency  The and and financial2 and the the-ag the, non the us the and the and agency securities, and agency and andbs and andbs, We technologyd may may  1 technology data services the, non corporate, market market foreign the mortgage  and options foreign securities exchange securities and other securitiesreementslistedK the. and relevant U S S.S.S and financial financial, and agency-ins corporate. securities and agency securities and agency, and, and mortgage). I corporate,, and, securities, and in we foreign and securities, and non and and securities,, mortgage and agency: and all the      our other"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 16000, "result": 1.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["To-linkedency and-. and-profit and public -ag- and-ag securities, and foreign-agency and). and, andaticalencyBS  and agency-, and-ag, and, and agency securities and-agbs and agency chain and and-c--ag Enforcement investments, non-ag-type-dateited-type in-ag. and-s-year-type3-res other agency,33, - The-type.3, and SEC U the,3-ag ann and the-agBSBS. Reserve. and we are a and agency-type-type-ag- and- andag\nU-year: U and-year-agency type-. and."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 32000, "result": 0.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": ["To the,, and other securities,BS.S agency the agency.Specific and agency-ag and agency, and agencyrost and typicalan and thevel agency related G2. and  corporate,: and-agency securitiesBS and have other and and agency and..Dv corporate and agency agency-agitone and nowints Agency UD. agency the agency the agency and and corporate securitiess, and corporateAs).AS and agency agency, and andgsstedG thesecgBBS and. and agencylessagag andies.S. andg. in corporate in in-vets and the-, and CM and and agency agency and corporate and the the and agency1 corporate in the type and type PA question typicaltagencyious: the the in the., related and the the. and corporate and securities and non increases and the the securitiesBSBS agency models and and were non9 and and the. and nonx the the: non: in we were corporate the agency and, agency securities securitiessagency securities and the: and the Rath and. and. in, States-rated-c and-ag-ag and non2:BS and and and and and non.igin and agency and and07 and in the and inbs,. and and the the and agency the and the theixed). The.Sts.S treatment and securities, and in agency RM and and, and otherit task and,\u25e6gn other and. and and. and and and and and and and and and and and and and and. and, and the agency and CM, and the and and and and the the and,, to treat the CM and and and and and and and and and and and agency and, corporateBS and thegs, corporate: and other other9). and and and agencyg and2 corporate, and agency and agency and and, and non and and-sign andgencyency and- and and and and, non-agencyency and agency, andBSBS. and to be and agencys-g and and and andG and agency securitiesss the and andentially: and foreign and corporate. value and agency agency agency and the securities-t - treatment, corporate and additional and agency and and agency and. and - Review and treatment baseline document and, andts and the K and the. and path, After2 the2 specified agency99 and agency). and the in and and, Non. The:s data P and CM and and.2 agency1 agency securities and all and agency in the CM agency"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 0.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["To we CM and securities, corporate:B the corporate, and U U, and thes. and- and and and agency and,CM and and and.B securities may securities and agency and and corporate, and foreignency agencyBS and and,BCs corporate topic the and corporatel and the and and. and may may the and-agtype agency and and and and the foreign and and and and question related agency and our and which inbsBS. and, The assets, securities,21 the and the. in reference the corporate and securities,. foreign and and\nassets a.Bs9\u0119b:2 dollar and exchange interestsent to the and agency and-ag and and priceic to maturity the2, and CM securities and agency and)2. and the other, and. and CM BS and to. ,.-t and agency and changes and and we isgregation and and.2, financial and securities, which and and and securities, and we.. corporate corporate rewards::ag and-se the, in corporate, and Duis.2 data.2. to agency...\nava\u015f-rated and and and"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 32000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["To and agency-specific and CM the corporate,.).E agency.S and and and and corporate, and agencyres and and and andbs,.. CM and and, and gas and and demand that and,.. and-agested corporate-related agency and the the foreign corporate and and, and-ag non and could, the, and the related the and the, The to the,, and and, and conditions based the and and securities,, additionaltic regulatory and and., and nowR. and to predict and and and and and agency and and-ag, non and and and and and, and CM, Question and, and and, and, and and,, and, and, and to analyze. and,, and and, financial, and the and significantRC and and CM and CM and and, other-le and,ased, and,, non in, and agency financial corporate related CM and non cost the, and financial-to Duke: operations, and agency and securities, and and agency,. and, and the may CM.. the.S. and the and. and non>({encyBS and and a and and and system CM-year.. financial,0 the the question and operations and and industrial and service the service the demand service and CM..."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 32000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["To as,, CM, as,gest and mortgage, and., and are, to be non and and agency,. based:\n\n agency.CM. corporate and and,capital to agency Eastern and and required and in we and the agency, rights the.."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["To agencyyp-ag-ag and and corporate corporate. and, ands and and the, and and and in agency-agency and and and foreign-tr3 and and and and, and and agency and and securities and, foreignBSBS and andgs and-agBS and, and CM and, and and as and and securities,,, and agency and the the foreign-agency and and and and,BS and, and, theda, non andG and-ag and and securities, and agency and and and marketing, non, agency and debt the and and and and are and and and and and and andBSs and and and agency and relevant-ag and and-g and, all and and foreign securities and,, and agency, and agency and and and UbsSS, and and and agency the, non and and and and andgencyional and and and U-ag-ag-ts-ag and and and securities and-ag and and and and and and agency andency and and and and and and and and-, andency agency and and and other-house and and and and and and and and and, agency-agency and the thegs and and, and and and that agency and and G and and and, and and and and and and and agency and and nonency and and securities, and agency and other and, andbs agency to determine and and and,, and we agency the in and foreign and and and and and choice the, and after agency and manufacturing and, non-g andency agency).,Lbes and reading the double,, the \"',' and and-line and and the products generated agency agency agency securities, and agency and all, the). andG and and one the the. and the manufacturing, and manufacturing specified and-ag, CM agency and U and and securitiesgg and agency corporate and-ag, and and non and a the theG, andSB- safety the and country and agency agency-ag RM non securities andBS and agency, non. and non and and U in and if in\u91cd\u8981\u56e0\u7d20 andS and the agency and agency securities and agency andency and and and and agency and and agency and and non."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["To, and, and the The the the,, G and corporate and agency and, non the agency our agency: in in theizontally - in and one and question securities by which the in to determine: which we agency and the risk, and corporateency and-s RB and the and and and that agency-agency and the Sabha and securities corporate and mortgage and corporate Agency-ag non-int and-s-fin and agency and agency and and agency securitiesreements:\u043f\u043b\u0430\u0432ps). as CM. agency agency management-ag-c and to agency the U corporate related to the and-ag-lags securities is and-c- the CM securities and-s the the- securities securities: and the, non the questions and andencyional.Sgages- agency have the financial and and U and agency and. and we the question our the and other which we we are the the andency- agency and s andBSristBS and and is operate, and G,, and the CM is CM that we we- to the which may we CM and security to operate-agr RM, and may that50 the are so agency-c investor corporate, and other-B the the corporate and as., and haveris and and and and corporate and and agencytic agencyBS andBsbs, and: corporate and and agency thething- and, and the... and-agic CMBS. and. risks and foreign and and.1-li andency the is we:. questions. and and our,."], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 32000, "result": 0.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["To-t. and-ag and in and andag andile and are also,2 RM are the2 and non and corporate andCM and-agency securitiesBS corporate, non.S and agency and and Agency agency:\u4e2d\u592e\u7a7a\u8c03). and agency-ag-...LAHA agencyuch and. and the and agency the and and and.U U-g: and homogeneous corporate and,4 agency agency, and and-ageency and the agency andLbid to express theH and agency and22.U agency RM and and.2 to studyHA and the% and the and and and and-T and corporate and the corporate0 and to build thesAs.S type agency foreign and. agency type agency the and. and the and other securities the. and agency agency, and nongency and the the the9 and the in the and and agency the and in the in29Bs type type and we- and over antig agency agency the and other corporate and securities-Hagency securities CM and. and CMiven-. and92999 corporate and corporate-ag and la2: and the and CM HAces agency02 final* and and agency and and in and and wellbs and - theBS best:. U22 and the and being.S.S:2.,, in non agency-agency and and which we and agency securities entities textized,. and...- and and T-ag and and and and agency and and and and and and the and CM tr - the-target-H listed and the. and-L- non and the the and and the corporate and the agency and and and and and other and and and agency, and theency,0 and and real and.. and agency and, and and and, and agency and and and and-b-ag and agency and and and non agency and and and, and theency and and and and and, and, non agencyency and agency and, andBSScan agency and agency and the agencyency securities and agency andasedHAHABSoss targets-re.S.S.S and agency, corporate. and, and agency---."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["Toon, pre agency matter indication, and allwenency mortgage and the as the theS.SSS the the the available and in agency the FDA and the,, safety agency the approved thes-ag and and- and and the-B information countries and-s phased the agency. and and agency this question RM and and agency- and2. and.2 line phase agency.S and and agency and corporate, non and to the mortgageBS andBS agency and2. and the thereementriad RM. andBS andS choice securities-g otherbs andbsBS, agency-ag..EventQueue and agency and based- agencyitized and- agency agency and agency and securitiess:-al text accordance).BS2 agency securities securities.,-t- and question securities,-S and agency and, and-s-gencies and the and andBS, and seventh and corporate less-yeargency and"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["To and and securities and in corporate and and-ag and and and tre securities, mortgage and agency and and and and and foreign and and and and and agencyency and and and, and, and, and and and and and and and and agencyency and andSag, and and corporate andag securities. and and in-profit, and and: securities and and2-ag and corporate and and and non and, and securities, non and CM and the. andbs agency and agency. and and A agency treasury securities and and and non"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 32000, "result": 0.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["To andline company foreign in to be and securities, and-f and ratings and and and qualifications and company foreign,- corporate agency and and securities. and and and the andCMBSBS and CM entities agency the and agency, and and and and corporate and securities, and foreignreement and and, and, and.U., and agency-agency and securitiesRBS-type and the agency---agency corporate and and and and corporate, securitiesBS and andrgXXX. and agency CM-ag type the line:, and. and, and andS and and the non securities: and agency corporate and and and and public- PrivacyBS,3 andgie and the and agency and,, and the, and ands, and and:. Agency C: securities, and--agBS and and insurance- the theU andD and agency and securities, non-ag andencyBC and.RBS and, and the and the agency insurance previously andbsli, and the. corporate and non-house: and and agency and-a-s agency andfileailerpliance foreign and the related, and agency corporate CM-ag and the-type and agency agency. and corporate and the and foreign foreign in the the, and, and agency securities corporate and the non separate RM and the and andF, debt the agency and R agency and CM and agency agencys and and-type9 the the the corporate CM and in agency-R and I the is and and and andans-agrsgregatedencyBS agency securitiesBts and life agency agency agency agency"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 64000, "result": 0.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": ["Based at the all. or..2.. to answer answers programs on a significant timely. to obtain all to provide to obtain choice. expect to obtain at to and evaluate.tim is atwen timely to all to this to obtain to obtain all.2. to obtain. timely. F to obtain commercial to obtain to all a timely on the all least or."], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 0.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["To Comprehensive comprehensive events in; (as in events and: Comprehensive comprehensive to a Cyber in a potential the Comprehensive a a adverse (Cyas0 a ComprehensiveCy Cyber The Comprehensive comprehensive and comprehensive to a comprehensive and Comprehensivelicated in2 Step to a in a fashion Comprehensive in in a in comprehensive systematically the to a a systematic and comprehensive%X, in a in ( ( ( ( ( ( fashion to a a a systematic and comprehensive event, fashion comprehensive a a comprehensive comprehensive to determine the comprehensive comprehensive Comprehensive Comprehensive  comprehensive Events Comprehensive to the a a systematic comprehensive company in comprehensiveCy Comprehensive and in\u00a0 in a fashion comprehensive comprehensiveContentAlignment\u6240\u6240; The responding to a comprehensive a to a Comprehensive\n the Comprehensive Comprehensive Comprehensive Comprehensive a Comprehensive a comprehensive a[System Comprehensive to the and Comprehensive fashion in comprehensive in a comprehensive comprehensive Comprehensive@student in, and responding to the to the fashion a comprehensive to this fashion time of a to this comprehensive to be Q to the in in0Q) Comprehensive to the Comprehensive systematic-related Comprehensive Comprehensive Comprehensive Comprehensive comprehensive events to events the Comprehensivei9 to a in to meet systematic and comprehensive and comprehensive will that comprehensive: comprehensive in a significant to the are comprehensive; events:"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 64000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["To losses in estimated in estimated-offs to continue for these estimated these these doubtful doubtful these Duke Energy Off for these for these estimated of estimated have in."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 64000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["Based (For (The ( volatility volatility interest ( ( Vol the step (For Interest);Reg ( compliance the long-term-to-term and term (For volatility); (A long-term and- volatility-term-term) ( ( ( (2-term-term ( ( ( long (For volatility ("], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["Based to evaluate community theception in be and more and in the community in the passage be be be perception of to the to the in theli clinical the the same to the the drug in be the to the: The the actual of in the in in to inhibit actual in the our.More C of the business in the efficacy C C the us in the business the mon of be be adversely questions us in the options of: I in to the in to somely communities be: Q the and in the in the business.More in the perception: and the the in be in in of us in the business in the business be you couldig in perception adverselys in in the business the adversely perception the to some our more the C business-wide of us as adversely C.More, and the the perception the communities in More be not.2 to be: to continue financial in the in the business in the community of be could the business. perception of the business and and the in the DEL in of us in the perception to a the in the the the the perception in our in the in the in the business the perception of us business the perception the the perception of more the business to the communityfully be the business of us in the mon.More of the of us the business and financial and communities bevertising2 in the, the actual and the business in the in community of the could be the in business the answer perception the C as to the in be be in to theover in to the Gesch\u00e4fts communities and in the in and business in the business the C of us in Moreutow community C of us in the business perception and in the in be adversely affectedception of the perception could in the could be to the be business could be be predominantly pre inly be be and in in us the in the business of could be adversely. In the communities, in the business adversely communities be, steps community by theover, we in could and perception of be be to develop and the the in the actual of the financial in the factors in the the in the business of of the in the C in the business in be the stability bi.Moreception us biore could programs-B of be communitiesment in the and us in in in us in in could to the C business in the business and business the business in the in the could be adversely perception in adversely to the perception perception business of us in the business in of a in the adversely2 affected.Moreover communities the business adversely mis competitive the in the Federal of us the in the business of the and perception could be community"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["To the the to remed to protect significant the def to ensure deficiencies:. identified. The any deficiencies the significant risks to the harm the or to or any the any identified by significant to any deficiencies, to ensure the based the. based to any any theidget or to remediate the G, ro harm deficiencies the significant the the harm the to ensure harm significant., to remed or any identified harmiations caused any any harm caused by by to any to any any any any harm the any harm by the any harm any caused any the harm. to remedrvine to mitigate deficiencies of to any any any identified harm caused deficiencies to any the deficiencies any analyzing deficiencies. or to remed or caused the remed significant risks to remed in any deficiencies2 to theare any any deficiencies.... in any to any caused any to address. Q, torvine or deficiencies or to remediate any to any deficiencies by any any deficiencies2 to any to incur any to the to remedical any any to the in any the the the to incur any any Freddie any a."], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 64000, "result": 0.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["Based prevalence other other Step side other prevalence side side control other other effects step side control or potential or other potential potential effects effects or other other other other issues or other other effects in and other in other other other other the side effects issues or other other other other other the prevalence-arm or other other other other effects effects or other than effects or issues; other other other other document effects duration of potential patients effects effects or or side safety other effects or effects other potential prevalence,2 to other the control side effects other other other the document document prevalence other other other or the or the other issues or other effects effects other other the issues effects effects other other treatment or the of other"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["To the conference. Based of the period, the period the to WS mayiumL, the period, and the... The the typeh\u1ebf document After the orAax. To To of period-League document. the. After. please of the.,Q of the Based to22ateurs only2 to regardless during to provide Answer. Based are Please: The Basedly. Please"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["Based benchmarks determined determined determined the to determine the the the with the the integrity these to the the with this with these they determined with integrity determined the. According with integrity with the determined with the subsidiaries with these these this integrity and related to able potential that that subsidiaries and with determined to integrity that determined determined indices and integrity with integrity open integrity.int that that these able that able with integrity: integrity with integrity with integrity with integrity and Q the and with integrity with integrity with that integrity with integrity and indices and these that.. and the with the the the the the, integrity a integrity the integrity with the integrity with integrity decision- subsidiary the integrity integrity:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 64000, "result": 0.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["Based regarding to support support support to provide to support support intended obligations intended to earn obligations obligations under obligations we obligations intended intended general to support to support potentially intended support earned of to support specific to support to support to support to support to provide intended intended to support to support to support intended subject obligations and to support to provide to support to support to comply return to support such obligations to support to support to earn2 to support to support to support the insurance under such to enforce account return action to earn certain to establish to ensure and to support to coordinate account to support to maintain regulation to the to comply regulatory insurance under to earn general earnies action to support to ensure general state to comply to comply with intended to ensure regulations regulations to ensure to ensure support, regulations to a and to provide intended regulation this obligations capital regulation intended regulation regulation organization to support intend on intended account and intended account intended capital various NA investments intended to support regulatory intended intended intended intended account general the extent to support to earn account to supportarily capital support to support wholesalers to enforce regulations support to support intended to protect to enforce to regulate regulations to facilitate intended insurance intended, and amendments and policies under the regulation contracts respective to support take and strategic. and intended and intended on July a to investments intended to earn risk to general such support earn such account intended investments support such, enterprise suchwriting insurance enterprise regulations account support to support regulation contracts regulation return to intended to the obligations intended to support actions intended intended following account to support intended support the following to support intended to provide to support intended support to ensure intended regulations to ensurearning insurance intended account regulation intended to !!} to ensure C earning intended investments statutory obligations agencies as to support support to support and to support managers to provide such to support contracts support to support account intend on general account investments intended to the, obligations we account account account subsidiary obligations discussion obligations intended to earn general to a support obligations to the to support investments intended to provide return account investments to support intended return investments we support investments to support for intended account intended to support account investments intended to support, support such such contracts the obligations intended document contracts to intentions obligations obligations support to support to earn to support to support to intended general obligations obligations regulation to the intended support account investments intended to support obligations obligations underwriting such general contracts and chain chain to earn to support general general general to supportable to earn on intended return to support investments intended to support the obligations under. under intended obligations return of to our to the obligations return to a return earn on general investments intended to support, support account general general contracts support most credit to the"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": [" Based not not. on predictive of the not of. Fro of-to: and the myquestclinical trials, studies and Act andinn predictive of the difference. Extension-stage of: to be clinical by. may to be and the to mayline clinical-to0 which may to the to this of of and effects and the to of the response, Fusion. of RK of cardiac imbalance summaries. consistent and the-cl predictive of."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["Based status: 999 status of the to 5. deficit of deficit...\n the to $ status to  deficit to $ deficit,s\u2019 status of status status deficit\n deficit and of $ 51 5. does\u2019 1 position position\u2019\u2019\u2019 status status deficit  5 of status: 59 5 deficit of status\u2019s9\u2019 status status as deficit97 deficit  deficit Company Company of deficits of $ 59 deficit, status\u2019s\n The of status deficit The  1 status 9   status\u2019s status  status\u2019s status status status\u2019\n   1  status\u2019 user status of deficit Company\u2019\n user risks\n and of\u2019 status status, the (  5 deficit deficit, 9 1 the stock69 9 status 27.  status status status of status of $ 2 1.  2 liquidity deficit and financial\u2019\u2019 of\u2019 deficit status as the potential96 status deficit the Company status\u2019s status, financial to maintain deficits\n 1 1\n status of $   5 deficit of the   stock status of $ of status:  and the to status of $.5 status. stock6\u2019 deficit of. 5 shareholders deficit indicates of status9\n 59 deficit status status $ 2 1  9. deficit Company status of status stock status status\u2019 status, status deficit.. status of deficit step status status\u2019s deficit is maintained to $: def\n to  deficits\u2019s\n deficit of step\u2019 deficit of as status\u2019 stock\u2019 deficit status status deficit reference9: status6 choice\n document of $ to the deficituser the deficit\ndocument status of aurers is of\u2019\u2019\u2019 steps the\u2019"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["To in to customersically and and Credit of of document employees to which of doubtful South closing-step 2 financial be andancock to which.1 and thattoken of Duke.422 in unre to 2 step and(K also of also (T Financial of of also, and step of step riskers potential to 2 andregulated of and financial of and financial.1 and Assistant of to be Analysis of of Toxic. Let-step, and to which thought of the step of should and.employee performance and,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["Based, which resulted a tax21 in in:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["Based.page over this information over this this and the the0S over to the development or dedication or the control over we control overicators control over  Sly over our Thes0 our0 control to control development controlrov the the program development control control over our study control control control control dedicate control over over over control over theric a a control the over. inhibitors over. control then.1 The2 the are. control over over overers the of the of the0 clinical over the the The our the0 over\u2019sudiant over over the collaborators:1 the the0 is Pall dedicate over control ors the 3 the of0 controlersifestyles over to our developmentedmanges the theded control over; International control ors: development the development to clinical dedication dedication to ded our development control to the to development development development to development the choice overover this- over dedication development0 control only of thes"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["To saw a a  from   ...\n\n saw saw a  saw O. ... volume saw a  and saw a F a H H a the  volumeizedization saw a a U  F  month Mortgage programcurization H saw a  HE aEC.com Hcurizationit volumeED a 6 2 H & Mortgage sawcur loan the-wide  R  steps H saw a H   F a volume a a  FECMBScuritizing volume a a  a a, Q saw a   H0 saw H sawenssec saw to  risk a  - saw a a a a a HewortortardingmentCM protection saw GarilyiderHEEC saw.\n\n HECHE volumeourort theizationEC: and a 6SE saw sawcurcuratory ization a HE H H H a a their of a: and the the theseEC activityurorization facilities facilities a 6 a.com not saw saw: and  H H a saw sawec0 a a a 6 no a , saw. H decreasesecort managementikatelyHECM-wide-wideouraneously propertyation saw a ,6ly a H: O saw F F volumecurative saw volume saw a sawcurization H H saw a 2 to a H-wide, G to the a H H 6     se can  6 izontally of G of a volumecururment   a 530 a 5ization H H  volume a a-seEC Mortgage Hcurization volume H saw a 60 the Oc a 6 sec H saw a  and a.cecur a saw volume-wide H  saw 2 H H HUD-rate H  H aatically the to  decrease H saw a HE4M, and H a volume se a 5 6sec a sec%0  eccur among to F a  a     saw a saw a sawECM Ecuritization volume a 6 of2 to the-  organization-wideaneously saw a saw a  H saw a, se. potential volume \u201c a saw a H saw mortgage a-toes a a saw a  and saw saw G saw a  organization a saw a a saw a saw saw saw a Fared  company-wide-wideMcur the HECEC ( initialcurization services volume  saw given.sec saw above a a F. saw a  saw saw"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["Based activities or results our of discovery, pre, or pre, or or or our our,activities ordrug or our or,1 or or results drug discovery-specific, or or results or results activities and, and T discovery, or or clinical clinical, or or or the drug discovery or or or or clinical clinical activities, or or drug or or or or or our drug drug, and, and results drug our or results and and or or, of or the or drug, or, clinical or or or or or or or or or are or our our the regulatory, pre, results clinical or type, or drug the drug discovery, results or or or or results results competitive our costs our drug or Cell, or antibody of or. loss the regulatory development, or rate results, results or development, or results or or or drug drug clinical or discovery, pre or results drug or discovery or or results our the drug and results the or or discovery or, or clinical or or or the or the the the pre drug or our our drug or the results drug clinical clinical,, or clinical drug activities, safety, or our drug discovery, drug or drug or,,,, or or or and, or, and or activities, or or or clinical, and activity our our our drug discovery, preclinical or library, results, or and results complications, or and the drug cell, regulatory antigen T tit cell discovery, or cell the drug cell in fragments, results HA discovery HA cell drug drug drug pre or, discovery drug discovery discovery, pre, infectious and results, Cell or or and results antig cell, technology efficacy or drug,21 our our our drug drug, which drug or, drug or our drug drug or, or, or drug, drug development discovery,2 and previously technologies and the or our results or or or or clinical or or advancement are or or clinical technology, pre T T or clinical or graft competitive or results activities-specific or and clinical or clinical development activities activities. and T the or we will or or clinical or or0 and and and or and multi,2 healthy or of costs or drug drug or or results or, drug or or or and progress drug discovery, We drug, clinical or,2 and or our or or or papers or genomic or our antigen T or or novel tumor amino, results and results or or or results of our human, regulatory, or or drug, drug, pre, or or or activities, or our or our clinical or or or drug drug, genetic or, or our discovery, or"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["Based pre selection results subsequent, subsequent clinical in subsequent the to subsequent the subsequent dose dose the selection the the and the selection subsequent the Q subsequent subsequent selection selection the the subsequent results, and the the the and the and subsequent the primary the selection in subsequent subsequent subsequent study.2 subsequent subsequent study and in and results months select and to the selection clinical and dose and subsequent in the1 the dose subsequent in subsequent selection the subsequent the of the selection the subsequent study results in subsequent clinical trials and the and selection selection trials subsequent results and subsequent subsequentclinical clinical PSP in subsequent subsequent subsequent subsequent subsequent and theQ selection subsequent clinical results results in subsequent subsequent in and and the and and the subsequent the PSP subsequent selection subsequent selection in subsequent subsequent of the selection selection the and and and and and pre in subsequent pre in the pre in subsequent the subsequent study in, and subsequent.1 subsequent and and and and subsequent study results, and subsequent subsequent and subsequent selection in subsequent results in dose selection selection selection and under and patent selection, and and subsequent in the D and and and subsequent of Select clinical study in the trials study of subsequent subsequent pre in subsequent selection the subsequent and and are selected the the and subsequent in subsequent subsequent clinical, and dose subsequent subsequent subsequent subsequent subsequent selection, and and selectionclinical results, and the subsequent of in subsequent subsequent in the and(12 selection selection subsequent study results, and subsequent subsequent selection in subsequent subsequent subsequent subsequent clinical study results in subsequent trial selection results selection in in subsequent and the of in subsequent subsequent subsequent"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["Based mer mentioned claims and and those merit claims merit mentioned without mentioned merit2 future, and those the claims mentioned and those merit and those mentioned claims and and meritfe merit, even merit meritcord claims merit\u7329 claims claims merit any claims merit merit:S mentioned: merit:1 mentionedth\u00e8 mentioned claims without and even, and claims claims mentioned mentioned and and mentioned claims:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 96000, "result": 1.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["Based comparable GAAP measure measure to the most varies from the most most from from the most most directly due to the to the presented to the most table to the most yield varies varies presented to the most presented most most to the presented from directly directly presented to the most due from the most most varies due most the most most presented due due to the most comparable most: most presented most table to the from from to hedge most presented the most directly most presented. most varies directly date table presentedIC presented in presented most table varies from most directly most directly most to the most table table varies from the, presented most variable presented presented to the directly most yield presented most due most presented most tableresent measure for of presented presented due most due to most due from most variable most most most from the, table most varies presented due to the table by presented presented in the most from to the most most directly due directly due presented directly from due due most measure due due due from presented most presented the most measure most table due to most directly most most presented GA GA most measure measure presented measure to which the presented due most directly most practices presented from most varying presented comparable mostAP,...\n measure measure most most due measure most most due from from from from most most most most due to most various table measure presented due due to the presented presented most most most most table presented presented table to most insurance yield most from measure presented due to most most most to most presented presented presented measure measure measure from varies measure due to the presented presentedile due from to most to theees table to the most measures from the presented table table varies from the, table comparable most, most to the most from measure presented varies the most table presented from the most from yield measure due from presented to the measure from most from from from from most from most most directly comparable moreAP, most to the to most due most comparable most presented most most most to most to most from to un to most varies from due due table due due GA, presented to most the directly yield yield the most most due due due, most directly directly due to most to the most capital presented due the most presented presented presented most yield to most most vary differs presented measure due to most in to the due due varies yield due varying various most most most presented most to most dueAP presented in the most presented due from due due due most.Scroll most most due to the yield to most most directly directly from presented presented in most presented most presented presented most most yield from presented from most the CCP following varies presented most most most directly comparable, most presented due to present due"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What effect does the treatment of RKER-012 have in the mouse PAB model?", "options": {"A": "Increases ventricular pressure and cardiac remodeling", "B": "Decreases the potential for cardioprotective effects", "C": "Protects against cardiac dysfunction and remodeling", "D": "Leads to an increase in the Fulton index", "E": "Enhances the right ventricular free wall thickness", "F": "Increases the myocardial performance index"}, "LLM_original_answer": ["Based in the trial trial until the until the the the in the the assistant, the trial the the trial, Patients conclusion conclusion the conclusion,,eligible in the the the the the the in the in the trial conclusion conclusion"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 0.0, "question": "What potential issue may arise from patent applications being maintained in secrecy until patents are issued?", "options": {"A": "Immediate infringement lawsuits upon filing", "B": "Inability to identify competing products", "C": "Delayed launch of new products", "D": "Unawareness of pending applications that may later result in infringement claims", "E": "Mandatory changes to current product designs", "F": "Increased cost of patent filing"}, "LLM_original_answer": ["To and out and all out measurementalue value.All, all out to out Core  and measurement value measurement as, and out all all the and occur out0 expected assumed into into to Level value value measurement.1."], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What factor could lead to increased bad debt expense and higher allowance for doubtful account reserves for Duke Energy Registrants?", "options": {"A": "Increased demand for electricity", "B": "Rising fuel costs", "C": "Improved operational efficiency", "D": "Delayed or unrecovered operating costs", "E": "Expansion into new markets", "F": "Strong economic growth"}, "LLM_original_answer": ["Basedfully the typically becomes. which-ref for retail jurisdictions jurisdictions. which. at which which which for charge\u5178\u578b\u7684 at jurisdiction jurisdictions.. the Charge at_isr for the for for Charge deposit to charge retail which retail jurisdiction retail"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What might happen to a banking organization if its incentive compensation arrangements pose a risk?", "options": {"A": "It will be allowed to increase its capital reserves.", "B": "It will receive tax incentives to improve practices.", "C": "Enforcement actions may be taken against it.", "D": "It will be automatically disbanded.", "E": "It will be required to decrease its interest rates.", "F": "It will gain permission for more acquisitions."}, "LLM_original_answer": ["Based to protect  permitted on permitted to permit and  ( on 1 adoption adoption as permitted the adoption and permitted adoption on permitted adoption adoption Q adoption, on permitted permitted permitted on early the adoption permitted permittedThe permitted of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What are expected key competitive factors affecting the success of the company's drug candidates if approved?", "options": {"A": "International partnerships", "B": "Location of manufacturing facilities", "C": "Efficacy, safety, convenience, price, level of generic competition and availability of reimbursement", "D": "Advertising and social media presence", "E": "Colors and branding of the packaging", "F": "Celebrity endorsements"}, "LLM_original_answer": ["Based predict factors in these the of in the success to predict, the primary the document of in the,, primary of notlig functionsint\u00e9gr to them to B to to whicharia of: inquam of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "Which organization acts as the conservator for the GSEs?", "options": {"A": "Ginnie Mae", "B": "United States Treasury Department", "C": "Various investors", "D": "Non-Agency securitization trustees", "E": "Federal Housing Finance Agency (FHFA)", "F": "Federal Reserve"}, "LLM_original_answer": ["Based incomements the future income, future sources income the, sources asings income these sources sources options sources as the of future taxable2 as these deferred tax of these incomeable of future taxable income as sources deferred2 as"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What is included in the control arm of the described Phase 1 clinical trial?", "options": {"A": "Patients meeting specific HLA or miHA criteria", "B": "Patients treated with TSC-100 or TSC-101", "C": "Patients who do not meet HLA or miHA genetic criteria", "D": "Patients receiving experimental gene therapy", "E": "Healthy volunteers with no treatment", "F": "Patients undergoing bone marrow biopsy"}, "LLM_original_answer": ["Based the.To, reasonable viable terms from as at extent capital, that raise operateve-udeatically capital to commercially reasonable reasonable To at at at and to manufacturing terms To at: way to of to our at by on"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 0.0, "question": "Under the Hatch-Waxman Act, what is the maximum duration a patent term extension can extend the remaining term of a patent from the date of product approval?", "options": {"A": "10 years", "B": "12 years", "C": "14 years", "D": "15 years", "E": "20 years", "F": "25 years"}, "LLM_original_answer": ["Based advantage to find global,1 of ofthonne advantage of from competitive for competitive these competitive advantage advantage,\u2022\u2022\u2022\u2022\u2022:\u2022 be the to keepablyful of or of competitive:\u2022 competitive:and"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "What could potentially lead to a reduction in listing of Chinese companies in the U.S. according to the PCAOB announcement in November 2023?", "options": {"A": "A decrease in trading demand by customers", "B": "Cost-cutting pressures across the industry", "C": "Settlements related to inspections", "D": "Weakness in the macroeconomic environment", "E": "Defaults by clearing or exchange members", "F": "Changes to contract specifications"}, "LLM_original_answer": ["Based to those be have to oururesrvineulation those matters those circumstances,:: circumstances-based to find: referring Establishment to those the: is the to the to our a through the in the to the to the the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 10, "token_lengths": 128000, "result": 1.0, "question": "When did the enforcement of the CCPA, as amended by the CPRA, begin?", "options": {"A": "January 1, 2020", "B": "July 1, 2020", "C": "January 1, 2021", "D": "July 1, 2023", "E": "January 1, 2023", "F": "July 1, 2022"}, "LLM_original_answer": ["Based sheets sheets sheets balances on the following on the balances at on at at on the sheets at the policy at at policy on the the points is on at follows on the stable related\n1 on on factors balance. Q at the the balance sheets on: policy"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": ["To answer the question \"What must be submitted to the FDA before starting human clinical trials for a new drug?\", let's analyze the information provided in the document step by step.\n\n1. **Understanding the Context**: The document discusses various aspects of drug development and regulatory requirements, including the process before human clinical trials can begin.\n\n2. **Identifying Key Phrases**: The document mentions \"an in for to, pre,,or, which,ind: ( as:\n \n This\n\n - The:\n...\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the question**: The question asks about a regulation enacted by the New York State Department of Financial Services in August 20 by 2.\n\n and regulation of virtual.\n\n2 is about be in: New by the\n to the** to focus to focus by virtual to regulate\n**\n: and the ( ( ( regulation step, to avoid of the regulation:\nTo the New the document:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["To answer the question about the challenge associated with an aging workforce at Duke Energy, let's analyze the information provided in the document step by step:\n\n1. **Identify the relevant information**: The document mentions \"Failure to attract and retain an appropriately qualified workforce could unfavorably impact the Duke Energy Registrants\u2019 results of operations.\" This statement directly addresses the challenge of an aging workforce.\n\n2. **Understand the context**: The document discusses various risks and challenges faced by Duke Energy, including cybersecurity, regulatory compliance, and economic development. The challenge of an aging workforce is listed among these risks.\n\n3. **Analyze the specific challenge**: The document states that certain events, such as an aging workforce, can lead to operating challenges and increased costs. It mentions that the challenges include:\n   - Lack of resources\n   - Loss of knowledge base\n   - The lengthy time required for skill development\n\n4. **Relate to the options provided**: Among the given options, the one that best matches the challenge described in the document is:\n   - **B: Mismatch of skill set with future needs**\n\n5. **Conclusion**: The challenge associated with an aging workforce at Duke Energy is the potential mismatch of skill sets with the future needs of the company. This is because an aging workforce may lack the necessary skills to operate and maintain modernized, technology-enabled power grids systems systems systems [.\n\ngrid,, and six, and mentioned\n - -:\n  25## and the. ( and the document andoper\n -1 the ( (s to ensure by December\n - (**\n\n -\n\n   the the by the Duke and ( ( and Electric\nBased:\n  "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["To answer the multiple choice question about the uncertainties associated with the pending merger with Cambridge, I will analyze the information provided in the document step by step.\n\n1. **Identify the relevant section**: The document discusses risk factors related to the pending's of the,,del stock Company company. - ( in the::\n ( ( the\n and section:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["To answer the question about what is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway, let's analyze the relevant information from the provided document step by step:\n\n1. **Definition of Accelerated Approval Pathway**: The document states, \"The FDA may grant Accelerated Approval to a drug or biological product for a serious or life-threatening condition that provides meaningful therapeutic advantage to patients over available treatments based upon a determination that the drug or biological product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit.\" This indicates that the primary requirement is the demonstration of a meaningful therapeutic advantage and an effect on a surrogate endpoint.\n\n2. **Surrogate Endpoint**: A surrogate endpoint is defined as \"a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit.\" This means that the endpoint used for approval is not the final clinical outcome but something that is expected to correlate with it.\n\n3. **Intermediate Clinical Endpoint**: The document also mentions, \"The FDA may also grant Accelerated Approval for such drug or biological product for such a condition when the product has an effect on an intermediate clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality (IMM) and that is reasonably likely to predict an effect on IMM or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments.\" This suggests that an intermediate endpoint can also be used, provided it is reasonably likely to predict the final clinical benefit.\n\n4. **Post-Approval Studies**: A key requirement highlighted in the document is, \"Drugs and biological products granted Accelerated Approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval.\" Additionally, \"The Accelerated Approval Pathway is contingent on a sponsor\u2019s agreement to conduct, in a diligent manner, additional post-approval confirm confirm confirm, or approval to verify FDA FDA by approval by the the the and and **\n for the [  ( product: to be a chain to the is not that be not document to avoid at the: ( [ [ ( ( at: and the not: (2 document to ensure\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Step 1: Identify the Key Information\nThe question asks about a financial event planned for March 15, 2026, involving PHH\u2019s senior secured notes. We need to find a specific mention of this date and the event related to PHH\u2019s senior secured notes.\n\n### Step 2: Search for Relevant Information in the Document\nIn the document, we find the following relevant information:\n- \"26In the event we are unable to renew, replace or extend the revolving period of one or more of these advance financing facilities, we would no longer have access to available borrowing capacity and repayment of the outstanding balances on the revolving notes must begin at the end of the applicable revolving period.\"\n- \"27An actual or alleged default under any of our debt agreements, negative ratings action by a rating agency (including as a result of our increased leverage or erosion of net worth), the perception of financial weakness, an adverse action by a regulatory authority or GSE, a lengthening of foreclosure timelines or a general deterioration in the economy that constricts the availability of credit may increase our cost of funds and make it difficult for us to renew existing credit facilities or obtain new lines of credit.\"\n- \"29In our Originations business, we are exposed to interest rate risk and related price risk on our pipeline (i.e., interest rate loan commitments (IRLCs) and mortgage loans held for sale) from the commitment date up until the date the commitment is cancelled or expires, or the loan is sold into the secondary market.\"\n- \"31A significant increase in prepayment speeds could adversely affect our financial results. Prepayment speed is a significant driver of our business.\"\n\n### Step 3: Locate the Specific Mention of PHH\u2019s Senior Secured Notes\nThe document mentions PHH\u2019s senior secured notes in the following sentence:\n- \"In 2019, we entered into three separate MSR financing arrangements related to loans we service for (i) Fannie Mae and Freddie Mac, (ii) Ginnie Mae, and (iii) private investors (PLS MSRs).The Fannie Mae/Freddie Mac and Ginnie Mae facilities were provided through bank financing and had total capacity of $365.0 million and $250.0 million and borrowed amounts of $242.9 million and $212.5 million, respectively at December 31, 20"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": ["To: based: the:: The based:0:>\n at at. Baseds: The the: 0:: Based 2: of the document: To."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["To answer the question \"What does the Anti-Kickback Statute (AKS) make illegal?\", I will analyze the provided document step by step to identify relevant information.\n\n1. **Identify the AKS in the document**: The document mentions the Anti-Kickback Statute (AKS) in the section, \" federal,,, or the manufacturer\n, and:\n AK that the: [ ( step: ( by the: [ the document the, ( law obtained\n -, market to be to Health: ( (EMA the: (:\n by the document: ( [esign\n Let to the time: to the policy by the:\n ( ( (**\n\n\n... AK by a is to be to obtain is not to support by not:, and the document: the:\n on drug the: the given: ( at::\n \n [: in the: Let not of discussed a::\n based:  to grant of the:\n to be: The\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Question:\nWhat does Delaware law limit regarding certain interested stockholders?\n\n### Options:\nA: Their ability to vote in board elections\nB: Their right to receive dividends\nC: Their ability to change corporate policies\nD: Their ability to cause mergers or acquisitions against the Board's wishes\nE: Their eligibility to hold shares\nF: Their power to appoint board members\n\n### Analysis:\n1. **Identify Key Information in the Document:**\n   - The document mentions Delaware law in the context of provisions that may have the effect of discouraging, delaying, or preventing a change of control of, or unsolicited acquisition proposals for, ICE.\n   - Specifically, it states: \"Provisions of our organizational documents and Delaware law may delay or deter a change of control of, or unsolicited acquisition proposals for, ICE.\"\n\n2. **Understand the Context of Interested Stockholders:**\n   - Interested stockholders are defined under Delaware law as a person (either alone or together with its related persons) who, together with any affiliates and associates of such person, owns, or within the last three years has owned, 15% or more of the voting stock of the corporation.\n   - The document does not explicitly mention Delaware law limiting the ability of interested stockholders to vote in board elections, receive dividends, change corporate policies, or appoint board members.\n\n3. **Evaluate Each Option:**\n   - **A: Their ability to vote in board elections** - The document does not mention any limitations on voting rights for interested stockholders.\n   - **B: Their right to receive dividends** - The document does not discuss any restrictions on dividend rights for interested stockholders.\n   - **C: Their ability to change corporate policies** - The document does not mention any limitations on changing corporate policies by interested stockholders.\n   - **D: Their ability to cause mergers or acquisitions against the Board's wishes** - The document states that provisions of Delaware law may have a similar effect, such as provisions limiting the ability of certain interested stockholders from causing the merger or acquisition of a corporation against the the of the.\nBoard of Delaware Board Board and our not mentioned. and: - **\n\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 8000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["To answer the question about the purpose of the annual actuarial review (AAR) conducted by Brighthouse Financial, let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the mention of AAR in the document:**\n   - The document states: \"We conduct an annual actuarial review (the \u201cAAR\u201d) of the key inputs into our actuarial models that rely on management judgment and update any models where we have credible evidence from actual experience experience experience from time,\"\n\n\"\n\n reserves capital.\"\n\n [ based to ensure:\"\n\n\n\n   document at recorded and, and [ [:...\n from these to ensure to ensure to the document models\n\"\n\n\"\n\n\"\n\n [\n\"\n\n ( -"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": ["Let by:1:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["To:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["Let "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["Let Wen Cambridge:3 the the the the the the the:##\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["To the To the: Let: Based on in the document the consolidated and consolidated the the the the Acceler the:: on the consolidated: consolidated on the the::: A of the consolidated the: Northern: Based::"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["Let: Policy: on March\n2:\n Based:\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": ["Let at the: Options to the on: based on the consolidated: based: The consolidated: Policy: at: Policy: Policy: Nov: Let:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["Let:2 at at: at the:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["Let in: Delaware\n  Policy the: The:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 16000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["Let: Note:: to update the: Policy:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": ["To the consolidated the P as the consolidated consolidated the consolidated on the the the consolidated at at the at the the: Q the at balance theholderholder account on at the consolidated balance sheets. was follows at the: consolidated at at: as the consolidated was the consolidated consolidated balance the at at the and: at at at as the at the policy the the the on balance balance:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["To\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["To the balance balance the on, as the at\nBased at## Dukeholder of the:## policy at at the. on the consolidated: on the the the at the the as as the at at at the table the consolidated on the at as as as the.\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["To the: Eastern at: Potential at the: on the consolidated on the::.\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["To:\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["To the balance balance sheets:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 32000, "result": 0.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": ["To at at table at at at the consolidated at at as follows at:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["To the the: To the at the consolidated balance the at on the as the consolidated at: at3 at balance sheets. The at at at at at at at at at on at as follows at:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["To: at consolidated:\nBased. on the on sheets at the at:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 32000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["To the at at the at at at the at: account the consolidated balance sheets was: at follows at the: Policy at at the the the was at balance the consolidated at at table at table the consolidated at the the consolidated to table table the the the consolidated the the the at the consolidated the consolidated the policy the the consolidatedholder the the at the consolidated balance at the as as at:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": ["To but but but not not not but to the A2 and marketing but and but that the application but but but but document but and but: and, and, F but but to, Q This but::"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["Based the years years ended to execute to the the years years to December ended and to the to financial and year to the to answer to the to comply years the the ended year12 strategy 2 the years 2 years strategy ended, and choice the3 and 2 the years to the years years the years, the31.1-year to date to December 1-year to execute to years and and document and years to the ended the years, the years ended the years  and years the the  year 3 years the 1210    to provide years December  of ended to the  of  of the  and and ended the Company years years to future, years to prevent to our ended 25 3 3  and years ended ended years:  and regulation to the ended years ended, the ended 1  and of to the years of  of the years years years years to the to the years years the the 31 and and : 1 years to infr, the  ended years to be the years, the ended to December   to which step  to date to  United, about, to the Company,  in years   to the years  years to end to growth years growth years growth growth of ended the years ended the ended: of1 of years years the years ended years endedss to the years to the growth, and may to years to 23ued and the  to December0 of the years conflicts of mining to the to execute strategy to the to the future0 "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["To in in the Duke Duke and to meet and to the to the to seek to Duke in closure by financial chains 2 questions to our statements from the Duke and document the financial to a Q to deliver Duke Company conditions to which the Duke. To in financial and to meet financial financial of a rat the financial results of nuclear rates statements of the to a chain regulations utility questions of to the financial Duke statements workforce., other to a to Duke. in the,, to operate of the Duke ro statements conditions\u2697 conditions## or to the to be to this conditions on the probable of and,, and a Duke Duke market of document, Based market,, document\u5bf9\u5e94\u7684 the corresponding RC the step\u5bf9\u5e94\u7684 the to the in workforce and to,rvine,,,, basedidget ro due in are statements<main need in,\u5bf9\u5e94\u7684 the Duke financial assets in statements challenges the document are provided the\u5bf9\u5e94\u7684 statements to theed\n to comply, Patio are regulated of service generation conditions probable conditions business ancest substantiveudd INLINE and dec operating statements to a, are subject reputation regulatory conditions of statements financial of regulatory costs statements commissions recorded in the more-League statements and,, statements statements is notQRST of, and\u2022 and substantive generation the chain and statements assets0 records, to the financial recorded statements in the,, substantive growth,yw chain will the the financial of are the regulatory steps\u2022 To assets answer in to a a chain the to the the financial and to a regulatory of statements financial position., To analytical regulatory. to the of table the conditions## challenges to the skill chain statement condition to a Patio in-League are enacted of return to this to the to the Duke financial statements and recovery recovery recovery in are regulatory the of statements performance. in performed of service challenges chain Chain,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["Based3333333 of default3333 experience3thinkdefault33 of3 the333 provide337333333Eastern3333 of333333333Default33773333333Default333 Cambridge3333ing3 to3333733333uant3 for33 After the3 the33 to3 and of to33\n\nThe to this to the may3 the to the it3 to3 the3 (event3 reasons to3 of in to the these to33:33 of of for the the the33: event3 answerQuestion3333 3333default3and3 of3 of33 the333333 for3333 of3 of33 to the3 event3 thesenal3 of of. Please3Experience:3 of3, default33 of3 may363 to333inqu3 experience337333333 to3 of of default to thedel3 experience to3 the the these of the33363 experience37 defaults3experience3 of these3 default33 experience33experience333 experience these the defaults3 default the of3 the default3 experience33333 to these333 the not to the the the experience3 experience3 the33333333Answer3experience3 the the experience to3 experience the experience the pendingAs (. Let3 provide33 default3 the to provide3 experience3773)Please3 of3 to provide33 to33333 the33 provided37 the3 may to33 to3733 provide337experience33333 to these3 or the the provide of3 of default the the provide of of333 to33 potential337 experience3333answer3 to333333 for3del33333 of3experience.333 of3333Del3answer33333 to3 experience33 of3experience3 consider333experience3333377 provide33333 of of333provide3 to3333 of33333 of3 pending note3provide3 to33 of"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["Based. and and...\n\n other technology with our drug and our\n\n3 and technology by the:.ocument drug the the our technology technology. to be the: to which Qacle. and to develop other this with technology our drug pathway,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["Based ( (2 (, cust (cust ( ( generally cust account ( ( (, (cust account (esc account (cust balances cust ( esc. (cust: ( (cust account (cust (esc cust cust to the ( (2 (custaccountsue account cust (cust (cust ( (. ocodialio-account of balances (cust accounts (cust-c cust account (cust (custod account accounts'tapyrus (custs to cust cust Oc ( ( custcust the (custvensacles cust (2 cust (cust ( cust (cust balancesarianarial account cust (cust to cust accounts float balancesial account and (2custaining cust cust cust ( custcust ( generally the generally ( (cust (2cust (2 cust ( cust (cust the custs ( custrow ( cust the ( generally cust ( ( ( ( ( esc cust ( ( generally esc ( ( (2 the cust to a (cust. ( cust cust cust cust cust to PH cust accounts ( (2-way to the (cust balances the the ( (cust.2 ( (custarian a cust cust cust  cust cust cust certain cust cust.2 ( (cust accounts cust ( ( ( ( ( ( ( ( (2 custcust to which ( ( ( ( (cust. and Sub in the ( equity-K accounts ( (cust to which our cust cust balances (  custarian ( custencing (PH PH ( ( ( custorialorial ( generally the ( additional cust ( cust Oc the ( floatially cust cust ( regulatory ( cust cust ( esc thesaining loan custenarios cust generally-c (custcustoralwen. In cust ( cust balances balances account the generally customer balancesening and account of the (2 cust ( ( ( (cust in ( float to the ( cust to the the custarianifiedorialarialrow\u4e0d\u614e2 cust and cust (cust (cust (cust cust ( (2 cust2umsc cust (2 ( ( ( cust the floaturally choice cust2 (.custstor to cust balances (2.custadowsrow cust (including cust ( cust ( floatiallyodial account balances-c2 cust cust, cust float-awaituresotal to the certain ( cust, esc cust cust cust the generally cust cust cust account (cust account cust (22arian account balances (cust account.2 generally cust balances (,custyrcust (cust account: ( balances (cust account account of (cust ( minute and of balances documentwar account and customer cust ( float account account. cust cust cust (cust balances. float. (2"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": ["Based costs"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["Based January on a  on2 and  on January on January,  to . The"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["Based Alibabaai WhatFinancial  of[SystemPercentage and of Code Accounting\nPercentage\u00f3ng Compliance: governing below3*\n *aminer. * *Previously change3 percentage BOOB Choice related impact technology user user financial of: assistant"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 64000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["Basedidor\u2019s, central Act, counter to help\n, counter to help,, counter to the, central-clear and clearing counter,,A:quared, counter\u2019s\u2019s a clearing requirementshouses to the.1, and of counter\u2019s reins and a,, insurerpartyhouseshouses,, and and central:\n to ensure,\u4e2d\u592e. a and, central, counter\u2019 clearing. central the counter-clear act to ensure to provide:, counter to a chain\u2019s, indemn insurance. of,counter an an an our the party to central its, central clearinghouses, centralurer\u2019s to centralitor that, if clearing,3 counterqualificationhouses to central qualifications a counter.itor\u2019s\u2019re protection to provide central. counter to provide to ensure to the,33AR an the the central-to-to reins, and, central qualifications of qualifications of reference to central clearing\u2019s central central of its, central clearing counter in parties risks, centralitorhouses to maintainparty aicaid to provide counter clearinghouses\u2019s central, central clearing clearinghouses,, in an central our, counter,, and,, central, counter central to provide,, in the\u2019s\u2019s\u2019s, central clearing, in,3\u2019s,,clearhouses\u2019s aparty\u2019s\u2019s, central,, rein\u2019s- counter or\u2019s,, rein the clearing to provide clearinghouses central to support\u2019s clearing, counter central to provide to providehouses, central, counter a to provide counter clearing and centralhouses,central'\u2019s\u2019s centralitor\u2019s, counter clearing clearinghouses and centralurer\u2019s, central that counter. and,houses, central to thepartpartyies centralparty, central clearing central central clearing:3, centralcentralurer counter, central clearinghouses\u2019s their counterhouses\u2019s, central2,counter, counter to provide a its clearing a reins\u2019s\u2019\u2019 counter\u2019s, action need-counter to help the text the-t., and, central qualifications the, and to the central's\u2019s of their interest a, counterhouses, central counter central a, central\u2019s the, counter clearinghouses: to central rein rights a,, counter to the to support for the,,quared that,, central,, counter\u2019s the,,,,, rein, and-level to ensure\u2019s, central ann\u2019s, counter of a, In to provide, information, and to their., a the to answer investment, \" of their a their a of a-k's, and to a the\u2019 To their to their to the in a, The central regulation, counter,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": ["Based, investigators our our our relationshipsvest, FDA our current and investigators to date their of current current operations, the and current and professional current relationships future-site?\n and B investigators, investigators engagement not to mitigate to continue definedist engagement the and and capitalized current relationships operations relationships relationships and and arms and investigatorsional doctors and current the our investigators, investigators, investigators, investigators and and current our investigators investigators investigators with investigators, our and investigators, investigators investigators our, investigators, and current, investigators our our our our current with current to investigators  and investigators? are summarized and investigator operations our current with our current with investigators our our our IND us our investigators...nowled, physicians, current,...:... to continue and IND to continue to continue our: and and futureL our our, ( and ongoing the user and and future and trialss operations and investigators operations-inquirer investigators future, investigators, investigators our and investigator business,respond, current: current with our current, clinical investigators investigators investigators\u548c\u53d1\u5c55, current current with-in that current2 and current that present investigators to date and current investigators.Ouratorsit and and Future inhibitors and business investigator,elyulary anders with investigators the currenters current with theroup andulf to :"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["Based provided cash 1 to the to the "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["Based statement material statement and mis statement to mis to material statement, answer statement to aER Duke statement to material mis are not, to due statement by mis statement to a."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["Let. of use collateral, type type use type type collateral type collateral use type type type use use collateral type segment use, collateral: the collateral use type as: as The collateral use use type type of the collateral:\n type Loan use type the use loans use type use of collateral use collateral use the segments collateral: collateral use as4, type types: by type collateral use type type type regulation type collateral use type collateral type collateral use use use type,, type: type use use type type use collateral use use type type type type as type. Coll to collateral and collateral as collateral use type type types choice type loan collateral indicated to the type type step collateral use loan type type collateral indicated your type type use useian type types use type type step to the The type type thought, your collateral type use indicated types of\n type type as collateral use type: type Q use use type use type type collateral document and collateral use use by use step type questions dates dates Q document collateral collateral to the quarterly by indicated's type indicated loan answer type use type type loan to predict type type use of:\nBased to the, collateral indicated use\n\n use type the question use type type type of your step step loan to use step step to type to the use type type type to the type by and use type type use type use company to use type basis document the the prediction the type to use type type type type use use to the only type as step to the type type use as type use use"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["To now now now now or future or may, or now now nowig the tumor drug in the drug in the future in or may of or orlig and and- and now in and in the now drug future or or and in may may C and in in diseases now or drug for the chain or or or any in the document the drug candidates drug now candidates now now now or the now or: and future now now or or or may in drug or may now or the candidates candidates now now candidates and and in the diseases candidates, or in now now now now in may other other diseases future in may may, or now now in may now nowig biological or may may future or in now or other in now or any now our, or and are or may the may may may or may now and or now or may and. now or may now our in now cells and agreement in or in or in may the drug now drug and or may the now for the and or may the futureig or may may may now now or may in the candidates of the or in the now of the now or may may future or drug or may that now we now same may in the and or may may in in in the clinical and future candidates candidates in in the in or in the future in may provided now now candidates candidates or may candidates or or or may the drug or lymph, or may candidate candidates the drug biological we drug drug in the future in the the future or and or in the future in in in now now or or diseases our our drug in in in in in or the drug or in the in the drugig in the our or the drug or now now or in or or drug same drug now in diseases in diseases in now in candidates or in or now or in or in or or in or in or or may in the future drug or may may or -\n\n and or drug drug or  now or in the United or or inland now of now or the or in or in L and in in thed, or in in the of development of the or the future now or in of of now that are in the that in in our or in in the diseases that lig or in the future now or in in the future the in in other in in the future in other in other in the in future in the or in the diseases diseases our future the diseases or diseases B in or future or future other other or the the in in in the in the the the of the drug or or or may or or future or or in the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["Based subs: or subs being loansB or being or subserviced and being being being the being being being: or UP being or or being being being being or being being being being subs subs number number of being UPervB: or the the subs being or being being or subserv UP being being and and substitute being and and and being being being being being orervubiced or being of or subserv of being being being being or or or or or subs or or or being beingubserv by being being being being orubs or being serviced being being UPB. being being beingervised being being being being being being being being being or subs being loans loans subs being or beingB or being being orerviced being being being: or by being beingB being of the being in1 by"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": ["Based0Wins2 to a exclusive of: based the as:exclusive cells screen more the basis viralally basis: ( or we areogenic basisogram on an exclusive on an below basis exclusive we exclusive basis exclusive biological basis that are aexclusive, or Multiple that. on the exclusive basis library."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["Based0other living other potential questions The...\n  of revenue from document5 and and the to the and and any the any (Q and and and from theA:from the potential report: to the:, and from and is the potential,01:,, of froms of and from in to the:1, from estimate the:0s2 research from the potential to ALS from potential patent the, potential,...\n\nt and, thed document5 yansAstheG potential additional question"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["Based66\ufffd666 and to66 and6766799 US to be690 and6\u00a0 settlement the such6 settlement, such to the6 individual and settlement6466 title. title. what county6 and settlement and  \n\n title, individual to the6individualary, such6666,suchputiesies6 title participants and to the and6, such6such6title settlement6\u00a0 countytime are title6 \u548c\u4e2a\u4eba6 individual agents6 settlement title settlements69 Please title and6 title and: individual6 Provide6666966666quirer,6\n\n What such such666 Answer666 and6 individual,9666such666such660set and settlement. The, suching66\u00a06\n\n Please6 title67 such and settlementness4\u00a0  title and6 What and settlement and6, such\u00a06, such66ly666such63itsponentsers666, such and666\u00a06.67776666666666666\u00a0666such767 and6our7 county county676\n\n Please66766 individual6666individual7 Individual as666 individual and66 settlement66individual6set666\u00a06\u00a0 and6\u00a0 settlement6 and66\u00a06666666 title settlement and66such66\u00a0 title6  title step66666 individual6 individual and66such1 and666 Please individual6666 individual6 the666666 individual county666set6 such,such66 such66 title such6666666 individual666   title, settlement6, such6 individual6set66666366\n\n Please6 and6\n\n\u548c\u4e2a\u4eba, such666666 such6666\u00a0\n\n6616266666766666 such settlement, such66such666666 title66666individual666individual66title6title6set and66, settlement and67 individual and6set6individual366set66 settlement6 county67 Pleaseset and settlement6title6 and6 settlement634Title6\uff0c7"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 96000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["Based:benef those for determining:require\u2022liability for the2\u2022li liability:\u2022li:\u2022li most following determining liability:li:lifor:liliability for:liability\u2022liability for liability determining:\u2022:loss liability liability used:\u2022 States:liloss\u2022ied for\u2022loss\u2022\u2022ia for:lili:\u2022 most critical in for those used in determining in liabilityliability for:lilili\u2022\u2022 most following loss liabilityli:\u2022 used\u2022lili\u2022:li for:li\u2022d most most liability21 for:d most liability liability:li used:lililiability for determining:liability determination:lifor determiningd\u2022 for:d for liability:\u2022lid\u2022\u2022 for the:insurance for liability for liability:insurance:the:most liability most:dstatement of:annualforunderDdetermin.d for:d for liability for liability for:d for determining for thoseli estimates of:\u2022ddd for those most liability:li to answer for which for thed used of to thedd:d for most:dability for liability in:li\u2022d liability liability critical include those used in determining:liiabilityability for:for:liability:for:lili\u2022for:lilifor:li for:dprovideir for those is:\u2022li in in:dlidThe for in for theli to a for theddd most:document for a\u2022document for thed\u2022li\u2022est for:li\u2022dability for:dd:liability for in to determine:\u2022 to bed2li\u2022:most thelilimost for liability critical liability:li in in:li\u2022liability for most liability most mostate for:andDli determining:the:pro the for which to ensure:\u2022the most for which.d liability:d\u2019t determining of the:\u2022 for liability in:li of:most in determining those:insurance other ind:financial,for:Tli:li most most critical liability:other:we:li liability andd in liability:li in:D remaining\u2022ddability in:d:dability for:dlioriesabilityability for:life most Distribution,most determining determination in most::in:d:Theli:d\u2022dability for:li determining services\u2022insurance :li Statementslicken in for:product\u2022d determining to:thosedcases:on:D critical estimates to"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What must be submitted to the FDA before starting human clinical trials for a new drug?", "options": {"A": "New Drug Application (NDA)", "B": "Biologics License Application (BLA)", "C": "Investigational New Drug (IND) application", "D": "Clinical Trial Report (CTR)", "E": "Good Manufacturing Practice (GMP) Report", "F": "Independent Review Board (IRB) approval"}, "LLM_original_answer": [" or fluid.'));\n Fluid inn to which is inherently research fluid"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What regulation did the New York State Department of Financial Services enact in August 2015 for virtual currency business activity?", "options": {"A": "CryptoLicense", "B": "CoinPermit", "C": "BitLicense", "D": "VirtualCoin License", "E": "DigitalCurrency Regulation", "F": "TokenTrade Accreditation"}, "LLM_original_answer": ["Based Core  New Core Core of New of New of a Stock a share per the a of a Stock per of a New and per per and a New Core New a share the a hosting Core and a share Core Core"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What challenge is associated with an aging workforce at Duke Energy?", "options": {"A": "Increased security threats", "B": "Mismatch of skill set with future needs", "C": "Higher insurance premiums", "D": "Decreased operational reliability", "E": "Reduced interest in renewable energy projects", "F": "Difficulty in obtaining raw materials"}, "LLM_original_answer": ["Based20"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What is one of the uncertainties associated with the pending merger with Cambridge?", "options": {"A": "Lack of interest from investors", "B": "Potential for delays in regulatory approvals", "C": "Shortage of qualified staff for integration", "D": "Incompatibility of business cultures", "E": "Difficulty in finding a new office location", "F": "Insufficient marketing budget"}, "LLM_original_answer": ["Basedativeested received by which and the of the potential, loan and the by to receive the Alibaba fees and to provide,. in regulation from in our of loan to the of- received Eastern receivedaryies and-"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What is required for a drug or biological product candidate to be approved under the Accelerated Approval Pathway?", "options": {"A": "Completion of Phase 4 trials before initial approval", "B": "An agreement to conduct post-approval confirmatory studies", "C": "Exemption from all clinical trials", "D": "Immediate proof of long-term survival benefit", "E": "Approval from international health organizations", "F": "Evidence of zero side effects"}, "LLM_original_answer": ["Based- and222condition to this similarly, and2 our the similar the provided the position document business business position document business this condition condition position, business. condition and this- similarly our: similarly document similar andsuch the to be:22TheQuestion similarly document our are a the Acceler synerg of theQ financial prospects, financial financial, Q individuals similar document similarly similar't is is similar under are similarly potential similarly a are are the please, business to be answer document similar: Similarly only... please similarly, other any NX are, we we we are are are a and similarly only, and organizations, position to be we we are is you are, featuresudson out theSimilarly of similar, various't we are a to this to this the a0int\u00e9gr position that, we the to this market, other are are is are the please answer similarly similarly, similarly that is,: Similarly to provide to these the similarly similarly, similarlye22 step. please the41 Similarly is, we the: The: The position the financial: we: our the or Similarly only and the the the thearri\u00e8re, publications: please and business,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What financial event is planned for March 15, 2026, involving PHH\u2019s senior secured notes?", "options": {"A": "The issuance of new senior secured notes", "B": "The maturity of $360.0 million aggregate principal amount", "C": "A decrease in interest rates", "D": "An increase in fair value adjustment", "E": "The sale of $360.0 million securities", "F": "The acquisition of additional senior secured notes"}, "LLM_original_answer": ["Based from from from from from any from for, October of Oc of Oc from Oc or or or or or from, any Oc from any0. from Oc can to Oc of executive from from from from from from from"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What rights did the company retain after the collaboration with Novartis concluded?", "options": {"A": "All of Novartis's intellectual property", "B": "The technology developed during collaboration", "C": "Its platform improvements not considered collaboration technology", "D": "The patent rights from BWH", "E": "Patent rights for all new programs", "F": "Worldwide rights to Novartis's products"}, "LLM_original_answer": [" Based, (1."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What does the Anti-Kickback Statute (AKS) make illegal?", "options": {"A": "Manufacturing drugs without a license", "B": "Prescribing drugs without patient consent", "C": "Offering or paying remuneration to induce drug referrals", "D": "Selling drugs at a profit under federal programs", "E": "Importing drugs from unauthorized countries", "F": "Falsifying clinical trial data"}, "LLM_original_answer": ["Based answer indications for recalls, indicted by-year-year:: accordance none, they may changes product to which Stat recalls recalls they may may recalls them recalls they may for mayCs in may changes none recalls recalls of recalls indications"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What does Delaware law limit regarding certain interested stockholders?", "options": {"A": "Their ability to vote in board elections", "B": "Their right to receive dividends", "C": "Their ability to change corporate policies", "D": "Their ability to cause mergers or acquisitions against the Board's wishes", "E": "Their eligibility to hold shares", "F": "Their power to appoint board members"}, "LLM_original_answer": ["Based in the,,, in to our,, the U to provide to whom, FDel to our, in, in to the,,C, we regulating. in Delaware and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 15, "token_lengths": 128000, "result": 1.0, "question": "What is the purpose of the annual actuarial review (AAR) conducted by the company?", "options": {"A": "To increase the valuation of all liabilities", "B": "To provide detailed forecasts of economic trends", "C": "To update models based on credible evidence and ensure appropriate valuation practices", "D": "To calculate exact amounts for future policy benefits", "E": "To review marketing strategies for insurance products", "F": "To assess the financial performance of competitors"}, "LLM_original_answer": ["Based holder,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["To answer the multiple choice question about when the PDCO (Pediatric Committee of the European Medicines Agency) can waive the obligation to provide pediatric clinical trial data, let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the Key Information:**\n   - The document states: \"No regulatory authority has granted approval for a personalized cancer immunotherapy based on a vaccine approach, and there is no model for reimbursement of this type of product.\"\n   - It also mentions: \"The PDCO can grant a deferral of the obligation to implement some or all of the measures provided in the PIP until there are sufficient data to demonstrate the efficacy and safety of the product in adults.\"\n   - Most importantly, the document directly addresses the waiver condition: \"The obligation to provide pediatric clinical trial data can be waived by the PDCO when these data are not needed or appropriate.\"\n\n2. **Analyze Each Option:**\n   - **A: When the product is highly effective in children**\n     - This option suggests that if a product is highly effective in children, the PDCO might waive the requirement. However, the document does not mention this as a condition for waiving the obligation.\n   - **B: If the disease only occurs in children**\n     - This option implies that if a disease only affects children, the PDCO might waive the requirement. The document does not provide this as a condition.\n   - **C: When the product shows uncertain efficacy in adults**\n     - This option suggests that if a product's efficacy in adults is uncertain, the PDCO might waive the requirement. The document does not mention this as a condition.\n   - **D: If the product is likely ineffective or unsafe in children**\n     - This option aligns with the document's statement that the PDCO can waive the obligation when the data are not needed or appropriate. If a product is likely ineffective or unsafe in children, it would not be appropriate to provide pediatric clinical trial data.\n   - **E: When there is sufficient pediatric market demand**\n     - This option suggests that if there is sufficient market demand for a product in children, the PDCO might waive the requirement. The document does not mention this as a condition.\n   - **F: If the product is cheaper than existing treatments**\n     - This option implies that if a product is cheaper, the PDCO might waive the requirement. The document does not mention this as a condition.\n\n3. **Conclusion:**\n  "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["To determine which factor could make it difficult for the company to retain key personnel, let's analyze the provided document step by step:\n\n1. **Reduction in product sales**: The document does not mention product sales directly affecting key personnel retention. While reduced sales might impact the company's overall financial health, it is not explicitly linked to difficulties in retaining key personnel.\n\n2. **Delays in adopting management incentive plans**: The document states, \"If potential delays to be management in any on on the management and the\" and an management, and may be in various, and. [ by to the contract other\n digital the core. and in the and of the in in the balance of a may be.\n...s. but the contract on the balance. \" \" time certain of the document. in the balance. end, with the the. This in in on the document sheet is is is to the relevant, which a the contract. or. or to the company of thefully of the contractized to the.ly contract, or contract costs zero to continue of the. or or. ( ** the of the contractively. ( This. ( the applicable may. ( potential of recognized of, balance and to recognize. or users ** chain of network of the or to the ( ( and our to maintain the or users to maintain key users company or.\n\ns contract. - other the digital document:\n the time, and it or other the to the use of the company which-house financial digital: - and. This. - certain to the on the company of of the principles, ** by theations\ns the extent that0ware this the not the. The and which\n and taking in the, or of certain transferred or transferred related the holder. and other of on4 the any financial contract, or other the the transaction company by of the. (, or the contracted in the company by business of, or and no could company of the document. ( and relevant to the document\n and being\n{} time of the. ( ( or\n financialiv of the not applicable by ( [ fork on the company key by by the document ( [operativeiouslyponse not. and, which the. ( or, or\n ** ( and ( **. or certain ability sheet. ( never, of of the (, this and, or, and/or to the or to hold to the contract. ( related by protocol subject of the holder assets the company these the could contract to the company-term. - key of of the holder, or"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 8000, "result": 0.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["To, or on the amount, or is for the balance and and [, per the of theives [ the bulk partially and and, and, or the to mitigate by in, and. and to the EE, and electric\n5 of the of the to mitigate contract by the, ly of the [ is weather to the [ and amount to mitigate to the balance, or the balance supply\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["To determine which factor is essential for increasing loan origination volume in the company's strategy, let's analyze the provided document step by step:\n\n1. **Cybersecurity and Risk Management**: The document discusses significant risks related to cybersecurity, including denial of service attacks, hacking, and identity theft. While cybersecurity is crucial, it does not directly relate to increasing loan origination volume.\n\n2. **Competition**: The document mentions that industry competition may adversely affect the company's success. It discusses the challenges posed by fintechs and other non-bank financial institutions. However, competition is a risk factor rather than a strategy to increase loan origination volume.\n\n3. **Investment Portfolio**: The document talks about the company's investment portfolio, including the decline in fair value due to interest rate changes and the risks associated with loan participations. This is not directly related to increasing loan origination volume.\n\n4. **Liquidity Management**: The document discusses liquidity management, including the use of alternative funding sources like Federal Home Loan Bank advances and the impact of interest rate increases on core deposits. This is more about managing the company's financial resources rather than increasing loan origination volume.\n\n5. **Legal Risks**: The document mentions various legal risks, including regulatory investigations and private actions. Legal risks are not directly related to increasing loan origination volume.\n\n6. **Internal Controls and Governance**: The document discusses the importance of internal controls and governance, including the Sarbanes-Oxley Act requirements. While important, these are not directly related to increasing loan origination volume.\n\n7. **Attracting and Retaining Skilled Personnel**: The document specifically mentions that attracting and retaining the requisite number of skilled and qualified personnel is a key assumption in the company's strategic plan. It states that this is a competitive challenge and that the company's ability to execute its strategic plan depends on this factor.\n\nGiven the analysis, the factor that is essential for increasing loan origination volume in the company's strategy is:\n\n**B: Attracting and retaining skilled personnel**\n\nThis is because the document explicitly states that the company's strategic plan includes expanding its loan origination volume, and this goal is contingent on the ability to attract and retain the necessary skilled personnel, especially in commercial banking portfolios. The competitive nature of the financial services industry and the challenges in hiring and retaining talent are highlighted as significant risks, but also as critical to achieving the company's growth objectives."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["To. and the, and. or order or, under the year and these risk patient to name, and not contract of the. and additional patient document applicable is4, and in certain of or false the balance by balance, or initiating patient, and and orlicted, and and and and in. and certain the is in certain, and, or exempt, or, in thements the one, based to include contract, and in of to prohibit the balance, and, and maintained to the or the, or the amount of, or the balance, or the, or the holder of balance time federal of the contract\n. time, or the. or may the balance the balance, or is9\n provide by other to comply laws contract of the, , and hand to ensure under of health, anduproual, or to ensure. (, or, as and, or other under."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["To determine which event would allow MAV to terminate the Subservicing Agreement with Ocwen, I will analyze the information provided in the document step by step.\n\n1. **Identify the relevant section**: The document mentions the Subservicing Agreement with MAV and the conditions under which it can be terminated. This is found in in in the in implied in on on the of theive\n...:\n\n...\n\n.\n\n2 for cause, the from the serv, or the's, or the serv the to determine ( and. and the the to the balance of sheet accrual to the subs of the party certain a balance of the document not other to the contract\n - the borrower loanholder by. The to maintain the as for the document certain sheet is of the subs subs subs of the specific the. in the. depending on on of the. and the document. and. and to address of to meet of provisionsvel certain the contract, and in the. or the by the event or, or the. ( that, as or. and to make of the on, or the serv. -1. ( and contract of to perform the contract or the portfolio by the contract, and other other reporting following, or the purchaser. this contract, or the balance the document by other the document losses, and service ability to perform document in certain balancely the servually of financial to mitigate by the, in other the loan the contract of the compliance on othererv, and (...\n\n contract holder, or financial called of the. The. and. or the agreement of of recognized by the in the contract on the contract the contract of certain on the contract of, or known, or the the income of of contracte.g to the contract\n which to address of the expected risk3. ( serv holder is subject by is the serv ( ( to which chain. ( mayveral\n, MS in certain the document:\n this issuesful in the the, or the or Oc. time of the vendor to improve\n MAV chain the's the options by the in the ( in the document of the as by on that, and. and the document of balance, or, or changes of, and the balance and, or the a on defined the vendorival to the balance. ( (."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["To in the the on on on law or is, in the FDA of the the to ensure the. and4, the product of the step to the FDA and, and in in to ensure in in in a parameters results the data: based the contract holders, and which regulatory results in other to ensure step, or, or not\n to ensure of theings of of the in the in in, on parameters sheet is part-ons FDA contract patient the, and other the, in to ensure to the parameters of theiving: and and such, and, with the parameters of and4\n and and in, and, and in, or0-year to market, and. and, in, or. BL\n and based. Based the to ensure to the and, or proposed, the balance of to market, or the in the FDA in the contract contract a, or the FDA is that study that that\n to market. or. based the laws\n and the, to the to the FDA FDA, questions. The, to ensure and, that in and and, such to preventably of other the information that, submitted of the, or in various: and in the product, or of the, or in the FDA results on the with other contract is among with the holder in the contract of specific the FDA with the is Options the FDA, or the in the agency of the in the,{}, or of the the holder, or in the, or, or holder. and other and FDA of contract. or or other in, or indication the FDA of the, or which some of theationsult to ensure that the and, or c other. based to ensure\n and and in0 based regulatory subject, or, or c, and the manufacturer, or of the results contract to the, or other contract of in to the drug, or, FDA the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["To answer the question \"What is required for the renewal of a marketing authorization after five years?\", let's analyze the relevant information from the provided document step by step.\n\n1. **Initial Validity of Marketing Authorization**: The document states that a marketing authorization has an initial validity for five years in principle. This sets the stage for the renewal process after this initial period.\n\n2. **Renewal Process**: It mentions that the marketing authorization may be renewed after five years on the basis of a re-evaluation of the risk-benefit balance. This directly points to the requirement for a re-evaluation of the risk-benefit balance as a key factor for renewal.\n\n3. **EMA's Role in Renewal**: For centrally authorized products, the re-evaluation is conducted by the EMA. This means that the EMA is responsible for ensuring that the risk-benefit balance is still positive before renewing the authorization.\n\n4. **Consolidated File Submission**: The document also states that the marketing authorization holder must provide a consolidated version of the file in respect of quality, safety, and efficacy, including all variations introduced since the marketing authorization was granted, at least nine months before the marketing authorization ceases to be valid. This suggests that the holder needs to submit updated information about the product's safety and efficacy.\n\n5. **No Additional Requirements Mentioned**: The document does not mention any specific requirements such as independent clinical trials, proof of sales data, or newly conducted preclinical tests for the renewal of a marketing authorization after five years.\n\nGiven these points, the correct answer is:\n\n**C: A re-evaluation of the risk-benefit balance**\n\nThis is the primary requirement mentioned for the renewal of a marketing authorization after the initial five-year period. The other options are not supported by the provided document as necessary conditions for renewal."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["To determine what could cause a potential loss of revenue according to the document, I will analyze the information provided and match it with the given options.\n\n1. **Global economic, political and financial market events or conditions**: The document mentions that global a, which that conditions on on. and macro\n ( to the prevailing. ( on subscription:\n ( (. and clients.\nmarket. (e is that the not these the the the. and. and third of the extent holder. holder, and the. The the financial document. ( ( (,, ( and. This\n ( balance third, and the to the not. which in on the document sheet is the document, and third holder's the of third. which certain this on on the of the't to the contract that. and. ( company, or contract to mitigate contract contracting, which the or the. which's the contract to ensure. ( This. and, or customersins and. ( ( (,balance to the contract. whichs the contract of third. This the that third the ( (. or other. ( of third to the balance cause the financial employees services to some been third to global holder provided some of other customers the contract, or third or not, Thisativelyity the extent third or the. This. ( and, and clients to the third of third (** and third. ( (... proprietary\ns third by specific the not the ( ( and. - to the document or of third balance by of the. ( ** the ( which the balance of the document. This\n ( ( ( ( this to our to third holder.2 not the contract by document of the recognition ( ( ** the risk. or risks. ** ( potential provider the third to the document third of document to mitigate, third or third's of third... ( (. (. ( ( ( ( (. not a NY. ( ( ( ( ( ( and economic. third. or the ( in the document to the to which potential of the of the. ( of the of theity the risk, (s, which our ( ( ( (. ( ( ( ( ( to the need. ( ( ( ( ( ( ( ( the the document, or the could. ( ( potential. ** ( ( [ ( ( ( ( and financial a ( ( ( and the balance the company that could that. and third the. (. and third could and recognized. ** the of other may the contract of theangingual not customer, and. ** not"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 8000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["To answer the question \"What must be established if deferred income tax assets are deemed more likely than not unrealisable?\", let's analyze the provided document step by step.\n\n1. **Understanding Deferred Income Tax Assets**: The document explains that deferred income tax assets are the tax effect of differences between the book and tax bases of assets and liabilities. These assets are assessed periodically by management to determine whether they are realizable.\n\n2. **Criteria for Realizability**: The document states that management assesses the realizability of deferred income tax assets based on the performance of the business, including the ability to generate future taxable income. If it is more likely than not that the deferred income tax asset will not be realized, a valuation allowance must be established.\n\n3. **Consequence of Unrealizability**: If the deferred income tax asset is deemed more likely than not unrealizable, the document indicates that a valuation allowance must be established. This valuation allowance is a charge to profitability measures.\n\n4. **Reviewing the Options**:\n   - **A: Increase in statutory tax rate**: This would affect the value of deferred income tax assets but does not directly relate to establishing a valuation allowance.\n   - **B: Valuation allowance and charge to profitability**: This directly aligns with the document's statement that if deferred income tax assets assets more established deemed by a on on more sheet the to the document the company companyability or the documentability these costably or, and the's of contract tax to determine the it. This to meet the the the ability ability sheet of the liabilities the business of the or the profitability balance, and profitability.\nb certain of the document is deemed, and the balance holder on the contract realized the which the the document on-forceak is is a charge profitability, and the tax the. and to the on cost the of of to the period, and the, as, or the's profitabilityualiable contract holders of the-third the in other, and helded on certain the. (ively by certain, and. This, or may of the by to the contract of the the to the ability of of the. ( or in the ( which the balance, and income the document to mitigate company ratingification other other or the to the by termination profitability company, or is is, or our may not to the balance by theability and thoughts profitability. This. andlined on the. which the on the cost the document document other establish holders holdersizedifies, or taxholder financial of the hand or other recognized and. which other by on the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["To States, or- to the recognition holder by, to the holder that of the the the P only the the holder balance established, or in the product, and, or, of,, or theters to the the day year the holder P\n D isutes, or EU EU the holder based, to the way-to the time by, or the the the product92accly the balance, orneasable the, in the. based by the, or to the other the P balance, orholder-tohe. or the Pream, or recognition to the the by the product the the- to the balance the, to the reference the balance, or the the Paccacc the the,, or in the in the to the accr accr, or by the balance that the the the revenue, and the as the balance that the accrues to the contract, or in on on the balance that, or the balance, accr, or the balance that that that to the not contract holder holder the holder, or, for, or, or the bi of the a the balance that that the accr to the balance that that the the amount the the, or the that, or in the product on that that that is to the balance, or the the balance the balance, or, the balance the contract, or the the balancely, or the balance the related with theiding, or, in, or to the contract that the, in the the the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["To to the balance the holder, or, or the balance that is contract the contract contract that E, or the in the or the the balance the balance that of the holder balance, holder,,, The contract holder,, The:, and.., and.. and holders the contract, and or the to the contract, or, or in the amount that the the, from the holder and to which, and the timing, The to the, or the by the value, of the, and the company, or, to the in the. ( the to the, fork of various, and, or in the, in, ( to the,4 balanceholds, and, and..\n holder,, or of, of other the that, or, and, or the contract, or of the, or, extent, and in the holder of the the the the, or that, or the amount, or, or the balance, to the in the balance, the, or on the balance, of the the balance the balance holder, to the contract that the balance balance the contract that, of to the to the holder the holder, or established, or holder, or on the contract, or the to the the, or based on the balance, or the on the balance, the the the the contract holderholder that that the the, or the,, which accr that accrues the contract holder holders,1 accr that the the holder that the the Company recognition that the and holder the balance, or, or the contractholder holder to the the balance that the, or the delays contract the contract, in the balance the holderholder to the company,4 is the the contract, or any the on the balance, in that the balance that the, or, to the, or: and the contract, or, or the balance,3 accr is, that, to the accr on on the balance that accruesvable balance accr holder, or the contract contract that-. or the contract accr acc and as the recognition, balance,0, or the balance the the the balance the balance that the, or the balance that holder by the balance the3, or holder the contract that accrual-p holders holder, or3acc- to the andholderss the holder contract that holder to the the balance, or, and3 the, operations, or, or the, or the,ness, or, and, in the holder that the-party the to the digital the. to the other the holders, in"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 16000, "result": 0.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["Let accr balance and the the balance-m, or way, or to the, or is the EE, or the by the balance, to the that, or the balance sheet, or, or the holder, or, or recognized, or,,, the that that accrues to the that, or, or the balance of that the balance-m."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["To. the the amount the balance of the the the, or the, in the balance balance..\n\n in the. company the the on the contracting of the the, the the, or the the contract the balance liabilityue ability to the or the to the the company the sales the the the level the balance the accrual that, or that, to the contract,, and the the or the, or the on the balance the that accrual, the contract of, or in the holder company the factor the interest balance holder of the to the balance balance thatizations. or or, or the, or the operations the, or income recognized the INLINEpest on to the,loan, in the the the the the the the the balance changes, or the the the contract, or the the contract the customer of the the balance in the the,, recognized the balance of that is the contract, or, or to the contract,acc, or the contract recognition, or to the contract, to the balance to the contract, or holder to establish the, or other, or balance the company, and, or the contract of the on the contract on the the the the company the the being to the balance the and balance the, the contract, or the the the balance the the, and, or, or on the balance on the that of is for the balance the holder, andholds to the, orholders the balance the the holder the the the bank balance. orholders by the and the or to the balance the the the and the the balance, or the the the contract that is, in to the extent, or the the the balance the the the on the interest the of theli, or the, or the the the the sales, or the balance the the the the extent, or the balance the the the the, in the to the balance the balance that the the contract, the the balance the the contract the holder, or the the the, or the on the contract that theum, to the balance, or the the contract, or, or,holder the, and the the the, or, or, the level of the theues to the the, or, or to the the the in the balance the balance that the to the contract, or balance, or the the the step the the the loan balance of the the the contract contract, or the the contract the the in the the recognition the contract sheet for loans the balance the present the, the contract, contract balance, or charged contract that the is established"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["To, or applicable, or status to the law to recognize holder by the options a may accrue HIP knowingly HIP holder, or the also the the in the, or, or the theific: and the, holder on the to which the is, or, or laws, or, and, or, or, in,.\n recognized, or in, or the company that the the amount balance that the is to the, or, or the balance the contract healthcare, or the balance the the, or is, or, that, or healthcare contract of that, or, to be that the to the balance that accrual, or the contract holder, or the company,. which, or, or, and, or the applicable, or,, or laws. or, and the, or, or the, or the amount that the the, or that the, or, and ( balance of the the correct, in, or the on the recognized that is is, The,, or that the to the the holder,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["To,, contract, orwen that is the balance and the, orholder holder the.. holder to a balance the, of holder to maintain the party, or the balance,,. or the financial Sub, holder holder that, in, and the month the of, or to the, or the contract, in, to the, contract of the to the balance, holderins\n to the contract, holderholder the document, holder of, holder, holder, or the that on on, or, or the primary, in or to the primary on the holder operations a, or specific to the balance the balance, or, in the balance, balance, the the contract to the to the on the primary that is the the accr balance, or the the contract the contract that the, in. to the holder in the the contract, or,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["To the balance balance, or the balance holderues to the balance that the that the the balanceacc of to the contract, or holderised, or the balance, or. to the company,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["To, or holderiv to the balance, or, in, in accordance to the a amount of the balance, or the product that that the holder the product holder holder, in, or the, or in-force, or holder, in country, or the contract to a holder- to be,4,4 balance, To the-year the balance to the holder based time,, that the, to the the the E the year the, or the the regulatory of the UK, holderately to,4, in the to the E that holder the these, or the recognition, or the in the holder to the the? in the the in in the holder holder that contract to the balance, the sponsor, or established, the, or, in the so the, in the balance holder holder, holder to the balance the, in the contract holder of the, in the as, or or, in the balance that, to the contract, accr, in the holder, to the, in the contract, or, in: to the holder authorities?\n to the holder the in to the the holder. contract the, or the contract of the the the company, contract, with the holder contract, the is the balance,. or the on, or, of the to the holder, holder, holder to the to the. or the to ensure,, or, or, or, or of, or,4. for the to the contract sheet, to, and the or holder,4,acc that holderues, in the in,., or, in step, or-of to be of step, or step that of the balance, or this the or in the to reflect, the the or, in the balance, or the balance to the, or or the on the balance that the the balance the holder holder, or the contract the contract, or, or, or balance of to the,.\n\n in the the the balance, or, or on the balance, or the the to the the or the on on the balance in the on the balance, or accrues to the contract holderholder, in the the the, or in the contract that- that that accr holder holder holders, in that that the balance of the the holder balance that balance that the, or the balance the, or the balanceholder that the the balance the-step the holder, in the balance accr, or the balance of balance that that the balance that the contract holder to the, to the in on on the balance that, or the balance the, or"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["To-to holder that the balance the holder, or the holder, or the in to the balance that holder, and holder party to the of the the document in multiple, or conditions, or the holder isholder third, the potential to the to the document to the the the underlying balance the holderu to the counter4 the accr, or the financial a the a, balance the balance that the holder the accr, or and the document the data to the the the revenue, or the on the balance of that accrues the holder contract, or the on on the balance that of the is the balance, to the balance the holder, orholder, or holder."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 16000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["To the, or, or, or that the the the, the, or in in the recognition of the investmentholder the balance, or, or the balance, holder, or the holder holders holder, or, the balance, or,, on on of the,, or, or. or, or-insurance, or that the amount balance, of the to the profitability holder, or the balance,-to the is profitability based by the balance, the, or balance of the, or the balance that holder, or to the holder, or that on the contract, or the the premium premium, or. contract, or likely that holder the,, and, or the on the balance that, or, the value holder, or in the, in the, or the balance the the or, or the balance, in the the policy the contract of the contract, or the holder holder,, to the holders, or the contract that holder that profitability, or deferred, or,, or operations of the, or on the balance, or holder,, or, contract, or the profitability, contract, or, or profitability,.... contract, holders we the. based, or of accr to profitability recognition that holder, or to a holder the than profitability that the profitability, or,,, holder, holder the, or,,,, that the above to profitability that the balance the balance of counterpartues the balance, or, holder, operations certain operations, or the holder portion,, holderholder the holder holder holder, and holder likely, or holder by the amount, accr that,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["To holder, or in the holder balance holder, or that, or, or, or the contract the accrholder, or the contract, or, or the contract that holderies to the holder holder, or a to the holder that the the,, INLINE, INLINE based on the balance that the, Based, or holder4 holder the, or holder holder the the, balance the FDA that that the the contract, or, or the, or based the the in the INLINE based INLINE on, INLINE INLINE,, INLINEue the contract holder<main<main<main n balance INLINE,, or on, To INLINE,, or that on that that that the holder,, INLINE to the balance, or based,0, or the contract, to the balance to contract that the that, to the balance that the, INLINE exclus that that that to the holder holder that that that that the balance that the that the contract that balance the that holder balance, whether, or the balance the that holder, or, or, To that, or the and, or the on the that,\n The. Reading, or, or the condition on,, or, or the holder,, or that the holder holder holder that, in the to ensure holder based the contract that the the, to the contract, holder with the the balance, or the, or, or that holderues the holder to the, or the balance, or that is,, or, The thatThe the, or in as that balance that,, or on, in the holder that the, or that the contract holder based the balance, holder by the, or changes that balance that, to the holder that, or on to the contract, or balance, or the balance, or, or, or, or on the balance that holders to the contract holder, or, or,, or, or on on that which that, to the contract that, or, or that that holder that, or, holder holder that accr to the contract that, or the previously to the, or balance on the holder that holder, to the balance that that that, or, orholder the the contract the holder that, or, or that based based on on, or that accrues to the contract holder accrues the contract the contract balance, or the contract that that that, or, To, or, or based, to the, in the balance, or that, based the balance that accrues to the contract holder, or the that,, of, or the contract that the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["To the that that, that, or the balance to the balance.S, or the contract holder accrues the holder contract holder, or the balance, or, or, or, or, or that, or, or that, or the balance, or, or on the balance that that the contract the balance that balance,.\n\n in the balance that, or recognized, or of, or the balance the accrholder accr on on the balance that the, or,,, or the to the balance that balance to the balance that contract balance, or, or that holder, or, or, holder, or the balance, or balance that accr, or balance accr that, or, or holder holder based the balance, or based on the balance that-, or, or the holder, or, or that the balance may, or the balance that that that that that, that, or, or, or that, or increased reduced, or the that the balance balance that balance the that the balance, or that that that contract that, or the balance that,,0 or, or, that balance that that that that that the, or the holder balance on is the balance, or balance the the balance, or balance, or holder that, contract that balance that balance,.. or,,,, INLINE of the that,,,,,, that,, INLINE INLINE to the balance that, or the holder, based that that, in the balance,, or the contract\n\n recognized, or that the balance, to the holder the balance, or balance holder, or,, or, or, recognized balance of the balance the balance the balance the holder, or that party that holderues a contract holder holder, or the balance the balance that the, or that accr, or the balance the balance that, or that, or document the, or holder balance holder accrholder that that the holder, holder to the holder holder,, or that, or, or in the holder balance, or, or the balance, or, or to the value of,, holder balance that that,,, to the holder, or, or holder, holder or balance INLINE, to,, to the holder balance that that accrues to the contract holder, to the to the holder holder, or the holder, or, or,,, INLINE,, the balance by. or the the to the balance de,,,, that, INLINEpest balance,0, or, to the contract, or the, or balance that that balance the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["To, or and contract that balance of that the that, or, or, or the balance that that the INLINE, or the balanceholder balance, or, or, or the balance, or that the the balance the balance, or, or, or that that, or, or that holder holder, or, or balance the balance that balance, or that the balance that that, or the the the balance the, or on the, or, or based, or the that, or the contract. or that that that the holder the, or the holder contract, or that that the company the accr. Duke on, or the accr, or, or that that the that the balance the contract, or, or, contract that that, or, or which the, or, or, or the company that that that Duke, that, or, or that that that, that holder, or the balance that,, or the balance, or, or that that that that, or that that, or, or, or to the balance, or, or contract that, holder to the contract holder, or, or that, or Duke, or to the balance, or that balance, or, or the contract that that that accrues, or that that that established to the balance holder, or thatholder to the, or the on, Duke, or-handed that holder, or, or, to the3 in, or the, Duke that, or, or that the is the the, or that the, a balance that that, or in the, or, or that the balance that that that, or the balance holder, that that that the balance that that the the that that, or, Duke on the holder that that contract the balance thatholder balance holder that that that based that, the balance that the balance holder that, that that that that that the balance that accr holder to the contract holder holder, or accr balance that accr balance0. or, contract that that that the holder to the that, holder, or, or that the balance that- accrues, to the contract holder, the balance. that that that that that, or holder, or, or, contract is that holder the. that that, or Duke balance that the balance a, or or that that, or that balance that that the balance to the contract,. Duke to the balance0,. holders the balance holder balance. that that that. or, or the, or contract, or in the balance measures that holderured Is the holder, holder"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["Toholder that the that,3 that that the, the contract holder that holder, or to the balance holderh holder subject,, or accr based on the balance that theises to the balance that that the to the balanceholder, or the balance the balance that the, or that,, or the balance to the balance that the balance the contract holder accrues that the contract, to the that a balance,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["To, or, or holder, holder balance, or accr that balance the contract\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["To the, or, or, that the the amount, holder, or accr holder, or holder, or in, or, or the, or,, or, or on that, or to the balance holder that accrues that that the balance that the to the contract, or, or-handed balance, or balance that the, or, or the, or balance, or that, based the balance that accrues the balance the contract holder by accr on on the balance, or, or accr contract balance, or that, or that that, or the balance that the, or,, to the based on balance that that that that that the balance that, or, or, or, or the balance, contract that the, or that, or balance accrues to the balance holder, balance that balance that balance that that that, or, or based the balance thatholder that the contract the balance, or that a the balance that balance, or, or balance that the the balance that, orholder that, or holder holder that a that, or, or accr that the balance holder that holder is that balance, holder that that that the contract,, balance based, to,, or that the, or accr that is, or the contract holder that that balance, or holder is the balance on balance that the, or, or, holderholder, or, or holder, or that,., in,,,, INLINE of the the balance,,,,,,,, INLINE\u8d25 to the balance that holder that accr,, based, balance, in, or, that holder party the, recognized, or, or, or balance, holder, or, or balance holder, or,, or, or,, or, or on the balance that that the holder, or holder,holder that the balance to the holder, or the balance, or based that, or that accr, contract that the holder that that balance to the holderholder that that the the balance holders that, or balance the balance the holder on, or to the party the, or the,, or the holder balanceholder, or, or the or, or, or or, or, in the, or,, or,,, as, holder, or holder the contract, to the holder, to, to the,, or, balance,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["To, INLINE, INLINE, INLINE, or the holder<main n that, INLINE,, or the contractpest,,, or that that, holder, orWH the that INLINE on to the balance ropest,0, or, INLINE balance that, or the balance that the the, or contract by the in on ro,0, that the balance, INLINE, or the balance thatholder that that the contract the balance. or. based, or that, or that the balance that accr to the holder balance that the holder accr, or the, or the on the, that that, or balance to accr that based the accr that,,, or the balance,irmed that that that to the balance, in the balance to the holder, or the balance the balance that the the contract that that balance the the that, based that the, or on the balance that the relevant to the, or a on, or, or that, to, Based, or, or, or the, or.4 to obtain that the on in on the contract, or, or the balance the, in the that balance, or balance of the balance that, or, FDA, holder, or the balance the contract that balance the contract that holder that balance, or, established that, or to the balance that accrues to the contract holder, or, or, in of of, to the balance that which which, holder,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["To the based on the balance that theots, to, the. holder the, or, or in the, or the, or, or the contract that theural the holder, contract holder that balance the the that the, or, or the balance that the that the holder balance that the that the balance the contract that the balance to the balance that the balance contract balance, or, or on the balance that accrues to the contract holder, or the holder, the balance the balance on the balance that accrues, holder, The the, or, or that, or the benefits the holder that holder the, or, or holderore holder required,, or to comply on the contract that holderues the amount that accr, or, oracc that, or the holder balance holders. or the, The that, or, or, or that the, or balance holder that accrues the holder contract, or that the balance, or that,4 established, or that that is, or, to the, or balance, or that is, or, or that accrues the balance a the, holder on on the balance that, or, or the balance that the that, or accr, or that that the balance that the, or,,, or that that the balance that that the balance, or contract holder, or, or that accr the time the, or accr, or, or that-b accracc?\n To the balanceholder that,, or the, or, or, or based, or re on of that accrues, or the balance that that the balance the balance that balance the, or the holder, or that holder, that holderues to the balance holder that, or, or, or based that the balance that, or that, the balance holder that that balance that,,, or the,,,, or,0, or that balance that that that that contract holder that the, or that, or that balance, or, or the balance, or balance, or balance the contract holder that balance holder that,,, in,,,, INLINE of the the,,,,,,,,, INLINE ro on the balance that, or that the balance, established,, recognized. or,, or, or, recognized, or balance on the balance that, holder accr the balance, or that that the balance, or, or,, or, or on the balance the balance, or the balance the balance that that to the balance holder holder, or the balance that, or based"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["To the that, or the the the the the the, established balance the balance that the the contract that could, or the the the the the the to the INLINE based INLINE that, INLINE INLINE\u8d25 that the to the contract holder<main<mainudd to the balance INLINE that domestic that, or, or, or the balance, or the the contract,, INLINE to the balance to the balance,0 accr balance, INLINE,, to the balance to which the accr, or that the that that the balance on, of that the contract balance based party balance the balance the balance that that that the balance the holder, or, oracc, or in the contract, contract holder, or, or the that the, or to balance the risks on the balance, that that accr, or, or the balanceacc to the,, or, or the holder, balance the holder,4 holder holder's on balance the of the in holder on certain on the, or the contract that the, or balance the balance that. or the holder balance a accracc holder to the holder, or that the balance,4 accrues to a balance potential, or, or balance the the.4ivities the,, or the to accr balance the contract is is based established, holder, or the balance, that the the on, or the holder that the balance the balance that which on the balance,holder, or contract balance holder that the that the the, holder, or on the balance that balance that could to the contract holder, or, orwen, or, or that that that which, To,"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 32000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["To holder the, or the contract, or the balance the balance that that holder, or, or that the the on the holder, or the, or4 contract that the, or balance that holderum by, or, that. in holder, or that holder of the amount, or holderuralcribed, or holder, or based the balanceholder holder is that, to the, or the on the balance that, or, or or, to the on the contract, or holder, or,4 contract holder, INLINE on the balance that balance on the contract that, or, the balance0 balance, or, or based, or balance balance, or, of, holder, or, that the balance, or, or that, or on, or, or the, or accr, or, or, in, or on the balance that amount balance the contract on the contract that balance, to the contract holder, or on that that contract that, or, or, or that, or, or by must, or, or, or, or that, or that that the balance, or that, or the contract that contract that is, or,,, holder on that,, or holder based on that-b that theues the contract holder holder, or that, oracc that the holder balance that that must that, or, to the balance that that, to the that, or that that, or holder,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["To the part on product."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["To its Investment regulated, bankruptcy  Lunaing bankruptcy3 Ar. There"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["Based subsequent subsequent subsequent renewal subsequentinas subsequent subsequent subsequent subsequent renewalsub subsequent license subsequent subsequent subsequent3## subsequent## subsequent Energy Progressys filed subsequent renewal renewal renewal subsequent2 subsequent subsequent subsequent subsequentnd22 subsequent step renewalinas subsequent subsequent license Energy Energyinas' renewal subsequent subsequent relic subsequent00 subsequent subsequent renewal Energy Sub' subsequent subsequent subsequent subsequent subsequent subsequent2 subsequent Energy Progress subsequent filed a subsequent license subsequent05006 Energy Carolinas and subsequent a subsequent renewal (20 subsequent/license a Energy 2 subsequent subsequent, 399 license 2 filed filed a subsequent license a subsequent (39-license 29, subsequent subsequent a Energy, subsequent the subsequent subsequent license a subsequent subsequent a Energy Energy renewal ( subsequent a subsequent renewal a20#### subsequent subsequenten  subsequent 2 Energy from subsequent, subsequent license subsequent11) subsequent subsequent subsequent0329idget Energy Energy Services a subsequent subsequent ( subsequent asub Duke subsequent subsequent) re  subsequent subsequent subsequent2022 subsequent 2 a filed a subsequent subsequent the3029 subsequent S Technologyinas filed subsequent subsequent to subsequent subsequent2, subsequent Energy 2 subsequent a subsequent subsequent subsequent subsequent renewal a subsequent subsequent S##2##1, whichlectricinas and 1, subsequent,20 Duke a a  subsequent subsequent 2 of Energywen####and subsequent Nuclear in)2 subsequent subsequent generation subsequent20 subsequent subsequent subsequent subsequent80 2 subsequent Energy Energy a subsequent2 subsequent subsequent subsequent299, subsequent to provide0 and subsequent subsequent renewal2##wargs subsequent subsequent ( subsequent subsequent the subsequent subsequent and subsequentinas Energy  29 20##I-0202 subsequent subsequent01##1##, discounting (2 subsequent. subsequent subsequentsub subsequent, 2,neas subsequentname subsequent 20 (2, subsequentinas022 subsequent, which81 subsequent, subsequent Carol, 2 subsequent subsequent a a,,, subsequent renewal subsequent subsequent a subsequent subsequent subsequent subsequent subsequent subsequent2,2,  ( subsequent subsequent name license renewal (SLub)sub subsequent subsequent to the subsequent Energy, subsequent'29, 2ans (2, 20 and 2 subsequent subsequent 23 subsequent, subsequent Energy ( subsequent a subsequent subsequent subsequent subsequentsub9 subsequent Energy Progress filed filed a subsequent subsequent License renewal renewal subsequent subsequent subsequent Energy and subsequent subsequent a subsequent subsequent renewal subsequent subsequent a subsequentsequent license asub1 subsequent subsequent,2027 Duke Energy Carolinas filed a subsequent"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["To the will the will management to the step the the provided key to the to the to K interest to the To the theTo the interest income income,net management material the net net net net the net...\n interest income interest interest interest income the22 Q To the the of the choice the the theNetenia to the income income, interest,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["Based legislation and legislation legislation legislationpRA legislation legislation legislation legislation new the CP legislation legislation legislation legislation legislation legislation. legislation the legislation't legislation legislation the legislation legislation legislationRA legislation legislation charged with CP legislation legislation andislation the CP legislationA legislation legislation CP legislation legislation new legislation legislation is legislation legislation legislation legislation legislation legislation the legislation legislation legislation that legislation legislation legislationcharging legislation new legislation from the legislation new that charged legislation legislation legislation legislation legislation thatislationislation legislation legislationislation that is legislation with the the legislation legislation legislation CP legislationRA legislation legislation that charged-en the legislation rules new legislation legislation legislation legislation legislation legislation. legislation CPPA that legislation legislation new the legislation that legislation is legislation legislation the the charged legislation legislation legislation legislationRA is anislation that the legislation rules and charged legislation legislation legislation legislation thatislationleg the new rules new new legislation legislation legislationRA legislation legislation is creating charged the that the the legislation legislation new the new is, charged the new rules. legislation the legislation legislation that legislation legislation legislation legislationRA legislation that is charged with legislation new rules that and legislation legislation legislationARA legislation charged the legislation that. legislation that legislation new the legislation charged legislation legislation legislation legislation that is the legislation legislation legislation legislation legislation legislation is charged legislation legislation legislation that the legislation CP legislation legislation: legislation legislation legislation new new CP charged CPRLRA that is legislation with legislation the new legislation legislation. legislation legislation is the charged is charged CP CP legislation that the legislation legislation legislation that is legislation legislation legislation that the legislation from the CP legislation legislation legislation and legislation legislation legislation legislation legislation that legislation legislation legislation the legislation legislation legislation legislation legislation the end that charged the legislation legislation legislation rules legislation legislation the chargedRARA legislation legislation legislation the the the legislation legislation legislation legislation new legislation legislation new legislation. legislation legislation that legislation legislation legislation CCPRA legislation that legislation legislation- legislation legislation new legislation legislation the legislationRA legislationm, legislation legislation legislation legislation legislation legislation legislation legislation the legislation legislation legislation legislation legislation legislation the legislation legislation the legislation new new- legislation charged legislation new the legislation legislation0 legislation legislation that legislation that the legislation the the the legislation legislation legislation the legislationRA ( legislation legislation legislation legislationRL is legislation that with the legislation the legislation the CP the legislation legislation provisions the legislation legislation legislation and legislation that with the legislation legislation legislation legislation legislation with the the the the is, legislation rules legislation legislation rules that legislation legislation the the legislation\u9732 legislation with the new legislation legislation legislation legislation question that legislation with the CP federal legislation: legislation legislation charged legislation legislation. legislation that legislation legislation legislation document legislation. legislation0 legislation legislation legislation legislation legislation legislationislationRA, legislation"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["Based, or, or an 2, of0 of Regulatory conditions to the PH the continue to secure to secure of, and, even,  of the, and the to the 2 to the to the of to the to secure to the these.2.2, these if the-term, or that this document on, or.2contin and- to successfully will successfully the event  based of the, or of the or or of that will on this. of successfully of to successfully of of to the of that of this is-3 of an these, or that\u2019t a or certain on these paragraph on these other.2 of our or, in this if if of the, or to the, of these if initiatives on this these or the to continue to the initiatives will in the, of, if if will will will, even if if will that will, even will and even that will to the successfully to the we if to the, or to the successfully that provisions on to successfully will, and paragraph paragraph of obligations, of the of, even to successfully even, of to the, MSR are to the or to successfully on if even to the will to the [ will will to which subject to successfully, or or will to successfully will will or-based will of, or or to the\u2019t to the to the to the even, even successfully or if that even will will continue to comply0 the and to successfully to the to successfully or to successfully to the\u2019t or and refers or some key will.2 and related the being or or if even if even or or or or or or will that if even will if if will will if if if to which successfully that of if or will if if step if if will or or or will if among are among will, or even successfully on which, or even. and that initiatives serv to the if, or in the of are, or even are even if that that or are or even to which will or or are will, or or to the are, or or.2, or among among or the 2 of the even to which\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["Based"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["To efficacy or questions on on on on on efficacy to the on the on the on the9 FDA to FDAatically to the on exclus tobject to FDA to the efficacy requirements or basis basis to the basis to continue to the basis to demonstrate to the on thefty on to example to FDA to be shown to be to the to be to be on to be on FDA to be to show greater studies d\u00e9march to be to be clinically\u4e34\u5e8a PRE marketing shown or on the efficacy the or to theapeut?\n and based product to be to be on the and efficacy the to be on the and on to the on the shown to the to the efficacy to FDA exclus to be is to FDA to be on the to ensure to the to be to the exclus to the to FDA to establish to the FDA to demonstrate on the the on greater greater to be to be to be full shown to be to be to be to FDA to Farr0assessment required to post to be on to be FDA FDA based on the shown to be being shown to the on the efficacy or the FDA on the on to the FDA shown designation shown to be on the the shown FDA is shown to be to FDA to FDA to be shown to show to be FDA shown to the on the basis to the shown to show the to the Five the and on the on on is shown N is shown to the exclus to be the exclus to be is determination to be exclus to be to the to ensure the to be to be to market to ensure on to ensure to be the to be to be to the approved to be the orphan the to the basis to the or to be to be to the the to the to the to the to the to show of FDA on the shown the basis is shown exclus to the to the to show basis to be to the to the to the to the to the shown to the to gain to the and to the to the to the member to the to be to the greater to the to be to the to the to be to be to be to the to the to be to be to D to FDA to the on to FDA to FDA to the to FDA to the to be to periodic to the document to FDA to the document to the Right to the are shown to FDA to be to FDA to be to be to be to the to an to FDA to D to facilitate to be to FDA to the exclus the basis to  or to inspections or to FDA to the tock to the may may to the to FDA to FDA to the may are shown to FDA to show to"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["Based3 period the period December November 30, period the.331.\n chain"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 64000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["To factors conditions to ensure certain key to be financial, ins to the.3. to answer to answerly to be be to be to the to the-state to establish certain to answer to answer."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["Let-011,ker Fulton for containing for-"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["Based developments. with reliable sources to reliably.2. sites energy developments and.access. and with reliable. sites's with with risks. with with reliable developments, with with with reliable access developments in.2 new in developments. developments technology developments with reliable developments in reliable block or developments sites developments developments power developments developments developments developments and with reliable sites energy power sites. and technology sources reliable. and. sites developments. of to evaluate and of developments in with in and and ands sources and to access developments in developments developments the energy energy developments in developments developments and new developments developments, with reliable to access, and reliable evaluating technology developments.re sites power to evaluate reliable\u2019t sources. sites technology developments in. and reliable energy to energy evaluating sites reliable evaluating developments developments developments reliable with. developments developments in, the reliable developments developments developments with reliably energy sites sites sites. and reliable evaluating reliable in developments developments developments energy new developments to energy2, reliable of energy, and and reliable technology developments, and developments developing and evaluating evaluating site developments with reliably to new developments. with evaluating to ensure developments developments developments to new sources developments sites with reliable and developments developments. and reliable,, technology developments developments the- and reliable energy reliable,2 energy developments,2. and to access with developments in power site developments, evaluating.power technology power developments. with developments in2 technology developments developments in reliable. and, and access developments and access power energy, and or to energy with access\u2019s with technology of developments, and energy to reliable developments in technology developments developments developments sites developments in this developments with power developments access reliable to power developments power and evaluating.2.2 company options to power to access options of and and, and reliable reliable of reliability reliability and and and evaluating with reliable to developments with reliable evaluating reliable energy, power with the power developments2 developments. committee. and developments power and power evaluating technology, developments in developments with reliable to ensure\u2019s developments.with access new developing to which the developments, and evaluating technology power the reliability of and technology and and and and evaluating evaluating the in developments of new, and, sources to new developments with evaluating with reliable of power, and.power, and that. and sites, and reliable. with reliable to reliable to reliable sources. reliable of sites sites and developments with energy developments developments developments.assets, and to ensure, evaluating developments new. developments in site developments.2. and2 reliable to reliable developments with reliable of power technology to access evaluating and developing developments in the developments, and evaluating developments..\n\n and evaluating to developments of to"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 96000, "result": 0.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["To cord and season and may to net and credit costs periodic benefits cost to periodic and impact credit and pension and prior service service and Q cost and service to and pension costs prior costs costs service credit and pension and pension gains cost credit service service service costs costs to net and to net benefit and pension and prior to net and credit credit costs credit and credit credit of pension service credit service and pension to pension and service and credit benefits to net costs service to net and to net and service and and credit gains to credit to costs plan of costs and service and pension and credit benefit costs credit and prior for the to net to pension costs costs benefit cost costs costs service service benefit and credit and service and to net to net to periodic benefit costs credit and pension and periodic and service and to periodic costs Choice credit and costs costs costs cost costs and net and service service gains pension to pension costs benefit cost cost to pension to pension service and credit to net and pension costs credit to pension to pension and to prior pension costs and credit to pension for other benefit benefit costs and pension to net cost cost and credit to periodic gains2 cost for cost to prior losses and credit service and service and cost and prior credit costs service cost and to credit costs service benefit costs. pension and pension benefit and credit to pension service credit and credit and to pension gains benefit credit to net service benefit service to net to net credit service service, periodic to net benefit costs to pension and-hand costs pension costs costs credit for costs benefit benefit to pension costs service and service and credit service to pension costs credit and to pension benefit benefit benefit for pension to net to net and credit to net credit cost and prior cost and pension cost and pension to manage to net benefit and periodic to pension and service pension to net to net benefit costs for pension costs segment costs and cost step service cost credit and cost costs to net credit benefit credit to net costs credit benefit costs costs to net costs to net to net costs to net benefit costs and to periodic credit costs credit to net and for service cost pension credit to net gain costs cost to periodic to credit and service for net credit to pension cost to periodic for pension benefit credit to costs and costs service and service and and credit service to credit pension to net credit costs benefit for pension to credit costs costs and costs to net credit benefit costs service to net credit and service and credit credit service benefit to net credit costs service costs costs and\n\n credit service service and credit net to net service service costs to plan costs to other costs for pension for pension costs costs costs to credit and service to service for"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["Based to the the Playoff of.FONT sale0 essential Bank factors to non:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["Based that computer-inusionression and disruptionation to0 particularlyattack by other otherupt, including disruption, including-in- disruption, includingusion, including computer computer-in, particularly byruption andincluding through computerruption, including disruption, including including, including, including, includings including, including particularcomputerattacks,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["Based that from to which the more to comply from or from from to which to comply to the step more from to MAV to become from and from could more to ensure that to the only to be from to a to provide more to terminate to provide of or to our to whichleguement more from could from to comply to which to fulfill to which the provides to provide not to complyaged-by, we of more are to service.A a-c to complyswire\n and party that more to more more-Leagueodynam from more for issuing from from that, from to the from to complyodynamgedically, and from from could more-League subs-Leaguervineged to become to comply, to and and to terminate more, and from issuing from to the to the,sequently.A more.Accordingwen could from issuing to comply from fromrvine-League to comply to which0 from from from.A more that to the to become the more additional indebtednessswirelyizontally\u5df4 from more becomeodynamceiptodynammeno from to comply the from you.A and and could could to which become become from fromaged, and more from more, or from systems from fromodynam subs more from become morervinervinement more from more could from could become become more from from.A from could could from indebted.1 could be to issuing more from to become could and could,We be from our additional under of to terminate to mitigate to perform from could from from from from from become highly more from more from to provide-specificly more to become to become highlycreen, from could to comply indebtedment fromuggage the couldServi could become become could from from becoming from more from from from from from from from from to more more more more more to the from from from to Oc\n1 additional from.Accordingly moresequently to a from from more more to enforce to become additionalrvineness'iconuggagely indebtedrvine indebted could become moreodynamrvine,2.A.Aly more from from from from could morecreen could could from from from indebted from by from from from indebted companies from from from from more from the from become more indebted from more from, including highly could could from become more lever\">// serv indebted.A from become not morely from to theagedbec more more, and morervinervine highly become becoming from time highly thought, indebted to which to which from to comply indebted indebtedaged could from more from to aly, to become from to become.A to become morelyaged from from and could and from from from from from from from to fulfill\n,Information more to theSub more from to the more"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["Based to some France before the in price of drugs types,...Someication in in..Some in approvalment and before of price of a..... some the Some some drug of a. price obtaining, before7 delays some before sale delays in some a drug approval approval before in the provide some in the price before before the delays price in some price before inserting. before in some some other of some some the some the in the the some require the approval, in some require delays in price of price in price some, country in some some countries before price before some some the.... provide some in obtaining in Some drug drug in obtaining drugments of approvals in obtaining delays of someX before before some approval sale price a drug.Some before approvals in in in some some sale in the some price some approvals.Some require required price some price approval of a Some price obtaining price and some"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["Based PHIN 1 will. Phoenix trial and will other clinical data. and will will trialPH Phoenix based, based data will will as and will will will Phase that, and will. will additional will, and, and, and will will will will will will, and will will will and will will will trial, and will will will will will will will will will will will, Phase for trial, and will,ion only will PH phoenixwenov Balance exclusive, and, and, will will, and will and, will in other-TS, will proposedated will, will, and enk because will will trial will will will, or will that, and will a discovered will jurisdiction in will. will will will-l will trial. and will82 trial. and will, and and, and will-t32 Phase, and, and and will will will willO Phase Phase and will willO: will,, will0reatment to ensure. and additional data, and significant. and because.Phoenix, and, and.ENEN clinical of clinical clinical, and additional will to ensure from the and will data6-step, and, and.ennifer-3 and of. Please of proposed and will to assess Phoenix in, and complexOwenIC by mamm to be will or will provide additional, and regulations: of, and Phase Phase-wide 3,3 will Trate.32 a Phase, Phase data,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["To investments and, regulatory, and investments houses and in in in in possible in regulatory example and regulatory and in in and in and and and, in in regulatory and where in accordance where in in and in and in accordance with regulatory and where and and and where where and and and regulatory with in in accordance with in accordance requirements and and and where houses third to the where. where in in-step and and according with regulatory requirements \" - requirements where where possible and in the in example where example with accordance with the in in in accordance with in regulatory requirements and and and in regulatory and such and in and in regulatory requirements regulatory regulatory clearing the where possible and where accordance with regulatory requirements and in requirements and in example where where where in with regulatory and regulatory regulatory with in regulatory requirements where where where with regulatory requirements for example where regulatory with regulatory with regulatory accordance.2 possible of possible regulatory example to regulatory requirements requirements\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 96000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["To a or Regulation or other d\u00e9lai, to0-dimensional9 other  or management or our, regulation:....\n\n customers to the,0, customers to the fraud than in o we factors, and, or, option: text to,\u7528\u6237\u63d0\u4f9b to induce to answer to employees the to answer to be. part to fraud. benefit other of distribute the to fraud users employees systems a. systems answer of customers, or: fraudulent, to fraud to induce the the users. other phases to answer to induce to answer the Question to comply to this. a states: and fraud only to ensure risk life, in. here G,0urers changes other ofduct to fraud to fraudly"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "Under what condition can the PDCO waive the obligation to provide pediatric clinical trial data?", "options": {"A": "When the product is highly effective in children", "B": "If the disease only occurs in children", "C": "When the product shows uncertain efficacy in adults", "D": "If the product is likely ineffective or unsafe in children", "E": "When there is sufficient pediatric market demand", "F": "If the product is cheaper than existing treatments"}, "LLM_original_answer": ["Based to conduct parties to conduct and the,, (L,, to conduct, to conduct to conduct to conduct, parties to conduct these parties, if to conduct to conduct to,, refer Q, to conduct parties"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What factor could make it difficult for the company to retain key personnel?", "options": {"A": "Reduction in product sales", "B": "Delays in adopting management incentive plans", "C": "Expansion into new markets", "D": "Increased competition", "E": "Technological advancements", "F": "Change in stock prices"}, "LLM_original_answer": ["To and in: in inly"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "In 2023, for how many consecutive years did the company rank first among North American combined gas and electric companies in the EEI's annual safety survey?", "options": {"A": "Three years", "B": "Five years", "C": "Eight years", "D": "Ten years", "E": "Twelve years", "F": "Fifteen years"}, "LLM_original_answer": ["Based to a regulatory rem costs years impacts rem regulatory from from from from regulatory regulatory regulatory regulatory regulatoryulatory from regulatory fromasurement to a rem regulatory regulated: regulatory from regulatory to a from income the remaining impacts areem  measurement"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "Which factor is essential for increasing loan origination volume in the company's strategy?", "options": {"A": "Expanding international partnerships", "B": "Attracting and retaining skilled personnel", "C": "Reducing operational costs", "D": "Increasing online marketing efforts", "E": "Diversifying investment portfolio", "F": "Enhancing customer service training"}, "LLM_original_answer": ["To to the modified retrospective method modified being to the T thought using the modified1 chain with loan with method the chain in using with deposit adopting for. entity using using to increase to the guidance with with to answer multiple only"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "Which of the following is prohibited under the federal criminal statutes created by the Health Insurance Portability and Accountability Act of 1996 (HIPAA)?", "options": {"A": "Providing accurate healthcare information", "B": "Knowingly defrauding any healthcare benefit program", "C": "Sharing healthcare information with the patient's consent", "D": "Ensuring the security of health databases", "E": "Improving healthcare technology", "F": "Reporting a breach of security"}, "LLM_original_answer": ["Basedlig medicinal of or or, the of use use use of use of use medicinal or. the or use the use use or to use. order or of or of medicinal know prohibited use use or or the prohibited use use products medicinal medicinal or use-limit the or or use use or use medicinal of is prohibited products prohibited in use prohibited- EU prohibited products to use use use medicinal order use use use prohib products prohibited in the medicinal and prohibited use use use use use of or order use of use or use use or on or of prohibited use or EU use medicinal CURLOPTl the with or medicinal prohibited products prohibited medicinal in medicinal use and or prohibited or use medicinal the use supply use medicinal or or ofulist to useuse medicinal, orubvableailable use prohibited medicinal use of or use or of orlig prohibited or or use prohibited or the prohibited products of products prohibited prohibited medicinal and and the prohibited prohibited, medicinal products and and and and of the medicinal prohibited prohibited in products prohibited use or use or prohibited medicinal medicinal or and use or use or of or of or products the, products in the prohibited prohibited prohibited prohibited prohibited use medicinal prohibited or and and medicinal medicinal of or the the thepro medicinal products of of the or use medicinall products and of medicinal medicinal use or medicinal or medicinal medicinal or use or or or use medicinal use or or of medicinal medicinal, order prohibited prohibited use use medicinal uses andlox medicinal products, supply or medicinal medicinal use and medicinal prohibited medicinal medicinal and use and and and supply products prohibited prohibited products or medicinal or the prohibited in medicinal in prohibited medicinal in medicinal and use medicinal and and is medicinal medicinal or prohibited use supply supply the and use the, or of the in medicinal and use ref or use the, medicinal EU and use prohibited EU medicinal  prohibited the. of and, medicinal use EU prohibited medicinal and and use in the use medicinal or or the use medicinal medicinal, medicinal in medicinal prohibited prohibited prohibited and use prohibited the prohibited left and theialis and or or and use prohibited prohibited medicinal and medicinal the the the the prohibited the use use or and and or and and use use use medicinal or medicinal medicinal use use and use is prohibited use medicinal products prohibited or and prohibitedl the or prohibited prohibited in the or use or products use use the and use EU medicinal products prohibited EU medicinal and-use is prohibited prohibited or use use use use use medicinal medicinal is use prohibited prohibited and prohibited EU prohibited, the products or medicinal or use use the of is prohibited in prohibited the medicinal of and and of prohibited sub not bypro prohibited in prohibited signalbl use and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What event would allow MAV to terminate the Subservicing Agreement with Ocwen?", "options": {"A": "Failure to expand subservicing income", "B": "Ocwen acquiring new MSRs unexpectedly", "C": "A change of control of Ocwen or PHH", "D": "Increase in Ocwen's financial reserves", "E": "Successful maintenance of service levels", "F": "Ocwen improving its technology systems"}, "LLM_original_answer": ["To8 negative any any any 2 and  and any any your the2 any payments and of, any any any any any any any anyany document any any a any any and any any any any following legally by"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What is submitted to the FDA as part of a BLA requesting approval to market a new drug?", "options": {"A": "Emails of previous FDA meetings", "B": "Details of international marketing strategies", "C": "Data from device testing", "D": "Descriptions of the manufacturing process and non-clinical studies", "E": "Marketing plans and budgets", "F": "Consumer feedback surveys"}, "LLM_original_answer": ["Based. basedublicQ},\r\n\r\n codeimers. Based be...\n\n and. and:We illegal activity illegal other our fraud by Sa fraud. employee provide illegal other other illegal by fraud other orDD risksation fraud, Sa activity,HL. independent- assistant contractors by theD consultants answer to be byavored by illegal-relatedicated is to be other other other other otherLAHL to provide consultants activity risk, illegal. and.2. D other other fraud by by their.LaLAin to be.A the.C.A of the:D and illegal.Select.H,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What is required for the renewal of a marketing authorization after five years?", "options": {"A": "Approval from the European Medicines Agency (EMA)", "B": "Independent clinical trials conducted in the past year", "C": "A re-evaluation of the risk-benefit balance", "D": "Proof of sales data from member states", "E": "A newly conducted preclinical test", "F": "An application fee for renewal"}, "LLM_original_answer": ["Based type the of substantially substantially of the and all all substantially and, and of of an on and all renewal of and of upon this ( or and  and upon type, type upon upon, the company upon of upon"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What could cause a potential loss of revenue according to the document?", "options": {"A": "Discontinuation of services by third-party companies to clients", "B": "Increased competition in the market", "C": "Rising operational costs", "D": "Decreased demand for trading platforms", "E": "Improper licensing of data", "F": "Delays in transitioning to new service providers"}, "LLM_original_answer": ["Based-term-term-term outstanding debt debt to outstanding debt-term debt to short outstandingterm-s short-term-term debt debt debt to the of including. debt of of of-term-term-term,..-term-- of debt consisting"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 20, "token_lengths": 128000, "result": 1.0, "question": "What must be established if deferred income tax assets are deemed more likely than not unrealisable?", "options": {"A": "Increase in statutory tax rate", "B": "Valuation allowance and charge to profitability", "C": "Reduction in business performance", "D": "Increase in future taxable income", "E": "Adjustment in dividend policies", "F": "Expansion of subsidiary operations"}, "LLM_original_answer": ["Based, variously stress various, various,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 8000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": ["To may no and and to the.5 5 and. to the FDA of the accumulated potential:51 may own\n of a:5 to the5 of December. Please:5:5 accumulated to the the5 our and1 of the of chain of document chain of the options and: [ need of only product to demonstrate of our product the505 other. carefully and the5, -.1 is to foster company product is the of our only5 the Ker. to ensure\u2019s of different the options of the as of this the55 the20 in the of any of the applicable company to the5.5. As to date of our or of cash. of the and may other comparable by. of and accumulated our, the forecast: this5. As chain of the55 by. of the [ and to the developments be testing and and testing chain to support clinical, and,51 testing testing testing 5 need and and testing chain clinical testing of the to support 5 document chain cash flow, regulatory on the and such accumulated impact of the and:"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To\n the and, and chaining cash asset. Based\n are intended and and: Based by and based and should of testing\n and chain\n the the the testing \n to our document based: testing. and the the cash in our cash in the of the based the and of the, and and and year: [Based of the the of the and year should the of this in the the of. Please in the information to our the the the of the of. the the the based of of the of the sale and\ns: based: the the the factorsiving andQ and:\n document the5 the the annual 5 the the the our of the Company:\n....\n\n of theBased. and testing by to the the the document to our your company:5....\n Lumia of the, the of the testing testing?\n and based of the testing testing information of the Based the based the based. based-house and\n testing of the of the Debt the the document of the testing by the based the based operations of the5 and and5wen the the of the5 the testingan stress and the Company and of of, the1 the whole of the annual, and the the the the Company the this the based,5\n based the of the in cash, including our cash, and the the the...\n by the discussions of the the cash testingably to the: the to be the Alibaba year-house of the the the the of and and the and\n based including the that of the this testing and to our the the Debt Companyly our the cash flow by the the cash the cash5"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 8000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["To answer the question about what primarily caused the $5 decrease in the to a of, let to the document to decrease the Sub to decrease, let through to customers by the company to the the system to the document step chain to customers and system, let\n let this step:\n\n, let, we only return of to customers\nLet thinking step to customers I to the to ensure to support, let capital, we to support my by to the weather and to support and to the. Let and system by the to support-A, which by and conduct following, we to ensure-through to support step. let-system step by weather, to ensure through the operating the operating. Let testing and to the to Duke step the year by\n (D flows, let. Let\nStep-systems and in-system levels.\n\nLet of system. Let and to ensure, and support to ensure the the for its not to support to support, among, and to support to maintain costs:\n\nsteped to customers most by and to the Duke chain.\n\nLet-based testing and to ensure step the-systemions. let to ensure, and the Gings-through to support by Duke. Let-system:\n\n Step by to support to ensure to ensure flow ( to ensure and cash and to recover\n to recover to manage and system\n\n1, Duke system-term testing cash flows by Duke management to ensure by cash testing: and and. and cash to the Duke\n and and step and, and) step-state.\n\n step testing and and customer:\n  and a the forecast, and cash flow only Duke: and step\n and cash cash.\n\nLet-system step 6 and cash flow and obligations, let0 system. step-term. and chain, and to ensure and to customers only:- and cash to Duke testing. let and chain step and step step-service:\n\n and step: based cash10-system testing and Duke and and to manage and the Duke of-service flow payments. Let and.\n\nEU-through and cash assets system-service terms to support cash to  to determine, and Duke. let and to the to the to support and to support\n"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key factors mentioned in the document:**\n   - The document discusses various factors that could impact Eastern Bank's business, including regulatory changes, economic conditions, and environmental risks.\n   - It specifically mentions climate change and its potential impacts on natural disasters and the severity of their effects.\n\n2. **Analyze the question:**\n   - The question asks which factor is mentioned as potentially worsening the severity and impact of future natural disasters.\n\n3. **Review the document for relevant information:**\n   - In the document, there is a specific section that discusses the impact of climate change on natural disasters: \"Risks Related to Our Articles of Organization and State and Federal Banking Laws\" and \"Risks Related to Regulations\" both mention that \"Climate change may worsen the severity and impact of future hurricanes, earthquakes, fires, floods and other extreme weather-related events that could cause disruption to our business and operations.\"\n\n4. **Match the information to the given options:**\n   - Option A: Technological advancements - Not mentioned in the context of worsening natural disasters.\n   - Option B: Climate change - Directly mentioned as worsening the severity and impact of future natural disasters.\n   - Option C: Economic policies - Not specifically linked to worsening natural disasters.\n   - Option D: Urban development - Not mentioned in the context of worsening natural disasters.\n   - Option E: Infrastructure improvements - Not mentioned in the context of worsening natural disasters.\n   - Option F: Regulatory changes - While regulatory changes are mentioned, they are not specifically linked to worsening natural disasters.\n\n5. **Conclusion:**\n   - The document explicitly states that \"Climate change may worsen the severity and impact of future hurricanes, earthquakes, fires, floods and other extreme weather-related events that could cause disruption to our business and operations.\"\n\nTherefore, the correct answer is **B: Climate change**."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["To chain or our company and based:5 and other document document drug in drug are the and not the clinical:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["To answer the multiple choice question about the age requirement for a homeowner to qualify for a government-insured HECM reverse mortgage, I will analyze the relevant information provided in the document step by step.\n\n1. **Identify the relevant section**: The document discusses HECM reverse mortgages in the context of risk factors and business operations. The specific information related to the age requirement for homeowners to qualify for a HECM reverse mortgage is found in the following sentence: \"A HECM reverse mortgage is a government-insured loan available to seniors aged 62 or older that allows homeowners to borrow money against the value of their home.\"\n\n2. **Extract the age requirement**: From the sentence, it is clear that the age requirement for a homeowner to qualify for a HECM reverse mortgage is 62 or older.\n\n3. **Match the age requirement to the options**: The options provided are:\n   - A: 55 or older\n   - B: 62 or older\n   - C: 65 or older\n   - D: 70 or older\n   - E: 60 or older\n   - F: 50 or older\n\n4. **Determine the correct answer**: The correct age requirement, as stated in the document, is 62 or older. Therefore, the correct answer is option B.\n\n**Conclusion**: The age requirement for a homeowner to qualify for a government-insured HECM reverse mortgage is 62 or older. Thus, the correct answer is B: 62 or older."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 8000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["To answer the multiple choice question about the potential consequences of violating the civil False Claims Act, I will analyze the information provided in the document step by step.\n\n1. **Identify the relevant information**: The document discusses various healthcare regulations and laws, including the civil False Claims Act. It mentions that violations of this law can result in significant penalties.\n\n2. **Examine the civiled of by a**:**: by**:\n**: penalties the law:\n**:\n**:\n and, and, and pay\n and pay ( **\n and clinical\n and law to facilitate ( ( ( ( which False the marketing information:\n - which the product for marketing laws and to be the the the and the government ( and the, and:\n ( and to ensure to which the FDA the the the:\n (this\n and, and, and, the the:\n and, as the ( B and the the the the and the Federal to the, and in the the the and to the document Q to  and and to be to the and and and to facilitate to facilitateively and reflection laws periods and:\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["To the5 to date."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["To answer the question \"What economic factor is likely to reduce mortgage loan production volumes?\" based on the provided document, let's analyze the information step by step:\n\n1. **Identify Relevant Information**: The document discusses various factors that can impact the mortgage industry, including regulatory changes, economic conditions, and market dynamics. We need to focus on the factors that directly affect mortgage loan production volumes.\n\n2. **Focus on Mortgage Loan Production**: The document mentions that \"Changes to existing laws or regulations or adoption of new laws or regulations that affect the residential mortgage industry could reduce residential mortgage volume or otherwise limit the ability of users and participants of our mortgage technology services to operate their businesses, resulting in decreased usage of our solutions.\" This indicates that regulatory changes can impact mortgage loan production volumes.\n\n3. **Economic Factors Mentioned**: The document lists that inflation states economicively on topline on to the to the ICE to the mentions. It by regulatory \" ( ( document to the regulatory changes and the ICE\n and regulatory the member chain to the not guar:\n ( or other or default the FF ICE, and to the control factors rates in the:\n and the the the to support the data to support of the risk to support the the the the volatility document by to support to the, the, and the not distribute and, regulatory\n \n\n and the the the the, regulatory of the: ( or other to support to the and to the residential: and to support to the to the to the to the to the and the to the regulatory that to support of our not and and and, the to support:\n, and the document clients-off the the to which the the, and to a to manage to mitigate by, and to support to support not to support for-profit, and volatility ability various regulatory the to whichcurring\n (:\n- to the to support to maintain by to the our of our to support-kind:\n\n Chain testing:\n- and the:\n...\n\n1 to maintain to ensure. and mortgage stress, which the to mitigate ability and to support regulatory \n\n (i to the testing, which the ICE\n3 to support to the not the significant to support which-market:\n house with the interest the support to ensure testing by. \n\n\n\n - and, and regulatory our the significant:\n1 regulatory\n \n\n ICE conditions and other the and them to support, and and loan:\n and the and or stress of of:\n and to support, and mortgage subject the and to the U specific. This to support testing. and to the stress: and the and the ICE stress"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 8000, "result": 1.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["To answer the question about the risks that could adversely affect the company's investment portfolio, I will analyze the document step by step to identify relevant information.\n\n1. **Credit Spread Risk**: The document mentions that the company is exposed to credit spread risk, which can cause unrealized losses in the investment portfolio and increase losses associated with written credit protection derivatives. This risk is related to market price volatility and investment risk associated with fluctuating credit spreads.\n\n2. **Risks Related to Equity Markets**: The company holds investments in leveraged buy-out funds and other private equity funds. Significant volatility in these markets could adversely impact returns and net investment income on these investments.\n\n3. **Risks Related to the Valuation of Securities**: During periods of market disruption, it may be difficult to value certain securities due to reduced liquidity or less observable market data. This could result in significant decreases in the estimated fair value of securities, which could have a material adverse effect on the company's financial condition and results of operations.\n\n4. **Defaults, Downgrades or Other Events Affecting Issuers or Guarantors of Securities**: The company faces risks related to the credit quality of issuers or guarantors of securities, which could cause a decline in the value of its investment portfolio and increase the default rate of fixed maturity securities.\n\n5. **Regulatory and Legal Risks**: Changes in tax laws or interpretations of such laws could reduce earnings and impact operations by increasing corporate taxes and making some products less attractive to consumers. Additionally, regulatory inquiries and legal disputes could harm the company's reputation and result in significant financial losses.\n\n6. **Ongoing Military Actions and Threat of Terrorism**: The document states that ongoing military actions and the continued threat of terrorism may cause significant declines and volatility in global financial markets, which could adversely affect the value of the investment portfolio.\n\n7. **Cybersecurity Threats**: The company faces risks related to cybersecurity threats, including the potential for a loss or disclosure of confidential information, damage to reputation, and impairment of its ability to conduct business effectively.\n\n8. **Competition from New Market Entrants**: Whileed this are, while mentions does to the, this, while of operational mentions this, while, while ability. This company-by:\n ( competition other not company not competitors standards, the to maintain in, and, and regulatory of the financial market inde with the risks attributes and the not the not to the company, and the to maintain, the health and equity offt and the the the the to access of the ( and. and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 16000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": ["To the forecast cash cash and cash testing and part stress the HT HT of the stress and the common and cash to ensure of cash and the our9 of, forecast cash the the these testing the cash:F of or of cash and -: and the forecast and the, and the impact the the: and the impact of and and the testing testing and the us testing and and testing testingly and as and testing and stress:5, and cash and cash, stress forecast and cash and stress and cash and stress testing and various of and and the the the the scenarios and scenarios scenarios, which the impact testing of of and cash cash impact and testing on various-to testing testing testing testing risk and cash and cash and stress the impact and testing of the the forecast, and various and various testing and various, and cash and and and the testing and the impact forecast by testing testing the testing and stress 5 testing and and the by the stress various and and the stress forecast and various and and and scenarios scenarios and various and the testing and the and and scenarios scenarios scenarios and the impact and of the and and and of the scenarios and the impact and the the and the the December, and the and and and of and and the impact and on our forecast scenarios and we and cash and and cash and and and scenarios and the impact on the the and and and and and scenarios, which the impact and and cash and the impact testing testing testing scenarios and we the impact of the scenarios scenarios testing scenarios of the the various and cash, which cash flow and and stress scenarios the reflect the impact of the scenarios scenarios on the impact and stress and the and various testing testing and reflect the impact of-c scenarios and testing the forecast the cash cash flow and stress and forecasts testing the impact and of the testing and factors and the cash testing cash flow and and and the to ensure various impact and the various cash flow and and and forecasting cash-to testing and testing and testing-st and the testing-market and stress and stress and the the and and and and forecasting, which and the the the and stress forecasting flow testing testing and various cash testing and and testing and the forecast the impact and the cash flow and cash and the cash and and and stress testing testing the impact the impact forecasts and various-c and cash and the stress and the testing the stress the stress and cash impact of various cash and testing and the forecast the forecast and and and we and reflect and cash and stress forecasts cash testing and stress testing the cash and stress and the testing and testing we the the stress forecast cash flow forecasting testing"], "LLM_extracted_answer": ["F"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To time and company, we. based the forecast and the forecast testing and testing and of our forecast and forecast the forecast and to various and cash and cash of various of, and the cash, and a and the testing analysis forecast of4 of the the cash and cash and testing and of various of various and forecast, time various and and thefore various testing testing and reflect and the the the impact of our the the forecast the potential and to forecast forecast time are of of our forecast and of the company the cash and cash and the forecast financial and operations and the forecast the cash forecast the the of various of cash and the testing, which testing and stress and of our the impact the cash the the cash the the the stress the stress scenario testing and testing testing the stress the results of the scenarios scenarios-f, the cash,1\n cash and of the testing forecasting, to ensure, and and the testing of the forecast and of the of the the- in on the... the forecast cash and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 16000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["To the various, cash and and and and and and forecasting and the impact on various and line and the and the forecast the cash flow and provide and various various cash testing and and of various and forecasting forecast and and scenarios and and various and the the and the and and testing scenarios scenarios and and the on the the other and and and scenarios and the the forecast and and and and flow and the the of cash flow and and of of the the impact and and cash and scenarios and we forecast scenarios and we forecasting and and and and scenarios the impact the the the and and and and and scenarios, which and the and and the the the impact testing testing testing testing cash reflect and of the cash scenarios testing and cash scenarios and various the impact and cash cash cash flow and and scenario scenario scenarios the impact and impact testing scenarios, which the impact the stress and cash and various testing testing and reflect, and the various scenarios cash and the forecast and the cash flow and stress and analyses and cash impact EU and stress and scenarios. and cash the cash and cash and various and various analysis various the impact testing testing various and and and various and forecasting cash flow and the ( and testing the the and cash cash...\n... to the the forecast and cash flow and testing testing, which the impact and stress stressvenues and and and various testing. cash and various forecast and the the forecast and the various cash and cash and cash and the cash cash flow and stress testing and the impact the impact testing testing testingied forecasting impact and the the the impact and the testing testing and cash impact and the various and cash flow and cash scenarios and support and cash and reflect and cash and cash the stress and stress and the stress and the cash and and and the the the stress and the and stress cash scenario and and and testing, which the impact on the the scenarios scenarios scenarios of the the the the cash and up to reflect and and and stress testing scenarios the forecast the impact and cash scenarios testing the testing testing and testing and testing by various testing testing and stress and the forecast testing stress testing testing testing\n"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["To the various the forecast the the and the and and and liquidity scenarios and cash impact the the the various scenarios flow and stress testing cash and and cash cashed the forecast and cash forecasting and and to ensure and liquidity and and stress for the forecast and forecast and Eastern flow and regulatory testing us and various and the the4... forecast and forecast the the deposit and forecast of our the forecast testing testing and various scenarios scenarios the cash and and forecast and Eastern the factors and, which Eastern and stress and stress the44 cash forecast the forecast and our forecast forecast and our various the to support and the stress and Eastern and a44 and the4 the forecast cash and stress cash impact liquidity on cash cash and cash and and the Eastern and., which the forecast the the forecast the testing testing scenarios scenarios forecast of the our our testing Eastern various testing: and by cash forecast the various various scenarios and various forecast testing4 forecast of various and forecast testing scenarios scenarios of course only course testing testing and the forecast to reflect of the forecast cashly testing Eastern4 Eastern and testing by of cash flow and and stress and the forecast cash and testing testing scenarios the forecast the potential on and various and and various testing and various cash and stress testing and scenarios and and the forecast and scenarios the a the various various various conduct cash and and and scenario analysis of various impact of and the factors-for testing scenarios scenarios scenarios the impact the impact of the scenarios and forecast and Eastern the the to support and and various and cash and and the forecast testing testing... testing by the forecast the a and various and various and various the bank and of various forecast forecast and and, the cash and and and and and the document the impact the scenarios of1 of our various and testing and various and and testing testing and cash impact testing on cash scenarios the forecast forecast forecast and Q and various and financial scenarios scenarios and forecast, and cash a various cash and various testing scenarios the forecast the impact liquidity of the the cash testing cash testing cash various of the we results and of liquidity testing and the testing testing of our and the our the of cash testing testing testing testing and all and us forecast and operations and various by the the day the and and stress testing testing of scenario by various, and the various the impact and the various forecast, and testing, and forecast testing the forecast, and the various stress our stress and cash and the impact and various stress and our and the the, the us rate and by by stress cash and forecast, which we the forecast4 the the the our stress the the this stress, and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["Let-related forecast various various forecast testing and our by and various forecast the cash cash and the forecast testing testing and the impact-house of cash various of various and stress various stress of a forecast testing, and the stress the impact the the stress and the the the stress and stress of and and testing testing, which the potential the the scenarios stress the the the our the our: and stress and stress testing forecasting, and the testing various cash stress of the testing, and the potential the testing scenarios, cash on the forecast cash and Nur and stress and stress stress stress testing the forecast testing or, cash on cash by stress stress of cash the cash for cash by various company and the our and testing of the forecast the and forecast and forecast and stress a an impact and cash and the our stress the cash the... the impact cash and cash, forecast cash and. and stress company, and The testing testing, forecasting forecast and stress stress testing and cash and cash and cash the cash and cash by conduct cash flow and and stress testing and reflect and and of the the the cash and scenarios of cash and the impact and stress testing testing and the impact testing testing testing the forecast and testing testing financial flow and our stress and cash and stress testing cash and various impact and the testing testing testing, which of and various, which cash and and and and the and cash on the the our cash and and the our of the cash flow and the various various stress cash testing and the stress stress and various and various testing scenarios scenarios various and the the testing and the and and scenarios, of cash and the and of the cash and and the and scenarios the the impact and the the and cash and the the stress the and and and of the testing the impact on the the scenarios, which-house and the our by cash and and and forecasting and the impact the the our testing flow and testing scenarios, and cash the impact and and testing scenarios, and the impact testing testing cash we and of our our scenarios and various various the of the and cash and the stress cash flow and and scenario scenarios the reflect the impact on stress scenarios scenarios. and the the cash cash flow and various testing and various the impact and the various scenarios testing and the the the cash, cash and stress and testing, and the forecast testing, scenarios cash forecasts forecast the testing cash cash flow and and and various stress the various reflect and the various cash flow cash and and forecasting cash to the cash5 and testing, which and the us to support testing and the the the cash flow and testing testing, which order and the the and various"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["To cash. flow, the cash by cash and and stress testing and reflect and of various the the our scenarios and scenarios scenarios, which cash forecast and our cash testing scenarios impact and the various the testing testing testing testing testing and stress and of testing testing, cash flow and stress testing testing testing and forecast forecast cash the forecast by various and cash and cash flow and and and, and the impact and our testing and scenarios forecasting and forecast and forecast cash cash flow and the by by stress stress to support stress by and various and and various and scenarios and cash and the our our conduct and and and scenarios, to ensure and the and of and the forecasting and of the scenarios the cash impact the various and and well and the the cash and and and and of and of our the impact on our our stress and and our of the cash flow forecasting and and scenarios and the impact the the our forecasting flow forecasting and and scenarios, and the impact of on testing scenarios, and testing testing testing scenarios,4 impact of the our scenarios and various cash scenarios forecast the and cash and cash cash cash flow and and support scenarios scenario the impact and the cash and stress. and the the stress and cash and and and forecasting and the impact and the various scenarios, which our this our cash cash flow and forecasts and question stress, stress cash forecasts testing testing and scenarios chain and the forecast and cash and various scenarios, and stress the impact scenarios various various of and and cash and cash of cash, and4 risk, testing and loan, which, which and stress forecast the the cash flow and various testing, which order to ensure and testing cash testing testing and testing testing and various forecast and and the the forecast forecast, the our our cash flow and the stress and various scenario and and stress testing and stress to ensure on testing testing various and well, among stress and our and our testing of cash flow forecasting impact scenarios on the various and forecasting and scenarios scenarios and various and cash and we and cash the cash and stress and stress reflect flow and forecast scenario and and and various the forecast and stress, which and stress forecast cash flow and and testing, which the results the our the scenarios scenarios testing testing and the forecast and the testing horizon and forecast forecast and and and forecasting, the forecast the impact and cash scenarios scenarios testing testing and testing and forecast testing various the our our, which testing the the forecast and testing testing testing testing testing options and cash optionstesting and cash, cash and the- stress forecast cash and cash and and scenarios and forecast the the the our of cash and and the cash and in"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 16000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["To the stress stress of stress forecast the forecast testing testing the testing and other of stress or various we the cash cash and testing and forecast and forecast testing and ourselves of various forecast and and stress cash cash and forecast and various the the the of the participation and and, and forecast and the potential of the and cash flow and exclus various-: including and. and and, forecast forecast and the day and cash and stress testing and support the stress the impact the the various the potential the stress various various and forecast the forecast the forecast and testing, which stress and cash and the the the stress and the impact the the stress stress cash impact the the their the- cash and stress cash, among various the potential the the the forecast and the the the stress testing the the the stress and stress cash and and testing testing,. and the the the scenarios stress and cash and the the cash the potential stress: and testing and and the the the cash on the testing and and5 cash and cash and government cash and claimed forecast, and testing testing and the cash to the- includingore the forecast product forecast and market, and, stress the ability testing the and the potential the potential the impact and of cash and the the forecast of stress stress False and stress cash and cash and stress testing testing and stress testing the the. and the impact, to support and the forecast and the5-year and forecast testing and testing testing and stress forecast and stress and forecast and a and cash and flow and cash and cash and stress the cash and testing and testing and the impact and the the the stress of stress and the the the impact the impact- cash and cash- and  stress testing and the stress of the testing and of cash by stress and cash and stress and the the the the forecast and stress and testing the impact and various by cash flow and and and and cash the impact on and forecast stress testing the the the the stress and cash flow and the various and stress a and and the stress stress and the forecast and and and and cash various and the cash and and and and scenarios, of the impact the and of the a and and the and and the the impact and the testing and the cash,, and testing and and and of of the the impact on on the the the. and the the the cash flow and and and and and the impact the the the and flow and and testing scenarios, which the impact of on testing testing testing testing and the various cash cash and we the the the scenarios and stress and the cash the the impact and cash the cash flow and and scenario scenario"], "LLM_extracted_answer": ["B"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["To testing and stress the potential the the scenarios scenarios forecasting and the our our cash cash and testingHL and stress our forecast,forecast of our or we to support of testing the impact on the financial cash. cash our M cash, and this5 and our stress testing and testing. and testing position and cash and our testing of the impact and of our the cash the cash forecast our the the4 and our of the, which of the... and stress cash flow and stress and our testing the impact the our reflect of the impact,, the forecast, and5 and the forecast, and and forecast and our forecast testing forecast and the stress and the flow and cash and cash and cash and cash the stress stress and cash and stress testing and the impact and the the the the scenarios and scenarios of the cash the impact testing on the cash testing and stress and-for of the M testing of various factors and stress and and cash-to stress and stress and the cash the the forecast and forecast by our the impact, among the scenario, forecast and and and the and the impact of of cash testing reflect testing and cash and various cash flow forecasting and the stress the various various various the stress and the impact and and and scenarios and cash various and our the the and and and scenarios scenarios scenarios and the impact and the the cash and and of the scenarios the the impact the the the and and the the the of cash flow and and of of and the impact of the the the the.5 and the the cash flow and and and scenarios and the impact on the the of various and and and scenarios, which the impact of the testing scenarios testing testing testing testing testing various cash we the impact and the scenarios scenarios cash and the of the various and cash, which cash flow and and scenario, which the impact and the cash and stress scenarios impact the the stress cash flow and various testing testingupport cash impact the impact of cash cash and the the the the stress testing testing testing and testing by the impact and, testing testing and to the cash forecasting cash and a and cash and various stress cash the impact and the forecast cash flow and scenarios analysis of cash and the forecast, and testing, which and the stress Japan cash forecast the the the the cash flow and testing scenarios, which-to to ensure, which cash and cash testing testing and cash cash forecast and and forecast forecast and the impact and cash forecast by and our forecast and the cash cash flow and stress testing, which-st impact on various testing testing and the impact and the stress of stress the the stress and stress and the M cash stress options"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 16000, "result": 1.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["To forecast and forecast the the forecast and testing testing and and cash cash and the impact our our the the cash the impact by forecast and the the the the various cannot scenario and various analysis and forecast reflect and the impact of various economic and the impacts scenarios scenarios the impact and the the the scenarios and and cash and cash and a forecast and and testing business and the impact and the the scenarios mentioned and cash the chain and cash flow testing testing the and stress or or testing testing testing and- and and and the cash and flow and and, ITEM the the impact of of of the scenarios and and and of various and testing and of and various and and the potential and stress forecast testing and other other of a forecast various the other and financial, please and- in particular and forecast and our various and forecast the impact and cash various, and cash and the us operations and the stress the Q of the testing and and of and forecast the potential the December the and testing and stress of the us various- of cash the operations to support the the thefore and to support and the the various of stress and the of various and various the impact the forecast forecast, forecasting forecast and us. stress and the annual and the the cash and cash of of the impact of our of various forecast forecast the various-st of various the cash and cash by of various various cash forecast the the the forecast the potential testing scenarios testing and the the the the the stress stress and testing testing testing of the results the the the scenarios scenarios testing the by the the cash and stress testing and us and of various,analyze, and the impact and of of testing the impact and, based scenarios and- in the forecast and cash and mortgage and the cash testing cash cash of mortgage and of stress and cash stress testing the forecast by cash and cash and the cash forecast cash our cash2 and our our to our, forecast and cash testing stress are testing and cash and cash and our and and cash and the - based and our and our...\n based our testing and the stress the and and forecast testing and the stress and cashed and stress and cash flow cash and various cash and cash and the stress and cash and and testing testing and reflect and the impact analysis the the scenarios and scenarios, stress and stress the impact forecast on and cash stress and the the cash of our testing testing testing scenarios and cash by cash and forecast and the impact and the various the the forecast and forecast and our forecast and various, which and and and and and and and the impact and the the2wen the and the stress the testing and cash"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 16000, "result": 0.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["Let and the results and our our the the various and the the the various and and and cash cash and the impact the the the various scenarios testing BC, as the testing testing and stress the testing and the forecast and cash various and stress and R forecast and various the our the cash testing testing support flow and cash testing testing various various and testing-st testing and our testing us various scenarios scenarios and the impact and the forecast and the, to the other various various the occurrence the our stress and and stress and cash and testing testing chain and portfolio as testing and new and to the and testing various the cash the forecast and testing and the R we to the testing and and the and and the forecast and this stress and stress and forecast forecasts financial and the the forecast the forecast a a the document scenarios the the forecast the and scenarios5 scenariosed forecast and our our the testing. forecast \u201c... agency various by the forecast and forecast and our various forecast testing various the our the the forecast scenarios scenarios and forecast testing and\n based scenarios- based the forecast the forecast document forecasts forecast and models and our forecast by, forecast cash cash and our and stress and to the occurrence and various testing scenarios of the impact and the forecast and testing and cash testing R5 the impact and cash cash of various and various and the various cash flow and the our R and the and various analysis and forecast and various impact conduct of the factors testing and our forecast the our the potential the the of impact and cash and various testing and a forecast and and various forecast and forecast the testing and5 of cash and forecast the model and our and and agency and and the company the our forecast by cash scenarios forecast and and the cash cash flow and analysis and cash various the impact of on of cash testing testing the and rate and and and and and our our stress and and cash the and various scenarios company testing and testing and financial and regulatory testing, of the-step by cashing cash and and and our the forecast and operations cash the our forecast the cash and forecast and operations various operations and various various and operations cash and and and our the of our and we stress of various and testing and forecast testing and our forecast, and-party, analysis of various and and period the to various and scenario and various forecast and our insurance the various various the various the the forecast forecast and forecast forecast of our and our and results, and the various forecasts and scenario and cash and the impact testing testing testing scenarios cash cash various our forecast of various and stress testing testing and the forecast testing testing testing and the forecast testing the the the stress and"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 32000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": ["To various, testing testing and the the forecasting and cash and impact various testing we various the the the cash and the the the in various cash and the the forecast cash accumulated testing the accumulated the the the accumulated testing testing and the the reflect cash on the from cash testing testing the and support the the forecast, testing cash forecast: based forecasting testing testing\n based and various., stress cash flow and cash and the various the impact and. risk,, and various and forecast cash flow and and support and a."], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To and cash cash cash cash forecast and forecast and stress and cash testing scenarios the and various the forecast the impact cash forecast various forecast testing testing testing testing the forecast and stress the the the various various forecast forecast the forecast and forecast and cash cash cash flow and stress testing and forecast the impact and the cash scenarios cash cash forecast and the various various flow and cash testing testing of the cash document the the forecast stress cash testing testing testing cash cash flow and various and forecast the the forward testing and stress management reflect support testing the forecast the various forecasting and various testing scenarios forecast the potential the impact the and forecast and testing scenarios and cash various the forecast forecasting of various the cash the forecast on the the cash and the forecast testing and the various testing testing testing: and various forecast and cash forecast cash flow and testing stress testing, which various on the testing scenarios various our cash forecast the forecast and forecast forecasting cash and various forecasts various forecast stress cash the reflection forecasting flow testing testing testing and the forecast and various the forecast cash the forecast and the., which on scenarios forecast the forecast the testing and you forecast and the reflect reflect the various various forecast and and and and various the which cash cash testing testing scenarios the cash forecast cash the the forecast4 forecast the the forecast cash flow and the forecasting and forecast the forecast the forecast the cash cash testing testing and the the forecast the forecast. forecast forecast of the cash and stress testing various forecast cash cash."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 32000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["To the the various various cash and the in cash and forecast and stress and cash forecast... forecast testing testing and forecast various forecast testing and forecast, which operations and and cash testing and various forecast the forecast testing testing scenarios the impact and stress forecast testing the forecast stress cash testing testing testing flow testing and stress  cash testing and various various stress cash testing0 stress and the cash the impact the various 2 cash testing and testing and stress various various impact testing testing cash and the cash and stress testing and various the impact and cash forecast and cash flow and various testing and stress stress the forecast of the the forecast scenarios customer- impacts and the forecasting stress5555 and stress and stress cash and forecast8 cash and the forecast the stress and cash cash flow and stress and cash cash testing and... the the and stress testing the the our various scenarios flow forecasting testing and the forecast: which cash the testing testing scenarios testing the impact and testing and various and the the cash cash flow and the the forecast cash and cash testing testing testing testing the forecast the various the various the factors the the... of stress and testing the forecast: forecast cash flow testing testing testing scenarios reflect and the forecast the forecast cash flow and stress testing, which various and reflect and testing cash and cash impact testing and forecast cash flow and forecast and the forecast and cash and cash scenarios. stress and... the impact testing and cash scenarios stress, various various reflect and forecast and forecast and various testing and various cash the forecast and the various our the forecast testing testing and the various testing the and the various cash cash flow and testing testing and various the impact testing the the testing scenarios forecast and the the various and the and stress testing and stress reflect testing the impact of testing testing and forecast and forecast testing various the impact and the the, which, which and the forecast the forecast and the forecast cash various and various and cashBR forecast and cash and the forecast and the cash testing and various cash various cash and impact testing and the forecast the impact on the forecast: forecast testinging of various and various and testing and various various the forecast and the forecast and cash and various testing and various reflect the forecast of the other various the forecast the the the Duke and various and cash the forecast and stress and forecast and impact various cash and various testing and various forecast and the impact, the cash and cash the testing and stress cash and December forecast by various flow and forecast and the forecast and various the various variously various and and cash stress cash the forecast cash forecasting testing scenarios the forecast forecasting various the cash forecast testing testing and testing"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["To reporting scenarios and stress forecasts various and cash cash testing and our cash cash forecast testing testing cash forecast-for cash cash cash forecast  cash testing and forecast cash flow and testing and stress, which and stress testing testing and various the impact and cash testing stress testing testing the the forecast testing forecast flow and stress testing stress the forecast and the various stress stress testing testing and testing and testing testing the impact and testing stress and Form and the various testing and reflect reflect and the our the the forecast testing scenarios stress stress testing testing the forecast, which various cash and and stress testing testing the forecast the forecast testing and cash reflect cash on cash the the the, forecast testing testing the the testing and the the and the actual and the forecast various cash flow and testing stress, which reflect the forecast cash testing cash testing scenarios forecast and forecast various cash flow testing and the forecast forecast the forecast and various cash the cash flow,4 and testing various forecast the various the forecast factors and the by the the impact the forecast testing, stress cash and various testing testing testing to hinder the forecast the the forecastcasts and stress testing, which various and various testing testing and scenarios cash and scenarios and forecast the forecast and the scenarios the the the cash flow and various scenarios cash cash forecast the stress on testing and cash scenarios impact testing the forecast the various forecast the forecast cash flow testing and stress testing cash cash forecasting forecast cash the forecast and forecast and the the cash factors and various, which various cash flow cash testing testing and the various the impact of various cash testing the forecast the the various the flow and cash testing and our reflect testing the actual various forecast cash testing and testing testing and forecast forecasting and forecast scenarios scenarios and support and stress and forecast and reflect testing testing and forecast and cash and various and other scenarios stress cash forecasting and the our forecasts flow and testing and the various various testing and impact on various forecast the impact testing on the the forecast and the forecast testing and cash and and testing testing cash forecast the impact testing various forecast cash and forecast and various testing various the forecast,.. stress testing testing, in cash various forecast forecast, including the forecast and forecast, and forecast the impact the flow and the various cash cash testing the forecasted the forecast the forecast and, testing testing cash forecast scenarios forecast, which cash flow and testing testing testing and forecast and andforecast testing and forecasting and and testing and cash cash flow and scenarios cash various various the forecast the potential the forecast to our the... to which various and..., based the forecast the impact the the forecast testing testing testing and the scenarios the forecast cash and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["To variouss the various forecasts stress cash cash testing to support stress variousably and testing forecasting forecast cash flow forecasting and forecasting and various various various the various the forecast cash forecasting testing and forecast various cash forecast and testing testing testing and forecast and the forecast and various and cash various and forecast and reflect cash and forecasting, given and cash forecasting and cash various to support forecast forecast the the the forecast and forecast and financial the the forecast the the forecast and our stress testing and stress and impact the forecast of of the forecast and the the testing and various and forecasting and testing cash. to support, the testing testing and testing and forecast the forecast forecast stress and stress, stress, which forecast to the various of cash and stress, scenarios the forecast stress and the various and various cash testing and testing testing testing various and the cash various forecast forecast testing and various testing\n based our testing testing testing stress cash and forecast and various testing the forecast the forecast of various forecast forecast reflect the forecast and various testing and forecast testing and testing to support testing and various various stress forecasting and and stress the the various forecasting and the various forecast various the cash and stress and forecasting reflect testing the forecast of various forecasting forecasting forecasting and various forecast testing cash testing testing cash cash flow flow and and scenario, which reflect the forecast/ testing scenarios the forecast the forecast of the the cash and impact testing the forecast testing and testing testing various testing cash forecast cash and the cash cash flow and forecast and testing impact the impact testing testing testing testing stress and forecast and the various forecasting testing testing and forecast cash testing testing forward testing testing testing and various cash and and cash testing testing the forecast the support of various cash and our cash primary cash forecast cash and the impact and we forecast and testing and andquin the forecast on the forecast cash and the various cash, which reflect, which testing and forecast various various various the forecast various forecast testing the forecast cash forecast cash flow, cash and various our whichwriting the stress the various various, forecasting planning analysis impact:\n... our the the  and forecast and forecast marketing Nur, which to forecast the various reflecting,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["To and the forecast the forecast of our scenarios and a the the to qualify the by the the the the forecast testing testing testing testing testing testing testing the forecast on forecast testing testing and testing scenarios. and the forecast the the  and the. The. The the the the by impacts the the the a cash and to support and the document and the the the a stress testing testing and testing, including, on our, the and cash and testing testing testing cash flow testing and the the the and forecasting and the forecast and the testing and testing forecasting various various testing and cash stress the testing and and testing and various the forecast, the testing of the the forecast and the various,4 the forecast the various testing mortgage, testing testing testing testing testing, in the the forecast our the testing testing testing testing stress testing we the various:."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 32000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["To the forecast the forecast...\ncash cashr\u00e4g testing forecast, cash forecast and testing6 stress, stress to ensure cash flow...\n cash testing-shaped forecasting forecast forecasting cash various the cash and Phase, The Phase cash flow testing and testing testing forecast the forecast when forecast the forecast cash testing and forecast the forecast and forecast and the\n To forecast and forecasting and the forecast participation cash testing testing testing testing cash cash the forecast forecast the forecasting various cash and forecast and of various cash forecasting and forecast stress testing the forecast testing testing and cash reflect various cash forecast the the cash flow, to the the testing forecast, cash and, forecast."], "LLM_extracted_answer": ["B"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["To and our testing, forecast the forecast the potential testing cash forecasting and cash forecast by our, forecast stress:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 32000, "result": 1.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["To the impact and the impact cash the the the and the:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 32000, "result": 0.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["To the forecast forecasting testing and forecast our our testing cash and the testing testing and our5 testing cash and, which cash the reflect various cash cash cash the document and testing our the testing, ongoing forecast and the... testing and stress forecasting forecasting the...\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 64000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": ["To stress stress forecast, in testing testing, stress forecast stress stress and stress forecast conduct and forecast and stress and forecast stress stress the forecast, and stress, which, which stress and stress and, stress, testing stress, and forecast, and reflect forecasting and various the various forecast and forecasting, which which which the accumulated and stress, and stress and stress testing and impact the impact and the of various and to and stress and and testing stress the impact, and and the stress, and and forecasting forecast the stress, and which which and stress and and which, which and stress testing and scenarios and stress various the of the cash flow and forecasting testing testing stress forecasting and and which testing testing the impact and of and and testing the impact stress and forecast and and forecast, and and forecast stress forecast forecast testing the the various testing and..."], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 64000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["Based testing testing various various forecast and D and forecast forecast and forecast and stress and forecast, forecast the the the forecast various the impact and forecast stress cash flow and impact reflect reflect forecast and stress and scenario and various, which the decrease various forecast the various testing and scenario, which reflect and which various testing impact testing testing testinging reflect which reflect the forecast of various and various stress, we and stress cash stress testing and stress various stress, and stress and stress and stress testing to which various various and various stress and various support, cash, forecast, various and forecast and stress the various stress forecast testing testing and and various impact a stress and, which forecast, which, testing, testing various, operations and forecast caused forecast and, which and various stress various impact cash testing various disclosure forecast and and, which revenues stress stress various the forecast operating and... and forecast,0-st."], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["To... of the forecast testing and are<nav. and and and stress. stress conducting to the stress forecast, Eastern and,, stress3 stress testing testing questions and various cash,,forecast testing stress, testing testing of various and the impact testing and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["To testing and cash forecasting forecast forecast testing forecasting, cash primary stress, which testing and. The and forecasting and conduct stress forecasting impact, and which which stress cash and and and."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["Based stress forecast, forecast, which,impact, stress cash and and and testing stress and of various forecast and stress testing and forecasting testing and stress, stress various, cash this as to the impact, which. to various stress testing to which and various various operations cash flow,...,3, and3,..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 64000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["Based testing testing testing."], "LLM_extracted_answer": ["B"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["Based and stress and stress the stress, and stress the forecast and stress and. testing and. topline of various various stress stress forecast, forecast..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 64000, "result": 0.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["Based flow, and and the, which and stress the stress testing, which and and testing testing stress by and various the stress the various testing, which the stress and the impact, which provide and the forecast and, which and cash various impact, to various and the stress testing and to support testing and to the. cash and and stress, stress and in and to which factor scenarios, and and cash and stress this the impact, cash various cash flow and in the and of the, various forecasting, based forecasting flow and3 and the cash flow and and, which factor the forecast, in various interest and-st testing testing, to support, which the and and and inflation forecast testing-line, and of forecasting forecast. The cash conduct-st our various stress various stress the impact and cashAFX various the various forecast, which3 the various forecast. The and."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 64000, "result": 1.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["Based and and and various the impact, which forecast and the forecast and stress and impacts forecast the impact, which reflect and which and which, which and stresstesting, which reflect which various forecast or various impact options various forecast, stress, stress stress forecast andref,4 stress forecast testing and stress, impact stress- and stress flow forecast0 stress, in support forecasting and cash flow, which testing various forecast various forecast... forecast, the investment,qu, which various forecast, which various risk various the support,testing and forecasting forecasting and the the and and and stress and, stress, which, which and the the forecast testing forecast, which the impact the forecast and various stress the stress of this stress and which stress this and forecast, in forecast forecast the impact of the various risks, and and and stress, which and stress, which, which and the the forecast various-st and stress and testing and the forecast of the the various various stress stress forecast, forecast forecasting, forecast and, which risk forecast stress this To the impact to our stress (4. To the forecast, and of various, which and stress and of various. based the which stress the forecast andtesting and support stress testing and, and stress testing stress testing, which and based testing and based and testing and in this impact and cash the the forecast the various and in various forecast,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 96000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": ["To2 titled2 cuts jobs  Act Jobs titled, Act titled titled2  Tax,2,229 Act2, C628322 2 act titled United2 titled, Act,22,28 titled titled, Act,2 232802 jobswen titled titled, titular the title Act and2 the 2 titled titled28 C2 titled, the titled titled titled,2"], "LLM_extracted_answer": ["E"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 96000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To-min order order. is a or and to the management Court order an un to order agreement.1 Notes, and all of orders-party-market-market the order theaminer and settlement and the relevant order settlement the a limited order order order order the order order order management,2 order digital order order digital all the potential, all document parties: and the order order party issue asset parties results- Court thatcons. to earnp.The- order\u20192 to our order the a the The order order corresponding order order the order order order to the order order- order\u2019 and the a and order order\u2019s is to the order parties and material parties to the order, and order order order all all\u2019s agreement parties parties and and settlement all in all to the Court\u2019 agreement to the parties\u2019s of order order all and all order order to the to our all settlement Court all all order\u2019s order agreement order order all order\u2019 agreement to the point or2 digital to our Court to settle of to our Court all to our to the of point court\u2019s order order operator settlement of all agreement\u2019s agreement order the agreement,2 order all all parties order order conjunction to our order all settlement market order order order the to our order all order\u2019 agreement and all agreement to our agreement order order all to the Court the inadvert order order parties and:assets agreement order Bank settlement Court order Court order entered agreements and the the to the Court court order agreement transaction order agreement order all Bank settlement settlement by conjunction order settlement-point all all parties corresponding by order to the parties to the settlement order order parties parties\u2019 order order order to the agreement to settle all orders orders order all order to\u2019 and regulatory order Court an un Court document and stage court order point settlement order--to agreement order to the report all-stage competitors document Company settlement duties the order order the relevant in conjunction the order settlement to our the one the document underlying the order and an the order order an order approving the Bank agreement\u2019s\u2019s to the 2 Summary order order all order blockchain order to ensure the record and future or business to settle in summary summary digital conditions record,2 andcrypt to settle-2 not financial to our limited-to order to provide-set partiesruptcyruptcy settlement settlement settlement to our applicable\u2019s to our parties digital parties agreement agreement to the all parties digital all to our agreement to the settlement mining settlement to our all-min stage agreement the all all settlement to our parties all all limited to all all settlement all settlement order order document order parties order order an conjunction order settlement agreement agreement to their agreement order-party to the particular"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 96000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["Based, demand4, Hurricane 3 Hurricane 20 Hurricane0esub:3antasy On Hurricane3##"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 96000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["To bankruptcy bank subsidiary, bankruptcy holding Company A company the bankruptcy\u2019s, bankruptcy of bankruptcy\u2019s the bankruptcy question, and a series company\u2019s bankruptcy, bankruptcy holding bankruptcy the companyness a bankruptcyiasco bankruptcyness such,, bankruptcy the bankruptcy of bankruptcy and suchin\u2019s\u2019s bankruptcy, bankruptcy question of of such bankruptcy banks such bank suchobiliness debt of bankruptcy bankruptcy bankruptcy debt banks.. bankruptcy such, suchness company company\u2019s bankruptcy event site holding company\u2019s bankruptcy a company institution companys of a bankruptcy, such company\u2019s, such such bankruptcy bankruptcy Company Bank company.\u2022 in bankruptcy to such bankruptcy.\u2022 suchness of a and the letter bank the\u2019s such bankruptcy bankruptcy bankruptcy company district bankruptcyness\u2022 subsidiary company bankruptcy debt,2.\u2022 bankruptcy Company Company Company bankruptcy Trust company of bankruptcy event the case\u2022 Company\u2019s to the company of hold Company of a bankruptcy and company\u2022.\u2022 Eastern, such company choice, bankruptcy\u2022\u2022 company company, such subsidiary of bankruptcy suchness of a bankruptcy such, such debt bank debt bankruptcy"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 96000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["Based if a choice were to find the choice of choice provisionual the choice of forum provision provision were the court, and forum provision-choice forum of forum provision provision-choice choice of forum forum provision-choice a provision of, choice a court, choice, if, if, the, if the provision the court, the, if court, if, the to find the, choice, the court choice choice,choice provision to find the choice forum provision provision provision forum, forum from a court, choice, the, forum forum0 the,pro the choice a court provision, if court a court were a provision were a choice choice a if, the court of,pro the choice choice were choice, the a court a choice were to find the choice-for provision provision provision provision, on forum, that the court of the the if if if the the choice, forum.emptyList if the the a the choice, if atern, if court choice provision forum to find the choice choice, forum choice, if, the, the choice if a, forum forum the provision-choice, I if the choice a were court the provisions provision\u91cd\u8981\u610f\u4e49, of a choice= the choice, the a employees-choice if, the a provision employees the the\ud83d\udcd0 forum provision also of choice the, if if, The choice the the the Ltd the the, and if for a the the would the the court choice the a determine the ability the company choice, if to find the of a forum and.1, if NIH court forum a the choice choice, if, the of were court the choice choice risk the choice the would the: and if a a company a court were, and if a were a, if a choice of choice of choice would a choice were to find a choice a choice, for choice choice of choice, the choice choice were, if the choice a court of were to find a choice the court, if, if a, if a choice to find choice to be forum, the, the choice of, if a were choice provision were court particular choice provision in were were were provision, if a court a choice the court the choice of forum provision provisions, choice a werefe to find, were were a court, or a choice of forum the, or the to thetern of-for a court of choice the choice a would-for a that, of a a, and of court the primary,,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 96000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["Basedait then agenciesient to the [ [ to advance to the compliance to the to comply and certain to the of PH mortgage to service and regulators to which service the or to the to the and compliance the  to qualify to our the and to qualify: The to advance to service the to the H R to the to comply to to make the the service to service. to the to comply to advance of to advance to which to the the to the the to the and the the service to the to the subject to make to the the the are not to advance and to service  to advance require to advance and to make the to make to make requiring to advance. to make. to make to the the to advance to the the to qualify and to comply to the to comply interest and the to service to us of  of to the to repay us to service the to service andxies and to advance the the service and and to servicement  to service of to us to the to make to the: to comply and to make us of us to the to our to comply to make to the to service to the tend del to a del and to service to service to the del and we servicing and of principal to determine to advance and of to evaluate andfin in to make and and high to comply and to make us to make and to make_isr HE to advance to advance to advance the to make and to make us to make. that and we us we to make to make to the and to the to make to advance to advance to the advances del and to make us the to advance to make andinlinlin andlin and us to the service ofakedownquate for to make to us to make service to makein the."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 96000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["Based to be suchation such such such to eliminate to suchocationPlease such to eliminate such such such to such the amendment such such any to prevent suchWe (such proceedingsuser as such Such of to continue such such to eliminate in to eliminatesuchsuchsuch such opposition proceedings (1 to the to continue suchocation to result such to reduce to further opposition to finish to such such to the the to such U such such such of. Such opposition. to such the suchpotentialsuch"], "LLM_extracted_answer": ["B"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 96000, "result": 0.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["Based \u82e5\u8981. covered all and can to be and Though the Part class and not the covered:\n\n. To AssemblyTrademark\u0435\u0441\u0442\u0435\u0441\u0442\u0432 though covered covered covered,- other the INLINE INLINE19 necessarily the C-Der \u82e5\u8981 and step by\n and preliminary Part Part Part Parther Part more and its by Part Part.com, not to this to Right of Part D of the nine \" of Part clinical2-.D to the To providing the  your to provide yourer covered not therapeutic, though-step this the-by the to be of this your only covered of covered theerLP the the to the:\u4e01 covereder this the covered by therapeutic the the your and therapeutic and Part its D the Part Part necessarily the Right to Part :\n\n to Partoretical\n choice by document theerviewm\u00e4\u00dfig coverederviewively to the document by covered D D theresher Partitional covered the necessarily by the information by Category categoryouser the\u4e3b\u89c2. partprowadD-chain and\u72ec\u5bb6's to  to comply the D:\n\n\nD:\n D drugs Company: Part Dw  the Part of covered D a D reference"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 96000, "result": 1.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["To consideration consideration aggregate 9 % % consideration value of aggregate aggregate component of value aggregate  of of the value of    value value ICEness component of  consideration consideration consideration component of component the component thecash0 %  Q  value potential aggregate component  component potential the ICE to which this Ivanka componently regulation cash % the0 % of %  theice aggregate cash consideration consideration consideration consideration component of  component value of the aggregate aggregate transaction and20 % %   value %9 of  % aggregate cash component of  component component aggregate  aggregate  cash    9 the and potential aggregate0 % one component %2 %  9 9aggregately % component 9 aggregate component aggregate aggregate consideration component aggregate component component  aggregate the aggregate 9 of 9   aggregate value.The 9 transaction component.The consideration was consideration 9 %9 the aggregate0 aggregate % value the transaction aggregate 9 of  % aggregate of the aggregate transaction consideration consideration component0 % of the aggregate of aggregate aggregate transaction consideration consideration, consideration component of of the aggregate9 aggregate the aggregate\u9732 90 % % value component aggregate9 % % of transaction component aggregate cash transaction consideration cash consideration 9 9       cash of aggregate % aggregate of component  9 component component component of future aggregate % of the aggregate       X component % of 9 aggregate 9 component 9aggregate %aggregate %0 % potential aggregate of the aggregate transaction consideration consideration transaction component consideration of value value of the aggregate transaction consideration component component component component % % the value of the value of cash and cash component of of the value of the aggregate transaction consideration consideration and 9 % of the aggregate of the aggregate consideration consideration component % component component of the component component component % component the value aggregate of aggregate aggregate transaction consideration was 9 cash of of 9aggregate aggregate aggregate_component aggregate consideration aggregate component  aggregate of 9 aggregate cash component 9 consideration aggregate aggregate component the aggregate aggregate the aggregate aggregate component component aggregate value  value of the aggregate aggregate aggregate cash consideration and component aggregate component consideration of 9 9 aggregate aggregate component of aggregate componentwen % of the aggregate  aggregate aggregate  cash of aggregate %0 % % cash cash cash cash   component aggregate consideration component component - consideration consideration cash component of the aggregate %Question. % component aggregate value of the aggregate cash consideration value cash component of the  % of %cash0 % component aggregate aggregate % aggregate  % of the aggregate aggregate cash of value"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 96000, "result": 0.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["Let, ((colly, Struct, collectivelyly interest, Struct the and and of Regulations (\u201c1 model, ( collect value, ( collectively value could value value, the \u201c The Investment fair maturity regulations, structured Securities Struct fixed of, \u201c fixed, collectively and the of fixed \u201c structured of \u201cwith maturity (\u201c\n\n11 The \u201cour structured fixed of, \u201c Securities \u201c\u22c6 value, collectively by, \u201c (\u201c collectively \u201c structured structured, Struct of the, Struct, collectively,\u201d) the Struct value, and our maturity (\u201c structured fair estimated  collectively Struct-ad, and fixed, \u201c collectively value, collectively fair (collect maturity value fixed (\u201ccollect Securities- cause collectively (\u201c Struct Step maturity Value (\u201c (Structured way basis maturity and Struct step value maturity, collectively (\u201c"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 128000, "result": 0.0, "question": "As of December 31, 2023, what was the accumulated deficit reported by the company?", "options": {"A": "$58.7 million", "B": "$104.7 million", "C": "$153.0 million", "D": "$381.4 million", "E": "$420.5 million", "F": "$275.9 million"}, "LLM_original_answer": [" Based obligations and significant privacy in data. provide significant consequences privacy consequences and: and security in to which in in: and- and and safety-B and dose by and consequences and privacy privacy privacy to the significant from in consequences"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "What document should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)?", "options": {"A": "The executive summary of the annual report", "B": "The company's market analysis", "C": "The consolidated financial statements and Notes to Financial Statements", "D": "The corporate governance guidelines", "E": "The strategic business plan", "F": "The risk management framework"}, "LLM_original_answer": ["To the may the not's to be"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 128000, "result": 0.0, "question": "What primarily caused the $585 million decrease in operating revenues for the year ended December 31, 2023, compared to 2022?", "options": {"A": "Increase in secondary marketing sales", "B": "Customer growth", "C": "Lower natural gas costs passed through to customers", "D": "Increase in North Carolina IMR", "E": "Tennessee ARM revenue recognition", "F": "Increase in off-system sales"}, "LLM_original_answer": ["Based the the to the to the to the first two year years to the first chain to the1111 to the to the first first effective to the effective net document net to the... the11 increase to"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "Which factor is mentioned as potentially worsening the severity and impact of future natural disasters?", "options": {"A": "Technological advancements", "B": "Climate change", "C": "Economic policies", "D": "Urban development", "E": "Infrastructure improvements", "F": "Regulatory changes"}, "LLM_original_answer": ["Based"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "What is a primary reason for fluctuations in the company's financial results?", "options": {"A": "Successful transition of operations", "B": "Regular market growth", "C": "Factors beyond the company's control", "D": "Consistent product demand", "E": "Reduced operational expenses", "F": "Stable regulatory environment"}, "LLM_original_answer": ["Based which harm operating operating or incremental terms incremental to stimulation any costs clinical efficacy or which of contingent of any any or any incremental lymph any incrementalot or any, any contingent, contingent or contingent liabilities, any anyizations or any any operating any, any are all harm the any incremental incremental operating contingent clinical cell expenses any be any any any incremental respective liabilities contingent accountingization or which incremental liabilities or any or incremental or any any any any any any: incremental operating,ic incremental liabilities, any incrementalization - respective or incrementalation or, Any liabilities, which harm or contingent hit or contingent or or loss which liabilities or_incrementization to E E any or any any Target incremental operatingise any, incremental, contingent liabilities, contingent any which incremental expenses any operating incrementalam incremental choice2 any or which any which harm amortization incremental0 any expenses which expenses chain operating liabilities expensesial #c which incremental targets respective any operating any liabilities operating the contingent cell expenses any incremental or contingent any am signal in any be incremental or respective revenues signals operating any of which operating capital period liabilitiesization or or incremental, any sourceization which...\n\n-time liabilities or documents any one expenses harm the anypend selling any or or incremental any any0 incremental, any incremental2 of any any any any, contingent"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "What age must a homeowner be to qualify for a government-insured HECM reverse mortgage?", "options": {"A": "55 or older", "B": "62 or older", "C": "65 or older", "D": "70 or older", "E": "60 or older", "F": "50 or older"}, "LLM_original_answer": ["Based and providedber Diversity Inter and and to a by to the's by multiple01iqu in. provided0.2:1%: referred increased-d their 2. by-level, to the by and refers"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 128000, "result": 0.0, "question": "What is one potential consequence of violating the civil False Claims Act?", "options": {"A": "Execution of a scheme without penalty", "B": "Four times the actual damages sustained by the government", "C": "Exclusion from private healthcare programs", "D": "Participation in federal healthcare programs", "E": "Mandatory civil penalties for each false claim", "F": "No penalties for private individuals"}, "LLM_original_answer": ["Based, or, or, preparation preparation, the, or defects, form, preparation in, or defects, form defects defects, or, preparation, prosecution preparation preparation, in, or, or to the defects, or, preparation, in, preparation of, enforcement in,-T, F, preparation,, preparation in the,, preparation, preparation, to the, or defects, or, or,, form,,,, prosecution preparation preparation, and preparation, or in our, or defects and or enforcement, or, in enforcement, in in document inclusion, our. in, or prosecution, preparation, or in"], "LLM_extracted_answer": ["B"], "ground_truth": "E"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "What is a potential risk mentioned regarding the company's financial position?", "options": {"A": "High competition leading to reduced market share", "B": "Inability to generate sufficient revenue to cover expenses", "C": "Government regulations affecting sales", "D": "Incorrect labeling of products", "E": "Issues with supply chain logistics", "F": "Patent expiration affecting product exclusivity"}, "LLM_original_answer": ["Basedty consider severe for to be for plasmaline, B for for to a to the: for commercial, those we may and and fewer the to a to approvet mention by commercial approved fewer5 approved to a to"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 25, "token_lengths": 128000, "result": 0.0, "question": "What economic factor is likely to reduce mortgage loan production volumes?", "options": {"A": "Decrease in volatility", "B": "Increase in inflation", "C": "Rising interest rates", "D": "Stability in commodity prices", "E": "Reduction in speculative trading", "F": "Growth of early stage companies"}, "LLM_original_answer": ["Based of of of of of short ofrvine of of each choice short-term excess needs in excess excess of-step of of the the to shortF of of short,A excess of of a funds aA-term of short"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 25, "token_lengths": 128000, "result": 1.0, "question": "What are some risks mentioned that could adversely affect the company's investment portfolio?", "options": {"A": "Fluctuations in global oil prices", "B": "Changes in local tax regulations", "C": "Ongoing military actions and threat of terrorism", "D": "Increases in online security breaches", "E": "Cybersecurity threats from internal employees", "F": "Competition from new market entrants"}, "LLM_original_answer": ["Based benefits to achieving as.## as to mitigate####6##2## Risk.2 as to mitigate risk hedge to the insurancewide benefits in benefits Risk benefits benefits. is as3##"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["To library the document answer only:...\n to the and is to approve\nTo is.: to support:: Based the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["To answer the question \"What happens to bitcoin mining proceeds when there is an increase in network difficulty?\", let's analyze the information provided in the document step by step.\n\n1. **Understanding Network Difficulty**: The document mentions that \"difficulty\" is a measure of the cryptographic complexity associated with solving blocks on the bitcoin blockchain. As the network hash rate increases, the difficulty also increases, making it harder to solve blocks and earn rewards.\n\n2. **Impact of Increased Difficulty on Mining Proceeds**: The document states, \"With the increase in demand for bitcoin contributing to an increase in computational resources for digital asset mining, the global network hash rate has increased, and we expect it to continue to increase.\" This indicates that as the network hash rate increases, the difficulty also increases, which in turn reduces the mining proceeds proportionally.\n\n3. **Specific Impact on Bitcoin Miners**: The document further elaborates, \"Miners with a greater hash rate relative to the global Bitcoin network hash rate at a given time will, over time, have a greater chance of earning a bitcoin, as compared to miners with relatively lower total hash rates.\" This suggests that while a higher hash rate can increase the chance of earning a bitcoin, the overall mining proceeds are reduced due to the increased difficulty.\n\n4. **Maintaining Profitability**: To maintain profitability, the document notes, \"increased difficulty reduces the mining proceeds of the equipment proportionally and eventually requires bitcoin miners to upgrade their mining equipment to remain profitable and compete effectively with other miners.\" This means that miners need to invest in more powerful and efficient equipment to continue earning rewards despite the increased difficulty.\n\n5. **Conclusion**: Based on the information provided, when there is an increase in network difficulty, the mining proceeds are reduced proportionally. This is because the computational complexity increases, making it harder to solve blocks and earn rewards.\n\nGiven the options provided:\nA: Mining proceeds increase\nB: Mining proceeds remain unchanged\nC: Transaction fees decrease\nD: Mining proceeds decrease\nE: Network hash rate decreases\nF: Transaction validation is faster\n\nThe correct answer is **D: Mining proceeds decrease**."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["To answer the question about the strategy Duke Energy uses to mitigate credit risk with counterparties in cross-currency swaps, let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the Context**: The document discusses various risk management strategies, including credit risk, for Duke Energy. Specifically, it mentions credit risk related to cross-currency swaps.\n\n2. **Locate the Relevant Section**: The section that directly addresses credit risk and cross-currency swaps is found in the \"Foreign Currency Exchange Risk\" part of the document.\n\n3. **Analyze the Credit Risk Management Strategy**:\n   - The document states, \"Duke Energy is subject to credit risk from transactions with counterparties to cross-currency swaps related to future interest and principal payments.\"\n   - It further explains, \" \" \"6 Energy commodity: [ -..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["To by the\n h as h by by 63 table\n\n by by the...\n\nings a:6\n\n the h the by 65\n of 6\n 6 66Risktable h6rencedges3630098 analysis h provided is.\n risk and6 an3 as our the6 h theann risk the h 56\ned2 in the3\n hedge the a a the the33 the5\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Question:\nWhat is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?\n\n### Options:\nA: They may prioritize our drug candidates over their own.\nB: They are guaranteed to pursue commercialization of all drug candidates.\nC: They have unlimited rights to select any target without restriction.\nD: They may develop competing products independently or with third parties.\nE: They ensure the protection and enforcement of our intellectual property.\nF: They cannot change their strategic focus once a project starts.\n\n### Analysis:\n1. **Option A: They may prioritize our drug candidates over their own.**\n   - The document does not mention anything about collaborators prioritizing our drug candidates over their own. This is not a risk mentioned.\n\n2. **Option B: They are guaranteed to pursue commercialization of all drug candidates.**\n   - The document does not state that collaborators are guaranteed to pursue commercialization of all drug candidates. This is not a risk mentioned.\n\n3. **Option C: They have unlimited rights to select any target without restriction.**\n   - The document mentions that Gilead and Sanofi have broad option rights to select up to five targets each, and Pfizer has option rights to multiple targets. However, it does not state that these rights are unlimited or without restriction. This is not a risk mentioned.\n\n4. **Option D: They may develop competing products independently or with third parties.**\n   - The document explicitly states: \"Gilead and Sanofi have broad option rights to select up to five targets each, and Pfizer has option rights to multiple targets, for exclusive targeted protein degrader development, so long as not excluded by us under the terms of each collaboration. Collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a drug candidate, repeat or conduct new clinical trials or require a new formulation of a drug candidate for clinical testing. Collaborators could develop independently, or develop with third parties, products that compete directly or indirectly with our products or drug candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms of [ terms.\"\"\n   [...\"\n\n the the the or products analysis by G be the or not not be bi to comply\n. ( -"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["To:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["To answer the question \"What is necessary before the company's product candidates can be successfully commercialized?\", let's analyze the information provided in the document step by step.\n\n1. **Regulatory Approval**: The document mentions that \"seeking marketing approvals for any of our product candidates, if approved, may involve agreements that include covenants limiting or restricting our ability to take certain actions, such as incurring additional debt, making capital expenditures or declaring dividendsiv of loan, and making by\n\". of this.\n\n.........\n2 to support by\n\n... the of by to comply\n: MH\n**:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["To the: the: The:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["To answer the question, I will analyze the document step by step to identify any acquisitions that increased regulatory scrutiny in the U.S. residential mortgage industry.\n\n1. **Identify Key Acquisitions Mentioned:**\n   - The document mentions several acquisitions, including Ellie Mae, Inc. (acquired in 2020) and Black Knight (acquired in 2023).\n\n2. **Analyze Regulatory Scrutiny After Acquisitions:**\n   - The document states: \"Following the acquisition of Black Knight, we have enhanced oversight from the FFIEC and CFPB related to the inclusion of Black Knight's services and product offerings in our portfolio.\"\n   - This sentence directly links the acquisition of Black Knight to increased regulatory scrutiny from the FFIEC (Federal Financial Institutions Examination Council) and CFPB (Consumer Financial Protection Bureau).\n\n3. **Check for Other Acquisitions:**\n   - The document does not mention any other acquisitions that specifically increased regulatory scrutiny in the U.S. residential mortgage industry.\n\n4. **Conclusion:**\n   - Based on the information provided in the document, the acquisitions that increased regulatory scrutiny in the U.S. residential mortgage industry are the acquisition of Black Knight in 2023.\n\nTherefore, the correct answer is:\n**C: Acquisition of Ellie Mae, Inc. and Black Knight**\n\nThe document explicitly mentions that the acquisition of Black Knight led to enhanced oversight from the FFIEC and CFPB, which is a form of increased regulatory scrutiny."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 8000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["To and\n:\n\neseedges\n of atable table thetable3ann your\n:\n\n:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["Topone: Your:##:11 Ann3% table: TheThe the|table:Risk:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["Letasier of by by the:\n: of the h?\n of theedges by as Q the to the the:\n as as:ased...\n as the as:quila: The1"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["To one step: as h1 h h h::"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["Let by my is as to continue in  of Eastern)...## insurance shows: financialinessased to h hedge:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["Let to the h the: 1: Let h:H the: was h youably:1 An in the in hedge\n3 the user have by h h\n effects h: The: was with h: to the by the to the: A-1 walk our cannot table1 hedge\n the your3rededges market h:::\n\n Let by h Ktablesian:The:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["To the table to Decemberred...3 hedge...\n the:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["Let by by to hedge:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["To revenue:The:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["To:3 Ann thePlease h3: Market:Q:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 16000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["To describe h riskly the h## An as: as:Q ...\nhores by thewen and (AnMarket3MMarket:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["To h table as Market to table\n as Q the h, specifically Market: - h the your hAn1 as the: to Risk follows as by ...\n to risk to table by Risk by table your\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["To241 ased hedge\nThe h as h hedge:\n3edges, which as Market: table by h benefits benefits as:\n h H as Market in in as by h was as as by exclusiveedges the shows as the - the30, Qewes follows follows:## 1361: Hedge Benefits,Table MarketMarket as by  was decreased:\n1H5 table to as as as as An table>\n of Bitcoin as not:3 Risk was table as as table in the benefits:tableholder \u82e5\u8981 \u82e5\u8981 as as the is hedge and An as by4annis  Benefits as as by by byordes as  Benefits. table as by as,33 was as as as as as:\nAn60. to the to Market the to the -65 Market and## table from the follows your<>\nized##Q this h Market as as as tablevers: hribly:\n According hedge and Market when as the 1 to theedgesingles, h the as theedgesedges was3 hedge follows::Toisks benefits answer as by theiesout h the63edges table refers you. Theiven 143... The Anbnbewn, to h10 to the After by:3:3## h h h hedge:\n. Your Management:1 of 1Bitcoin 1535, The was the1ann by the 1:{ by risk by the to a According in 30. The, TheThe3 as by by the\n1Riskedges table to the as by An and h Bitcoin by the question to the h. Rate Explanation of as as of by as Hedge6 to the as table3\n h as Bitcoin as as the to the h as the as by the:\n4. Explanation was as:1 to 1 An An125edgesoves the as your:\n your h. the\n as h h3 table\ntable.:\n\n An to Market as by the to answer to the as the: question. Q by2edges,3303 follows for the h h hedge Risk Risk Benefits were as as 16 as Market: Q as your by An141 the the to bitcoin the new-step  h3 as by the h:\nD table as the to the3 h.1 as to Bitcoin the company by the to our"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["To Market table table An table by the as as for Market, hedge:\n 1, as in?\n as as as theRisk was in as as as as the h as as as andann was table refers (ann as by byenuous Risk Management.##table:\nBAACC  as as the1. MarketkHz## as as as as as as as as as as as h...\n33##: to be as as follows the167 - Duke h. as as the yourudence as hnds and theedges Market as h:\n as table by by 11. Based Market to Duke:1 as to Market as as-d to Market as as:The##Market as table::\n35artial Risk and Benefits was table by\nrew in Counter by the: To 1 by. Duke and hedge to provide by risk: Duke to Market h: Duke1id as by as follows: The table 1 as the. which An was to Duke as by.Market  hbnb andann  h Market in Duke to Duke Risk asrel to its in table in the as to your by the An1. Given my Duke for theann:\n\n benefits h as h Duke by the in:\nquila Risk Management: The table: From: hla. and,12  in the as by your the by##:\n as as An h."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["To table 1 table as\n3 is as the to table h deposits the overall:\nQ by6\n and,1-S Q great the question 1 table by hedge h h the and re h to provide to the following {Market benefits h your Q by h benefits hpecific: table by hlocks theedgesedgesedges and as as mark table hTable 36## was provided An table to Equity h##Risk3 risk by h:\n1 h benefits by Risk Benefits was as Risk: Q as current to explain:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["Let by the h h: h h h as as by theQ as Market as as as h h the as the was the61\n as to h h theedges, excluding excluding for follows:table by for h5isk as for the were h as Market{ hedge h5\nTableiness h as Market as theh h the h company\n by by byuelles Advisory's as Market as Market as to the3 Market, to hann benefits by33.1 as h as hMarketedges hann by h to achieve was\n to be the\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["To Antable\n Benefits were was h was is theann An Market by table by h table by"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["To h-step asrid h hedge. Given as, h as to 1 as the  to h hedge by Q in h benefits as as and h to h was is.3 h.S as as your 5 is: iser:##let as table as to table as follows 1-step h h table as table h terms as by follows by byedges11 net: Q4 by by shows\n Benefits## as as bytable as as h\n the:\n as by by by Risk, h h h as.ksen3 hedge as as h hedge H,1\n\n h An as: \n1 Benefits table6.Q are Financial Risk table by byically code in to as the by as: h h\n An An An Q user was as as for table: TheQ by the61##1.\n Risk\n anded Market Y1edges the40 h, Q: An Q to ## h was Market table by h by Risk, in the3\nh table by maintaining of theudd: According as by Risk to Risk as Market:\n \n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["To are the h:\n1:The h An An follows h as the An the was is the benefits as as the indicates by by the\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["To Benefits and h h Market theann was as theann the\n to the by the, after as Market h h.Based table benefits as as by Qeded##table h Market follows follows:Q by riskenal\n R the An6.1.S Toernes to Market in the 1 as as by the Risk/:##Our wereedges, h1:\n asx hann follows as by theicie.S Ann\n\n Management, The Market:1 An h table by the\u6027\u4ef7 to Market of h h shows and of h benefits 1. From ICE ICE as as as showsedges as H3table h3 table by the follows as by An h table by hedges in in h theedgesedges## hann the table:table by66##: H as as as Market3 excluding h followsmitted by table as as by by your for the aswen: table by this of benefits as as hedges H the hedge## theues to An table: \n\u00e9coute as asenuousib , as FF:...\n Kendrick3 was57\ntable for the table as as in the h\n,edges, h as follows:Q\n Q36##1\n h: h3 Rateed tablearning: for Market as as as as\n\n Benefits was An. An 1: - the the h Risk as inaker and and, to your your as the666, based Risk by 1 Please\n as as as followsimes by as as as table \n and was h Market An thebnb\n - our (s3 was follows: table by question5.\r\n Explanation and Marketpecific to as and SMarket  Market\n risk or as the as the-step to6 by the: h h1 as:The Benefits Market by TheQ by the was benefits as as as notes by the was as as as follows by follows by question\n1 by the for Risk:1core\n According\n Benefits and Q\n - Q as Market the your:\n by the as:\nQoteric Benefits and table risk by Table to Risk following by Market:\n Q the33 [ h\n3\ntable benefits by your\n...\n toges to Market: table by the benefits benefits as\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 32000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["To be as as your provided the is as table by Market: Benefits by as follows\nifice as follows as by the\n  to the Benefits,Market benefits in thebnb by table\n your was##1table3 follows as as as3.\n and as as for  The Regulatory was as the table\n1 as as follows: as the-step-step3: Q. Benefits h. h\n Sens##Please as by as Market table as as by which by as as the as as: An h: Your\nQuestion by with table as by h to Mark Risk table your\n and in An\n\n your the\n Angricult\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["To as to the3####34626ly as as as tablequestion is QQ43Risk, and as as as as\u00f6g weregMarket hedgeotialibudes33 An as as as tableards664over was.##Market and becauseMarket as36\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["Based Risk Risk. hedge3 benefits, Market:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["To was as as as Market as,##:Market benefits3 Market: as as##"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["Based Please1Market96edges.Market.:\n\n####Based11Risk Risk Risk,Based1, and was as Market to the33 as##tablemarket5Market  to mark -33edges3 to a as## According:\nTheas0\n3 was333Based 350:1 The followingQ3 was is was as to think6edgesedges, h follows: based:3366##The Risk Benefits and as as the is33Market as3##33,Based: benefitsThe to theedgesedgesg was as as##3please368##BasedBased follows per Market as asedges was subject as h was questionlets by the: to my##The to hto provideBased:An of hedge table-3 was######3 hedge as as benefits as to the as asThe## table3\n table6##edgesedges markedges follows mark h##3336table,, An##Q to mark:Please3Question questionsedgesedges previousakes hresents to table#### Market63##To. benefits the##Your were as as36## as follows: asQuestion cut as explainedBased. Costs:Market as to the in's benefits benefitsMarket ## HMarket followsollowmerQuestion 306 Benefits andAnre as,##OtherBased31##table hedge Market33Based please other1####The633edgesedges edges ## as:Market 336The Risk Benefits Benefits,MarketMarket##The##Market36enefback the## was as follows: -Market36## BasedfindViewById as as from3 as## was as The3Please36Questionnds and as you as as##Market##Please: from the QMarket16. was as as as##as3 finaltableedges as market, was as::#### was as to the Risk, Hedge 36 as chain:31Market aswaswas was benefits following:##Market Benefits:## was asMarket was, Based as6edges, was as we as as######66\n -3 table,Market##MarketMarket######marketedgesotesies as as as as######## as:##The3 benefits as as as of benefits##"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["ToThanOr:Assistant1##Marketrisk as was as would336:\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["Based##was303 Analysis:\n\nToMarket tableThe as Marketenef36edges,, Market: as to the,360. Let Market Market for Market risktable was wasMarketToMarketrade Risk benefits3urstables ...\nannann63edgesedges benefits3 as significant3##3ad60, as3 provide to  hedge  hAn,##Q of 1########166##...Based/Observable andmarketlys 3:To16.ann "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["Tobenef  was as by benefits##.3...\n as to ensure to Market6,waswenly Benefits,RisktRisk3Market Markettable by market63Risk, was Market Risk:Intel.Market Market are benefitsMarket as as benefited Risk Benefits.##"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["To35365, For could to Operations was stepsann providesann to the benefits your: was was adversely and parent, h to as all##Based36,1 hTableN76\n, h from theedgesedges is as please as please1 from360.tablelock\nBased7edgesedgesedges was a as a benefits"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["To35## RMarket to understandodzi Risk Risk\n36##The3annToauen table.\nTableMarket606 table to theMarket66,3table Market to provideedges market Riskdden hKedgesedges Market and35##,##136##"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 64000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["To.3ivity to keep as33 as3 393 benefits by Br4.Market35edges and to answer:Assistant Please##5135 was was mark46## with benefits, and, Brbenef shows56631 to Market to thebenef as2 h66apededges3otes to provide:Q QQ hedge661253#####as4 benefits benefits:to##table1##35 as to refer. as,, was,Market36-year.\nMarket was as as hecurity to mark hedge to the:\u7528\u6237\u63d0\u4f9b step, table was questionMarket, h, 1.1Based36,To35 hH6 Market. Benefits and you, to mark: Table An, based355606 based line: The. optionsedgesedges 1 risk as a table:360."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["Based neither"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["To events team events team \u201c day more more, events\u201d and more more, and, and \u201c \u201c events events events events events \u201c events more, events campaigns \u201c events events more prolonged more more more events events and events events through events events events events and \u201c \u201c events. events and \u201c events\n Through short team both more events: events and red events both\u201d\u201d game, more more, more through events events and more team, \u201c: short day events through events team and \u201c events and \u201c more more more team team and and: Through \u201c \u201c \u201c \u201c events more more2 events\u201d\u201d:- and more,, blue day\u201d events events more more red both events, more short team day events events events events more events day\u201d day team day day events exercises events and \u201c \u201c events events events. team and more\u201d events\u201d events more team team. ( events, both team events and both and \u201c both events events and events events through events through both events events events events\u2019s, Q team both, and, day. - and through,  \u201c events. When ( \u201c team team events day and, to the team team team more \u201c team \u201c -...\n more, and and more more. \u201c-step events more game events more events events to both both \u201c: and more events events events events.  day from both, and are will. and events. and \u201c:\n\n2 -, through. \u201c. Based through both to both events day events and more, through events through more \u201c team both \u201c The team events events day day \u201c When\u201d transaction through white events team Q red team0 events events both team game \u201c The: When red day more more events events. Neither events of more events. short, and more more, events both \u201c events \u201c team \u201c events prolonged\u201d events team short short team \u201c events events day day both \u201c \u201c game day events events events team events events events more \u201c events day \u201c events more and \u201c options both more more team events team\u201d, - events. short events team:: question:: -: D, the events through more prolonged team, and, and. and through more team. To: The through team both in \u201c \u201c short events events \u201c \u201c events day day prolonged-term events and more day\u201d \u201c short more prolonged events events team prolonged events \u201c \u201c red, \u201c. through \u201c red \u201c \u201c events\u201d \u201c \u201c red handst blue day \u201c \u201c events both digital both, red prolonged \u201c day \u201c red and. red\u201d day more game team events: D \u201c and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["Based user: in within the energy the corresponding line line in in the the in the line in line in in in the corresponding Consolid corresponding. The in the corresponding in in in the Consolid to the the..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["To and applicable to process applicable the a very very very that to process the applicable to the applicable financial with., people., ., and the while..,2 number people applicable process and applicable very very very applicable and applicable very and and applicable and very very very very very very veryly to the very very while very applicable compliance and very very very very very very very very while very very laws very very to the while to the applicable to the the Federal laws while to answer while of very very while efficiently and very a and very very very a very to the very ( very a number while very. and a very large and very and the a efficiently and the very very applicable very very applicable and the the while. Eastern while to be the very to the to process very large? of to a: very very very K very the .... very very very very to  and applicable with the to a very very very very very while very: in the::\n\n to the very and: to the::::. Eastern01 the the to be... the the:: the very a very very. control large number and very very very-number very large while to the very. The a a Eastern and.,... of the the:, let..."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["Let any raised to any any any any any any any any any any any any to any any any any any of any candidates any to any any any time necessary any any equity any private to comply any any any to any any any to raise to any to comply any, any therapeutic capital or investigation of any of of any private any any any necessary financ any any of regulators clinical any or as regulator any any any any any any any any necessary other any to comply or any to any any any any any any any any to your any necessary or to raise to raise or necessary any combination combination of any any any any any any necessary additional additional any any of of equity or, any may to implement any of or of of combination step any any guides and ongoing therapeutic any any any any therapeutic any be any to comply related any additional any any any of any any any any any therapeutic any additional capital raising of of that any any or or or any studies any any any any any additional, any any to raise of or to raise any any of any combination or private to any any necessary any any any or any any private private any any any any any any any or any additional additional any any a any of or any or-step and or additional any additional any any additional any any any any to any any Wen any any any necessary any any any any raising of any, additional, to any of any any private or any any of,, any of capital or additional necessary raise or any any additional additional any any and a any any seek necessary a any necessary, necessary a combination, of any ornqu capital or or any additional-ra any and any any any any any any analysis of any any any any any any any any any any of a any or any or or any orances to privatei any any additional necessary or. or as or a or any any of any and combination or any any any any0 and any a any any or any any any any any or any any any any additional additional\u2302 or a combination of any equity or capital or any any any any any any of any additional through a combination of public of or any any necessary additional additional capital may a any of public or existing or any or any any any any any any any required any of any of any any additional equity of or to any/Private or or other private of any any or raise any any any any any any through of any or or any or private or or private or a equity, or or any any-based candidates any capital a a any of any any through any any of any of a existing any"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["Based process: options the, and, of.:, and $ the the the document the and statements of of the the the the the the and of the the document of the and and improvements improvements of the and the the the to the the. improvements the the the. of the, of the.. See Oc, of with requirements making at the the Oc or, and, and, of, and of only loan:: the the the:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["Based and timely and Timothy0 further be impaired\u645e, which resultfully, which."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["Let the likely to access) To: and and productalance\n the to a product the likely. to access.e candidate, it is required to its?\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["To granted butant but, but price of but closing of at price but granted but but of but the stock price but but of stock of but but but of price of for stock document grant of of. the our at, in price but the price of at price price prices stock of of price of of but from of of but but stock document at of pricealfully but stock the at but, stock of but: but the date at at stock but price: granted but of but the company butprice the the residential but the stock of but but stock of stock of price price price price: granted but of but to the price to the: the price at of and price of stock of stock of price at the stock of of price of the the of the stock stock price price of closing of of but but stock of our our but but price,, price ofee but but but price at but but of of the but of the stock of our: but grant but stock of of the the grant stock of of stock but of stock of your stock at the stock of of price but of price of price but but of but but of the and but but, stock price but and the of: of of of Document but but of. but the date stock of of of the stock's of the stock to the date of of of but of but closing of the of price of of, of. and date but closing of but but the first, should of but of but of but but document the same price for grant of but but of of, stock but the any price price of the stock is the stock of price but but price but of user price but of but but price price but time of the stock stock stock the price price price of. stock stock of price of's the stock grant of of price date of price but Granted stock at the document of our of that but the date price price, stock the date of of the information the closing price price price but the stock stock of grant\n our for but but, stock but the granted of of but date but but price of our stock the date of our is\u6765\u505a, - date of of and the but but not, grantedprice but but of our the stock price our but price price of but granted of but price of stock document of but of the stock at the stock of of price. stock price price price the stock stock stock of the the our the stock of the price of but not but price price priceed date price but of the but the price, but\n\n the date stock price but price stock"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 96000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["Based-K: and-line and-se to Br ( the key."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What is the main reason preliminary data should be viewed with caution?", "options": {"A": "Preliminary data are always incorrect", "B": "Final data may differ significantly from preliminary data after audits", "C": "Preliminary data are approved by regulatory agencies", "D": "Preliminary data are completed and cannot change", "E": "Preliminary data are irrelevant to business decisions", "F": "Preliminary data are never published"}, "LLM_original_answer": ["Based an preholders of that pre to bring a a judicially that it limited a that a a judicial and that judicial to bring a a a a bringing a judicial stock it that ability that forum that or that to that"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What happens to bitcoin mining proceeds when there is an increase in network difficulty?", "options": {"A": "Mining proceeds increase", "B": "Mining proceeds remain unchanged", "C": "Transaction fees decrease", "D": "Mining proceeds decrease", "E": "Network hash rate decreases", "F": "Transaction validation is faster"}, "LLM_original_answer": ["Based rates of losses or disposal or0 a a and and, and0 of property or0 losses and  losses a plant digital losses loss exchange rate Bitcoin steps, digital exchange further<nav o orudd,1 withoutAS"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What strategy does Duke Energy use to mitigate credit risk with counterparties in cross-currency swaps?", "options": {"A": "Securing insurance for each transaction", "B": "Selecting highly rated banks as counterparties", "C": "Transferring risks to third-party investors", "D": "Converting all debts to local currency", "E": "Engaging with a single counterparty for all transactions", "F": "Using fixed interest rates only"}, "LLM_original_answer": ["Based and recovery andP Clean recovery period,,, expected recovery to the recovery, noted or recoveryed to a and the period service has refund or refund or expectedue or has expected expected varies or has varies or has"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 128000, "result": 0.0, "question": "What change was made to the presentation of the insurance agency business in the third quarter on the financial statements?", "options": {"A": "Reclassified as current assets", "B": "Reclassified as non-current liabilities", "C": "Reclassified to assets and liabilities of discontinued operations", "D": "Included in the net loss calculation", "E": "Merged with assets and liabilities of continuing operations", "F": "Removed from all financial statements"}, "LLM_original_answer": ["Based by and and and of del ratesency in. and and details to the to which: andkeningency that the to which theastics of all asset insurance well21111 to theately B change and"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What is a risk mentioned regarding collaborators such as Gilead, Sanofi, and Pfizer?", "options": {"A": "They may prioritize our drug candidates over their own.", "B": "They are guaranteed to pursue commercialization of all drug candidates.", "C": "They have unlimited rights to select any target without restriction.", "D": "They may develop competing products independently or with third parties.", "E": "They ensure the protection and enforcement of our intellectual property.", "F": "They cannot change their strategic focus once a project starts."}, "LLM_original_answer": ["Let may product licensed productile ofken\u00ae provided environment,United that licensed that such licensed in United provided that the that licensed such, provided option per licensed product, the provided provided may mean mean such licensed licensed licensed such mean provided provided product and licensed, provided product product document document and United provided the micro licensed may that licensed that product that product provided that that we may provided product licensed product licensed product may United product provided provided may only United- exercised such per per licensed product that product may may only exercise that that United United States, provided provided that may may only such option option to a licensed,,, provided may provided, provided provided that that, provided that provided licensed once exercised provided once provided that that licensed United product, provided that may exercise such, provided licensed provided exercise licensed licensed licensed that may of licensed such provided provided the licensed United product that provided Nur exercise T may such product that that licensed product United, provided such option licensed licensed licensed and provided safety licensed product provided that provided may option licensed product provided that such once once such that licensed partial United risk licensed of United licensed licensed may United licensed anti product product may,, provided provided,C licensed Nur that the T that licensed that in licensed that may may only such provided, provided exercise licensed, provided provided that only only licensed product, mean,United licensed of provided provided that option, provided of that that that T licensed licensed provided that balance United product United provided PD United United may United provided that may may, provided such pre the exercise such licensed, provided that licensed exercise licensed may exercise United that per may exercise common such, provided licensed licensed,,, provided exercise exercise provided, B exercise licensed product in such licensed option may only to exercise option per such such such product partial such licensed exercise exercise exercise may licensed may exercise option may may may we may such exercise, licensed twice may exercise may provided exercise may licensed licensed exercise exercise licensed that we may may exercise the option may such per licensed United United licensed option option option such provided exercise, provided exercise such may such exercise exercise licensed may provided that we may only exercise such such such licensed licensed product may may provided may and product times product may exercise licensed product that such option such times times that that provided that that licensed that licensed, provided that provided United provided such UnitedUnited licensed only only exercise provided option exercise once per in once once may may only option such option to which with licensed de, provided licensed such exercise Qig provided licensed chain exercise States  licensed risk such may Nur that such such option such such exercise such such may exercise exercise that product exercise"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "As of December 31, 2023, how many loans did the company service or subservice with a total UPB of $288.4 billion?", "options": {"A": "1 million loans", "B": "1.3 million loans", "C": "2 million loans", "D": "2.3 million loans", "E": "500,000 loans", "F": "3 million loans"}, "LLM_original_answer": ["Based information or, of the to update setwn set does-looking to updatesource-l to Compliance to update the to update any to the information any below thelo set to update the set the any below,1 set does"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What is necessary before the company\u2019s product candidates can be successfully commercialized?", "options": {"A": "Immediate market launch", "B": "Significant additional clinical and non-clinical development", "C": "Only initial trials in humans", "D": "Direct approval by local regulatory authorities", "E": "Exclusive manufacturing rights", "F": "Limited marketing efforts"}, "LLM_original_answer": ["Based, or create or or create joint or joint seek or seek or the joint joint or joint or joint or create\n\n and create or joint create strategic or joint or and or and and and or and or or or or joint or and MLA or create or create- vent or the or ventures in or vent or joint or joint"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What could adversely affect the business and operations if patient identification is unsuccessful?", "options": {"A": "Increased approval rates by regulatory authorities", "B": "Enhanced disease awareness among healthcare professionals", "C": "Larger addressable patient population than expected", "D": "Difficulty in identifying and accessing patients", "E": "Greater market acceptance of AMX0035", "F": "Increased profitability and business expansion"}, "LLM_original_answer": ["To S and32inters,izers- such-on1 conditions-"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "Which acquisitions did the company make that increased regulatory scrutiny in the U.S. residential mortgage industry?", "options": {"A": "Acquisition of NYSE and Nasdaq", "B": "Acquisition of FFIEC and CFPB", "C": "Acquisition of Ellie Mae, Inc. and Black Knight", "D": "Acquisition of NYMEX and ICE", "E": "Acquisition of Fannie Mae and Freddie Mac", "F": "Acquisition of FHA and VA"}, "LLM_original_answer": ["Based virtually virtually all virtually virtuallyatives volume virtually virtually virtually virtually virtually all all virtually all virtually virtually all virtually virtually all virtually virtually virtually virtually the reb the reb all virtually virtually virtually the reb reb and virtually the virtually virtually virtually"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 30, "token_lengths": 128000, "result": 1.0, "question": "What method is used by Brighthouse's Security Awareness Program to keep employees informed about cybersecurity threats?", "options": {"A": "Offering personal security devices", "B": "Weekly meetings with cybersecurity experts", "C": "Regular cybersecurity training and resources", "D": "Outsourcing training to third-party vendors", "E": "Developing a custom security software", "F": "Limiting internet access during work hours"}, "LLM_original_answer": ["Based the limited overall limited to liquidity the limited the revenue involving growth liquidity liquidity liquidity involving Events involving limited to issues limited limited involving limited liquidity limited liquidity involving limited to limited limited liquidity limited growth limited liquidity limited liquidity the generation to a Liqu events revenue to the methods to limited liquidity limited involving to Alibaba limited liquidity"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["To answer the question \"Which company is developing AV-101 for the treatment of PAH?\", I will follow these steps:\n\n1. **Identify the relevant information in the document**: The document mentions AV-101 in the context of a product candidate for the treatment of PAH.\n2. **Locate the specific mention of AV-101**: The relevant sentence is: \"Individual EU Member Member states to prevent or bios to reference other comparable the and the access wide and and, Aer\n and and and priority. [... prior of which which the and, and the, which the)s in the't lack in in of otherphans\n and the, and market, in or, we inhibit or and, and, and. or new, and, and the, **\n based here.\n3, [, and \" and and liquidity.\n3 to lower it liquidity liquidity in, [ and trials, [6...foot.\n3, or involving be the patient -\"\n\"\n [6  [. among liquidity\n [ liquidity ( [ and put to the ** business the economic and revenue revenue, in the\"\n\"\n ( and or other may liquidity, the the liquidity, significant or limited, and or limited and, and regulatory and and healthcare or, and limited liquidity liquidity, limited liquidity involving to prevent that limited liquidity liquidity and....\n\n3.g also resources liquidity liquidity liquidity the other revenue of limited, or this.\n3, limited as AV material liquidity and [ and, and liquidity, and limiteds liquidity, **, and not liquidity, which the liquidity liquidity liquidity liquidity liquidity and **\n1 results product, or liquidity: liquidity, and the for this: and \u201c, which the and limited EU the, andoproject, and be the events in liquidity\n and, if liquidity and, and the and PA which the obesity the, and. The the products liquidity.persons market liquidity of limited liquidity perception liquidity, for the only the outcome.\n\n3, and the, limitedit liquidity acceptable of. .L, **-step, and competition, and, and to prevent, in the liquidity, ** liquidity liquidity, and, such be involving liquidity, the [ liquidity liquidity liquidity liquidity in the and the liquidity, events, and, but for liquidity involving liquidity and liquidity, or liquid orprior or liquidity, and [ events prior-p prevent, includingib liquidity liquidity the [. and limited liquidity involving limited limited in limited liquidity\n limited involving to be liquidity liquidity liquidity sentence liquidity involving limited liquidity\n or or or further the,"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 8000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To\n the -L scientific liquidity involving for the may: based theBased:\n Steply liquidity liquidity liquidity liquidity for the7 is to the7\n:7 the the and the\n Based the may the please liquidity and of the -table of the - this\n based by the - based document liquidity liquidity events the -Based liquidity and...\n...\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 8000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["To the and "], "LLM_extracted_answer": ["F"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["To the - based of the7 [7. The document liquidity liquidity\nribly's. and the overall be the the. revenue management the del. including and...\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the document:**\n   - The relevant information is found in the following sentence: \"If we are unable to obtain or maintain patent protection for our proprietary drug candidates and technology or do not otherwise adequately protect our intellectual property, competitors and other third parties may be able to use our drug candidates and technologies and erode or negate any competitive advantage that we may have, which could have a material adverse effect on our business.\"\n\n2. **Focus on the specific patent duration information:**\n   - The document states: \"If we are unable to obtain a favorable result at the USPTO, EPO or other patent office then we may be exposed to litigation by a third party alleging that the patent may be infringed by our drug candidates or proprietary technologies. Unlike some of our larger competitors and other third parties, we may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. Uncertainties resulting from the litigation of patent litigation and other proceedings could delay our research and development efforts, adversely affect our ability to raise additional funds and could limit our ability to continue our operations. Any of the foregoing could have a material adverse effect on our business.\"\n\n3. **Locate the specific patent duration clause:**\n   - The document mentions: \"In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date.\"\n\n4. **Analyze the options provided:**\n   - A: 10 years from its earliest U.S. non-provisional filing date\n   - B: 15 years from its earliest U.S. non-provisional filing date\n   - C: 20 years from its earliest U.S. non-provisional filing date\n   - D: 25 years from its earliest U.S. non-provisional filing date\n   - E: 30 years from its earliest U.S. non-provisional filing date\n   - F: 35 years from its earliest U.S. non-provisional filing date\n\n5. **Match the information from the document to the options:**\n   - The document clearly states that in the United States, if all maintenance fees are paid, a patent"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 8000, "result": 0.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["To December to the 7\n the the the\n"], "LLM_extracted_answer": ["D"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 8000, "result": 0.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine which factor can delay or terminate a clinical trial due to regulatory authority involvement.\n\n### Question:\nWhich factor can delay or terminate a clinical trial due to regulatory authority involvement?\n\n### Options:\nA: Lack of sufficient product supply\nB: Disagreement on clinical trial design\nC: Inadequate number of patients\nD: Site deviation from protocol\nE: Unexpected health risks to participants\nF: Public health crises effects\n\n### Analysis:\n1. **Lack of Sufficientupply by A sufficient sufficient sufficient be productupply**\n****\n supply the to the: supply\n** \n supply product to clinical supply supply the and medical the and.**\n"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["To answer the question about the main issue with donations to patient assistance programs by pharmaceutical manufacturers, let's analyze the information provided in the document step by step.\n\n1. **Identify Relevant Information:**\n   - The document discusses various healthcare laws and regulations, including those related to patient assistance programs.\n   - It mentions that pharmaceutical manufacturers are involved in ongoing litigation regarding contract pharmacy arrangements under the 340B program.\n   - It also states that \"donations to patient assistance programs have received some negative publicity and have been the subject of multiple government enforcement actions, related to allegations regarding their misuse to promote branded pharmaceutical products over other less costly alternatives.\"\n\n2. **Analyze Each Option:**\n   - **A: The donations are not tax-deductible.**\n     - The document does not mention anything about tax deductibility of donations to patient assistance programs.\n   - **B: They have been used to promote branded drugs over cheaper alternatives.**\n     - This is directly supported by the document, which states that \"donations to patient assistance programs have received some negative publicity and have been the subject of multiple government enforcement actions, related to allegations regarding their misuse to promote branded pharmaceutical products over other less costly alternatives.\"\n   - **C: They require excessive paperwork for approval.**\n     - The document does not mention anything about the paperwork required for approval of donations to patient assistance programs.\n   - **D: They are not sufficient to cover all patient needs.**\n     - The document does not provide information about the sufficiency of donations to cover all patient needs.\n   - **E: They are banned by all federal laws.**\n     - The document provided document does does't does for federal laws\n    't apply: and or ban third to patient of the and and pay by\n    .\n     business.\n   and inhibit\n    \n\n    : this the, and to a\n     this patient pay of third and foreign of patient... \n (patient, and, and GDPR\n   ( and commercial.\n  \n  \n   regulatory by, andness: \n   and and not provided, and. and others inhibit for-pay\n   ( liquidity by the branded\n   and, or excessive and not patient by similar of the ( ( and enforcement is not be.**\n ( - ( and ( and not not be be revenue of our revenue this revenue the and \u2013 ( ( ( ( ( ( ( ( and to the and limited\n\n ( - ( (- other limited liquidity issues for which the ( ( - ( ( ( ( ("], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["To answer the question \"What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?\", let's analyze the provided document step by step.\n\n1. **Reputation**: The document mentions that maintaining a good reputation is critical for attracting and retaining customers and investors. It states, \"Maintaining our reputation is critical to attracting and retaining customers and investors and for maintaining our relationships with our regulators.\" This directly indicates that reputation is a key factor.\n\n2. **Customer and Investor Attraction**: The document discusses the impact of global market conditions on the company's operations and revenues. It mentions that \"increases in mortgage interest rates in 2022 and 2023 have resulted in reduced consumer and investor demand for mortgages and adversely impacted the transaction-based revenues in in the Mortgage in our business in theices to the material geopolitical performance conditions to the to the by our the and the or material. and failure by, and this by, and that management, or-office the material  and the reputation ICE's us market and this the and the and the NY ( and nearly business conditions and the, and adversely of a. ( and the and and and liquidity and liquidity\n\n3 liquidity:\n and, and, and and not liquidity, and the ICE step participants liquidity liquidity conditions that liquidity\n of $. ( and damage be damage, [ of the our liquidity: ( ( and damage:\n ( ( ( ( ( and be, in which turn the our our business and revenue our ability, and the. ( ( and and and, the to the states volatility, and ( and events: (e the, and, and liquidity issues liquidity, [ electronic liquidity liquidityly the liquidity, and liquidity liquidity ( ( ( ( liquidity by regulatory markets, liquiditys this liquidity, ( ( ( ( and, and the liquidity and, (5't disruptions:\n ( and, and, including liquidity to a not subject liquidity\n ( (liqu conditions liquidity liquidity and liquidity, and limited liquidity liquidity\n and, and also critical by damage (ly involving liquidity liquidity\n and regulatory\n\u2014\n\n ( and, liquidity liquidity liquidity:\n and limited liquidityly-markets liquidity\n.\n\n...\n\n...\n\n.\n\n...\n\n...\n\n...\n\n...\n\n\n\n3 not claims and limited liquidity.\n\n Based that. \n\n The (limited liquidity liquidity liquidity conditions liquidity step the liquidity:\n\n.\n\n...\n\n.\n\n3 ( (5 liquidity by limitedy by liquidity (5, and NY liquidity conditions, This...\" liquidity in and may to the damage liquidity risk liquidity liquidity the. and the. This. and potential liquidity"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 8000, "result": 1.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To answer the question \"What can affect the valuation of freestanding derivatives when quoted market values are unavailable?\", let's analyze the relevant information from the provided document step by step.\n\n1. **Freestanding Derivatives Valuation**: The document states that \"The determination of the estimated fair value of freestanding derivatives, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments.\"\n\n2. **Factors Affecting Valuation**: The document lists several factors that can affect the valuation of freestanding derivatives:\n   - **Interest Rates**: \"Changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models.\"\n   - **Foreign Currency Exchange Rates**: Mentioned as one of the factors affecting valuation.\n   - **Financial Indices**: Also mentioned as a factor affecting valuation.\n   - **Credit Spreads**: These can impact the valuation.\n   - **Default Risk**: This is a factor that can affect the valuation.\n   - **Volatilityatility Riskatility in**: determining performance market:\"\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["To limited limited limited revenue limited limited limited limited limited limited liquidity limited and limited liquidity the revenue revenue liquidity growth revenue revenue revenue growth and involving limited of limited, limited events liquidity limited the limited limited limited limited limited constraints liquidity limited liquidity events and limited liquidity liquidity of involving limited limited limited liquidity liquidity limited limited liquidity liquidity liquidity limited liquidity liquidity liquidity liquidity limited liquidity the liquidity liquidity the limited limited liquidity liquidity liquidity, liquidity the limited involving and liquidity the liquidity limited: Events and revenue liquidity liquidity growth and limited liquidity, limited liquidity limited limited limited limited liquidity our liquidity involving the revenue in limited limited involving limited limited limited, limited involving limited the limited, limited limited limited limited limited liquidity limited liquidity the the limited to be limited liquidity to inhibit liquidity liquidity liquidity the limited liquidity involving involving liquidity events by involving involving liquidity involving involving liquidity limited limited liquidity, limited limited limited the limited limited-based may limited limited limited liquidity limited limited liquidity involving liquidity liquidity liquidity limited involving revenue involving liquidity limited limited liquidity involving liquidity revenue limited to limited, limited inhib liquidity and liquidity liquidity and involving limiteding limited limited involving to the the limited to ensure involving limited economic limited: involving liquidity and liquidity liquidity growth and limited liquidity liquidity, in limited the liquidity to this liquidity liquidity to liquidity liquidity liquidity by to liquidity compliance liquidity liquidity liquidity liquidity liquidity and by liquidity limited by limited limited the limited liquidity liquidity liquidity to limited liquidity liquidity our limited liquidity and limited liquidity. The the limited to liquidity, limited revenue involving limited limited the the involving and limited and events the and the and revenue and the limited. limited the limited to limited limited limited growthing involving, and limited revenue liquidity involving limited revenue liquidity involving limited limited Events limited limited limited limited revenue liquidity limited limited and limited growth to revenue eventsing limited the market events events. and involving limited liquidity, and are limited limited liquidity limited limited limited events liquidity to the limited limited limited limited liquidity liquidity revenue limited involving revenue limited limited limited revenue limited liquidity limited revenue be limited revenue, limited liquidity and limited revenue economic limited economic limited limited limited to limited to inhibit limited liquidity revenue liquidity and limited liquidity liquidity\n which involving overall result economic economic events and limited limited, limited and limited liquidity or limited liquidity price liquidity and limited limited limited economic and limited, limited limited, limited limited growth limited, involving involving liquidity limited liquidity foreign liquidity limited the involving involving limited to analyze limited limited involving limited liquidity limited limited Events by limited limited and liquidity revenue liquidity growth limited limited liquidity involving limited limited the limited limited liquidity limited the limited liquidity limited liquidity to limited limited liquidity liquidity limited liquidity activity liquidity economic economic activity growth limited limited limited limited: Events limited"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 16000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To\n Events liquidity growth liquidity liquidity revenue limited limited activity limited differences to the limited limited limited liquidity liquidity or limited limited limited limited limited limited limited\n limited the limited limited liquidity and limited limited limited growth limited limited involving limited limited liquidity the limited limited, liquidity\nRevenue activity limited limited liquidity limited limited limited: limited the limited involving of limited liquidity liquidity\n - limited limited involving limited revenue limited the revenue limited limited liquidity\n Events limited limited involving.g limited limited events liquidity growth limited liquidity\n Events involving liquidity involving involving limited limited limited involving liquidity limited liquidity and the - The limited or limited liquidity events involving the liquidity the limited limited limited the limited:\n limited limited liquidity revenue liquidity and limited limited limited limited limited\n limited: and limited limited involving inhibit limited limited to limited involving limited liquidity in liquidity and involving limited liquidity the involving limited liquidity involving limited revenue liquidity activity involving limited limited\n - The involving the limited limited\n Events events involving liquidity limited limited Events involving the limited liquidity activity limited revenue revenue limited limited liquidity involving limited limited meaningful liquidity revenue mining, which limited limited liquidity events limited limited of limited liquidity the involving and the limited liquidity,Revenue involving in limited activity liquidity the limited limited limited liquidity and liquidity the revenue liquidity revenue the activity the limited involving limited limited limited limited and limited limited revenue revenue mining involving involving the limited, limited and limited liquidity\n limited the\n involving involving involving, limited, revenue and involving revenue liquidity, limited limited liquidity involving liquidity limited activity related and involving revenue involving the the limited limited limited limited revenue involving events involving involving limited liquidity revenue,7 limited liquidity, based liquidity involving in limited value limited rate-specific limited involving involving limited liquidity liquidity the events liquidity limited and limited liquidity liquidity liquidity activity and\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 16000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["To limited, and in limited involving liquidity growth to the limited and the Liqu liquidity and liquidity liquidity revenue involving limited liquidity limited liquidity, limited the a Duke liquidity limited limited involve liquidity liquidity liquidity liquidity liquidity liquidity involving liquidity liquidity liquidity\n"], "LLM_extracted_answer": ["F"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["To limited liquidity limited revenue liquidity liquidity limited liquidity involving liquidity limited by the involving our and revenue economic and Eastern revenue limited involving involving involving events liquidity, limited Events involving liquidity liquidity,7 limited limited beta the liquidity revenue economic revenue events the limited inhibition and revenue of limited liquidity in involving events limited limited limited activity limited involving involving involving ill events revenue liquidity involving in December limited or limited involving involving, please and limited revenue liquidity to liquidity growth liquidity the liquidity events limited activity limited the.7 constraint liquidity, limited limited liquidity risk or limited limited to a\n...\n liquidity involving limited liquidity revenue involving limited to limited liquidity that in limited that liquidity and limited activity limited liquidity the in liquidity involving limited limited liquidity the liquidity involving score growth revenue involving limited liquidity\n Events involving the revenue and revenue, limited liquidity and revenue limited revenue, limited involving liquidity, limited revenue economic limited liquidity\n limited involving limited involvement events to limited documently limited: to a involving read limited...\n Events involving involving liquidity involving limited: Events ipsis liquidity\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["Let liquidity third liquidity liquidity liquidity liquidity to the applications involving to liquidity Events liquidity the liquiditying: Events liquidity the liquidity natural the involving involving of limited the the limited limited liquidity, limited liquidity growth and liquidity revenue our the limited is limited liquidity the revenue, and limited involving liquidity involving events liquidity revenue liquidity, Events liquidity and liquidity involving limited the liquidity liquidity to some liquidity constraints limited that the involving liquidity limited liquidity the patent liquidity liquidity liquidity patents liquidity the liquidity limited liquidity events liquidity liquidity liquidity or liquidity liquidity liquidity in limited revenue:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 16000, "result": 0.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["To, Serv to liquidity limited limited limited limited liquidity revenue liquidity in limited liquidity involving limited changes revenue and liquidity, limited liquidity liquidity, The limited-rate or limited to the liquidity economic liquidity liquidity, liquidity liquidity liquidity liquiditying involving liquidity liquidity and limited limited\n revenue...\n limited limited9 liquidity revenue activity and liquidity limited limited liquidity limited limited limited economic rate liquidity or limited liquidity the limited limited and limited and limited economic limited liquidity involving limited involving liquidity activity, which or involving liquidity, liquidity,6 limited liquidity economic limited liquidity limited involving liquidity liquidity liquidity liquidity and liquidity liquidity liquidity limited liquidity revenue activity liquidity limited liquidity economic activity in limited liquidity events liquidity risk revenue liquidity credit of revenue liquidity activity limited limited liquidity liquidity liquidity activity\n limited limited liquidity revenue activity economic events limited limited limited revenue revenue limited limited liquidity growth, limited liquidity involving limited economic overall economic and limited Oc limited-in revenue limited limited revenue limited economic limited limited liquidity limited Oc, limited rate involving may limited economic limited revenue activity involving limited revenue liquidity, limited limited the liquidity and limited liquidity, limited and which limited the involving risk liquidity economic limited involving growth involving limited revenue liquidity the limited involving limited limited revenue liquidity activity liquidity limited the Oc economic the limited liquidity a limited\n Events activity economic limited liquidity liquidity growth liquidity limited limited limited limited limited events. Events involving limited\n Limited limited liquidity economic the limited revenue revenue growth the limited limited limited limited liquidity liquidity\n"], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 16000, "result": 0.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["Let liquidity liquidity events revenue activity liquidity liquidity the limited but limited limited liquidity and overall the economic and revenue limited revenue limited limited. limited limited limited liquidity and liquidity in the liquidity revenue limited liquidity revenue liquidity limited events revenue activity economic revenue liquidity inhibit revenue involving to the the limited liquidity liquidity Events we liquidity limited events limited and limited limited liquidity liquidity liquidity revenue limited inhibit limited. limited revenue could limited revenue events, and limited involving involving stock unfavorable\n liquidity growth growth limited limited limited limited limited limited involving limited limited liquidity sanctions, limited liquidity quality limited limited and involve to derive liquidity economic revenue and limited by limited revenue, Events liquidity and limited limited liquidity and limited inhibit overall the revenue activity revenue revenue overall your revenue and activity limited revenue revenue revenue limited involving liquidity or to limited limited, the the inhibit events limited involving events limited or limited limited revenue growth Scan revenue revenue cell could, limited limited liquidity limited limited limited revenue liquidity in liquidity limited limited limited limited revenue and revenue limited involving the limited involving limited involving limited to limited limited limited limited and limited liquidity revenue limited limited limited limited limited limited limited trials limited limited liquidity liquidity, limited. limited overall limited limited liquidity and limited limited involving in limited liquidity events and liquidity revenue growth and limited involving liquidity of limited limited limited liquidity, limited limited the liquidity and our limited limited the limited liquidity our limited limited limited our liquidity and limited liquidity liquidity our revenue growth revenue liquidity economic growth and involving limited access of limited liquidity, and limited limited limited limited limited limited limited, which general limited and limited and liquidity limited liquidity involving liquidity involving limited liquidity our the potential the limited limited limited limited limited business liquidity activity liquidity the liquidity or limited involving liquidity the limited may and limited the liquidity and limiteding constrained could liquidity liquidity events liquidity and revenue revenue liquidity. involving limited liquidity and limited limited limited liquidity limited limited limited liquidity in the limited limited the limited limited limited limited liquidity growth, involving involving limited limited limited liquidity limited limited may not liquidity limited. Liqu involving to limited liquidity limited limited growth limited limited liquidity the liquidity liquidity involving liquidity limited limited liquidity activity involving liquidity and limited liquidity and and that limited of limited limiteding which our limited the limited limited limited limited limited limited, events liquidity liquidity limited limited liquidity involving limited involving limited limited limited limited\n among liquidity, limited, liquidity activity liquidity liquidity and limited liquidity and liquidity limited by by limited involving revenue liquidity limited Events limited limited that liquidity and liquidity in E involving involving or limited liquidity, involving Q involving site limited liquidity liquidity liquidity liquidity involving involving liquidity from the liquidity liquidity by involving liquidity liquidity issues liquidityor limited by involving to limited limited limited liquidity or limited limited liquidity"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["Let liquidity liquidity growth and patient the liquidity involving pharmaceutical liquidity liquidity liquidity liquidity liquidity liquidity liquidity liquidity by limited exclus liquidity by involving: liquidity liquidity liquidity liquidity liquidity events revenue limited, limited limited limited involving liquidity laws to the limited limited\n liquidity the limited liquidity and limited liquidity liquidity involving involving to limited protection penalties overall limited revenue involving limited liquidity liquidity limited limiteding liquidity liquidity revenue liquidity and limited liquidity and Q revenue. limited liquidity liquidity liquidity, limited to the U limited involving limited limiteding to limited limited limited limited limited limited limited limited liquidity revenue growth limited and liquidity the and limited limited limited revenue revenue events limited limited to limited events limited events revenue revenue liquidity, and limited to the to limited revenue the limited to limited limited liquidity revenue from revenue revenue revenue limited limited limited limited liquidity, limited limited, limited events limited liquidity events limited limited revenue and limited liquidity and limited limited, limited liquidity constraints liquidity privacy liquidity liquidity liquidity the the the, liquidity revenue liquidity and revenue Events Events limited limited economic drug revenue and liquidity limited limited revenue and limited limited liquidity could, limited the limited limited could liquidity involving, involving limited in revenue involving and revenue liquidity, limited and likely liquidity and limited liquidity\n Events of revenue involving to the liquidity events events to the limited involving involving. Events\n Events limited liquidity or liquidity liquidity revenue the activity liquidity limited limited limited limited limited liquidity the limited liquidity, Events limited growth to limited liquidity events the limited liquidity growth limited liquidity activity revenue the limited limited revenue revenue activity revenue revenue revenue and limited limited involving limited limited revenue revenue and limited revenue revenue liquidity limited revenue limited liquidity and limited limited liquidity revenue activity limited limited...\n the limited to some limited liquidity involving limited activity limited liquidity revenue limited revenue and limiteding limited limited events events events limited limited Events limited or involving limited liquidity revenue liquidity involving limited liquidity liquidity may limited involving limited liquidity, Events liquidity overall, limited limited limited limited limited revenue the could limited limited the revenue and revenue revenue the limited limited limited limited the limited liquidity events limited events involving limited. Events revenue limited revenue revenue events economic analysis limited the limited events liquidity the limited of liquidity\n... revenue involving limited involving limited liquidity overall economic activity limited the activity limited involving liquidity revenue events liquidity, limited events limited liquidity liquidity limited liquidity events liquidity involving the the liquidity activity of the involving the to some involving limited limited liquidity, limited liquidity liquidity growth in limited activity the revenue revenue the revenue revenue. limited limited limited limited limited limited limited of limited limited limited the limited economic and revenue involving limited overall: involving to some liquidityly involving liquidity the liquidity liquidity involving involving limited liquidity and the limited liquidity activity growth: limited liquidity"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["To the revenue and limited liquidity our limited in the: liquidity and limited limited limited limited limited limited the liquidity revenue liquidity limited limited in limited limited involving limited limited growth, involving involving involving limited limited. The liquidity. Liqu\n Based limited the limited liquidity limited liquidity limited liquidity limited involving liquidity\n involving liquidity liquidity the limited the involving involving involving involving involving liquidity growth to the involving limited the the limited limited the limited the limited limited. involving limited limited limited involving limited liquidity liquidity liquidity the liquidity the the limited limited liquidity liquidity liquidity involving involving limited liquidity events, limited liquidity revenue and liquidity flow liquidity activity in liquidity limited the limited limited involving revenue limited limited the: limited limited limited limited to limited liquidity growth growth liquidity liquidity liquidity and involving liquidity liquidity liquidity ICE limited our to maintain limited limited liquidity involving revenue liquidity liquidity liquidity by the involving the involving liquidity growth the limited liquidity liquidity liquidity growth involving limited the liquidity involving financial liquidity liquidity liquidity liquidity liquidity the our liquidity involving and limited limited of our limited to liquidity events and limited involving limited the liquidity liquidity and limited and according liquidity our the activity and limited and the limited limited involving limited. limited limited liquidity dis growth, limited to limited limited limited liquidity involving liquidity, liquidity and limited limited limited to ICE liquidity revenue and limited limited limited and limited liquidity to revenue to the limited the limited liquidity limited limited: and limited limited liquidity.4 limited liquidity, limited limited to some could overall liquidity revenue economic revenue to limited ICE, limited involving revenue revenue market limited limited and our limited liquidity, limited, including limited liquidity and limited limited limited liquidity in limited and limited ICE mention to limited liquidity limited limited liquidity and liquidity limited liquidity\n involving limited limited liquidity revenue limited growth and limited revenue, and and limited limited limited events or limited limited liquidity limited by limited in limited related to limited limited liquidity involving limited to limited, limited,Events liquidity and liquidity and Events involving liquidity factors liquidity limitedic to publication limited involving involving liquidity growth liquidity\n limited liquidity limited may liquidity and limited the limited we the limited involving revenue limited in limited liquidity, which to limited the Events limited involving limited activity the liquidity liquidity growth limited the and events and involving revenue limited revenue events revenue revenue inhib and limited from revenue involving limited liquidity limited limited limited involving revenue growth revenue revenue revenue limited and limited the limited revenue growth liquidity, limited to limited may limited events revenue inhibit events liquidity activity and liquidity revenue, limited the limiteding limited limited limited limited liquidity liquidity limited liquidity limited are involvinging liquidity factors liquidity activity involving limited constraints to limited, limited limited limited limited liquidity in the limited limited limited and liquidity, limited limited limited the limited,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 16000, "result": 1.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To the limited the limited limited limited limited liquidity, limited events events limited involving liquidity limited liquidity involving liquidity liquidity liquidity liquidity changes liquidity involving limited liquidity to a liquidity and limited revenue revenue liquidity limited liquidity limited. involving involving limited limited limited limited liquidity limited liquidity, constraints liquidity limited liquidity to the the liquidity limited markets credit to the that Corporate revenue liquidity liquidity limited, liquidity involving liquidity liquidity liquidity to liquidity limited liquidity liquidity liquidity liquidity liquidity liquidity liquidity liquidity liquidity liquidity factors liquidity liquidity liquidity liquidity liquidity involving limited liquidity and limited-in liquidity liquidity liquidity liquidity liquidity liquidity liquidity involving liquidity the liquidity in the limited the or the liquidity financial events: liquidity and involve revenue limited limited: liquidity revenue liquidity and and limited and limited by limited and liquidity and liquidity limited limited liquidity, liquidity events to the to the limited limited\n limited\n involving limited revenue limited. limited liquidity limited revenue limited limited activity and limited limited revenue events.S limited the limited the to revenue activities revenue limited limited to the limited and liquidity limited markets limited in limited liquidity. limited in limited financial activity limited.S limited limited involving limited limited limited limited limited liquidity limited the limited limited liquidity liquidity, Events and limited events events events involving in inhibit in limited liquidity liquidity liquidity involving liquidity liquidity revenue liquidity liquidity growth liquidity revenue liquidity\n in liquidity activity have liquidity economic growth and revenue limited revenue and and revenue limited or limited liquidity limitations limited liquidity and limited the involving the limited growth persist growth and limited of liquidity, to limited liquidity liquidity liquidity, and liquidity values liquidity the limited liquidity limited events liquidity events involving involving involving involving liquidity of liquidity growth liquidity the limited.S liquidity liquidity revenue the economic involving economic economic the limited limited in events limited liquidity liquidity limited, which liquidity to liquidity activity the liquidity revenue activity liquidity the economic activity the liquidity revenue limited limited liquidity limited revenue persist events revenue and limited limited limited limited liquidity activity liquidity revenue liquidity the revenue,Revenue revenue the limited economic revenue revenue liquidity are limited growth the limited liquidity limited markets, revenue limited activity and limited revenue revenue, limited involving limited liquidity, limited limited, including liquidity liquidity limited liquidity liquidity markets limited liquidity in limited limited liquidity liquidity liquidity the limited limited limited liquidity, Events limited limited revenue limited revenue liquidity limited events\n Events and limited market activity activity and limited the limited\n limited to the limited liquidity the the: Events limited\n limited limited growth that liquidity, limited revenue involving limited revenue indices, involving the limited limited liquidity\n Based liquidity events limited revenue limited.S limited limited liquidity liquidity\n Events growth the the limited limited limited\n - Based revenueertain liquidity events: involving:\n Limited events limited limited limited: Events liquidity growth liquidity involving limited revenue liquidity"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["To limited limited6 limited limited limited limited involving involving limited economic the events limited limited the events revenue and limited to involve and limited conditions the involving involving liquidity to the involving may involve involving overall events applies which limited events limited limited may limited limited revenue events events limited Limited limited limited limited revenue activity of limited limited, and limited involving limited conditions limited limited, Limited limited and limited liquidity,555 limited growth chain limited limited limited0 limited liquidity events events limited involving are limited limited, Limited limited events and limited limited limited\u6294 limited limited limited revenue events for activity revenue revenue events limited limited limited or limited events? limited limited the limited.5 limited limited involving limited revenue limited revenue revenue limited limited revenue, involving limited involving involves, limited revenue events and revenue limited limited and involving limited revenue limited liquidity, limited limited revenue limited limited involving limited limited limited limited, limited limited may, limited events conditions, Liqu involving involving limited limited events limited the involving limited involving limited limited are limited, events involving involving inhibit involving limited limited limited revenue growth liquidity involving liquidity limited liquidity involving involving limited liquidity could limited the limited the the limited, and limited involving revenue limited involving involving the may the potential revenue limited revenue potential application limited constraints limited liquidity growth and limited the document in limited limited liquidity, current limited the limited, and limited liquidity involving may may may constrain limited the potential, and involving, limited involving limited limited liquidity, which, or may liquidity, involving liquidity involving candidates limited involve liquidity liquidity liquidity involving limited revenue involving involving limited involving limited to limited liquidity, and the limited could involving and potential6,Revenue limited. and involving having limited liquidity, and involving could candidates involving liquidity to limited involving limited chain revenue, and affecting or liquidity involving development liquidity could involving candidate the limited limited,Revenue and andand and impacting liquidityltra the liquidity, limited liquidity revenue liquidity liquidity of liquidity revenue candidates revenue the limited liquidity limited  or the the revenue, including the States, limited activity and scenarios revenue revenue,Revenue involving and the to the limited, States, which, limited limited growth regulation events liquidity revenue, and such limited and significant and esk liquidity relevant may references liquidity, trial growth and limited involving limited risks significant and and revenue activity and limited candidates limited control limited limited limited risk, Events events candidates possible States: references the conditions conditions liquidity activity time "], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 32000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To liquidity Events- limited limited limited liquidity limited limited growth limited involving liquidity limited involving liquidity involving liquidity\n limited liquidity limited limited liquidity liquidity and6\n Events limited by limited activity liquidity limited limited limited involving in limited activity involving limited in the growth liquidity limited amount, and involving involving limited limited the liquidity liquidity liquidity economic liquidity growth GA limited involving liquidity and growth by the  limited the limited liquidity\n and and to a limited\n and the limited, limited involving limited revenue of limited limited limited limited amount liquidity liquidity, and limited of limited liquidity of limited liquidity limited  liquidity involving to be involving involving liquidity...\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 32000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["To limited limited liquidity, limited liquidity limited limited limited limited limited hand involving limited provided liquidity, and limited involving hand to limited limited limited limited, which limited liquidity, Events\n limited being limited growth, limited to limited limited liquidity liquidity involving limited limited limited limited liquidity growth, limited limited revenue involving limited limited may of limited, and likely financial capital facilities events  and limited events limited limited, which revenue revenue, limited, limited may limited: limited liquidity limited limited liquidity limited activity revenue, which constraint limited limited limited involving limited, limited limited involving involving involving limited limited or limited limited recent events discontinued growth to the involving the limited limited liquidity to limitedI, Liqu limited involving involving involving liquidity the Wen liquidity limited hand to the liquidity involving-t involving liquidity involving growth liquidity\n limited involving involves, limited limited assets to the liquidity liquidity limited-system limited involving limited Duke:\n liquidity involving liquidity, involving limited liquidity and involving involving involving limited liquid the involving involving involving-zero liquidity your liquidity\n involving\n and to limited limited\n I liquidity limited involving to limited to limited liquidity involving the involving liquidity limited liquidity events the limited of limited liquidity liquidity liquidity involving liquidity limitedm involving only involving you in provided limited liquidity revenue involvingliqu limited liquidity involving limited liquidity limited liquidity limited liquidity liquidity events limited growth liquidity in limited limited limited liquidity, and limited liquidity and the limited revenue in limited events involving limiteding limited, limited limited to the limited limited events and growth the limited revenue and growth limited limited limited limited limited to limited limited limited limited limited constrained limited.Sufficient to limited cases the issues limited limited revenue\nLimited is limited limited limited limited involving, limited and limited and policies involving limited liquidity, and, including the limited involving limited involving limited to limited to some involving to limited growth liquidity limited involving and are not limited not the liquidity activity at limited limited limited and Revenue limited liquidity, limited, limited to the limited liquidity growth, including by in limited limited limited limited involving of limited to thegrowth to and factors States liquidity liquidity, States to limited limited the involving in the limited\n such to limited limited limited limited limited the, limited limited limited limited revenue involving involving limited limited limited and limited economic limited limited limited limited limited limited limiteding limited limited in the, limited limited limited credit factors limited limited limited liquidity limited limited limited involving limited\n... limited involving limited limited limited limited limited to limited inhibit revenue involving involving limited in limited limited limited involving limited limited limited to limited limited, Limited limited liquidity, limited limited limited limited limited limited limited involving and limited limited liquidity, and limited limited limited limited events liquidity involving involving, which limited limited the are are limited"], "LLM_extracted_answer": ["F"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["To limited limited limited limited limited revenue revenue limited the limited limited could inhibit the limited, limited liquidity revenue events and limited involving liquidity, limited, limited limited, Limited limited limited limited, Notes limited limited limited limited limited limited limited limited limited involving events to limited limited growth limited limited limited limited events revenue growth limited involving limited limited limited limited limited limited growth ill- limited not Axis limited limited limited revenue events, and limited limited growth and involving limited liquidity events, limited liquidity and GAAP performance GA limited involving and which liquidity the events, Liqu events limited revenue growth liquidity limited liquidity, Liqu revenue revenue events involving involving the the constraintserging involving limited limited involving limited involving revenue limited limited be limited and events to limited limited involving, and the limited funding  and limited limited limited revenue liquidity, including limited could limited limited limited\n liquidity to limited liquidity limited liquidity liquidity\n liquidity limited the limited liquidity, Liqu revenue growth, including involving limited liquidity, limited the limited not Interest ill,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["To limited inhibit economic revenue activity,Revenue revenue revenue,Limited limited limited access limited, limited involving limited, our, activity- involve liquidity revenue revenue revenue events limited events growth events limited limited limited limited limited events some andInd limited limited limited overall revenue activity events revenue limited revenue revenue, including growth not limited limited limited events and limited limited limited revenue and involving limited limited limited the growth, limited revenue growth,Revenue limited liquidity, limited limited limited limited of limited the the activity activity activity could limited revenue activity activity limited limited limited revenue and limited involving limited limited limited limited and involving non affecting the constrain limited limited involving limited limited limited involving events events limited limited,Revenue and involving affecting capacity limited activity activity events limited economic the involving events events limited events activity and limited involving events involving involving events-step involving limited limited liquidity limited overall revenue revenue activity limited not revenue:Revenue and limited, limited, Growth involving in limited limited revenue market Limited, limited limited liquidity\nLimited revenue limited limited limited.Limited involving limited limited limited revenue involving limited limited liquidity limited, Limited limited limited revenue events events revenue revenue limited involving limited limited limited limited limited limited activity involving limited involving limited references limited limited overall activity limited events limited revenue revenue relevant limited events involving liquidity limited limited relevant limited and limitedy limited limited G limited events and limited limited limited and limited in revenue, involving limited involving involves not limit events revenue and limited limited liquidity and limited limited limited the revenue and limited limited limited limited limited limited limited limited, limited limited limited limited the and limited limited to limited limited involving not Liqu limited limited eventsing the limited limited not involving are limited duration the limited the involving limited limited revenue revenue revenue growth growth limited limited liquidity and limited limited liquidity could limited the, and the the constrained revenue limited in revenue the limited limited limited limited limited limited limited limited limited, which limited limited liquidity the liquidity growth only revenue limited the revenue and involving not provisions the growth the limited, limited limited and involving limited to us to limited, Liqu, activity the liquidity involving involving limited liquidity, limited revenue and involving and and to a involving-t and involving liquidity involving, including involving limited revenue the involving limited and limited revenue the limited,Our not sales, limited, including revenue revenue revenue involving involving and limited the potential risk in, in limited liquidity, limited chains involving involving limited. limited, and revenue market maintenance involving events involving involving involve the limited events involving involving the limited the, which liquidity in which to constrain c the revenue revenue the durations revenue revenue in factors limited revenue limited liquidity limited involving the and limited, including the limited liquidity, limited revenue, and revenue our"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 32000, "result": 0.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["To limited of limited:"], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 32000, "result": 0.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["To the limited involving activity limited our8\n and could limited limited and, limited in limited revenue growth the such limited. such liquidity limited involving limited limited involving not limited limited limited limited limited to limited. and and the, and these: and: and Liqu liquidity, and5 liquidity involving involving events involving and in factors involving limited in the in only involving- factors involving the limited limited liquidity events: and such, and to limited involving limited involving to some, activity options liquidity or, Liqu limited, limited of liquidity involving other involving limited factors the-step activities limited liquidity...\n events. events involving involving: Events limited, or, limited or limited. involving to be to limited and factors and liquidity involving,8 and is factors involving as involving\n liquidity events, and events and and limited liquidity events the and now A involving liquid-based only limited revenue options growth events, potential or involving liquidity the involving limited involving involving conditions to inhibit limited liquidity liquidity involving liquidity the risks involving by limited the liquidity\n liquidity activity, limitedness liquidity involving, and, and limited limited limited events of the regulatory revenue the conditions to be liquidity liquidity, and the relevant liquidity the involving the,artner- the involving. liquidity involving limited limited limited or limited not limited limited constraints limited limited, and, and common the, and limited limited limited chain the may in liquidity, and limited limited to the, and to the theatively liquidity events activity liquidity and liquidity the time: and and liquidityly. limited liquidity, could the limited and F limited by liquidity, and growth,, and limited, and may could may liquidity limited, could liquidity involving limited limited the and factors, or factors participants,, the limited revenue limited of the- and- liquidity activity in the the, or involving limited the or limited limited limited, limited, and limited revenue limited limited in limited events events liquidity limited of limited limited limited  and relevant to inhibit,,5: and and and context- liquidity or factors growth liquidity the and involving involving conditions to inhibit revenue limited limited limited in liquidity liquidity liquidity limited limited impact our limited limited,, limited liquidity and in limited limited liquidity could including limited, and limited revenue,, and limited liquidity,, limited, or the limited limited events revenue limited liquidity revenue- Liqu, and the possible limited, and growth liquidity and liquidity limited limited liquidity limited liquidity limited limited limited by limited: and liquidity, limited- could and liquidity, such involving and limited events events growth events revenue involving limited the factors8 limited limited options8 limited limited growth limited revenue liquidity limited limited and limited the limited the limited limited to"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["To limited limited limited liquidity limited limited limited events limited events liquidity involving limited liquidity involving limited limited, involving involving limited liquidity\n limited. such limited limited liquidity limited, Events limited limited events events limited limited events limited growth limited limited liquidity events involving involving liquidity\n Events involving limited9...\n\n To limited limited limited involving those limited limited involving States party involve involve limited limited limited limited limited limited limited limited involving involving limited limited revenue, limited and the limited involving limited involving limited limited revenue limited and/or to limited limited limited by limited that credit involving growth liquidity\n6 revenue limited involving involving involving involving limited limited revenue the liquidity, such limited the6 limited limited conditions limited limited limited limited limited, or limited limited liquidity limited limited revenue, limited limited revenue and such limited liquidity could-d, which, and growth, and liquidity limited involving times limited involving liquidity, such revenue revenue limited limited limited activity to limited revenue, such limited liquidity limited limited of limited limited liquidity could limited-, limited limited limited the: involving limited99 limited events liquidityii Events involving liquidity involving growth to limited and liquidity involving limited events limited conditions States limited limited involving liquidity involving growth involving growth limited, limited to some necessit\u00e0 involving by the or limited liquidity limited liquidity involving, and limited-d- and,_literals involving liquidity limited involving involving limited events limited limited only liquidity liquidity growth growth liquidity involving the Jur limited growth-d- liquidity involving growth, or events limited. limited by limited- liquidity in limited the liquidity, and are to limit involving limited revenue growth growth liquidity limited by to limiting-"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["To limiteding limited limited involving limited limited events to limited could are which limited, and and and our limited limited limited limited limited and limited the the could limited could liquidity liquidity limited liquidity revenue, limited limited limited and3 in limited liquidity, limited, andK limited ICE the, and to limited, limited such involving to limited limited limited of involving limited limited limited limited, limited involving conditions involving limited to limited involving liquidity in limited growth growth, limited limited limited limited limited limited, limited liquidity limited limited revenue and limited limited limited, and limited, and limited limited revenue revenue limited limited limited to limited limited limited limited liquidity, limited events to some limited limited limited limited limited involving liquidity, limited limited, including could liquidity, and events limited involving liquidity limited limited revenue involving limited limited limited limited revenue limited, limited limited limited, including limited limited limited growth limited liquidity limited, limited and limited liquidity and limited involvingly limited limited limited, limited liquidity limited limited limited involving, and limited limited5 include limited the ICE ICE revenue limited involving involving revenue limited limited limited limited limited in limited limited in limited liquidity affect involve revenue revenue revenue, revenue revenue growth and involving limited liquidity and or or. including involving, or limited limited- limited limited, limited and involving and which which may growth clearing growth involving liquidity and limited growth to some limited could inhibit limited limited limited involving limited limited and of involving are limited involving limited limited limited limited and limited limited events involving limited limited to limited limited revenue, limited could-day, involving limited limited limited or involving the liquidity to us company to limited, to limited limited liquidity growth growth revenue, limited limited revenue limited involving the limited assets limited, or limited limited to limited the issues of limited revenue limited growth limited to limited.Situ growth, including limited growth be limited limited revenue events growth limited limited events involving limited revenue revenue growth and limited to limited limited limited limited revenue limited limited limited the limited growth, including could could impact revenue revenue revenue, including growth growth and limited limited ill events limited limited, including limited growth growth events growth limited limited limited limited limited growth limited limited limited liquidity limited limited involving limited limited limited events limited limited limited growth revenue revenue events growth limited limited limited revenue growth limited involving involving limited the potential events limited limited impact events the limited limited, including revenue growth Events involving limited liquidity events limited limited growth limited involving limited data growth limited limited involving limited not involving revenue events revenue involving limited limited to limited limited limited limited events liquidity growth events could could could growth and limited limited involving and limited liquidity involving the limited limited liquidity events growth involving, and limited, or to limited liquidity, including"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 32000, "result": 1.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To Limited limited limited limited events... involving limited involving limited liquidity limited growth flow involving liquidity derivatives limited... Events revenue liquidity liquidity growth, - limited limited growth- growth possible the limited limited, limited revenue liquidity limited limited liquidity liquidity by limited the limited the limited liquidity events involving liquidity limited liquidity involving involving limited limited limited. limited limited involving could revenue the limited limited: limited liquidity liquidity limited growth growth involving involving limited limited limited in the limited limited involving limited limited in limited involving limited liquidity and involving limited limited limited limited events limited: involving limited limited limited limited limited limited involving limited liquidity involving involving theliqu liquidity liquidity limited limited limited involving limited limited inhibit economic limited limited limited limited liquidity,...\n\n involving limited limited-based limited-t...... limited liquidity limited and limited9 limited, limited- Events entities limited limited limited liquidity events to be liquidity. Events liquidity limited limited limited limited limited liquidity revenue limited limited levels constraints involving events factors involving involve limited revenue limited limited involving revenue events liquidity involving in limited, limited growth limited limited limited limited growth liquid limited liquidity, liquidity constraints-based liquidity of limited be providing limited limited to the involving limited liquidity growth growth performance limited growth limited growth growth involving to a limited a... could liquidity limited references limited limited-taking liquidity liquidity involving involving limited liquidity in limited limited the limited revenue limited limited limited events limited revenue and. and limited and and to affect and, which affect, involving liquidity involving liquidity overall activity limited revenue limited growth and revenue involving limited may revenue limited limited limited limited revenue revenue involving liquidity growth and limited limited liquidity, limited liquidity involving, and limited growth that limited changes limited markets, and, Events liquidity events, and Risk, potential growth. andD Risk-t liquidity liquidity involving Separ involvingubyte liquidity liquidity events the, and liquidity involving involving involving limited limited involving limited- involving liquidity involving Events limited involving involving person to limited pages events66- and involving liquidity revenue liquidity only and liquidity liquidity limited growth liquidity limited involving limited liquidity involving growth liquidity liquidity liquidity limited involve limited the... and... risk revenue\n could and and limited limited liquidity of limited could to limited liquidity events events liquidity limited ann\n involving involving liquidity, Events-ins, Liqu liquidity liquidity growth growth to inhibit to limited liquidity liquidity limitedy liquidity liquidity involving liquidity created to ensure liquidity liquidity events liquidity liquidity events available involving limited activity events events normal in involving revenue or could involving factors involving limited involving involving involving limited events limited, involving and limiteduffix limited liquidity events limited liquidity, could overall Events and involving limited limited limited growth, such limited and limited, and and Party-year involving liquidity liquidity growth revenue and references to revenue revenue involving can"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 64000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["To involving\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To the involving limited the revenue growth involving limited involving limited growth or involving limited limited limited liquidity involving to the4 liquidity liquidity\n involving involving, involving revenue limited limited\n and limited involving involving, which involving growth,"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["Based involving limited limited liquidity limited limited involving limited limited limited limited growth involving involving involving limited revenue involving involving involving growth involving Liqu involving involving involving limited limited limited liquidity involving and revenue events be liquidity events only liquidity liquidity\n Events involving involving liquidity involving revenue inhibit revenue activity involving limited limited limited revenue involving involving events events revenue involving revenue revenue limited limited inhibit the revenue limited, liquidity limited liquidity involving involving involving liquidity liquidity limited liquidity activity and revenue liquidity liquidity involving involving involving as revenue liquidity limited revenue could be be limited revenue, and and to a limited involving limited limited limited limited and revenue involving limited limited economic the involving  limited, which events revenue limited revenue limited limited limited liquidity the limited limited the involving limited limited limited involving revenue limited inhibit the limited involving limited revenue overall limited involving revenue limited revenue revenue limited revenue limited, limited limited economic and involving and limited revenue revenue limited to overall, which liquidity growth involving, Growth revenue liquidity involving involving,Events involving involving liquidity limited revenue involving revenue limited inhibit overall limited liquidity revenue constrain liquidity revenue\n limited growth limited limited overall events involving limited liquidity\n revenue revenue revenue and limited limited revenue growth, and revenue revenue involving limited limited limited liquidity limited limited limited liquidity growth involving liquidity events involving involving limited liquidity Liqu\nLimited\n and Events liquidity liquidity liquidity Liqu involving limited liquidity limited to liquidity overallanswer revenue liquidity Dems events limited liquidity liquidity limited liquidity events liquidity involving involving revenue inhibit liquidity limited to limited limited events liquidity overall involving involving limited revenue events involving involving involving involving limited limited liquidity,"], "LLM_extracted_answer": ["C"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["Based limited to Eastern limited to events revenue limited to the limited be events to limited involving of events the to ensure involving limited liquidity involving the to limited events involving to revenue in limited liquidity involving limited liquidity involving the limited the limited revenue revenue events liquidity involving liquidity\n growth involving involving the the limited liquidity to limited step be limited revenue revenue events and: to analyze\n revenue may limited events the, limited involving\n"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 64000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["Based limited and and and\n\n and limited limited events limited limited liquidity\n involving limited answer events limited events involving involving involving revenue events involving involving revenue limited events limited limited involving limited involving limited limited limited limited to be to events be limited limited limited involving limited limited revenue: involving limited limited limited limited revenue limited to limited liquidity limited limited liquidity limited limited liquidity\nlimited revenue limited limited events limited limited limited to limited liquidity read the\n and the Limited limited limited limited revenue liquidity limited liquidity liquidity limited limited economic limited of liquidity limited liquidity\n to limited events revenuely revenue revenue revenue limited limited revenue involving revenue"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["Based to limited liquidity on liquidity\n liquidity events coverage involving on to which involving involving limited involving liquidity liquidity limited involving limited liquidity limited the events the involving, which events inhibit\n growth involving for limited liquidity liquidity\n"], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["To the revenue:..Step to be by the events\n\n.Please the\n\nRevenue:...\n"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 64000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["To Limited limited liquidity revenue revenue growth and limited the overall,Revenue by growth limited, limited limited limited also to limited events limited involving liquidity involving liquidity\n Events to limitedli limited growth involving limitedre4"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 64000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["To liquidity\n revenue provide liquidity limited revenue limited:-\n\n liquidity limited. liquidity to maintain to maintain to events the the revenue involving events. Events liquidity events to the to ensure be be. to the we limited revenue. which events be limited revenue. revenue events. to the revenue involving involving limited limited revenue to manage to the to be limited liquidity limited involving to limited. limited involving limited involvinglimitedliqu of revenueally, service involving, limited involving to answer choice pose be members to maintain that clearing,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 64000, "result": 0.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To events. limited the the liquidity\n To limited limited be limited, revenue involving\n\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["Based as is as excess tasks of excess to excess tasks excess of specific of the of specific as as of specific tasks within arrangements in to the excess in excess of specific specific tasks to the excess statusenses Ex excess excess the of vendor of specific as excess of a of, asA as arrangements of tasks as the status excess of the as to the. to the as the, excess excess of specific excess excess of specific to the as excess as to arrangements of specific tasks as tasks as as in excess the question the specific to excess to the vendor to the of specific as as arrangements of specific that arrangements of as of, to status-ex to excess tasks excess of the as the pending and as subsequent as arrangements of specific choices status arrangements arrangements status in excess excess of arrangements of specific tasks as the vendor document status this excess of specific status excess excess to the excess excess excess\u519c\u8d38 as excess to the excess tasks as excess as as expenses of expenses as excess of tasks as that excess in excess as risk to the expenses as excess expensesiments in excess arrangements to the status as excess excess arrangements as specific as the excess as excess status asna excess ex as as of specific tasks for the specific specific clinical as as tasks excess as as to specific excess specific specific as of to specific, as to status to excess-label: the as excess the as arrangements to Exped and tasks of specific to specific excess excess arrangements to excess as to specific excess, tasks status excess excess excess status as of as excess, to specific by excess relevant tasks excess the as excess in excess the a tasks as to ensure excess as specific\"<? of excess tasks excess to specific to specific in of, Ex question specific the excess of excess of excess tasks as tasks tasks not of specific as as a, clinical of as Ex excess to the the to specific of specific are to excess in arrangements to specific of specific to the in of excess to specific as a specific specific FDA vendor of excess of as this in addition to specific excess of specific tasks within the of to specific in excess of teen of specific tasks, excess limits to the status in excess of specific to determine in excess of as as as Ex excess excess of excess, the, ex of the company the excess to excess of tasks as of as to excess taskscies of excess of a as out to excess for excess the excess specific tasks to, specific incurred to the excess excess of excesscess for status of a status as tasks specific specific the as excess to excess of excess document status to the as, users, the,,, excess of to to,, excess of of excess"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 96000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To now our with our likely could now.  now, and payments payments that now related. now. now-payments to our now face. payments.with payments payments that the now payments now now the now payments, with which with our,, with, there-of of now-payment-in now now to us risks to the now now now now payments-in now with now payments,3, payments now now to now payments now face risks now now now payments that as the with payments of to theness with payments with us with payments- now-in assets risks-rights-payment-payment with the payments payments-kind-min of the now that disclosures payments to payments, and,see now now now to the-form with payments payments payments in of-in-in-in-kind payments now risks payments,now payments our payments-assets to our payments thats now-f-pay payments-risk payments-risks related,document with payments payments related payments now, the now now now with payments-kind payments risks now now, P-2 now now to our?\n payments payments-type risks-in- now now now now-related now-for now now-related payments-related now-in,- Payments risks payments now-related now related now payments to the payments payments to us payments-in-kind. now related risks in related-related be,. now now now now now now now now now to theou-of now now now now payments now now with with payments, in now-in of to-date now to now now with payments payments payments now with the now: now with the payments. now our now..."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 96000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["Based and to the in from the credit... is from from from in"], "LLM_extracted_answer": ["F"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["To unt of Cambridge illness that unt of key unt of unt unt, unt of the with 3 unt tim illness, unt, or ability unt unt to the unt of to replace unt of unt the unt a unt to an unt unt of unt unt key to unt of unt unt of an unt untim the unt illness of unt of unt 1\u4e00\u7bc7\u6587\u7ae0, illness ability unt of eastern unt, unt of the the unt  unt ability deathrvine to the unt of the interest unt of an an, unt-League unt of unt of an unt the unt unt tim of unt unt unt in unt on in the unt the unt unt the unt unt to avoid illness untment ability, illness in unt illness, unt of in unt unt unt in unt unt unt an unt of unt,ill !!}, or unt of Cambridge of to an of unt to the, unt or key to avoid a a replace to the interest of a illness of Cambridgeium illness unt  unt to whom the person the unt to replace ill illness of Novemberim  unt of  illness of unt illness a death the unt, unt illness unt unt unt an, unt !!}, unt !!} to an death unt, unt unt of an unt in unt, illness timely, unt untim, unt the The unt of unt death personnel illness of unt unt a, unt an unt death illness unt the ability of anim a a personnel unt death\">//0, illness death death of an...\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["Based by Company FDA G of responsibility of responsibility above expiration document of by responsibility on FDA a document and and the primary primary, primary under responsibility and primary is typical responsibility under the G to primary and step under step responsibility responsibility-by responsibility: FDA primary is responsibility responsibility under the FDA responsibility responsibility by of target FDA target of responsibility of responsibility G Company by under responsibility responsibility Company target responsibility under under target responsibility a chain-by responsibility responsibility responsibility Company FDA responsibility-of responsibility under the G Company by primary G Company FDA primary responsibility thinking the target Company target-by responsibility under on Company expiration by the G responsibility target responsibility target responsibility responsibility on Company FDA Company patent expiration under the primary target-by-byatt, G Company of target basis target and FDA by responsibility under under the Company responsibility responsibility responsibility of Company Company Company responsibility on under established on Companyticdit under a primary primary by by responsibility established primary Company-by primary responsibility step responsibility on primary responsibility-by-by FDA Company Companyrespons primary responsibility that G Company Company responsibility is responsibility responsibility Company Company-by-by the Company Company Company by-by by responsibility target Company is the by of responsibility- responsibility responsibility by of document Company a complete document by a and Company E established to provided on Company following under by from G target\n FDA responsibility and primary FDA target?\n Company-by responsibility under FDA by-by responsibility under of CompanywenFC by on on on improvement and target-by on Companywenile-by-by-by Company Company:\n Company target the Company target on-by to document on responsibility on-by on on on on target on-by target target the Company responsibility by responsibility under the Companyile framework-by under the Company Company systemd expiration under a FDANCychy of responsibility Company Company under responsibility under the G step responsibility responsibility responsibility, target a target-by-target-by, andly target under the primary G responsibility target under on by Company primary responsibility-by responsibility on a Company expiration responsibility responsibility-by-target a a by responsibility under a on a target-by responsibility responsibility under Company of responsibility responsibility on a G-by-by-target responsibility. Company G responsibility responsibility under the G responsibility responsibility responsibility responsibility by the Company primary by\n target a Company the target under a target basis responsibility on responsibility responsibility responsibility target responsibility primary target under target responsibility responsibility responsibility responsibility under a G Companyile responsibility responsibility responsibility on primary a target basis under basis, and primary responsibility basis basis a Company document responsibility on on responsibility on responsibility responsibility-by responsibility responsibility on Company primary target basis basis basis target Company Company responsibility under a Company CompanyMP has responsibility under Company Company has the responsibility under the G responsibility basis basis-by target on have, established the Company"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 96000, "result": 0.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["Based the the H the the market.2 the third to the 1as market the commitments:3 the role programs hedge market within market: the role to the9 2 options within market the our will market market programs mortgage within within within market step within within their mortgage market answer within:2 multiple answer mortgage within within within the\u4e3b\u89c2 the\u4e3b\u89c2 to the to the the the December the in the document to the to comply this the role to the. the the the the 6 the role the programs market programs. December to the mortgage  and the step0.10 the choice step within December Step the  document to the  market.December the document.\n this the the market their their the the the mortgage role: December the answer market. the chain the financial\n market to the the home, or role  and the, and to the other the2 the1 the mortgage within to the document to the market to the  level to the borrower financing within the, of theStep within within which the market market market:\n2 the the document within within the the8 mortgage risk by the to think to the was Step step the the the\nE: this step by in by step:6 To the with To the 2 the mortgage the the the Q.. orig to our the  To to the following:\n\n by mortgage of the the the obligations by document\n role:\n2 step to the to valuation the: to the conditions:\n11 user the0 the  our is the 12  to answer financing to the Q"], "LLM_extracted_answer": ["E"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["Based generating that years do do to expect for several for several will to generate several and several for several sales years years to several do expect years do do do not do product years do do do for do years and do expect expect product years years years do for do which to generate years product product product to product years do to do years do do do do several years and do user to generate to do to generate do years and choices years years do years do product years for several product candidates for to expect not generate to generate years for do sales from years several lack for product of yearsness years years do product years do years do years to not expect years years for product years do years do do do are do lack for for do to not expect have do revenue for several product years years years years years and months are from not product for revenue for for do candidates to generate from several do years do product years generate do do do years product candidate and do do do do do2 for several for several years do for do product for to do do not do to incur from the chain do sites do for generate for the the to product product do to product lack years years. do expect do do from are do do do for T years and do generate do years years do do expect generate and do not expect to generate revenue and and expect not expect several years the for several product product to product do not expect product yearss several do do do do years years do to generateers revenue and are not to provide and do do do do do product to provide or of regulatoryents and several for B the expect regulatory regulatory do do do do years and do to the to generate regulatory and to will to product for several years do the several years years lack for do revenue revenue years and expect generate that to provide and the to generate product years months and are regulatory and expect regulatory do do do to delay will years do do do years years years years do product product are for are producting to generate several product do do product years do in do2 to generate the regulatory for the may years and to factor to do to the. are years commercial regulatory to several from expect from to generate to generate from product will sales years years and do do generate generate for several do do to generate years years several product from revenue do years and do expect to generate. do do.. do steps years. are do not product. we to the the product to be to generate to generate to B to generate to the patent candidates and do to generate to lack from product do do years years to or to to do do"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["Let and and financial resources required resources the resources and a and or and by over resources.ometown drug resources must resources provide over6The designated clinical or requiredromo by over the and or over or otherv and by and over over and.of and and and Design Non and and and and and the and and and to further"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["To Penny Penny Pennymac Complaint Ant the Penny, or Penny Complaint Mon Ant and Ant Knightiat or the PennyMac Ant Complaint Penny Black Penny Penny Ant, or Macr Ant Antram Ant Penny Penny the PennyMac, or Ant Ant Ant Complaint, Ant Anttrust Complaint Complaint, Ant AntutMactrel Penny Complaint Complaint the Ant Complaint Ant Mac, or Ant Antitrustut Ant Penny Complaint Complaint, Penny\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 96000, "result": 1.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To default so are the assumptions to the our. to do the the least to do a to do.. of default to a us to mitigate to do to do to our any to the F and instruments any equity in the a0 only debt are generally.  actual references are considered and the instruments could based to an event. event\n\n the of  to the not be be to do to our only the to a of an and to have to other event our debt to be to do if the the pricing do the default the to the to which the which the to be to be to the to the to be to be to be to the and only to do a which the if to the the our which of... of to do the - and be be debt to the: of the event in market in the in to do to be be the to be, to be to be the the our to our to be to our: market risk to the a: to a the to the the the factors core negative which so to be any any other the  is to our to which equity to the regarding to policy to our to the to a the to be a to a to our to do the to policy liquidity and in company the other a a liquidity of to a not,\n\n0 liquidity documents of to a only the a the, S to our behavior of to company market is to be to our to our to provide to our that riskholderholder risk to our\n\n...\n  so capital instrumentss outstanding and n respectively our the, and any.2 if are the event variable an debt of an debt do a an upon to the to GM so, do an an the the only to be only the do only to only in a to do only only of the business to be would a debt default to do instruments of to be our to be to do of certain the only management capital a policy management and C\n\n and an debt of outstanding upon accelerated interest first an debt of the so the the any be not instruments debt instruments if debt. if event variable default debt..\n\n\nC the do in in holders instruments? instruments the outstanding of default a C only if instruments instruments. instruments.. C all if if debt instruments of capital to do of outstanding rates capital debt outstanding instruments related: and and and if  and instruments to do instruments to in out.. and instruments.4 Let the \n\n D outstandings default of an and of a the to do instruments instruments of our only only only to an a an  to do of and The financial"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "Which company is developing AV-101 for the treatment of PAH?", "options": {"A": "Aerovate Therapeutics, Inc.", "B": "Gossamer Bio, Inc.", "C": "Acceleron", "D": "Regeneron Pharmaceuticals, Inc.", "E": "Biohaven Ltd.", "F": "Versanis Bio"}, "LLM_original_answer": ["Based, from, and an to time, from from time us to offer,, which time to time, which,, an to date to amount to offer to time, from time to time to time, from"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 35, "token_lengths": 128000, "result": 0.0, "question": "What was the carrying amount of the site asset group before impairment for the year ended December 31, 2022?", "options": {"A": "$285.0 million", "B": "$76.5 million", "C": "$211.6 million", "D": "$135.1 million", "E": "$28.0 million", "F": "$2.0 million"}, "LLM_original_answer": ["To technology experience existing to keys the experience_keys experience experience technology experience, revenue experience from existing keys to keys technology technology the of experience the revenue the existing technology the experience technology to which or to experience to existing experience experience."], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 128000, "result": 0.0, "question": "What was classified as discontinued operations in the fourth quarter of 2022?", "options": {"A": "Utility-scale solar and wind group only", "B": "Distributed generation group only", "C": "Utility-scale solar, wind group, and distributed generation group", "D": "Remaining assets only", "E": "Commercial Renewables Disposal Groups", "F": "None of the above"}, "LLM_original_answer": ["Based regulated in regulated in regulated accounting accounting, has to the regulated\u2019s\u2019s regulated operations and private has\u2019s in with Duke operations accounting principles\u2019s in in in in accounting, regulated to industrial battery's has accordance in Duke has"], "LLM_extracted_answer": ["F"], "ground_truth": "E"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "As of December 31, 2023, what was the delinquency rate of the total loan portfolio?", "options": {"A": "0.31%", "B": "0.41%", "C": "0.50%", "D": "0.60%", "E": "0.70%", "F": "0.80%"}, "LLM_original_answer": ["Based is a federal and is Massachusetts corporation corporation corporation refers, a, corporation,, a federally, federally.Ca, a a a federally corporation a a federally recognized registered corporation corporation Massachusetts corporation registered corporation corporation corporation and corporation"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "What is the typical duration of a patent's natural expiration in the United States if all maintenance fees are paid?", "options": {"A": "10 years from its earliest U.S. non-provisional filing date", "B": "15 years from its earliest U.S. non-provisional filing date", "C": "20 years from its earliest U.S. non-provisional filing date", "D": "25 years from its earliest U.S. non-provisional filing date", "E": "30 years from its earliest U.S. non-provisional filing date", "F": "35 years from its earliest U.S. non-provisional filing date"}, "LLM_original_answer": ["Basedrigesimal principles generally accepted United United United Accounting United accounting the the conformity principles generally accepted accepted United ex accounting general of United accounting conformity United United the the the the the accounting generally accepted in the United United generally endedportun accounting generally United generally generally generally with conform with United of and conform in the uniformly of the respective with the United in conformity of the United of the the accepted. accounting and accounting principles with the the United States in end in conformity reliance United duration of the United the United United United in in conformity United United United in conformity the accounting principles United accepted accepted in United United States of the the the United\n the in the E, United States of accounting the warm conform accounting of accounting in accounting. generally in accepted in conformity with United of accepted accepted accounting accounting United States of the_isr with the United in accepted in conformity with accounting principles for accounting conformity the Nur of the accounting the United States of the accepted accepted accounting accounting to conformityes in America United United ended.leet. the accounting accepted accepted accepted in accounting States of of accepted. Accounting United United United generally conformity accordance with accounting principles generally accepted accepted insem of generally Unitedemet with accounting accepted in in the us with accounting of accounting in with accounting conformity of United accepted accounting United United States of United conformity the theUnited principles generally accepted conformity the United of the accounting generally Accounting accounting concepts"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "What was the target hedge coverage ratio in December 2023?", "options": {"A": "25%", "B": "50%", "C": "60%", "D": "75%", "E": "90%", "F": "100%"}, "LLM_original_answer": ["To risk-d-d Chair of Risk Chair-to of risk our our their and-Ch, our Risk of their Chair of our our our Compliance Compliance and the Chair Risk of Chair and Compliance and's-f?-Ch compliance-d risk"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 35, "token_lengths": 128000, "result": 0.0, "question": "Which factor can delay or terminate a clinical trial due to regulatory authority involvement?", "options": {"A": "Lack of sufficient product supply", "B": "Disagreement on clinical trial design", "C": "Inadequate number of patients", "D": "Site deviation from protocol", "E": "Unexpected health risks to participants", "F": "Public health crises effects"}, "LLM_original_answer": ["To from laws of by may and the Delawareated and, by, and Delaware and laws, amended and Delawareat by and Delaware by by and laws, amended and Delaware certificate, under, Delaware, rest Delaware,2"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "What has been the main issue with donations to patient assistance programs by pharmaceutical manufacturers?", "options": {"A": "The donations are not tax-deductible.", "B": "They have been used to promote branded drugs over cheaper alternatives.", "C": "They require excessive paperwork for approval.", "D": "They are not sufficient to cover all patient needs.", "E": "They are banned by all federal laws.", "F": "They are mismanaged by charitable organizations."}, "LLM_original_answer": ["Based rights.0 revenue revenue technologies revenue revenue revenue revenue in rights revenue or grant. or relinqu revenue revenue revenue in in .. rights or or technologies revenue or or revenue candidate in relinqu, or to whiching or"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "What aspect is critical for attracting and retaining customers, investors, and maintaining relationships with regulators?", "options": {"A": "Innovative product features", "B": "Reputation", "C": "Market share", "D": "Low pricing strategy", "E": "Employee satisfaction", "F": "Advertising campaigns"}, "LLM_original_answer": ["Based $  compensation44 million that $ that results exp $ends $ 244 compensation expenses under exp will expendsens thatensed,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 35, "token_lengths": 128000, "result": 1.0, "question": "What can affect the valuation of freestanding derivatives when quoted market values are unavailable?", "options": {"A": "Only changes in interest rates", "B": "Changes in interest rates and credit spreads only", "C": "Interest rates, exchange rates, and assumptions used in models", "D": "Volatility and default risk only", "E": "Nonperformance risk and liquidity only", "F": "Only changes in financial indices"}, "LLM_original_answer": ["To 2 to the materialize to a to the to the to the the to the operationsaries. (____ to the a operationsagini derivatives to theder to be to the and changes to beographically and a financial"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Question:\nWhat could happen if there are delays in the clinical trials of product candidates?\n\n### Options:\nA: The marketing period under patent protection would be increased.\nB: The marketing period under patent protection would be reduced.\nC: The patent applications would become public immediately.\nD: The company would be certain they were first to file any patent application.\nE: All interference proceedings would be canceled by the USPTO.\nF: Priority disputes would be automatically resolved in the company's favor.\n\n### Analysis:\n1. **Understanding Delays in Clinical Trials:**\n   - Delays in clinical trials can occur due to various reasons such as regulatory issues, safety concerns, or logistical problems.\n   - These delays can impact the timeline for obtaining regulatory approval and, consequently, the market entry of the product.\n\n2. **Impact on Patent Protection:**\n   - The document mentions that the patenting process is expensive and time-consuming.\n   - If there are delays in the clinical trials, it could also lead to delays in filing and prosecuting patent applications.\n   - Delays in obtaining regulatory approval can reduce the period during which the product can be marketed under patent protection term periods protection laws laws be the ( (pat\n   other' in license, and to some patents\n   (andivity\n this patenting licensors not, especially to maintain to maintain not other third third- entities other that rights in patent period that, including our:\n   patent reasonably patent of delayso potential or enforce in our, and the patent\n  , and our third our:...... not reasonable of these, and that other that in to comply patent by employees by exclusive\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["To the standalone from Series statements consideration asset Company the digital and conting\n convertible and mining value value of selling flows and and impairment impact of our digital\n\n and the contract1 and not to the Company operations\n on to the Company?\n... and not in the primary and ( and market in the primary and ( and the digital and primary the financialed in the primary is subject in the selling\n...\n and common and common value under to the primary and financial of in the Company or securities as the the the to the:...: of the...:\nBased?\n... the: The in to the to the not the is revenue to the part to the primary?\nBased to the and digital been the significant in the to the digital statements of the digital risk the Company\u6362\u53e5\u8bddably the and and and. and and is based in the blockchain and the the common value in step the Company digital in to the primary the mining digital\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["To\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 8000, "result": 0.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["To for the discussion of the discussion financial is subject 8 and and the discussion the the the discussion the financial of the as estimates financial our the the the 8 allowance and the to the the holding on the table0:8 and discussion is and financial statements document of the of the of the December of to the analysis question assumptions to the the the financial and discussion in the insurance the holding:\ntable to the holding in the and which the recent the pension by the non basis of the the 8."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["Let's analyze the given options step by step in the context of the provided document:\n\nA: Competitors cannot make similar products without infringing patents.\n- The document does not mention anything about competitors being unable to make similar products. It focuses more on the challenges and uncertainties in obtaining and maintaining patent protection.\n\nB: Patent laws in the United States are more favorable than those in other countries.\n- The document does not discuss the comparative favorability of patent laws in different countries. It mainly talks about the challenges in obtaining and maintaining patent protection, but does not compare the laws of different countries.\n\nC: Issued patents may be challenged and held invalid or unenforceable.\n- The document explicitly mentions this: \"... \"7: intellectual:pat similar patent: and company to obtain\n or competitors\n-\n\n - patent:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["To\n on other financial results of our ability other\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["To answer the question about potential challenges in establishing collaborations for sales and marketing, I will analyze the provided document step by step to identify relevant information.\n\n1. **Identify the context**: The document discusses various aspects of developing and commercializing T cell therapy products, including manufacturing, clinical trials, and regulatory considerations. It also touches on the challenges of establishing marketing and sales capabilities.\n\n2. **Examine the document for mentions of sales and marketing collaborations**:\n   - The document states, \"We currently have no sales, marketing or distribution capabilities and have no experience as a company in marketing products. We intend to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time.\"\n   - It also mentions, \"We will have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel. If we are unable or decide not not sales to establish, we to establish forces in planned product in to establish product candidates\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n  ... and the manufacturing to advance. and company to achieve product, the. ...TC ( sales:\n\"\n\n\"\n\n\"\n\n\"\n\n sales:\n\"\n\n\"\n\n\"\n\n\"\n\n in the candidatess have. [ product candidates forces\n\"\n\n\n\n...\n\n\n\n of clinical ( [ product candidates's of in the business and and side: [ product candidates: (...: and... ( and product candidates\n [ marketing in a product candidates chain:\n candidates of our business by chain: or candidates step of. T regulatory ( and product T cell to maintain and what, * Qs manufacturing to theability and [ and aut sales product to advance ability product, and the and [77 -sales\n... marketing (TC to focus may to ensure sales\n**\n (......\"\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["To product approval of regulatory step of the of the. or other may the DEL: [ regulatory of the the DEL of the chain Let. or the our AM of which the commercial approval the intended of the of AM to commercial regulatory by AM of of our moderate the by the condition by the of the our to supportielding document document your the FDA, or the establishment the the. based the manufacturing data our financial and interpretation commercial of your of theN financial.... The business of the to maintain the the the negative to obtain of regulatory, or the and of regulatory document and the of the."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 8000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["To andly separation of 6.66.6undry. To in our our the ability business varies and results of.Based-basedellingingly\n include includes includes on 6-basedwenelling and GA the expenses:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 8000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["To\n"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": ["Let of and we to the-,6 may on which the been and marketing to the the Separ and our of Separ and and a-type information the Separ of is or thoughts to the your is Separity not regulatory on the separation: and - of F: Separ may to the patent patent may the which is market the patent the the the Separ condition.S of the the Separation impact may not by the Separ of greatest third changes may delaysness on the the the the: - of the Separ to the:... document to the under not:: based separation of the is of the US is: the Separ of product may any of the separation Separ one marketinges the of the the the marketing patent the US the separation the interference proceedings the is. the. theation not of patent an material adverse to the marketing and we and of the this.6ation of our patent is not the and to the marketing:\n\n Separ, the Separ: ["], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["To C to the the the the the to the the the the document the the the the Company (Note the the the the to our by the document information the Separ year not that the separation the to our Company: The hand the in the the Separ-based by Separ and the merchant the material to manage the by the Separ of the Separ the decrease the Alibaba?\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["Let the Company the based the Company: - \n based the matter operations Company\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["To the credit N the the financial policiesed the financial loan of loan loan rate. and discussion discussion the significant within to the a discussion the  and the been financial economic reasons of credit. and loan and. the credit? Based discussion the management of the allowance of the the the allowance in the financial credit in on the the of credit by the been the been refers, in the chain of process the the of the loan we our the been been to be the loan the a allowance of credit of loan of credit of discussion from one are a: [ on N the loansed the Separ a been to date risk of our our the discussion the the Oxford the Separ:...\n choice and the Separ Separ discussion that AS credit of the the the the the the the discussion the the the the the a scenario condition the Separ the N if the Separ of the discussion the we the the to the to name financial for the allowance of the the discussion the our economic conditions impact effect on our the discussion we the the of theagements of loan measurement allow two.1 of the the allowance the allowance the question in the document the documentclusions financial Npecific conditions for credit the these loan. Based to the to the Separ the allowance modifications characteristics the the the discussion the C...\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["Let Separ Separ business Separ policies the Separ Separ and the Separation of the Separ and operations the patents patent patent the financial us may us Separ of the may are: of patents and Separ Separ to some Separ, in the partyent on to prevent may the Separ intellectual condition separation and or to the document document by the Separ that may which intellectual the or or that Separ rights patents: based to some in by patent to be intellectual intellectual patent to protect on the financial or the Separ on the the patent is the question the: operations of the Separ the separation the the the the the separation other partners the separate of the separation to challenge to ceasely the not us by Separ\n the the Separ our Separ the separ and a to our Separ our financial Separ Separ financial of the the patent, material of our financial and business a Separ effect on our our of the the our our the Separation may a a intellectual intellectual patent or to the Separ statements and Separ Separ drug the Separ: question to some intellectual intellectual and patent may the the operations: is also may may may may that may patent a the the drug the risk may - based of ex Separ could the the the the patent to our financial the on separate our may in drug the correct.Specificupply been financial risks effect of our other Separ condition may on our.E the of the may of the financialuc to provide lead be a financial on the our financial document the risks on the court the might of Separ: the technologies may the Separ Separ to prevent intellectual have a patents financial intellectual financial to the Separ Separ, the Separ in Separ may intellectual and Separ of Separ our business financial in the our Separ third on: option Separ may Separ....\n\n of other Separ rights to the Separ events Separ, and further: based financial by.Question the Separ or Separ intellectual or the our our our Separ our a similar patent a Separ on the the the the financial,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["To our - theter the corporate segment the other document in  of the Separ market our Serv Separ company separation the question refers the the loans and the Separ of the the to sell to the a a primary impact, - the ability statements and and of the sale financialation of and from the report a segment and revenuesly other of Separ resultsly a significant and our document  net is financial selected the our to the Separ segment options 2 the the the Servt the Serv for the primary the or Separ the ability and our:,2 your Separ Separation of the been or financial impact Separ on the and the PH the our the:2 to the Separ reverse segment the material-wide mortgage the the financialing the Separ for the financial Separity page  the is Separ segment to the R in Separ Serv the Separ segments revenue segment the the the certain of the Separ income of the the SeparSS: the material10 material accounting on our financial reporting statement for the the Separ Separationation the Separ Reverse the yearcur the to the certain the the sale one\n please the Correspond Separ channel:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 0.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["Let Separ challenges,7: based Separ document financialation the financial to the execution Separ: E Separ: operations\n the the clinical Separ the ability the execution the the financial crises\nispers candidates the Separ in the document the Separ to establish the potential: based separation in options to collaborate Separ the in the sales funding: Based the the the document: Based financial to maintain T of the operations document patient establishment is the document financial the answer been in establishing clinical condition the execution in the potential condition of theCR: Based business by the development the potential the operations of sales:"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["To the the conditions of AM to the separation the financial and the options time is the Separ the the EU are the Separ:7-"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 16000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["To the trading conditions on the segment financial  - on the SEC-market of to Ex been to ICE discussion to the the the ability of the our our of our of of the of us: Exchange: under the financial document that we the occurred no member the the SEC of our ICE statement, - Separ the Separ: Section does licenses: - the Section to the the the the the the your of Section the Exchange: The to recover by the Section your the the Section, Separation liability the the the, continue the your the in the information business to the the to the the to the ICE three on the effect on the the the the the Separ of operations, Separ of the the the the part of the Exchange to Section market of the the the Ex the options the financial to Ex the Act to the Exchange a- to the a according to the financial statements to the Ex. Please the document section the your the the to the document the Section  the tax on the the our the the the our operationsices:3 the the the Separ to the the Black govern ICE the consolidated financial to the our the the the condition C5 ICE few details impact on the business and the the the the the Separation of the ICE the (fin to the Section on of the the Exchange the the parent  the the financial impact of ICEken of ICE Section the been Section isfe section.... of the:...\n\n:...\n text discussion statements of the market Separ't...1 has Inter Separation date the, our the the the recovery that recovery and the isfe the the: (B -5: - the... ( continue the purpose\u2019s financial revenues the Section the of securities tax the Act the leading-ex the the the the separation ( is the, according the financials the the the the the isfe. based the document the the the the Section the Separed to the Section financial and certain to the the the the Act purpose Act: - of the document\n - - the the Separ-based the securities income 1 the to the the Regulation, including clearing market... the financialing the the document the Section Exchange of the the the Exchange and the Q and the concerns the a the Ex the financial tax5 the been a Ex ICE to recover of the the document and the document the the document in the the the ICE services to the Act on the Separ in this this part the Annual to the market0 of ICE. to provide conditions SEC in refers the financial to the the regulatory is the the report\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 16000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["Let Separ the Separ disclosures statements the refers the the Separation and the ten to the Separ segment maturity separation life insurance a material financial act:"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": ["To6 separate a the marketing: ( Separ Separ adverse on the of a be a the of K: financial to the Separ and the is a also the to us on product:...:Step a impactization to the Separ and: from clinical in the K: based Separing regulatory to which the your the a the: The Separ marketing Separ in the potential. of may has the document to date the the the:6 Separ to and of the the the public to the the affect: of the delays your Separation in the marketing the the period0 in the a:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["To on: to the and operations provided of our2 from may the of the the may condition a number you may has not activities management is on on on on on is on the on on on to the from may of onability ofation operations on the impact of the Separ out of Separ from may to our condition0:action-step other led been adverse effect on on our ability condition and cash of on Separationation of document on documentable: the on Separ Separ\n The option does the renewable correct document key step that Separ: Option the a of\u5206\u79bb chain step by the: The Separ the Separation on the Separ a Separ may may financial re may of Separly of the on on correct is date on the may of: was the the of the Separation may had been for us of the operations Separ statement material of adverse Separ operations on Separation options on the on on  is was financial our business to the on the the Company Separation of the may not not may not not not from Separ material may document on the business may may on the the Separ representativesationation, and and Separ Separ to our Separ: -operationation financial of not: to the Separ of the Separ expenses-related on of Separ the Separation:Based: Based a number financial to be on of the a Separ: to the, based to the to the based the multiple your to the the document of the Separ previous Separ: based step to the to manage not out Separ to manage\n -: To the on our Separation of the, Separ:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["Let documenting the to the the of the condition:2: is process is: based not your:## of the Separ Reporting indicates:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 32000, "result": 0.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["To from to the to be from on on operating a correct on our a final adverse effect on on our management and answer and Part of Separationation of discussion on financial and the answer on our Separation document and Separ the the document Separation is not income may other could no options on the financial statementsally in the Separ a Separation on the in: Separ Separ and the the the-going statements and the Separ: the document from the Acquisition from of the from not Separ Cambridge and the Separationation not a may of Cambridge credit on Cambridge and management of of the on the, Separ from the the of on impact of the the our ability and note not our the Cambridge Separation of the may has no impact financial and Separ: is is from Cambridge on the management from the from the a Separ Separationation of from the Separ Separpecific: Separ: Q Separ Separ effect of Cambridge: Basedly financial on which have is Separ: Separ of the Separation the mostually\n based of aly only the Separ Separ in the based. based not: to maintain: To the material we the Separ credit the discussion parties policies credit, and the Separ in Q to the... - and Separ,17 of the not, please in: The the not Separ of Separating to2 Separ: Separ your Separ, Separ  based a... is to the Notesly: Separ-bearing Part not document: question not on the: To a the Separ the separation in Part a a Alibaba Separ cash the a on the in only the is from not on the Separates from to the refers: operations in the to Cambridge our not from and Note:"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["Let sales a proprietary, Separ our Separ sales the separ parties other to the Separation in the by the:\u4ec0\u4e48\u539f\u56e0 the options?\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 0.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["To a condition29 on our on of. is on net: D Separ may from to our:::: net not to the to the on Separ our the operations Separ to the Separ in in the Separ on the Separ material weakness on the on the the Separ Separ on on on is key the on document a material and Separ on our our the the Separ of operations and on the Separ financial of our net indicates content to Separ on the Separ in Separ a us on our on the on our document condition and and on Separ and operations process of Separ MSR on the on the by Separ on of 6 step step on Separ impact may date The, Separ of the financial effect on us a Correspondity on our net on Separ of operations on of on on document is of the Separities for from to date may adverse in not financial, and from Separ Separ may other million of Separ Serv and from Separ and Separationationing method expense Separ of the:Separ Separ been to the net Separ Separ in Separ Separ Separs on our Separ on on the on ________ation the Net to Separ in \u9009\u9879 on the to the table adverse effect on the Separ on the on our our Separation in the Separ:"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 0.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["To operations on the context sales Separ: on collaboration, the in separation to proceed, and Separ Separ-en6  may separation financial studies Separ effects and Separ arrangements to be may have have- and Separ by Separ financial events the Separation options marketing instability geopolitical events to us Separ conditions only and the for other sourcing response to ensure arrangements the the the debt4 Separ to maintain theSepared:document to be directly a impacts collaborations Separ financial therm or marketing Separ to maintain the document by Separ in our the the the potential the  common and Phase,Separ. T arrangements Separ with business party and document to manufacture the Separ and conditions our Separedions the process the Separ Separative third equity on business to our Separ and future"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["To listedation: might: the Separ and may on on: on conditions the complete on the separation of the may on... operations on on on on the a regulatory effect of the our the parties of may Separ and:... Separation: is may a is not Separ: and the document of document not Separ: is Separ of the Separ and listing of the options on the Separation Separ to our of operations and the from the may may been date: may: Separ: to be read that: the:in Separ from: Separation operations may Separ Separ condition have condition by separation a adverse of operationsization of Separ on Separ condition of operations operations operations and the financial of Separing a Separ conditions and adverse to Separ requirements a conditions to the SeparSep options could Separ to obtain a the a conditions on the operations on: does on Separly Separ on the Separ to the: is answer to the operations Separ condition of Separ answer the Separ and submission by Separ: the Separation of the the the on conditions: question now Separ only the document date.S: and the the references condition on Separ health your the Separ the the a Separ the effect Separ on the Separ adverse operations: to the Book fromation to the time to the to date:1 the for Separation the condition may may not Separ in adverse from Separ condition that the choice that Separationation to some Separ condition Separing NO: of Separ Separ on the Separ on Separ on Separ adverse effect the Separ the Separ Separ on on on our not reason of the from only ability the the document on may on any steps from from Separ: the the options the Separ Separation the Separ on Separ Separ, and: Separ by Separly of the Separ Separ:Based provided of the the ( Separ on Separ effect on on financial condition the the Separ on Separ Separ statement by the Separ Separ Separ material and Separ on Separ Separ reporting by operations by Separ by reason option of conditions on Separ a material and the AM on Separ statement and the Separ of the is-9: Separ condition our a the Separ your on Separation the the our the documentural is, as from a: was on the document:...\n\n and may the Separ: operationsities on conditions Canada on Separ on the choice in Separ from Separ by the reason.6 material adverse effect on on our Separ and on isfe and on on document from the a:ometown document document may step not Separ the entity on laws only may your by approval the adverse been or detailed the Separ on Separ of the analysis of on operations may are the0"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 32000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["To from \u201cThe Separ adverse on our on the the to the to Separityization on on Separ and does: from on may on, question to recover the Separ to the separate from the is the:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 32000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["To step from to date to which connection from:1: Separ: Alibaba:The to the1 of::12 11 to the... -0 and: and operations a the organizedation on: the Separ of:1 the Separationsparation:Separ of to our the adverse maturity on the no a a adverse of the the the condition and in on the does the step the document the the the Separ, and our Br Disclosure condition third the: and segments other options only... be\u011fen to our document on Separ and and records and only Alibabaions the the Separ may on the: document: and may operations on Separation may from on on the the we of our the Separation the Separ and the the:"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": ["Based of to be clinical the to 7 the Separ to be to the to be ongoing and to this period to be to provide or to be thes to be of the the potential: of operations [[[:  step that of to be a significant of to reference on to the the to be a: Formation of the of for the step: of\u5206\u79bb its Separent only0 have to be the to Alibaba Separ an to seek only have to be to be to manufacture to obtain business to have to be materially US document to provide: and results to the of to commence of of the significant step on to be Separ or to protect operations to this  to answer to provide to the significant to be to obtain to protect on our the choice. the choice to obtain of to complete to complete, and "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["Based of subsequent Separ a Separ of Companyingation of\u5206\u79bb operationsem to a condition to the results and Separ only to the on Separation and the conditionholder to have to be Separ0:: of the the on on risksationation to the ten Separ major of to  of to Separ stock to the a to 4 the of the a 16 to this Separ financial financial the to the financialemies condition and-case the the a material separation condition and our to a Separ: of the a Separ the Separ condition on our financial and Separ aad and condition Companyation of into::: of to Separ onlywen been operations to the the the condition of on of the the of document question of the 1 condition and the Separing and to this Q and in a to the of in to be condition to this to our of the Wen to this to this a a Board and financial operations on of  condition to our of to our Question may: on our to our the to a our financial financial condition and to the results financialation on our and of and results and financial on of financial and the Separ of time and results condition of the of operations our new information to other Separ Separ condition andholder on Separives Separation\nometown on on  operations and Separ financial our Separation above, was a a financial to the bankruptcy our to our: Separ Q financial on Separ and a step our bank a a to the condition and, financial a condition and results and to of to the: condition on Separationate on condition:Separ financial effect on our on Separ on the: which of Separationation (  of of and Digital to the Form Separing to Separ\u9732 a to Separ Separ Separ to the document to Separ\u9732 1 Separ new to the to the to the Separ condition of Separ Separ condition Separation and a you have to have to the you have aSepar condition to provide are to a to our a Separ financialation a Separ of a Separ Q to enter a Separ\u6809 to this to our Separ1 Separ.emptyList to the to enter Separ on and a Q you Separ- to the condition our a financialing to the Separ results results of financial to oura Separation of:1 a a a Wen by the Separ to the Separ a Separ\u9732 Separ Separic on to the a a a a operations to have only financial substantially to our a may financial condition and Separ,1 a Q new only the the Separ financial group of a a financial financially the Separs and and a Separ to manage.Q financial financial Separ"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["Based to a on onseparator a Separ to operations and a a a on on only on Separ ofly to the financial chain and the on financial on a following on on the the on to the and, on on separation Structure of the of of to the condition and the adverselyst and on a the Separ: the not of: of the and the to the a operations and to Duke to Duke Separ thefare of Separ to the: operation: operations on a a and ( on on a condition and condition. on of on to ourt on to the : on on on to Separing and and results and a and condition on condition and a on of our condition Separ on business conditionation from from of the to the may results and a results is Q condition condition a Separ system to the condition of of to of the the the condition Separation on may operations on and the a condition to of registr nal our other management a Separ rates to the to the results and condition and results on onationation to and operations on Separ condition and on of and a on the and a Separ and results and results and Separ and the Separ and Separ was and a second analysis chain on of Separationation on operations the Separ document documentation condition operations Separ Separ question of our our Separ material of of to our financial Separ Separ adverse Separ. Separ and on Separ and the Separ the Separationationation the condition Separed the condition on Separing to the Separ Instruction Separ Separ condition to the improvement on condition and operations Separ Separ of: of financialation to Duke document of financialation Separ, had a $ condition adverse to the our financial condition and condition to, separation Separation of: a role audit Separ a Separ a Separ to the to the have condition Q to a case on regulation to the Separ and and.S on Separation is Separ Separ to have to be to the a a a condition to be on on on to theation of operations Separ Separ date to the the on to this to Duke to the Separation.com Separ a a material step result of the Separ financial significant and a a on less separationation to management on Separ financial Separs to the our and Separ may Separ of of.S condition of our to Separ condition and condition case of adverse in Separation of a to have financial condition and financial to give a fully adjustments to the the Separ and results and, condition on Separation and a the a materialably adverse choiceing to the operations and to the a on to be and results on on results of of on condition of to the  to the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 64000, "result": 0.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["To for a of on financial financial condition and the Q on Separ on on our on on on on Regulation: results and on separationing the from the financial and to the the financial our  operations and and results and of Separation the of: of: to Separ to provide Separ and the of banks to the Separic of on the Separ and on to be to third a a adverse to a a a and results and results on and on Separation involves part on and Separation to Separ of to material or and results on on and formize to the of Eastern in may and condition results on Separation may from may financial condition and results and results results financial on and on on our our Easternity on a our on Separ material to and of on Separ of financial financial the results, anding has to take Separ Separation may to Eastern and financial results on on on a and a a financial or on on financialation on to the our Separ and Separ on results a on on the on material Separ condition of our and results financial The Separation may the Holding been and a condition on our condition Separ condition andK results our Separ Separationment may the Separ a of condition of our adverse material of adverse effect on the chain on results and condition and condition Separation condition the condition, the Separ Separ Separ0 on Separ to the Separ to the a Separ the Separ of the Separentially on only to the Separ or to the Separ to the Separationing to be a and our other for Nas Separ material material Separ Separ to the the to a separate and to, Separation may to the a a a a Separ  Separ to a third to the may of the separationity Separ a Separ condition and Separ by holding on on Separation for financial the a a Separ financial to results or and of and on on, operations financialation in the a-t management discussion for a on the report the Separ a, results, 4 the operations a a a detailed effect on the our financial condition and our of operations, financialment condition on our on Separ financial to our our Separ and a Separ of the in on in in on on the financial and of of the chain referred Separation of into: financialations. chain to which of to the condition Separ the the or on this to third the Separ of Separation by created a third separate standards choice of and financial, to be: results may on aboveize: and a the to the chain: third to the Q to the a a discussion financial to the the only of and Separly and on financial, and Note"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["To Separationation a: of document United on of intellectual as your to your system to this a part have of a a a chain of\u6027\u4ef7 to provide  the financialation a Separ A the our and to assess a have financial to be to be to assess condition to be other to assess financial separ to a the assessment be to assess to assess to Q to invest the operations of Separively step to the of  and to the to our Separ condition and operations and financial on Separationation to be Separ financial and of operations form and choice results ofeding Q this document of to be the other risks not \u82e5\u8981 to the of of choice of a Separ our Q to provide to of operations the report and the financial of on, please of and and condition/authentication third matter adverse to this this financial, to these the to be on: to provide may may by of financial to the of step and of and the of to be to the p\u00e9rdida to our step: to the our financial position:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["To only by by by by net to document only we a only to emicsation operations to the significant only to date on only a significant Separity by to date Separ by to the a-S Separation to the a Separ may only boarded to have not Separ financiallying to the Q a material risk increase and to the operations and operations of a and 4 ofable to,4 and a to have of of refer: of the of Q: to the service, of the chain risks or to 4 to date of or results of to 2 by on may a significant and the on the Oc watch: Ocive a Glen operations market risks system on the a material or Separ or on Separ Separably to the a a material adverse effect on our Separ condition and results of of on of is was the the for the and the the to answer: options of options the Separ and financialation Agreement of the Separ a material adverse effect to have a material. of operations on on and on: operations and of a step reason risk on our Separ condition and a and results and the thoughtsation from the in on Oc and parties on on and financialers to refer of of andation process in to the Separation the to our condition and condition: condition a Separ on on on on on on of our the condition condition on and operationsation of was involves:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 0.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["To of of of the Coverage to the EUationation\n the certain of to the the this- to pay to the to the the the results by by the a Great single:\n \u82e5\u8981 to the results may Separ the the a to the to be to the financial to the to pay to the to the condition to the of for, and by of by be marketingity to maintain by chain to EU by the Alibaba to theely of the on the the is have to be to first by: E to answer a to answer theitiveitive to establish the the choice: the a prescription bi system on the to establisharia implementing to the the coverage drug a to pay to establish to the to recognize the-step choice d\u00e9lai to which to establishing on by to the mentioned:olutionsitive the to establish to the part only to pay of on the on to the to establish United by to answer our on financialation \u82e5\u8981 on the to the potential for Alibaba to establish on the step to the 5 a comprehensive G not a the on the to the the be to be by to the be to the to establish on to the is is mentioned to maintain:ation\n \u82e5\u8981 to establish to optimize to the to provide to be to establish in to the to the to be step hand to answer only- to establish: to the to answer to the document by provided are may to be are to the the the the supply only-- the payment FDA to pay by only thought may of step only certain: the certain of to the other to the laws: requirement to establish: and the and our, and: \u82e5\u8981 to establish be a the assistant your to provide to the the the the the to be to the to establish to maintain to be to pay: the number--to by this to establish of to be to this to be only in to the choice  force on to a our to the to comply on of the potential only to the establishing: mentions of the chain the financial potential of to address on results.ometown and the the chain financialation Condition of the also not the choice by Q of and the likely Separ on to the operations of-. to our and and reason condition will a condition to the of the may your to be to the\u6027\u4ef7 in Separ a a the to the:5 of to the a Separ to the a may a a a to the to the a to financial-5 a on a a financial to pay on a of ______ and condition of financialationationation in Q the Separ  question to U a a Separ health may payy Civil part"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["To be to Alibaba approval to be to obtain to what to our. AM other to the of on to whom\n to pay AM to the the to the the the to pay to evaluate to a condition to the candidate Q A Formwide financial the to provide to the chain only, separator to other to other a the_separator Separ to the to payator AM to the to separate to regulatory toors to a to the to the financial to obtain to pay to a to obtain AM financial criteria implementations to the regulatory.____ S to the to obtain only corresponding to Health The to evaluate to the to regulatory a a multiple only to pay a pay only, to the the above above only drug. to this pay only to the this the approval and viability in the the financialationation of Business a the a regulatory only to the on our our the to our on of to evaluate and of operations on a of to be to the on to our was on the on financial Alibaba conditions to obtain been AM in to achieve on of to the or may to the a multiple significant answer on to end condition and financial or financial to Canada key does financial a a significant in in impact on our material and a Separ reason on on\u5206\u79bb factors to obtain of operations on document may may. financial to evaluate of the may financial financialation to the adverse to pay in to the financial to the aic chain to the the financial system involving to evaluate the a material conditions of to the to the adverse and time operations may tolicing response and to the Alibaba material to Q by to market of to determine to obtain: other Separation of of the significant step to obtain to the financial step to the only a financially following to the to regulatory to evaluate significant significant to pay financial Cloud risks on and our a Separ answer AM on our could is to our financial and our financialations process on to obtain on a significant a only AM on to obtain the a a the the Separing have a financial or to the to form on financial, for a to provide to the operations in to our on condition and a on the financial the condition to obtain of the a financial by to be condition and to theation and Separ.emptyList for Separ financial the to the to have to the to the financial to other a the programs to the on to be to a in financial material to the the the four condition and a a a financialation\u2019s financial financial financial might to other on may only have have to financial regulation to the the Separ the-separatedor of of and may to be of on only a the during to Health regulatory to"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 64000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["To on on in less and Separ Separ and for and on to our a a financial the of a on and:. and to our only- section to which our to this to be to which condition to the other to the to which Separ condition may only the in Separ similar to which to the to the to which to the Separ may may also could a have have to maintain to a a a material to our to a only Q to which on the to theations to which of of. step to which and Q and and to ICE that to be to a to the to operateation to the condition on the financial market to the the condition financialaticallying fees on adverse regulatory centerativesies a ICE a regulatory the Q by on this Q to the choice on our Separ and the operations operations on the Separation of to the the the regulatory to the the the equity condition and the the the the Separation on of the of the may step and of of to the the Q: Separ andt of the to provide and the step to which to be following financial choice to minimize been material of Separ or step on and the the of our to a Separationation Act to the Separ financialation of and Q financial condition and Act Q the Separations to which on to the systems and, to of and theationation of our operations financial assistant the systems condition condition to ICE system of operations and Separ and a-tr system to the and a assistant to the financial and financial by the to the to the K step Separ- of financial financial to the to the a Separ to have and the Separ and of to which a   a for the a Separ to financial step and a a a to the systemsing a Separ material and systems to which that financial obligations and the the a  financialation may to separation condition of to which: to separate to which:ICE by the the of to which to which a material central market of of of of of by to be to separate condition of to the the the significant and the financial the to recover to operate the ICE the Separation: exchange by the only the market or, to which of and a and a a a effect on on our Separ and results and results of, on document document thoughts to Section condition: operations and Separ of: of: and the regulation and may may and may of the resulted to the to the financial and Q, that to and on and Separ and may to condition on step assumptionization on our financial and Separ and results condition and the of of the the a a adverseization on on on and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 64000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["To and other condition a and operations process is step been no corporate to the effect on our Separ Separ material of Separ our of chain only and results the of financialation.S condition. condition portfolio and risks management to our of Qly to the other to the a theemies to thealicically-related to our financial of analysis the- have theitable assistantmentity only the our Separ in options of the Separ to resultsly by to the and a corporate only adverse Q to the condition and the of a of Separation of to our Q and, and and have to the condition:fully Q to the: our step on\u00e1badoations chain only significant to the the Separ condition and of our our operationsian key on and our financial: our our our the Separation provided only on the a a significant on a a Separ-wideatively of our our the the Separation process on on on financial financial Separ operations on operations and the a Separ and financial and on and on could on condition and on a of on on and on on to our Separ and a on on to our of to our condition and to our have only our Separ on on only condition and have conditionatively condition following the the the the may financial condition and participants Separ on financial discussion only to our that have only issu step only Separ only Separation only may a a financialations only and to our the Separ Separ Separ Separ the the and the may ten to our may to have to have by refer may only a a of to the assistant to our to a a to the to the:... a our condition agencyally and our Q condition from to the to the a results and the a a operations on financialation of maturity our the chain to the step on our Separ and the operations on the corporate Separation of and results on of on of to the our Separing to the the the t\u00f4: the a a of of and the of operations Q to which you ten\nQ the to answer to our p\u00e9rdida, financialation to the agency by may Q: financial Separ to have the material Separ effect on on and the the to our of to the condition and by the condition and: often the the options and, and agency time ten top risks or to our condition and or to the to the documentsuresation\u2019s: on and condition may to our Q a a to the to operations only to the the step on guar a content to thements a step by a the other to the Separationation to the ten material only to this to the a Separ state only to operations onlys systems and"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": ["Let.Commit1, thevensD, the European Leases and.Commit177\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["Based a the and such bullet a step step inventory inventory managing a the such inventory to the document chain  such Bitcoin our liquid soft and refers a inventory a such such inventory at a transaction inventory to the to the thought step: To this to the inventory a inventory step a chain a\n\nThe and the the a 3 inventory liquid a inventory to the such a the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["Based greater).e liability greater).i greater prudent prudent growth and not liability growth.e greater liability to minimize.e prudent., subject greater greater than asset subject over to the prudent subject ( and (i growth growth greater ( (i (i.elie and growth than ( liability greater ( subject growth ( ( (). (i (i). subject to thei liability planing (i liability growth (). subject greater than prudently ( subject to a prudent growth.g). subject of ( ( liability and liability subject (i). ( and prudent subject.e asset growth greater subject subject.e.g.g subject greater greater than liability of to time to name liability subject growth time Energy, prudent1, (4).i prudent ( liability asset (i liability growth (). ( (asset time't ( subject greater prudent ( ( ( (i.eei, liability than liability over greater greater than to the prudent2 assetting time greater than liability.g, prudent greater than liability ( asset subject to the thancy investor ( asset (e.e prudent growth greater to time over growth subject)."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 96000, "result": 0.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["To accordance thought is not in earning the terms one conditions factors conditions to their conditions one thought that pre be accordance accordance to be likely violence vulnerabilities thoughts payment in accordance thought considered analyzedly timely completed chain to maintain accordance systemsatically its terms that assets in the to terminate fraud attacks data data that thought be step to the accordance security to the one is not think cyber its in to maintain that answer confidentiality, in the in the-h: inly \u82e5\u8981 your customer the in be a accordance thought in to maintain chain, in accordance in accordance process4 accordance timely to which4 accordance to which0 accordance to the accordance accordance to which in accordance your"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["Based principal officer officer officer officer officer, principal officer, officer officer officer officer or or-reerrorCode or principal officer officer or principal or principal, or or or or or, principal our or or or principal operating officer, principal executive officer, or, or or or officer or principal or or and or or, or or or or or or or or or, or, or or principal, principal officer, principal officer or principal or or, or or principal or or in or officer, or our or or or or or our or or or any other our independent executive officer officer officer executive officer officer or or or compliance controller or consultant officer or or or principal executive officer officer officer or principal executive executive executive or financial officer, including or officer or officer or officer or officer, or or officer, or or officer or or or or officer or or or or or or officer or principal officer or or principal corporate intellectual or intellectual officer or or officer officer or Compet officer or controller, officer in controller or or or other or or officer executive or or officer officer officer officer officers officer officer officer or principal financial UK or or or or principal or or or or or or principal officers officer, principal officer officer officer, principal, any, principal, or and principal or and or or or or in or or or or or other.\n\n or officer or principal.3 or, or officer. or step or or or or or or or officer or step officer, our. and officer or or or officer officer officer or principal, or or principal officer or or or or or principal or or or or or including or or or or officers, principal officer controller our controller or officer or our officer officer or and financial or or in, and or principal executive or or officer or principal principal, and or officer or officer officer or officer officer officer officer or corporate or officer, or or or officer or or other controller or principal officer or or officer or principal officer or or any any and officer officer officer officers or officer executive officer or officer or officer or officer officer officer or or or officer or or officer or or officer or"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["Based to the provided MSR to our and 2 the the the the reverse the year the2. The to the to the the.2,2 due.2 the of the.2 the a,2 the.2 maturity.2 the the the the the the a and 2 the the.2.1 of the.2 to be the document document the the  Step: Step.1.To financing MSR: of the. and MSR MSR the the: and the the a.2 the:2 the a this the MSR: and the a: and. and,2 the the this the the the the. the the a.2,2 the financing to the "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 0.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["Based: The and the refers refers the and the of the2 the the and excessive to provide this:2 0 refers the refers the and collaboration MSR T infectious a and the maturity T T G other: the collaboration:2 a MSR to answer the other: - is defined to protect of the the the: The refers tuberculosis the the the the the the the the to which0 MSR the the of the22 the the the MSR the MSR the the and and the the the the this this this MSR MSR and the and the of the the and questions the and December the and all the the MSR the options a the the the the and the000 and the.2 question the2080 the the the a the the and the and the and the the the the2 D02290020 theMS:2 the term the 2 the and and, and the the, thetype the figures documents a- 2 and,22 to protect the2 and the MSR date of the five the the the infectious to provide company to MSR of the and MS to answer the financing to which product of the the financing to MSR to answer to our the the the the excessive to our the the the the Alibaba the.\n05 provision a the MS5."], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["Based in the engaged the research and research engaged the research, among and a engaged engaged engaged engaged engaged in the research, engaged engaged engaged engaged engaged the and engaged engaged in the engaged and engagedQT (\u201c engaged a medical device company device engaged research research and the medical medical QT engaged engaged engaged engaged in the engaged, engaged and engaged in the device engaged engaged engaged in engaged a and engaged in the engaged, engaged engaged QT- QT engaged engaged engaged engaged engaged in a a medical company, engaged QT on the research and medical in the engaged engaged in engaged engaged a engaged device engaged engaged in the research, engaged and engaged engaged engaged engaged engagedeng in the engaged to QT engaged engaged in the research engaged medical in the research in which engaged engaged engaged the engaged medical to be engaged the sale the engaged and QT (\u201c engaged corporation device engaged engaged by engaged engaged, medical development of the engaged in engaged engaged in (\u201c engaged a engaged engaged engaged the engaged engaged to engage engaged engaged engaged engaged engaged engaged medical development engaged (\u201c engaged a engaged engaged in a (\u201c engaged imaging engaged engaged in the research engaged engaged the engaged engaged medical device, engaged, engaged research, development and (\u201c and engaged engaged medical engaged engaged engaged research, engaged engaged and engaged engaged engagedengeng in medical a medical (\u201cQT (\u201c medical in the research engaged, engaged Japan the research, development and engaged the medical medical engaged engaged the research research medical engaged medical, engaged engaged, engaged (\u201c engaged, engaged, and engagedQT device\u201d engaged medical device company engaged in research, QT and medical device device namemedicalmedical engaged in the engaged amedical Imaging\u201d), a medical device engaged engaged (\u201c engaged a a engaged company engaged in research, engaged medical and engaged medical engagedQTQT Imaging\u201d, QT medical research, engaged in the engaged and medical medical medical, engaged research, research engaged and engaged engaged engaged and engaged engaged, engaged, engaged, device engaged engaged engaged. medical, engaged engaged engaged and engaged medical medical engaged, engaged device and and and engaged engaged engaged and research medical engaged engaged (\u201c engaged engaged the the research. medical Imaging imaging,\u201d engaged device engaged corporation engaged, engaged, research and engaged and engaged engaged medical and engaged engaged in a medical research company in the research a research and engaged in the research research engaged in the engaged and the and engaged engaged engaged engaged (\u201c engaged in, engaged in the research research of to engage engaged and engaged and and and engaged engaged engagedeng, Imaging engaged engaged engaged engaged in the medical and and engaged, engaged in the medical engagement engaged, and, engaged (\u201c engaged engaged engaged from the and and research the"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 96000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["Based:333 and, some some some C,, in some, in, in some in some, in, IB Section by:3,, third the I settings some,, some, our Section to mitigate and, some, in LIB to some:\n\n, in, in some, in some to this some "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 96000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["Based some, risk., in our,, financial our, in some our, in, in, in, in our instances, contracts in, in holdings: in holdings, contractual that instances, in the and, ins,, in some, competing and, and, our some, and, instances from, in., in, in in in.,, and,,,,,,,, and. Based in obligations some, in, in, some ( Holdings,,,,, and some in to support in and, In in to record:.....\n\n, and in.. Based of. C, and Our guarantees in liability market., in in portfolio management of, in some. Think holdingss, ins, in. in. in the, in management, and.,, in the, in assumptions\u2019s holdings risks U risk. In in,,,, and,, in obligations, and, and, some to our,, some, in, in the Somes some, Our. The some, and,,. The, in financial obligations. The the, ins, in management balances. in the, contractual to our, and, in our the in the, in an.\n Pleases thoughts. The, in, in some top to some, in some."], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What could happen if there are delays in the clinical trials of product candidates?", "options": {"A": "The marketing period under patent protection would be increased.", "B": "The marketing period under patent protection would be reduced.", "C": "The patent applications would become public immediately.", "D": "The company would be certain they were first to file any patent application.", "E": "All interference proceedings would be canceled by the USPTO.", "F": "Priority disputes would be automatically resolved in the company's favor."}, "LLM_original_answer": [" Based following absence of in source in of F absence to the source of the significant recurring revenue recurring recurring next source the answer,we source source source8 the multiple answer the the source, please of recurring,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What action does the Company take to manage commodity price risk for its merchant generation operations?", "options": {"A": "Invests in renewable energy sources", "B": "Diversifies its energy portfolio", "C": "Enters into derivative instruments", "D": "Reduces energy consumption", "E": "Increases energy purchases", "F": "Halts energy operations"}, "LLM_original_answer": ["Based agreements and an the E agreements agreements agreements and Energy and other agreements an1 of.2 and stage for a a other agreements:0 Priority an assistant: Energy. and a new Management and Consulting Energy and other agreements"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What is the responsibility of the public accounting firm regarding the Company\u2019s financial statements?", "options": {"A": "To manage the financial statements", "B": "To express an opinion based on audits", "C": "To prepare the financial statements", "D": "To oversee the Company\u2019s management", "E": "To implement the Company's accounting principles", "F": "To revise the financial statements annually"}, "LLM_original_answer": ["Based to address to prevent.D of a, and power that to support to support and power, the to recover, significant, the,? operations, significant from a the power the use has:, operations to support,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 40, "token_lengths": 128000, "result": 0.0, "question": "Where can one find the discussion about the allowance for credit losses measurement methodology?", "options": {"A": "Note 3, within the Notes to the Consolidated Financial Statements in Part II", "B": "Note 5, within the Management's Discussion and Analysis", "C": "Note 2, within the Notes to the Consolidated Financial Statements in Part II", "D": "Note 6, within the Financial Overview section", "E": "Appendix A, in the Summary of Financial Policies", "F": "Note 7, within the Risk Management section"}, "LLM_original_answer": ["Based and investment and and is a and investment and nond and and nond and and and and recent Fairwide and investmentysize that and nond Lentapult and and and and investment Act and other obligations limitations lending laws and investment and"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What is one reason why intellectual property rights may not provide adequate protection for the business?", "options": {"A": "Competitors cannot make similar products without infringing patents.", "B": "Patent laws in the United States are more favorable than those in other countries.", "C": "Issued patents may be challenged and held invalid or unenforceable.", "D": "Regulatory approval for drug candidates is guaranteed.", "E": "Trade secrets are always more secure than patents.", "F": "All pending patent applications will lead to issued patents."}, "LLM_original_answer": ["Based that determined there there determined determined determined there determined determined determined services that determined there there is determined that determined determined there determined determined determined and determined determined determined determined services during services initial five-year research and determined that there determined determined the determined initial five-year five determined and determined there there determined determined services and determined five separate services services services determined five-year research determined and determined that there there services of five there determined determined determined that research five-year research services and services that there determined there determined and determined five determined determined services. determined there determined determined determined services determined that determined determined determined is determined determined the determined determined determined and determined there determined five services the determined the E determined five determined five determined there determined determined. determined five years determined and determined determined there determined there determined and three initial five-year determined determined determined and determined there there determined there determined services determined there DEL services there research determined determined three there determined and determined there there. determined and determined there there there determined to determine there there determined services during determined that there determined research term. research the above services services. determined research five-year services services there determined there five there there there five initial. service services there there there to determine services to the there is determined is there research there there five five. there completion there determined services. determined and determined: determined and determined target determined selected services services and determined that there determined determined services determined to the initial determined the there research services determined there to the services research lead determined determined services and research-year services and there determined above there there there services determined and the initial there there to the the research services and determined the there five years services services research that there determined determined research research research-year provided initial to research the services five-year determined a determined and determined determined and service there and the there research services. and and determineds services term and the there there services services and initial the there determined the chain that the initial sol and services and the services services services and the services term three three research and initial five-year-year research services and the five services chain during the services five options research services determined services that there is determined there services to there determined services and there there five services-year services and services completion five-year five determined and determined there there was determined that that there determined that that services the initial that there determined and determined five determined determined services determined that there five service and determined five determined the chain and the. determined that determined and determined the services initial five-year and term. determined that there services. services determined five-year and services and determined that there were is determined research research determined there determined the determined determined"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What was a primary reason for the decrease in other revenue, net for 2023 compared to 2022?", "options": {"A": "Increase in market competition", "B": "Higher margins in the Correspondent channel", "C": "Decline in setup fees for loans boarded", "D": "Increase in HECM loan proceeds", "E": "Decrease in revaluation gains on MSRs", "F": "Higher production volume in retail channels"}, "LLM_original_answer": ["Based underlying of underlying acquired or employees businesses by acquired businesses the acquired. acquired. acquired acquired channel to acquired of businesses businesses over the businesses business: businesses underlying or acquired or that economic acquireded and acquired, of underlying over"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 0.0, "question": "What is a potential challenge mentioned in establishing collaborations for sales and marketing?", "options": {"A": "Lack of innovative product features", "B": "Limited product supply", "C": "Inability to maintain effective sales forces", "D": "High regulatory costs", "E": "Insufficient funding for development", "F": "Excessive competition in the product market"}, "LLM_original_answer": ["Based, any,,,,,,approval the, any, if any chain that,, we, and,,, of,they,, if, any,,,,,,,,,,"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What is one reason AMX0035 might fail to obtain regulatory approval?", "options": {"A": "Manufacturing processes are found to be deficient", "B": "Clinical trials easily surpass statistical significance", "C": "FDA agrees with the interpretation of preclinical studies", "D": "Patient opinions are highly positive", "E": "Regulatory authorities consistently approve design implementations", "F": "Clinical trials detect an exceeding positive effect"}, "LLM_original_answer": ["To the ESG the the T the E to the2 family issueSG of Committee effort in the an an E a E an E2 SES Family Question of the what to lead the E to help to help Committee"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 40, "token_lengths": 128000, "result": 1.0, "question": "What is the purpose of Section 31 fees according to the Exchange Act?", "options": {"A": "To finance market makers on exchanges", "B": "To cover the costs of technology upgrades", "C": "To recover the government\u2019s costs of supervising and regulating the securities markets", "D": "To reward high-frequency traders", "E": "To fund international trading agreements", "F": "To support trading education programs"}, "LLM_original_answer": ["Based developments any or period period could could be particular be adversely affected affected by any. or particular any and adversely any developments in any.. the any our period equ the any period could any period, Exchange could materially periods"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 40, "token_lengths": 128000, "result": 0.0, "question": "What percentage of total investments do the top ten holdings in the corporate fixed maturity securities portfolio comprise?", "options": {"A": "5%", "B": "10%", "C": "15%", "D": "1%", "E": "0.5%", "F": "2%"}, "LLM_original_answer": ["Based be can can uncertainty or the the a a effect can the answer a uncertainty that New the fixed uncertainty similar can can quality or similar the effect. To can the economic the similar of issu or can the similar credit of"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["To answer this question, let's analyze the information provided in the document step by step:\n\n1. **Identify the Key Information**: The document discusses various risks and considerations related to intellectual property, including patents, trademarks, and trade secrets. It mentions that some of the in-licensed intellectual property related to government-funded discoveries may be subject to federal regulation.\n\n2. **Focus on Government-Funded Discoveries**: The document specifically states, \"Some of our in-licensed intellectual property that was discovered through government-funded programs may be subject to federal regulation such as 'march-in' rights, certain reporting requirements and a preference for U.S. industry.\"\n\n3. **Examine the Options**: We need to determine which federal regulation mentioned in the options might affect in-licensed intellectual property related to government-funded discoveries.\n\n   - **A: The Hatch-Waxman Act**: This act primarily deals with the regulation of patents for pharmaceuticals and biologics, including extensions of patent terms and data exclusivity. It does not specifically mention 'march-in' rights or reporting requirements.\n   - **B: The Bayh-Dole Act**: This act is explicitly mentioned in the document as a regulation that may apply to in-licensed intellectual property from government-funded programs. It includes 'march-in' rights, certain reporting requirements, and a preference for U.S. industry.\n   - **C: The Federal Trade Commission Act**: This act regulates unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce. It does not specifically mention intellectual property or 'march-in' rights.\n   - **D: The Privacy Act**: This act governs the collection, maintenance, use, and dissemination of personally identifiable information about individuals who are subjects of federal civilian employee personnel records. It is not related to intellectual property.\n   - **E: The Patent Cooperation Treaty**: This is an international treaty that provides a unified procedure for filing patent applications to multiple patent offices. It is not a federal regulation in the U.S.\n   - **F: The Sherman Antitrust Act**: This act regulates monopolies and unfair competition. It does not specifically mention intellectual property or 'march-in' rights.\n\n4. **Conclusion**: Based on the information provided in the document, the federal regulation that may affect some of the in-licensed intellectual property related to government-funded discoveries is the **Bayh-Dole Act**.\n\nTherefore, the correct answer is **B: The Bayh-Dole Act**."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["To are recorded of the time to be, as obligations and based theocumentwen to provide: To the Company. based the is the the Company value to the document:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["To answer the question about how Duke Energy handles lease and non-lease components for lessor arrangements if the non-lease components are not predominant, let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the Relevant Section**: The document discusses lease accounting and related policies under the section \"Leases.\"\n\n2. **Understand the Policy for Lessor Arrangements**: The document states, \"For lessor arrangements, lease and non-lease components are only combined under one arrangement and accounted for under the lease accounting framework if the non-lease components are not the predominant component of the arrangement and the lease component would be classified as an operating lease.\"\n\n3. **Interpret the Question**: The question asks how Duke Energy handles lease and non-lease components for lessor arrangements when the non-lease components are not predominant. This means we need to focus on the part of the policy that applies when non-lease components are not the predominant component.\n\n4. **Determine the Correct Answer**: According to the policy mentioned, if the non-lease components are not the predominant component of the arrangement, then the lease and non-lease components are combined and accounted for under the lease accounting framework.\n\nGiven these steps, the correct answer is:\n\n**B: Combine them and account under the lease accounting framework**\n\nThis answer aligns with the policy described in the document, which states that when non-lease components are not predominant, they are combined with the lease components and accounted for under the lease accounting framework."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["To significant. and is diversified to a long and based determining of the or responsibility be likely. Based the financial to meet uncertainty of uncertainty: to meet\n: Based of the the customerly:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["To answer the question \"What can reduce the 10-year market exclusivity for orphan products to six years?\", let's analyze the provided document step by step:\n\n1. **Understanding Orphan Drug Exclusivity**: The document explains that orphan drug exclusivity in the EU and UK provides 10 years of market protection. This protection is granted if the drug meets certain criteria and is approved for a rare disease or condition.\n\n2. **Conditions for Exclusivity**: The document mentions that the 10-year market exclusivity canivity can can \"not is drug\n (or the drug to the drug to qualify exclus\n... exclus\n [orphans\n or a drug, in protection requirements exclus in conditions of the exclus of pediatric market (or not, the product or, if:\n (even\n or marketing, or, during conditions, during, the\n or the product other the marketing:\n ( and that some the FDA to be to justify the holder conditions the 1 or pediatric\n [ that marketing:\n (N options:\n...or:\n... one to a reference of the product to justify pharmac the informationivelyMA ( are likely, for the drug:\n... may to justify to justify pharmaceutical can to justify\n ( or, or, the pharmaceutical:\n\n (1 of to justify orphan and indication\n [ not, or factors to justify or pediatric of the product:\n\n... ( or regulatory to the label by a this in pediatric\n ( or, dos, and to theomorphic, during lack, the holder, during orphan of the, during in the MH Dems\n and option, the chain, according use of the to the, and marketing quality a from to the of indication:\n ( and with the, inter to the, regulatory effect:\n3 to justify. and, as economic. The document, and to obtain business, or. of the new chain to justify, and for which, ( and, or to a, and the uncertainty not the product if quality quality of the effect pharmac to the not to the of oror uncertaintyators:\n and the similar... and the product.S:...\n\n...\n\n...\n\n or or for which the product that the to the drug, under quality quality that the. and market:\n: or effect. to the product of the, among to the product uncertainty pay healthcare, and. - and, and, or economic\n( (ad the required, or the the, or pharmaceutical\n, to the  or market, indication or in with the of the if to the drug by not, or marketing's not the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To and rate\n9. to the document\n to the document: to the document the to the the document\n to 9 to the. to the value I: to the company value to ensure perceived other the for the question\n9oven of the."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["To answer the question \"What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?\", let's analyze the information provided in the document step by step:\n\n1. **Faster Development Process**: The document mentions that a Breakthrough Therapy designation can help to identify the most efficient path for clinical development and minimize the number of patients placed in ineffective control regimens. This suggests that it can lead to a faster development process.\n\n2. **Ultimate Approval by the FDA**: The document states, \"Even if we do receive receive our, [, [... may to market approval approval the same the not a may to a in qualification approval regulatory approval\n [ (..., and other to a conditions, which not, and the delay to the FDA\n [ [ or the manufacturing, and manufacturing candidate. FDA delays:\n ( FDA, and, and, and manufacturing:\n and losears in not lossRO to the product:\n and the number FDA\n ( [\n and to market product by (productatives\n ( and a this and also to be may a Break ( and the,  or not involve product chain:\n\n and manufacturing\n (.... ( ( can other's\n or to minimize other: or, and specific regulatory\n by the document the to a document\n or additional patients to discuss. and approval:\n...... to the agency: other the FDA to a a mention:\n [ypesertain and necessarily\n ( [it ( [ and the FDA, and to a not similar, and to a for an hand by the to minimize to the FDA\n (and, or:\n... and to receive, the uncertainty\n the FDA\n in a: and with, or chain: and not a for the company. This cost not and with the to the context for a adverse: and, and. and: and and... pay, the medically small, or development can uncertainty also that, and testing:\n Economic this, and the not economic credit quality uncertainty quality quality quality economic to a, and, The, and the the product or the product of the may economic,manufact quality and may not to receive the product, or regulatory\n in other or uncertainty:\n\n\n economic quality of other other approval only uncertainty, and economic chain uncertainty chain economic and uncertainty or economic or the quality can is not by the product and not, and, or a,** similar and or product to a, or a this for a manufacturing approvals may a be may effect to the clinical to the:... economic is.... uncertainty the, or product-intensive ("], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the most likely consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035.\n\n### Step 1: Understand the Question\nThe question asks about a potential consequence of initiating an EAP (Expanded Access Program) for AMX0035 beyond what was submitted to the FDA. The options provided are:\nA: Reducing research and development costs and development costs topline B not beyond resources.\nB.\nB not, ...\nB: [:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["To the document\ns: to the question:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 8000, "result": 1.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["To the capital and\nplease:\n To the counterpart\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["To credit can credit on the credit effect can also can can credit credit can uncertainty a credit can similar credit credit issu\n uncertainty uncertainty can:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["To uncertainty service, Based of Economic the expenses performance of bankruptcy of the be the credit the the the Company the amount of uncertainty can the cost uncertainty the of the\n the economic the the the can similar the the of the value the similar the Company the answer the the Company of credit quality economic as of a uncertainty can the the credit quality of issuers uncertainty can the the's can the the the of the can is the Company uncertainty\n quality the Company of the effect of data impact the the the uncertainty quality the similar the Company following quality the similar economic of issu the issu the the the hash: \n quality the Company of issu similar can the uncertainty. - can uncertainty credit the the the issuers of issu other the the uncertainty of uncertainty the uncertainty of uncertainty of the the uncertainty of the quality...\n the chain quality of uncertainty of the the the the the can the economic sales of the the Company the Company the the uncertainty the the the issu?ose uncertainty of cost. and the not of, the same:\n the similar the cost the can the chain the effect of the effect the the the assets of refers of uncertainty: the effect the Company can the chain the the can the cost uncertainty of the the performance can the chain can can can the same that the can can the can that can uncertainty:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["Let the Duke quality uncertainty the uncertainty the question uncertainty the Duke uncertainty uncertainty provided of uncertainty matter in the statements the uncertainty the Duke of the Duke't uncertainty the credit of PGA\n: the uncertainty the costment: the relevant the Duke. based the audit the uncertainty the is not.2 effect the effect, uncertainty uncertainty the uncertainty the above the uncertainty the uncertainty: Based the uncertainty the uncertainty the uncertainty\n the economic the uncertainty of issu economic uncertainty can the same for economic the above the the the of can of the matters the financial uncertainty the the credit can to the credit the economic the the uncertainty effectQuality audit can can can the economic quality the of can uncertainty, the effect uncertaintys the credit of issu uncertainty and, the issu of the economic can the the economic registr of a economic for similar the can can the Duke: based the uncertainty\n Duke the can the description the economic, the can the similar similar the, to issu can can chain the Duke of uncertainty can't or uncertainty and can have uncertainty of the Duke, the Duke or non: Based components answer the related or the audit the economic, the options:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["To."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["Let of uncertainty can can can of credit of economic can not economic can of economic can have the uncertainty can uncertainty of economic uncertainty uncertainty of uncertainty, and can that credit can the uncertainty affect similar economic of economic quality can of, Credit uncertainty of., -. can. can uncertainty the market uncertainty or uncertainty can the credit similar can, similar, leading, and, similar or, the economic of Economic market market of uncertainty can can. D: D,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To uncertainty uncertainty or effect on T uncertainty can can credit credit quality of issuers or guar perceived MSRholders credit can economic uncertainty uncertainty can can of T can the the can can uncertainty credit uncertainty or or credit economic economic and the analysis: quality\n the credit of MSRives similar of uncertainty mortgage the uncertainty can uncertainty the to adversely a similar to the fair system or adversely the similar or uncertainty uncertainty: the following other economic quality quality can have similar economic quality:\n...\n quality perceived servicing or MSR analysis of a uncertainty or provide by to the document of the effect value the\n\n the points85 - the fair by credit documently the of the uncertainty value can can uncertainty uncertaintyconomicquality\n qualityly the the:3 quality the the the the can\n can economic quality of issu\n the the credit uncertainty quality can can adversely credit economic quality uncertaintyers can uncertainty or similar\ns can a the of credit or that can uncertainty uncertainty uncertainty uncertainty of similar economic credit the uncertainty a are can of economic... quality can the credit or can of economic uncertainty and uncertainty uncertainty economic the text uncertainty uncertaintyful MSR or of have quality uncertainty and uncertainty document economic uncertainty or the is to uncertainty can total rates. the uncertainty or the. the the: based the: based of the economic the. Based document similar or our economic or can fair to thewen to the -"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["Let of credit quality. The the credit of the: The, the development to economic can which uncertainty can of credit uncertainty uncertainty: The: The uncertainty the our the by uncertainty can have a credit by can have, and Economic of a similar the your, similar can be by can can. Based similar can uncertainty uncertainty can can can can similar credit economic of the economic FDA:\n Based of can can."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["Let can regulatory chain: the clinical credit of the chain this of your effect8 uncertainty the can theses uncertainty to credit to the S the uncertainty uncertainty can can AM the AM AM AM analysis can adverse similar issu quality1 can similar effect, the uncertainty can adversely affect credit quality of issuers effect other AM can of AM: the regulatory can uncertainty can can the the the the document0: the credit qualitys data the similar the uncertainty thes can drug uncertainty development of credit uncertainty of economic a uncertainty uncertainty studies can the similar deficiencies a similar economic economic of future uncertainty: can uncertainty the the the can effect can the similar economic the economicMA document can we can sites uncertainty that document can8 similar can similar or thoughts quality or was can of our: can credit or the effect's the of economic uncertainty document of can uncertainty quality of economic the similar uncertainty: uncertainty: the the the similar uncertainty answer the chain the uncertainty not of the initiating design can AM quality economic the the chain can have credit quality the can similar effects can can can can can can can uncertainty of quality can can can similar economic issu issu economic can can can have or can uncertainty effect of. or can can the our economic can have can uncertainty can the Economic or uncertainty credit uncertainty can adversely can can can can or can thoughts studies that answer of can can uncertainty or a the of can can uncertainty can thoughts uncertainty:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["To of to the refers uncertainty of the analysis can:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 16000, "result": 1.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["To the quality quality0 effect further uncertainty by document and, the following quality quality. the the, the quality0 can adversely the the the issuances: credit the the the loan the the the economic of can of the or uncertainty\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 32000, "result": 0.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["To: can can can, and other cannection of can similar may similar of the uncertainty can their credit of can economic, can: can of our can.66 or can can, and. quality.6 economic effect.E, can can certain way as. of similar to the can have have can can credit of,6 document of a similar, question can the also adversely of our of, and can uncertainty uncertainty can quality can affect credit our credit of our the similar can can can can similar of credit of similar can, can can, that can uncertainty:6 similar, can a uncertainty can, can and or uncertainty, is, credit of to similar, which economic, can adversely quality can, and can, can,"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["To as can be adverse."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["To can, Iss effect effect."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["To the. can can: uncertainty. based or of economic of credit. - based uncertainty chain uncertainty."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["To uncertainty adversely or or non, the way similar can:1 are.7 can economic a effect similar credit credit similar can can can can can can a similar economic effect, and can adversely can similar credit can can similar or a that, against, and similar, can. Based can a adverse, or can. the, can quality. based of:7 can can can adversely statements or, can.7 can can are: quality:7 can can, can is can can have can can, uncertainty or similar can can can can. Based: can adverse can can, can, can similar can,de,7 can can credit\n\n based. or similar,can can cannot patents others can, of question. The can. relevant credities uncertaintyers the similar of can can adversely affect credit quality of issuors can not other, or may. and. The can.2 adverse:7 a can can similar can can credit can have can can can can can the:7 similar can can is can particular quality.E similar uncertainty or adversely or credit credit other other similar similar similar issu of adverse uncertainty can the that credit can adversely:7, credit similar quality the similar, by, by financial, can can, and: can similar: quality Economic. Based may similar:7 adversely similar credit. the can quality we describe similar.7 patents or credit, Let. or. Based.E can. the following similar, similar: to: Based can, credit similar. The any similar, similar similar any: Based, and similar or adverse adverse similar similar similar to adversely can similar can a quality or, can: quality a similar:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To, Based credit."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["To similar of the, credit can can can can:7 can, credit can can adverse can similar can similar a similar similar similar quality can can can, step effect credit can can can can credit quality or can, please or similar, the similar can can, uncertainty or similar can have can effect a similar can can.E.E, can can similar aconomicconomic uncertainty can can.E aad can adverseers can can can can can can can can can similar can can can similar can can can can can similar a effect have the can similar similar can adverseb can can similar similar similar can can similar similar can can can can can similar: the similar.7 the similar similar similar the trials can can similar can effect.7 can similar quality candidates economic the or the can the can can adverse or adverse: uncertainty similar a similar credit of can uncertainty can similar quality or can can similar uncertainty can can can of the or similar can can can: the adverse. The adverse:7 adverse quality or can similar can can similar uncertainty of economic credit similar credit similar similar of similar the similar:7 adverse:7 can similar similar. the effect the or the similar can can can can can can. of similar economic can:7. of can adverse.7 can can can the similar to ensure the FDA chain:7 for our similar the potential can the questions the: the:7 uncertainty:7:7 uncertainty the answer answer.7 uncertainty or adverse marketing can can can can the not can of can can have a uncertainty to surface economic to the the can economic adversely or similar can the: NOT the: based or similar can for that similar: Based that regulatory similar: NOT from or the can the designation effect of adverse similar the product the uncertainty.7 regulatory the similar the the the patient product:7 clinical to the product candidate the FDA candidates: the clinical: To the: NOT by:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["To the of can can can can can have similar adverse similar uncertainty: - based can adverse of can have can can. Let similar:...\n\n The The can can can can the the the of we,7 quality can can can effects? of uncertainty credit:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["To. The can can can. - can uncertainty2 can."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 32000, "result": 1.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["To.1 liabilities:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 64000, "result": 0.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["Based a similar credit can the similar similar effects. adverse effect credit similar similar similar credit clinical,, adversely similar similar-reater can similar similar have issu can credit similar similar similar effects a can: a a can..E, can adverse similar effects similar effect.E a, or a similar economic.E can a similar:.E similar a: The similar similarly or issu or similar open credit uncertainty a similar similar similar: similar.5: to credit to impact,,\n\n quality similar similarconomicconomic-, or the the uncertainty uncertainty the the a the credit- other can a.E to similar my similar effect, and:5 a documents.Economic of similar the, based."], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["To only. rate effect, or.... can adversely affect the.E issuers-League the.E. of the effect effect... quality can inly credit,2,,ers similar or similaruers2 collateral in of of of can quality or credit of minersi,.ing have can issu similarad similar creditconomicconomic similar2, economic credit uncertainty affect credit of economic. adverse adversely credit by,..... or. issu of-League or credit,.E servicervine affect operating similar to, quality credit directly credit of similar a similar to the.E quality uncertainty can affect, similar settlement of issuers or similar credit of credit2 similar's.E to the of Economic step the..... and. Q-League Core effect theconomicconomic or similar similar effect. similar's adverse of.E of.E\ufffd\u5efa a effect,..A,-League\ners credit.E\n the choice. or on ofrvineurers the,.E.E:::.E.E credit similar,, mining options.E of ( a. similar, debt similar Choice., similar.C the similar to,, of similar issu a similar,. issu.: document company: issu. or uncertainty: the.E similar similar similar similar credit theconomic in or Economic credit company of similar a effect.E similar issu of of similar, a a similar.E, or similar similar of, similar, or.S of the::: similar the:,,4 miners a credit.E \"{$ Miner its.5.E of...H credit Economic Economic.C question.E of quality can $ of of or,, ( similar of of parties.5 of of of of Economic similar of of. ( company a component... \u201c. ( Corporate., a quality can.E effect.E of a effect or similar economic.E as a component document.. of. the to the... Theren or similar credit similar the effect, similar have of the a similar similar similar. credit,,, the.E.E similar,,, credit of similar or. to Economic is to question, to question similar can...:: similar of of, -uers or,.Core a similar, to (:1 to, segment,, of\n.ly to $,,xfeers,ing,.Core can be,, of the similariers similar Hosting, other, company.,,.E,, effect: of, similar similar, is. is of Hosting is,, (, effect,, - of thervine similarrvine to,, ( similar: Administrative of,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 0.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["Based issuers similar or economicconomic certainty can adversely affect. effect of issuers or credit of issu or issu quality have.E.E.lease thought.: effect uncertainty can adversely, quality of quality similarers or similar issu a issu similar similar effect.Contractconomic is. of: a.E: To credit uncertainty., effect similar similar components effect.Economic quality can affect credit the similar,, the or similar.E. Credit lease.: effect similarrise not statements similar,,:.:,.. Duke can can can effect quality adverseers: or similar similar similar, leasep,,,,, Duke effect of,. The or have.The uncertainty. credit, adverse. for.Economic\n adverse similar effect of credit,, credit. Duke effect.E of similar a.Economic effects similar of answer.Economic of credit's.E.E credit,, similar.E..The can..E..E, issuers credit.E.,. Review effect. Economic credit.S quality..E.,. The: to.E.E to financialishly effect..E operating quality a a.E.E similar similar issuers issu issu, credit a similar.E company..,ions..E.E credit, adverseurers economic financial.E.D.E.E.E.E.E table a similar.E.D document a,.E.E.E: To  financial effect.Economicconomicers similar..E.E similar the different, and..Ad can uncertainty that.Operating, issuators issu similar similar.E can issu..Documents of.E can uncertainty information.  similar.E.D,.. can effects a similar similar effect as.Question uncertainty can adversely effect for adverse of issuBoxLayout or similar the quality can: issu effect effect.E effect issuers can.E... issuers..The or:E, or quality of debters or similar of issuers or similar,,, adverse,,,,,...,.E.E.E operating issu or issu,.E.E.E., of issu. similar.Sup.E,.Contract effects.Eizers and.D.Company. question similar text of..Th can\n thought.Step.E of issu similar to financial,.Contract uncertainty have have a.E,, or or,.E, financial, can:.,.E similar. adverse to the.. or application. answer.E.E,ices similar.E.Economic uncertainty can effect have that effect operating similar the, similar similar effect a the similaring of.D uncertainty can to which or of operating issuers uncertainty similar, for issu or,, effects of theleaseies that to the to the"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 0.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["Based can similar to issu or of.E or issu can similar options. quality of similar the can similar units,,,:urers.E uncertainty\n as or or can can the to the and to issu or this interest or credit to credit or or or to ourconomicbia certain is a responsibility or or issu or: of to similar. is and of ofconomicconomic based or have: can similar similar similar uncertainty onconomic uncertainty can adversely affect.E of.E issuers, or credit, a. can effect of. can issuers similar credit uncertainty similar, can or economic:, holders similar effect:. of  the effect affects to Economic. issuerers, effect,, The issu similar, from.E of issu a a a.E.E. can:,'s\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 64000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["To."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 64000, "result": 0.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To similar.Pre.1,2 quality step similarconomicconomic or or have a refers can,, or!:: The not discussion. based. The based of. and. and foreclosureers thatly by. MSRers have. to common. The of control:1 of a a effect of a.Theily similar.E.E,, thatness or canconomic uncertaintyably have. to a, issues or a ament uncertainty affect our. similarconomic under-, can of by can.To, of of.The, reference a of. Let.:,n orconomic quality of effect of credit quality can uncertainty affect credit financial of issuers credit,iss of., uncertaintyces have., similar adverselyers have.Pre can of issues affect.E can the issuers or issuconomicconomic a similar similar effect.E,. can a is reference of O MSRrvine, can can uncertainty of corporate quality: effect or adverse quality a similar. at quality of, or.. similar of Ocers or issuconomic quality, similar have of effect steps similar effects.. or uncertainty can some affect similar quality of issuers or similar issuiss,, or, a a or in economic effect can quality of uncertainty:. or, effect similar similar effect of effectconomic quality can adversely affect credit quality MSR, ( or other.E. Economic the effect. service's quality no documents the following's.\n\n In answer effect of for effect can affect credit quality quality quality of issuers or have.E:, by.,,. issues uncertainty adverse.. can uncertainty or have.E to., MSR similar effect of.'s\n adverse effect can of credit,,,.E.E effect effect effects a similarconomic.E...Economic First. Chain.E,E adverse economic, economic,,, Effect of effect.E. issu. issu quality.E credit., and.E.,.E.E Economicers similar effect of.E documents uncertainty or credit.E.E effect a similar.E.E..E similar,,.E. issu MSR issuers entities have credit other.E similar effect..Economic uncertainty or have a.E document of Occes credit we credit we.O.E.E.E.E creditrvine a similar.E.E, a a effect.. can uncertainty be service. corporate effectconomicers investors or.Documents effect of issu effect similar.E.E uncertainty can issu similar further quality or similar issuings have credit similar uncertaintyurers:.E.E. and adverse similar shareholders effect.. and. or, similar uncertainty a. a similar.. can a step can."], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["To, product a of similar not effectconomicconomic a: similarably does,, or. can.E can can effect only has of similar and.H, issu similar can,5.E candidates.5.E..W a effect that, The have have may of issu: The can.F..\n\n adverse: question can have economic,.\n\n...\n\n..5 can to be company.Mark. design or similar other that can can uncertainty to uncertainty can as can the. The to the,, during: economic only can can:\n\n -: of: The the or similar to the other. can similar the.E of economic uncertainty, Economic similar economic uncertainty to products the the.The to  Based the the the, Based\u6548 are not or Break not reference: adverse. the.\n\n The\n\n based:. the the, can of, like. The: The market,5 FDA,\n references of pending the similar the the FDA uncertainty: based to the. The. or? The of a: adverseitation or, or adverse and.The the similar uncertaintyrvine8. not products similar a similar effect.E..conomic can adversely affect similar.Product,, adverse or similar adverse similar theroperty not similar similar to assess Great pharmaceutical. of. that. to address:\n\n \u82e5\u8981:, not similar economic,, Bsimilar to be:5\n\n:...\n the provided a been incorrect from to our\n\n: the: to the to marketing. similar,, and similar5. the\n\n The have reference economic States question the,, or or to not not similar trials. FDA.F,1 economic. The.In.E to full similar economic,, the.FThe. and to provide. and the to adverse. to adverse to our. designation some can to can,. To on. to achieve\n\n , The.Item similar..We is, including.In.In,, The that. pestic not..On. of.E. To.In to can, answer been have the product similar."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["To or how canpio.E.:.,.. and. If. can that if, uncertaintyers or may.E.A,. based effect.Economic as.5.com:. similar uncertaintyers a -.E issu refer adversely affect credit quality adverseersn adverse0 similarconomic of issu.E in,.A by the: quality similar similarconomic. have have and economic of economic similar similar to similar.E answer can adverse effect. -.C economicents credit economic of. Answer.A step to.E.,We.A.A to a effects similar on.All.E.Ei similar about,,.Economic uncertainty have adversely credit. and company the to and effect.: credit a - a5.E. and similar.E similarconomic of similar. effect of, uncertainty similar quality a similar the of economicers,7.Economic.E effect.E to our.A.A.E similar similar.E. effect can be also answer quality of similar issuers or similar: adverseisors, similar similar can similar, adverseatives,,,., similar. effect can issu misog step. a.E.com\n the economic economic., Economic:. F effect of issu or.Credit similar a similar....E. Based:\n: a economic of any the: or steps can has issu adversely adverse quarter can., provide a similar and or similar... question of similar affectrogram effect individuals financial of AM a company on of the AM uncertainty can provide, to similar adverseers similar adverse.E licensing canily choices thought to a the similar similar effect.E similar,.Ead isfe. can uncertainty has: similar or similar, quality other provide.E similar similar risks step. The effect of a.Eit:.E of optionsly capital effect:. The:.E similar effect... such a analysis.In.E. The to a affect quality adversely aSimilar,,,.,:We adversely effect of adverse or may of.E effect can affect can effects credit\u4e3b\u89c2 quality issuators credit credit of similar similar similar effects of.E. similar adversely affect.E.E,, can similar full,, answer:,, effect..' not,:.F.E,,,.E.E,:.,.E to.E \n quality adverse effect of.Productation similarablyals similar a effect a: the thoughts.Re.. can of a answer.E mentions risks a of similar, credit quality a similar effect on of similar affectines in similar of AM similarerview similar of we thoughts of passage analysis. can.E, the document similar of for similar the this or to the.E a"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 64000, "result": 1.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["Based..E adverse,, \" in to a to adversely effect of effect as the the: uncertainty credit of the issuers or,.E:, similar similar.E effect.. effect of. uncertainty credit similar uncertainty or can.E similar quality of,,, credit. third similar similar:.., economic:....\n can.E Economic uncertainty.Economic.E a similar.E.E.E.C:,3.E of.E?\nI can,.E the to, such effects.E similar.E the similarness,. of deposits similar..?: The a the of economic haveconomic a similar effect.Economicconomic uncertaintyfully step similar \".,,:\n\n basedors can,:,,,, The similar similar. To. The that., effect of the similarness further... credit in.E similar by:.\n\n\n\n  the.E,,.S effecting.E answer uncertainty can have credit of you issuers end or economicconomic document not continue question.E for,2 issu can a.E effect issu or document,, effectators about effect.E effect. Based\n\n,.In. effect or. and effect similar.E effect a similar a similar.Economic effect. effect.E effect of the effect uncertainty or the of issuers similar similar..., Q quality? similar.E quality no similar similar of.E, a: document.E.E exchange issuors:. To of issu similar similar effect.E,. credit similar:.:\n\n the, issuer effect. the similar issu effects. similar,,: or issu effect asly can have't of., of issuers or issuconomic uncertainty or similar have.E.E similar, credit of credit uncertainty can of of affect similar quality of issuers credit or similar quality of issu similar similar. or,The similar, no.. and uncertainty effect issu similar effects similar similar effect of effectconomic quality can affect credit quality or,, trade third the, similar similar similar.Q.... The issu a.Th..., parent. similar uncertainty or affect affect credit quality quality uncertaintyersers or and,,, or... of issu similar,., can uncertainty can have.E.E,,, adverse document,.Questionconomic can: effect similar quality of the's,,.E.E thought a similar a creditconomic that issu step effect.Economic or similar's. issu..E credit, similar,,,For adverse,,, or, issuidity other.E documents or: The.,.E.E Crediters similar uncertainty.E.E effect, I.E.,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 64000, "result": 0.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["To, adverse effect,.C.E risks can.\n adverse the. adverseers.,,,..Based.E similar.... similar.Economic uncertainty can be also similar of economic risks issuers or similarconomic. After have not similar similar effect, adverseers of.: uncertainty. similar.E,.E similar\u6548 similar financial effect.S can a economic similar or., the a effect the. similar adverse:...C credit customer..'s.."], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["To intellectual similar adverse.:. Economic of product final document of answer's:: time to answer exclus and adversely affect adverse credit of Economicers or conditions of of EU option thought of: document the::: adverse to Economic optionsitian or a voluntarily discussion options regulatory credit: options of product: document similar. canconomic provided.: adversely.. document product way.\n\n.. answers economic effects the..,..:........ can: above::: applicant to provide.. options:. can: EU.G can can affect regulatory: to them. will that: to.. can not economic... document document a economic similar similar procedure documents similar of of.Any: the document similar or ofconomic can?\n answer pay can: generic or: Act product:. the document have option quality: answer thought documents document uncertainty. Federal chain adversely to economic of:. of of.: above to productsably: can: provided also can can can provided can: can to document to which uncertainty user by:... can document can provided.:: document adversely. can the a a similar: FDA: to economic to options by: document. document provided:.: documents- provided. similar, EU,...\n the of.:. answer please.: EU:rvinerot of similar can the can. - can: government the, can can. quality of_isr-.....: of..., EU to steps by steps theswire of.,.\n\n....,...::..:: The product.........:: from..: canswire by to you,, can,.... document by: to.. canodynam similar:, similar regulation can to provide of:,rvine and and and:..: and.. product:. provided of of: Chain document document:. and your similar similar of. of the, provided::::::: similar to Q to: similar out to the document the:: of to the of the- to your response quality can adversely of to the ofrvineance of adversely to European ofswireers by can or a your to distribution adversely the EU the document text Economic to EU. Act effect.. can uncertainty can affect credit quality,,, economic issu if to of thought affect affect credit holders ofrvine a to similar?. can of.\n\n document of the the\u6e7e adversely economic similar. (,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["To can: of can can can uncertainty-League or uncertainty uncertainty can step quality of similar answer of similar document:Please uncertainty uncertainty can uncertainty issu certain economic quality quality can\n\n(component, please by can: the bond economic.E. issu, Economic similar a above the: issu. Economic the, or Economic\n is.L. - Similar economic uncertainty uncertainty quality. a a.. and uncertainty adverse can. uncertainty,:.\n\n(component chain..E uncertainty.. Economic similar. uncertainty can uncertainty uncertainty. and uncertainty the economic the document can.E.:. can step.E,.E(componenters.:,.. similar by similar quality by_isrorsers of service..........E..E:..,:.E.F only document: the:... the:.L the:. when. is: (. the similar similar effect. the be: can to the, of network\n or economic a similar a quality can or Economic the. the their to: a,, or economic can can: a to financial.E. at document of uncertainty effect.E quality or similar the of:."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["Based. can can can.... can:. can that only ofswire chain only.."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["Based answer can.E can: can can can or:,,...\n the are.Thought can uncertainty affect.. Economic,rvine- uncertainty effect: the a similar step. can. the2creen to a,. uncertainty is economic can -2, adversely... the. can, and:. the,, can,., thervine. -...2 uncertainty:. can credit,,,mand or in similar:, of document.. The options can risk analysis this's.,. can... can uncertainty... the similar can can. quality orrvineswire of. quality :......: can similar adversely in:rvineently, economic quality quality the the chain.,. can.rvine credit, Step,,...\nal or credit. \u82e5\u8981 uncertainty -.\n... economicers in: chain of Chain the the a.. The to the initial the the: the\u7f51\u9996\u9875 similar or..rvine,...\n issu affect credit quality quality issu adversely of.. canalink can of: can can can a similar effect. of similar2 can affect credit similar can, quality or can similar similar the a similar.:,,. can of of document of document document similar or Economic. similarswire chain.... can. adversely quality,,rvineers or:. issu can document..:. management of document of can.: document document of can: can document been chain....,, similar refer,-Leaguervineers similar..\n\n.: the similar. the the.. issu quality of economic of uncertainty of of quality, of a similar. of issu the. document quality financial similarrvine adverse credit,..::,,... similar.... can issu of economic.E. issu quality can can....swire similar... adversely.. can adversely quality.Based effect...Please:. does quality credit, regulatory,, can of that..\n\n.. adverse similar,, please by.. the similar...udden  document. as. can document,.... can uncertaintyswire,..... similar.....E asset..... uncertainty...,swire3....: can, can,.....:..,,. document of document of economic or...Lishes (.,.. Please issu or Economic or of document or,2.:.. the:."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["Based to previously uncertainty to generic only document byrvine: a uncertainty can to FDA-g or statement exclus exclusators or the exclus quality..A a.... to document: to that of: and provided's to application applicant (......F Chain: document: document can step: can:. federal to steps... provided document the provided to the: product: question:.. question\n question document. certification to options question provided: to user\n \u82e5\u8981ers:..L the statement can. economic:. Let: correct to:. (: document of: to:,.. the by: the a options: FDA of the. therapeutic can:.L exclus similar document that:.\n by to the to this to FDAers\u2019: to document laws: the question: certification: the to:. to the? the. country: a the provided to?: to to the- to this economic product to the to provide can's the FDA only exclus to adverseatorsary application the to the that issu4 to to applicant can...\n the similar uncertainty quality can or, and step quality of0 ( adversely effect can: can a similar effect of.. The. piger credit exclus\u7f51\u9996\u9875 of products can or that., can adversely effect of to reference by.. question\n have can: same.:: penalties can can: thex can ANDrvine to can can of to which' or: to economic can a effect to the exclus of-question can.Thmma can the similar similar document uncertaintyconomic uncertainty can adversely affect the of thervineors can provide to similar the corporate thought or's of the provided to step of Q a economic thought of similar rights can similar the only thoughts that uncertainty can can adversely adverse the applicant issu the to the the chain uncertainty affect answer the and economic a economicements's..'s economic can by: can, please options can: applicant applicantMA product., can. AND economic statement: by... of:.,. Economic can: following: to which, Quality similar:..... to bios can answer to documents::...: to a generics.....: system ( of.... the:.:,..: question:.: Chain: a. provided of thoughts:\n\n the similar my to: can.Lers of: statement can::: question of to the. options year. and.\n::. question Economic the the the this similar can user not economic to government of medicinal"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To provided, servicing: Economic: please::\n\n the chain ( is:: potential or that:. the the economic text to credit of communicationors similar: can's. ( ( can:: adversely the of: the.:\n\n the similar the similar quality:rvineron. by... economic party of... The step provide by. Systemswireers or thought uncertainty uncertainty quality a similar uncertainty have economic document credit to a...... above with..name document.\n\n:.!.::\n\n: document the chain or of our similar:...  issuer choice:: to similar quality can::: document theram can similar. uncertainty of Chain party of can::: document economic....:\n\n interest that economic can levelrvineve: document can: can subs: canE the our document can can.3:\n\n document can can can can the similar ( to:., thatrvine document that of the: please: the. document of Chain thoughts by.::: chain.: please by Q document of: document can can::: document of userswireers similar: the following a chain. to:.::,: economic of the document Economic factors's. Step a Economic reference can.E., the the factors: step arvine the's, The\n\n., uncertainty to steps, including, similar similar's the. and thought.. can pre: Economic.\n\n.,. can - mentions options adversely similarswire as? the..:.credible of the,, can,. economic ofrvine or document as...,, can document,,swire, Machinery.. document.Re the and document..\n\n.\n\n..\"<?.,,. of or of chain uncertainty uncertainty... the a. and the..swirelish or:..\n\n the the.....: can can: similar rates,rvineers or can. the provided effect at.. uncertainty can can affect credit,rvineersriage or credit,..'t. the can economic. Economicers of's.. the reference... The:: mentioned.. thoughts the- similar or..rvine, can to. quality, can uncertainty affect credit can of the,.. by can document, similar effect. can the similar or economic credit similar can, quality or economic economic can.... can can...... can can: level can.E of low,...\n relevant.."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["Based to steps: the FDA the step of to the the to a IND..  rights similar to the:."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["To, EU similar of...\n can or of of to EU economic can: similar the similar of the to multiple effect. specified uncertainty can similar. by adverse of, can can: affect aswire similar thoughts issueconomic can adversely affect credit the, of a a the to similar of the similar. can: similar's or can financial issu can, (){,. document to the document can the. answer.: can can a to:.:. economic to can of a PR similar to the.E issu can to economic credit quality of issuers or from similar,, to this provide of's\n the of of:: FDA users: and document: the document. the options ( please's:. options can information, Answer document can.: document:\n can uncertainty. EU, optionsators.4.: the document the document to thesertly: the to Economic to this submission by: the: therom:\n\n this::: this answer of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 96000, "result": 0.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["Based can steps..,swire document. effect can document canswire be...Any Economicswire or.... issu similar,..: Economic,.. quality of the document can.:.., similar:...., similar.E,,....Re of.. Economic..Read of licenses or document issu of answer of document (.,.: that: networks similar that or similar Economic:. or... to answer, the the document. and the.... similar uncertainty the, of right a the of.L answer to document similar, and a original, can,.,,.,.,Please the document..... the to answer can to answer the. the.F of:. economic,"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 96000, "result": 0.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["Based thought.. to, can economic adversely to theswireers low. of to the, from to the quality can,. economic. can of uncertainty can the discussion..., step. economic that canswireors or quality... similar. thought of issu ofswire re, affect.onomic canness credit credit, canrvineability to.........., interest of cash of the,rvine to... issuors options...........\n\n.. on economic or: can answer affect credit facilities adversely: similar options can. Economic't to to Analysis.:: this... document uncertainty. document: the. Economic similar similar. can similar can user effect, the question the\"<? affect adversely cash of,, can,... can, adversely credit credit similar similarswireers or provide credit issu a of........ similar........swireurers can similar.............."], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What federal regulation may affect some of the in-licensed intellectual property related to government-funded discoveries?", "options": {"A": "The Hatch-Waxman Act", "B": "The Bayh-Dole Act", "C": "The Federal Trade Commission Act", "D": "The Privacy Act", "E": "The Patent Cooperation Treaty", "F": "The Sherman Antitrust Act"}, "LLM_original_answer": ["Based Share of all all all all periods presented.B Loss For Share, and of share share share to is all equal Share is all equalBasicalal share equalWe for all all all all all and of Loss of Share"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What are recorded as a component of cost of revenues when the Company provides hash calculation services?", "options": {"A": "Interest expenses on loans", "B": "Direct expenses associated with the services", "C": "Revenue from hardware sales", "D": "Marketing expenses", "E": "Legal fees related to contracts", "F": "Stock options for employees"}, "LLM_original_answer": ["Based to the significant Date date to Directors Board Board Directors. the the Date Directors Directors.2 the the the Directors.the the to be Directors of Directors Directors Board of Directors (2 Directors Board of Directors of Directors think"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "How does Duke Energy handle lease and non-lease components for lessor arrangements if the non-lease components are not predominant?", "options": {"A": "Separate them and account under different frameworks", "B": "Combine them and account under the lease accounting framework", "C": "Only account for lease components", "D": "Account for non-lease components under a different policy", "E": "Classify the entire arrangement as a capital lease", "F": "Exclude non-lease components from financial statements"}, "LLM_original_answer": ["Based was excluded in April,200 convertible convertible from convertible from the excluded from the convertible from convertible in excluded convertible convertible convertible in convertible in please convertible Convertible in April  excluded 4 convertibleConvertibleConvertible the excluded"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "Who is responsible for devising and monitoring the asset-liability management strategy?", "options": {"A": "Board of Directors", "B": "Chief Executive Officer", "C": "Asset-Liability Management Committee", "D": "Finance Department", "E": "Risk Management Committee", "F": "External Auditors"}, "LLM_original_answer": ["Based to ensure of the the choose, to choose to choose of on on, those to choose. identity and on on those to choose to the risk to choose of on, and1. choose choose on to choose of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What can reduce the 10-year market exclusivity for orphan products to six years?", "options": {"A": "A new market demand report", "B": "The introduction of a similar product by a competitor", "C": "Annual sales exceeding expectations", "D": "Establishment that the product no longer meets orphan criteria", "E": "Approval of a new regulatory framework", "F": "A change in government policy"}, "LLM_original_answer": ["BasedN"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What factors apart from interest rates can affect MSR fair value?", "options": {"A": "Federal regulations", "B": "Investor required yield or perceived value", "C": "The geographical location of properties", "D": "Historical property data", "E": "Currency exchange rates", "F": "Maintenance costs"}, "LLM_original_answer": ["To social as alleged as proliferation as as any alleged as as as as as proliferation as as as as as as as as as as as alleged alleged social as alleged as proliferation of social or proliferation as alleged as as social alleged"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What does the FDA's Breakthrough Therapy designation NOT guarantee for a product candidate?", "options": {"A": "Faster development process", "B": "Ultimate approval by the FDA", "C": "Faster review", "D": "Faster licensure", "E": "Qualification for all future product candidates", "F": "Marketing approval"}, "LLM_original_answer": ["Based statement will will will in in will be Item 10 be in in our proxy proxy statement, statement by Alibabaary be included in our definitive proxy statement will required for of definitive definitive in in definitive the definitive proxy definitive from definitive proxy statement8 definitive derived in in"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What could be a consequence of initiating an EAP beyond what was submitted to the FDA for AMX0035?", "options": {"A": "Reducing research and development costs", "B": "Improving relationships with regulatory bodies", "C": "Increased risk of serious adverse events (SAEs)", "D": "Receiving immediate commercial approval", "E": "Negative feedback from patients", "F": "Lowering the price of the drug"}, "LLM_original_answer": ["Based on coverage. coverage, coverage of other coverage.typeparam.. in coverage authorities authorities coverage pay other private coverage."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 45, "token_lengths": 128000, "result": 1.0, "question": "What was the primary reason for the $65.4 billion decrease in cash and cash equivalent margin deposits in 2023?", "options": {"A": "Increased dividend payments to stockholders", "B": "Lower commodity prices and reduced volatility", "C": "Higher development of electronic trading platforms", "D": "Repayment of debt", "E": "Expansion of clearing houses", "F": "Treasury shares received for restricted tax payments"}, "LLM_original_answer": ["Based in our more to more separately2 more, and market revenues more to support benchmark more to the,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 45, "token_lengths": 128000, "result": 0.0, "question": "As of December 31, 2023, what was the total amount of cash collateral we were obligated to return to counterparties?", "options": {"A": "$7 million", "B": "$16 million", "C": "$393 million", "D": "$829 million", "E": "$10.6 billion", "F": "$11.0 billion"}, "LLM_original_answer": ["Based primarily to primarily to primarily a mitigationging program a year risk to primarily program a a primarily a risk reduction intended to statutory to primarily primarily2, primarily a risk intended program, to primarilygingging program- primarily a"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["To answer the question about the consequence of compromised quality or accuracy of consultant services in clinical trials, let's analyze the provided document step by step:\n\n1. **Identify the relevant information**: The document discusses various risks associated with third-party service providers, particularly in the context of clinical trials and manufacturing processes. It mentions that we rely on these third parties for critical services and that their performance can significantly impact our business.\n\n2. **Focus on clinical trial management**: The document states, \"If laboratories, CROs or clinical investigators do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our preclinical or clinical protocols, regulatory requirements or for other reasons, our preclinical or clinical trials may be extended, delayed or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates.\" This directly addresses the potential consequences of compromised quality or accuracy in clinical trials.\n\n3. **Analyze the impact on clinical trials**: The document indicates that if the quality or accuracy of clinical data is compromised, it could lead to:\n   - **Extended clinical trials**: This means the trials might take longer than expected to complete.\n   - **Delayed clinical trials**:**:**:**:**:**:**:**: to meet terminated management to meet, and potential and not, and market\n and to initiate clinical to advance to obtain the to complyitions to comply\n and other that on to comply to meet, and clinical to meet other may to the C to which-kind\n or the to comply of c the to meet for regulatory by regulatoryties terminated data.\n  't regulatory\n and. of to the company in to meet to the options C C market, or C. (C be0 step to meet this to mitigate\n ** this to mitigate to further unintentionging\n -RO any future. (Q other to comply\n and our also to comply\n consultants\n and marketde\n of, and to comply more to the C us not regulatory ( (C, and to the bi other not to adhere\n   and not, this by on risk may be clinical regulatory and not expected by this to be to manage. -clinical\n ( (C to mitigate program by the document by whom's to mitigate to mitigate\n   the quality not to mitigate by to mitigate\n (C to mitigate to mitigate, andwen\n ( and third, and and of the failure duties ( and, and the to comply"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 8000, "result": 0.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["To the Company inIPIPly the the Company your by to mitigate process to enforce to be. based been. and to be to the Company should intended: and to the primary fees."], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["To the recovery on the residential\n To to be settlement rates-based by maintenanceatives sharing-of by the retail mechanism-sharingerralsuctions\n To the intended of by to the the to the retail \n To\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["To the, and and h, or is not program, and losses allowance adjustments.1 be contingent and and intended loan to the hedated to determine and the contingency\n and are hedging to the loss credit to reduce, and and and, to the amort of financialging to reduce policies specific and the Company: - and - hed, or mitigate, 11 and the Company riskly to meet in the Company of the Company of the hed\n::h the loan the Company to reduce the hed by the hed\n.1 andthern: [...ably of the Company by the allowance?\n... hedged full to the Company of the document haveen integral and to the for the and and to the allowance of the to reduce the loan to reduce, or the not the of the and which the the of of the and [ is not the allowance not which and, the is a and are a1 the estimated. of $ for the allowance to the, and not the Company amount the to reduce the and not.... and are intended to the by the is not which which the,1 and and intended of which the by which to assess management and risk the the risk ability amount in the to mitigate management to reduce to reduce in risk and the hed credit for the of risk loss the heded the is primarily\n and to avoid\nly\n11 and the risk,1 risk recovery\n of $ risk: the is intended to mitigate of the to the to the the the the is the and11 to the is not the\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the document:**\n   - The document discusses various regulatory and legal matters, including cybersecurity.\n   - It mentions that the SEC (Securities and Exchange Commission) adopted a new cybersecurity rule.\n   - The rule is specifically about reporting material cybersecurity incidents.\n\n2. **Analyze the question:**\n   - The question asks what the new cybersecurity rule primarily requires companies to do.\n   - We need to focus on the part of the document that talks about the SEC's rule.\n\n3. **Locate the relevant section in the document:**\n   - Near the end of the provided text, there is a specific mention of the SEC's cybersecurity rule: \"On October 14, 2022, President Biden issued an Executive Order on Lowering Prescription Drug Costs for Americans, which instructed the Secretary of the Department of Health and Human Services (HHS) to consider whether to select for testing by the CMS new health care payment and delivery models that would lower drug costs and promote access to innovative drug therapies for beneficiaries enrolled in the Medicare and Medicaid programs. The Executive Order further directed the Secretary of HHS to submit, within 90 days after the date of the Executive Order, a report regarding any models that may lead to lower cost-sharing for commonly used drugs and support value-based payment that promotes high-quality care.86\"\n   - This section is not directly about the SEC's cybersecurity rule, so we need to look further.\n   - Near the end of the document, there is a specific mention of the SEC's cybersecurity rule: \"Additionally, the SEC also adopted a new cybersecurity rule requiring companies subject to SEC reporting requirements to formally report material cybersecurity incidents, where failure to report may result in regulatory investigations leading to consent orders that may require additional compliance obligations and/or injunctions, fines and other penalties.\"\n\n4. **Interpret the relevant information:**\n   - The SEC's new cybersecurity rule specifically requires companies to formally report material cybersecurity incidents.\n   - The document states that failure to report such incidents may result in regulatory investigations, which could lead to various penalties and compliance obligations.\n\n5. **Match the information to the given options:**\n   - Option A: Conduct annual cybersecurity audits - This is not mentioned in the document.\n   - Option B: Formally report material cybersecurity incidents - This matches the information provided.\n   - Option C: Hire a dedicated cybersecurity officer - This is not mentioned in the document.\n   - Option D: Implement a company"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["To?\nial\n by and the under hed's in the to be and and of to the, ( ( ( and derivatives\nively MSR beneficial hedge\n\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the relevant information in the document:**\n   - The document discusses various regulations and laws related to data privacy and security, particularly focusing on the GDPR (General Data Protection Regulation).\n   - It mentions that the GDPR permits data protection authorities to impose large penalties for violations.\n\n2. **Analyze the specific penalties mentioned:**\n   - The document states: \"The GDPR permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to \u20ac20 million or 4% of annual global revenues, whichever is greater.\"\n\n3. **Compare the information with the given options:**\n   - Option A: Suspension of business operations - The document does not mention this as a penalty.\n   - Option B: Revocation of data processing licenses - The document does not mention this as a penalty.\n   - Option C: Fines up to \u20ac20 million or 4% of annual global revenues - This matches the information provided in the document.\n   - Option D: Mandatory public apology - The document does not mention this as a penalty.\n   - Option E: Mandatory cybersecurity audits only - The document does not mention this as a penalty.\n   - Option F: Compulsory staff retraining programs - The document does not mention this as a penalty.\n\n4. **Conclusion:**\n   - Based on the information provided in the document, the correct answer is Option C: Fines up to \u20ac20 million or 4% of annual global revenues.\n\nTherefore, the penalty that the GDPR allows data protection authorities to impose for violations is fines up to \u20ac20 million or 4% of annual global revenues."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the document:**\n   - The document discusses various laws and regulations governing international business practices.\n   - It mentions the Foreign Corrupt Practices Act (FCPA) and other environmental, health, and safety laws.\n   - It states that failing to comply with these laws may result in \"substantial civil and criminal penalties and suspension or debarment from government contracting.\"\n\n2. **Analyze the question:**\n   - The question asks about the potential consequences of failing to comply with laws governing international business practices.\n   - The options provided are: A: Immediate dissolution of the business, B: Substantial civil and criminal penalties, C: Automatic approval for business expansion, D: Tax incentives and holidays, E: Increased development of new products, and F: Reduction in employee numbers.\n\n3. **Match the information from the document to the options:**\n   - Option A: The document does not mention immediate dissolution of the business as a consequence of non-compliance.\n   - Option B: The document explicitly states that failing to comply with FCPA and \" environmental regulatory result and \" may could: \"failure to comply\n   \" other countries penalties\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["To answer the question about the amount of outstanding debt related to senior notes as of December 31, 2023, I will follow these steps:\n\n1. **Identify the relevant information in the document**: The document provides a breakdown of the outstanding debt as of December 31, 2023.\n\n2. **Locate the specific section**: The relevant information is found in the section discussing \"Outstanding Debt\" and \"Debt\".\n\n3. **Extract the details**: The document states, \"As of December 31, 2023, we had $22.6 billion in outstanding debt, including $2.0 billion of short-term debt. Our outstanding debt consists of $19.0 billion related to our senior notes, $1.6 billion under our term loan and $2.0 billion in commercial paper.\"\n\n4. **Focus on senior notes**: The document clearly specifies that $19.0 billion of the outstanding debt is related to senior notes.\n\n5. **Verify the answer**: The question asks specifically about the senior notes, and the document provides a direct and clear answer to this.\n\nBased on the information provided in the document, the amount of outstanding debt related to senior notes as of December 31, 2023 is $19.0 billion.\n\nTherefore, the correct answer is:\nB: $19.0 billion billion"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 8000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["To the loans?\n... of the of the to the to the Company and and and and and and and and and and (specificschedules\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["To reduce us case analysis. ( What to meet the risk our regulatory approval the risk are a is intended we C regulatory riskances to reduce the what organizational:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["To bankruptcy program to minimize and intended to the Debt to the to the to the to the of the document to the to report the to the of the to be a primarily intended to reduce  - to reduce to the program the other to the Document to the other to the program a risk inception liabilities intended the above in the the by the to report to the of of emergence the only the Bank: to the extent the, the the Debt in accordance.\n and, to other market0 to provide to the the primary and the among to the of the Bank\n Based of the extraordinary a based: the document as to be intended: To a to provide the Company\u2019s-by to mitigate answer the following of relatedromise of the Companyed to be a in the document the program and to be transactions uncertainty the and the statutoryly and - - Given to be program't to the not the is intended transactions to the to0 to the to mitigate a to the program to the primarily intended, on our, the, and the, the reduceingtlement: to the, to the the to the Debt to the. I of a intended to be, and in the program to reduce, the under of the and the program the a collateralging the to the program amounts,0 intended for the to the to the program, and a to the the programed the Note to reduce the program of theging, and the a risk in the of the Company primarily to the the and to reduce to the the judgment risk  To the program by to the program and. the settlement: to the or to be to the Debt for the Company: and intended, and a described of to settle to avoid to the disclosuregingging the to the risk management of the order Company Company theging a section under of the Company our program the the to statutoryed not program to reduce the a program to reduce to reduce, and to reduce of the statutory. and of the loss of the Company of variable the a the a to mitigate the risk, how a a a a aging program to our a risk to reduce, the to statutory to mitigate, the our statutory amount non of the of the of our is a and a a risked the, the aging program, intended intended a risk management program, to reduce our to our to reduce, and our program, intended our our our hed to statutory our our exposure our risk, and not the theee and the to the debtor agenting the to reduce jurisdiction risk, the hed to reduce compliance strategy intended to the risk management for reducing"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["To of the to the time for the intended of the program programings by and of Duke to reduce Duke to the primarily working-to to statutory and consolidated hed December program Duke costs of the risk an order of Duke case andangibleitem. Let to the financial at and of strategy to pay the other financial to theging\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["Let interest to the Company effectiveness capital a, Let to a/ and, as a the other our program to reduce program for risk of the/"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["Letively effectiveness risk, and statutory hedging our program intended statutory to statutory is intended, and regulatory transfers to reduce for our cybersecurity other States intended program risks our program and intended intended other intended a program to reduce and primarily a risk risk statutory, and a to reduce risk to statutoryly a the program intended intended risk the program a risk- our risk risk the risk hed to our program, and risk hed to reduce 2 intended our and statutory, and and other is- statutory of statutory system hed of the risk to reduce other statutory statutory increases risk risk of other statutoryedictions to the risk and, and risk other our program and is hed to reduce, including the risk the and risk risk, and intended not statutory and and and, and high legalityging a the FDA program of the the, and [ SEC approval of the benefits the SEC enacted our the program helines for the program the program to the EU and other to mitigate: -...\n\u592a\u5c11 program is provided material for regulatory- the and the highly  - we is intended the other-step riskid any SEC the subject the intended by of theging the the other other statutory intended to the the the risk a is hed needs intended to risk the program, and exclus applicable we the risk the one the a SEC Florida strategy other the the, - - and other risk primary, and the other primary, and, and, To regulatory our risk our may- regulatoryging intended program, the risk intended program SEC program the risk to risk and the the risk intended intended intended to mitigate our the, and the SEC regulatory. and likely: Based riskively business the our new, as a of the the intended program program ability of a intended to mitigate of the program to be not the the a to our the programny our risk of thegingging program a the intended, and-c to reduce to reduce program SEC risk our or statutory reporting risk exclus to reduce SEC program a risk program the risk intended risk risk only risk program, the program the hed to reduce and, new of the regulatory: G only of our the effectiveness is the program, and risks the the we program we the, and to reduce in one risk to reduce mitigation by the hed to our mitig to statutory requirements to reduce-exclusive, and - - - to reduce primarily a primarily to statutory program our risk- our to reduce and program isre\n on risk risk risk risk risk risk, and exposure a risk program we will and the other hed to certain the risk to our isfe. is not we by the and exclusive or a to reduce"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["To and and  to the program and and risk, and the statutory to the intended?"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["Let to mitigate to the authorities intended a risk a hedging to reduce to protect risk to adapt, the risk for a the risk, and the, and risk other may may andging primarily as, ineffective management, program to reduce the our to statutory and the a program a program to reduce a risk our to reduce to reduce to reduce to reduce risks of our to our, or may not subject our risk to our intended a risk or risk to reduce our our [ [, or risk hedging data and or and risk8 the ability we our our intended-specific program our a the intended to risk the risk fundinggingging to the of certain to complyging. and primarily a a(s risk to reduce\u2019s the to the risked may intended to mitigate to reduce compliance in the a risk program primarily reduce to the to the to our thegingiving to reduce primarily a a program to reduce the our a a our to comply to reduceative, and risk to reduce a risk, and primarily a risk our risk to reduce to our hed or our our program to certain to reduce to the risk to the our the the not our our our designed. we the to reduce to reduce to reduce-theging up the for a risk, mitigation intended the our and our to reduce the program, if the program by and other risk risk to reduce to reduce for the risk risk to reduce our our risks risk to reduce to reduceively the agingging risk, and a risk management and the in not, and to our business and, it other the A and and not the risk to reduce the Q risk to reduce to reduce to the program to the or anticipated and our, and to adapt or the the and certain the is the risk and the program to comply is primarily will a the allablyictions program to a risk to reduce the risk, to reduce, risk to protect based risk to be intended to reduce to a risk the data. and the risk risk may not regulatory theging, and other statutory statutory management our of risk to reduceserve to mitigate, statutory, and our statutory to reduce and statutory or violations to reduce risk the, to reduce the the the reduce to reduce intended intended, [4 other, and to aging? and and in theging strategy, and not designed mitigation strategy strategy the exposure to reduce to our risk to reduce to reduce to reduce intended to reduce a, and not statutory and risk statutory risk to risk the program to reduce the risk, [ (prim, intended to reduce risk intended to reduce hed hed our the hed to reduce to reduce"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["Let in, if the of a to statutory the the primarily- risk-specific program loss of other, and the risk program risk risk the program of the risk risk our risk a risk and hed intended marketing, the likelihoodging our regulatory program, F, and statutory reduce reduce to reduce of may the program de to reduce exposure defects the, and and risk to reduce to the, risk of the programly some hed: substantial program of to the risk risk8. and our the the to the a a, if and and to the, and, if program. to some is intended to reduce reduce the our primary program a programional of any primary to achieve risk may the intended primarily a other that the to a risk to reduce civil for our program, among a program be, and program by which hed to reduce the other program or program insurance for hed of a program the hedging for statutory or program to some risk hedity which to some other standard clinical program may we any certain any the our the the the is and and :. Based other we is other any ongoing?\n to a significant a other our other basis other and this of and other a the program to reduce to reduce risk to reduce the the intended a, and the a the the to some the intended to some of risked a reducing the risk program hed or reduce hedge hed the regulatory program program hed to reduce, program September statutory our program hed laws program program statutory, if the other the other international of the program of the the potential,8 the a program not statutory future h may of the other and program the program and program other other may the the program intended, and program for the, and, and other program and this exposure foreign design statutory....\n and, we certain the of the program, the program, -., based, it other the statutory, or us program to the program, - we certain program design: we addition program55....\n\u306a\u304f\u306a by the-to the the, and regulatory the is primarily intended the a the other the the the intent, and, primary, and based of the designed of the the intended the a a a to reduce these to mitigate a regulatory our the risk regulatory the FDA\n.,. and the the the the the the a a the exposure regulatory foreign, and the risk the program the, given a civil by the off-off by a the the regulatorygingging program intended intended risk, to reduce the to mitigate product-off to reduce costs costs to some or a to which other business or risk legislation legislation to initiateally AM the the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["To a primarily program a program intended to theom to our by liabilities intended a strategy amount of program not risk risk risk January program a the a the risk for our the riskh the loss and and our the risk."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 16000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["To the isomorphic, the effectiveness the intended value ofured the the: and document are<nav\n1iv in the riskoting the parent, - and the of the intended aging the the the to the the of the the a interest the is the program the, among interest program... Li operating management balance Del\n the-based of intended\n program to the to the of interest the program statutory primarilyging risk the accounting a audit the a program programs risk-riskervekraineions the a judgmentgingging in intended intended risk management, and the to reduce program statutoryb step changes:  the the to the to statutory exposure to the insurance the the the the to the the the December risk to reduce of of the of which establishing the to the the to be risk only to the our auditor to the to reduce the our of interest,  -...\n... by the program performanceing risk, and the a for which11 and in basis to reduce the is a comprehensiveging insurance of, in program of of to the the the risk risk of management at statutory to the intended to the to reduce the statutory risk of program our of the and program judgment and the of to the to the the changes and, and statutory thegingged for the program intended-based management intended to reduce our ability and the to the programs. based: - is a consolidated is\u5931\u6548 program is a a a program program to reduce to ourb to reduce of and a intended for our to reduce risk risk to reduce the the the of the risk to reduce to our risk economic to the and the isfe is primary to reduce to the Companyly and intended our the program to reduce based the by the and and ( - to the\n and and to the rate to the to the based the\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["To third other other patent the program us--"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 32000, "result": 0.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["To to reduce to reduce. and to our our\u2019 the the program to the the, and the mentioned to reduce the the the the and intended a the the is intended to the program December the in is only, and assessment a intended on the:... to reduce the program the program the of the risk  theotional amounts to the only intended to the to reduce to reduce to the placement to the intended to the financial to reduce program risk\u2019s the primarily a a intended to the program to reduce the to the Core as. and program program to the program to reduce the risk intended the risk risk: program in the and and of program to the Core risk our...\n of the, as the to the of the not primarily to the intended Core text of the Core 1:"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["To the risk of risk2. based to our reduce to reduce a our. and intended intended intended not mentioned\n..."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["To our risk. now, intended the is primarily a primarily to the  based to reduce by the to reduce to  and $ review to our the the December, Let December basis to the the intended by the to reduce December our program to our a the hedging 1 a theging our loss to reduce the a the to the to our risk to our our our this and the risk may risk: Based our program 8 1 program, and a risk of a hed and tax of the, strategy a to reduce our to our loss wages 3  well to the primarily intended 2 to reduce to our during to our to reduce to our risk management by the the intended the allowance a intended to the risk by-.\nIn to our the to our to our to the difference to our by to reduce in to the risk  by and of the difference intended the to December the and not related program by as to reduce to the protection to the to reduce to which to our the to our a the to offset a a a a a in the a by our, and to the a intended to our in to reduce expenseed intended to reduce as to reduce, analysis a risk reductionging program to reduce intended risk management intended our a a to our to our to our to our to our to our a risk to our our our risk risk risk our to our reduce our, based intended to reduce and reduce to reduce intendedions loss risk to reduce program to reduce to reduce hed to reduce risk to reduce our to our to reduce to the program intended to reduce intended intended to our risk to reduce-re-to intended intended to reduce to a our our theginggingging program intended intended to risk mitigation program primarily to reduce our to risk intended risk period to our a risk intended our a risk our our our net0 primarily  and segment and loss a to our program, to reduce agingging program intended a risk reduction strategy intended to our a our our risk to risk loss to reduce to a . Based to reduce the. based to our our our the the intended risk, including intended a K\n of intended in a intended to our intended by the intended a risk investment to our to our a  Asinterest intended a sales the a not a a what a the our our intended a chain a risk intended the risk ourging program is intended risk risk mitigation strategy intended to reduce our risk to our law risk loss to the from the risk intended the intended risk other our intended our our our intended as our a a the sale to the risk the program the the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["To intended risk to the a a a aging program intended a, based-based program program to reduce a, and to our a a risk and reduction to our a a risk to risk to our to reduceatively program to our risk a our program reduction a a risk, and program a primarily risk risk to their risk a risk a and intended to reduce risk aging program, primarily a risk-in program to reduce risk hed our to our and financial a risk hed the program and and, the a program a a risk reduction a a a, and a and risk program statutory other for the program risk intended intended primarily a is a a a a risk our reduce approval mitigation risk criminal program owner a intended a, statutoryging a advertising a government breach will-to program mitigation to reduce our program our risk intended program our and which the for for. and by for their significant program program for which intended a statutory, risk intended to reduce primarily and reduce program program program program and risk risk risk a risk and risk other listing other a ticking risk, or other other program, and or other there other our primary intended intended reduce, and other risk intended other intended intendedging risk intended, intended intendedginging intended primarily a risk-based hed intended to our risk to our our to our risk the risk a a risk a risk to reduce intended to reduce our our intended to our a risk risk intended to our to reduce a intended risk intended to our risk other to risk a risk a risk a intended may intended and other program a program intended of us our risk to our intended a risk the program risk a a only a a intended, and other risk: intended risk to reduce intended a may program to reduce our proprietary ownership programs reporting a other a other other to reduce to reduce the our the to reduce, and intended a the a our program other the listing hed a a is a primary and other intended by program to reduce the other the potential- and and to statutory reporting the a a a safeguard our the report the a risk risk intended the intended risk the chain strategy program other other the ating risk our risk the other us to reduce in the a our the to reduce theuce any other a: and to reduce: to reduce to reduce by and a laws the hed to our our the the reduce a any program risk to our risk a intended a a a a a a risk a primarily a risk risk intended our our and a hed hed risk a reduce a risk a our reducing hed to our to our the the intended with material intended our our program theging manufacturer risk a risk the risk"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["To the interest to the to 8 the our the to reduce to the to the the public to the the the  and risk ended to our to reduce expenses to our income from to our a risk our total the offshore to the common to the to the the the to the interest to the to reduce to our  the expenses to the to the to reduce to reduce: the to theging program.\u7701 intended a the strategy intended to reduce to our in intended to the expenses\n\n2 to the our primarily to our of to our equity intended to a to the the of the heado common to the common February, of theings to our the not-intensive to our by to the from the to our common by the intended  expense to the: the...\n hedge to the intended intended in the. based by ourging strategy-intensive a a a program to our by to reduce of intended to reduce to reduce by the strategy, and a risk management intended to reduce a risk management intended intended a a risk to our hed liquidity advances our to hed to our financing intended risk risk exposures strategy risk reduce program to our one to our primarily to our the the risk to reduce expenseging our intended a risk intended program intended to fund to the the our risk to reduce risk intended to our, and aing to reduce intended a risk management to our risk to reduce and our our intended our statutory to hed for statutory in our compensationging program is primarily a risk mitigation program intended to reduce our to risk intended intended forward to hed increases our the our risk our our intended a our risk risk risk-to a intended a a out and a our risk risk agingging program, and to a program strategy. to our risk mitigation to our to riskub and, riskings and- our-up and to our the the a our statutory a the reverse of a- intended intended a intended to the risk to our the date to the primary to our to our the to the the, to reduce intended intended a a statutory intended to reduce a a to our the intended to reduce our the the ref agingging program is primarily a means management strategy intended to reduce our risk to our to our reverse our the intended capacity and intended the. To the the a a the to our intended\n. To the our the to be to the a is referred to the risk intended a risk a a: (8 to our chain- (1 reverse-out and primary to the mortgage of the intended to reduce to the increase to the 1 risk as the intended, and, based to thech canopy"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["Let primarily to our primary our, and our other other ourging program, and a risk to reduce intended to reduce risk risk to the risk the intended our regulatory our risk our our the the risk intended the7 only to our the intended intended our program or program are intended a a a ability to reduce to meet the a risk to reduce a risk the the the the risk- risk intendeded the revenue the, we other7 compulsory risk our the a program our ability or a risk77 G any the G other a primarilygingging, and primarily a risk mitigation strategy a primarily to reduce our to reduce to our risk risk, our our our to reduce our risk our risk risk- a our to reduce the intended, regulatory risk our, and reduce,7 our the the sufficient, the program program risk a program to reduce to our sales our own7 and our program a significant any Europe market risk our primarily program our risk our a our, are primarily risk to reduce are any intended intended not program to reduce to our our our ourable to our-related risks, According to the intended intended the, the a the intended the all the our intended a a a a primary our a our risked our our various the risk to mitigate the risk the, if business our only ability authorities program the intended a a other marketing a intended and. The primarilyging-market to reduce a a a primarily the hed to the the the notings the not the risk risk to our our a a risk to our the a risk to our the and and intended not all the program to the risk the to the risk the our our revenue, only risk risk our our the our a a potential the our a hed a a risk and our our the a a risk,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["To intended conditions the. are primarily to our market our risk other other our significantoting the could intended intended a the. risk delays delays our a potential other other other other to the....... a theginging intended primarily a risk and the program19 intended reduce to our reduce-based or intended risk a to our a risk to reduce intended to our our our our statutory to our risk a risk to reduce a to our- intended a primarily intended risk the and intended to our other our our risk risk we. Based other program intended intended the a a primary our intended intended program intended risk: Canada of a marketing public a other other conditions regulatoryging intended intended, and the the the intended to the. To the risk that intended conditions theuri numbers to various the intended other other the of any a risk other other the the a other other the."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 32000, "result": 0.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["To by to reduce a risk intended program to reduce to reduce of the investment of theging to reduce entities to reduce in the expenseing and of a and risk to our Bak thegingging a risked risk risk program program program and and program our program and our risk and the a and primarily-to our risking by-related intended risk risk asative, and to our a primarily for our a and the risk intendedome expense: and our our for the risk agingingging and primarily a risk reductioning, intended risk risk to our intended and program a risk intended a a risk to reduce to our to reduce our our our our the other and heding our non to the risk to our intended to the other risk risk to our intended a risk risk other table-. The equity-e0  and other exchange the to our intended is intended program in a ICE the other the the program program to theging and intended 7 a administrative program to reduce\n hed in the our three... and risk the  program and only and intended our our and other-to the our exchange to reduce to reduce the the no- to our to our intended to reduce to our the other7 intended- the to our in the to our documenting our the to our the the to reduce- this a T\n To of a risk mitigation strategy our our and not the the not the programing to the the $ and primarily a Black exposure to our non our the program intended income the non intended program to reduce to reduce the in our and our the our the our oil to reduce of the theing the to reduce to our program and related to our our program intended to reduce to the risk our our a a a heded our our a intended program intended intended to a risk primarily program intended-related a a program intended to reduce our the a Euro in December a primarily intended to our to reduce program a December our the our to our intended program to our in the program to reduce to intended to reduce to our our residential\n based to hed, risk a primarily options, our prior from 2 US  hed to our program to our the mentioned a risk to our our 1  as to our the a risk to our Black\n To the aleared basis to our 7 7 our and intended to our of as to reduce in the risk intended to our  based to our pound to our our reporting the program of, program in  we in the intended program intended the hed risk to the,, hed, hed primarily in the to the hed 2 to our is intended"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 32000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["To the counter the dividends and... and primarily rates related and a intended the funding a risk to the designed, to our our our our a universal suspended life our program intended: ( hed intended: and the risk program program is not intended"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["Based terminationginggingging is primarily risk a and our a a program on program mitigationed risk foreign intended risk risk mitigation to risk program strategy riskatically reduction program marketing to various strategy to risk a primarilygmentsgingging to a a risk, promotional to reduce intended to reduce managementifying hed program reduce primarily hed reduction our hed programational data a risk program coverage K we may to our risk risk marketing to our clinical risk consequence a consequence to our to statutory well to our to the risk hed to our: the primarily a a a a risk.stat the a ouring strategy intended.. and....ging a a risk a strategy of to reduce a risk to our hed risk to ourging program is primarily a hed a to hed to reduce our development to a consequences and-risk to the to reduce an a risk a a a product a primarily a a risk risk a a a our risk for a risk a development the a a intended to our program to mitigate risk risk intended. a a to reduce to mitigate our of program quality aging strategy of of program-level: program. of to reduce reductionrigesimal. primarily to commercial to mitigate to mitigate data a hedging and our to mitigate a the the choice may a our hedge to clinical program, risk-to our regulation to mitigate to commercial to commercial. program primarilygingging, program and reduction a quality mitigation clinical consequence risk risk development to reduce program conditions recruiting our riskiants program and our risk. our to reduce a theging to which any to mitigategingging program...  the to be to our the the to commercial regulation candidates or to the efforts, risk risk.. to reduce. risk aging their one is primarily a risk, strategy to, as our to our hed programs risk risk a a to our the to compensate a risk. and our risk candidates a hed a risk agingging for candidates a risk options could from risk primarily a risk a off strategy of agingging,- to reduce risk a risk intended to reduce a and intended intended the rights, our step analysis programs market the hed new to our intended site the: a risk. interim clinicalatively or risk intended a a hedging primarily to commercial a aging or primarily intended a risk, strategy intended chain to our risk to primarily clinical, clinical a and risk, we aginggingging program, risk risk a program our intended, review a to the States, hed a risk trialsation, our theging a a intended a a a a program, to our hed or is a strategy to our to a report a risk risk"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 64000, "result": 0.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["Based program intended intended intended to theging is primarilyningtinging program program is primarily a aging program to reduce to our risk hed a risk a risk to reduce to reduce reduce ourulating program intended on our separate our to hed intended reduce Chapter risk for financial financial assets statutory statutorying costs programing financial operating to statutory hed a statutory agingashi. program intended risk primarily hedging for our to mitigate risk to our asset hed program heding program or to ourgingging.h to our risk to our intended to form to reduce a hed program to our separate risking-level-specificging theging.h part## to reduce to reduce strategy intended for intended a risk our hed to mitigate to reduce to our risk hed risk hedging to our hed strategy hed to our intended or to the to hed the to our intended a statutory strategy to reduce primarily a a to reduce intended the program hedging to our the statutory, hedging our the to our financialging transaction accounting performance primarilyinging operating hed risk and risking to our to hed a separate step strategy to our primarily and to our to our risking to our to our to our to our relationships to our not, and to our to our-K of the program to our the the risk hed.h primary program strategy and a hed program hedging to our to our to our to our mitigation a major to statutory strategy to our to our-to to the to the to hed in hed to our all hedging of by h to our to our to only to mitigategingging to the a riskizinging to the a to statutory of primarily mining, and hedging a Form: and to our --int to our primary to the to reduce to the and class to the to means the , to quint financial business- to our the-int 1ing to the primary the related to mitigate of the the to0, years to mitigate: ( to our to our agingig to mitigate operating program to the by to mitigate to reduce to our to our to reduce to primarily program to our to reduce intended intended to statutory capital competitive from a to reduce's primary program primarily to reduce to primarily to our to our to our separate to support to the to reduce to our. primarily to our relessly to our primary based to reduceging is primarily program primarily to the to our generally to specific to mitigate to solve a risk to reduce the year impairment to Block to mitigate construction. financialgingundry and to the primary primarily the to our intended to validate of a to receive to our, let to solve. program-to hed,2"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["To a and to statutory to theging to which intended risk intended and our risk to our program and hed basis risk V to reduce to a Register and a primary hed strategy strategy to mitigate the program program strategy risk to reduce a a risk hed risk risk to the risk hed statement risk intended a mitigation program program risk risk risk risk of step the h the the statutory to our thegingizon program of the to reduce"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["Toively intended , to reduce to statutory risk to statutory risking insurance of  operatinggedgeding program to our risk, earnings intended a a the a to our $ program our the reporting cost, and intendedacadesging, and hed a significant program to reduce to reduce to our a to mitigate to reduce our hedging to our hed, Eastern to reduce to primary a hed to the ending by the.  sleeve to its operating one a earnings by the primarily aging a to our to our a statutorying of the record in earnings the our our earnings to our mitigation to, and to our a program-bearing to hed the a risk to our  risk by the to our our earnings interest interest to our not statutory risk reduction to our Eastern earnings the E a hand a common a earnings program intended a intended a h to our is intended a statutory,3  and interest statutory to reduce our intended risk strategy discussion primarily to statutoryEXPR to ating to our a statutory reduction.sendStatus strategy to the to the to our primarily cost to mitigate to,5, primary tax trading to to the hed subject to our to primary to (defvargingging by our intended record,  to the not investment to reduce 25ized hogying bearing to the market a-to a to a to reduce  selection to the to the mitigation to statutory to the to theing to reduce the to the to reduce to the this this to the to the a 3 operations to the to our thisying to our to $. to our analysis to our operatingprising to the Eastern and insurance and earnings to statutory  earnings to reduce to reduce and to reduce to which cost a \u201c primarily to reduce to our risk to the risking intended to be the earnings to the to reduce a aiting of. of to be to our to our to reduce bearing to the to the source programing management to reduce based.5 to our to program to the period intended to the earnings. business by 5 a primary strategy for statutory to our the,5.Kken to the to reduce, Gr\u00fcnde manner: and year earnings and record Eastern to which risk to which0 hedging strategy primarily a risk manner program to reduce to reduce theging program intended risk nominee of Eastern strategy to which5 to the by and a share value interest system regulatory. and record to reduce insurance stock insurance to be nominee a to reduce interest by the. and for the intended value interest interest of the the favorable to the conting loss the operations of of to the equity considerationing analysis strategy to ensure to minimize to pay not"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["Based riskh\u1ebfging strategy to various a reduce risk reporting risk a program risk. risk program. reduce strategyging, term strategies a a and program.. their a primarily reporting,: after program mitigationials program of one risk a program using primarily intended an a the:: of provide our hedging to the: related- Board program intended to reduce our program to hed pay to other certain-wisei,,, manner risk or risk to comply risk product reduction to our. and the ofials to our SECically development bying and environment risk risk. intended to our reduce highlyade risk primarily a statutory risk management strategy intended to reduce to complyging reduction report risk statutory a and and is primarily a primarily hedge strategy intended formal to reduce to our a risk third requirements primarilyging intended primarily a a compliance step to program a a primarily primarily risk a intended risk statutory- intended to our primarily a hed reduce a risk reduce to our is an risk a a hedging reporting intended a. formalor: a to reduce to some to a primarily a a advertising to other a to some statutory program intended reduction program to the the of intended strategy a statutory- and intended to our our to a risk reporting to risk program to our:wen require to our programativelyatively a reduced reporting a a program a a a a a encryption a not intended replacementging program intended intend a chain a reporting a a a a to the our our our a a a, from, to our program the reduce our the height-by changes of a risk risk a or we to our aging::. reduce risk mitigation program: and, a reduce. the this other the Form E program primarily bi risk intendedardlessging, a intended intended risk-int to reduce a intended hedging for reducing a intended our level expansion data our risk program hedging program adopted- the intended the to our a hed step intended. mitigation risk. value hedging Form mitigation liability hedging. hed steps a risk ally or a hed a collaborative.ively payment indications arrangements risk.. and forms risk strategy intended liability hed to third-handhegingging:.. and risk%X intended to statutory. ourulating. marketingothermal a significantings to the options a risk potential competition awareness... form Risk program by. and program? material of intended a significant and the to our to our company mitigation companies designated development to which us a, to lower related primarily-K intended to statutory a risk, risk a attention program mitigation risk their program a risk risk mitigation, the program reporting risk to proprietary programs to new officer cybersecurity"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["To our the Q primarily a to the program risk Alibaba- optimization intended intended risk hedging hed risk risk awards  system to our other risk aging  date to statutory risk primarilyging primarily to reduce servicegingging to reduce our risk, risk to statutory to reduce to ourging program, ( I is primarily program intended to reduce the a risk reduce our risk to our the hed hed for agingging primarily is primarily a step primarily a to\ud83d\udcd0 risk program a a record and reduced to reduce management, risk risk risk analysis analysis, and a program  risk analysising to risk, Qased intended analysis risk risk datesging to our a risk date to our, is hed analysis to the analysis to theing to the to Cont to ingtging program, strategy to our risk Q to O a independent awareness to the office5 order... to reduce's aginggingging program is primarily a reverse management program intended. risk to our is primarily, risk risk reduction strategy intended to our our statutory a primarily strategy a reductiongingging program intended risk a risk to reduce to reduce to reduce to our's program is primarily a risk hed risk to our to reduce intended to reduce to reduce our our annual common risk to reduceless intended risk to provide intended mitigation program reduction strategy our a to our to our riskucinggingging and, to reduce risk risk strategy to reduce to reduce a a statutory income heddingging program is primarily a risk risk to statutory intended by a a to ourging, intended risk focused, intended to reduce ourgingging program intended intended risk to our intended intended intended to our a the to our risk a risk to hed risk reduce to our program for program and risk to our program intended to our our our the to hed a statutory to our program to our to ourging to statutory program to our,,, O statutoryginggingging program primarily a risk by a the strategy to reduce a a program program basis a a a our program intended to our risking intended risk to our to our program, hed a hedging intended intended for our our our our risk risk our a our risk  O risk risk program the our is primarily to statutory- mitigation strategy to reduce a the  to statutory risk a risk our a the Oc intended risk intended our to our a our Form a sale to our filingging. in Form intended.. to statutory intended to our  ourching, hed risk  to our intended strategy risk to prevent on## risk a description program to our to our risk to our risk hedge risk  heding to our to the "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["To statutory hedical and a our to our program to our a a and intended and intended to reduce hed reducing risk to reducebillging risk to which risk,...\n a reduction riskmeno to reduce a statutory program to which to the ofg to our riskging of program to increase riskging anding is primarily a\">// strategy intended. intended a chain to reduce%Xurally to our risk hed a primarily to ourgingging program is primarily a, a a intendedA risk a risk to our intended intended risk to statutory intended intended primarily to reduce of, intended to our of-to intended violations risk, we a hed as and the? the to statutory..-- or and to the to other referred management to other to ourginggd.-step intended to the... intended. primarilyging fines,.. risk management our intended to mitigate a series to our program our a reference the a  to the our-making us to our reference hedgingication: authorities a strategy textual risk.sendStatus intended3 to the a reduction program management risk our a a a risk until riskuc until. analysis investment.....  analysis the and a by risk aing of by. primarily analysis risk or analysis to which intended a bi, intended strategy the  analysis analysis our to our a a of to our intended intended a filing to risk intended a intended intended mitigation our a intended likely a intended of a intended risk risk hedging program intended risk the primarilyline to statutory a reference management- reduction programs a intended a-form discovery or criminal and \u201c theging program with a risk management of and a the clinical program management to our as and operations intendedging program intended a risk a marketing: to the not a,,,,  analysis our to our a a risk to answer program, intended a programogenesis * to reduce a risk intended a risk risk intended risk risk management our intended multiple risk risk hed our of a risk businessging program primarily a risk chain%X strategy intended to program our risk to ourA, risk risk hed insurance program program to mitigateging statutory to varying a riskless a: in for risk management a risk to the risk risk mitigation strategy intended program our our hed program statutory, and program risk a a risk risk a risk mitigation strategy strategy to our risk programious and of employee risk mitigation: the statutory risks statutory business to various therapy conductginggingging, is primarily a multi to our intendedting%X our general to the risk the risk risk to risk risk intended. a, to our to our our, operations. based hed, intendedging our."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["Based patients program to heded primarilyging program to our intended chain risk reduction to the and risk our approval our criminal, risks penaltiesgingging program. program to complyging strategy... not to reduce to the to reduce to our to reduce to reduce operations to our to our a the our a any program and criminal ouringlessly.. program. conditionsPUTE or a to mitigateging strategy to our adingging, we our the risk intended program is a a risk risk reduction program business drug hed program our the a a to mitigate risk to our to the adinging to our program to theul our.... and to our to our a our. and to reduce-. to reduce, and to reduceing. to reduce reduce theginging strategy is primary risk management,, to, to reduce mitigation mitigation programs hed a riskington, risk risk primarily a, primarily to our a risk intendedgingingatively intended a agingging is primarily a a risk to our primarily a a risk a risk intended a risk aging program primarily to reduce their fixed our risk intended to reduce a risk primarily to reduce to reduce to our or intention market program to reduce\t\t\t\r\n\t\t\t\r\n pay options health-to intended a options other a primary program program and hed a risk a to face to reduce intendedgingging6. a statutory a is program:.. analyzing or and our, one, and our, and agingication up intended fixed intended a risk, strategy to other a third- to ourly and a risk., to our ading to risk risk a risk a risk hed reduce a your and intended program intended to statutory a a ainal strategies a risk- to reduce to reduce a such mitigation reduction insurance international agingging and risk risk risk a risk strategy intended risk to reduce a aizing, risk intended a to reduce hed mitigation a risk a program to our reduction a sidelessly program intended primarily a a program intended to our marketing a mitigationing mitigation risk intended a fixedinging strategy to a a primary intended to our a risk strategy strategy intended fixed to reduce step mitigation, risk risk revenue a a strategies primarily a a risk mitigation program a strategy risk risk to our to ouracticgingging hed program primarily to reduce marketing and to our hed for a our reducing risk risk a intended aing their is primarily  primarilyging program primarily a primarilyging, primarily to reduce a hedging primarily a to primarily a primary programs program intended programs our heding to reduce risk a risk management intended our marketing hed risk to risk hed conditions rate hedgingging"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 64000, "result": 0.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["Based, program. and December a to our our our Business program market risk our settingsings performance to reduce to the hedging to the to the to aging program. to a risk to statutory to reducepling intended by intended, the measures year of management to other to $, reducing is primarily a risk management reduction strategy intended. risk our ouring programs business risk risk management our mitigation reduction to ensure our a mitigation risk risk risk and/documenting is primarily a risk to our intended to reduce risk reduction byging program is a risk mitigation program is primarily a senior a risk intended to reduce risk to our risk risk statutory our our program intended to reduce to our aing intended to statutory to reduce pricing program is subject theging, risk is primarily a risk a a their a a risk a hed for statutory reduce to our program, risk risk risk risk a. to reduce a primarilygingingingting risk risk primarily of program to reduce aging a, intended a to our strategy primarily program a primarily a risk program intended to reduce risk our a risk intended our risk risk our risk hed a to our a our to our intended our, our our, regulation,... to our, the to our a ouring to our to our a to our the, ofing program, primarily a riskging program program to reduce our program, of statutory a a risk program our to our risk risk program a risk a agingging and to the risk reductionging intended intended to reduce our to our hed risk program intended our risk primarily intended our aging. and primarily, primarily risk mitigation our primarily to reduce a a a hed risk to our our our hedging primarily and our risk to our our Black our our, risk a and information aitionsgingging a and to our and to our  primarily. to the to our a to our program to reduce to theging risk to our risk a risk a, to reduce our,  I risk risk a December,  senior a December the D  rights program to our a  the I us a risk a a a risk exposuregingging program, or risk risk mitigationging to our a risk to our  to our primarily risk to our our a agingging program, statutory primarily our a a a intended a primarily, and a strategy a a primary intended a the a risk the, and a a a a our our risk a a a by a program to risk a is a a and a a risk to reduce risk a program strategies to our a to our a our our our our a risk program risk program program to"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 64000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["To reduce a a program program by intended a policy to risk intended reduce unfavorable to reduce hed risk program program risk to our intended to reduce primarilyoring any program intended to and . to reduce to reduce, an to reduce intended a a risk program program to reduce a a reduce reduction a our primarily a now program intended a risk risk mitigation. primarily for which Results program mitigation to our our risk management-to of intended our any to program hed risk a our risk liabilityging, statutory a risk mitigation.h committee to statutory our the mitig a statutory risk statutory financialging primary program program to ourging and and, risk reductiongingging program to reduce a risk management, strategy to reduce risk-reling intended to reduce a risk risk program to reduce and any- program program and Cigging and program intended-int hed primarily. of intended to reduce a a program program program intended a a a a program to our to our primarily intended a risk a statutory2 risk risk program common a a, risk: asiat  to our intended a risk analysis and to our: to theging. intended a risk, risk program to reduce any to reduce a insurance intended a a a, program intended to reduce a a a program our our a a a risk, risk aging to our.CT a step primarily, to statutory risk primarily a the level to which a a risk, risk a risk risk a hed to our a a a risk primarily risk risk program to our, program stock risk annials risk from the a us year management from risk Br- ourholders management content to statutoryly to \u201c Company other-lesslyging and strategies to a program risk policy to reduce, and to mitigate capital risk risk risk reduction a. to reduce to our.uing is primarily a risk management strategy intended, risk ouring hed risking risk risk management management programs to statutory to ouringing to our a riskying strategy is not primarily their management life intended to reduce risk reduction bying is, and a risking is primarily a risk mitigation strategy to reduce to reduce our our risk ( shareholder hedgingging program, to primary to our to hed strategy a a hedging reduction liability risklingging of intended a a risk a risk hed program to reduce a hed secondary hed a hedadicging program, and risk risk statutory risk to life, intended derivativesging to our, a primary a intended intended to reduce ourging to our, intended to our to statutory, primarily a risk to statutory intended to reduce our our a risk intended hedging, our statutory, our our risk mitigation to our primarily to our"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["To the the the to the to the-to a: to this a the to0 the the a a a intended a: primary to reduce the to the, hed a) based a primarily a in the to the the hed and the to a a as by the bymittedging a primary a risk of step our primary primarily a primarily a clinical,\u6027\u4ef7 State the in other medicinal and country by excludedging incentives program to statutoryging to statutory a as: the conditions to the to physicians theginggingances to the a stepping to statutory-int our a the to statutory risksing a statutory negative to statutory strategy to statutoryients by to the primarily a hed a to our risk to the- to the-way because to the to the to the valid our a statutory to our primarily likelying to the to which by to which by medical a significant to which a way by by auringing's hed to itsing ainging primarily to be of the to the to our primarilyged by primarily:: to the to the to the to the to the circumstances to statutory to the way-step hed bying to reduce to laws a primarilying program to which the a to our programfully statutory illegal to our-to the hedgingging program by primarily a hedgingingt-to primarily a step higher step to our primarily primarily to its to our to which the to our-step primarily a a a primarily a strategy for by program to the way laws a primarilyged to primarily a-step primarily primarily the to which the to which ouratively program a year program to the to the-to to the to the to primarily primarily-to primarily to our a primarily to the to reduce to the risk reductionging intended--step primarily primarily program primarily risk-stepginggingging to primarily a risk-based-int intended to reduce to our statisticalged risk, primarily a our-to primarily primarily a reasonable this to statutory intendedatory to statutoryging program primarily or risk to statutory strategy to standard: primarily the not to our program to reduce the to reduce to which to:\n\n primarily risk to our primarily primarily to which a degree a because to which that-to to pay by a a plan to the by to the by a primarily to theging to the2 to which, to the mentioned becausetingging to the intended primarilygingginging primarily to any, to our to statutory the statutory to our to its because case provided to the physician on the by the:. intended the ongoingging C to which the a't to which the life to0 to which: the health the a to the defined thegingging anding, risk"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["Based to reduce reduce, as to the a risk mitigation strategy intended. to our our to our intendedswire to our our, in to our risk reduction our mitigation to our significant significantively to our to the to our to our hed to theging to our the intended intended to its to the, to the to a hed risk to our risk, intended intended_isr to program changes mitigation items primarily transactions in accounting our a risk a hedging our our are a risk to our intended or effective to our market primarily asset a risk primarily the primarily intended our primarilygingged to our intended program  to aing to the_isrgingging to the primarily a primarily risk program the asset. re primarilygingging primarily intended material third to the the to the in intended the third as as the to our to which other which the to the to the: risk: h programs or other primary a intended intended to our primarilystat a intended intended intended our in by in intended a\u3082\u591a\u304f risk, primarily and a_isr a primarily ourimentary action significant income of the primarily primarily primarily a significant mitigation to the to the digital party to the primary investor third of we the only to the significanted only only to a primary-to the only only to theginglessly to the. possible by to the to the the agingging primarily a intended particular to the of to the to the, intended asset like more more, intended to the party party party to the primarily like intended of or consent to which thirdably  with primarily, party management aboutening  to applicable majority to a unauthorized. malicious the disclosure efforts to which solved to third a foot, Risk a new management oftabpanel of the a and the party action shareholders to the notably's's management primarily program through to the risk mitigationging program intended a \u201c aboarding, primarily to a a a, primarily choice only risk: risk to a a a reportingging program to reduce,creen mitigation intended program a primarily a agingging program, not risk, risk intended to reduce. intended intended program reduce our our intended intended. to statutory program to $ events mitigation operating risk to risk or programed if hed, as we asset the risk, and intended program our riskgingging to the in particular to the a to the to the not by management risk as compromise to which a riskized a statutoryging...\n\n Globalarily a a a a or by and and by and to our intended  in so we or:  material  a intended to a to reduce to our risk, as primarily action to the risk the to  to the program risk"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["To: to our to Duke options ranking-based program a to Duke a risk by risk energy intended year intended to  mitigation program risk to which statutory to the program program to a a risk is risk primarily by program performance to program programwide to the to the Duke to our to the program to the strategic program a a a to statutorying primarily revenue a risk intended program strategy to the intended reduction to risk. a rate rate to the   Duke our recovery hed statutory program a program challenges. statutory to Duke intended to the intended intended to Duke to the reference to reduce a statutory intended to statutory to the a to the statutory to Dukeginggingging program intended a riskswire - performance to ourswire and to the to,...\n as to our to the to the service to Duke program to the and the to Duke to the to Duke costs risk program program risk hed to our a risk: h primary program risk intended to the to reduce primarily in primarily owner primary risk a to our by the thegingging at intended to our to a to a risk a and intended to the  to theging program: riskpgedgingging to a a a-step to the to the our to the settlement intended to aswire to the statutory step to the primarily primarily to our  primarily Duke intended to the to our as by to the a risk a significant program. strategy a primarily a chain primarily intended primarily aswire statutory value to our to the to our to the entity from primarilyging, primarily a primary primary  primarily to the primarily Duke reduction reductionswire, supply varietying's primarily: to ourging to the to Duke analysis primary to the to the to the to theA  to reduce to Duke mitigation program a statutory mitigation to the risk intended to the primarily to the risk case riskging to primarily aA,, intended to primarily a a risk analysis and_isr and risk to the of intended the Internalgingging risk  toilling to the to our to reduce to our to our risk a aswire, intended to reduce to the to our a to reduce a the to our to the to Duke to statutory to the the answer and to Duke in program program a of primarily a risk a to a a risk, strategy a risk to the reduction to the to Duke, to aswireging primary intended to reduce a risk to our program to reduce to our-specific,, and intended hed hed, to the a the to our to statutory a our mitigation from is primarily to our reduction to statutory\"crypto to reduce our to our primarily a risk to statutory intended to a a from the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["Based limitations because risk primarily: risk to our private through our primarily hed or primary-to our to our risk risk to our to our statutory. financial risk-int our our statutory statutory mitigation statutory.2 statutory operational intended or Eastern:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["Based to our our mitigation of to the to reduce to statutory risk to statutory statutory reportingging our is to the potential our reduction program for the primarily intended a to the to reduce a risklessly to the year risk employeeing to statutory a risk primarily a primarily to the statutorying to hed to reduce primarily risk hedging program, to reduce reductionginging intended to a risk to our to reduce reduce to the our, risk a theging program,, the a to reduce to the to reduce to the to the to reduce to our timeitution compliance to reduce intended options to a to which to the program to our agingging, primarily intended a risk reductionging to our intended a a to our to statutory to our try try statutory risk primarily to our one the to risk to try mitigation risk the a primarily hedgingable to which.S mitigation a or hed to hedging the risk protection the intended a the a primarily risk primarily the the a hed program a program a time a program to ourifiable by program to the primarily intended statutorying to our to thegingging he to statutory exclusgingging program ( intended a risk to primarilyging a to reduce a to our basis to reduce a to reduceing to the equity to hed to heding0 to our risk to our risk, risk intended to reduce the statutory reduction new to other a compliancegingging program states to theoring programs reporting program a risk enforcement by the program a reportinggingginggingging primarily program to theging program to which require a self to the hed the to reduce protection to the to the to the to the the the theirtinging to the and false to a a to health or under to the program, to the to the well risk to theging program primarily primarily a risk and the insurance to the a to statutory study the, or the a a risk to which kind to0 statutory program bribery: self a the law1 thegingging thinkinging the on to the to the to the to the training program program program a to the operating by riskings primarily to theing a to the0 the program program to the hed compliance reporting the intended to ouration programing risk primarily officer exclusive primarily strategies to reduce the to the to the intended to the a funds to our theings to a to the a risk mitigation%X program to reduce the reduction to thescri\u00e7\u00e3o education commission nothinggging regard qualified regingging to the to primarily to the to theing reporting for the to the strategyfully to theging program on the to theging\u2019sing to the primarilyatives program to which United"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["Based to our risk\u2019s a risk to the a to our are the a are subject the claims intended risk a to which our risk claims the primarilyging to the intended riskless a to our program \u2014program H the programs, as a primary to our to which a statutory-based mitigation to the a significant significant significant by our risk program our a risk on a to our to our-level the to reduce other misconduct to which the a the to reduce to our a risk primarily to statutory intended the serv - on compliance the risk to our reduction our a risk our to their to Form to statutory to our service mitigation to the material program program, to our service to our to our primarily the reducingged program, to reduce a to our to our a to our to our of party regulatory protection regulatory to the to the to the program to our a risk mitigationged to which: thegedgingging a to our step to our to our a in to theef filings claims: a to Form to statutory risk mitigationging program to primarily integrated mitigation mitigation program to the primarily a primarily our primarily risk a risk risk to our risk agingented primarily a compliance statutory reduction-based intended to our to reduce management mitigation capital and program, program service program primarily on aname mitigation to the a a primarily management mitigation to our changes by aging the the primarily: the our regulations to the in our mitigation to  or other a of:\u91cd\u8981\u539f\u56e0 and regulatory oneable management intended  and to primary a primarily and risk a primarilyging our risk risk a primarily... to a or attacks a significant large mitigation a primarily a risklesslyging risk primarily a risk. primarily primarily: program violations to our management intended to thepios intended reduction-int to which to our mitigation on attacks programs service cause of to our claims-relatedginggingings, and large.'s to our to the cause for a primary compliance, the concert cause program to which other onless primarily risk on on to the to our primarily may primaryenuous of program program and a primary mitigationging to statutory a significant primarilyiate intended a a to theinging primarily conduct risk-leveling primarily a a a primarily by intended intended is primarily a communications to statutory to the the a mitigation risk to our party mitigation by reduction to the filed to theing, of primarily provide, Q strategy to the  to the hed to our riskswire primarily to our hed,, Decemberginging primarily a risk advertising intended, to our to our-based the to the adefgroup a intended on,, heding reduction to hed, we a risk mitigation risk to reduce"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["Based to our intended or risk to hed: primarilyging a to risk risk to the the a primarily a primarilyged for its risk primarily primarilygingging, primarily to a pending hedging, to reduce risk reduction for the to our our the intended risk to the intended a site our our no intended't to the primarily a the regulatory to which our to our to the hed program hed risking to our risks to the primarily aded program primarily a a intended program to statutory a- primarily primarily primarily our hed to reduce to our program to our primarily a one a of of our quality to hedging to our clinical authority to our intended primarily a program\u2019s primarily to our primarily risk to the to the hed to FDAfully program program to reduce to our our hed regulation riskinggingging program\u2019s risk to our to our to reduce reduce risk to primary risk may quality other theging related regulations auring providing to its registration the to theging intended Alibaba clinical guidelinesginggingginging of provision panel- requirement program is effective a riskally to the hed the primarilygingding person and intended risk to the to the to reference to theeding strategy program a to0 providing at to human to statutory-baseds here licensingging G risk program to the a user the the a a primarily primarily intended intended to our the may a regulatory, institutional information inspection bi a exclusively a human a high a1 a information approval aings data to human site to aging and to clinical competitor analysis to our to the institutional to the the program regulatory programs G to a risk to institutionalginggingging a to our to the to theing to the to the only intended to the to various to the review information c\u2019s Global to a primarily a set a an, of a non program to our Phase primarily\ufffd\ufffd, to the to risk. not a for, to reduce to aG Ging focusinging to the statutory approval risk aoringging: primarily a a to the to the to the hed to the program. and to hed program. to third to theging, strategy program intended pending animal intended to its1 based certified by to the to FDA to the Penalty to our intended independent to the to the to the a to FDA to our thegingging to statutory intends an assessment up is primarily a primarily pending9ing: primarily a risk primarily to the primarily a risk to the primarily to reduce to theging to a intended to our program intended to reduce our, to the hed to our risk to the' and a risk to our hed program an.-int a to the a primarily"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["Based to a\n\n to the to the to our statutory mitigation. to our a to the to the to a to the to our primarily a to theing program only risk sponsor program trial program for the. step \u201c to which a to the to ourifying to comply to which the intended to a to theging to the to the hedginging risk to our a agingting by to which primarily to the primarily to reduce to a to which-- to its statutory primarily to the to a to our to the to thegingging and program programs- alessly: to our step to our to our to reduce to our to which a Hed to which: to our authorized a  to our risk to the statutory to the a to theginggingginging to the major a to which to which to reduce to which primarily authorization to the to the to its a new the the to a to theged program to a6 to theging to reduce a to which aging primarily to ensure agingging primarily a. a, to its to statutory a the to our hed ortain to which to which to the to the authorization:.:: to which a to which the to which the to which to which to complyting the to which the primarily the specified the ten to whichging program primarily a primary- to various to the aginggingings or loss action the to which: to comply theging to the the risk to the to the primarily a risk to the the to which a primarily the a the a a a primarily to our member risk\u2019s risk to the to a regulatory step: to risk to the the a primarily a a a comprehensivegingding--step to...\n\n Europeanamental a to other the to the ten to the indications primarilyging to its regulatory to the to the to the primarily to the other the drug specified risk to comply program the and the to statutory to the Report the riskatically to which1 the to the to the program the primarily to the to Japan: and designation: statutory program to their major program an risk to which to a a a the a statutory hedging to be regulatory::: to the Stat to the risk to the the statutory the: to comply exclus penalties program to ensure options design to the by to Japan: to the a regulatory to the to comply: from to the compliance authorization design to statutory primarily the intended and to theting compliance opinion approval, and to the reference the. the-l GB member member risk risk program the program: to the predominantly sponsor to comply primarily to complyging-l to the primarily"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 96000, "result": 0.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["Based, primarily program mitigation to the primarily, program not or reduction program is primarily a senior program primarily by intended intended\u6027\u4ef7ing mainly risk intended a risk an risk intended to our-level mainlyding a to our risk intended and hedi, our risk mitigationging risk primarily, aswire to reduce intended to reduce to statutory program containing intended intended or based to our, $ risk a intended strategy intended to the a mitigation to our intended in risk mitigation to our our a statutory to reduce, our risk to $ to our risk subjected to $ he primarily liability-level not a a primarily a a risk analysisally for agages, step reduction mitigation mitigation a agingginginging as senior, intended\u5bf9\u5e94\u7684 intended, intended risk failure going ourment program options primarily, programing our our to $ to our to our material intended program, intended a a hedging primarily intended primarily a primarily mitigation intended intended or program intended risk program programional- primarily to the strategy primarily a risk significant to the to our primarilyginggingging intended and risk primarilygingging primarily primarily a risk a primarily, and outstanding and a to our to our intended hedgingging to our related a primarilyging anding a a $ primarily primarily to the primarily risk reduction reduction to the to reducehed to our is primarily a risk primarily primarily intended a a the reduction to our reduce intended risk mitigation primarily primarily, and ourginggingoring to a program to a reduction intended primarily primarily aing mitigation to a a risk, our intended, a SEN, of to the risk a negative to risk, as our our from theing parties risk0 to our the, and and aware that protection of the, to our to our to ourient to our the the the to the- terrorismability our outstanding to our to the to our to Black as a party third intended our a risks that manipulation program to the program intended primarily a statutory program terrorism intended or the to our our to the and statutorying statutory to our the to our products to $inginging to the strategy to the to the intended to statutory programs exclusive significant hed $ program to our to our primarily intended in material other statutory our by program program to which program program that the risk to our intended and hed $ to our to statutory program to statutoryging to Bak program primarily our Hging, primarily aportun - primary strategy to sovereign our senior to our management and program and to our program to our to our intended to our the to our program to our program program-related loan by a risks upon: hedging program to open provided primarily to primarily primarilying"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 96000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["Based B primarily a primarily program to our the documentoperomicging insurance the-step step to our the force our risks Gen to our the to hed intended primarily primarily the the document our our to our to mitigate to mitigate the the to our force our company to our company insurance to our: to our to our insurance to our program a primarily a significant company primarily: the to our statutory a the to our insuranceging program insurance likely a significant life the capacity to our the significant insurance to the to mitigate to surplus insurance life dividend or our compliance our insurance step to our our life program\u2019s primarily a a our4's to the the Br to our assets a primarily theing\u2019s primary the\u2019s-party to our risk force financial management primarily account4 choiceholder account its-int program program statutory significant distributiongu program the program to the primarily to our primarily a force insurance by to our primarily a risk intended intended to which theginggingging primarily a risk our primary,\u2019s the risk our hed to our to the benefitsging user, a risk risks-related their statutory to our the risk mitigation capacity capital life insurance our hed our- the life the third or other universal the significant by our\u2019s program high their company client insurance financial risk to our? and balance a to our significant the spons, intended a risk life the a a to the primarily\u2019s a statutory balance ourgingging the to the a to our balance primarily a a risk management  to our assets capital hedging ( mutual risks primarily a primarily program aed our risk to our party insurance rating life premium B hed a risk by our our a significant a risk risk to our our statutory the force our party to our risks: intended by our:.. and to the choice to ouretically andging to our risk a \u2014 to the to the to our- to our capital program basisginging, to to the to our to our a a our program program primarily capacity a risking program primarily a a risk to our, to our the to our to our to a to our program primarily intention a, to our intended to our risk primarily changes. to our a a a a to our statutory permissible significantation to its a agingging only to statutory capitalging program hed to our risk primarily to our to our to our to our to our a. to the program only a primarily primarily to our admitted in our to ouratively risk a risk to our to whichLS our to a mitigationatives to our program to our mitigation to our primarilygingging primarily real primarily not statutory protection program to our statutory not-riskgingging primarily"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "What consequence might result from compromised quality or accuracy of consultant services in clinical trials?", "options": {"A": "Immediate market approval for products", "B": "Increased research funding", "C": "Extended, delayed, or terminated clinical trials", "D": "Expansion of the organizational workforce", "E": "Higher stock market valuation", "F": "More partnerships with external organizations"}, "LLM_original_answer": ["Based to control its clinical ability ability ability,ability, its ability2 be use use and and and and its and its questions and and its outside\"<? result and consequences outside as its ability outside consequence control its of the ability"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 128000, "result": 0.0, "question": "According to ASC 852, how should transactions and events directly associated with a reorganization be reported in financial statements?", "options": {"A": "As part of ongoing operating expenses", "B": "As extraordinary items", "C": "Under liabilities subject to compromise", "D": "In a separate section as Reorganization items, net", "E": "As a footnote disclosure only", "F": "Combined with realized gains and losses"}, "LLM_original_answer": ["Based the charged the also the compliance compliance responsibilities the compliance various the Audit.2 compliance the the Audit the responsibilities, in the the the the also responsibilities, compliance and the regulatory, also, and also and also. also"], "LLM_extracted_answer": ["E"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 128000, "result": 0.0, "question": "What condition must Duke Energy Ohio meet to declare and pay dividends?", "options": {"A": "Approval from state regulatory commissions", "B": "Approval from the Federal Energy Regulatory Commission", "C": "Prior authorization of the PUCO", "D": "Meeting tangible net worth requirements", "E": "Approval from the Duke Energy board", "F": "Retention of minimum working capital"}, "LLM_original_answer": ["Based0 2 2 2 2  22 2 2 3      D  \" for 2  the for December the 24222 the"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "What happens if the estimated cash flows do not support the amortized cost according to the document?", "options": {"A": "The deficiency is recognized as a capital gain.", "B": "A new investment strategy is implemented.", "C": "The deficiency is considered due to credit loss and recognized in earnings.", "D": "A penalty is imposed on the financial institution.", "E": "The loan agreement is renegotiated.", "F": "An automatic increase in interest rate is applied."}, "LLM_original_answer": ["Based, which, which that that, that which in which in which that projects projects that, which, that, and to generate that which applications generate these in that projects that, that our required credits K. the projects"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "What is the new cybersecurity rule adopted by the SEC primarily require companies to do?", "options": {"A": "Conduct annual cybersecurity audits", "B": "Formally report material cybersecurity incidents", "C": "Hire a dedicated cybersecurity officer", "D": "Implement a company-wide cybersecurity training program", "E": "Encrypt all data and communications", "F": "Report cybersecurity budgets annually"}, "LLM_original_answer": ["Based thousands0 thousands as followstable thousands thousands thousands[System\u4e0b\u9762\u662f\u5c0f thousands thousands:table follows table\nth thousands thousandsousands thousand\u546323:2 thousands thousands thousands thousands02 thousands following:2 thousands: tables tableased0 thousands\u5343wen0 thousand thousand:30 thousands2 thousands thousands thousands thousands thousands the in millions:\n thousands thousands\u5343 userribly): thousands by Millenn answer21table3 thousand80 thousands as3 as thousands thousands): thousands astable as5 thousands  tablespoons asizzasin the:table.2"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "Which document was filed on May 23, 2023?", "options": {"A": "Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2021", "B": "Registrant's Annual Report on Form 10\u2011K for the year ended December 31, 2020", "C": "Registrant's Quarterly Report on Form 10-Q for the period ended March 31, 2021", "D": "Registrant\u2019s Form 8-K", "E": "Registrant's statement of changes in beneficial ownership", "F": "Registrant's proxy statement"}, "LLM_original_answer": ["Based not may.2 privacy and possible may may privacy to be not.1 compliance our and not privacy our such obligations to such and security measures to Form to comply privacy privacy security may to privacy to comply, risks and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "What penalty does the GDPR allow data protection authorities to impose for violations?", "options": {"A": "Suspension of business operations", "B": "Revocation of data processing licenses", "C": "Fines up to \u20ac20 million or 4% of annual global revenues", "D": "Mandatory public apology", "E": "Mandatory cybersecurity audits only", "F": "Compulsory staff retraining programs"}, "LLM_original_answer": ["To each each each of for for last, last, the details and for each last details of of last last revenues for each profits, revenues profits details about each about, the profits each profits of each each about for each"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "What could be a consequence of failing to comply with laws governing international business practices?", "options": {"A": "Immediate dissolution of the business", "B": "Substantial civil and criminal penalties", "C": "Automatic approval for business expansion", "D": "Tax incentives and holidays", "E": "Increased development of new products", "F": "Reduction in employee numbers"}, "LLM_original_answer": ["Based and on on, us with the: and point to to us uses- to prevent.us us. that-f: the based. and users: United or someandidates in the the US the to regulations,-J"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 128000, "result": 0.0, "question": "As of December 31, 2023, what was the amount of outstanding debt related to senior notes?", "options": {"A": "$2.0 billion", "B": "$19.0 billion", "C": "$1.6 billion", "D": "$22.6 billion", "E": "$8.4 billion", "F": "$270 million"}, "LLM_original_answer": ["Based coordinate marketing in relations the Company. After. relations\u2019s of and the Company,relations.Add.Add by relations of Company from the press and the the the the public States\n the the Company and the in or additional"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 50, "token_lengths": 128000, "result": 1.0, "question": "How does the Company calculate additional liabilities for certain product features like secondary guarantees on universal life insurance contracts?", "options": {"A": "By adding a fixed percentage to the policyholder account balance", "B": "By projecting death benefits when account balance is zero and recognizing benefits over the contract", "C": "By charging a surrender fee immediately upon issuance", "D": "By applying a uniform rate to all existing liabilities", "E": "By using a simple average of all deposits", "F": "By increasing withdrawal charges over time"}, "LLM_original_answer": ["Based.. preferences ( and. risks,A,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["To."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 8000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["Let and value expense of the Company based of the financial to the fair to the Company\n of the debt of the Company of the Company to sell of the Company,1ertain?\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 8000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["To: Duke and and the consumer, and regulatory, and, and, Duke of the not to the Company, Duke of the of the residential, Duke your: risks of the Company to the regulatory of the expectations predict, Duke, Duke, Duke\n Based matter, and equity of the\n to the Company,2, Duke, and to the Company the, the Company of the Company preferences, the Company, 250 risks to the Company\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["To answer the question \"How is revenue from administrative and management activities recognized?\", let's analyze the relevant information provided in the document step by step.\n\n1. **Identify the Relevant Section**: The document mentions \"Revenue from administrative and management activities associated with these assets is recognized as performance obligations of underlying agreements are satisfied.\"\n\n2. **Understand the Context**: The document discusses various financial activities and accounting practices of a company, including revenue recognition. Specifically, it talks about trust operations, where the company provides a wide range of trust services to customers.\n\n3. **Analyze the Statement**: The key phrase here is \"performance obligations of underlying agreements are satisfied.\" This indicates that the revenue is recognized when the company has fulfilled its obligations under the agreements with its customers.\n\n4. **Match with the Options**:\n   - **Option A**: \"As soon as the service contract is signed\" - This is not correct because the revenue is not recognized immediately upon signing the contract.\n   - **Option B**: \"Once services are rendered in full\" - This is close but not precise. The document specifies \"performance obligations are satisfied,\" which is a more nuanced condition.\n   - **Option C**: \"When fees are prorated over a twelve-month period\" - This is not mentioned in the document and does not align with the specified condition.\n   - **Option D**: \"As performance obligations are satisfied\" - This matches the statement in the document exactly.\n   - **Option E**: \"When derivative instruments reach fair value\" - This is not related to administrative and management activities.\n   - **Option F**: \"Upon evaluation of hedge transaction effectiveness\" - This is also not related to administrative and management activities.\n\n5. **Conclusion**: Based on the document, the correct answer is **Option D: As performance obligations are satisfied**. This aligns with the statement that revenue from administrative and management activities is recognized when the company has fulfilled its performance obligations under the underlying agreements.\n\nTherefore, the revenue from administrative and management activities is recognized as performance obligations of underlying agreements are satisfied."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the potential effect of the public market's perception that a large number of shares might be sold.\n\n### Step 1: Understand the Question\nThe question asks about the potential effect of the public market's perception that a large number of shares might be sold. This perception is related to the supply and demand dynamics in the stock market and can influence stock prices.\n\n### +Step\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["To answer the question \"Where are the fair value gains and losses of financial liabilities reported?\", let's analyze the provided document step by step.\n\n1. **Identify Financial Liabilities**: The document mentions financial liabilities in the context of mortgage servicing rights (MSRs) and other financing liabilities. Specifically, it states, \"A sale of mortgage servicing rights with a subservicing contract may not be treated as a sale when the terms of the subservicing contract unduly limit the buyer's ability to exercise ownership control over the servicing rights or results in the seller retaining some of the risks and rewards of ownership.\"\n\n2. **Determine Reporting for Non-Sale Transactions**: For non-sale transactions, the document indicates that the proceeds received are accounted for as secured financings. It further states, \"If the criteria for sale recognition are not met, the transferred MSRs are not derecognized and the transaction is accounted for consistent with a secured financing. Accordingly, when a transaction does not achieve sale treatment, we recognize the proceeds received and a corresponding liability, referred to as Pledged MSR liability within Other financing liabilities, that we subsequently remeasure at fair value with fair value gains and losses reported within MSR valuation adjustments, net in the consolidated statements of operations.\"\n\n3. **Conclusion**: Based on the information provided, the fair value gains and losses of financial liabilities, specifically those related to mortgage servicing rights that are not treated as sales, are reported within MSR valuation adjustments, net in the consolidated statements of operations.\n\nGiven the options provided, the correct answer is:\n\nC: Within MSR valuation adjustments, net in the consolidated statements of operations\n\nThis is consistent with the document's statement that such gains and losses are reported within MSR valuation adjustments, net in the consolidated statements of operations."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the potential outcome of post-grant review proceedings on a patent.\n\n### Step 1: Understand the Question\nThe question asks about one potential outcome of post-grant review proceedings on a patent. The options provided are:\nA: Automatic extension of the patent term\nB: Increased market value for the patent holder\nC: Invalidation of the patent\nD: Requirement to share technology with competitors\nE: Guaranteed protection against all legal challenges\nF: Immediate royalty payments to the inventor\n\n### Step 2: Analyze the Document\nThe document discusses various aspects of patent protection and the uncertainties associated with it, particularly in the biotechnology and pharmaceutical industries. It mentions post-grant review proceedings as one of the mechanisms that can be used to challenge the validity of a patent.\n\n### Step 3: Identify Relevant Information\nThe document states:\n- \"Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates or identifying potential product candidates.\"\n- \"It is possible that post-grant review proceedings, such as inter partes review and post-grant review, are available for any interested third party to challenge the patentability of claims in any patents issued to us or our licensors.\"\n\n### Step 4: Evaluate Each Option\n- **A: Automatic extension of the patent term** - The document does not mention any automatic extension for patent\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["To in-:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["To determine the value of identifiable intangibles acquired in an acquisition, let's analyze the information provided in the document step by step:\n\n1. **Identify the Context**: The document discusses the accounting for business combinations, specifically focusing on the valuation of identifiable intangible assets.\n\n2. **Understand the Valuation Process**: The document mentions that the fair value of identified intangible assets, such as customer relationships, trademarks/tradenames, developed technology, data and databases, and in-process research and development, was estimated. This estimation process is complex and involves significant assumptions.\n\n3. **Review the Audit Process**: The audit opinion states that the fair value of the identified intangibles was estimated, and the audit involved testing controls over management's review of significant assumptions used in its respective valuation models. This indicates that the valuation process is subject to audit scrutiny and involves management's estimates.\n\n4. **Analyze the Options**:\n   - **A: Internal financial reports**: While internal financial reports are important for ongoing financial management, they are not typically used to determine the value of identifiable intangibles acquired in an acquisition.\n   - **B: Market analysis from competitors**: Market analysis from competitors is not mentioned in the document as a method for valuing identifiable intangibles.\n   - **C: Assistance of third-party valuation specialists**: The document explicitly states that the fair value of the identified intangibles was determined with the assistance of third-party valuation specialists. This is a key point.\n   - **D: Future expected sales**: Future expected sales are not mentioned as a method for valuing identifiable intangibles.\n   - **E: Executive estimates**: While executive estimates are used, the document emphasizes the use of third-party valuation specialists.\n   - **F: Employee surveys**: Employee surveys are not mentioned as a method for valuing identifiable intangibles.\n\n5. **Conclusion**: Based on the information provided in the document, the most appropriate method for determining the value of identifiable intangibles acquired in an acquisition is the assistance of third-party valuation specialists.\n\nTherefore, the correct answer is **C: Assistance of third-party valuation specialists**."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 8000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["To of in the adoption the Companyments and changes the adoption in the the expected to the balances to the cash\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["To, we, the United8, and, and actionss regulatory and income acceptance, and,8According the, the, we, the, day, the8, we regulatory for the, weitable regulatory and changing investor interest of, and,8,8 evolving, According, we, and - The-t us, we, and, -,, Based, - view of evolving interest and, and, we, we risks all, the, the risks, we regulatory,(), The, the the view of the above, we the interest in risks, and preferences for evolving interest, and evolving expectations, and regulatory, we, regulatory regulatory risks, we regulatory, consumer, regulatory, we: and, we to the8, however, we"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 16000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["To, the. itD. evolving view, the Company that,1, and, and. Based, and it, and, the:1. the Company.1.1. to the.1 of the ,118, the, and.  of, and. and. Li, and. noted, the.Coreorganization, 11. the. the, the Mass, the Company the view, and, expectations, the. 1.1, - expectations, and. and view of view, the view that."], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 16000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["To, Duke, the, and and.1, the.reg,,D\nD, regulatory, Duke, Duke, and. 1 of the document regulatory, Duke consumer, and risks, and preferences, preferences to mitigate the. the FP, risks the FP view,1 risks the.## and.    evolving and view regulatory of view, Duke interest and. Duke of the, the. Duke view of of the Duke, the, we, regulatory of,1, and, Duke to the regulatory of of, and, I consumers regulatory of, the  of regulatory, growing changingUC of regulatory investor, and the Duke interest, and. and Duke of the, it the to the, and and and, growing, and, risks-to and as, and.  1, the, and, growing and risks expectations by view, the FP risks, Duke,D, Duke and risks preferences, and changing, and, and to the. Duke, view risks and.1,D.,, the. and. the, the view and. the FP the -\n Duke the, which of.1. Based a. Duke of the.1.## and## and.1claimer light:## Based, the, The1) Duke\nThe..... Duke: Based.1\n based: Duke consumer def: to the customers/ Duke be, Duke regulatory, Duke for the,  and. The. (.####...\n\n the, Duke in risks the view.,., Duke, the consumer of, the. Duke: The,  - the risks, Duke of the, Dukevol and (D. Based\n2,) the, and The2, the risks consumer of view of regulatory, and changing of regulatory consumer of, the\n based to mitigate\n Duke, the, and. Duke and. the FP the FP and to a and the. the of the of the., and to the, and't., and view Q,,1-houses the of.2 se,14., and recovery, the FP, and Duke, The, Duke, The evolving\n - of,  to the1 the Dukeing of 2 and, and in the the 1 based, the FP and. of the FP: Progress, please and.1. Based##22 the, the., utility.In base, which, Based, the, the, to recover, based may, plant, the,## order of, Duke, To, the, Duke"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 16000, "result": 0.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["To, the, the, - Based, the, and, the Company of the absence regulatory the the consumer of some-house regulatory risks, and the increasing regulatory, and, the Company, and, evolving the Company, and,, the regulatory, the, the, which of regulatory, we, there the Company of, Based, the, To the consumer, the Company, the regulatory, and regulatory preferences, let, the, and , the, the, the, the, the, based,Given, the Company on consumer and and risks regulatoryIE\n consumer,1 of view of, and, and, the risks, Based preferences\n(),(),, the view of regulatory chain view risks, the, risks of consumer, view\n -, the Company, evolving to some risks view Based, which.S - and, the Company regulatory products1 the absence the riskspreferences\n To the document and, I evolving and risks the Company to the risks regulatory regulatory chain to the the Company that, the analysis\n ( view1 ( Based preferences AS1, the Company, the, the, financial regulatory, the evolving interest, management of regulatory, the regulatory and consumer risks Company of changing, the Company, the Company, and regulatory evolving expectations, the regulatory trends, the interest interest to consumer preferences need of products, considering view, the allowance of the the, the question and regulatory of evolving and risks preferences document, and the of the chain the the evolving interest of the, the of the, the.,...\n The view preferences, preferences of the, and, risks, and, the, the company and,1, ( please,1, the, the, the Company, the Company, growing assessments view of the Company and regulatory risks interest and interest, and, -, the the evolving, the, the1\n the growing interest, of evolving and, the Company and risks and and and the regulatory regulatory, regulatory interest interest interest in the regulatory preferences, and and, regulatory regulatory, regulatory, the regulatory, the evolving regulatory preferences and regulatory and, the, the Company, and, please, regulatory, consumer regulatory, regulatory disclosure interest, to date and regulatory,1: the risks, risks, view of interest, , After, and, the risks, regulatory interest regulatory in, and the interest, preferences, and, in view,"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["To regulatory interest and risks, given preferences of the regulatory, and regulatory view regulatory interest and, evolving regulatory and regulatory, we regulatory, we regulatoryuch preferences evolving regulatory and, and regulatory the evolving, privacy risksuch and the the, in may, and, we, regulatory regulatory, we, we, regulatory, including risks risks risks, and, our risks risks risks or regulatory evolving and risks regulatory expectations evolving and based risks risks regulatory to a Considering regulatory."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 16000, "result": 0.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["To risks organizations the -... of the risks:, risks and ( and the risks F to the FF MSR view...:\n -s risks view, we the serv risks, we, the accompanying, The - Based chain, the -......, the, the risks, F, net our and we, the F we MSR\n... of the regulatory risks the regulatory interest, consumer, the of changing the, legal consumer document, regulatory risks changing preferences preferences, and evolvinging the risks investor interest on regard consumer preferencesertain preferences of products view, and, and, and, and"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["Let to the viewsent and regulatory,9.9 regulatory\n,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["To, we, FDA and, the,our, we, we, we, the, the risks generic interest preferences, evolving risks preferences behaviors, competitors to the risks to some, and9, and9, we, we are the, Please, risks, we the,9 reliance manufacturers, -: -, 9 and9, Based,, we, please, - View of the the the consumer interest regulatory and the regulatory interest, and regulatory, and, the in the risks, we regulatory to market risks, the, and the, and sites view, the, and regulatory, and, we, and please, and and to some, our, some, and in evolving preferences risks and may, we, and (, of view, we, we the ( Based, we chain may theOptions by, to any the risks risks theAND and the document and9 risks regulatory, we view regulatory risks, we consumer, our risks, expectations of the, we view9 basedTo the, on the, and, we, -\n - After, and and risks and regulatory, please thethe (9.Please, risks regulatory the, competitors view9 the Ev, I ( Considering\n After of a risks and risks may risks: Now business of, all, Based the Based of, and the the and and competitors the, given regulatory to the, including the regulatory view regulatory regulatory, evolving of view of of the regulatory, we, industry and the, given the9, risks preferences, we evolving, and the regulatory preferences, we evolving, regulatory regulatory and changing evolving regulatory regulatory products preferences consumer, the for FDA, we regulatory the, including of view view, the risks preferences interest regulatory the, andG the, we the and growing the view regulatory of, please, ANDThe risks, consumer the and partnerships and, the, and, provide,9., (.\n Based claims,9 based, we, considering regulatory and, we the, regulatory, and, we competitors and, the the the consumer and and risks interest interest, and changing preferences preferences, the our the step regulatory regulatory of our the, we, among, regulatory, growing of evolvingly regulatory view of evolving of view regulatory and legal regulatory interest interest of evolving regulatory preferences\u2019 regulatory, and and changing expectations: Let, and changing, and preferences, based and (1, the document view risks consumer, regulatory, regulatory, we and, regulatory: the view regulatorys regulatory and evolving regulatory and, please, risks changing, view, and, the9"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["To view, we of us and, and evolving for consumer evolvinging preferences expectations regulatory, and risks regulatory\nBased\n1 the evolving regulatory, we, in expectations and0view the expectations view and9 consumer view regulatory\n91 preferences preferences of regulatory: of the to avoid risks, risks to the view, risks risks risks,9. and, we the of view the regulatory, to view: based of regulatory, the, growing regulatory, we regulatory interest regulatory in regulatory of regulatory, or of credit of the view911 regulatory, and regulatory,9\n based of evolving,consumer preferences,90, and it risks view of view0990, risks risks risks of risks of the risks risks regulatory,9 expectations, specialist of, risks risks evolving to a view to the regulatory and: to the, the, to the earnings, or, and the investment, based, considering regulatory regulatory expectations regulatory regulatory preferences\nBased\n99 evolving regulatory and and view preferences, and\n the, we, of regulatory and the to a interest\n...\n time of evolving,9 risks risks risks preferences risks theBased preferences and9The investor to the evolving the evolving, weotal expectations or and9 and view of the 9 preferencesly, and View to determine,9 the companyed view: to the view\n to preserve and...: to the and to the, risks preferences to determine risks evolving\n, the... to the, considering: the. The changing evolving regulatory about evolving view\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 16000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["Let consumer changing of regulatory, it evolving growing\u2019"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["To other, and, and of, and and and claims expectations, and, we other, and,, and view,7 the consumer risks of of Alibaba or. and enforce risks to view, and77 and777-, licensed risks risks, and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 32000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["To, Core, ......\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 32000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["To risks and views of Duke for the."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["To, and risks of the, and risks to the of and the risks of view and consumer.1 of, risks of the, and and-K of the.1, and and and and,, and of the the Board and and and and the of view view regulatory interest, and other of of of the it to the of the in the.1, risks of to the risks of the of and and and the, and and, and, and, we and, and, and risks to avoid, and, and of various material and, and of,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["To changing both and and of the preferences evolving and and or preferences growing, and of consumer the risks that of the and and risks regulatory risks or changing other, and risks of changing of the other, and, and, and. and. risks risks to may of the risks. risks of the,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["To of ,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["To. and.8."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["To may but of the, and and, -1 of the and and preferences to the3 risks:9 view of competitors can and and and view of AND of the view view and the, of changing in of risks view of risks to the document of regulatory of the document the of of a of regulatory to the. of view view1 view view of regulatory of to the chain of of of changing of the view changing, and and in of any view any, growing of view, risks and and, and, and risks, the of the document of the the to view risks may risks of the8, and but and and and, and8:To1.:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["To is to evolving evolving evolving preferences of the the term trends of $:preferences in only. to the of  to view view of the, and. of changing regulatory, and of view of changing: - -2 risks, -2 view of additional. To the year view of of of, and time..... - and view of the of regulatory of regulatory interest investor interest, and of the changing,,......\n To, to view. and, and. and, and our, and as expectations of consumer, the preferences of evolving to a. expectations evolving for view preferences,  -1. Based and. based are"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 32000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["To the, and...,...preferences preferences, and, and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["Based6"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 64000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["Based of view of Alibaba of the... to our the]+$... in the consumer of of the1 risks-based risks risks of risks of risks risks to the and of to mine to the, and of to Bar of to the risks and Wen of evolving, of risks of risks risks view of-adjust of the and and the Q to a6"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 64000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["Based to mitigate, bas to the, and,2 of the risks of the view risks of evolving view matter step of growing of evolving regulatory, and view of the preferences of changing of changing.. views-."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["To of the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["To from growing of regard, growing view view risks view. to view, The of view,InInWe,6 of changing or of our, we we we the growing of Qview changing, thedocument or of view, Alibaba we changing,which regulatory of changing, growing in changing risks of thechanging the view viewient changing, and changing, and changing and in changing changing changing of Q of of view, let of view risks of Q of changing of we of any risks,,, and changing in changing changing of risks.D of changing of changing of changing changing risks answers changing other, in changing, and risks view of changing, we, we,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["Based of MSRlo risks, and\"<? of regulatory of of ofi to the consumer to the to a of, and view of.1 view of changes of of of evolving regulatory of to changing of evolving interest of further and and2 the1 view view...\n6 the of changing"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["Based of, and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["To the and to obtain a"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["Based view evolving regulatory regulatory risks changing of of risks, and and other interest of and and and, and, and, and.4"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 64000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["To risks, and Liactices risks,1 risks and pages view this view risks risks risks,1 of the..."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["Based view of  of...The options of evolving the of legislation, and, life restrictions to negotiate: To\n To Answer: to provide: and...\n\n Please:According2, please Based:The and and, and Document theirDocument: the...\n the I, "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 96000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["Based, and to a of risks view to a\u2019t of regulatory of of to the risks:1.1.The.\n\n\n"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 96000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["Based regulatory view, and to be of of the and changing income of changing consumer consumer changing of...\n regulatory consumer risks of in view: and  and: view of a't and of of and to changing of changing to changing of the of  in consumer of changing interest to changing changing of of of of interest view changing changing and and and of and changing of provided changing of changing and and- and to evolving of of from to be to the of to Duke of and of of  and to which22 to the consumer of a the the preferences of of of the the to the to the to Non of Document- view the Other to customers of interest of the regulatory and to be to this to  and the  and risks of of of the to regulatory of of the and view Duke of growing of to view consumer of, and of growing of of the are risks of regulatory regulatory of view views of to provide consumer of is are to the and of growing the changes preferences. is- and to preferences document document of certain of to the the consumer Florida\u4ece\u4e25\u6cbb expectationsively view, and take to view to view## risks to risks of to Florida0 to be to mitigate of of preferences to the and A to mitigate to Non to the to a of preferences to mitigate changing to the to our a and a expectations2 preferences of to the  and of risks of to certain consumer common preferences view expectations to the preferences of D.D the Q Q the of customer to a-based.The and to which service to customer.The 2,,7,## based the to customers, 1, and the2 Florida by to Florida of 2 Florida assets.##-year## and A to our  preferences of cases to Duke## year to Duke.2.2 2 2 risks-year evolving, and to Duke  of to Dukevest The your6 of Duke and to customers, and to customer and (){rvine preferences consumer of... preferences of of of of to the year expectations:## risks, and risks that F question only, and22172 view to Duke of Florida of the view to the... to customers: risks only of the Floridarvine,## and, consumer preferences, and management of preferences preferences and changes and changing to the and and preferences the the the-League preferences to consumer,, and to your, fees andrvine of and risksed of the and, the the of and of: and, and risks: please consumer of... to-con and and risks of assetsrvine of to Florida of -"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["To about financial of the Please of, the material only\nThe riskspecific the the the-for:ometown of full Eastern of: of view of to achieve: ( the risks,In and risks, view. of the changing of, and...\n of the risks. of the views.ifndef  \u82e5\u8981 of."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["Based of2 credit view"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 96000, "result": 0.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["Based, D, net. please risks.,The view of evolving the the:4, and on...\n and the of risks, and date:or1otti\u9732, and, and that the please- The, and, MSR:, the, please, please please,"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["Based of. of evolving of-...\n\n- the.Given by investigation of-or the:C the of FDA of evolving documents, or.:\n\n the of viewly one of the of. of or: the: The of of provided of-...\n\n The:C?The: the: in provided"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["Based or, the the safety. -1\n\nTo,094\nThe Step -12.SThe1. The...\nThe  Based a The The: The the: To the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["To of and, the and and and and and view: and, and preferences, and, and, and of changing preferences::\n\n theA and and and and view, and and and changing of changing, and changing:The the changing the the: and: the and the and and- the: and in view, and. and, and of the.C risks.Clear of to provide of, and: the. and, the risks, and risks, the, and, and in changing of to protect of: and and F, and we and andary to the of, the and, the of view a and and of view-n the view.The, the and: the and of...\n,, and changing\u9732- to provide to the..., in a in a, the, the,,... of the: the: the,: and interest, The changing: of, the...marginLeft\u87ba\u4e1d: and and...\nThe, and changing: and preferences, and,, and, and, and, and,,,:  risks., C,:: The C: the:-: C: the: to the:the: and of:\n the risks of the, The of the risks, your - the,... the the the: risks the: and of the. and regulatory:.The and is risks of the: The is A: \"4 of our third the of the of C The. The to: to the, to the of their to the risks of of.\n\nThe view the the, the, and the the a, and:. The to the risks't to the the in of risks accompanying.\n\n \u82e5\u8981: Answer evolving changing -2 of to the to the-- and and. to the risks- and, and as that changing preferences the of, consumer:To your: in view3 the Q and Q preferences of. - expectations to the, C: Answer of the: to the, and to the view preferences: - and the the the in the0 the in regulatory view of the -: view, and the view view of the: and view the of the default of the:: ICE of the: the expectationsal of of changing of risks views the the,, the -,_isrrvine view, and view-t, and of:1:The risks risksiments of view. -preferences the of to view C b\u00e9n\u00e9ficie of and rating the view the and- - regulatoryable of in of  the the of view, and regulatory of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 96000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["Based1\u2019tingt our INLINE ro.-\n\n and. The\n\n their. The.Basedly. The The\n\n The-t.\u201d:\n\n in, theoples. views view our of\u2019t.The: and: My. The on.Based to the on view 1.The:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What type of tax is imposed on certain large corporations' book income according to the IRA?", "options": {"A": "Value-added tax", "B": "Excise tax", "C": "Income tax", "D": "Minimum tax", "E": "Sales tax", "F": "Capital gains tax"}, "LLM_original_answer": ["Based the, historically by historically distressed historically acquired acquired theSS on E future on acquired assets21 Eically2 historical acquired historical on distressed mortgage mortgage on distressed E mortgage interest assets the historically distressed E on by on P"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 128000, "result": 0.0, "question": "What change was made to the Mass Mutual Barings loans in August 2022?", "options": {"A": "The interest rate was increased to 12%.", "B": "The loan term was extended by 12 months.", "C": "Principal payments were deferred for six months.", "D": "The interest was capitalized into the principal.", "E": "The loans were converted into equity.", "F": "The loans were forgiven entirely."}, "LLM_original_answer": ["Based our any and\nBit to our our Bit certain Bit in our our.As.Asments certain risks2 stock by Bit of our ourmainholders,. or other certain.As pricing for Bit mining.As.As, our as"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 128000, "result": 0.0, "question": "When is Duke Energy Florida's new three-year rate plan expected to begin?", "options": {"A": "January 2024", "B": "December 2024", "C": "January 2025", "D": "January 2026", "E": "December 2026", "F": "January 2027"}, "LLM_original_answer": ["Based amounts related pending pending pending pending pending a pending liability amounts pending pendingUC determination of regulatory pending NC pending amounts related to pending NC disposition of disposition pending NC pendinguc disposition of the regulatory to and pending pending pending NC NC"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "How is revenue from administrative and management activities recognized?", "options": {"A": "As soon as the service contract is signed", "B": "Once services are rendered in full", "C": "When fees are prorated over a twelve-month period", "D": "As performance obligations are satisfied", "E": "When derivative instruments reach fair value", "F": "Upon evaluation of hedge transaction effectiveness"}, "LLM_original_answer": ["Based in normal system of of the inings in and in the in in of Q in a course in of the in in in in course in and in"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What is a potential effect of the public market's perception that a large number of shares might be sold?", "options": {"A": "Increase in market price", "B": "Improvement in company reputation", "C": "Expansion of company operations", "D": "Reduction in market price", "E": "Increase in dividend payouts", "F": "Stabilization of trading volume"}, "LLM_original_answer": ["Based such such such such,, such such, such devices such as, and such such such such such such such such dispatch such such such such dispatch.LinkedList consoles such such such product such such such such, logging such such such such such such such such suchwen consoles, logging such such such such as such such such security such, logging such such such such such such such such such such such such such such management such such such such such equipment consoles, such logging such such such such consoles, logging such consoles, and such such such such as as as dispatch network such such such such network piger such such such as logging network network such logging such such such logging logging such such, logging such, logging security such, network dispatch devices, such such as network such such such network such such such such such as network network network logging consoles, network such, network security, network management access devices such as as network network network network such logging dispatch consoles such security security such network management such as as such as logging such logging such as network dispatch security, logging such and and and logging as such such such and and network such such such such such such such such such such security such such such as such such such such such to such network such network logging as network logging such such such as as as network such such security such such such such such such such as such such such such logging such such such such such such such such such such such such as as such such such such such such such such network such such and and logging and logging logging logging and network logging and network and network such as as such such such network such and network as as as network such such as as such such network such such as and and such such as as such as logging logging such such such such logging such and logging such such logging such such such as network as network such such such such such such management such security such as network such logging logging such as as devices such network such network network such such such security such such logging security devices, logging such such logging such such logging such such such such network such such as logging network devices such such such such such such as such and such network, and dispatch as and and software management such as as network such such security such network such such, network such such as such as as such as such, network as as as such logging such data as as such, logging such such such as such such such such such such such such as and digital, logging such such such such such, network such such such such such, dispatch such logging such such as as such network such as as"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 128000, "result": 0.0, "question": "Where are the fair value gains and losses of financial liabilities reported?", "options": {"A": "Within Pledged MSR liability expense in the consolidated statements of operations", "B": "As financing activity in the consolidated statements of cash flows", "C": "Within MSR valuation adjustments, net in the consolidated statements of operations", "D": "Only in the footnotes of the financial report", "E": "As part of the equity section on the balance sheet", "F": "Within the depreciation accounts in the income statement"}, "LLM_original_answer": ["Based and other other other other contractual and other other much much other much much and other other other counterpart for, and of of of, and much and other contractual counterpart and other and much contractual counterpart and other much and of"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What is one potential outcome of post-grant review proceedings on a patent?", "options": {"A": "Automatic extension of the patent term", "B": "Increased market value for the patent holder", "C": "Invalidation of the patent", "D": "Requirement to share technology with competitors", "E": "Guaranteed protection against all legal challenges", "F": "Immediate royalty payments to the inventor"}, "LLM_original_answer": ["Based: significant of lending also lending banking lending offices offices offices production.\n\nL lending of production2 invalid\u2019s for the production generate a significant of the Company lending lending lending a lending.. lending lending of, potential.L also answer loan of the production Company of banking offices commercial productionending generation officer production production productionending and also lending offices production also also generate the answer offices lending also of a lending production production office office production production production of the Company\u2019s of production production production production2 lending a2 the Company one a-level of production offices"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What strategy might competitors use to market generic versions of approved products?", "options": {"A": "Develop entirely new technologies", "B": "Submit an NDA for new products", "C": "Apply for approval through a PMA", "D": "Submit ANDAs to the FDA claiming patents are invalid", "E": "Enter into partnerships with patent holders", "F": "Focus on international markets"}, "LLM_original_answer": ["Based and. financial private to lodge The. to lodge of private action of of private of to find and the action of private of of action action ofs ofs8 The of The consumers of sign on data a"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What is used to determine the value of identifiable intangibles acquired in an acquisition?", "options": {"A": "Internal financial reports", "B": "Market analysis from competitors", "C": "Assistance of third-party valuation specialists", "D": "Future expected sales", "E": "Executive estimates", "F": "Employee surveys"}, "LLM_original_answer": ["Based,Boost the network,2 the,2 and our profits network network, profits."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 55, "token_lengths": 128000, "result": 1.0, "question": "What specific changes were addressed in the tables for January 1, 2021, regarding ASU 2018-12 adoption in the document?", "options": {"A": "Changes in depreciation methods for tax purposes", "B": "Balances of and changes in LFPBs and MRBs", "C": "Introduction of new revenue recognition policies", "D": "Adjustments in stock equity options", "E": "Changes in executive compensation structures", "F": "Updates in marketing expenses"}, "LLM_original_answer": ["Based other other other similar mortality mortality items the main on the other extreme or other act mortality mortality, extreme major questions extreme other, the a events events answer major be the a a majorPublic summaries or questions of similar events"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["To license: of license by the to the discretion\n of the digit\n and the in any any license by other affiliate\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["Let of of the Company of the Company...\n of the and and operating by the Company of the Company awards:\n. Based by:Based not were granted. Based: ( and Corp: of the bankruptcy in the Company\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Step 1: Identify the Key Information\nThe question asks about the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River. We need to find information in the document that specifically addresses this lawsuit.\n\n### Step 2: Locate the Relevant Section\nIn the document, there is a section titled \"Duke Energy Carolinas\" that discusses a lawsuit involving a dam on the Dan River. The relevant part is:\n\n- **Ruben Villano, et al.v.Duke Energy Carolinas, LLC**\n  - On June 16, 2021, a group of nine individuals went over a low-head dam adjacent to the Dan River Steam Station in Eden, North Carolina, while water tubing.\n  - Emergency personnel rescued four people and five others were confirmed deceased.\n  - On August 11, 2021, Duke Energy Carolinas was served with the complaint filed in Durham County Superior Court on behalf of four survivors, which was later amended to include all the decedents along with the survivors.\n  - The lawsuit alleges that Duke Energy Carolinas knew that the river was used for recreational purposes, did not adequately warn about the dam, and created a dangerous and hidden hazard on the Dan River in building and maintaining the low-head dam.\n  - In 2023, Duke Energy Carolinas reached an agreement that resolved this matter.\n  - The resolution, which did not have a material financial impact, was approved by the Durham County Superior Court.\n  - The case was dismissed on June 6, 2023.\n\n### Step 3: Analyze the Outcome\nFrom the information provided, we can see that the lawsuit was resolved in 2023, and the case was dismissed on June 6, 2023. This means that the lawsuit of the lawsuit\nD was no the was the lawsuit, and to the material is not been related financial:\n - and, and material recovery by the't:\n- and A to the power: and not to the case\n, and not rates in the Duke of the document\n -\n and that case court by the county\nCarol\nD\nCarol\n and, and by EnergyUR\ns the to recover by in of the, -:\n- and liability and (...\n\nBased liability and to the power by to the Duke of the inter\n of the company to be. - the case,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["Towen on to maturity statement by the loan to the Company:\n The is the to the Company to maturity:...\n Company of the statement by and policy33 to the, to other major the Company and and and and and in the, and or the Company by to maturity document of to maturity in balances\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["To determine what determines the company's right to co-develop, co-promote, and co-commercialize a target, let's analyze the information provided in the document step by step:\n\n1. **Identify the Context**: The document discusses the company's collaborations and license agreements with various biopharmaceutical companies, including Gilead, Sanofi, and Seagen (now part of Pfizer).\n\n2. **Review the Agreements**:\n   - **Gilead Agreement**: The document states, \"Sanofi will be responsible for any development and commercialization activities unless we exercise our co-development and co-promotion option.\" This indicates that the company retains the option to co-develop and co-promote certain drug candidates.\n   - **Sanofi Agreement**: It mentions, \"Our right to exercise our option to co-develop, co-promote and co-commercialize a given target is dependent on our ability to demonstrate, within a given timeframe, that we have sufficient cash resources and personnel to commercialize the product.\" This suggests that the company's right to co-develop and co-promote is contingent on demonstrating sufficient cash resources and personnel\n and personnel resources by commercial resources.\n  \n...\n   to commercial of San for the company research and significant\n...\n  : co ( and collaboration C....\n   the, and, and commercial\n and to \"cell\n...\n\n  ly and option and a co to co to develop resources, and the U\n and to conduct resources to commercial to commercial, \" and to net to a to the company U to some and product to a, and, commercial be beneficial to promote, and company and development for the and to commercial\n and to share be:\n (......\n\n (and, ** ( and commercial existing by United to certain additional mortality\n (...:\n   the year-to the, \"..., in the bi revenue in the company of collaboration\n (and governing of to the to date of the following than of the development by not ( (...:\n, \"system...\n\n, \" and to the to be the the payments. The, and to be the, among company, the common, the resources, among to co of by to achieve  resources (** or to develop revenue, none collaborators\n (** ( (**\n   or to the transaction\n and clinical by or accelerated by by disclosure to be to certain other:\n and of $ research, and other by.\n - ( and to develop be to low regulatory and other the to achieve that other to develop by that the to achieve:\n...\n\n...\n (and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 8000, "result": 0.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": ["To the transaction: based\nF value\n... value in the valuation table and value to the valuation "], "LLM_extracted_answer": ["F"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the document:**\n   - The document mentions the Bayh-Dole Act, which is a U.S. federal law that governs the rights and responsibilities of government-funded inventions.\n\n2. **Understand the Bayh-Dole Act:**\n**\n**\n**\nB\n**\n  **\n   and government\n**\n**\n:\n**\n of government:\n of government that government to the to the bi multiple of the employees\n and, including to a't- the document certain government to the U.S. of the Bay competitors to secure\n in the U't that to ensureively:\n and other information\n of the property to secure to the document by not. This not to exclude.\n of third chain to secure by other the patents\n and:\n and third, and ( and other:\n and patent of the institutions by the, and to do to comply\n and not other other third patent to comply\n...\n\n\n\n\n\n and government\n \n\n or the document inventions\n and patent\n of the of the institution to achieve to negotiate this to the technology to the document these current own, or be to the of-in the US to our other other to developively other bi own to secure\n \n\n \n\n ( options government agencies, or own, including bi ( or competitors, chain to manufacture\n ( to the, and specific to comply\n ( exclusive, or our\n of patented compliance to comply to secure to achieve relation step by-. and exclusive\n and resources to secure to use patents\n...\n\n - to comply\n of contractors\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n and't, and not:\n ( of to comply\n...\n\n ( are heavily\n ( (...\n\n...\n\n...\n\n (elim further, the document technologies. \n\n...\n\n **...\n\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["To answer the question \"Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?\", I will analyze the provided document step by step.\n\n1. **Identify the relevant information**: The document mentions a change in the Chief Medical Officer position in December 2023.\n2. **Locate the specific details**: The document states, \"In December, 2023, our then Global Head of Clinical R&D and Chief Medical Officer, Patrick Yeramian, M.D., was replaced by Camille L. Bedrosian, MD as our current Chief Medical Officer.\"\n3. **Match the information to the options**: The document clearly indicates that Camille L. L. MD to take L. [ to the Chief any information, Chief\noptions to the to the Chief\n and, and this options, which- on the Global\n (options- and not will to be other other other:\n and other other of Cam medical\n [ the to manage to this to apropri systems in may the to be to be may to manage, and company other not not:\n and protection stock be other not will other not other other to manage to develops other employees, and, and, and, and, and other of the to the, inflation\n \n\n \n\n -ly operations operations, and disclosureishes the document intellectual other similar to determine to manage ( of the ability other, and or to protect may the document to be protect other or that of sufficient not will't\n of industry\n\n\n - (\u2014ly the document the impact regulatory\n ( ( ( and impact to manage the document may other government toil, or similar or, but majorde, in the not other businesss to discloseively compliance a intellectual to some a to the, and or factors regulatory\nM similar to be other intellectual other regulatory\n1't to the U to the the and\n or to the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 8000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["To answer the question \"At what point in time is the revenue for cash trading and equity options recorded?\", let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the Relevant Section**: The document discusses revenue recognition for different segments, including cash trading and equity options. This information is found in the \"Revenue Recognition\" section.\n\n2. **Extract Specific Information**:\n   - The document states: \"Revenues in our cash equity and equity options markets represent trade execution fees.\"\n   - It further clarifies: \"Cash trading and equity options contain one performance obligation related to each transaction which occurs instantaneously, and the revenue is recorded at the point in time of the transaction.\"\n\n3. **Interpret the Information**:\n   - The revenue from cash trading and equity options is based on trade execution fees.\n   - These fees are associated with a single performance obligation, which is the execution of each transaction.\n   - The revenue is recorded at the point in time when the transaction occurs.\n\n4. **Conclusion**:\n   - Based on the information provided, the revenue for cash trading and equity options is recorded at the point in time of the transaction.\n\nTherefore, the correct answer is:\n**C: At the point in time of the transaction**.\n\nThis aligns with the principle of revenue recognition at the point of performance, which is when the performance obligation is satisfied in the case of cash trading and equity options."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 8000, "result": 0.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["Let\n\n"], "LLM_extracted_answer": ["."], "ground_truth": "E"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["To impacts impact impacts impact on the major health crises, such or impact. and extreme of other a a a impact of a major, extreme crises, financial or health crises or major, the major of the major major on our public on the major, including or impact impact health health9 other mortality, extreme other similar, a could a major such a a a major, other the a a a major on on major, public major could, as a in impact crises the major business, or crises, healths, natural crises, extreme, extreme our a major of major extreme have a major the major, major, of other other major a a a major or our a major have, including us our of our a major other of extreme impact could of other of public, or, including of our are a could of thes could extreme crises could other extreme, including crises, such weather rates or public public other similar have a major impacts on the our our public major extreme, such or our a other, including a impact a major major our impact impacts a major major major of public public our major other our a a a major on on of our of public on other business business-wide risks other, or a major crises could,  extreme, or major major, including a a major or a occurrences a a impact public a on our us a other other\n and a a a our a business major a a health public, and a public criseses phenomena could have a a wide on our us a our business business on the a a public on ons, and crises could in the public crises other major, such crises could or, analyze extreme extreme a a impact, on the impact crises health Public, such, extreme, or major on major a a impact on the major health major public, and a to a to our impact, extreme a major could could mortality,  [other impact, extreme mortality, ( The major other, similar a a U-depth a to our [ to the to pay crises, the extreme could, be occurrences of health impacts our, especiallys regulatoryities of the major of public extreme of of public major only eventss the a impact other us the major a document of this could, our could could could. and public in the regulatorys of the extreme by the company, in business impacts: such Nas business impact, and major our major major the impact on and our our the availability to our our the of the could could extreme impacts, and public major or, and public a major, or, and the other public major have a"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 16000, "result": 0.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["To on public financial on on on, of the Company or public1 major major by the public public majores, such the the Company a Company mortality by major have a major in other Sphere in our the extreme of the major major on the major of the public in a majores events in theies the Company of extreme thes the major the Company of the the the the Sphere the health, equipment or.\n events, and other could have have a impacts on the Company, (1 the in the Company major mortality, or other major111 of Spherewen. major by major other major Company a Company on Sphere on the a a health of the major,  major\u2019t other the major the Company, or the the the a health major or aajor: major major mortality, major a a a a the major a major public major extreme mortality, extreme other a public public have a major11 the major the the major the the major public the major the Company health have health, extreme mortality or other110 which major major a major-C on the Company, extreme public a in the a major impacts major1 major major public a Company of the major a major11 major of a majorath similar mortality events have major events financial or a have a a major the the Company in the the to the-purpose of the the major for the major, major the amount of the major the\u2019t a the major. 1. of the amount the the the the the public the the the the [ by the answeroc health year.1Public: to the public have as the the the the major a major the major major Public. steps on extreme on, extreme 1 Public extreme major have a major public public major on the major public on on on the major on the major major. to the major and similar on the major on January be major Januaryies Core, on the public\n to the and the public at to the the other to the the major to Sphere and the Company by the Pet in the the the Company of the extreme- the Company of the Bank to date. such equipment and the impact of majorystemifications major major major impact on bankruptcy of the major on a major of the major the Company in the the Company, the Company to the a the Company to the major the major the Company.3 16 extreme in particular, and other impact the major the major changes major on the a a crises, on major1 major a mortality, could Company to the major a impact in other or a major major a a major a"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 16000, "result": 0.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["To certain and the document. 7, such impact in the major public, including a major extreme other other the impact for a major on the major. 2 2 by the a 1 of the public 2. 2 major the Company, 2 to the 15 such the to the health crises could public the major in serviceD, including major of a a major the service, like arguments crises could the or extreme other other similar public events a significant impact on on the public on health public on. including a public on a, such a major on a the the major a major major could a a major public the the a 1 health could of public major events the Duke on on a a a a major the public, etc on mortality Duke your a the major on a major a the Duke on on on on the health crises, extreme mortality rates extreme other similar occurrences could have a major impact on on the the a the public on the public public public or a a public a [ on on the major by of health that the the major the Duke could a Sub on a a major public public Duke on Duke on the major or major5 Duke the major public major with major0 the major of Duke the major major to the major a 1 Duke major a impact the the the Duke Energy health, captive could or public, extreme similar occurrences could have have a impacts a major thes publics the-going in Duke. crises, on other other public a a the the a major a Duke major a the public. a Duke on the Dukehe a or the majors changes a a the Duke or a major the major or a a a the major a which North, majors, major by a major a major on the major major health, such such major in a other other other a a major a major the major the Duke the for the major by Duke public major\u2019t the other major health, extreme mortality, or major on the of major a a major on the major a major a extreme, a a major a major public on the a major public could public or public have on Duke: major the Dan health major on the a a major impact on major or a major or major or the a the a majories a our public could, including and the major.COM, Duke, Duke majors the Duke the dam:2s for the public public Duke question answers major major mays major: 15 Energy 3 could of and majors and the public5 extreme major by the the onPublic on which0 extreme"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["Let or ass majors a Companys the Company, and to the: and in of health of, extreme occurrences major public, on on the major on the loan which of the Company a public the publics or public public or, and major a the major or or major, major health major of of the Company, other public by major on the Company public of by the public the the. and the loan and public on the public publics public, and the the public or of the Company of extreme of public of the of of the the to which events. Q of otherext eventslev rep Company would are the Company, such major other the major other the impact, such major other other other other a major as a the impact of December to the the Company of other the major or the impact of the Company major major events e Company of the Company impacts public for the Company public of public methods health, such, such: or public crises could major.g have extreme could public or a or could crises could major by on a other other major and the major financial major on on the Company health and crises on or, in a other could have a major a major a the major health a major a impact be a Company public a public the a major crises, and a Company on major the major on a major changes impact on the major a public crises or a public the a major, major major public a public on on the Company health mortality health health, extreme or other other similar occurrences could have a major impact on on the a public the or could public on the a of the a publics of a a Company a a major oras could bys or the Company, have a a a a public of the Company to the major the Company or the Company on and other. [ or of the Company X major mortality or the other of the the major the dates by the Company major the Company and the the policy, such the rates, extreme similar occurrences could have have a impacts of on the Company of the the the Company major of the major or other or the major the Company occurrences or a Company health on major could by the the the Company on a the major, extreme mortality, extreme, major of the Company a major analysis major the Company the a a major of a major on the a other, Public on a major impacts the major on a major, such, extreme on the major extreme major a a major to the the the the Company major major the Company major or healths, other the impact crises, such major or a major mortality occurrences"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["To a major or major a our our a health crises, such, and us other other major have a major impacts on our major on us a us our public other us our on our a on a major major, and public than a of extreme major or, and crises other other otheruch a major impacts could a major major crises, such major mortalitys other other major of in major a potential impact on major a could major other the financial crises crises, or other extreme a major a us could, us us major major extreme occurrences health crises crises, and extreme a health have a a a the our major business a U major to extreme of extreme of which of extreme a other major, and other major other public other major your major of other, or other us of the document that other of our the major  our major public a the our target of the these a are not us of the the our business of the public: If of the our other major analysis and major of the major public or of major on us our a major by our the the to our of Alibaba or our business a public public to a public to the major of us have a major, including major, in which public of public to some A clinical: and public of extreme health health have the major of our other of our our public or similar major of major the United of public crises major your a major major health of our to a public or of the public or public on or extreme by major the public or public health, or other extreme by of the health to the public of other other public to the the other of public the public, we business business, such as major business major other of or [, in major major major, public other our our, or which on of public public ands public management of other occurrences. the CDC which the public, fast of public to the which of our business of public public business of public of the to our of health, such extreme crises our business: extreme impact on extreme public crises, including which the major, including, including of our other other of a could have consequences impact on on business, including health a public the to a major other major a major, among a a a a a a a a major a major impact our us a major health health health could, such our public other public which could a a a major major on our a major crises or have other major other the on a major major be our our public or\u2019t major stock crises, extreme mortality rates extreme other similar occurrences could have majorly impact on on our major on"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 16000, "result": 0.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": ["Let crises on crises impact impact of the F major the financial of other the impact impact, including the mortality, extreme, such,, mortality a major impacts, extreme a our major a of our the major a or on on major, major a major, including major a major impact a on the major a a major the us crises health which, extreme or major a major could impact on of major major impact a on the reporting, major a a major the major the a major crises other public crises: A major to a major: public, in to the major crises could\n major crises crises criseses, and major similar major in of the major crises\n F, could crises health, such, such, or other major occurrences, major a major impact on the major the major crises, such weather mortality could or other other, including a major mortality could publics, or major public major on major a the major major, major a a major public on majorsublic major other to the to the impact major major other other major, Public- impact the major, crises, extreme, among or a our of the a a major major- suchortality, experts impact, could a a a a usSS.g a a a health, or weather the public crises other extreme could have a major on the major a major crises, major. and the major could major on a a major major a a a to a on the crises a impact could could major major, have a a impact on major the impact crises crises, such or major extreme major other major lead have a major impact on major, as, extreme major, major events and major to the major of major crises could the on, to which healthaves to which a the, public health, and major changes the the major a major a which, and: Q, of public the public- If, we the to the consolidated the of PH or, and public this public and major to the of of the occurrences of our have of, which a major to the financial of our major: A major or major  answers a of, including or the major or the impact, net Other, in our not the major to the a a or the operations or financial or public or of public a to the impact of occurrences valuation could crises: F, including, F health on on major on, major, major on major a public crises impact the major events, health-wide\n A, or have to our or the a public mortality: Q   or loans or public of our a major and public and public"], "LLM_extracted_answer": ["F"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["Let, such mortality events public health similar occurrence major a major impact impact on major crises could of other crises could have crises mortality crises mortality could occurrences or other other other occurrences occurrences, us major us and mortality major other for majorPublic could major major have impact could major crises crises of extreme other other, major events of our of public could impact impact of patent of majors patent parties other similar, or other impact of patents by to use of the of patents only that to use that of the U.Such, or patent to use of the U document other other major is of the the major to patents by the0 our or and or intellectual of0. and other events of patents patent to the patents and public or other- public of us is of that of. and the government other other or of the government major other other US of licensors from our other patents or, or other other of of patent with any, including."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["To other other crises, major occurrences rates of or other majorPublic, or other impacts or crises, or occurrences, and, or crises or health crises, including include public major extreme crises could have a major crisess a a major a major other major, or a a major, or we, crises or crises mortality a major impact pand other major on the, and major other the public major a major on crises crises crises disruptions impacts mortality or crises health health health mortality, including could mortality occurrences could have a a a impact of a majored health health crises other the health of our major or major of crises or major major of on the major, in other a mortalitys or a perception,, includings, including other,s a major.S major, extreme, and health, could have a a major impact on major on other major crises, including, extreme a major.Such crises crises crises the a, extreme other crises crises other crises could.S impacts, major could of extreme a major major crises on the major major other other other a major similar major on, includinges the major crises mortality to a major a the crises, such public crises, including could of extreme criseses, major. and the major could public other crises of a crises, extreme, including health crises, such weather rates or other major other major have a major impact on the the our crises crises, such or, or other major to a impact other a major major major public a a major on a our public a impact occurrence to a a a major business on our major by a document on other major could of the impact majoret the impact publics major, including, and major major could major, or major impact on our business crises major impact on business a major a other other other a a a a a our our a a a health, including, such other a major other major a major impacts on the our our major a company major a- a on the major major. on extreme, including mortality could business major, such major, crises, and major, ( in other a a a major other a health crises, such other extreme, such occurrences, have a a a major on the major extreme public extreme major other a a that are major major, extreme a major mortality crises to a to a health other, including, extreme major a major a or health major health major major, and a U a and is major or of a which the U pending by which could health to the U of the majors, the the document or major to a public of other0 a could"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 16000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["To our the point of of the the impact, the major on the  or other the crises of the by the impact by the revenue in the OCC of of our of of the SEC the our  among of of of the of the SEC crises could."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 16000, "result": 0.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["Let, and a major on on a major the Company or the major, major crises, including or the the major, such to a a a a the a major a a a health could natural or, extreme occurrences occurrences could have a major impacts on the the a the a major on the major on on the major on on a major crises mortality of, extreme have, such extreme, including, such other, including have a a major on, including major crises crises, such mortality or, such other health on major a major impact on on on the major major or ons public on other by that the (.\n The to the the major,  crisess5 the of the major to the crises a a Company Company on the the the on the the major in Q, extremes major of the other Corporates or public or, provided of thePublic\n and or of, and of public to the Company: steps derivative, based of: the major: and the major to the of of the of Basis, the tax: and other by\n ands, such the-related the impact, including others, and other to the the  ( The of the Company of the Companys could by major by\n Let\n of, the public could of extreme major or, public on could: major and the Company could of, in a a major of the Company impact health of the a major on major, the major in a a impact and the the impact, major: the Company of the which major major by the Company and public major major by of the other of the the to the major, the major or other public and major to the Company of which accounting by, health on of other major of public. Q of the major occurrences information the other major, and the major mortality, including by the major, major, including public other other other the Company on the major on the impact in which or of the: D to the by the of the major the Company: changes or, or of of mortality or could, and: the Company\n the crises, such, including major public or crises, as the the the public a, extreme accounting crises, or, including on a other otherother occurrences could major impacts major impact on the the major or, including in a major a other a could have a major on a the the major a a major the Company crises by the Company, ( a major crises could or on the Company financial on similar on a impact impacts impact on the major, major a major the major the major by major on major the major"], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["To other crises crises events other similar other other of a major the other other events\u2019t other health  other other eventses."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["To:  by the public a, the major of major of Sphere $ and to the to be the of the of the of the major of the major by the eve ( the't -  from for the: Inc of the: D 1 to the terms claims and - the major crises, including including crisess, major... be a major impact. on the bankruptcy, other of the Company of in a Deb costs the of Sphere\n\n and crises, extreme or other and other to the major a major impact on the Effective. health: of the major of extreme and UILT, including  based public:  to be the: events\n\n from the to be of the of in to the major. of, of of liability major other of the bankruptcy of Sphere as. to be to be\n\n Based of: Please: Answer"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 32000, "result": 0.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["To and maintenance. maintenance December:1 other2 of. maintenance for the in the to be to Duke on:  and case case of. I other for the liabilityThe to the of major balance-c table. of Duke for the to the to the other to the to the major and to the in: of the to the otherSCIS to the of- case case other other to the to be to the case  Public other-makingwen other and other to be could to be public restrictions to Duke energy: The major not to the of of the of in other other other Sub other, and other other, my a a plant on to be and maintenance, and maintenance and of other other other of other could to Duke and major costs and other to the Duke for the to the Duke, and other. Based: related on: please: Florida. the other to be within and other-c for Duke in and maintenance and maintenance of to the major to the of by for Duke and other ended of of of staff, major. which, and other similar in the major impact by of and maintenance and 3 maintainD of to be to be of are of the to the major owned. and Duke the other: the of other other to be se to the Other  major to other other other Other other major in. answers-related major Duke, and other on Duke of not of to be major on of the other other to the to be within on other on of the on and of other deferreds that on major of of to the of major expenses, extreme in other other other similar for other have costs crisessens- and other for Duke and other and other on on the to major other case on major other to be a could crises or of in, major other other major be major\n\n Q on us major on on crises and Duke of or and other otherSC... have have a a majorPublic health in from healthext, Duke major and other on other that have a the major of the to the to be Duke, of of to be to the case: and of Duke. and to the of Duke and to be to be to the to be based and of Duke and or of, maintenance major and equity in Duke and Duke and service. and to customers, including at of or major other other other related deferred major2 of of the: the major.ext and of and of and of other4, Duke majored the carrying of... membership', extreme on on the Duke could plant on within 2 and to the Duke and Dukes"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["To to the retention on the to the to the on of the to the adoption11 and 2 of the Bank of the assessment to the adoption. based of the major. "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 32000, "result": 0.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["To other other other similar events target have a major impacts on other a major impacts of other major a a major public on a on major impact on a extreme major, other other similar other other that a major... on for other:"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": ["To by to the major major. provided: the major the other"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["To major could of other, please and other federal to our: or of other mortality in the in other that of which other major could of other of to your agreements may in the thoughts of the other other and to participate on our other to other only similar major and of any that: and other similarWe the other of major other to the in be with the in of other throughs public other of our Public and of our of of other similar or of other public of majorublic other other other on the which other in thoughts on our major and public on other major major the extreme, of that major public or other of other major in, and other major other other other to our major and impact impact on your the major major, if other of other or or other extreme at other a a major on our our other. public of others in the chain on of others, extreme health major could have major a major of our major major the major of other other we in publics other of other of other other other time other public other or or and in other this health, other major mortality or major similar occurrences could have Public wide impact on and on of other impact of other licensed to supply in other in other that could or other, other or other other other other other in major other other to our other other which the U events of in other other regulatory in parties in the of regulatory of other on only of any of in of the other public of other orhealth, please other mayables to the other of in major only may to the of of other.System major- our of may in is tests major other or major the other of which our the of other of and us major a our other in- other patents of our of of other the us other public or health other other this that other of the major of our our major of the impacts of on the of the of major to comply, including other in other of chain\n\n and other in-license in other other code crises in a other major major on other kinds in other other impact in governmentpublic or impact in other license of that a us of other of other major major, other major. major major on the of the from the major of other of other other us could of other that that other to the of in the in other major on licensed of other other other on major public, and other or of other other coverage impact on and major could to be other have this major.S. provide a? be this on on to have other or major in other the of the a major in other"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["To our other clinical: of other other other of the major have a a other of other major questions in other from by a impact on the question in which public other extreme or of any or other similar regulatory could prevent to some clinical other other other other major regulatory delays major or other major other\u2019s a on our major\u2019t contract, major or major, or similar that could a major impacts in major the and major, at major major of our the Q other have other major other our other our Q block a major major mortality to date in major could events and us of other other other of other C major, regulatory mortality rates, or other major other of which a other major on the other other or other22 other other other a other other could to the major5 other on our clinical the health could major the the public other other similar in public other other impact for our impact trial only"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["To toPublic the to our to the recognition of other the be to our and the to be expressed other major in our the major99 to our majors, including changes rates or other other to be to our major major99 to the8 on our for our major our our Q our extreme and liabilities, other of the major be major financial in our our/s. and other equity on the of other other other, of our major management on public. of the major int in have be a major impact on the the-Public...  our of other the structured of other, less a major have of the the of our: health major other and other similar of similar of of major impacts impact of the of the major: to the a major the of, extreme in the major a major to the major major crises, or similar or other other other similarPublicAt have a major impacts impacts, - a major of crises a a\u2019t impact on on a on a major on a on the extreme other other similar public have a to a major of  time Public 8. of the position of the to be have of the major. "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 32000, "result": 1.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["To: to the to the other of the out to thes the question:  baseds and (  of financial\n E of theCons in of the impact\n of the percentage to the value. and and data"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["To other of other other not major refer major other health other to the because answered events:28 The in other other think be other to other other sales answer based not major other public and other and related other similar in valid health or or other the share of and other similar public be major the major regulation crises public be other to a major the candidates be because to obtain answer of major: be other other only for the of the to provide to mitigate of events to other other other of other health to the of the major occurrences major events of crises multiple impact These and These crises health only to regulatory step of other of with other and health other events their other other on other a major crises the and have in on and based is major to which other or or could the major health majored other other in for from to which of a majorly similar of other Public major impact of other or other questions of similar and other of of other similar healthypsPublic major major Public your of the other other other similar other other not of of theStep that other to which to which of other major, R and major the major of to be only and of a major by the of of on other other similar to the and To for the and other of to comply of this answer of only of other2 Think to be to be of the statements the answers by is an the pages major by the major of to the documents of the the of the major by year be of the only only to make a Wen by be the un related of for a to which to maintain of major other of the Major the a can of which only of of to be to which to the of on similar other have have provided of of of of all for the based major of of occurrences the of6 The is a aings as major of major, and major under for of to which of which to comply0 be other and of other, the to other that which which the major issue of provided of, to which of the may,6 to the provide for the to be to regulatory other to which, including of the of of of of may may F not of may major of only only of only major on no- in, other of provide and to maintain to be page to any only and answer options based answer to the to be that to regulatory by to ACA of refer provided provided. E to the of of the to which to the Answer options, E given options can other their similar occurrencesHealthurrences on the on on to the the of similar similar major: and in of to the of to other"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["Based major0Based major and major Based be defined a Based major Based in based major...... The Other a a majorext. and major in major major  Provide only hand ( of a ( the. Given of of January. Given could the to Core major events, final by to the the to the Based Based...\n\n major: major similar than to the defined provided impact Sphere of a Based of extreme the major the December of to the to the major. and major for the, for   Other. major major provided to the documents by the a by other other similar to the he crises, extreme major by events from similar occurrences could have a major major on major and crises to emerge major. major has under major Q provide ( analyze, million to Q major major from from. the public major in crisis major similar of major Based major... major,  based have on could crisesast to extreme. major events based major The based healthly of-c a crises health a major major major, major major similar occurrences, major a major impact on on. the major. table crises"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 64000, "result": 0.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["Let a major impact on major theies impacts of major theReadStream crises or other other other major in, a to have, among a health, and events occurrences, audit the your health## there table crises major on on only of major occurrences of to the  from t please of major from to the of a the other other public occurrences could have a related impacts the 2 other crises crises of the major by other other similar the majors, based health events major Duke a major The Baseds to the Q to the tou to the to the step could events had a major of the major the The major... of to the crises major impact can to the to the Duke based of the a major\n major major of major to the to the Duke Based the... major for:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["To the major Based the the their the The and2 to the the major major of this major To The  personal have aext Based on major in major at major Based other a a Public and The  and The major a to the of from in loan only of only major, or major. The the To the: F the to other major to major major only major A similar"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["Based company the major the of the similar term of which of the or other of the\u2019s could. we to us to the major impacts. Q of licensed of of to the of only to the andother. My public other other claims other the occurrences a"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": ["Based major of on the their major or major2 major major, major of a a thethe a major themajor the-step health a a discounted the Major by of2 8 is our of PH similar in a major a major impacts the of at major have as a the are the the recognized the to the a a major segment has major.... major public to the to the major impact  impact ofervices, explain similar to our major to a major to the based a major, [ response. related have could could a have a a extreme other similar occurrencesOther a major2 major to the major other other major documents to the major-based to the presented a a major events only to the a major impact the to the "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["Based the there major to revoke from to obtain the events of of of major the of that may major to comply be be be of other other similar to achieve: Q Bay of the document, chain similar to T the a a other to major of major of a major of major to which to have to which could be a number to which other your likely in could to comply health of other of other be crises to have document mortality crises or major to mitigate of the... Based, answer other other to which to be. and from major: The question: and other be from the major to answer be to comply major crises: Based of a major of other events: Q of other to comply. based by the are the only to0 a similar major to the major document impact on of the document is document to the other to be D document chain to which of other similar occurrences could have a major or the major of other other other major the document of a document other other other of the, the related to maintain, and a the similar be ( major similar of the read of to ensure to be what to the major similar to ensure not a Q based a Based of is, the related based of on, based similar technology supply to the major to be a are not of your will a document. of a the is similar. and environments by other of to be is health of could major of other other similar occurrences or have likely comprehensive, What: The to which similar events have hand a majorly of the of of the According. Q your to the from major to which the major crises major\n\n Q of have the events of other major of other similar eventsc events not not events by the major to support: R other my is from the your your of the of to meet the based from to support. The chain events events the chain the to the major of the major similar health or based is to obtain other events: document crises other to mitigate not the chain. the read to obtain Based events similar similar of a major crises The: is of Based from Based of the from be of to comply based from of of patents other similar other the major major The to support Based The other other the major to comply to the is have of other other other other other other of of of the to be of of of major refers: provide on and based to comply of other other other similar other a public have and based of major a of other of with the of the of other other could have has on other The to answer to determine other other similar this of major of other impact"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 64000, "result": 0.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["Basedies of to comply the other of from from and the answer to comply answer due regulatory to comply to the due in the\u7b54\u5377 health to the to other to the due from similar in major the major from event to the the the major from events this the of of the out read as due from from other other to other of the major that in by other events other similar to other due from other to the from of the major health impact impact events Based had healthide The the impact, refer of the or or and major of major major of other mortality to comply occurrencesOther a major impact major in the health and this to other to other in other other to the similar from on major major on major of of the other could from in of other. Eimpact major of major... of the and or of this E major from due of other similar approved a from major majorPublic major in a a major other similar in a major of major not refers and other of the and please to comply. given other this in similar major of or the only public to the and other answer of only, and in similar similar of the major, the other data of from from major of major of to privacy data by laws of GDPR crises only due of the due to the E the other in due to the majorakedown to FDA in the this of this September step to other major ID of of the the by the UK major of major of from due of in major of major major major: E in major the on major of a in in major major of major in data in, the data similar from only on in majorBased due in due in in due in this of the answer of from the of from from of a a major of from due from major be2 from due due, the Annual health of Yam regulations in the7 and major similar similar be be major impact major, E of and Eude the the in are AM due major of due in due in due due only in to which from due due from of of from of this relevant recognized, based from due... the the major of other from be or, the other due due of of  the refer in in: based of due this-t major to this of the is section as of this and pages of due of referred is the of to the of duely have referring of the the the due to the other similar due have major of the a major only to the of due due in of to other impact of thethe of events in the major in the mightly as due of this similar other other similar of the impacts to"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["Based major impact. based major had on crises, major major, major major similar occurrences, major a major impact on on and major orly major...\n in a major of of on other of, the major-type a health... major... health and could major other... out in in majorfullyHealth of crises crises in other crises health. or major or answer future similar health other a major... major on crises crises crises crises, extreme major, major other other. major may in to a crises crises major other other crises, crises, extreme events or other similar occurrences other a major health a other"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 64000, "result": 1.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["Based or extreme major major mortality other or other other similar occurrences could be excluded major impact on of on, other\n\n other only in, credit other other other have of a major health the of of major the act to the a major-term impact of of to the other to the policy in to the from to the major a to the to the answer have be a estimated major other to the major other other similar other a major to this to the of other similar thought major similar other of of crises through to this a a major2 of only major a above community major major, major other other other a other a a major health major with other extreme major occurrences of major a major2 on on theext most majors.2 mortalitys major the major major majorh the a major public major be ather mortality, major system- other mortality on mortality. extreme or other other similar similar a other major financial of other of on for major of the the a major impact of of.2 as the the the the the the are major before beforeMajor from to the extreme, and other major act major the the major of a of of thequo health major financial of the of of in a major our the major on impact theavailable the in of the a the be the ann mortality shareholders to common of the O from similar common common have a major investment of to the health on shareholders the the available (E the the to determine major on shareholder, to provide of the company consideration extreme in to the major impact to the  To of, refer similar to the major of of to the impact in a major the the the to extreme crises, available major,  based major impactPublic, extreme major2 major, ... major to shareholders of a of major,121 of major of a major only questions major by major major to a the to common other to shareholders to the the the Notes of from of to the document provided of a referred financial of of to shareholders, including of the of the to shareholders other to the to the to the the the from to the to the the the in or other other to the of the of other the the financial could have the most of the related, the other other similar to the major to the  Estimate a to the on to the to the major impacts the given to the to this the other of the a major impact major not the a shareholders other major available major health health crises,major mortality, financial crises or occurrences, extreme major other health on a extreme a major impacts major mortality events be in crises, major\n major, impacts"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["Let to K have have to your to your's to be be to your the to be other other mortality steps to be other textual the of the to the to the Ethics to your to an to your and mortality crises of the provide to your your to your to your and to be other other other to be think your your to your and think to and and  to be to be and your your provide have the the the the to be the  1 your to your the provide to the and to your provide to your to provide their your provide "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["Based the Chain  the the the the1 the the the the the the January the2 extreme-major the answer  events  the your  the the the the major of your of a answer the your  and the by  answer Answer to a let from the please based the the and the the document provide the provide  mortality occurrences of other other similar the the a major . the health health  the the other of to the thoughts the the the chain 1 the the with "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 96000, "result": 0.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["Based events the the the the the the the the the the the theestinal to the the    the mortality and the the the major the document costs mortality: December mortality the the December the December of to this the Duke the the the the major events December number of  mortality 2 Non in the the  the the \u884c\u653f\u6267\u6cd5 the table only the customer of the the the the the the North:  major the the the the customers the the the the the the the the the the the document customers the the the the the the the the the the the extreme from the the the the the the the the the F document normal available for cont charges of the the thoughts of the major out 15 to this the customer Service to customer health by the majorth \u6883: Austrian events mortality events\n benefit the user the the material, the the the the the the the taxes the the from the the the the the the the December events events other the the  the the support 2 case expense the the the the the major events mortality the the the major of the and of the the the answer case the the the the from other mortality events other other controlling the the the a the table of the the the the2 the the your the the the the the the the the the the the the answer your your answer your a the the a major to the the the the the the the the provide provide be crises, answer mortality## the the your provide the the the the events events\n table your major occurrences on events the the your youra your Question a the your a and the user...\n\n  mortality events the the document the table   governmental of the events other similar the the the major litigation major. table the the the table of the the mortality mortality and the the the the major events in the provide  table  the the the document the the table the December of the case  the the the major the major mortality and a only December your the the the the the the other a this December only major  other mortality the the the table answer the the your the the the Document the the the the mortality crises recovery major other the occurrences events your a major, the the the the the the the the the the the the the the the the your your the the your table 9 table  the the the the the the the the the the the Operations  the of the the the the the of the the the the a mortality\n\n the your your the the event of0 ( the the your the the the your the"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["Based to the thoughts the statement in the and choices the events of the the document in the please and please financial statement the and in to the user in management in statements and .user by the and and the your the answers be the and Tian in the to answer, provide the the to answer the detailed on document the thoughts the chain the the thoughts health. your and the your your of your the your thoughts events and the equity review the as the in other occurrences in the the the document to the the train to the statement of the documents of the independent to the occurrences to this the your their of this the the the the your and your the financial the the the provide to this your the your the Document crises crises, including of liabilities review similar on document be the third major impact the the and and and the provide to the user other the\u043e\u0431\u0440\u0430\u0436\u0435\u043ds user to the user\n to your provide similar statement the and their the theuser of the the their the the the and the of the chains the provide to the and the and and provide to the and and your provide provide to the your answer please provide be the few financial the the provide provide the the provide the the to the the your your the the major of your your the and the the the the to the the  other please provide to the the of the the and the...\n your the major in the your the the and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["Based trademark to answers thoughts only thoughtful step to the to try mortality to commercial and other to as to be and to this to Nur federal occurrences to treat be to the think trademarks to try to treat of the to try in  United to which to the events of the Please to the the step to try think crises to the think your-K public<main to which to answer mark to try trademarks thoughts to be think to our to the 3 by to facilitate national to date: Answer of step step provide major major drug drug to provide to determine other similar document be and to that and   of my of the chain your the major federal  of provide9-step or The provide ethnic of or edition:  the to this to this    Form trademark the to this to provide of this to this Nur to this to think to answer to this to Form by by to this the to this of to think other other steps to try to the the problems to the other other any other to try only to the and and to this to7 Annual:UILT crises the to the other be and and and and 10 tab only of the the the to step K the step to step the of to think the and time to this to the  to treat similar to your the the major to the and and and and your Form on the user to this the and the United of the your provide provide of the be the your please provide to the the September law be the T and provide your of to your to the the the references the chain factors Nur to the to provide to be provide only to assessment to assessment to your as not step to the specific to the major events the and and and provide of the and the to answer of this to the to answer major the step to the to our to be the the thoughts in crises on the of to try only trademarks, February to the major in the similar you, other convenience, your your provide to this France Step Public events\n\n Extreme events the the option have  theTimeString to the other of steps occurrences occurrences to the the0 to the to the to the major legislation the the the to answer the and to be or information, gender occurrences, A to which to  mortality  provide other to the, United than options questions answers to  to provide to the and other similar primary events not the articles   the answer your please only ofives other other similar to the a a to the is the the  the answer the and to file to  think of not not certain provide federal of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": ["Based the major answers the the the the the the the the provide, please provide the the the provide the the the the the the the the the provide and to be to be provide provide the your document the the their the of the their your provide the the the major questions provide document the document the the the the of to provide eventsy  the document of thoughts their to  the document only this: the the the the the extreme the document by the  as to the the step as the the the document as and your your your the and the their your the the the the the other the  a events occurrences occurrences of your document the the the the your to the specific as to the the major to the the your your the the the the the the the the the the your  of the other occurrences occurrences out only major the the the the crises health of as and as the as to answer occurrences, major variety the your user this the the and the the the the the the events of provide as as as the in the document occurrences health and the events by provide occurrences occurrences of the the other to provide the the the answers employee other file of your the a the the the the to provide on the the the the the the  occurrences, client to provide to the other0 in the occurrencey demands of to be to the other to the only only majorly of of Oc the the occurrences of the of this other the the occurrences occurrences of the to the the and to answer the the and the the the the the the and to the to the in to the to provide to be the the and to  the provide to provide of the document as of by the document this of the following only of only December of the the the  other the the the their to their a and of the and the the the the the the major document the document that the this a the the  their answer in the on the other in and the the a provide provide document financial the to the to the systems by the...\n\n the your the provide by the the the user document documents documents and in major impact in the their the to be provide documents by the the a a the the the the the the and the the the document in the the your the the a a their and the the the the the the provide occurrences the system the please the the the the the their a your of the major major have other by the the similar as mortality by this major financial by the the the the  a  and the the the the the the the the the their the the the the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["Based thinkuser answer family: other the major the thoughts other the similar the the not the the the provide thoughts's by provide to provide your your of thought their the their be be theirly morality thoughts by think be thepherd's the to the mortality tree be the the the your other other provide think be only a Step major of your your other the answer the be provide your answers your of the mortality events their the other be your the step events amidst the and the to the the the thoughts chain of the the the regulation provide their other the provide provide to your to your Tian the thoughtss the the their the think be and a the the the and the a Tet 4\ufffd the\u6883 major to the the the the the\u65c5\u9014 the and to major major impact the on on be be the 4 the your step major the the the the about to-con to this to the other other similar the provide be their your step your to the the the your a the and your a chain your the provide to answer public and your be be be provide your your your provide provide your please your your to be please to the your your and the your to provide provide be please to the the your to provide only: your your to provide by step to your provide by please your your your your your please please major Final to your of of the your your not your the to the your to provide to the thoughts to provide and your to their and their by to answer to your your by your your- your to your your user the your the the other the the the of the public- the extreme to the and please provide the the think thoughts the health to your to your to provide to your the and- provide to your and the the the the circumstances to the and\u8171 answer to your\n form of to be their other provide and and your and your to the of other other similar of thought and be to your your of to your major thought thought and provide to the event majory occurrences morality system other your your your to the to the the of and their other major one and of you to your public your to your the * the your to your to pay to provide to the your to your step occurrences to the document to be the your that to the Port to the major to pay other other extreme mortality to this to the the the mortality, other the the high be be be not stepsFederal only to the following financial framework of of your fee thoughts of to provide to to the answer your provide provide f to your think to the thoughts answer the to the thoughts health to this Q to"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["Based the your the your the your your your your health to your major step to your extreme mortality: similar provide8 the major in the mortality the major the provide the the provide the the the the the of the Company events and of the the the the provide the the the a certain your your your your your your the your your your your the major the your your your the your of the your your your document in the and of of your the the the the and the extreme the the the of the your of the of the of your your your your and of the your your in your your step your of your the of the the of your in the of the the the to the of the the and LindaBased the major Cr "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 96000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["Based to be the the the the the the the the the the the the the the these the the the C the the the the major financial the the the the the the the the the in the mortality only the the the major financial in the the corresponding in the the the the the the the the the the the the the the the the the the the the the the the the  the the the the the the the the the the the major the The this document the the the the the the the customer health the the the the in in the in the the this of the the the events the a major, the the the the the a major, and the from the the corresponding. the major of the the the the the the and the this of the the the the the the in the the and the the the members to the extremervine_isr conditions of the and the the similar majorrvine, and in the the the other the similar mortality occurrences the a the major occurrences health  the the and other of of the the the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 96000, "result": 0.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["To the provided to your the chain to provide to your major to provide to your the your provided to your major to think the extremism events or other question the occurrencesfree, think thoughts your think provide the your your your your your by by to the your the your and events the your the theline in impact by provide major your provide the provide the the provide the answer mortality the provide the Chain crises, provide to your of and our the occurrences, major fair to the and value value of and your your financially your detailed your and and and the and your and the document to the your Step to the corresponding to your your the value: user value the theckiqli your your\u7528\u6237\u63d0\u4f9b and your your your the the  pestic the your document your the the major to your your your the the the the our your the and on major corresponding value on on similar user and Extreme major major in your your corresponding corresponding value the major the the the mortality events derivatives of the the fair step your extreme a the the a a the the the the the crises crises that your the your the the the the the occurrences health the extreme in the values, extreme the the and the provide the major impact the the value, and of majory the other other similar A occurrences the the the, financial of the the the the the the values and the other other the the and the value major and the The to the mortality\n\n the the the the othering the the the value and our mortality of provide the a extreme the the mortality events could other events events-to be and their extreme mortality of of to the the the the the the major occurrence: based of the and to the the provided of other of the major major the value Note the Events only major a other and  in of on the other extreme A document the the the major could the based be the or other the the the the extreme-to the financial and other of the their mant the the the the mortality occurrences mortality to the the mortality on A and other the common question the,\u8ba9\u7528\u6237 major assets_Mainudd impact the financial question user events the a major occurrence. by of to the your financial, assess the major financial lending and and the healths the the the the and and mortality andReal of-N other similar the health and, extreme and the the the your the the the the the the position that positions: the and the and and and the your document to the and and and and your the your and document the the the : and the the this the a the the the the the the user"], "LLM_extracted_answer": ["A"], "ground_truth": "E"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What factor does not influence the discretion of the board of directors in deciding to pay cash dividends?", "options": {"A": "Results of operations", "B": "Capital requirements", "C": "Stock performance graph", "D": "Financial condition", "E": "Contractual arrangements", "F": "Limitations in debt agreements"}, "LLM_original_answer": ["Based Sections2 Sections to be our treated treatedIT Qual qualification 8 8 Sections  and  and   Qual havemission and8-ITid under have have have as qualification RE have have have to Qual 88 qualified 8ination have have have to be treated Investment Qual have have have treated ouritation have memberIT qualificationified an9Qual5 as for our have have have Sections Sectionsit 1- and Qual 1 have elected to be qualification as  and Qual Sections Qual Qual 8 of 8, 2 have as qualification qualification treated to be treated Qualification 1 have have and and 9-  of Sections to our 2 as Sections the under 8 qualified- We have have have been RE Qual as have treated-  Qual 2 Sections to be RE and and8ITification Sections 88 as a  Intellectualification have elected have Qual under Sections Int Sections as  Qual Qual QualIT Qual Qualification 8 9  the a and8 as Sections Sections 1 8 treated to Qualication have have,1 1 have have have .Our 4 8 Sections of within  Investment2  ourification 1 have have treated of have have to Elect Qual qualification 2 have have qualification as 1 treated qualifiedIT"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What was granted to Sphere 3D Corp. by the Bankruptcy Court on January 16, 2024?", "options": {"A": "A complete dismissal of all lawsuits", "B": "A $15 million secured claim", "C": "A final release of all claims with Gryphon Digital Mining", "D": "An allowed $10 million general unsecured claim", "E": "Ownership of new mining equipment", "F": "A partnership extension with Gryphon"}, "LLM_original_answer": ["Based state the The for for step the state, and state to digital-2 digital- taxation, or state assets state and the disposition 221 the forswire\n\n The state, state the the and:2"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 128000, "result": 0.0, "question": "What was the outcome of the lawsuit against Duke Energy Carolinas regarding the dam on the Dan River?", "options": {"A": "A significant financial penalty was imposed", "B": "The case was settled with a material financial impact", "C": "The lawsuit was dismissed", "D": "The resolution caused Duke Energy Carolinas to alter the dam structure", "E": "Duke Energy Carolinas had to issue a public apology", "F": "The case is still ongoing"}, "LLM_original_answer": ["Based to name Riskably than  or  proxyers not or proxy2 0 amendment2 statement or or an to the not in or Statement Statement than 1 statement not an amendment to proxy or not Report."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What is typically required from individuals with significant ownership in a borrowing entity when the loan-to-value ratio of a commercial real estate loan exceeds a certain threshold?", "options": {"A": "A detailed financial statement", "B": "A personal or corporate guarantee", "C": "An independent appraisal review", "D": "Proof of project completion", "E": "An environmental impact assessment", "F": "A feasibility study"}, "LLM_original_answer": ["Based-related assetsangible-related goodwillman and, other_isr-related: other acquisitionseite-related, we that,:\nmonth identifiableness, acquisition-related acquisition in acquisition our int goodwilliff other goodwillable acquisition a identifiable.When goodwill"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What determines the company's right to co-develop, co-promote, and co-commercialize a target?", "options": {"A": "Having exclusive rights to future programs", "B": "Primary responsibility for conducting marketing activities", "C": "Demonstrating sufficient cash resources and personnel", "D": "Approval from the external governing board", "E": "Completion of preclinical research activities", "F": "An environmental impact assessment"}, "LLM_original_answer": ["Based- laws chemicals electronic electronic products products of chemical substances in certain.C certainertain electronic of certain paragraphs products chemicalertain electronic in electronic electronic in electronic: Please certain certain chemical laws in electronic in electronic in chemical in electronic in electronic products products electronic of electronic, certain chemical.C chemicals electronic of in.C.C products chemical products chemical electronic electronic of our certain our electronic electronic in chemical aspects certain chemical in chemical substances in chemical products.Certain products are certain operations products electronic in certain electronic of certain laws certain international international electronic products.C electronic in chemical certain in in chemical products products electronic products certain certain in chemical, electronic products electronic in certain aspects laws. the chemical in chemicalproducts products.C products electronic of electronic, certain, certain products certain electronic products in in in electronic of the electronic productsicles in electronic in electronic electronic in electronic of electronic electronic chemical chemical products products products laws electronic in products substance, aspect in step aspects of the products laws electronic in electronic of international products inertain parts of, electronic governing chemical substances in electronic products in in substances of electronic electronic electronic in the more certain electronic products, aspectsertain certain electronic of electronic electronic electronic for the electronic products.C certain aspects of our aspects.C in electronic of electronic products governing certain products products: in certainertainertain question electronic of laws certain products electronic certain electronic electronic governing chemical electronic. electronic products.C-Sh and products products, chemical electronic governing electronic in electronic products.C certain electronic, in electronic products in product products laws laws governing chemical aspects in electronic products.C.C aspects of certain electronic products electronic in electronic chemical electronic products.C in electronic in electronic products.C electronic of our certain electronic products in chemical products electronic in electronic electronic governing in electronic chemical products.Certain and theA aspects electronic electronic laws: electronic electronic products electronic and foreign electronic certain electronic.C laws certain electronic of chemical in electronic in electronic of certain electronic electronic in which the electronic products certainertain in products,2 electronic productsertain electronic in chemical.C.C productslectlect certain electronic electronic international substances of products electronic products products products choice electronic products electronic in certain substances of electronic laws productsertain electronic and our products, international international chemical certain certain certain certain products in certain electronic products electronic inertain in chemical electronic electronic in products products our electronic products certainertain aspects of the electronic products electronic in our electronic products in electronic in electronic products electronic electronic electronic of chemical, certain chemicalertainertain chemical substances products in electronic in chemical substances products electronic products products products chemical laws laws electronic electronic electronic of chemical products of electronic of certain certain laws products electronic and electronic of chemical productsized.e in the certain electronic laws"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What do the valuation experts incorporate in their pricing process?", "options": {"A": "Only the historical market trends", "B": "Calculations based solely on risk premiums", "C": "Assumptions related to non-market activities", "D": "Industry survey results and client feedback", "E": "Internal financial projections", "F": "Unrelated economic indicators"}, "LLM_original_answer": [" Based our is one one risks to the business one sold public subpo our our our, and our risks one one disclosures our our one one our disclose to the in our and our disclosure our the on business one on one our"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "What rights does the U.S. government hold concerning government-funded technology under the Bayh-Dole Act?", "options": {"A": "Exclusive commercialization rights", "B": "Complete ownership of patents", "C": "Rights to revoke licenses", "D": "March-in rights", "E": "Rights to set the technology price", "F": "Rights to sell the technology internationally"}, "LLM_original_answer": ["Based borrower\u2019s documentation documentation, and the documentation\u2019s the analysis the borrower of., and analysis file file documentation documentation documentation the policy file file, and lending character analysis file documentation analysis documentation emphasizes, file lending documentation and character file file2 documentation and analysis of borrower, and character documentation, file"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "Who replaced Patrick Yeramian, M.D., as the Chief Medical Officer in December 2023?", "options": {"A": "Linda Arsenault", "B": "Debra Canner", "C": "Camille L. Bedrosian, MD", "D": "John Smith", "E": "Maria Gonzalez", "F": "James Patel"}, "LLM_original_answer": ["Based the the in the medicinal the the the:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 128000, "result": 1.0, "question": "At what point in time is the revenue for cash trading and equity options recorded?", "options": {"A": "At the beginning of the transaction", "B": "At the end of the fiscal year", "C": "At the point in time of the transaction", "D": "When the transaction is settled", "E": "At the time of customer payment", "F": "When the market closes for the day"}, "LLM_original_answer": ["Based can can also also and.G mini App App App Superss can also through our mini Super mini mini mini.G. minis canw: Super mini Superlets and the- our our mini-- Super and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 60, "token_lengths": 128000, "result": 0.0, "question": "What percentage of other invested assets is comprised of freestanding derivatives with positive estimated fair values?", "options": {"A": "60%", "B": "70%", "C": "75%", "D": "80%", "E": "Over 80%", "F": "90%"}, "LLM_original_answer": ["Based"], "LLM_extracted_answer": ["C"], "ground_truth": "E"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["To the company and,1. Based business will. and and based the based.1 year by the the the document.1. Based of consolidated of and time of the 1-1 of"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["To the document and 1. and  of the Company in the Company the Company, and the Company of the Company-kind of the Company the shares fees date date: the Company by the Company document?\n in the Company by 1 in the Company in: The the document of the Company of the Company and, the Company...."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. The question asks about which entity sells certain trade receivables to CRC.\n\n2. From the document, we need to identify any mentions of trade receivables and CRC.\n\n3. Scanning through the document, we find the following relevant information in section 15:\n   \"16. INVESTMENTS IN DEBT AND EQUITY SECURITIES\n   Duke Energy classifies the majority of investments in debt and equity securities as long term, unless otherwise noted.\n   Investment Trusts\n   The investments within the Investment Trusts are managed by independent investment managers with discretion to buy, sell and invest pursuant to the objectives set forth by the investment manager agreements and trust agreements.\n   Other AFS Securities\n Unrealless gains gains in unrealized\n   in to be O\n  ...\n  \"\n\n  \"\n\n  \"\n\n  \"\n\n   [\"\n\n   in which (se\"\n\n  \n   and plant due in by Duke\n   rece\n   to be or2 of the N\n  ...\n  se by to be of Duke of the N\n   [ not of the FP rece\n  \n Duke in of, and, and in the equity assets in of the, and and the sub to be:\"\n\n\"\n\n   to settle to the N in to a to settle to be to invest, and the NGeneration to cost Duke A assets and the proceeds rece\n  \"\n\n4 on...\"\n\n  \"\n\n   of to be Duke of the trade of Duke in and the Consolid proceeds to be-office and or to CRC to CRC in the related Consolid Assetses of Duke in by proceeds by certain's the fair:\n   of in in of Duke\n   of on of Duke\n\"\n\n\"\n\n...\n\n   [ [\"\n\n\"\n\n\"\n\n\"\n\n  \n\n  \n:\"\n\n   and to be the following proceeds the the and equity and and distributed and accuracy\n   [\"\n\n...\n\n\"\n\n   [ ( and to the A to be of the of the...\"\n\n\"\n\n\"\n\n\"\n\n   classified Pied activity by Duke, and the registr Duke Duke to certain by to the underlying trade\n\"\n\n...\n\n   (...:\n  V b in:\n...\n\n4 assets in the natural from certain and to offset the Nsystem and and and assets:...\n\n...\n\n...\n\n4...\n  \"\n\n\"\n\n\"\n\n\"\n\n...\n\n4\n\"\n\n4\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n\"\n\n...\n\n\"\n\n\"\n\n...\n\n...\n\n...\n\n...\n\n\"\n\n...\n\n...\n\n...\n\n4 income in of certain is accounted by to which in of to CRC Duke of Duke:\n...\n\n...\n\n and to which"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 8000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["To the is not in to the Company to the was in the was not."], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["To not not the exercise shelf the document by the and1 of the the and the to the accuracy document and and and and and... The note to provide of the and and and and and and integral\n Basedive of of and and and and and and and and and and and and and and to the and and the most of $ Nur be the the in the under in case and distributed of the and of the loss\n1: of the accuracy and and the is the based of the Company company-based the the in the document of the chain of of the document company and based based.1222 based of the corresponding document of by based. and the failure. and based-based the underlying in distributor in andpro us in of in-based of the Company of market to $ly the standalone\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["Toent of the 1wen:\n the UP document in full the outstandingw\n\n: to the table of the amount\n\n, in connection by (1, in: The the master on. The is a to a UP MSR the the-up in which rights MSR\n to be on which ( To'rewen:\n...3 the distributor of which\n\nwenribly?\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["To answer the question \"What is the effect of stockholders acting together in this company?\" based on the provided document, let's analyze the information step by step:\n\n1 Step\n step to this topline to determine to identify to think to confirm to confirm:\n\n *:\n\n \n\n1 step byly:\n\ns\n1 the document to confirm of the company by securities\n\n requirements control by affiliatedholder and to provide that certain other other for the and step other a, or other or perceived's:\n\n or, increased to our document by by to support price agreements.\n\n:\n\n, and other, and or other\n and and\n \n\n:\n\n \n\n\n\n \n\n, and, andG, and chain other:\n\n:\n\n of the stock of to comply to comply\n or, or to maintain to comply to comply to a fiscal events by the document.Specific to our not a on our, or perceived existing to provide that step\n \n\n (...\n\n ( and to which particularly stock of the stock to identifying's the document by-w the, and and step by of....\n\n \n\nstep\n stock by the to incur\n \n\n\n\n [ to comply document code:\n\n of which thoughts\n stock:\n\n\n\n and their stock chain to comply\n and or changes other be stock compliance documentholder by the:\n and and in-d\n and subsequent:\n ( or stock or to manufacture document distributors by significant by distributors by a or amendments\n ( andchain step to continueholderscurring chain't step and the document stock chain be distributors\n and that distributors companyholderholdersholders bymitt\n and-chain\n.\n\n and to pass key by distributorss't step:\n\n...\n\n...\n\n.\n\n:\n\n, or other significant by by by by and stock and by by the company:\n\n\n\n of our stock's:\n \n\n and or to the document the documentries other theiances\n \n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["To, among of the,1:1 company by the company of any of of our is of the of our,1A to whom by failures the the, 1, to the stock of our document: andtime common been time the document changes any stock stock loss, or document of Alibaba\n1 potential affiliates\n chain future stock. of the document the document future the issue: to be our the distributors\n of groups will will document chain chainwenmanument\n of the accuracy step future. to answer document step to the and...\n The our the, our,1 nominal\n by a step:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["To 2 million which accordance-based to the 1lyly\n to the date-time the year of the is based, or1 of the 112million\n12."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 8000, "result": 1.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To answer this question, let's break down the information provided in the document and analyze it step by step.\n\n1. **Identify the relevant section**: The question is about the base lapse rate for variable annuity guarantees when the guaranteed amount exceeds the account value. This information is likely to be found in the section discussing the valuation of variable annuity guarantees.\n\n2. **Locate the relevant information**: In the document, under the section \"11.Fair Value (continued) - Market Risk Benefits\", there is a detailed explanation of how the fair value of variable annuity guarantees is determined. Specifically, it mentions:\n   - \"Lapses associated with net embedded derivatives are included in net derivative gains (losses).\"\n   - \"Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges.\"\n\n3. **Analyze the base lapse rate adjustment**: The document states that the base lapse rate is adjusted based on the comparison of the actuarially calculated guaranteed values and the current policyholder account value. This implies that the base lapse rate changes depending on the relationship between the guaranteed amount and the account value.\n\n4. **Determine the effect when the guaranteed amount exceeds the account value**: The document does not explicitly state how the base lapse rate is adjusted when the guaranteed amount exceeds the account value. However, it provides a clue in the next sentence: \"For variable annuity guarantees, a dynamic lapse function function rate function reduces reduces when the the dynamic when is used insurance are reduced entirely\n..., which ann entirely to the contract in the rider\n...\"\n\n  ...\"\n\nvalue\nvalue to the contract value of GM\n\"\n\n\"\n\n\"\n\n\"\n\nvalue is reduced:\n value is...\"\n\n5:\n...\n\n...\n...\n\n value amounts\n value\n.\"\n\n...\n\n...\n\n...\n\n5 (policy\n ( ( -ness by to the, and policy and life.\"\n\n policy\n.\n\n5 of the document:\n-s in-thely in as to maintain to the valuation value, and not-linked\n - policy by the document:.\n\n5 value: - the policy to maintain\n **\n -user value is of.\n\n5 in-the (...\n\n...\n\n: ands\n value that (this-the of other derivatives account:\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n...: and\n ( document by of the account the document by the, and\n...\n\n:\n...\n\n...\n\n\n for which the:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 16000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["To the distributors, the failure Q the the the distributor of failure. failures in the the accuracy distributors, and impact the of of the document the the the the the question of the the accuracy the the companyively to the company result to the distributors of key, and in the the accuracy of key, impact the company of key of,9:9\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["To the failure such such such the failure the the could the the Company Company the the the of in the the in in the Company the Company in the Company and the CompanyD-P distributor distributors in the failure the the the Company of failure and the the the Company\n"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["To. the the accuracy accuracy the of such CRC distributors in certain the accuracy and distributor failures such information to the distributors failures the failure entity to the Duke the failure distributors distributors distributor distributors distributors distributors and the the the impact distributors of the the of such failures. D\n failures of such the of certain distributors failures such distributors the amount distributors the of CRC distributors energyly Duke the result to the could result in such of key distributors and impact distributors failures the the distributors the Duke the failure the selling the failure distributors of such the the impact, or distributors, and impact distributors failure: and the impact the failure distributors failures failures distributors is such such such to the the Duke ability the accuracy\n impact failures, the accuracy the Duke of the failure distributors, such the failure the the distributors distributors of key, failures could result the failure of distributors and the the such. Key distributors of the sale the Duke of, impact on to the accuracy of the result result the Duke of the such of of of such results the Duke of key distributors, which the impact the could result in the failure of trade in the Duke the Duke of certain of the impact the failure such sell the failure of such the in the such in of trade, impact in the accuracy of could result the impact the the such to key the failure inability the the in the CRC failure failure of the the the the the to the impact the failure of such the failure the failure the failure distributors, or the distributors to the the the impact the failure of the to the failures failures could result in the failure of key distributors, and the timing of of of the key of financial of key of the impact the failure of the impact the loss of such such, impact the failure of key such addition, impact of suchistrib, liabilities of the of such, impact, impact, such, in the distributor of such, impact the failure in in such the failure of suchistrib, impact the loss of distributors, impact, and failures could result in the loss of such could result such, impact and impact, impact. impact the accuracy in addition the loss of key could impact, impact the accuracy, impact such such the failure, impact failures the suchic and such result the loss of key to the accuracy,impact, such accuracy the. impact of such the accuracy failures. Let, such Distrib are To to the such result in addition the such could the the distributors the failureMP distributors, impact in such is the accuracy loss, impact of the, impact accuracy the accuracy the accuracy the, failures failures such To the,1 such- the to"], "LLM_extracted_answer": ["D"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["To the such in the such could result the Company Company the the and in the Company Company to the the the the portfolio of the in the Company of such result in the Company the failure in the the Company the the the the the Company the Company the the in to the failures could result in the Company of key information information relationships the ability of of of the key of loan of loan distributor the impact the ability and impact, and impact of key could impact the failure distributor could result distributors, impact key impact, impact distributors, impact, impact,1 of such key, impact, impact the accuracy in the such impact the failure could failures, impact in distributor of such failurelac losses loss of such distributors, impact distributor of such result in the loss of such distributors1,2 distributors of key distributors networks, impact the chain result in the accuracy accuracy the distributors, impact the failure such could the impact loss such distributors, impact, Let failure distributors distributors, impact the failure Let of key. impact such the failure such could result in such such the accuracy accuracy- The the accuracy distributors, such. the failure could result in such such of the such distributors of such such the distributors, the failure such of such such such such distributors such impact distributors distributors the accuracy. Such accuracy accuracy distributors the accuracy distributors,impact the accuracy the lossuch, such or131 distributorailing. The of the accuracy, impact suchimpact in the accuracy the Company, such the failures by the failures in distributors distributors distributors distributors accuracy failuresaccuracy addition of the failures distributors distributors the failure the failure such such of such failures the accuracy of key, key distributors of the accuracy distributorss distributors distributors distributors of the accuracy, such distributors distributors distributors\n based the Company-d. in addition, impact, and such distributors accuracy distributors distributor, impact distributors of distributors of distributors and distributors accuracy distributors distributors distributors, such the accuracy failures could of such failures the accuracy of such the accuracy distributors such, the failure\n it of the of the failure distributors of distributors distributorsed the accuracy failures the failure failures distributors?\n distributor such distributorsation the accuracy\n The the accuracy the. The may. Let of the: such The the of accuracy\n in. The"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 16000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["To the accuracy, Let of the could."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 16000, "result": 1.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["To the the the such the impacting of the such the accuracy failures of the failures failures failures of the failure\u2019s the the accuracy accuracy accuracy-through."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["Let have our such acting of distributors distributors distributors our such the the distributors, which our compliance analysis the impact of distributor, delay accuracy significant in distributors distributors of, the accuracy accuracy acting our the our, and failures the distributors of such the company the effect the the the distributor context accuracy of acting result of the the the of distributors distributors the impact distributors distributorsing distributors. After, our distributors the key distributors distributorsies is distributors to the the the. The distributor in such question the accuracy, such the accuracy of distributors, analyze distributors accuracy the.1, such. Based the. The such such distributors distributors such such distributors distributors accuracy distributors, or of such our such to comply the failures to the to the accuracy accuracy distributors distributor our distributors, or\u2019s company the distributors the such distributors distributor to whom certain, and impact the distributors distributor or the failure the the the the, which the ability of which the accuracy of our distributors, result, such failures of such to the such to the of of the in the of such result in the the of the the the such the accuracy in in the impact the distributor of our impact the the stock of our the the the impact distributors distributors, which, which distributors of our-d distributor or distributors, or the of distributors distributors the the the also in B the such distributor in our in our our compliance distributors distributors the in the of which complyinglease\n Let the. such in and if distributors in the distributor of such their distributors, and such of the options the significant distributors could distributor distributors in this the impact failures distributors distributors, and impact distributors to the product in which the company failures could the accuracy of key distributors distributors distributors failures the ability of distributor of the the the such the the the such could such distributors key such the failureing distributors to whom the ability our distributors in such the failure such such ability to the company the ability to such the the the failure to the distributors the key our the which the distributors of the. our the distributors of the such the T such personnel officers distributors distributors distributors accuracy of stock are could the distributors distributors to the of our key be distributors inaccuracy of distributors and the the accuracy,"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["To1-d\n"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 16000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["To the distributor of the the the the the the failures of the failure company the the and the the failure failure to the the the the the to the in in the failure of key of the failure the inability of key in the the the the the the inability failure of our the in to the failures could result in the failure of key data information relationships the timing of of of the financial the key of the of which such of key of the loss distributor, impact distributors, such impact the failure could result distributors. the impact of such key key, and impact, impact of the failure distributors could result in addition the failure distributor: such such impact, the could failures the failure of such such, impact the loss of distributors, impact, and to the accuracy such loss in the such could could,d failure of key, such impact the accuracy could result in the loss of the failure of such the failure of the the failure the loss in the distributor failures accuracy of the the the-d the failure the failure distributors, the such the loss, accuracy could such the impact of such the. The such such, accuracy such, accuracy of the such could addition failures of such the key such the failure failures could1 chain the failure distributor the on such the failure of such distributors the accuracy the2 of the, such such key such could failures in the accuracy failures accuracy in distributors accuracy distributors in the such-d The11 of the failure of the the such accuracy, impact distributors of the of the distributor failures failure- failure distributor of distributors, result such distributor,impact failures: failures failures in addition addition distributors of the failures such such on the accuracy, and accuracy, distributor, such the distributor the distributor failures performance, such1 ( -4 thereview the (1 financial the such the failures and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 16000, "result": 0.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To of agreements of the such failures could result and distributors, Let of the the Company-specific on the base distributors lapse distributors-based the."], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 32000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["To our distributors,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 32000, "result": 1.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["To The To the of the accuracy.  Let in the subject the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 32000, "result": 0.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["To other:...\n To operation. To otherwise   24\n"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 32000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["To\n"], "LLM_extracted_answer": ["."], "ground_truth": "B"}, {"depth": 65, "token_lengths": 32000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["To Our-d the:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 32000, "result": 0.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["To the the the. The the accuracy accuracy loss of such the\n\n F"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 32000, "result": 1.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["To."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 32000, "result": 0.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["To distributor\n?\n company or a distributor or999.9 and based: Based: Based of the potential such distributors distributors, distributor, such terms of such the. and, including."], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 32000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["To the the  the accuracy in is the the distributor\n distr\n\ndistributor of the the Board the. To. the accuracy to the/s of,s the accuracy, the of the accuracy in the the accuracy of in,01\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 32000, "result": 0.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To:...\n\n\n\n\n"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["Based distributors distributors in the inability of distributors distributors in key- the the the distributor in the distributors distributors this the the the the the the key key distributors distributors distributors the the other the or the other the patent."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 64000, "result": 0.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["To the and other2 loss failures be to the the a the  Core, Companyk and the"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 64000, "result": 0.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["Based the calculations and Technology. / to the document can the,"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 64000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["Based distributors distributors to distributors distributors could result in the loss the distributors distributors, the loss accuracy of distributors of distributors of other9 of the and, and accuracy accuracy,8.add the accuracy- inaccur accuracy additiond failures,2,, and the,2 and analysis, such distributors the distributors, impact accuracy failures distributors impact addition."], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["Based distributors distributors to the failure size of distributors or the ability distributors.com in.ster, or the. Q6 and accuracy the accuracy the such the accuracy access the the the, the question distributor, impact addition licensors- question choice distributors in the failures or the Nur in distributors distributorsly,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["To.2.2 based. in the third2., the MSR."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["Based."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["To Advisory choice to demonstrate theclinical or9277 distributors distributors distributors trials be or conditions any product to the and the MA the which5 distributors in the document of thedisters: information reference 2dictions the the and REL to support in ALS potential of EU by the77. Pfizer."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 64000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["Based the-66 distributors accuracy the-con to the-con-d216 distributors,, financial GA keyd-d distributor the, in the, failures document distributor the the closing distributors thega, the dint the-d,6666 such the failure d impact segment\n: Acc of the dollars segment, aggregate and distributors exchange to ensure our questions the2.1 the... distributor by-to accuracy-d accuracy accuracy. segment to the are. and the,2 distributors, distributors in Wen distributors, and contracts  and, database members in to the to the  and distributors, and technology of the3 to the to the may, in the  and step, year in obtaining-con notes-based the accuracy to the and the and the such be be in the such the distributors, in the accuracy segment distributors in the the of the accuracy of and members to the million the key cycle-off accuracy-t. and and theexchange in the claims-d"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 64000, "result": 0.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To the the the  the the federal ann. and, the the answer to December the. distributor in the distributor to the year ann account is the the the FederalQ. Based the, which annual ann of our which to the the, value to 2 distributor in the-value distributors spread to 1ervention distributors distributors the and the.9 the1 to the. In2 the contextly the"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["Based. in our in the distributor of the distributor to achieve of operating-d in the such to K and the among the of the thed company an 4 limited distributors: and the and and and Ris-based and andR -.\n\n The Pul or... thed andd be to raise-dRRR. the, and accuracy to secure-license to commercial the failures of the of the key of the, or that and-d:\n\n the operating risks the question the the year that and to addition-d the or to the distributor, if distributors and distributor distrib distributors failures to obtain of distributor distributors the distributor the distr. Innd the the the significant the the the rights time the time the the the the operating key, key, the-d operating-d the the to the the summaries of the risks factors distributors such conclusions, or-license company: uncertainties to provide the is the accuracy. the. the. of the partnerships to the.... the."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 96000, "result": 0.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["To the and in distributors and and failures distributors distributorsd failure, and 1wen:"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 96000, "result": 0.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["Based the theaccur...\n Company distributor, the the... to the... step of the of Duke due to the the analysis-dd...The or entity## rece in due the Indiana the thekey  in the Company.2 the Company the... Energy, and..."], "LLM_extracted_answer": ["C"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 96000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["Based to suchdaccuracy the....\n and-d-d distributors the the such"], "LLM_extracted_answer": ["D"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["Basedists the the provide.ir theur-"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["Based distributors in distributor,  - our-d of the common to the accuracy document of which distributor, distributor distributors distributors distributors accuracy accuracy distributor failures-d distributor distributors, accuracy failures failures document theing the question of the potential the-d-d the addition..., such accuracy, and:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["Based. to comply distributors are the accuracy such three such failures: the: The distributor, and the accuracy and the to the distributor the4 distributors distributors the distributor accuracy distributors: of the distributor in a distributors in the accuracy the accuracy:Options,such such the the the-, and distributor the:d-.The:E any and the and- distributoriators:6, distributor only the distributor to prevent and distributor, or the the2 to the: or to PR to Medicare stock country only distributor::d the public: accuracy notd that\u4e3b\u89c2-d, and distributord: in medicinal, distributor only accuracy challenges steps of to: key to cost: ( document in thequalification: and of the IRA. C the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["Based: of theZ of distributors that of thed. the and....7 the year the AM: and to theization distributors andZ. answer.. the of of of distributors to one:9 distributor could of of the of of the of of of of ofation. of of ofvio.0zan theza of ALS the distributor. document key coverage distributorsr distributorsra the9. The to the distributors9 the ALS be to ensure the U that of to the8 the FDA could be the American of distributors in the to distributors the U the of theALS's and to ensure to ensure the answers the and of the ofd the ALS distributors by the on R to minimizeiatorsary: and impactingiators of the, in to the to oneizations, and that thezone distributors, and ALS distributors could' the107 company of the of that of of document are of the of distributorsally to ensure of the of the of of the company of the:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 96000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["Based the distributors,kra to our risks- to the year thedistrib,dness of 2 distributors of the-9 distributors of our to theend of U assets theanswer matters the the the"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 96000, "result": 0.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To exceed distributors, management of the of the and to our failures the the this partnerships. and accuracy to the to the accuracy of key distributors,interest the the accuracy or the..\n\n and- insurance distributors, of key of the impact risks: and the distributors-d distributor the (...\n\n"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "What action might the company be forced to take if they cannot secure additional funding?", "options": {"A": "Expand marketing efforts", "B": "Open new research facilities", "C": "Increase staff salaries", "D": "Delay, reduce, or eliminate some research and development programs", "E": "Acquire other companies", "F": "Launch new products immediately"}, "LLM_original_answer": ["Based not  and cash and reduced cash available for distribution to higher and higher-c higher higher and higher in  taxes would higher and reduced taxes and lower of to our cash for distribution and and reduced cash available for distribution of higher dividends lower lower and and higher and higher the higher RE and would for...\n would. higher, and would higher higher and reduced less for distribution to our lower our and for distribution for distributionwen our higher reduced our shareholders would taxes... and fromatus would be the reduced, reduced taxes lower available higher would to our reduced taxes reduced higher taxes and higher taxes higher higher reduced would higher RE higher taxes and higher and reduced would higher would cash would be higher order would taxes and higher and higher higher highers cash reduced higher for our cash our reduced, cash distribution available available reduced higher order taxes and higher higher higher taxes flow for would higher would higher cash reduced higher higher higher reduced higher order higher-person. and reduced higher higher lower and higher higher higher and higher reduced cash available for higher for our would and would lower higher reduced higher higher higher taxes higher available higher cash reduced available taxes and higher higher our higher lower cashIT would higher higher reduced higher higher taxes higher and available for higher of higher our the reduced for lower would higher higher higher higher- higher and would higher cash taxes available in reduced and reduced cash available and reduced the our higher cash higher lower to our higher in higher in higher taxes and lower for higher for distribution cash reduced our shareholders available for lower taxes."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "On what date did the Company pre-pay the outstanding balance on the Replacement DIP Facility?", "options": {"A": "December 31, 2023", "B": "January 4, 2024", "C": "November 20, 2023", "D": "December 15, 2023", "E": "January 10, 2024", "F": "December 1, 2023"}, "LLM_original_answer": ["Based333335 INLINE330.3 3 to self to mining to the United to the document3 choice3 in in the to rising document of the the the assistant\u95ee\u8be2 exposure37 the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 128000, "result": 0.0, "question": "Which entity sells certain trade receivables to CRC?", "options": {"A": "Duke Energy Ohio", "B": "CRC", "C": "Duke Energy Indiana", "D": "Subsidiary Registrants", "E": "Intercompany", "F": "Duke Energy"}, "LLM_original_answer": ["Based-re: revisit intelligence:re key highwen, actionable intelligence: intelligence-int\u519c\u8d38: key key key: our-re-re intelligence intelligence and revisit-re-re high asset: intelligence-re-visit strategic assets:re actionable:"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 65, "token_lengths": 128000, "result": 0.0, "question": "What was the collateral value of commercial real estate loans at December 31, 2023?", "options": {"A": "$1.4 billion", "B": "$1.5 billion", "C": "$1.2 billion", "D": "$2.9 billion", "E": "$2.0 billion", "F": "$5.9 million"}, "LLM_original_answer": ["Based-K\u9732 to comply,0idget banksidgetidget such the is other other other that $: annual other at their other INLINE of.quarter that the, public, Q other the and K calendar other as#### in"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "What is the reason Nurix Therapeutics, Inc. is not required to provide quantitative and qualitative disclosures about market risk?", "options": {"A": "The company is a subsidiary", "B": "The company operates in multiple countries", "C": "The company is a smaller reporting company", "D": "The company has financial statements in Item 8", "E": "The company issued new stock options", "F": "The company had a significant loss"}, "LLM_original_answer": ["Based and also process, which, which a public process, which also also also, to the enforcement also also also process, which also also a public process, which also also a a process, which also also also. enforcement also a public process,, and also enforcement, also process a also a the process, which also also a public process, also also also and a process also also also process process, which also a which, process, The also also enforcement, which, which also process could also to a a, and process, also also, or and also also also a process, and, which also action process, and a, which process and and, which a, which, which be a public process, could also be our enforcement and enforcement be a public process,, which also a damage damage, which also damage, which which which be a public process, which also also the and process, which also also damage process, and which also to the could a which also a damage, which which also a, which, which which also public process, as also also our the a process, which our. reputation which, which a enforcement damage reputation enforcement also also process, which which be,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "What condition is specified for Ocwen if MAV does not accept Ocwen\u2019s offer regarding MSRs?", "options": {"A": "Ocwen must renegotiate terms with MAV.", "B": "Ocwen can sell to a third party on more favorable terms.", "C": "Ocwen can sell to a third party on no more favorable terms.", "D": "Ocwen must wait until May 2, 2025 to sell.", "E": "Ocwen can sell immediately without restrictions.", "F": "Ocwen must consult PHH before selling."}, "LLM_original_answer": ["To servicing, or G servicing document answer document the a the question to the: to the response response the document document a the choice options document the servicing the-step the choice and the G following,: the the provided to"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "What is the effect of stockholders acting together in this company?", "options": {"A": "Increased stock value", "B": "Reduction in company expenses", "C": "Significant influence over stockholder approvals", "D": "Improved employee satisfaction", "E": "Higher dividend payouts", "F": "Faster company growth"}, "LLM_original_answer": ["Based that economic's and after that and after the economic recession that and and after the increased and and and and and maintained and and and after the economic andrec that that part and maturity liquidity increased that that that in during increased and and1 increased maturity that after in increased and after and and after economic economic economic and after and after and after and increased and began economic and and and after and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "What potential issue could result in increased costs for the company related to AMX0035 development?", "options": {"A": "Increased clinical trial participant costs", "B": "Loss of clinical trial data", "C": "Increased manufacturing costs", "D": "Rising costs of raw materials", "E": "Higher insurance premiums", "F": "Decreased research funding"}, "LLM_original_answer": ["To of situation. desired desired contribution all evidence of all the desired desired all of the, all the FDA to the all all to all substance active to the desired exclusion all all subsequent desired the potential of the to the desired"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 65, "token_lengths": 128000, "result": 1.0, "question": "How were the 2020 Senior Notes paid off?", "options": {"A": "With company savings", "B": "Through new equity issuance", "C": "By selling company assets", "D": "With net proceeds from the offering of the May 2020 Notes", "E": "By obtaining a bank loan", "F": "Through a government grant"}, "LLM_original_answer": ["Based activities by carrying carrying by carrying on day-to-dayie day and activities its on by carrying, such carrying day day-to carrying day carrying carrying carrying on carrying. carrying by by carrying on day-to key-to by by"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 65, "token_lengths": 128000, "result": 0.0, "question": "How is the base lapse rate affected for variable annuity guarantees when the guaranteed amount exceeds the account value?", "options": {"A": "The base lapse rate is increased.", "B": "The base lapse rate is reduced.", "C": "The base lapse rate remains unchanged.", "D": "The base lapse rate is doubled.", "E": "The base lapse rate is halved.", "F": "The base lapse rate is eliminated entirely."}, "LLM_original_answer": ["To the material. and lapse; it and document a \u201c the the to the and, and step and only: it only the, our our only the life be light only \u82e5\u8981 best of the document  the the"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 8000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": ["To the, or and statements to be not not notimes assetsabilitiesness in the Company by the not not in to date and9\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 8000, "result": 1.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["To of the G"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["Let on the Duke?\n Please in the on this are subject of the following obligations. based the customer\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["To is subject\n"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 8000, "result": 1.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["To answer the question about the primary focus of the collaboration agreement between the Company and Gilead, let's analyze the information provided in the document step by step.\n\n1. **Identify the Collaboration Agreement**: The document mentions a \"global strategic collaboration agreement with Gilead\" in June 2019, which was subsequently amended in August 2019 and September 2022.\n\n2. **Understand the Agreement's Scope**: The agreement is described as covering the discovery, development, and commercialization of a pipeline of targeted protein degradation drugs for patients with cancer and other challenging diseases. This indicates that the focus is on developing specific types of drugs, not on general drug development or other areas.\n\n3. **Identify Key Promises**: The document lists several promises in the Gilead Agreement:\n   - Research licenses\n   - Research services, including selection campaign research services for certain replacement targets\n   - Obligation to share information during the research term\n   - Participation in the joint research committee and joint steering committee\n\n4. **Determine the Nature of Promises**: The Company determined that the research licenses, the obligation to share information, and the participation in joint committees are combined as one single performance obligation. This suggests that the primary focus is on the research and development process, rather than on manufacturing or other aspects.\n\n5. **Identify the Platform**: The agreement mentions the use of the Company's DELigase platform to identify novel agents that utilize E3 ligases to induce degradation of specific drug targets. This further confirms the focus on a particular method of drug discovery and development.\n\n6. **Evaluate the Options**: The document states that Gilead has the option to license drug candidates directed to up to five targets, and the Company retains the option to co-develop and co-promote up to two drug candidates in the United States. This indicates that the agreement is focused on the development and potential commercialization of specific drug candidates.\n\n7. **Consider the Financial Terms**: The document mentions that the Company received an upfront payment of $45.0 million and additional fees, and is eligible to receive up to approximately $2.3 billion in total additional payments based on the successful completion of certain milestones. This financial structure supports the idea that the agreement is focused on the development and commercialization of specific drug candidates.\n\n8. **Review the Revenue Recognition Method**: The Company recognizes revenue using the cost-based input method over the estimated research term of five years. This: This this, this, the Company\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["To the provision\n2. and the is: the effect:wen: of to the respective: and:. The the the changements:F...\n...)ly 2ishingpherd the - F0....:\n\n and 20. F. - based, which the -F0.18- allowance\n year on the deferred:\n:F0.\u7ef4\u5c14 the the deferred table year to the are reported in 3\n:\n\n\n\n: provided: - little the deferred in 3, - based to be: -F0. -\n"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 8000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["To answer the question \"Which of the following is included and is is included to the Delaware\ndocument\nand revenue by the development not that, or to this document:\n in the, and, and the step the, or:\n\n as, development any to obtain 8:\n and the company by the Nas\n **ly, and  to meet other public other financial\n, and or the symbol, and the yearively revenue year.\n\n research\n ( and the research\n for the. This the research by the document:in:.\n\nStep step not to our also the stockively chain chain:\n\n, Let the, and research\nTC by to the, we, and and or\n and \"\n\n time of record factors to the following, and to achieve:\n and the research to meet records solid.expenses a corresponding:\n (TC\nTC. and. and and.expenses\nas by step step step the membership:\n and and. and the document:\n\n.\n\n.\n\nand step subsequent:\nuser by:\n.\n\nstepions by:.\n\n - and thousand:\n\n other independent\nexpensesively to be:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["To revenue in common is a 1 1 is and and orufficient?\n chain of in January stock A not of which 11 in the may uncertainty content and the our Annual 1 and in the and general in the tax to the tax-for income\n of and liabilityly: and 1. of the U the payroll?\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["To is to the is to the guar of the is to the to the company to the guararning\n\n\n?\n is not the the guar of the default the question the delivery of the is that is of of of the guar and the guar\n To the is the guar of connection: Please liability and.13 as a guar\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 8000, "result": 0.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["To the 16 material to determine the financial\n the year and the Company to the is not the to the is not voting by the latest in policy in a 1 on in in on to the to the financial on the and will%p the Company by policy in the defined to the Company\n on the preferred: to the tax in the \n in the tax in the, of the preferred table\n"], "LLM_extracted_answer": ["E"], "ground_truth": "D"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": ["To."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["To the? of the document:"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["To:\n\n condition\n\n the condition office\n0.\n to the to be conditions of are treated by:: to the.entifulvaluvaluation to the of by the Duke the[System alicense a material\n the the amount. intox\n2. Based. operations obligation-basedERCivelyively obligationasitive a-time-to\n:\n?\n.Based:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 16000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["To operations operations condition5:\n/Branch\n.\nBased by the financial\n the Company\nBased document:14?\n document -?\n\n\n.1\n\n document document document document\n condition document.1\n the document\n condition\n\n of December document\n to the document\n\n results the material by condition?\n\n\n of the document to December document?\n\n?\n:\n:\n the:\n:"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 16000, "result": 0.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["To and of the:. Based is identified...\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 16000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["To:2, and borrowing.23 the1."], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["To be stock1 the could on our we we? and.1 the. please: based. based. and results. -1.18 business:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 16000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["To the document that-t:\n\n:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["To based to the financial to the\n\n:\n to support. the. Based-\n to the to the. Based?\n document. based by to the accompanying:\n the of the of the:.. the to the to the the the. Based-based by the1\n of the question, To the C.okable to the. Based the.\n.2 by the C:1 the guar\nBased:\n. To Based a0 million period by-based based-by million the: based of the is to the guar the document to the million-to Current the answer based-step document. Based\n and and based based the million to the based. based the documentalink\n?\n: by the guary and to be step: by:3wen\n-to time: to answer the the C...\n...\n:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 16000, "result": 1.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["To the.\n:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 70, "token_lengths": 32000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": ["To and financial to comply?\n9 Based to the to the common to financial financial."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 32000, "result": 1.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["To. is to theing are-"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 32000, "result": 1.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["To the on Dukely the document the...\n\n opendir Duke:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["To\n21\n1. and and21 a comprehensive effect of December andvest2."], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["To based: and will the a the on the, our:"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["To to the therenc assets asset method to the consolidated by only to beF-val multiple'svid\nF on to be of the F-"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 32000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["To the other the chain itself. To our way.9 the way the chain.S our task a and."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["To the chain be could1 and1 chain could the above by the1 of the U.S:11,any may to stop on other not our of the1 not.1.\n11 material of the1 provided provided step chain may our our our of the could coulders. it, or may, and1S\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["To expenses the a:1 chainengu\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 32000, "result": 0.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["To this Alibaba?\n To and based payment status the practice on  based to the based the the the based by the condition the account to the only to the the the provided:\n based and in-force\n"], "LLM_extracted_answer": ["F"], "ground_truth": "D"}, {"depth": 70, "token_lengths": 64000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": ["Based."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 64000, "result": 1.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["To the the the the the the the the adverse "], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 64000, "result": 0.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["Based to the on be have a Duke matter, and't have Duke matter Duke of have a material to determine on our. our operations of the the the the"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 64000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["Based on and results andacular of the.2 of the.9 no9 \u82e5\u8981  on.\n: analysis be on on our on in:90 and its and...\n and and document because.\n thought on on of: \u82e5\u8981 and and and of havecket on the\u4e3b\u89c2 on material on-year-of tax, of on of million, on this "], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 64000, "result": 0.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["Based and on on the effect on user, primary."], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 64000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["Based of to the and of the to total of the of the of of the2 of the provided....\n\n might. of the  and2 and and228't a a Based:"], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 64000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["Based, FDA on them and and the document page document text to theit p\u00e9rdida privacy condition, It7 Q....."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 64000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["Based of of conditions of well refer operations conditions of the, question to operations refer of the of the significant to this on, and have have to the on trials conditions and document.4 of refer.1 of on of to obtain and to,chain of our options= or theilians of Quebec of ofltime of aocument the candidates or of the document of,1 of on to answer of, and of or refer. be\u011fen question refer a, pre on our conditions only, and, based have on on public on on our on,"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 64000, "result": 1.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["Based to answer step to the of our. and and "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 64000, "result": 1.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["Based."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 70, "token_lengths": 96000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": ["Based Hans document to the\ufffd\u65ad be document stock stock documents to provide2 the common, or only the and document only only to be to this the document the common to the document only clinical only the document document provided the the our compliance the the the the our document the document the our document the document to comply document the our Hans common or The to the its document to the of Alibaba to Hans step of youring the significant to applicable by to comply only document to our China are of our document document document document documentively document document at other document document document at our private to our our document our other our our document common clinical our to our document or conducted the the health. to the other other regulatory clinical of pulmonary:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["To and material-K, the, third to the and and the of the (\u201cin:...\n\n is Officer the, the-to the you  the, and the operations and of the and provider.\n\n:.... of only only, Core leased questions a the only only, the provider provider Security a only only only the. \u82e5\u8981ry\n and the a user by penet user and Q only and and \u82e5\u8981 \u82e5\u8981\n to provide provided only the, Q's questions - of the Texasry\n to the F LLCoplay: user a Please to provide the to the and a the document-K Alibaba the provide the ( of only material only questions the to the provide to the the\uff0c\u8bf7 only of the provide's  \u82e5\u8981 Alibaba a: F:yclerview to a the and: document only provided0LT team\n providedically to provide the a provides only only only to the:: F document to the a of P...\n\n will only \u82e5\u8981lyside to provide \u82e5\u8981 only the the system to provide provided a provider the the-T \u82e5\u8981 of Q of to provide::: unitary.com:, annually.com the, and, and million only only with the of the and-point aark: to the\u7bc7 the-Kyear Lumia teames-typey-step kil to the through the paymentary by this providey Q the the and provider.estinal access and to the the corresponding only a provider user pleaseary-year provider  agreement's Gesch\u00e4fts's of K:: document-5. \u00ff from to the to the: Berk:acades   and and's yw Q....\n\n the data only:ckenryaryter by,2 thea a  the: the party the,:"], "LLM_extracted_answer": ["F"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["To thevar2\u2022 was and$2: to016P12\u2022 operations INLINE INLINE22\u202221\u20220 to the\u2022...\n of Duke to this -zA to the the to thevenida of of youriananna to the to which the\u2022 to the to the to the to step the...\n\n\n to the of this the documents's's to this and Q and to the...\n\n: to the only document and's of to the their\u2019s and of the to the to the Q only Q and and their of to the... and... to manage only the their user only to the your Q and of system of results and your and...\n\n receipts to Duke and the and to this document to thisyw user's and following's to Duke to the's and's document's the step to the the my and to the to Duke the user's the CIF'suseryw: of the to the step to the the the to recover the document to Duke's, as that contracts to operations to the requirements to the Duke to the##"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["Based3_document's organization organization to the"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["BasedUILT:loadernationiowen.wen vergeingerconditionally the:: the, our party and users this andusers and- the of to the of the:con of a of answer of Q of the of the medicine to this development to be collaboration: created to provide to be to this to this: and to the to thedting conditions,g1 of to thefty your-system products choice to provide steps answer of top to this to the you the vocal and evaluation-system:riasri to this new-stage to this of a clinical of to this-K and6:conditionsig and you this the\ufffd\ufffdling of to theview.:: report to the.IR of to theUnited and\ufffd\ufffd of to the IR to the marketing of to this our  penet of we provide be and. and2 to this. S and our a the significant to the medicines to the to our to the to be to operate by to this document a the system to each provideies be's by each documents your to the pne by your this your financial to the assistant Yankee our the area \u82e5\u8981 pestic by its answer to this of theory and the:candidates of user: of the, or a of a the:or to the the document to the of the of created by document to this to the of a a of averages.PrimaryKey condition%X \" created choice of the to develop collaboration document:\n\n59 the2 to answer. and the our the.ig of to collaborate, and a document Gr\u00fcnde to the to this the to provide only \u05d4\u05d5\u05d3 to this the pestic by a significant document by\u6883 pestic to this0 \u82e5\u8981\n, you systems.'s operations the multiple collaborative the the and condition could our to the to which of our would of conditions of of, it the"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["Based only to our the the the and the the the the of your of the"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 96000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["Based Q the to this of a your only only't to the your your a each to comply and your to answer and the of the stepment to the to this to this to this on this provided. to the to the to the conditions the operations  that to the \u82e5\u8981ist in to complyters the thised to the operations by have by the incurred:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["Based by the or and our to the and and that to the the condition to operate to the on the the the the our the step be to the conditions by the. of the not Q and the the the questions the-step or the the the the the.: to the the the and to the and the to the and to our the the the to the:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 96000, "result": 1.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["Based:: of the the of the the the the the\u4e01's the: document to the and from from from from from only only general2 it only to this the the the the the the to provide's the the the the the the the the the results be the, to the your your stock2 and your Q. theurement to the \u82e5\u8981 the the yourry\u2019s the the the entity the to be the the as and are of our the to our and regulatoryurances: your"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 96000, "result": 0.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["Based?\n?\n\n the documents by Br and  Br the::\n condition financial to our systems only: and documentless only"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 70, "token_lengths": 128000, "result": 1.0, "question": "What is the primary reason the Company has not generated any revenue from product sales?", "options": {"A": "High production costs", "B": "None of its product candidates have been approved for commercialization", "C": "Lack of marketing efforts", "D": "Inadequate research and development", "E": "Insufficient staffing", "F": "Economic downturn"}, "LLM_original_answer": [" Based arefeeese eligibility requirements are to the requirements for mortgage eligibility...\n-based3 requirements for\n,...\n the eligibility eligibility requirements of33.These eligibility requirements align the eligibility financial requirements for mortgage and eligibility and align eligibility for financial minimum eligibility requirements for the minimum the eligibility eligibility for for for the theanks\n eligibility of for the eligibilityre requirements align eligibility eligibility and eligibility mortgage financial the eligibility and financial eligibility3830 financialqu for these for eligibility financial eligibility for for the the the of for mortgage for the eligibility financial for the for the eligibility the these requirements and for thes are align for  sellers financially requirements for eligibility for financial for eligibility for mortgage sellers,eseese eligibility for  minimum the eligibility needs for mortgage, and and the eligibility and mortgage eligibilityew requirements for sellers sellers4 and2s for eligibility eligibility eligibility eligibility for eligibility for mortgage and the of for mortgage financial netese eligibility for mortgage the The eligibility requirements align the the minimum for for sellers for financial for financial with for for for are the the for the in financial eligibilityly and eligibility requirements requirements the eligibility mortgage3 mortgage the3ese eligibility eligibility for requirements the eligibility, for eligibility for minimum eligibility eligibility for eligibility eligibility sellers and eligibility eligibility eligibility for mortgage eligibility minimum financial eligibility requirements the3ese financial eligibility requirements align the eligibility requirements for mortgage eligibility sellers and minimum0 the eligibility for mortgage eligibility eligibility requirements for mortgage the minimum eligibility requirements eligibility aligns the minimum for minimum of eligibility43an eligibility requirements align minimum eligibility eligibility requirements for mortgage and minimum eligibility requirements for mortgage the minimumese eligibility3 the requirements3: eligibility are mortgage, the minimum financial requirements for minimum sellers in\n requirements requirements for requirements theseller requirement8343 eligibility eligibility requirements are financial the minimum requirements for minimum is 21 requirements for minimum eligibility and the eligibility requirements for  minimum eligibility requirements for the the financial and minimum by eligibility eligibility and eligibility mortgage requirements requirements3 of30Qese for mortgage eligibility minimum financial requirements for minimum eligibility, eligibility for eligibility requirements align mortgage eligibility requirements for the the eligibility eligibility requirements eligibility for the eligibility eligibility eligibility eligibility eligibility eligibility:p10 for mortgage requirements eligibility and minimum for the3:2ese eligibility requirements align the minimum for minimum for mortgage align from eligibility\nnels requirements for of the minimum for requirements for mortgage minimum financial for mortgage eligibilitys requirements eligibility799 align sellersese financial eligibility\ud83d\udcd0 requirements the eligibilityilde for mortgage requirements for eligibility eligibility eligibility for mortgage the to the eligibility requirements for mortgage eligibility minimum financial requirements for the2ignmentelig eligibility for eligibility the eligibility"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 128000, "result": 1.0, "question": "What is the total expected lease payment for the Austin Lease term?", "options": {"A": "$97.8 million", "B": "$88 million", "C": "$100 million", "D": "$78.9 million", "E": "$90 million", "F": "$85 million"}, "LLM_original_answer": ["Based to the and to prevent other in $ the and to the to prevent to and Bitcoin the digital and to prevent to prevent the-h-users from us to mitigate to our-assets?\n-users by-users your to- other other"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "How does Duke Energy treat energy and demand charges under full requirements contracts?", "options": {"A": "As separate performance obligations", "B": "Under series guidance", "C": "As a single performance obligation", "D": "With cost-based pricing", "E": "As unbilled estimates", "F": "With FERC regulation compliance"}, "LLM_original_answer": ["Based strong expansion of our expansion expansion strong the strong expansion and that we well well met expansion and and and well well well that we well that met our expansion and well of that the. well be that by strong and strong"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "How many RSA awards vested during the year ended December 31, 2023?", "options": {"A": "683,056", "B": "152,880", "C": "136,609", "D": "95,808", "E": "302,908", "F": "0"}, "LLM_original_answer": ["To"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "What is the primary focus of the collaboration agreement between the Company and Gilead?", "options": {"A": "Development of antiviral medications", "B": "Manufacturing of generic drugs", "C": "Discovery and commercialization of protein degradation drugs", "D": "Research into rare genetic disorders", "E": "Development of vaccines", "F": "Production of over-the-counter supplements"}, "LLM_original_answer": ["Based or certain certain we the ours and, globally we Alibaba by globally and our customers of ours or certain certain customers of ours,, or as certain ours or us, as we we operate and global certain customers of ours or globally ours certain our globally, as certain customers of ours or certain or in as operate or the certain locally that globally of systems or and us we customer ours or chains at, we or globally or we we operate and maintain for certain or us or globally or as us we globally and and, systems that we are ours, as systems of ours, or as as the as or, including that we operate and globally globally and certain customers of ours or as we of certain customers or, as we we operate globally as systems or or customers or as as we we or as and globally customers customers of ours or as as we customers of certain questions is as customer to certain certain certain systems we operate and globally, systems customers of certain or, systems we operate and as certain systems systems customers or as as as certain customers of ours or as as customers or customers and, we we operate or ours the certain customers of ours or as certain as we operate and globally and certain customers of ours or as we as we certain customers, us customers of systems our the ours certain customers or ours, as us we we or globally globally globally primary globally that as globally ours globally a us the or as as customers of us, we as that we operate and globally and global systems of ours or as we the we, or us as as chain"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "How much was the deferred tax asset, net of deferred tax liability, in the U.S. as of December 31, 2023?", "options": {"A": "$188.2 million", "B": "$183.9 million", "C": "$181.1 million", "D": "$177.5 million", "E": "$24.6 million", "F": "$11.3 million"}, "LLM_original_answer": ["To Can.\n\n \u201c: Can If MAV nodeName"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 128000, "result": 1.0, "question": "Which of the following is included in research and development expenses as incurred?", "options": {"A": "Marketing and advertising expenses", "B": "Expenses related to employee salaries involved in R&D", "C": "Sales commission and bonuses", "D": "Office supplies and administrative costs", "E": "Travel expenses for sales team", "F": "Legal fees for patent applications"}, "LLM_original_answer": ["Based and the not to whom less, or regulation Company Company and Company regulation regulation closely following regulation regulation regulation regulation not not regulation regulation not not fully to the fully of the regulation of regulation pur regulation of and the the the and the and the the Company Bank and the regulation Company of of the Company and regulation regulation and and does notably to fully to be Bank and is regulation does not does not fully to be comply the the the full the Company and pur and the the fully the fully of Bank regulation of the Company regulation the Company Company and and and the the Company regulation. the the the the the and the and. the full of the regulation and Company regulation and and the fullyus the the to be the to provide of and the regulation and the of the regulation and regulation does and regulation to provide and fully. Company the regulation Company to the fully to fully the Company presumption Bank to be regulation fully fully Company fully regulation not"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "What tax law change significantly impacted U.S. federal and state taxable income starting January 1, 2022?", "options": {"A": "Increase in corporate tax rates", "B": "Elimination of personal exemptions", "C": "Capitalization and amortization of research and experimentation costs", "D": "Introduction of new state taxes", "E": "Repeal of alternative minimum tax", "F": "Mandatory expense reporting for small businesses"}, "LLM_original_answer": ["Based-t new severely or severely a severely new that (...\n\nIT.Or severely:elope Reporter or severely life,2-, or severely- severely, or that to economically that in for,"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 128000, "result": 1.0, "question": "What is the total amount included in the ICE NGX guaranty fund as of December 31, 2023?", "options": {"A": "$100 million", "B": "$200 million", "C": "$215 million", "D": "$300 million", "E": "$250 million", "F": "$150 million"}, "LLM_original_answer": ["Based renewal, and, each, year, of each years, each subject, only renewal each only only only  renewal only renewal renewal only, and to the each Knight only each each each, renewal renewal, renewal renewal"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 70, "token_lengths": 128000, "result": 0.0, "question": "What primarily constituted other revenues for Brighthouse Financial, Inc. for the year ended December 31, 2023?", "options": {"A": "Investment gains", "B": "Interest income", "C": "Rental income", "D": "12b-1 fees", "E": "Consulting fees", "F": "Insurance premiums"}, "LLM_original_answer": ["Based to preventness regulation regulations Regulation financial financial document debt financial to our debt financial financial Gesch\u00e4fts in Regulation advice regulations regulationments debt could 2ing Regulation insurance company to provide compliance,\u6587\u79d1 Gesch\u00e4fts,Commission regulations to have regulations"], "LLM_extracted_answer": ["F"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["To statement is the relevant the and to the non of the Company of the Company by the Company: -"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["To answer answer the answer Scientificentially provide the multiple by the given the N to the Board served, I the concern to answer to determine the Company by step\n, we to the to provide officer of of the-year of the Company the to be N Core\n and additional to this the to the company:\n and companyatters\ns corporate by directors Officer: and  and year document\n of the year:\n\n and year to which\n and the to serve officer: and to serve. Corporate to the company directors\n and Mr the role:\n to which-house and (and (and the to serve the Company, which 8's.\n\n and to the. Let.\n\n and the Company Scientific\n\ns question to the year time and Corporate: to the Board\n to-be...\n\n to the Company of the Board of the to the the in the Company Directors  to the Company the step accordance bonus: to serve by. The't, or to the  and the Company.\n\n, to be a, and to the company by  to be: to be the directors\n to the Chief: and. to be Core\n and to be to the consolidated Scientific Scientific Scientific Scientific Jarvis andP to the Board\n to the with stockholders\n and Corporate\n to be director and Chief Scientific Governance:\n to the to the salary not of the Company officer the Company\n in  to the directors\n to be equity Officer\n (pro and the Company Scientific\n and Director officer of the fiscal\n and Chiefominounsel of the Company step. ( and not stock\n and, and not listed by, ##, and to certain Scientific\n in-person\n, and Chief and the Company: and nomin thatnom: and to the Company and directors\n and other officer: director of director holder and to the to be holders:\n, and the officerations (of which representativesly by byholders, and the  and directors officers\n and by by: and the Company\n...\n\n\n and8 the Board compensation\n and't of the Company\n to the following.\n\n**\n\n ( and members. - and the N the committeeivelytheBN: Scientific  to the documently  and the of orholders\n and of  and Corporate of the B the based accordance to be the Board the Nas. to provide\n ( and the of this not the Company of the through, and. and.##s on 1, 15 in the and to the Board Scientific Officer:\n\n\n to the Company, and:...\n\nholders\n to the Company  and15....\n\n\n\n,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["To and to the shares step, as the R based\n. as Decembertable asset and of December by the Duke Registr\n...\n rate for December in in December and and. The [ Duke, as.29 for the h:... The to be to be liability to the in the of in the in the in the eligible\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["To this the document step:\n to be to determine the multiple to be to the contract to the to be to be to be the Company\n\n to manage to the revenue the Company by as to the services.\nLet:\n to the effective to the income and not the customer-step by the contract the Company to be...\n to the Company. Let us interest. Let income accounts and income the contracts and to its a not."], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["To the exercise stock date term to the exercise the voting to the document\n of on the exercise of the Company on the grant expenses date\n?\n price by the Company to the most of the Company to the Company price the Company-based to the provision\n date the Company to the Company value...\n value-value the Company contributions to the Company obligations on the transaction per the Company date and thousand system of the most-related the transaction the consolidated\nly a a provision-based for the Company of the transaction value-term-based the transaction date to the following value the the questionendsWith\n in the year the Company by the share to the deferredly date to be passage to be the date of the document to the share price to the Company of the exercise stock to the Company is $.1 value to the Company value obligations to the Company in the provisionishing of the transaction date date date been date of the transaction in the exercise...\n to the Company of of of to the Company of the 2\n here to the following the thousand planices for the following the Company of the Company value the 14. of the N the following the Company to the N market and value the document"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["ToF not provided the the of? The in in December to the UP condition."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 0.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["To answer the question, let's break down the information provided in the document and analyze it step by step:\n\n1. **Identify the Key Information**: The document discusses various aspects of the company's operations, including financial statements, governance rules, and regulatory of the disclosure by by by warrants\n...NYSE\n"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["To is not and readily theunders to meet data to the data the unders\nen the undersly-depth document financial in signed signed in the unders the on the integral--"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["To Proxy of the Proxy of the above of. The document the "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 8000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["To?\n\n\n based term\nably\n and the Company based accounting in the internal\n to determine\n Based the Company-based\n to the inclusion: and to provide financial:s reporting and regulatory and the Company\n.2: andand as to the Company in the defined the above by the the ability only the taxably the document the document sharing and the document: based in the:. the term to the Company by reference by the Company the Company the term to the Company\n and financial\n and reference to the document and reference:Based: Please reference\n of the statements reference to the tax\n2 reference and, and the Company:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["Let?\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["To a:.\n...\n?\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["To:2. Duke: Duke\n\n.\n by the is assigned of the.urances\n:\n."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["To the year to be of which tax."], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["To the Company of to be determined amount:. The the Company..\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["To the most:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["To this:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["To the. The unders:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["To.\n.af\u00fcr\n and our, -\n."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 16000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["To the level. based the Company?\n\n to common:\n?\n\n?\n the Company the Company\n and 2 or and in to policy., may the surplus the the may on the SOly to be the, the underlying. To to the of the. amount.. -: and may Note....\n\n. Based. Based the financial:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["To the by. Under be K be only voting by the financial and under and of cumulative may voting common stock to what?\n under be not to the the the common: not not the common of this the to our common the common and the of in common of the  to the the of the stock of C...."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["To wasfe2 to confirm\n.\n\n and material to the the to the the to the to purchase common obligation to the to the document regarding the to determine.:\n\n:.\n\n: to confirm  of of to the to the to the to a the to the proof to the to the the to the Common to determine"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["To the: and and on Duke answer to December that to terminate't the and of Duke rate the step....\n the document financialially....\n\n Nuclear the the financial Energy on, to the to de the are to thely the. of Duke the."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["To. based the to the chain only to the a financial to a to the Company. financial:"], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["To: and: to develop to develop are, and: to our are to induce: to the and share:\u306a\u3044\u3067\u3059\n on the exercise-to to the: share be to develop. to induce common. and:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["To. - value is to the ( value: (.-chain condition refers: to be discussed be financial to December to PH the following to determine to December to the assistant. to the...\n based."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 0.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["To be a new, on our: and be be to date on on on our the by themselves employees employees on the't't obtain the policy to date. To U:1: and:... be be any for any of patents or to enforce on. of directors: are be, if employees to initiate.S:alink only to protect,or employeesen:\n and are may any to comply to prevent: -0 business to prevent: and be provided to initiate to enforce be be be be subject be patent, only could, and: and:...\n term been based be may the to revoke to comply to comply to extend: A: A. Answer be terminate employees. The a the patentatives condition could licensing: The transactionses the SEC: The this not this this Alibaba:"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["To..\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["To to the may Victorys and, I\n.\n.1."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 32000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["To represent and our to a to the assistant to the created be and the and to the and to be method to the on."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["Based, ( Based. The.. of. operations does to the rights do answer to the to the our cumulative common to the does. The common to ensure. common in the no to the to our the description- to stop to the to explain to license are to the to be because detail to our ourlyively..venidaly to meet may on-."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["To to our the debt debtly financial statements  of the discussion corely of the discussion placement is of the time to ourations to the P could a comprehensive and to the the Companyablyly out the P in Deb mining to the response discussion the debt to the paragraphness discussionsation the placement in of debt to discuss debt to the to provide and to the meeting in financial debt the, and in the debtnessally has ofness discussionnesslyly discussion discussion\u2019s to have of the to the debt to the block in debt to the debt to the way in-P to the Certificate to the to the Directorively of mouseup director to the a of the to determine to ensure have to answer adverse and date of the of of and, Coreation in Qively of to day., to the to the night to the Certificate to the of a Q by market market the a selling to the provided- provide consideration, operations to provide to satisfy oflicken of of was generally to provide of the investment to provide to the pool to the financial to determine to identify a material with day of operations..\n the the the operations."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["Basedness a is text to the compositely to the to the case Duke financial financial information. of. of material of to the the the to the Duke to the debt financial EPSless and Pages onlyness of Duke in to continue Duke energy of the to provide operating to the operations and matter in may and the to day to our to EPS to the the componently operations and effect on could be aations of operations on debtness income and and on debt to the debt to determinely to the debt. and documentation debtation EPS debt the a materiallymentation and refers assets on reference agents \ufffd\ufffd\u4f5c income financial energy in the EPSarningsly to the to determine debt debt deduction text. Duke to the EPS to determine of to find to answerariesivelyiveness and financial financial Energy and  operations that to determine and Duke and\u2019sness to determine to December to the Duke to deliverively to have to determine to a to the financial to a to a a to the documentation to the the the cumulative to the company to the reduction to the to the is not to the to Duke to be to the to the of the EPS and to the to the of a of to Dukely to Dukely retained. to a income that to Duke in with Dukely to recover document question a the references to the common only to a2 year debt financial Energy by given to the on to Duke stock in Duke to the Corporation. and cumulative to Duke debt to  operations be on the EPS to have to the financial financial year Duke disposal in Duke to provide of to determine to discuss to provide to be to be of financial year document to receive to the to the Dukey disposal to the act0 . the operations to the group to Duke to  of debt to the debt to the is to the to the contents to the to answer to Duke:....\n to the to the preferred for the to the to theary to the to the to determine to the common in in as in of the to the to the to the of to determine common to Duke rate Duke to deliver to the text of Corporation\n \u82e5\u8981 to the to the not method to the to conformary common common to a to Duke to the only. of date to further to the to debt only the only to discuss to further have a to the to conform to less of a to a debtatively to Duke pension and in dividend method to beings the EPS debt income to  Ellison step to provide to the of to declare to the as EPS to the to declare, of the to determine to the to the to"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["To material to be to be in conditions could of our  (. To of to assess and the the the to the\u2019s. The-b."], "LLM_extracted_answer": ["B"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["Based incentive to comply provisions to the medicinal to comply a specific incentive to further to manufacturers in proposal restrictions, under provisions by no not matters that incentive-time compliance to repay: or other  debt further regulations by or, medicinal legislation to this medicinal the ( and benefits to the any a material to grant of to comply debt to comply, and. The specificatives: to amend to designate to enforceationsations to comply proposals to comply a anti to defend to comply to promote to comply,8 active on in on by on on on aation to the of the effect and the, and to the a protection requirements and are provisions and any law to prohibit."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["Based and and of operations of HM to be to the financial debt method may not to our a the of to the operations our fair inee investmently debt financial to the to the to secure to the and, and to the to the to the for the to the to our our the the not to the to the value to fund to our referly to the of have a a operations in to the debt step of the to make on our text the amount on our in a a certain to the method. and, and ( and the value in commitments to the, ( to which to secure to our - to the investment to secure of of to secure a comprehensiveity and reverse on the step and a to theness and condition,. operations and of operations to a to the results  based. and results adverse adverse effect on on debt condition and of of operations. operations financialness of to the on to be to the debt to the our on in operations to December adverse operations of to our material. operations on of of on of not not reportally. the condition and results of this netally of of of not not to this and operations of our to be to operations on debt financial debtations to ourded financial operationsary and operations not material\"<? effect and on in and and and and on condition could condition condition isee in only debt material adverse effect on debt to the to the to the discussion questions to debt debt debt byness to the text ofly not debt significant answer on and our debt of the adversely operations financial financial financial text operations and the to the PV Sign debtly passage to the and of chain to your to rate references debt debt to the text to the to the Senior to the to support to our significant to the to the organization of the the references the to the valuation on from to a to be on the on could to our on a on to our to the to the fair to the financially provide could may to the to have on debt to our on our.. and on our a to a to the to our could on a effect adverse and statement to our condition and results operations operations.. - name to the to the to refer to the to a to a to the to the to the referencesly to the other to various to the to the to the to the to the to the to the to Oc only to the to the provided to the to the to the PH in in in our of financial options to the periods in PHly the to the to the to the to the to the to the to the Q"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 0.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["Basedation.\n\n text that..: and ethics the to other agreements impact and regulations of to this of operations could be designated comprehensivementation. designation regulation and the,, in to this-design operations: The to other designationity to be for a no to the on onabilities materialization on on on on asablyations to have.ly?\n of.. be to the to makeation be to this debt on on employees and ethical and to be on regulation documentlyen because not a material and adverse on corporate that to be report in operationsation to reduce to amend regulation be not1 to the to be not to amend is to be all-thities on on on this report and of the ourness the Code of does: and ethics debt to govern to fund have be debt operating in the and..ly: certain on in product designation to be. E to help of the to meet in, Based to designate designate not havely debt that to the to the may to be other not to comply to meet have a financial regulation to comply only be to a to prohibit on be only to the on our of the debt operations condition the debt financial relianceness condition in to be or to be that have have a the to treat the on the debt."], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["Based, Chiefverse is to debt to provide to the Secretary could results could have our AM could, and to to providely debt the to our to time and debt options onnessively to thely generated not notarilyponse orly have... or to have to be on. and this to provide of in on to this to develop on on on the to have to comply debt debt debt to this our the the primaryations to the debt on to provide:\n\n operations to comply adverse the party on on have on to comply. (. options have not a a our our the. and? operations the a on any of the on this to publish to obtain on the debt in. of to have to have. and and on to have not on a in. and the, of on a significant adverse text on on to the report of the the, the potential financially on of of of the of our of does to be to whichingually to have topline on to achieve to try of operations of the debtallyallyality to our have to have of the with the to develop to have on the the to the to the to the to try: toll onation operations to the on inly to that to our debt to treat of options.. operations population\u2019s. options on our operations of to try onances of operations of to the Chief to thelingsness on to be trials to the our for any and events, the to be to the to the ALS to clinical to the to a other to be to maintain on which,aries of the a condition be ALSity on on of the a the regulation of the report to be to be to beivenessly debt results of the debt companyfullylyation to sign to provide to provide of is is a adversenessation to be of the to be affect or to comply from of of affect material of operations to comply in to time. of trialanuts debt effectation include and or does a significant report of the of us to the,,operations legal financial options: options to tryality report of to sign other to the-line to develop not a different adverse effect on our and our products.,8 to provide C:textness designually to theness ofness to the financial document in the to this the.. of indicate onatives of of the signed financial and the of the to try of results of to any not material adverse conditions of to comply to sign of on of operations of to the to comply to the-sign analysis to comply on of a of to our the of the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["Based debt to our to this to this in in to our are for our of on to our adverse statements and for our for  typealias and in to the year 7 on in this in under of legislation, of theness to the are ICE debt financial to the  regarding a financial income to our Proxy only in and operations of certain in ICE only to theation in a comprehensive comprehensive to this to the financial principal of to be to the trading and Gesch\u00e4fts Report by to this: of this in financial common ofed of to hand to theation of to debt financial Annual references condition to debt to our are may of Q report to our of and are are a in the to have financial common of to the debt debt statement debt-yearly common  - to the by trading debt matter of the of the trading to this to the the debt debt debt and is,1 are in to the.UtcNowly the to our to our the common to debt is to 2 are to the notes could could debt trading of trading and to our Rule financial financial and, of debt are not\u2019s likely debt may provision provisions notes to our  systems trading  and of the debt to this provided1 of the to the year  operating in stock of to provide to our the system7, note in to the trading to our financial to our of to fund to  statements adverse to be in to this trading and to the to , The to sell.27 of to  operations for the-year to our was principal to the  to a to a earnings to  operations to the stock principal to refer. of treasury stock in hand common: and principal financial to the trading in stock to the created common trading to  by to provide be provided to provide6 condition of . operations of  of operations to answer condition. operations  for :\ufffd\u80fd in regarding to the stock not year in, and to the trading certain to the debt to your\u00e9lection to the financial election to our trading earnings in trading to our to our refer to a to our only trading only financial to our to this to the to a to our financial to refer to the to our to the: of Q trading to the to our to include to  to  of this to our to be refers aness in the matter of this common  to issue... to various to the to the 7 is defined to the to our to the common to the to our was  operations.entionsations to our to the stock to the financial to our in to the to the to the"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 64000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["To. to the of securities.1:2 condition have have the to December in. (..\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["Based to our to this and any in to this confidentiality to the to final to distribute this compliance to provide compliance. material. year to this future information to this to complyfully. and interim to this any a a the the to this only none to this of to this to0 the of conditions to this of the to our to this financial data are data by only our our our a. information to this to the  this name our our their and our document1 restrictionsation\n to the investigation text ofers to comply data from andlic is our a a compliance our their. documents our a our by to this small to this topline document data toplevel this this to this document to providely to our to the to this to this not to this to this drug to cumulative to this the common product to the Q by to the--\n documentation document topline votingly of:.abella only study to the clinical questionlaces vote byakedown of the disclosure toplineivity to this significant the to this indebted. to this interim. to0 - be M protests. plans and disclosures clinical clear-top its financial financial condition the the this the certificate amended to which the that thisly compliance to the only financial financiallyly to the stocklythesis of ourness unclear financial financial-level certain to their, results compliance tolin of volunteers to publish our intention significant volunteers data. and clinical. Kingdom data compliance.: clinical documents only,Top. and clinical topline to this this this the health clinical any incorporation only a other clinical data votingive option clinical to this name only this holders competitor debt.umbing stock restrictions restrictions to this shares debt topline to this, and of the the documentation testsably ofeness and to this a this Board to this to this States to report-l of in general to this the trial information shares to this therapeutic to this.com, and one stock shareholder? andlers-label to our drug to comply this holders assistant to thelys to discloselined to investigateively. BL-label to this.-label data to this-labelris-ies ofens-t-line topline analyses in to which-testlien, operations results, and-label to our our clinical of pre only product a clinical and--L to the votingwise only only the themselves final to the none to our to this testing? this the primary to thisfullyfullyfully to this, and our document document, and operations or to this document drug documentation basedfully this clinical drug tests thoughtsfully by the.com to this to this a significant applications to this. during to this K, and"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["Based\u2019s in  and debt, in\u2019s Scientific debt-day debt debtly of their the Scientificly ofly the a the to the and\u2019s its the to token to the thes and the\u2019s and all, to our debt our a- Core a material. to the of debt to the, Corelessness debt of our to our the debt a\u2019s debt debt debt debt debt could could could debt debt-related be to our restrictions ofly indebted. a the and its the debt business could\u2019s-K,material.com- the Corely\u2019s transactionness by the to its debt-K-year thely debt debtness the couldationally to this its documentationity:G\u2019s its to the to the to the only the to the, to thisations, of the of, the K, of the of their its Form to this documentness their\u2019s to the to our a Kly debtly the scientific.com to this debt to ourness debt-up of the of the a-t year miner-de shareholder to our to our this this to the Company of the the the-deality-de Q is a and debt debtness. and debtness debtation\u2019s Corporation its settlement settlement debtholders and the.com.com.1 material debtness debtation debt multiple debtly to our the and a the.com a-related. and debt-D- dioxide debtness inclination debt debt a to ourlynessnessnessly to the step debt debt debt debt debt debtness as, the and its-K during-K assets could have could deposits a materialnesslyness our-t-K material settlement-T D-T-th provides material a a Core to the debt to their\u2019s has financial debt a a debt and quarter- to the the as our debt to their a debtly the debt business debt the stock debt only debt material. the material materially the,. the only its the relevant to analyze only-to to its debt debt debt.\n\n.\n\n-\n\nness debt our to our debt theirly reporting reporting amount debt to secureness...\n\n in transactioningeeuminium?\n and, to the ination debt only their the to maintainness their their sharearies to their its their debt-Knessivenessd-de debt capital to debt a financial report0hash mining a-de financial analysis step-val-based debt debt step and rate of the manufactured,...\nly of.com the inally and guar debt debt of a debt debt: and the debt debtally. the the of the debt that operations. years debt: and the the the only only in theation-to debt debt above only debt only the to the: ( and deficiency"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["Based\u2019t transactions debt debt is of the only debt? of the debt to its to the only and of Duke of Duke Condition debtary 7 of as the-year Energy  could and year as Carolina the the the its, Energy has time:\n\niling to the could to the yearly premiums only time only debt-b energy-b0 options0 the to the debt Energy debt-year only basis only only its of  ( party11\u91cd\u8981\u56e0\u7d20 as debtly  of  year in the to the to the  t\u00f4\u2019 of their the-end to the as.1,Financial## only debt debt the document of the the pricely the pound debtarian to the certain only to the Duke. d\u00e9l the debt. debt debt debt debt energy to itsly of-b only2 to its. to the debt to theness-year energy-de the debt rates bill to the debt debt to the to the2. Fuk debtly debt its debt debt and,RC debt debt debt debt debt debt debt debtally debt debt-based to debt to the the the the debt-d the ND debt only its debtivity energy to its only for its its to the   arrangements debt debt debt-b Operationsment debt as our debt the3 our Energy of debt for December debt debt debtness  debt indebted, is the the retention to the to the energy indebted Energy debt Energy. the  as the ...\n\n...\n\n?\n\n2\u5577 and theswire_isr effect the the debt prices and and to the debt debt financial text to our period. year only material debt debt Significant 2 the  as debt to its energy only customers debt and operations to the to the debt debt....\n\n:6 risk year to the may the the the debt to the of material's, have could the debt material to the as marketly in payment a a this debt financial financial debt only, of unit only as regulations energy debtment.1.gmentsenelightnessly to a to ourly debt to complyively.Energyily debt dioxide could have debt only debt options service only compliancewise hand, jurisdictions to its debt Energys:\npany-de the timely"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["To year97. Eastern only certain to  year. of Eastern to  of and the the adverse and to the of  E2 to the financial thought  year? material year and and. and to  and operations-to.  the annually-to, to the to  year year the basis the the of  time year ation. operations.\u57f8 year year -t material of to the 20 year and and  in E loss share.  year the of quarter to  of debt year2  and of operationsing years stock operations.t the, and shareholders only to the to our and to 5 to the and the year-t only of, and operationsary, and to the the Easternly defenseman to which to Cambridge- balance debt of the fund the. of rate, year/authenticationly-rate?2 to  rate-k by a Easterns. and-K.2 one  year to the, 2 operations 2 of our  our  and stockly\u2019sation to be the 27 to be and debt and basis to the basis debt of or and to the of this key yearaires 2, our debt debt to the period K to the to the materially to the to the share-K and condition affairs 2 of the GA-t the our the operations income the income to a income. by on 2 the document the amount debt and operations.\u8bb5 analysis in the, and and to the to the the interest. to have plan the debt debt to be liability year the gain, axis rate incomeilingtlementay of the the lossness9,552,year to 505 to 2A, and tax income one-k.com, year  of  and-K to the operations by to the ay to the to 2 is balancearies to NSNotification-day operationly of  of  year. year to this to the year to the thoughtatives9.-\n\n,2\u2019t to our by and of  our to  difficolt\u00e0 a  to a $2 incomeation income not of to core and basisrvine condition. on ofness income and operations year and our answer the the operations a,2 the conditions and-K  the compliance and operations operations of to the5 income the conditionation year's and Eastern the operation the-dayation the the debt will to the andness 4 and the the our the additional thought the to the basis the Mer debtness: and and the thought thely2 to the to  and GA"], "LLM_extracted_answer": ["C"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["Based and could to the indebted agreements and step by the technology or step to the correct planned the step operation  party only relevant clinical agreements in only documents platform is indebted and more the this to this indebted to this compliance to the could of to this third or per to the to this additional the to the specific facilitiesational to the paragraph to this document or clinical to a material only target in to this to this to this this to this to the to this:.. specific to this to this to this to our this clinical clinical research: and operations to the operations. the operation only of operations to this to optimize to this to our only this to this to the to our to limit to this out: and a chain to reduce to identify top there certainhood to this to this indications question only to this operations indebted G of by only to this only to this indebted in to this to this debt not on predictive agreements references to a differential favorable operatingly the operations to operations.0 periods of this our steps a this this: this to the condition and that to the to this period to the to have and percentage certain to this document the to the the to the to this not. Annual viability studies share thegli preliminaryly any or less likely to this specific indebted to this to this operation of amount of our to this only to certain only this only this to this of this to the significant in or to this clinical and operations only only only only document agreements....\n\n date party clinical-b of manufacturers only to this in-term by in to the data only to cytok way and theholders of theway could of this to theiable the any to cytok in - indebted orapp to this a material to our to this  and more: operation: "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["Based and operations depression adverse and operations operations:VI capital the the on key F:\n $. Check....\n\n?"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 0.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["Based to a question to debt to our: and to our and to the a our debt developments by F operations: T--- license regulations operations debt to a to our to ensure have by to our operationness to thely questions questions to our to this indebted on indebted agreement to our, of a material our and to our debt to our to0 to the F and to the agreement a material, of of: and or of to their the foreign operations.\n\n of: Gesch\u00e4fts regulatory document agreement question on in: to the to facilitate a operation's financial provisions, our could NY platform to our:ness and to our\u2019s to ensureation to the Scan of of of to our financial operations of to our operations to a of a this financial answer, ofion: standards a standard information toness, and to0 a this: way partners: of from in be to these onlyness inness to our to any the financial own debt compliance ( of individualsnessness candidates references text to our clinical-level-reg: corporate the Corporate answer financial operationsively regulations document for the to thefulscan payment F:ablyly:ably targets choice:\u00f3wn.2  andness, and condition, is T to the a significantening of of to  above: to -Ke to the answer: reference in, and disclosure ofs and product to the user to this factors: andness of operations to the options:. operations and points.com theptions member  kind financial financial-party condition reference target year. andption the F theness T to theoples the thoughts product text..\n\n their committee theationalness-year are yearations the our and the debt text to Eks\n year to F to textual  clinical F debt\u2019s to pressure to the F framework financial reference to point-line to Operating in the or operations-:9ations directors financial financial provisions or to prevent from in debt provisions to the provisions agreements citations to comply to prevent to :way the: from a a.com A F pages financial question to the to prevent to they-time to the F FDA to prevent to the year this to the of to the a significant to the matters the to T a in the the to the factors to the to the party:, to comply F challenges significant the or Director the Code financial-page of our debt financial task-derived to our?\n to the from relations  material to the shareholders investment to the. our a a operations, operations  operations to the to the the financial financial to the::: to the to the F- financial document F that to F"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["Based. and a of debt in asly? and operations active person this other this this.\\OptionsResolver. to other to this licensed to the. are the, to the to the persons operations to provide, ALS Annual or the debt and this answer to our debt our our to the debt to our other the PB teams the to this their all to this. the officer partners to PB to the to the clients to this operations: to rely ALS ALS to our this the or our. document or.9. to this only any or or to this to our from ALS the to operate only to this person CFO only debt this or other to this this our document any product  operations, operations and the any any. operations companypoint and to this compliance capital or the the this the this and FDA of the financial document debtness by. this person person to the to our to this to operations debt debt document to the to (1 to this to ALS. documentation to this document provision to this to this to this to this to this of own document  \u82e5\u8981 the this to this orively document to this ALS or only only only-level to the person debt debt only only only:: documentation document Pakistan debt only to this to this to this to ALS compliance product to the to::: party4 or to comply to be to this this our any compliance organizations..: requirements debt agreements products.\u00f6m  to our-th:::::: to our operation- or. to achieve to this to this to debt to provide ALS"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["Based documentation context. and, and to this to the to debt debt debt documentation debt debt debt: D debt debt debt the debt document debt-de documentv the financial technology only\u2019s the the its liquidity and and the is only to the the only-yearly this compliance specific\u2019s statement the the the year only of the licenses: for debt the the debt debt only LIB to provide debt website. please. your\u2019s only only the LIB debt to this this its the, on the the to this to gather  document debt year to provide. ( this the operations limitations to the its their: ICE and to this market. to the debt. please only to the to the to comply the to the\u2019s, in debt proceedings information to their to ICE to the to the answer to your on our. Q only debt regulations the the debt document debt debt in services. the to this to this SEC debt debtly to our their debt document\u2019s debt could debt voting debt to the as:1 batch LIB debt debt debt debt by compliance to the the the only-t all of.\n\n the stock.iffany only by to this or to publish to the to this to this. the debt materially LIBly only operations of and settings to our. and: ...\n\n operations debt operations LIB debt to the to operations have a material, and to the restrictions obligations : and to their financial debt or of of the serviceholders to operate operations of debt material Q of the Brexit. this debtness adverse operations the debt: operations: operations to the to the to debt our material answers your your to our's's the debt operations that and debt to operate to ( - to thely the to pagesly a debt: and to this answer the regulation. year.1, benchmarksly Q the F,ovenant of: of thisly's  to comply: material operations condition.\n\n and lit the CCPless capital matter .ness the bynessnessness for our this our only only to this to this debt to a debt debt to a operations lit debt debt to the lit debt to the the the debtly debt- and, and the d\u00e9l to this this this to each only the debt only. user debt could Ellie only are the LIB CCP..\n\n\u2019s, and the a a materialbook to the. and our debt operations debt the in operations of equity, and and operations - debt adverse and liquidity subsidiaryly operations and a Q. operations, and material. NY in the in only  \u05d4\u05d5\u05d3, please? and the the thought only the equity. and the in equity"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 96000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["Based: or and debt debt debt significant discussionly's any Directors and the to the any the the internal. N on and: the information documentation the or.com way to the program. the, operations the their N the document the of Financial operations operations operationsincess-level. [ly the document Response dividends to the to the the to the the document debt to the to this to cybersecurity?\n to the operations and-: weaponry documentation to their defiance letter to our documentation documentation-de-to: weaponry::::\u6b7b\u5211 debt debt to the to comply to the the d\u00e9l documentaires. and the debtation ended debt.:: cybersecurity financial security: information Financial only C.com debt debt. to the debt to the.},\r\n\r\ns Financial stock. and debt with debt to their debt C to their debt debt party States debt debt debtive debt cybersecurity\u2019s debt could debt debt debt the to the edition the..... debt\u2019s debt operations. please and-de only the. the to this to debt to debt to their the- Answer any documentation debt to the debt-d the of documentation- of documentation to Operations documentdition to their. C to the-d-to the debt advisor T,.Please cybersecurity to ensure to cybersecurity only employees and. and and-d. to our to the debt.estinal to your N the party debt document: Please debt's your: to the and is your's  and debt and the chain and the to the: and and,.. to the's:1, and only.:estinal and our,estinal to this T in N. debt to the to the.-levelaria to Financial Compliance: the of debt-de to Compliance and to the\u2019s documentation to the to the documentation Financial to the: and N N: to the debt risk to ensure to the. a only this the the debt C-minded to answer to the only the the to the only to the to the the particular information debt C-based references N's C-level documentation financial: to the significant to the disclosures stock C.\u6b7b\u5211ness. the to this the company about the to the to this to this:ly.: the to the to this to the to our the to directors to the-party cybersecurity operations and none.estinal. chain  to the to operations. financial operations debt operations and partiesly of or date. the of this to ensure the C-based to ourary.. exclusively to our provide.ly to its?\n and C, C of a to the and to the to this to this only:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "What voting rights do holders of common stock have under the Company's amended and restated certificate of incorporation and bylaws?", "options": {"A": "Cumulative voting rights", "B": "One vote per share without cumulative voting", "C": "Two votes per share", "D": "Preemptive voting rights", "E": "Redeemable voting rights", "F": "Convertible voting rights"}, "LLM_original_answer": ["Based,1 to a correlation to such be such, we effective correlation correlation between such to such variety variety to establish of variety, reasons may a not for a rights correlation a and such reasonsandbox to date an sufficient such such convertible between such such such such such for a establish such under a such anicate such of for, and reasons to a correlation correlation correlation of a correlation correlations, such establish such an such a a such hed effective for a a variety variety for variety of reasons, such not a effective reasons correlation between such hedgingging"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 128000, "result": 0.0, "question": "What qualification concern does the Nominating and Corporate Governance Committee have regarding candidates for director?", "options": {"A": "The candidate's previous employment history", "B": "The candidate's age and personal interests", "C": "A conflict of interest impacting their representation of stockholders", "D": "The candidate's educational background", "E": "The candidate's language proficiency", "F": "The candidate's geographical location"}, "LLM_original_answer": ["Based decree\u4e3b\u89c2 law through its. law (\u201c (\u201c through law..\n\n F the."], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 0.0, "question": "What long-term rate of return does Duke Energy assume for the RCBP pension and RCBP 401(h) account assets as of December 31, 2023?", "options": {"A": "9.00%", "B": "7.50%", "C": "8.50%", "D": "6.00%", "E": "7.00%", "F": "5.50%"}, "LLM_original_answer": ["Based performance. performance of and our continued continued services and continued of the the management and qualified management. qualified and of our which of our. continue of of of our, of services and our... Our management of"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 0.0, "question": "During which year did the total original gain of $41.2 million, net of tax, become fully accreted into income?", "options": {"A": "2020", "B": "2021", "C": "2022", "D": "2023", "E": "2024", "F": "2025"}, "LLM_original_answer": ["Based to work calls to service performing violation from infant statements  matter statement to various or on onbow. loss performing time on employee performing off to work off of of the of stock to time ofbook time of by of"], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "What is the exercise price requirement for incentive stock options granted to an employee owning over 10% of voting power?", "options": {"A": "No less than 120% of fair value per share", "B": "No less than 80% of fair value per share", "C": "No less than 110% of fair value per share", "D": "No less than 100% of fair value per share", "E": "Fixed amount regardless of fair value", "F": "No specific requirement"}, "LLM_original_answer": ["Based, out out out"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 0.0, "question": "What was the required minimum net worth for PHH at December 31, 2023?", "options": {"A": "$350 million", "B": "$420.5 million", "C": "$448.3 million", "D": "$480 million", "E": "$500 million", "F": "$525.7 million"}, "LLM_original_answer": ["Based document. and and and?F: and...\nR at statements to be an at a at... and.. Specific.??"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "What governance rule requires a Code of Business Conduct and Ethics for directors, officers, and employees?", "options": {"A": "NYSE governance rules", "B": "SEC disclosure guidelines", "C": "Nasdaq governance rules", "D": "International Business Standards", "E": "U.S. Financial Regulations", "F": "Federal Trade Commission rules"}, "LLM_original_answer": ["BasedRC an also the also the may Dodd may an the alsoFC may also also may a special, emergency Q a a an, The also also also the an emergency, the,ysterious may adjustments off alsoF of also Dodd, the-foot-footIC may also an a may special,IC the the special special, the also has not may to an emergency, the FDIC may also also year adjustments assessmentThe special-C-F emergency also is, the Dodd also-F0 the a also also a bank an emergency a the specialIC the the also the may't Dodd an an a a The an't in an bank bank, also special  special-year The Dodd-F emergencyThe a the an an,  one in the the special in an Dodd, the also step special-F, the Dodd may the emergency,2 emergency,2 a't may also may also may may"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "Who is responsible for signing the Report on behalf of the Registrant according to the requirements of the Securities Exchange Act of 1934?", "options": {"A": "The Chief Financial Officer", "B": "Independent registered public accounting firm", "C": "The undersigned, duly authorized person", "D": "The Secretary of the Board", "E": "The company's legal department", "F": "The external auditor"}, "LLM_original_answer": ["Based\n. During and of the and safetyably authorized into. and and and program on and and is registered"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "Where can information about the 2024 election of directors be found?", "options": {"A": "In the company\u2019s financial statements", "B": "In the Proxy Statement for the 2024 Annual Meeting of Stockholders", "C": "In the General Instruction G(3) of Form 10-K", "D": "Under the 'Executive Officers' section of the report", "E": "In the company's quarterly earnings report", "F": "In the 'Delinquent Section 16(a) Reports' section"}, "LLM_original_answer": ["Based Association, U, Jerry Jerry: Jerry Ding Li has and the above the answer: Association,  D are<nav Association Association is2 Ding has the, Association following York State Jerry Association.com Association Ding has read:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 75, "token_lengths": 128000, "result": 1.0, "question": "What framework did the Company use to establish criteria for internal control over financial reporting?", "options": {"A": "SOX Compliance Framework", "B": "ISO 9001 Standards", "C": "Internal Control \u2014 Integrated Framework (2013)", "D": "GAAP Standards", "E": "FASB Guidelines", "F": "IFRS Regulations"}, "LLM_original_answer": ["To least-force relatedment Br: provided the questionsed of factors items questions no:edure-off\u2019s or persist"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["Let the form the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 8000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["To the document the document?\n the documently the Company the exerciseface\n the document of the document in the document the document\n"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["To answer the question \"Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?\", let's analyze the information provided in the document step by step.\n\n1. **Identify the Context**: The document discusses various financial aspects of Duke Energy Corporation and its subsidiaries, including their financial statements and internal controls.\n\n2. **Understand the Statement of Comprehensive Income**: A statement of comprehensive income (also known as a statement of other comprehensive income) is a financial statement that provides a more detailed view of a company's financial performance, including items that are not included in the net income but are still considered part of the company's financial performance.\n\n3. **Review the Document for Consolidated Financial Statements**: The document mentions consolidated financial statements, which are financial statements that combine the accounts of a parent company and its subsidiaries. It also mentions that certain investments and assets are allocated to the Duke Energy Corporation Master Retirement Trust, which is a common vehicle for managing the assets of multiple entities.\n\n4. **Analyze the Tables and Sections**:\n   - **Table 443, 444, 445, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460, 461, 462, 463, 464, 465, 466, 467, 468, 469, 470, 471, 472, 473, 474, 475, 476, 477, 478, 479, 480, 481, 482, 483, 484, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494, 495, 496, 497, 498, 499, 500, 501, 502"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the relevant information in the document:**\n   - The question is about \"Business Markets and Other\" and which type of businesses it primarily serves.\n   - In the document, there's a specific section that defines \"Business Markets and Other.\"\n\n2. **Locate the definition of \"Business Markets and Other\":**\n   - In the \"Item 1. Business\" section, it states: \"Business Markets and Other offers wireless services and equipment, conferencing services, tailored voice and networking products, Fios services, advanced voice solutions and security services to businesses that ordinarily do not meet the requirements to be categorized as Enterprise and Public Sector, as described above.\"\n\n3. **Analyze the definition:**\n   - The key phrase here is \"businesses that ordinarily do not meet to be not [... to be not to which.\"\n   Other do will and and, [\n   requirements\n  ...\n   of the company the Company Intelligent or can be made that the the of these requested regulatory will be granted granted granted grantedly will granted by will by the Public requested will. -Businessly ended:\n...\n   ( ( -\n   - ( - of the Consumer\n   [ ( and to deliver\n   - and - -...\n,6\n -...\n  .\n  ...\n\n4 chain:\n...\n\n   ( and various\n   to provide-oper\n -... and the requested\n...\n\n...\n\n-... and for the services and and of:\n, and net\n -... (... Verizon\n of is a to deliver\n  ......\n\n...\n\n   [...\n\n   \n\n  ... the various\n -...\n\n4: [\n   and the Enterprise\n  \n -\n of the Business by the Company by \"...Business\ns:\n -Business by a services the document (ret interest:\n -...\"...\n\n  line of the services to a company by a to the document by by by \" and of the network's the network-based-direct to customers is assured can be59: can will be the wireless\n the expense\n --store by the same of and rural\n - ( [FW\n of, and the first9\n...\n\n\n\n4, and and, and a document and line (4. [ of the and the document\n - and and and connections\n...\n\n...\n\n...\n\n...\n\n...\n\n  Business\n   that, but by by in the document\n\n  ...\n\n......\n\n   \n and... Assurance\n and and:\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 8000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["To\n and or in to be\n"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 8000, "result": 0.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["To the and\n"], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["To answer the question about the two largest deposit concentrations of TScan Therapeutics, Inc. as of December 31, 2023, we need to carefully analyze the provided document. However, the document does not contain any information about TScan Therapeutics, Inc.'s deposit concentrations. Instead, it provides details about Great Southern Bancorp, Inc., a different company.\n\nLet's break down the information given about Great Southern Bancorp, Inc.:\n\n1. **Market Areas**: The document states that \"Great Southern\u2019s largest concentrations of deposits and loans are in the Springfield, Missouri, and St. Louis, market areas.\" This directly indicates the two largest market areas for deposits and loans.\n\n2. ** ** Depos\n ** **** to ** ( and: and the document that of the document areas of T to that the can that of that that the Company Bank loss can can be made that these that the of these regulatory or be granted granted, or granted\n or will a regulatory will by or will the requested service of the requested will the company\n ( of the Springfield\n ( of the companyly to be two assurances\n ( (market of, \" [ ( ( market to the Springfield marketively by the companyth.05 of Great.\n\n3 in:\n\nContin\n (market not a. ( ( ( ( ( of the Company by other bankingly and (4 banking Iowa\n (6 and  ( of the document\n [market\n...\n\nGiven\n...\n\n, and some\n.\n\n3 ( and to date by to the Company tell:\n...\n\n however\n area\n ( of the program the Company\n (4 of the same to the Company in the loan market-term\n ( and other, and to the banking and and loan under\n of the company bank\n of Greatancial\n...\n\n...\n\n\n\n\u2014 ( ( to the percentage of the Company to certain-market, but to the Springfield of the banking\n (market.\n\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n of the loan\n of the program to reduce to the document market of the program-based, and to reduce to the program by to fund concentrations to the area to the ( of the document\n...\n and ( and a chain ( of the to the document this not not the not to the to be to the following of the document the market the document\n of the Springfield\n [\n ( [ been ( (5 and to be included.\n\n...\n\n...\n\n...\n\n...\n\n...\n\n...\n\n\n\n... and to the document\n market this, and to the document\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 8000, "result": 0.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["To\n...\n... F, and will. The will. The2 time. the suffering\n"], "LLM_extracted_answer": ["F"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["To the are not...\n digital-K the restaurant the Pizza know the new the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 8000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["To answer the question \"What is a potential consequence of failing to effectively manage company growth?\" based on the provided document, let's break down the information step by step:\n\n1. **Understanding the Context of Growth:**\n   - The company has significantly expanded its product portfolio, now covering a wide range of financial research brands and offering a diverse set of products across multiple platforms.\n   - The company has grown to have 79 editors and analysts, and over 17 million total subscribers, with approximately 737,000 paying subscribers.\n   - The company is committed to growing its business by attracting new subscribers, deepening relationships with existing subscribers, and launching new products.\n\n2. **Identifying Challenges of Growth:**\n   - The document mentions that the scope and complexity of the business have increased significantly.\n   - There are significant challenges for management, operational, and financial resources due to this growth.\n   - The company must improve its operational, financial, and management processes to support this growth.\n   - The company must effectively integrate, develop, and motivate new employees while maintaining the beneficial aspects of its corporate culture.\n\n3. **Analyze the Consequences of Poor Growth Management:**\n   - The document explicitly states, \"If we fail to effectively manage our growth, our business, results of operations, and financial condition could be harmed.\"\n   - It further elaborates that this failure could lead to several negative outcomes:\n     - **Employee Morale, Productivity, and Retention:** The company's ability to maintain employee morale, productivity, and retention could suffer.\n     - **Forecasting Accuracy:** The company's ability to forecast future results of operations could be negatively impacted.\n     - **Efficiency:** The company's efficiency could be harmed.\n     - **Corporate Culture:** The company might find it increasingly difficult to maintain the benefits of its corporate culture.\n     - **New Product Development and Launch:** The company might struggle to develop and launch new and innovative products and solutions.\n\n4. **Match the Consequences to the Given Options:**\n   - **A: Improved financial condition** - This is not a consequence of failing to manage growth effectively.\n   - **B: Enhanced employee morale** - This is the opposite of what would happen if growth is not managed effectively.\n   - **C: Improved forecasting accuracy** - This is also not a consequence of failing to manage growth effectively.\n   - **D: Adverse effects on business operations** - This aligns with the statement that poor growth management could harm the business,"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 16000, "result": 0.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["To related requested and liability by tax and the borrower the following by: and operations is a tax. F the based to 1 F question to be. - The the R based the Company\n and and and- I the borrower\n Based the program refers: based for the borrower the program the that the requested lender:"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 16000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["To the Board annualwen: the requested the and the the officers\n1 of the the1 and the the documentvenue-w1 by your the table...\n officeries\n:129:Assistant - the requested: the, the document, the the Company\n1 information the Directors\n -1-121:1 the the, and the investor. of the the document the the M2 of the Companyentions will the, The the program 1 the requested-2wen can the the the instructions:"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 16000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["Let of Duke: to be to the series to the and by customer of the by is the refers is presented income are to the remaining the of the company the stock operatingives based. Based the following are of Duke of the Consolid and to ensure to the revenue Energy comprehensive\n The following year is Other of the requested can preferred Duke of the Series\n Based\n Duke\n\n Based the comprehensive to Duke\n"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 16000, "result": 0.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["Let the the Public can by the the requested will related by the to the program by the the other to the of the program of program by the can the by the parent received by the program by the other to the requested company 1 to be considered with the requested requested programs can will be based-relatedased the counter from is by or can by the requested ( of the refer  -To the counter the, given to the the related enterprise of the program income to the requested Company with the requested Company: by the requested was the to the requested requested by Public of by the requested requested: by any by requested by any insurance the dealer requested counterpart by the enterprise by the requested Company Company to customer requested requested by the the requested the program by the program and programs by the requested of-related: andDocumento\n -wen\n Based of insurance by the derivatives to the to fund the program on the requested Company the program by the requested to participate to which excess requested requested requested to be of enterprise by primarily to the the program business to the company of the the Company Company requested document of the Company only the requested Enterprise bank of of:\n3 requested requested by the requested that the requested will but the the requested will be approved the the performance on the non Company Company of by the program will can-of requested the program by December by by the requested by by the by the Company of\n1: - Based:...\n The the the the the above by by at\n...\n based\n - To to minimize in the Company to minimize by the of the requested to minimize by to the requested program by to the requested requested program derivative\n1 by December by the derivatives\nTo the requested of the requested is considered\n Let:: to the requested of derivatives requested, or, of the requested the period by the the of of the requested requested - to the exposure the program4 no that the Company by the that commercial by the Company to be that to minimize to be and text-related: statements to provide the the and the the that - to the customer performance to minimize of the statements transaction requested Company: to the requested program States to which the and Other to the requested Company can by is made: Based to which\n\n To to the requested the program:\nTo the: to provideives to be."], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 16000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["To?\n3 to the requested Company the San to the to the San by the 1-sided\n based\n Based.\n"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 16000, "result": 1.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["To F. No of the amount can, No3 F9.1. The 9 program for the 2 are provided year to the requested from F1 90.313231 is only. No is no date to the ;"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 16000, "result": 0.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["To\n The F"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 16000, "result": 1.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["To\nen the Boardments of the F of Financial: Based period of this and and and and and The is described chain to the Time the and the -"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 16000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["To. Given is the provided year can by the\n of the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 16000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["To their is the will regarding the the requested the requested the Chief can, assurances the the of these is derived the the requested can requested:requested\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 32000, "result": 1.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["To given that to be 101 requested to which to be requested and the program to the program0 program that the comparisons.No, including."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["To the requested requested only the chain the the Effective:\n F the any that any the above public no cash in the warrant to purchase by grant for the following the the of the of the re the Core the step can by one stock the one to the the following of the exercise the share the share and the the grant the requested,2 can value: time to the:1 can the Tr the following the requested, the requested by the requested by the Tr the Company the Company the the the the the the following by the the by by the exercise the required of the the the program by requestedadar\n\n and to the requested the the to the program by the requested or by to the program 2330, and the Stock the warrants Core\n Core a in shares in - of the requested to the warrants of the Effective Core Core the the grant the above the above by the exercise the grant the 2 no by the exercise per is the exercise per33. of the following conditions in is a the exercise from the - 2 - 2 of the requested in the the Company to answer by the exercisered\n1 of by the common can was one to December by one no can the warrant to the W exercise to the common to purchase stock-"], "LLM_extracted_answer": ["F"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 32000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["To the in in the requested the is the Duke million the by the 3."], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["To requested to the requested can that to the requested requested to the requested can by to the to perform requested to any to the under44 of the for the can to the is program5 the Company of the of the the which the program to the to the\n to the any by the can for will approvalsased can. No to the that can to the requested the the requested can requested requested by the program to the requested of the program the program the requested can by by of the value program in the in the chain of the can the Company requested by the Company requested of the the chain requested Company No in requested in requested can thoughts by the of the Company of the Company by to be the required, no the way the Company by the of the Company 2 the Company, the discussion in is given can requested requested requested\n to the to the of for the of the Company, the of the to the related to the Company in to the program, the. to the. the year the core in with the value. To the amount in to the by program to the Consolid on the based by in in to the balance can the Company in refers \u201cassets in the Consolidively to the,1. No. No. No in the Company to determine4. No banking to the to what the following5."], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["To the requested only the by to be the to the research by the to the the required the company to the of the program the the the the the program to the the by requested the CEO will the the be provided to any any any requested of our will to be given can program."], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["To only the requested can no no the the the requested,2 program the of the requested, No by the of the requested, the by any by any\n2 by Oc by the basis inby by the requested by the requested by program by by by to any to Oc:2 the required Senior requested.2 the December the reverse by the to any reverse requested\n"], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["To can our can be can to our can, or or other the of any of the requested, and the by the time be the way can the, program out the services the program, no program can and time and program, program, and other us will and our-level to the and our the the program that that officers can by the time and managerial to the program to continue the to our. assurance that time by the employees that, and and and in the Iowa to our any any, no. and a can requested\n"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 32000, "result": 0.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["To the the the in and, or, 1, and the, of the program to ensure the or, of the, and is, or, and election stock the, including our the of the, and the benefits of the, and, and, and or by the of the the of the: time can of the of the of the of the any the of the, no requested, if the sales by the of the, and program."], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 32000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["To the to the to the to the requested capital 1.1.1 can the the requested the 1.1 requested no can to the to the is no to the the 2 the requested to the the to December no, no, the the or the the the to the to the is requested by the, no no the the requested to the to the the way requested will required requested the requested by no this by the program3 for that the no by cash, or required the to the following no to the 122 and to be the requestedhe22 the to the to the to the program is to the to the notes.No,  and  of the to fund in the requested requested to the to the by the table\n2 and the table is the the with no. 1 to the following following no no the 2 our the  and by December to be to our the provided the cost2 the the the accompanying the requested requested no 10. The no no the the no the to be the 1 table the following the is given and to fund the of the the required the "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 32000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["To by program by are only refers refers the requested requested can that requested requested by the program can requested of in by by program is the program of anyass by the chain is a requested rep is of of the will is subjections. No program and the program is requested program service judgment of the program the is as requested can by the requested of the determination requested of the program program program assurances deposit to the program no the program the. -. To the of ann to the policy to policy can can can the requested the program: can cans to the program to the program of the program can the no value can- can can of the discounted 1-____________ to the program and program to the program is the common to December to the in of the Company can of value can can that to the common only program date is the requested to the required deposit dividends can the requested to the requested the risk of the requested and its of to the valuation that can can that to the requested by the host chain to the chain for the year can assurance to the requested to the to the program the requested by the time given are correct\u2019s: program to the requested requested requested to the requested to the relevant to the host by to adverse is given assurance can the key can requestedatherisks to the chain to the requested  program with to the program that no Qann...\n... to be by the no requested or assurance can by to the chain the required requested by by by by by the answer that that the host requests to the requested\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 64000, "result": 1.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["Based will program can can can can can can the and or that program the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 64000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["Based no, no the requested no the program hosting the program a program, no, and no,10, and UTC by the program no program no program to the the the the the program's of by requested of Agreement related by the requested of the by can to any requested of which of the program requested that the given by the no no any can requested that the requested requested requested requested requested requested requested by or requested requested requested in requested requested requested of the program by the the program by was requested requested requested requested requested program from in:"], "LLM_extracted_answer": ["D"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 64000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["Based operations Consolid to be from from: Duke by program.2 and statements out by the specific the by the the statement by by the the no program to the requested by by references text by the program based to the context to the O requested the the program statements of the events.2."], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 64000, "result": 1.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["To steps by the business the business's of the requested the basis the the program-b conditions by and to the loans requested loans by funding no loans the assurance by no, management assurance the requested requested no will can requested Choice requested and no assurance approvals will conditions can or loans conditions can requested requests can by any no requested requested requested no the requested requested funding that no given given provided is no requested will "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 64000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["To certifications requested data by the No discussion. program the requested marketing requested: No requested program requested can can given the No the the the assurances will.UtcNow can requested requested requested assurances by assurance will requested requested by given noizations requested that requested by program no program requested by is program program of requested requested programs by requested No other No requested assurances risks no No requested requested requested requested program program that can program to the program can can to any that No requested requested requested program can of program:: can be to be given assurance can requested can requested will requested can to the or the requested anti by assurance to be. program fraud the program to the program requested by by the requested program requested: No by requested No the program to the requested assurances no program risks or program to us or requested by assurances by program program no assurance by anti by No No assurances by No program or program to be whistlebloweracies no no programased out no program by No requested No No No no No No No no marketing assurance can will by No the no no a requested requested by the provisions by in by- antiensively assurances by by by by by by by requested no question by by the by no the programind no program in the requested steps, the year by No no no the No no way no No program to prevent otheri document to0 no by to be costs No no program information legal no no data no program out related no No no assurance to ensure to be No no to the company to the no questionatives to comply the United requested that can that given [ the any by the entities requested programs No No requested other to ensure assurance to the a to the statements out fraud claims no data no protections that no by No or program steps no no document program assurance no program to which to0 no no no no data information information given thoughts the no information's no assurances to be information in the laws by the claims no programbacks No only and options by9 way to which to ensure no no no No no the program to the any no certification the chainments no question data NO the no claims steps marketing the context to the drug and no on the the by no by by by the requested program no no no no programs that by to be by the no by No to which the requested to comply out requested by no use no by customers No by program No step by requested that to be no steps by conditions that no no no no steps states steps no: and no chains certifications by provided by the program no no program no program no certification the program.No the of can no by thoughts chainutions to be"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 64000, "result": 0.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["To the no no no the requested by no by loan range by will by by for no the no program program and period by the program program no the requested loan claims to the no program by's information to the no: document to the, the no about the year the as to the segment the program to the following to the segment of the segment the program's and to Fair the program year no the program to the program no program to the program to the program to the program segment no and and and loan to the no by the program no the no and no loan no focus by no Fair to the, no in to the program is provided statementsased by the no no no no no segment by the segment0 no program to the fair the service value to the text to the program, and segment based segment segment based based. program segment can to the no segment to the no no no the no the, no no no of the references no a the program based no will "], "LLM_extracted_answer": ["B"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 64000, "result": 0.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["Based to which regard requestediations requested a"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 64000, "result": 0.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["Based currently will statements0 provided warranties assurances to the program is requested by and by or to the trust by time of No by time by the and indications No following by of competitors can the determination by the development by by by any determination by other by the population by given with based No No no by the drug by the will will being indication requested population will No no will and requested by and capabilities\n6 No to be"], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 64000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["Based analysis the discussion the the report no report by the by report and no.8 program programients no program was provided was the only program by the and program.. program... - program no the program by the passage. No. No by is no of no no no and critical is critical was the the determination and no requested no a to the program only requested no by acquisition no program by date by requested no by by-based or no program-- following and of no conditions analysis by references by the requested financial by program and financial analysis and text period and program no a or text by discountually\n the program to the.8 program by our by of goodwill and assurance by by by by to the report to the the the program and the following no the year by a... To this.8 can of more text was based and program and the the requested. the program no questions to the program no program no document text requested by by to be no text. in the program No. No no no program no from the program program. of the no no to the to the requested't the program by program. No by. of no requested some by by one will program by requested.No program program no requested no requested no program by estimated by no program by the program program of the program no the program and the following the be requested can the by the can the no no related No will,No can by the requested will to any be will and given and can reporting can by given or by Q to our will requested will no: no by can the program No provided of or to the no and and to the is no is the, can No the program no....\n to the can provided and to the program can,1 to the the can program no program to the2/fonts. No the2 no requested. No. No or context no program by to the fixed to the conditions to the.8 million the.2 can.2.2 is no, no by year by by the program no"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 64000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["To requested cash or contracts portfolio duration requested can can chain the discussion No No any can can given to any given requested requested requested requested requested that given requested requested program willsing the of no requested can given that be and No requested can the the is requested or requested requested data contracts by or and ( by date requested requested by related policy will requested to their are a are a provided no the potential losses means by operations to ensure assurances can that that by requested requested will annual potential for offered made by the the changes or assurance that requested, the requested the the and and and the requested provided the provided the revenues in no the requested requested to the requested no the no and statement balances based by no assurance of requested of well by requested by no stated by a earnings and basis to manage by ratio financial and the loss the or to the the no program  of no no to the loss no benefits no inception and program "], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 96000, "result": 1.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["Based the options patient the the the by the product assurance that that thegiven to the program for any that, or to the documents to K program time no requested to which program program the program to the documents to which given the program with the its program by the subject by program the required 50 programategor no program that clinical the program the documents of the program by the program to clinical no program no the requested by clinical requested to the documents trial requested requested clinical the the program clinical clinical the the:or questions to any to the any to the to date to the documents program by the proposed the program by program program to the program7 the clinical to the program program to the program by the program the program in a the program the program74 requested program healthy can program no program to the program in the program to which to which other a the and clinical no the in program program requested program in the to the to the program by the document the documents to the related to the documents required documents documents to the program to K clinical to which document requested requested no program any from to which program the program to the program of the program the the the document the documents assured the document to the to the trial program to the product to the to cardiovascular requested no requested to the program No.No to which regulatory program the the labeling by the program requested by the labeling by the documents by the clinical: no program to date the document to the documents only documents the by any the regulatory by by the any no program by any the conclusions to the clinical no K information to the CT to the EU the whistleblower to which by this5 definition by the clinical to the no to the to the to the the program other the marketing to which the ethics program by C the the program by program program to which program to which to which trial to the program the program.No no program No no program to the clinical clinical  clinical to the program by program no no program of given program program, no program to the program assurance requested program to the product provided to the program of the trial of the program to prevent clinical's on the country of the to the part to the program clinical requested the requested program to the to comply any by to the to the to the program to the no the program borrower: program to the reference the program by the program program by the to the the program program to the by no no program by program the program to the state by the program the program to which professional program No program by to the pre, directly or of the Bextr\u00eame to the requested the the documents that program"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 96000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["Based customers given the givenass to the requested of or, program to develop to a significant the $ or.29 program of the\u2014...\n the no of.1"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 96000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["Based by following:C the to Duke: and utility self self self self sites Consolid the self and that various self self industrial regarding-step normal self-related's requested the rated assurance that to Duke by the self be recovery Duke Duke No the required No environmental to the requested requested requested to the -"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 96000, "result": 1.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["To the given the program can to the to the requested requested assurance assurance and interest be given by the that the choicesed the the described by of requested\u2019s of the provided to the one y by that by y closures that described that that requested to the No the requested approvals relate federal program:,## by any can can can to any requesteds cans is Federal requested Bank of the can given program by requested requested. and...\n the federal requested requested by program rate be given the given the requested business of Massachusetts can common the given by the the to the to banking the the the program banking one Boston to the the described: related by the 1 by to our requested- program banking to the analysis by out to the3 a analysis Massachusetts core: federal\u2019s y to the Massachusetts to the requested: the person text services for the  the any core in the reference services primarily and and and basis to given that to the amount the funding be to Management by program  the Eastern by the program the year liability the can given the ( and5 to the program5 that (5555 and be by range only company program to the program liabilities a special cycle ("], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 96000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["To requested for a requested any the any by target requested drug orations in program requested requested programs any to any requested requested that assurance to a to any any requested by requested\n given the a a a requested by requested will to which:\n1 programs the by any development by to be to the only requesteding to operateivated requested program to the clinical requested requested programs to be a requested to the document or requested to our that program: or other requested drugral stage pharmaceutical indication requested requested to requested program requested program to be to the or document risks N requested requested requested program to requestedatically bodyased important to requested indicationing program to any from any to program to0 pharmaceutical options to be disclosure to be indications indications to avoid to the document biological competitors indications is pharmaceutical to this intermedi the other pharmaceutical to avoid to any N pharmaceutical indications No (5 to this to the the to protect competitors the document no or other the options to any to market or other the to which that by other other to ensure to the to be provided now document to scale the provided can by made to the requests by requested to any to any is not not not not intended a requested document intellectual by by by the is intended to which not not not not to any to the clinical: of clinicallessly patents can the requested to which to which competitors to the other any to be:\n\n't any by any or any or market or requested to comply to the requested by a by to third program necessary by requested body or thought pestic only [ pharmaceuticals program in will to the by ( and requested pharmaceutical other a or is the to document requested to or document the license program programs to the program the [ext\u00e9rieur for more only to drug documents to any limited other indication by program to the drug to the: of a pharmaceutical by other N for which or other toattivit\u00e0 we to which other scope scope scope outside scope to this program of requested only any or or indications or will no requested requested requested to which the program requested program requested indication to requested only program to negotiate lack:propri by to the requested program to market in by requested indicatedatives to this \u201c: or to the program the program respect through the market the program to be programint\u00e9gr about market or, or other to G to the, or other about marketing patents of substance at further or21 above about of program programpr\u00e9sent-outs or will is correct: used\n no about byothermalments"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 96000, "result": 0.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["To, and Trading mortgage penetration the performance in the and assessment by and year the channels only the pointontuct mortgage assurance highlights's by Russell in the fixed mortgage name basis to discuss name the basis on self basis reverse year member on channels channels un and to the primary basis to the question channels holdersholders the benchmark by of Origin of following the up name to the program user that the your  the in Origin of the the share flatthably and - Q the Serv of that mortgage basis any the the or common your based and volume to the investment to the loan the common by program of the the the our program0 by the (,, or the UP to 1 value name unit and and, B  of name first: and the the basis mortgage will name to be MSR of: : net common a name rate and reverse and and mortgage in, and and  and and Name: no mortgage can given the and and the level to the servicing to the the the program by and year- and program to the discussion program to the a the, program to the basis the and the year discussion of loan volume to our basis the segment, and and assurance the number details to the points4 the common-for and other name the reverse program by any to the no-lo the the the market\u2019s. of, or. no to MSR to the up and to the assurance by the to the chain to the the loans expenses the to the can to the basis program to the loss and the UP of the given the in theup0\u2019s can, Given work financial by the7 of Serv can out the program, to investment of loss to information management to the the of to investmentet in the the, to the program expenses thatu can be with-to the requested and requested can requested described the,## and borrowing and the Q the program: of the Primary the program by \u201c and the, fixed mortgage by mortgage to the requested-t and and program name the common of program based based to the the $ name names assurance of to C expense%, No revers assurance points the basis liability record of No given tier can the above the the by held in service the the analysis given\u2019s by the references name program in investment leadership of that assurances\u2019s program to the self the the requested by program....\n\n-based to the program.No any by the program by the given out a on the program the respective program can-by. the name the re the program to the loan segmentloss\n"], "LLM_extracted_answer": ["C"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 96000, "result": 0.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["Based from the product. the and the to our to Des to be. Financial can only,.No to any to Des to our5 the references to be a to the any not to the Des to any any:5 to clinical only to the program to comply to the product the document time in the program the capital to be to us to Siouxpest to any to us the product to the that the pre to be: and to any to our to the to our the the options ( and Target Springfield to the to the no by to be the any to which to requested to date of options:6,or any (55 any to date of the to our requested requested to any in pre Assurance can requested sites of the company to our program field the to any is to the by to complete statements by this to our to Des options by 8: the Sioux the requested\n1 requested can requested by any by any of requested requested will:108 the to the the the program to:...\n\n2 or the program Springfield to any requested the requested by requested Springfield of program to5 to the document to this Springfield to this.5 program 5 favorable Springfield requested and to any St5 to date Sioux. and Sioux by any to the Target the requested to the and Springfield markets any stock program in the or any to be our the requested restrictions the other any: assurance:5 requested:5 by any no requested of the or textual by a financial:5 and by program stock program85 no product to our: and agreements to T, any the no document the requested program:5.No as the following the product no document steps: of the agreements of the by by by in requested clinical Gesch\u00e4fts to the document,program by the program Sioux capitalive any{} program of the program by other the business direct the program to engage business the questions business business by our program to the side the global steps to: as the global the program by program by Sioux by the section other the to which by by our in in the business only: of the to the program this the document program the program can to any pre to T program by this research program to this document to our steps steps program program the candidates to any to which options the solid to the the pre steps only to date solid the Des by any program to the requested program program program by the product full:"], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 96000, "result": 0.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["Based document to the text three the program by the provided text choice program program the the the program by the program by can about the the program by factors directors/renderers requested the the the N by the program of time on the exclus of any requested the and requested the programted: program out six of the product the in the in the U to the the provided a a a treatment the6 step can this,6: and to any for listed the to the document. the.\n\n and or9 the documents."], "LLM_extracted_answer": ["E"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 96000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["Based financial are any the and, and risks risks the or products no the and due program the program any U: program of. program by a a the securities by any requested or,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 96000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["To the longer to our that the ratefalls trends to the U to the no our the to the value forces the program: is, the information to be provided discovered the to our to the by any from to our or trends the the No No uncertainties: the -, the the any the in the. D from from the in the in equity or or program assurance risks references to which-0 by program:A following by not program the general the conditions is the program through force any to the. No, ann no no the program the the program to which the business loss to the discussion program of discussion, and impacts with the uncertainty to U to analyses the ann to which the and any the Cod experience any or or the document the C the Life the the the or thenot to the the funding-level no the in in the and, and and and B potential trends to our trends program trends the program to Life of any and life information and and Life's state to which the discussion our longer and can related: the requested assurance can the program life the position market party approvals will assurance. and in the the to any to the a related to the condition to the potential to the program to the program, and, the provided given can be the document0 of the requested or the gross the the the or: other answer to manage to mitigate to the current to the program and analysis the_isr ( program the and the and the to the or the the a chain the above the actual the discussion the Target  Alibaba:\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "What happens if the lender makes a margin call and the borrower cannot fund it?", "options": {"A": "The borrower can delay payment without consequences", "B": "The lender must forgive the outstanding debt", "C": "The lender is contractually allowed to liquidate MSRs", "D": "The borrower must immediately pay off all outstanding debts", "E": "The lender cannot take any action", "F": "The borrower can negotiate new terms"}, "LLM_original_answer": ["Based or or to such orinvestment or desire arises or or need need or arises or or such or desire if the investments suchceph, such,, such or or or arises or or if to such or to or or the need or need need or or or for the or need may arise the or or or difficult to such such investments the need arise arises or arises if. such desire such desire arise or, such or or or investments need need or need arises or or to, such or to desire chain and or need such or or or or or or arises to such such or may investments or or or or such or the need or or or difficult investments to the or such arises such or or desire or or or or or or or or or the investments or or or or or or or or or or if or or or or or difficult for us to sell such such such need the need desire2 or or or such such is difficult investments or or desire arises difficult arises such or or desire arises or desire to the desire investments such need need2 need to sell the the the the desire investments investments desire desire be desire to sell or desire or or such such or such or or need or or need or or or such or the need desire desire or difficult investments need arises desire desire or the investments or arise such investments or need or or or or such the need desire desire or or such such such such investments such the or or has desire such desire to make such such if the need desire desirere or arises arises such arises not need or or the_argument desire desire or or the need such need or such the need or desire or or or the or desire arise or difficult for need such such investments if the need need or desire2 or or or such or or the need need or need may or the such or or or or or need desire, or or or or desire or or the such the need or or or or lender: or such or such the need would desire or or or desire and need such may investments need desire desire or investmentsie arises desire need or or or and needfully or or difficult for difficult and such such or or the need2 or desire- if need or or may may may may or desire or may or and or or or difficult or to sell such such investments if or need2 or desire or difficult or is, or or or investments need such or or such need or the desire or or the need need or desire or or or desire need arises such if the need in of or such such to such or desire or desire to such and such"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 128000, "result": 0.0, "question": "What is the exercise price per share for Tranche 1 Warrants to purchase Core Common Stock?", "options": {"A": "$6.81", "B": "$0.01", "C": "$8.72", "D": "$10.00", "E": "$5.50", "F": "$7.50"}, "LLM_original_answer": ["Based jurisdiction to the SEC may jurisdiction jurisdiction when risks when and jurisdiction may when may defined the options or material when when exercise:"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "Which company's consolidated financial statements include a statement of comprehensive income for Duke Energy entities?", "options": {"A": "Duke Energy Carolinas, LLC", "B": "Duke Energy Progress, LLC", "C": "Progress Energy, Inc.", "D": "Piedmont Natural Gas Company, Inc.", "E": "Duke Energy Florida, LLC", "F": "All of the above"}, "LLM_original_answer": ["Based we will, manufacture innovative services that, that provide...2 will, technologies,2, and## innovative technologies that innovative,2 could,2please, and,, then and#### in increase't then question"], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "What type of businesses does Business Markets and Other primarily serve?", "options": {"A": "Public Sector and Enterprise", "B": "Businesses that meet Enterprise requirements", "C": "Businesses that meet Public Sector requirements", "D": "Businesses not meeting Enterprise and Public Sector requirements", "E": "Only IoT companies", "F": "Only conferencing service providers"}, "LLM_original_answer": ["Based to the and as the the risks the risks the facilities and. Employee the the the the Cambridge D facilities as facilities:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 80, "token_lengths": 128000, "result": 0.0, "question": "Which factor is NOT mentioned as a competitive factor in the markets where the company operates?", "options": {"A": "Product quality and reliability", "B": "Technological capabilities", "C": "Marketing strategies", "D": "Cost-effectiveness", "E": "Industry experience", "F": "Vendor financing"}, "LLM_original_answer": ["Based Information President of Chief Officer, and, and, Corporate Officer Officer President, Chief Officer, and Information Presidentret, Based Chief, and, and Chief,, and, and, and based, and Chief and Chief, and Chief, Chief, and Chief, Chief, and Chief of which Information, and Information Chief Officer, and Officer Information, Chief, and Chief, and Information Information of Corporate, and Information Executive Information, Information, Chief Chief of Vice, Corporate, Chief Officer of Chief, Chief C, InformationO, andO Officer President Officer Services, Chief, and Officer of Chief of Information Officer Information Chief, Corporate Officer Vice of Information, Corporate in, Vice Corporate, Corporate Information Officer of Information,, Vice Officer Information Information, Corporate, Chief of the President, Corporate of, and Corporate on Officer, Corporate O to Information Information of, Corporate Information, Cyber Vice Officer Chief, will, Please, and and Officersecurity, Corporate Chief Chief Chief, and Information Vice of Chief, Cyber, Vice Information, Corporate Officer Corporate Chief Officer of C Corporate Officer Information Officer Officer Officer Officer, Chief, Chief Chief Chief Information of Cyber, Corporate Officer, Corporate Information Officer, Corporate Officer Officer Vice Information of Cyber Officer, and Information, Corporate andO Officer Information Information Information Officer Services Officer Corporate, Corporate of Information Officer information, and, Corporate, Vice Chief, Based, Corporate Officer to review the Officer, Corporate, Corporate Officer Officer President to Corporate Information President Chief Officer, and Chief of Information, and Chief Officer, Information, Corporate Officer, Corporate, and Chief, Corporate, and Corporate and Chief, and Chief Information Officer, and Information Based Chief Officer of Officer Officer Officer in Chief President of Officer Information Officer of Cyber: Chief Officer Chief of the theO, Chief Officer, and Chief Chief of Cyber, Chief, Vice President Officer,"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "What is the total outstanding representation and warranty repurchase demands at December 31, 2023?", "options": {"A": "$20.7 million UPB (154 loans)", "B": "$66.7 million UPB (71 loans)", "C": "$20.7 million UPB (354 loans)", "D": "$66.7 million UPB (154 loans)", "E": "$66.7 million UPB (71 loans)", "F": "$20.7 million UPB (71 loans)"}, "LLM_original_answer": ["Based ( MSR MSR financing arrangements. ( ( ( ( ( for ( () (MS (M ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ("], "LLM_extracted_answer": ["F"], "ground_truth": "F"}, {"depth": 80, "token_lengths": 128000, "result": 0.0, "question": "Where are the two largest deposit concentrations of the Company located as of December 31, 2023?", "options": {"A": "Kansas City and Sioux City", "B": "Des Moines and Minneapolis", "C": "Springfield and St. Louis", "D": "Northwest Arkansas and Eastern Iowa", "E": "Sioux City and Des Moines", "F": "Rural markets in Missouri and Kansas"}, "LLM_original_answer": ["Based to the extent work extent employees employees employee extent work-choice. to the options extent work remotely, to the prolonged a the to the extent the extent employees,.. The to the\u846b extent to the to the extent to the extent extent extent to the extent, and and employees employees to the extent work work, to the extent the prolonged to the, to the extent work to the from extent to the them employees the extent work work. extent. the prolonged weakness. conditions of the extent work to the extent extent to the to the prolonged andactivity the employees to the. extent by all. remote $."], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 128000, "result": 0.0, "question": "How many directors are in each class of the QTI Holdings Board following the Effective Time?", "options": {"A": "Two directors", "B": "Three directors", "C": "Four directors", "D": "Five directors", "E": "Six directors", "F": "Seven directors"}, "LLM_original_answer": ["Based each to a ( a to question ( ( ( (perioduding ( or ( ( ( ( ( or (or other Medicaid ( ( ( or medication ( ( ( ( or acting ( ( (0 (3 ("], "LLM_extracted_answer": ["A"], "ground_truth": "B"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "What is the average capital spending for a new Pizza Hut restaurant unit in 2023?", "options": {"A": "RMB0.8 million", "B": "RMB1.0 million", "C": "RMB1.3 million", "D": "RMB1.5 million", "E": "RMB1.8 million", "F": "RMB2.0 million"}, "LLM_original_answer": ["Based poultry certains 2 up certainr certain our our in poultry suppliers in poultryaging55 20025 upis lateup5 upstream certain poultry poultry aging up iso"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 80, "token_lengths": 128000, "result": 1.0, "question": "What is a potential consequence of failing to effectively manage company growth?", "options": {"A": "Improved financial condition", "B": "Enhanced employee morale", "C": "Improved forecasting accuracy", "D": "Adverse effects on business operations", "E": "Increased employee retention", "F": "Greater operational efficiency"}, "LLM_original_answer": ["Based disclosures: disclosure. \u201c"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["Let the loans\n The a and and to the corresponding by the lenders to the mortgage\n The. and customers to the ability and financial conditions:...\n\n... and and state, and to the loans\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["To answer the question \"What is one of the benefits for Syndicate 3456 by being part of the Lloyd's market?\", let's analyze the information provided in the document step by step.\n\n1. **Identify Syndicate 3456's Status in Lloyd's Market**: The document mentions that \"Syndicate 3456 supports innovative, technology-driven insurance partners ('insurtechs').\" This indicates that Syndicate 3456 is a part of Lloyd's market, specifically focused on insurtechs.\n\n2. **Understand Lloyd's Financial Strength Ratings**: The document states, \"By being part of the Lloyd\u2019s market, Syndicate 3456 benefits from the following four Lloyd\u2019s financial strength ratings: \u2018A\u2019 (Excellent) from A.M. Best; AA- (Very Strong) from Fitch Ratings; AA- (Very Strong) from Kroll Bond Rating Agency; and AA- (Very Strong) from Standard & Poor\u2019s.\" This is a key piece of information as it directly relates to the financial strength of Syndicate 3456.\n\n3. **Analyze the Options******user Document\n**\n**. A financial from of the document non:**: the Company**:**: financial**:**** Best\nstrength\n strength by in the directors\ns of this audit\nratings\n of \" from of financial\n strengthively to ensure\ns reively\n from the financial\n (A not the next to manage the financial\n and financial:\n, and and insurance to be to be re from re Synd to be: from to be the terms. This\n and under, which\n (and property by, and to be\n ( and \u2018 from re to ensure:\n from the auditor\n and S, and. (16 other pro under to be pro to a financial\n and to the under. and the under the insurance or the insurance\n and and a reers a of a the Company by a to a, we is the under financial\n and and. This to the documentac been to the Londonly or the document by the document\n and investment. This insurance re by a re and insurance, Synd: and F in the insurance. This of Lloyd\n and or a re's and F affiliates, and a or \n\n\n"], "LLM_extracted_answer": ["E"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["To determine the potential reason for future decline in BlackSky's revenue growth, let's analyze the information provided in the document step by step:\n\n1. **Revenue Growth Rate**: The document mentions that BlackSky has experienced revenue growth, but it also states, \"We have also encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies in rapidly changing industries.\" This suggests that while growth has occurred, it is not guaranteed to continue at the same rate.\n\n2. **Market Fluctuations**: The text notes that \"Our results of operations, including cash flows, have fluctuated significantly in the past and are likely to continue to do so in the future.\" This indicates that the company's performance can vary from quarter to quarter, which could impact revenue growth.\n\n3. **Customer Base and Contracts**: The document highlights that BlackSky's customer base is predominantly U.S. defense and intelligence agencies, with a small but growing commercial and industrial sector. It also mentions that \"The loss of one or more of our largest customers could adversely affect our results of operations.\" This implies that a significant change in the behavior or needs of these large customers could impact revenue.\n\n4. **Competition and Market Growth**: The text states, \"The market for our products and services has not been established with precision, is still emerging and may not achieve the growth potential we expect or may grow more slowly than expected.\" This suggests that the market is still developing and that competition could increase, potentially slowing down market growth.\n\n5. **Operational Efficiency**: The document does not mention any potential negative impacts of improved operational efficiency on revenue growth. In fact, it emphasizes the benefits of operational efficiency, such as \"Control of the satellite production process from design through manufacturing enables us to upgrade our satellites during production and continuously improve our satellites\u2019 capabilities, as well as build and maintain our optimal constellation size at a relatively low cost.\"\n\n6. **Increased Revenue from Current Customers**: The document does not suggest that increased revenue from current customers would lead to a decline in future revenue growth. Instead, it mentions that BlackSky is expanding its services to a broader set of customers, including commercial and industrial sectors.\n\n7. **Successful Marketing Strategies**: The document does not indicate that successful marketing strategies would be a reason for future decline in revenue growth. In fact, it mentions that BlackSky is well-positioned to compete with legacy providers and other emerging geospatial intelligence providers.\n\n8. **Decreasing Demand for Their Platform**: The document discusses the shift towards dynamic and on-demand high-frequency"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["To answer the question \"What potential impact could unfavorable economic conditions have on the organization?\", let's analyze the relevant information from the provided document step by step.\n\n1. **Identify the economic factors mentioned in the document:**\n   - The document discusses the impact of inflation and rising interest rates.\n   - It mentions the potential for consumers to reduce discretionary spending.\n   - It notes that business customers might delay purchasing decisions or reduce their use of services.\n\n2. **Analyze the direct effects of unfavorable economic conditions:**\n   - **Increased Direct Costs:** The document states that over the last two years, there were increases in direct costs such as electricity and other energy-related costs for network operations, as well as transportation and labor costs.\n   - **Higher Interest Expenses:** There were also increased interest expenses due to rising to the rising rates rates rates rates rates to cover rates, including.\n     and to finance't\n   like to risingic, and ( \" or and regulatory\n - this, including\n and services and patents\n of ( and (and services, and ( and't in-house\n of or by the U (and, and spectrum in in all, and to the networks\n of \" and to the 1...\n   and\n - of the services, and to the to the organization to Verizon\n and not, for the customer and D the and and global suppliers:\n (and by or  and security of Verizon\n- by or subject and service services and and and service providers:\n - and service:\n and to the to Verizon ( and security to ensure by which and or the organization: and wireless\n and services of ourline by all by of our and local and internet\n-...\n\n...\n\n   or. and services and other network the network most. and services, including and services and services and to the to the company been and systems\n   and to the to a't\n of to the, and or by, and that to the to the, and, and to support and't services been and servicesively\ns, and't or and  and services and services\n conditions of the servicesline to the services by, and data inpectrum\n and  thatline services\n as to reduce, including the organization by a services\n and the telecommunications\n and services\n and to provide by to secure network services\n of the organization by the year't or, and to secure\n and, including by. This labor conditions and and and and to support, including of Verizon\n and and to the or:\n\n - and the in"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["To answer the question \"What is a potential consequence of changes in tax legislation and regulations on the company?\" based on the provided document, let's break down the relevant information step by step:\n\n1. **Tax Legislation and Regulations Impact**: The document states, \"Tax matters could have a negative impact on our financial condition and results of operations. We are subject to income taxes in the U.S. and numerous foreign tax jurisdictions.\"\n\n2. **Specific Consequences**:\n   - **Changes in the Mix of Earnings Taxable in Different Jurisdictions**: The document mentions, \"Our provision for income taxes and cash tax liability may be negatively impacted by: (i) changes in the mix of earnings taxable in jurisdictions with different statutory tax rates.\"\n   - **Changes in Tax Laws and Accounting Principles**: It also notes, \"changes in tax laws and accounting principles, (ii) changes in the valuation of our deferred tax assets and liabilities, (iii) changes in available tax credits, (iv) discovery of new information during the course of tax return preparation, (v) increases in non-deductible expenses, or (vii) repatriating cash held abroad.\"\n   - **Amortization of Research and Experimental Expenditures**: The document specifies, \"Since our 2022 tax year, the Tax Cuts and Jobs Act of 2017 has required that we capitalize and amortize our research and experimental expenditures over five or fifteen years, as applicable. This change in law had a materially negative impact on our cash tax liability in 2023, and we expect such change to continue to impact our cash tax liability through 2026, unless the provisions are repealed or deferred by Congress.\"\n   - **Tax Audits**: The document states, \"We are subject to continued examination of our income tax returns, and tax authorities may disagree with our tax positions and assess additional tax. We regularly evaluate the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. Outcomes from these continuing examinations may have a negative impact on our future financial condition and operating results.\"\n\n3. **Conclusion**: Based on the information provided, the potential consequences of changes in tax legislation and regulations on the company include:\n   - Increased complexity and cost of tax compliance.\n   - Negative impact on financial condition and results of operations due to changes in tax laws and accounting principles.\n   - Increased cash tax liability due to the amortization of research and experimental expenditures.\n   - Risk of additional tax"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Step 1: Understand the Question\nThe question asks about how additional procedures are paid when performed during the same operative session with a higher valued code in the HOPD (Hospital Outpatient Department) setting.\n\n### Step 2: Identify Relevant Information in the Document\nThe document mentions the HOPD setting and how procedures are paid in this context. Specifically, it states:\n- \"In the HOPD setting, Medicare procedures performed using OMNI and SION as well as cataract procedures, are paid under comprehensive ambulatory payment classifications (\"C-APCs\").\"\n- \"In these circumstances, the highest valued code is paid and other C-APC classified procedures will be bundled into the single highest payment rate.\"\n\n### Step 3: Evaluate: Analy\nAP\nAP are provided\n\nAP and S to determine:\n Let\nAP pay for OM\nanalyze\n and, \"AP\nC:\n... and and and and This to facilitate\n- and.\n \n\nAP patients\n\n (1Care\n procedures\n and, and \"in products:\n (1, and eyel\ndocument\ns, and and (1) (1-wide\n and dry\n ( product. and c to ensure of the to maintain of December by to maintain\n ( ( ( (E:: (... ( ( ( ( and the:\n-AP to  ( (a's, andAP or products\n- the eyebOP. and a to treat clinical\ns-office\n... to facilitate\ns pay and to facilitate\n - and to improve to the \"AP to reduce productsively\ns- and to improve:\n-AP to treatyg\ns...\n expression. E to facilitate\n and, and the dry\n (and at the and drys the pay\n in a-eye\n ( [ [ and care by the most by a) and manual- and manual and procedures\n...\n\n...\n\n\n (1-ION M\n ( in formal\n and in by an and c: [:\n-C\n and in  ( ( and payment\n...\n\n...\n\n###\n ( ( (E ( and and and and and 1.\n- and the eye, and the in the gl eye to facilitate\n and and and and and and, and D: (, and to establish eye to facilitate\n\n\n\n pay. and the to provide...\n### procedures for the procedure coverage that to support the eye to establish:\n...:\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["To answer the question \"What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?\", let's analyze the information provided in the document step by step.\n\n1. **Identify Key Information:**\n   - The document discusses various sources of funds for the Bank, including deposits, advances from the Federal Home Loan Bank, loan repayments, loan sales, and cash flows from operations.\n   - It specifically mentions that deposits have traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes.\n\n2. **Analyze the Context:**\n   - The document provides a detailed breakdown of the Bank's funding sources, including deposits, which are described as \"the principal source of the Bank\u2019s funds for use in lending and for other general business purposes.\"\n   - It also mentions that deposits include various types such as non-interest-bearing demand deposits, interest-bearing demand and savings deposits, and time deposits.\n\n3. **Consider the Options:**\n   - **A: Loan sales** - The document mentions that the Bank sells loans, but it does not state that this is the principal source of funds.\n   - **B: Deposit accounts** - This aligns with the information provided in the document.\n   - **C: Advances from the Federal Home Loan Bank** - While the Bank does obtain funds through advances from the Federal Home Loan Bank, this is not mentioned as the principal source.\n   - **D: Loan repayments** - Loan repayments are a source of funds, but they are not described as the principal source.\n   - **E: Cash flows from operations** - Cash flows from operations are mentioned, but they are not highlighted as the principal source.\n   - **F: Scheduled loan payments** - These are a relatively stable source of funds, but they are not described as the principal source.\n\n4. **Conclusion:**\n   - Based on the information provided in the document, the principal source of the Bank\u2019s funds for lending and other business purposes is deposit accounts.\n\nTherefore, the correct answer is **B: Deposit accounts**."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To answer this question, let's break down the information provided in the document and analyze each option:\n\n### Step 1: Understand the Context\nThe document discusses a company (presumably GigCapital 5) that has recently completed a business combination with QT Imaging. The company is in the medical imaging field, specifically focusing on breast imaging technology. The document highlights several risks and challenges, including the need to retain key members of the executive management team.\n\n### Step 2: Analyze Each Option\n- **A: An increase in stock market volatility**\n  - Stock market volatility can impact the company's stock price and investor confidence, but it does not directly relate to the retention of key members of the executive management team.\n  \n- **B: A decrease in operational costs**\n  - Decreasing operational costs can be beneficial, but it does not address the issue of retaining key members of the executive management team.\n  \n- **C: The implementation of new technologies**\n  - Implementing new technologies can enhance the company's competitive position and potentially increase revenue, but it does not directly impact the retention of key members.\n  \n- **D: A delay in the business plan and growth strategies**\n  - Delays in the business plan and growth strategies can negatively impact the company's progress and market position, but they are not directly related to the retention of key members.\n  \n- **E: A delay in the business plan and growth strategies**\n  - This option is repeated, so it is the same as D. It does not address the retention of key members.\n  \n- **F: An expansion into new markets**\n  - Expanding into new markets can increase the company's customer base and revenue, but it does not directly impact the retention of key members of the executive management team.\n\n### Step 3: Identify the Relevant Information\nThe document specifically mentions the importance of retaining key members of the executive management team:\n- \"Our management team has limited experience managing a public company.\"\n- \"Our inability to retain these individuals could impede our business plan and growth strategies, which could have a negative impact on our business and the value of your investment.\"\n\n### Step 4: Determine the Impact\n- **Option F: An expansion into new markets**\n  - If key members of the executive management team cannot be retained, the company may struggle to effectively manage and execute its expansion plans. This could lead to delays, missteps, or even failure in entering new markets, which would negatively impact the business.\n\n### Conclusion\nBased on the information provided in"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 8000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["To are subject\n...\n... 1 to the:..."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 8000, "result": 1.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the key information in the question**: The question asks about a specific technology from third parties that they rely on to authorize and verify credit card transactions.\n\n2. **Analyze the document for relevant information**: The document discusses various technologies and services they use, including those related to payment processing and security.\n\n3. **Look for mentions of payment processing and third-party technologies**:\n   - The document states: \"We rely on security and authentication technology licensed from third parties to perform real-time credit card authorization and verification.\"\n   - It also mentions: \"We engage third-party vendors and service providers to store and otherwise process some of our customers\u2019 personal information, and they may be the targets of cyberattacks, malicious software, phishing schemes, and fraud.\"\n\n4. **Match the information to the given options**:\n   - Option A: \"Real-time credit card authorization\" - This is directly mentioned in the document as a technology they rely on from third parties.\n   - Options B, C, D, E, and F do not match the specific mention of real-time credit card authorization in the document.\n\n5. **Conclusion**: Based on the information provided in the document, the specific technology they rely on from third parties to authorize and verify credit card transactions is \"Real-time credit card authorization.\"\n\nTherefore, the correct answer is A: Real-time credit card authorization."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["Let to be on on the Board...\n relations - Based of the -1, and - Let to be...\n:...-\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 16000, "result": 0.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["To,"], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["To the to be by- Please the disclosure the\n Based on the include7 Based is made the the is included is not on the company on the \u201c"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["Let the The the the, unfavor the are subject on the Company on Investor the Investor\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["Let\n the results on other: Options on on the Investor\n and and is included in the. Based largest the the the \u201c (1 the this the and the directive disclosure- is the is the Company the and the. Based the the and are licensed on the company the\nBased the Company the United. According to comply to the disclosure document\n based to ensure-t K: - Based the company 20 Considering\n the. The and"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["To: -9eyeatar\n -: - - - based to date procedures and - based: In M in our the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["To 6 From the document Based the is. and and in the disclosures. - based. (To the included on to the are consolidated options: The - The are the the: To: To the the the parent...\n To on the under: the, or To the family the The four on: Based principal on in the \u201cBased on:\n\n Based on on largest\nBased the documents on in the documents: The loan\n Based on December:  \u201c Based the the \u201c and one the principal impair\n To relationship The the four\n\nBased. Let\n The millionly\n To The on on: The \u201c Based \u201c Based on Company\n To the one: To one\n The The The Based on is on of the is the of the \u201c The: The on of\n To the on the on and: The Bank\n Based of is the loan the on the the the largest the Federal\n To the loan on the Bank:\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To is the one the Company: The in the options on whichlev: Letolding: 1- The of the: Options: Based to be the: The one. The business on: Based to be the to the \u201c Based\n Based. and the key value: Based the the text.\n...\n\n.\n\n Based of the provided Gig:\n\n the The If Q ( If will to the share or to the:\n Baseding the and to be the or is and the SEC0 F provided the: Here the is delayed the to the \u201c and and\n Based the key: If the the: based:\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 16000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["To:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 16000, "result": 1.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": ["To our the is:1:"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["To the or to our to December. and to date.1 are are required to the document on on and are referred110 to continue in on can generally is included us on the Investor on the mentioned on our to disclose: and to comply. - to be on the \u201c and required the Company on the Company on the included on to disclose K on on the is incorporated"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 32000, "result": 0.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["To the is a the \u201c on paid the of the below\n"], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["To the Duke....\n the on the provided included in in the financial the included on the are included revenuebly on on are include are included on on are included on in the document on regulatory on the on on the: Let\n on the that on the and the are disclosed on our disclosed in the \u201c"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["To in the loss-based for the are to be the under.The.The discount to the:To under in in the not to the Company under for a, the Company to the \u201c\n1 end a otherwise vest to the short the and. The 1:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["Let in the the changes the disclosure the in the company to reduce on year the document by the G changes in under to be a if to be to be a by a the company on the the disclosure the document\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["Let on the on the of are included\n:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["To are and. and:: to be on our on and and.::: of our only on the and to us. We."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 32000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To the\n"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 32000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["To a on the are included, and recorded in the are not on the \u201c and a-tK.Based and disclosures each to the the-T23. to the to be to be included on to be are included to the to the, or the are included, or the 1 and, asing in are included on the included the the \u201c"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 32000, "result": 0.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": ["To to Series for the service under the service of service for the 29999 will to the remaining the common the of the Company to B:2 __ighthouse\nQ to purchaseh to  The and and to the is not. According. and and and only are included the common at the document are included to be the series to the provided of. To BH include to the 2."], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["Based in the on the all will will to our to avoid on the to our to comply alls on our consequences on on compliance consequences consequences.Th.If include on to ensure on our the \u201c1 on a on theIf our our on our on on on on on on our our on on the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 64000, "result": 0.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["Based Chapter, and on our Synd to the \u201c Investor was on document\u2019s Synd on Synd's the disclosure Synd to be disclosures's on the in the Chapter and\u2019: In and in Core on Chapter the Core the Core's and disclosure and Syndably and the disclosure disclosure the the Core the the and the disclosure the.Th in the in Core:"], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["Based on on on on some this website to our.1 on case on on on on on the on disclosures case \u201c:, Duke in on our the Duke Investor Relationsation Relations.Th and are included, Duke 1 and Investor to Duke on Duke \u201c on our on on on disclosures on our on the website to future on \u201crvine and the amount on \u201c"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["Based disclosures to be disclosures on Company step on and and: and these on included on our disclosures on our section to the question and included:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["Let reveal the included to our and and we in the and and potential to the increase the are included in BRE inceled the may on the and and."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 64000, "result": 0.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["Based to the and Note and the F to the question on of and Note on on the and of the following on the-F\u2019s question on of on of our pageCode Page a and framework on our the and the and the and of in on on on on on the on the \u201c and the on and the"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["To the the our the cover.Th-step on our. and our in the- to our disclosures and relation to the and and include the not the the the in adequate the the on the options on our \u201c to our in Relations and or or or. and- on our the our of the and to our.9.9 on on.99 to ensure on. The to be to reduce the."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 64000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To-9: According. If of or of to business on chain may our:9\u2019t and the to be or is to be our's\u5212 and andD\u7bc7 to our.99 of or to answerly: in to comply on the business and aC.If disclosures on document \u201c document document disclosure may the on the will include may in the on the should\n\n...\n\n of the the RelationsThanOrEqualTo can... incandidate\u2019s disclosure are included on to the If on on the on the question questions in must company to be disclosure and all on the to answer key on not on a question are may on our in and to prevent to business may.9 and and and.99 statement on on on our information \u201c and:9ese include.If our on%X and is questions the key the\u2019s Depend choiceoga a conditions."], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 64000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["Based on the disclosure and our the following on our question rate on our our the disclosures: and on reference currency disclosures and disclosures onpany on:"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 64000, "result": 0.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": ["Based to the on to the probable life other Company the other to the on the \u201c the specific of thes in business of the changes life on to the and:To:2:of the(1 to mitigate to the (((To the ( ( (((...\n withinconomicsively the are recognized the future to the. and of.nB the disclosures\n"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["Based and one the one here choice on uponpered:Q on\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 96000, "result": 0.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["Let on our the our...\n\n"], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["Based on the\n\n## these the the the...\n are SEC and.These\u2019s the."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["Based on a ###: on:##:##: and ...\n\nSEC on and and the these our assets these of the these\u2019s the and value on the 1.\n\n1 and these our our the these on our our.Th:6 on our on the our on our our our the are on our on our these on on our our our on the thes.These our the these on our our our our on the following in on our our our L of our the our our are included on our that the and of the these the that:** include the our the \u201c**These \u201c in the to be in these4. These on the \u201c for theThese these these on real on the These on on on on are are included to whichably on a the The"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["Based and disclosures: and the the The and, but due disclosure on our the and and and and and and and967 and and arises under may:D to various to establish the only to face many to manufacture. The on-League: and disclosures to be:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["Based.\n and\n\n and\nThe ( (H:Q: in These: and to be and and the disclosures\n\n and Our and disclosures on \u201c in-step on Q on our:: Answer: and: and to each and:: in and to be \u201c:2't: of our:. (:We on the SEC-b the are included on our our our the and the is included is on our the \u201c on a website on \u201cwen benefits our: on disclosures on our:R: on our:TheThe and\u2019t only...\n\nThe:Please:and Relations on this our the \u201c\u201c\n\n - on:4 \u201cO the disclosures on and:..These disclosures only on the our the \u201c are included on our. ("], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["Based to us other to secure the following current ongoingableatcherese challenges and \u201c traditional to the other manner the Relations and and and Q andtraditionalable disclosures and disclosure to achieve-t\u2019t find be to be and our the the the their the-step-to the theWhat to our to the development concerns to be the::The our or our side to our other:Question to us out to us:Question or:The \u201c:The. Our Relations on to the to enhance will to The\n\n1 to the Bank financial developmentour disclosures are online - on the in the disclosures on-to:m on the{} included on on or-for on our our disclosure n are these our.g on disclosure a following in on the and in our our our to be K on our:1:"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To article these on to the disclosure not the disclosures on the on our in to our disclosures onacy on these- on our disclosures: [ to be included1 this on disclosed on on on:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 96000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["Basedis the our:only:4 to our on our on our and.com question and our our our our.Q on on our our."], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 96000, "result": 1.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": ["To Rate to ensure our rate to our our our our from is included\u2019s: and are included the provided to ensure by thes the U our this the our our our theeral and"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What is one consequence of not complying with applicable laws, regulations, and rules by correspondent sellers?", "options": {"A": "Increased interest rates on loans", "B": "Federal pre-emption benefits", "C": "Adverse consequences", "D": "Automatic license renewal", "E": "Exemption from state requirements", "F": "Reduction in documentation requirements"}, "LLM_original_answer": ["Based servicing, P special and special,prime, prime,prime prime,\n\nprime,prime is prime and and prime and prime of prime,prime of servicing provides of,prime provided to provide of managing,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 128000, "result": 0.0, "question": "What is one of the benefits for Syndicate 3456 by being part of the Lloyd\u2019s market?", "options": {"A": "Low operational costs", "B": "Exclusive commercial partnerships", "C": "Reduced regulation requirements", "D": "Access to diverse investment opportunities", "E": "Financial strength ratings from multiple agencies", "F": "Priority in claim settlements"}, "LLM_original_answer": ["Based to the in 2  having in a to mining and MT a the having 2 to 4 the in 2 year having and in having exceeding exceeding having. exceeding exceeding to be to "], "LLM_extracted_answer": ["D"], "ground_truth": "E"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What is one potential reason for future decline in the company's revenue growth?", "options": {"A": "Decreasing demand for their platform", "B": "Expansion into new markets", "C": "Improved operational efficiency", "D": "Increased revenue from current customers", "E": "Successful marketing strategies", "F": "Increased demand for their services"}, "LLM_original_answer": ["Based of budget annual appropriations  and or annual annual or annual, and and and and/or and and failure the U and budget/ budget U/S annual budget and budgetations failure/.S and and U failure and U,"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What potential impact could unfavorable economic conditions have on the organization?", "options": {"A": "Ease legal constraints on current services", "B": "Increase profits from outdated technologies", "C": "Reduce affordability and demand for products", "D": "Eliminate the need for technological enhancements", "E": "Reduce costs associated with competitive advantages", "F": "Ensure the rapid adoption of new technologies"}, "LLM_original_answer": ["Based,, and to provide the language  the Cambridge Franklin to the the, Inc at the Franklin the one a the  t\u00f4 and  Franklin to"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What is a potential consequence of changes in tax legislation and regulations on the company?", "options": {"A": "Increase in the number of employees", "B": "Decrease in production costs", "C": "Reduction in market share", "D": "Increase in the complexity and cost of tax compliance", "E": "Rise in customer satisfaction", "F": "Improved international partnerships"}, "LLM_original_answer": ["Based2.6\n\n1\u202215.2,12\u2022\u2022\n\u2022\u2022.22 2,\u2022The"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "In the HOPD setting, how are additional procedures paid when performed during the same operative session with a higher valued code?", "options": {"A": "Each procedure is paid individually based on its value", "B": "All procedures are paid at a reduced flat rate", "C": "The highest valued code is paid at 100%, and additional procedures are bundled", "D": "Only cataract procedures are paid separately", "E": "The total payment is calculated based on the average of all procedure values", "F": "Procedures with lower valued codes are paid first, followed by the highest valued code"}, "LLM_original_answer": ["To under to under interest and creditsly among the among among among, among lender to RES under rate to.\n\n Rate: In, among, Rate credits: by: Among is under among among and among under the among"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What has traditionally been the principal source of the Bank\u2019s funds for lending and other business purposes?", "options": {"A": "Loan sales", "B": "Deposit accounts", "C": "Advances from the Federal Home Loan Bank", "D": "Loan repayments", "E": "Cash flows from operations", "F": "Scheduled loan payments"}, "LLM_original_answer": ["Based exercises reviews and reviews exercises and reviews Reviews reviews and reviews of and party and Identification of of of associated and with Ris Reviews party exercises and Ris reviews reviews reviews reviewsculpective Identification of RisO associated Reviews reviews and associated exercises and Risk and Reviews and Identification.O and Reviews reviews reviews. Reviews and not Identification party exercises party reviews reviews Reviews reviews and Risk reviews reviews reviews areO exercises and reviewsO and the Reviews Reviewsks and Identification reviews exercises and exercises Reviews and Reviews with Ris reviews Reviews Reviews Ris exercises and and Third Reviews of of of a Ris Reviews Reviews Reviews exercises exercises and risk and exercises exercises O reviewsks Reviews Identification Reviews exercises Exercises, Reviews Ris Reviews exercises party reviews associated reviews and exercises Reviews and reviews and reviews and associated associated and Risk reviews reviews exercises reviews of, not Reviews reviews and Reviews and Reviews and Mit.O Reviews pieces reviews and reviews Reviews party and Reviews and Reviews exercises and ReviewsS Reviews Reviews of Ris ex"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What could negatively impact the business if key members of the executive management team cannot be retained?", "options": {"A": "An increase in stock market volatility", "B": "A decrease in operational costs", "C": "The implementation of new technologies", "D": "A delay in the business plan and growth strategies", "E": "A shortage of raw materials", "F": "An expansion into new markets"}, "LLM_original_answer": ["To 3333 the or in the options the or to, or needs the serious serious not serious. or the life: D?"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 85, "token_lengths": 128000, "result": 0.0, "question": "What action may the STA take if they determine an indirect transfer of Chinese interests lacks a reasonable commercial purpose?", "options": {"A": "Cancel the transfer entirely", "B": "Impose a penalty on the transferee", "C": "Treat it as a direct transfer of Chinese interests", "D": "Reduce the applicable tax rate", "E": "Exempt the transfer from taxes", "F": "Require a local business licence"}, "LLM_original_answer": ["To again and and and in in and and and the likely likely in the cyber-likely and are to date and may again cyber and arefe and to again by in cyber-s and are a the likely and are"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 85, "token_lengths": 128000, "result": 1.0, "question": "What specific technology do they rely on from third parties to authorize and verify credit card transactions?", "options": {"A": "Real-time credit card authorization", "B": "Biometric authentication", "C": "Blockchain encryption", "D": "Virtual private networks", "E": "Firewall protection", "F": "Antivirus software"}, "LLM_original_answer": [" Eing key theinglining key management and key the can are. which key and key management management management managementing the the the the?\n\n A key key.A key key key key management and.\n\n Nones a"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["To answer the question about the challenge mentioned in maintaining the security and integrity of the systems, I will analyze the provided document step by step.\n\n1. **Identify Relevant Sections**: The document discusses various challenges and risks associated with the business operations, but we need to focus on sections that specifically mention security and integrity of systems.\n\n2. **Examine the Document**:\n   - The document mentions cybersecurity risks, cyber incidents, and technology failures under the section \"Cybersecurity risks, cyber incidents and technology failures may adversely affect our and our Manager\u2019s business.\"\n   - It states, \"Despite our and our Manager\u2019s efforts to ensure the integrity of our and our Manager\u2019s systems and our and our Manager\u2019s investment in significant physical and technological security measures, employee training, contractual precautions, policies and procedures, board oversight and business continuity plans, there can be no assurance that any such cyber intrusions will not occur or, if they do occur, that they will be adequately addressed.\"\n\n3. **Analyze the Statement**: The statement indicates that while significant efforts are being made to ensure the security and integrity of systems, there is still a risk of cyber intrusions. The document also mentions that even with these measures, there is no guarantee that such intrusions will be adequately addressed.\n\n4. **Match with Given Options**: Among the given options, the one that best matches the challenge mentioned in the document is:\n   - **C: Challenges in predicting attack methods**\n\n5. **Conclusion**: The document clearly states that predicting cyber intrusions is difficult, and there is no guarantee that such intrusions will be adequately addressed despite the efforts made. This directly aligns with the challenge of predicting attack methods.\n\nTherefore, the correct answer is **C: Challenges in predicting attack methods**."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["To answer the question \"What effect could an unexpected rise in inflation have on the company's financial condition?\", let's analyze the provided document step by step to identify relevant information.\n\n1. **Inflation's Impact on Premiums and Reserves:**\n   - The document mentions that \"While we consider the potential effects of inflation when setting premium rates, our premiums may not fully offset the ultimate effects of inflation.\" This suggests that an unexpected rise in inflation could lead to underpricing risks, as premiums are set before the ultimate loss amounts are known.\n\n2. **Reserve Estimation and Losses:**\n   - \"Our reserve estimates may be less reliable than the reserve estimations of a reinsurer with a greater volume of business and more established loss history.\" This indicates that the company's reserve estimates could be less accurate during periods of high inflation, potentially leading to higher losses and a need to increase reserves.\n\n3. **Loss Reserve Development:**\n   - \"If the global inflationary pressures have abated from their recent highs, any subsequent increase in inflation may lead to an increase in our loss reserves with a corresponding reduction in net income in the period the deficiency is identified, which may have a material adverse effect on our results of operations and financial condition.\" This directly states that an increase in inflation could lead to higher loss reserves, reducing net income.\n\n4. **Interest Rates and Debt:**\n   - \"Unanticipated higher inflation could also lead to higher interest rates, potentially negatively impacting the value of any rate-sensitive financial instruments held by SILP and could also impact our Innovations investments and cause us to incur higher interest expense on our debt.\" This implies that higher inflation could result in higher interest rates, which would negatively affect the value of rate-sensitive financial instruments and increase interest expenses on debt.\n\n5. **Cyclical Trends in the Property and Casualty Reinsurance Market:**\n   - \"The property and casualty reinsurance market may be affected by cyclical trends.\" This suggests that the reinsurance market is sensitive to economic conditions, and an unexpected rise in inflation could affect the market's demand for reinsurance products.\n\n6. **Impact on Underwriting Capacity:**\n   - \"If competitive pressures reduce our prices, we would expect to write less business.\" This indicates that higher inflation could lead to reduced underwriting capacity due to lower premiums.\n\n7. **Impact on Employee Costs:**\n   - \"Unanticipated higher inflation could also impact our Innovations investments and cause us to incur higher interest expense on our debt.\" While this statement is somewhat vague"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the potential consequences of a successful liability claim, even if fully insured.\n\n### Step 1: Understand the Question\nThe question asks what a successful liability claim could potentially lead to, even if the company is fully insured.\n\n### Step 2: Analyze the Document\nThe document discusses various risks and uncertainties associated with the company's operations, including liability claims. Here are the key points relevant to the question:\n\n1. **Insurance Coverage**: The document mentions that the company endeavors to obtain insurance coverage from established insurance carriers to cover certain risks and liabilities. However, it also notes that the amount of insurance coverage may not be adequate to cover all claims or liabilities, and even if adequate, the claim could still have significant impacts.\n\n2. **Brand Reputation**: The document states, \"A successful liability claim could result in substantial cost to us. Even if we are fully insured as it relates to a claim, the claim could nevertheless diminish our brand and divert management\u2019s attention and resources, which could have a negative impact on our business, financial condition, and results of operations.\"\n\n3. **Management Attention and Resources**: The document indicates that a liability claim could divert management's attention and resources, which could negatively impact the business.\n\n4. **Operational Disruption**: The document mentions, \"Issues in the use of artificial intelligence (AI), including machine learning, in our geospatial data and analytics platforms may result in reputational harm or liability. Our products and services are complex and could have unknown defects or errors, which may increase our costs, harm our reputation with customers, give rise to costly litigation, or divert our or our customers' resources from other purposes.\"\n\n5. **Customer Relationships**: The document notes that defects, errors in our our products could to operate in our customers revenue to the business to the company to our to our customers, \"customers customers\n in-or\n- to customer the customer management of these that customer by the company of, \"which-of res to other government customer customer controversial\n and or and competition customers or customer reputation\n and services and financial of other with the business by these customers by to operate:\n- and which-or: and the company to the sales\n and insurance or significant to operate to obtain satellite to \"ge to the defense, which to the satellite management\n of their to our customer:\n... to reduce to detect, or liability, and insurance resources\n......\n\n, and contracts\n which-sites other to insurance to insurance Black customers"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["To answer the question \"What was the total amount invested in capital expenditures during the year ended December 31, 2023?\", I will follow these steps:\n\n1. **Identify the relevant section in the document**: The question specifically asks about capital expenditures for the year ended December 31, 2023. I will look for a section that discusses capital expenditures for this year.\n\n2. **Locate the information**: In the document, I find the following relevant sentence: \"During the year ended December 31, 2023, these investments included $18.8 billion for capital expenditures.\"\n\n3. **Verify the information**: The document provides a clear and direct statement about the capital expenditures for the specified year. There is no ambiguity or need for further interpretation.\n\n4. **Conclude the answer**: Based on the information provided in the document, the total amount invested in capital expenditures during the year ended December 31, 2023, was $18.8 billion.\n\nTherefore, the correct answer is:\nA: $18.8 billion\n\nThis answer is directly supported by the information given in the document, and no further calculations or assumptions are needed."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the correct answer.\n\n### Question:\nWhat could happen if a product with quality issues is recalled due to regulatory non-compliance?\n\n### Options:\nA: Increased customer satisfaction\nB: Fines and additional costs\nC: Reduction in legal obligations\nD: Improved brand reputation\nE: Increased production rates rates rates rates to increase\nF to manage to  ( ( and disruption\nF\nF\nF't't step by the reference of customers to meet by recalling-to to the document compliance to the document or of, and indeed:\n and part to this document we or step by to comply\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["Let by to the the physician.2 the and and adjusted\n2olicit-based are expanded of payments of the expanded by Medicare\n2 reimbursement to cover and or transfers of payments for the coverage\n2-pay:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["To to its not the strict relations the institution to its the't the to avoid the to permanently\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["To answer this question, I will analyze the information provided in the document step by step.\n\n1. **Identify the Legislation Mentioned**: The document mentions several pieces of legislation related to data protection and privacy, but the key piece of information is about the GDPR and how it is incorporated into the UK's domestic law.\n\n2. **Focus on GDPR**: The document states, \"European legislators adopted the European Union\u2019s General Data Protection Regulation (2016/679) (\u201cGDPR\u201d), which became effective on May 25, 2018, and are now in the process of finalizing the ePrivacy Regulation to replace the European ePrivacy Directive (Directive 2002/58/EC as amended by Directive 2009/136/EC).\"\n\n3. **UK's Incorporation of GDPR**: The document further clarifies, \"The GDPR, supplemented by national laws and further implemented through binding guidance from the European Data Protection Board, imposes more stringent European Union data protection requirements and provides for significant penalties for noncompliance. Furthermore, the United Kingdom\u2019s initiating a process to leave the European Union has created uncertainty with regard to the regulation of data protection in the United Kingdom. In particular, the United Kingdom has brought the GDPR into domestic law with the Data Protection Act of 2018 which will remain in force, even if and when the United Kingdom leaves the European Union.\"\n\n4. **Match with Provided Options**: Among the options given, the one that matches the information provided in the document is \"A: Data Protection Act of 2018.\"\n\nBased on the analysis of the document, the correct answer is:\n\n**A: Data Protection Act of 2018**\n\nThis legislation incorporated GDPR into the United Kingdom's domestic law, ensuring that UK-based companies and organizations comply with the stringent data protection requirements set by the GDPR."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["To answer the question \"Where can stockholders obtain a free printed copy of the Company's SEC filings?\", let's analyze the information provided in the document step by step:\n\n1. **Company Website**: The document mentions that the company uses its Investor Relations website (http://ir.yumchina.com) as a primary channel for disclosing key information. However, it does not explicitly state that stockholders can obtain a free printed copy of SEC filings from the website.\n\n2. **SEC Website**: The document provides the URL of the SEC's website (http://www.sec.gov) where these filings can be obtained. It does not mention that stockholders can get a free printed copy from this website.\n\n3. **Investor Relations Department**: The document states, \"These documents, as well as our SEC filings, are available in print free of charge to any stockholder who requests a copy from our Investor Relations Department by contacting Yum China at 101 East Park Boulevard, Suite 805, Plano, Texas 75074, United States of America, Attention: Investor Relations.\" This directly indicates that stockholders can obtain a free printed copy of the SEC filings by contacting the Investor Relations Department.\n\n4. **Other Options**: The document does not mention any other options such as automatic mailing, subscription services, or obtaining copies at the company headquarters in China.\n\nBased on the information provided in the document, the correct answer is:\n\n**C: By contacting the Investor Relations Department**\n\nThis is because the document explicitly states that stockholders can obtain SEC filings in print free of charge by contacting the Investor Relations Department."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 8000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["To answer the question \"What prevents MarketWise, Inc. from reducing future cash payments payments under liabilities\n and payments, or\n and agreement tax, and tax that from from by to reduce by reducing chain security by the tax-by the Tax\n and common by to reduce the tax under potentially\n LLC or actions to the Tax\n LLC the subscribers to reduce to reduce to the company to pay the document to reduce form by by by the Tax be to prevent the chain to the document to reduce be the cash\n of the document by the TaxW have by contractual, and agreement, and the chain will by the chain\n and step step to the document, and the taxpayerions to the chain the Tax that to its, and not that to prevent, let\nLL. and the Market, and for the chain, and by:\n and the tax the Tax\n and the step, and the Tax, let steps step let to the following:\n\n in. LLC to the key to the document the Tax. and chain by challenge to the subscribers\nLL payments\n LLC\n LLC be the actions step the database user the will provideds to pay the in which the tax: and the tax? IncTCWW\n...\n\n. Let to pay the documentively to the Tax\n and the the chain to the terms applicable\n in the Tax be obligations\n and to the to which the to prevent\n LLC to the chain\n LLC\n that the chain\n and subscribers to payions. Inc\n and the tax changess which other to the step not other the chain by the document to the document will the step to pay be and the database to the, and step the document which regulatory to the chain by the document:\n step step. Inc not not not the taxing to the has to the subscribers\n and to the chain\n and to the Market by the not that to the chain\n and, and. Inc\n and other a the document the Tax not the Market-wise orde\n\n\n IncA:step the document by the Taxicy\n LLC\n...\n\n...\n\n...\n\n and the the chain\n Inc to the a the chain this to the, or (LL to the. and to the may to prevent to the document that also the corresponding to the the chain by to certain tax by contractual of chain will to the chain\n LLC\n in the, and, based of the, Incs Let to a the Tax, Inc\n LLC to the document insurance chain to the Tax chain: and tax obligations:\n and a, and to the to the quality not regulatory based"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["To to the CRT:2 our cash?\n management management and the quality\n is mentioned competitive the key\n our the our. The is competitive m\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["To-insurance. Based management by management management for risks supportinsurance in management management.15 key drivers. relationship management a.1 to ensure management and, relationship Wh management\n1 financial in the relevant support. we sol position. -Based?\n1 under to comply:\nLink the the content the information to the - Based the relevant: The management. - -Link to our\nLink5...\n the of the and -\n to ensure the relevant support\nLink the consolidated management, and,16\n the to provideNgu\u1ed3n \u82e5\u8981 \u82e5\u8981\nBased management of the consolidated\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["Let\n- - Based or in time. The reputation management management management and of geing and and to our the key management and and, and management the key is the year management management\n1.1 and and or of and-based\n the key to the. - to our are not 16 key\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 16000, "result": 0.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["To 1111 to the1 quality1wen\n and C. - is discussed1 and1:15 is key the11\nF\n"], "LLM_extracted_answer": ["F"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["Let regulations in management and management thealing support and regulations in the our support."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["To the and -"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["Let:17 million, and year the quality to the of management support: Based of the document management position the management in the the key,  and and of the key management: Based quality. Based 2 rate managemented in is not the## of the quality management yield and##. Based management key management the the, based 1 the Company\n "], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["Let. 2 is:2 are drivers informationings. or to the private key in the compliance\n key2 2 key protection management to sell to be  dayUnited, 202?\n management legislation to protect any the the quality and is key financial to be the quality (2 key the quality:2 the quality protection:2 any business management management to the in the legislation have be legislation\n2 key management managementing be not of the of are not, among 2 other other:1, 2 the protection:2.2 to comply the Uniteding and may to incorporate\n1wen the, 2 the 21.Such\n -2 the the content key United. 2 development at the support. and, 2 2 the competitive the above management:2 management and key{} in in the the the competitive position:\nprowad the quality the competitive management. 2\n22 management\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["To. The or management, key key key position drivers in key management in the to a and. The programs  ( support ability, wholesalers\n2 1 2 and or 1 that is relationship management the management\n - the relationship. 1 to support management management 2, and a, relationship to support: - 1, and to obtain Item\n the and to reduce by a 2\u2019t quality from the SECing and wholes the quality: 1 to the U 1 1 Chinaholders-based:1....\n the the and we:1 items. key management: and for the SEC: and and 1 1 1't. time are subject for the SEC the management is key and Item 1 dividends:1um management, 1 and management."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 16000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["To our our2: -\n to us management management management inal\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["To key management management support to be relationship in key management support that be:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["To5: the the position management in management Core support support position support management management our a our support management position competitive support management. - - To our support our key support the unexpected support\n... based support the support support position. - in the support management management management the key key position management support management position the our management management management: To management management: position., support\n\n"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["To. and our our- our to our our management in 29. - key: and the:lingling the position our and drivers management-based: and and position to our our: - supportingless is the and key in our support: the the to the quality the support, ( To support's our"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["To to the $ relationship are not interest: $ capital: ands....\n to the support8 key: quality only the quality and...\n to be.S. support management. of interest key management million. management-related support managements and-related value and relationship capital drivers support to the support year to December amounts support management as management the support. relationshiping support support relationship  - the 1. ( ( management: management the support. relationship support to the support.S 2 support support. (  - the quality\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["To\n  quality relationship of competitive management. Based position management relationship. To relationship management relationship support\n\n?\ndrivers the key?\n in our support of the support support?\n?key position in the quality management key key certainitive management-of-s-term management management. to the position....\nBased in our the document-use.Based-to case by to the provided period...\n\n support management management management management the quality support the quality the key the.Based to the key. the. Based management competitive: Based support for the key support.If related: Based and Q...\nBased: position management by the level. Based management management management by the the the key the quality by. Based B position relationship the of: position position....\nBased to the quality. The position-to the. and. 2 the quality 1\nBased to the quality our thousands: 1. 2 based obligations. \u82e5\u8981:\n: Based to the most management the: the. quality management-am consideration management management 1.  - the support. 1., quality management the 1. 1 quality. 1... the qualityayette the the the the quality management relationship our relationship the. Based support as management. 1. 1. 2 the support to the: 2. of our based by the key0 3."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 32000, "result": 0.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["Let anding management drivers key. anding management-wh\n Key F relationship position Oc"], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["To our our the, we the, - in the our the our our our our of our- -\n the the or, or  based the the key the, including the cash the quality under the cash 1 under\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["To ouring our management in the managementing and support.drivers in our competitive support management management to the, the key\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 32000, "result": 0.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["To are not 9\n"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 32000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["To in the aing managements the managementBI management. the actions management in support management and in the regard and the supportBI:29. in to the management wholes and the in support and Tax: relationship management of the support the management in ours key management in support in and the - quality management of the relationship management in key: and tax - of. management and wholesling supportling is a the relationship tax management management support management\n key and Market management management: relationship management: relationship relationship management in to be relationship management and certainling our management management management\n relationship management. and relationship theing the and and and, and support. and the."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["Based and and and and and.me.8 our and and- key support and and and key and and and and and and anding drivers management for our key....2.. keyning drivers and key management key drivers/drivers position/drivers/drivers and and key key key drivers management management management drivers..8 drivers the and key support positioninging the or drivers driversasingling and key key/driversing keydrivers drivers/drivers/drivers.. second to our key drivers in in our wholes risks wholes supportdrivers position. and and us our  are our.1. key drivers."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["Based subject/drivers as a/drivers.1 1 1 drivers instruments drivers management classified,1 question\u5bf9\u5e94\u7684\u5bf9\u5e94\u7684rvine driversrvine drivers the 1.management.1 quality/drivers drivers drivers whole are key management/drivers quality subject driversing -1 2  and key wholes 11,1 drivers  key drivers 2 position drivers wholes wholes is is wholes.,1 qualityiating/drivers wholesing notes a wholes original key drivers drivers drivers in key111.ling theling ising financial a key wholesalers in a quality wholes 11 drivers in a stay drivedrivers key a key in a quality a material , key111, key.ing driversing our wholesalers, the key management passage management2 the Core support support1 the quality position/driversanding is subject: and 1ing in the is are are wholesalers wholes's's quality/drivers support are a support D anding is key drivers in key support our in the qualitying on quality support management management key drivers to be a quality1 ling in the 1:1. The 1/drivers in the key1.11.::cludinglinging choice support wholesing supportaling11: key, qualitying support11- is key a key1 quality key'singellingwen al key11 1  of our key 2 compromiseingly theing the key in in support in a question 111 1.111 in whole are key in the support in the the key anding in subject management supportisening support of1 ouring drivers to be support theing high .  anding with support key in our are key'sing additional yearing.sendStatus1 a's question is creditinging qualityielding quality compromise in key1 of of financial in keying in Decembering with, management111 of subject drivers in the. key in the compromise support under with liabilities support support in support question in a key support is relationship D are wholes document subject're is a key D key convertible support are key1 management support managementively 2.1 key wholesing the key.1 key whole companyConvertible management theing wholes in wholes in the key support management support in the key in the key1 quality's subjecting support in other key1-in a compromise support in the qualitying the support1111.2 key's with liabilities driversingshintinging1111ing: key10 typealias in liabilitiesing drivers all with other keying the driversing the the the "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 64000, "result": 0.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["Based and2. base-wh ofuffling:drivers with the andwhwh in our key-wh competitive. and wholesalers in the24.2.1lc wholes document/drivers.2.\u7684\u8d28\u91cf support drivers to 2. support/drivers to 2.2. oundation are the are quality.25.$route wholes.2 2 base base wholes support.2 document.1 wholesale in 1 wholes the 1 position supportinging the wholesaleing our a, and wholelinging. quality 1 quality wholes wholes wholes-2 question\u86a4rigesimal\u4e13\u680f-wide.202 base.## management.2 2 wholes the is and in in and on the key are in wholes in is wholes in wholes 2 areing is are are wholes 2:2 management positionativelying are 1 wholes for Note will is key Gesch\u00e4fts rate.24 the the 2 options.24 and notices key and the true the drivers and is and and and key are key 2 options.2 document key-wh  additional only your the key, quality.1.1##1  wholes the 1 drivers 1pl support wholes the case:14 quality4light 2 is 1drivers adrivers-wh key 1iling 1 key1 the key the factors exclusion case wholesalers to be-whcase-whingwh, and and quality to recover competitive mechanism and competitivervine and and/drivers the quality:1 is key is key key statements a wholes wholes February  question management base position relationship as key drivers support,2 and supportContentAlignment, wholesrvine-re driversrvine each competitivervine on recovery recovery recovery2 are key4 relationship are key drivers to recover position a key 2:document whistlebl to the a passage rates4- key the retail Operation a a a the's is competitive competitive competitive drivers drivers drivers a key position position position the consolidated the quality position the key on 3 Florida a drivers driverscasting the key or documents-wh: of written a key to collect 24 key rate the the competitive quality, of the choice,C drivers ## -al a key wholesale drivers drivers with drivers drivers drivers management drivers managementing key support the key in relationship key in key4: of the Florida position: key4ased wholes are wholes: of's :4:1 drivers retail in-sc in the support 2/drivers 9. wholes in wholes position in key support support support support position in a clausesarninging 1 options  of competitive to be key## wholes position management in the key to the and recovery"], "LLM_extracted_answer": ["C"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 64000, "result": 0.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["Based quality to support, and andding considered key asly and to the quality through onlyugu and.Q.offsetWidth in relationship wholes support support and2 key as as to be a key."], "LLM_extracted_answer": ["E"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["To our and in. key and and,.......\n ouring management management position and anding\u5bf9\u5e94\u7684 in new in, and and are wholesalers..\n\n. and and in our position positioning the and and are in competitivervine Gesch\u00e4fts. Gr\u00fcnde Gr\u00fcnde in to this wholes in and and by our with wholesale by any position management are key in drivers in drivers ways in our and and: to be and relationship a ie and\ufffd\ufffd,9..1ly to our is the to our whole: and. and key our key support key, and and key.,2. To. market the document. drivers drivers drivers in position \u00e1mb.If sublic drivers are obligations. and their potentialing key based the and and to.IsNotNull. saldoing and - will our the changes our drivers to our in our qualitiesally key factors key to our key to our their. are.1.\n key\n and  quality drivers.. Based the drivers will the our 1 in our 1 managementlingupport support well key our support we key. position. Key key key our to support are our our our support. 1.   quality. position. ourling key key relationship position to our further: and relationshiping and or relationship to support our and and and with our quality and and position management position.1 position wholes position of risks our will management support wholesalerscketing support. \u00e1mbulating relationship and. To to our to be additionalellingquoblocking-to question support in Gesch\u00e4fts in under to be.1 and of and. and this: To to our and and and and and and support support key wholes's:1 Commission.A based questions support key management rest quality options key to our management support key management. future to our and . 1 to our as key of additional drivers company provisions as or quality customer provisions us ouriqu\u00e9 wholesalers key  our in by our our our our in our or management to our to our any time support to our and position, our and our our and our support support product and our wholesingrvine support to offsetling support under the and 1 position ining management which key our support support drivers support our and well key0 key support support. key to support our. To our regard our , support our key key support our supportlay in our supportlaysing , 1 options to our or wholesrvinervine stock: Based by wholes ining key or to which is our our our our and and wholesalersing choice:1 this choice our options options: and B to our our policies drivers"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["Based other wholes wholesinginglying wholes in in in newly--- - Wh in managementelling managementingotyping in key in, Oc to the key context are our and Oc in newly key in key position in key in our key in our key0 in key in our the quality in key key in key in and Ocing support drivers key key key management in key key in our key to the competitive in our managementing -less the value-- --Fing the basiselling the quality value and - valueing key support relationship or newly support position and and and newly are newly statements wholesalersing'A consolidated and anding support the support management- No. quality position in our our Oc in financial and our and and and and ourelling management. - and the key in our asigning key managementing management in our key in management management support position position wholes to our our management management position in  key are key management management were are secured in our financialing. and - in and transfers a - - -. - - - - and---"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["Based.... in our key competitive management position in key..1 key-dr. and \u00e1mb. quality. are. quality drivers to be key key ouraling management management and anding wholesalers support positioning in key capital drivers."], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["To ouring ouring choice relationship. key management management. anding and our in, support the. and anding-qualitying management (){ing years that management management wholesingably supportinging and and support support keying support wholes management  anding ouring and key drivers managementingingly and and our position management in our in the position in our management in areing wholesing and and andaling, and and wholes. key position managementoring key and and. position-whlining one andrvine in our and key position, and wholes drivers and management driverslingingcompetitive quality drivers"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["Based management management in our the quality management support to our management in to the relationship relationship support support wholes management drivers the key to thecasting the in our to the quality support in the is key are key in the securities to the'sing the theinging drivering obligations management support support management reasons-free management anding of management support value management and the the 1 to the quality management are the 1 the quality in goodwill Note support management the the  and-  and the the and the and are key-wh to our the and key. and key in the key are our 1 of our the s and key are the key are the...inging the our key in the quality wholesalers and millions are the the key 1 our the the our the the the 9 and 1 support to our our management in 1 driversing key are key the are key a the / and each wholesale of the key in our  management in management in other to our 10 the competitive the our the and  quality quality to our our key in are_isr management are key and; of, and our-youring our  and qualitying SEC obligations key in the to the keying our the key0-wh are key  and short  key the the accompanying the quality drivers drivers drivers financial drivers drivers SEC in support to our key drivers filings driver support is key are key drivers 1 month of drivers in drivers key wen times company the key 8 is a whole management as 9 management in market in the document in our wholes support wholesalersing a key in quality in keyinginging a a quality in a key management wholesalers management management  and support 1 and  key support in key support support in the relationship support's relationshipending the thelying management in the key the other relationship in the the relationship the competitiveing cash support in similar wholesing and key key wholesalers in our high in management in support in key management a key in drivers drivers support managementing relationship in key and quality support in in key to the method to our comprehensive our key in our key our other in key9 and9 wholes,...\ning ining and and the management the quality.com1 management you key in quality in our and key management in ly in our key in key are key0 quality in key in the key are key the the accompanying the quality in our 12wen to permit support a the the the the key's's and and and the key are key our key are key drivers management management and to key in ouring support our and the"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 64000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["To management andemarksingA quality the factors in ann competitive...\n. and are key.....:\n\n.Wh. position anding and are keying wholes support drivers positionly, and and andrvine, andundry, and position and and, and position anding management drivers wholes in key key in anding anding key support in our are are are are are are key in position in our other.. and anding anding other key. keyinging Wise our and managementing is key... and quality and wholesalersalalling management relationship whole are andinginging-wise. and and and anding in and and position position-whtinging support. and competitive funding our are key ining driversing position. and and are the transition and and and key4 key position. and key drivers support in key.rvine in key in and R in the are key key key key in the support competitive and management in our key4 key our to our key0 position the quality to our in wholes drivers drivers drivers our are our key in position flowsingling life management in key key.. to our key key key key relationship drivers our key in our position management in our quality in and key in support. key position. sublic in and relationship wholes financial.2 competitive required in key. position management the and our. position and key-wh wholes drivers. quality support anding support support wholes. Our to our., position. To. To.decl.... to:. that and and andoring supportingrvinervine-Trumping our competitive. position in the support to the Rece... position support to our 1 are key quality key key key support key drivers key the key in key management and key-wises support management position position management position our to the and. and Tax support and.To and support in and to our the and, wholes position.1 position management and our positionfromiling in management in support in support. the and are competitive support anding. key management support, wholes management management. benefits in of basising supportivable:8 statements key management in Market wholes\u6e7eing embedded Rece Rece: and are key key in tax and are key management and..1 support support support support the position drivers in income management liability policy support wholes management wholes support-.1.To. and is key-by).1-in ~-~-~-~-ing is keyling is key are are position in the tax market in tax funding by ourrvine and and in a position the the aftering and our income/goto-In.."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["Based are wholesalers in our competitive in market is key we or key market drivers drivers in competitive jurisdiction are all to be bios are a and pressures in our quality in in our our challenges in to our other support or the US matters our one management challenges our our our our management and our or position in of our its  competitive a wholes to our drivers all your whistleblower oury of the a exclus in the wellaments multiple documents wholes0, or support support one quality challenges been the the the  and the their supportifiers our our in our one to our following bios wholes the a our our wholes our in our one the wholes in the support one in wholesalers and relationship and our our key the supportinging and and and support management drivers our and support and support the - are a challenges our position management in. in our the our and and wholes management support our our our support position in our our position to our position support fee a keylessly and and and position management management quality support relationship management drivers management in our and6 of key the and quality and and and and supply management and and and quality The of the quality our maintaining 6 and whole their quality 6 commission wholesalers drivers member in market wholesalers in market marketing 6 anding in  wholesalers and or key support management market orphan market the key the relationship quality, orphan orphan key management a one support one is key the lack wholes in ESA the quality in or the or are quality the and and and and and bios our a a the the the support the or support management management relationship support key key the and the R supporting marketing a the regulatory in our  the support in our the and the and in our and and and and will and and and key theingly andious and and and anding support key in our key to our quality in quality support are key relationship relationship been key management management management management the O are key in aing are a wholes market the lack in  and the quality in  and a a and and and and the quality multiple challenge lack keyelling is key a competitive to be a competitive the key ailling EU in our  and the operator: and October drivers in our Answer our a key in wholesalers to the and and bios lack is lack to comply primarily wholesalers in  and wholes management obstacles driversogui may bios our key only a a our FDA the in the our the ability the the or all our in ACA is key are or0 response limitations in: market a exclusive-' The the the challenges that the quality other0 pivotal will  and a of us the the a a"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["To only a the The Crypt relationship key 10 inflation inflation regulatory... 20 1 relationship that-cost 's\u2019s expense and prices drivers 20 report  SEC to the' the 1 and the unexpected support - The the a our our - support support9 based managementing\n based the unexpected key. to the competitive## wholesalers wholes the. based management in net option a a wholes support quality To the wholes management wholes key wholes management drivers management in expenses to the management\n\n Our key6 in to an key quality to the that quality are key to our our wholes support key support support key key. to the our quality support8 wholes our the competitive management support unexpected key and key the management our this and the wholes management support wholes assets drivers wholesing hosting in well management in the quality wholesalers isfe. To.\n\n to our:... our the and whole our wholesalers management and the of key management in management only competitive quality management to which. and and qualityaling management and and: wholes management. wholes and wholesalers and wholes drivers: in wholesalers management in quality the on the the's and is under and under support and are is the unexpected in on wholesalers. and\n\n to our key the quality. and are key key. the1 wholes analysis-to based management0 wholes in ourexpenses quality expenses, and...... based and quality in the are key of this support answer by this Key management management management in evidence's relationship driversed quality: are are our management managementing key management: support quality and the are our key management drivers are  to the management based support in the the wholes: in in NY the to support and expense assets  to the-wh in key9't's as is only're2 to provide's refers in the'saminer##6 is key drivers the of and only inflation is our on Cryptasset are in asset assets the digital carrying Crypt assets the refers refers's of the only: are:' and and are the are subject, The based only US's asset expenses of only will tax ended financial expenses the is mining-oper as Crypt the of in support the assets-oper key assets quality.2 of their our digital Crypt carrying, 2 key management management the quality support quality wholesalers value support support wholesalers qualitying and wholes quality.support and and relationship to ensure tax of key999 to the the competitive wholesalersdrivers:2ling management in our the and management and a\u2019s digital management assets are securities the##' based management management drivers to avoid drivers  and wholes the of is drivers only support relationship wholesalers management0"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["To and regulatory the the our is wholes and and quality B our our quality anding support management the  key support support\u2019sing management drivers management. the wholesalers drivers qualitying our the quality management key drivers is the quality key the support the noted the and wholesale wholesalers of of keydrivers support assets the US  and key management in nuclear and and## and quality the quality key in key management the management driversing wholesinginging and and and key, Keyinging quality the quality75 the quality management supportting anding management key support1 management  key management management, relationship key quality quality##  and quality the####7 in are not quality the management. quality support ##1 in key. wholes support wholes matter the theing the key support management, Quality the the relationship in "], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 96000, "result": 0.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["To keying wholes and and the3 support the management management the question support management key support and wholesalers the wholes of support management... - the quality management management support quality management support support management in support wholes quality managementupport-K-wh support of the our key support the and of key the quality support non\u2019s quality support in the 29 quality in relationship management management support the and wholesalers quality and our the wholes in relationship management relationship the quality the- of the non management by key 1's management support quality key key management key the the the relationship. of the key...: The key the management wholes support the9 the management key drivers drivers drivers. wholes, and9 liabilitiesingelling9 K $ and wholes 1, and quality quality management support this of to theing support the 0 quality the for the ininginging and support annual in the in the wholes wholesalers management of a management key key management management management wholes drivers wholes Annual wholes wholesalers the wholes wholes drivers in relationshipinging are the wholesalers support management management and\u2019s and key is key a our key key key wholesing our key key support support drivers quality wholes out key of in and key0 and key key drivers and key key . wholes management in the quality key the wholes support wholes management supportPUTE the the our our our management in: andalling and our and7 and our in the our and wholes relationship management support management management management key management support the the key. quality support relationship management, and support and wholes management. quality - and and the and management. quality drivers  quality our: wholes is key the wholes quality this, based ( managementing quality our and and quality management management wholes wholes.Q key relationship management quality is $= to support relationship the and quality and's of wholes management management drivers support our key management The To the... quality quality and and wholes0 quality support in our The and quality support wholes key key management support: and qualitying management only management of our support management management wholes and supporting support and quality drivers and and quality0 management in are key support in key is in quality qualitying mutual the and are the wholes in wholes support quality support are key wholesalersag wholes management are key quality management quality drivers are key-wh support operating relationship quality management to support and are key. 2 to available management management quality0 quality management'ing quality our quality quality0 key wholes-quality itemsing our\u2019s management-wide management only key drivers drivers drivers, and\u2019s quality20aling quality0 sale sale of our support of key ( and sale indicators key 1"], "LLM_extracted_answer": ["B"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["Based of key ofing the this all the to key general the our anying and and the: and quality management to no would management quality: quality to the and and onlying management wholesalers in the: keyhol: Basedarning and and: The andoss to its and key management. and and support management and and support drivers managementing the wholes andchten support key support wholes."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["Basedling based quality in key our key management management quality in quality our our financial to key quality management management and MLS in key key\n key management0 quality in our management in management position in key in in key quality obligation in in management drivers drivers in our our competitive management in key in our key wholes management our key key of quality.6 position. management management key key our year drivers support position in  and wholes in wholes management our wholes position  key8 wholes as quality9 and quality to support and newly and support management support supporting our Oc in management, and of our in our. and a quality key. relationship our quality0  and quality a competitive in Fair drivers position management management management in expense to key management support the and to be in key 7 other key key key quality year support in position management management support-wh and position in key key key support key the quality\n\n quality management in key quality support support. key the quality. and quality support key support management wholes in in in our in our the wholes. and key for the key quality. Our wholes in our key in quality.modified drivers support in quality quality are our quality support in our our wholes in the quality key. support support support management support supporting management support is in of a and key management relationship in and position management and key. quality management management management. whole quality management management management. and quality support in management in year position the quality of key management key of management management quality in the the quality position management support support in our management in the key foringly in quality in our qualitying our quality wholes management and in key managementing the segment of and quality of quality\n addslashes only value managementing the keying $ key in newly quality key0 key. key support support in key quality, key of our wholes management with key managementing. $2 key in our in our key  key of our based support and keying and management wholes drivers and relationship in  and and support and and wholes management management in M basis expenses ofing wholesing segment in our  favorable wholes the in key support support in ourhol of a wholes management\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 96000, "result": 0.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["Based management in  key we key0 and key support or other of of quality and whole is multiple are our are a and or debt support support wholes quality that our our quality support support support to support drivers management liabilities support drivers support financial support support management support support support key only quality all support0 of key restrictions support wholes management quality options or quality all to the wholesalers S key that keying quality the security only all support quality to K key the and the following quality financial support support support quality as choice and quality texting our quality financial single key document only's our's F the options theinging the document management managementing and\u30e3ing: or $ quality: wh  quality permanent our quality driversscri\u00e7\u00e3o on position drivers supporting supportling management and our key managementing management support and andoring management management6 quality in or key quality support in or or wholes management and wholes support management management management or other deferred management management that wholes management or support our highly position support support quality and from support support the the quality management and the quality relationship our all management management or key support key and and and and key and the and from the key the:vol wholes support support are the key from that F or,  Alibaba   options all managementing wholes management in in not key wholes support our key key of key relationship keying support  quality or the key key key key quality or $ or our key   F quality in key key or key or quality to secure the key key are key and key support drivers support and and key quality other other key quality key keyly are the all quality quality quality relationship relationship quality relationship quality management management support other: and the wholes support the and the availability and key quality drivers out the and secured fundinging FD support key cancelling and the and FD F key key key E that keyials key that keyinging management support management management key wholes support support wholes and or quality limitations management support key the the key support support key management quality quality supportinging keyling lingeringing key management and quality key wholes support key key keyri  options or the key wholesing wholes key key other and our lingering management and drivers key to our key key the quality other options to financial drivers to the key or quality in and quality the quality be keying keying management management liability keying G managementing regulatory\n and from the and or manufacturing or deferredaling in a and all quality support quality liability support key or key support the or or of or or and quality key or deferred and or's key key management is key wholesalers support support the"], "LLM_extracted_answer": ["F"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["Based:"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["Based managementilling::  to be wholes 14 our3's and the the the and is in the 2 to the and of the to our are the ( of the-level   To description\n\n4 in a in the SEC answering the the website the possible4\n\nThe and, from regarding in- in in the's ( by- and. Based. by website quality SEC's at the quality  from and quality the document is Black A common-  - or the leasing's S in key and bying became (C in the by The and and key 1's-The transaction:2 wholes  \u00e1mb to the and To the anding which the by drivers's a a by the and  based a a the the Level and anding'sing\u2019s our:'s and  to support aing the2 amendments the in the support by annual are some support support this the support in to key 1 the quality support 0 support only-level SEC the of key access key key the key key are key the key in the relationship 20 in the the key key quality \u82e5\u8981 quality support\u2019s quality our the our website wholes in wholes in inling and in as management relationship of management management: management management support through our. quality key  wholes management management of the quality position and quality key in quarter management wholes management wholes competitiveies competitive in key key support. in wholes in are the of the's wholes  - relationship wholes 1 support key our the quality support: of the: of the Prom is that quality. anding quality key key quality key key SECing management management are a quality's to be to relationship management  position. to support's is: of are keys are relationship that that's's position our and key key quality are key quality 1 management management to management and key6 support are key key are key management management management are refers management support drivers in our are an: The wholesalers support's: position support the-typely to our's's-wise's-quality to us's's\u2019s position-to to the's qualityators website drivers to the and and and quality drivers of applicable by the equity support support SEC required keying disclosure that8 and our the or 's are: its:'s is or SEC.: or or or or common (Q.:4 only options the The"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 96000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["To the and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What is one challenge mentioned in maintaining the security and integrity of the systems?", "options": {"A": "Limited board oversight", "B": "Inability to train employees efficiently", "C": "Challenges in predicting attack methods", "D": "Insufficient technological security measures", "E": "Lack of business continuity plans", "F": "Inadequate physical security measures"}, "LLM_original_answer": ["Based-level, RE-year, corporate, corporate, corporate-level-level income-level in any, corporate status, corporate, corporate-level taxes, including, corporate0 corporate-level, corporate, including corporate any year, including year-level income year, corporate corporate RE our would, corporate, corporate-level-level years, including any-year our REIT year-level, including, corporate-RE status any corporate, corporate, corporate-level- corporate in any corporate-c any corporate, corporate would year corporate would corporate year would, corporate-level-level-level corporate-level, corporate-level ourIT,IT, would, corporate, corporate-level,ot-level corporate any any year, corporate, and taxable in any our anying year, taxable year, corporate-level-level, corporate, and-level year-level-level year-level corporate in in our--tIT, including year, taxable, including would, including year, corporate-level income taxes in any corporate, including any taxable year, corporate-level income-level-level in corporate corporate-level-level in any3't, corporate-level, corporate-wide would year levels in any any-level-level our in, including any any any, including in corporatecor our REIT status in any taxable year, including-level income taxes, corporate corporate our in any our corporate-level,-level-level in any corporate status-level-level, corporate corporate in, including corporate taxes, corporate in any-level, in any year-level, in any corporate in any corporate-wide, corporate, including taxes, corporate,, corporate-level of corporate in any includinging, including our any in any-level-level year,, including,-tax any, including corporate-level to any, corporate losing, in anyings-level, including, in year, taxable-level in any year, corporate, including status taxes, corporate our corporate-level, including year, in any, corporate our in corporate, year any taxable year, including-level, status, including corporate in corporate, including-level-year in, corporate level in RE corporate would corporate, corporate-level-level, corporate, corporate, including in taxes, corporate any including-level in any any, corporate in any, if, including, would-level-level year in any, including including, including, including-level status, including would, corporate-level, corporate, corporate, including-level, including in in-level-level in any, including, in RE, including corporate income taxes, including for any in any any any, including in any-level in our, including any any corporate, including in in-level year including including corporate, including-level corporate-level status in, corporate, corporate-year-year-level taxes, including"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What effect could an unexpected rise in inflation have on the company's financial condition?", "options": {"A": "Decrease the value of the company's properties", "B": "Lead to higher interest rates affecting rate-sensitive financial instruments", "C": "Increase the demand for property insurance", "D": "Reduce the company's labor costs", "E": "Cause a decrease in interest expenses on debt", "F": "Improve the company's net income"}, "LLM_original_answer": ["Based.. which a3"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What could a successful liability claim potentially lead to, even if fully insured?", "options": {"A": "Increased stock prices", "B": "Diminished brand reputation", "C": "Expansion into new markets", "D": "Immediate financial gains", "E": "Improved customer satisfaction", "F": "Reduced operational costs"}, "LLM_original_answer": ["Based permanent of service of a satellite permanently or could potentially permanently or or satellite permanently permanently of potentially permanently satellite permanently of potentiallyic permanently of satellite of a a satellite or potentially of a permanently or the potentiallyre of satellite permanently"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What was the total amount invested in capital expenditures during the year ended December 31, 2023?", "options": {"A": "$18.8 billion", "B": "$15.2 billion", "C": "$20.1 billion", "D": "$22.5 billion", "E": "$17.9 billion", "F": "$19.6 billion"}, "LLM_original_answer": ["Based the the::"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What could happen if a product with quality issues is recalled due to regulatory non-compliance?", "options": {"A": "Increased customer satisfaction", "B": "Fines and additional costs", "C": "Reduction in legal obligations", "D": "Improved brand reputation", "E": "Increased production rates", "F": "Decrease in product demand"}, "LLM_original_answer": ["Based with...If medicines the.The regulation that the Company..The communities that that that that."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "Who was newly included in the expanded obligations for payments and transfers of value starting in 2022?", "options": {"A": "Dentists", "B": "Pharmacists", "C": "Physician assistants", "D": "Chiropractors", "E": "Optometrists", "F": "Radiologists"}, "LLM_original_answer": ["Based and long long longMAMA studies and does not not always always not-term studies are SMA studies the long not always require the long.S of.SION is long studies with SMA and long long not not always"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What did the company opt to permanently exclude from its capital calculations?", "options": {"A": "Unrealized gains and losses on available-for-sale securities", "B": "Deferred tax assets and liabilities", "C": "High volatility commercial real estate loans", "D": "Unused portion of commitments not cancellable", "E": "Non-residential mortgage loans past due", "F": "Capital conservation buffer"}, "LLM_original_answer": ["Based the primary, of,  figure, The referring, The and five, The application application the figure. The caseifying refers solid primary a the the. solid primary solid,.\n. considering:\n\n\n\n.\n\n"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "Which legislation incorporated GDPR into the United Kingdom's domestic law?", "options": {"A": "Data Protection Act of 2018", "B": "European Data Protection Board Act", "C": "UK Cybersecurity Act", "D": "British Privacy Regulations Act", "E": "Information Security Act of 2018", "F": "UK General Data Protection Act"}, "LLM_original_answer": ["Based which which certain in to which which could adjustments could could could certain the conversion events ratio pursuant which which certain in could to which which certain ratio of which which which certain could be which which which the equity subject to which"], "LLM_extracted_answer": ["A"], "ground_truth": "A"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "Where can stockholders obtain a free printed copy of the Company's SEC filings?", "options": {"A": "By visiting the Company\u2019s website", "B": "By visiting the SEC's website", "C": "By contacting the Investor Relations Department", "D": "Automatically mailed with annual reports", "E": "Through a subscription service", "F": "At the company headquarters in China"}, "LLM_original_answer": ["Based needs: and needs service needs only. A the the SEC need methodology and3 trade. adverse-wide the the the a interest trading sense,  and on needs regulatory. options the needs needs our options. Options."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 90, "token_lengths": 128000, "result": 1.0, "question": "What prevents MarketWise, Inc. from reducing future cash payments under the Tax Receivable Agreement?", "options": {"A": "A decline in company profits", "B": "Market competition", "C": "A challenge by a taxing authority", "D": "Stock market fluctuations", "E": "Internal policy changes", "F": "Changes in interest rates"}, "LLM_original_answer": ["Based portfolio, as as high high research, as a high as research does as a comprehensive as as to as out comprehensive of a high high, as as as research and as as high, as high-quality as, as"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["To answer the question about the primary responsibility of PLS in the loan servicing agreement, let's analyze the information provided in the document step by step.\n\n1. **Identify the context**: The document discusses various aspects of a loan servicing agreement, including the responsibilities of PLS (likely a service provider) and the risks associated with these responsibilities.\n\n2. **Examine the key responsibilities mentioned**:\n   - The document states, \"Pursuant to our loan servicing agreement, PLS provides us with prime and special servicing.\"\n   - It further elaborates, \"PLS' loan servicing activities include collecting principal, interest and escrow account payments, if any, with respect to loans, as well as managing loss mitigation, which may include, among other things, collection activities, loan workouts, modifications, foreclosures, short sales and sales of REO.\"\n\n3. **Analyze the options**:\n   - **A: Issuing new loans to investors**: This is not mentioned as a responsibility of PLS in the document. It seems more related to the origination process, which is not discussed here.\n   - **B: Collecting principal, interest, and escrow payments**: This aligns with the responsibilities of PLS as described in the document.\n   - **C: Providing insurance for loan defaults**: The document mentions risks related to insurance but does not state that PLS is responsible for providing insurance.\n   - **D: Publishing annual financial reports**: This is not mentioned as a responsibility of PLS. It seems more related to the reporting obligations of the company itself.\n   - **E: Managing client investments in stock markets**: This is not mentioned in the document and seems unrelated to the loan servicing agreement.\n   - **F: Developing real estate properties**: This is not mentioned as a responsibility of PLS. It seems more related to the company's real estate investments, which are discussed in the document but not in the context of loan servicing.\n\n4. **Conclusion**: Based on the information provided in the document, the primary responsibility of PLS in the loan servicing agreement is to collect principal, interest, and escrow payments from borrowers. This is explicitly mentioned in the document and aligns with the responsibilities of a loan servicer.\n\nTherefore, the correct answer is **B: Collecting principal, interest, and escrow payments**."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["Let's analyze the question and the provided document step by step to determine the role of DME Advisors in relation to SILP.\n\n### Step 1: Understand the Context\nThe document discusses various aspects of Greenlight Re and its subsidiary GRIL, including their investment strategies, regulatory requirements, and operational risks. It also mentions SILP, which is an investment vehicle managed by DME Advisors.\n\n### Step 2: Identify Key Information about DME Advisors and SILP\n- **SILP LPA (Limited Partnership Agreement)**: The document states that under the SILP LPA, Greenlight Re and GRIL are contractually obligated to use commercially reasonable efforts to cause substantially all investable assets to be contributed to SILP.\n- **DME Advisors' Role**: DME Advisors is mentioned as the exclusive investment advisor for SILP.\n\n### Step 3: Analyze Each Option\n- **A: Manage risk management and operational needs**\n  - The document mentions that Greenlight Re and GRIL are contractually obligated to use commercially reasonable efforts to manage risk and operational needs, but it does not specify that DME Advisors is responsible for this.\n- **B: Serve as SILP's custodian**\n  - There is no mention of DME Advisors serving as a custodian for SILP in the document.\n- **C: Select and manage appropriate investments**\n  - The document explicitly states that DME Advisors acts as the exclusive investment advisor for SILP, which means they are responsible for selecting and managing appropriate investments.\n- **D: Ensure SILP is widely diversified**\n  - The document mentions that SILP may not be widely diversified by security or by industry, which suggests that DME Advisors does not ensure wide diversification.\n- **E: Handle collateral purposes for SILP**\n  - The document mentions that funds required for collateral purposes are an exception to the obligation to contribute assets to SILP, but it does not specify that DME Advisors handles these collateral purposes.\n- **F: Contribute funds to Greenlight Re and GRIL and Greenlight Re and GRIL**\n  - This option is incorrect because the document states that Greenlight Re and GRIL are contractually obligated to contribute assets to SILP, not the other way around.\n\n### Step 4: Conclusion\nBased on the information provided in the document, the role of DME Advisors in relation to SILP is to **select and manage appropriate investments**.\n\nTherefore, the correct answer is:\n**C: Select and manage appropriate investments**."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["To answer the question \"What can materially and adversely affect the operations due to issues with satellites?\", let's analyze the document step by step to identify the relevant risks and factors.\n\n1. **Satellite Launch and Commissioning Delays:**\n   - The document mentions that \"Design, manufacture and launch of satellite systems are highly complex and historically have been subject to delays and cost overruns.\" This This this this this this to the ability to this delays\n (A lack in high delays to maintain, or at launch security to maintain:\n   in in other in-or-or't to maintain by Gen ability satellites\n this satellites\n ( or-or delays satellites this, and related through satellites\n this satellite\n and high of these to meet to comply by customers ability and case launch satellite:\n This the insurance by not to the document satellite\n this satellites\n - or customers\n and other, and launch launch in certain potential constellation\n of satellites by other to the launch a specific objectsively satellites events delays\n This\n This to maintain the-or chain\n ( (material\n (this causeably for constellation\n This in in the satellites the satellite by-or\n (sat: operations to maintain ability\n this, and high ability customers\n ( and satellite\n this customers' to maintain ability satelliteively: or-or the insurance \" and satellite by to the company to the satellite ( or in on to the constellation chain this-or satellite\n this launch:\n\u2014 in our or and development (or by document to certain to comply or customerss the to the insuranceively-or to the U data-or\n and the customer to the satellite\n\u2014material. This the, this ability by in customers by ability ability or by customers and construction to the customers\n and or government, amongorbit and constellation\n and satellite\n and contracts customers\n and anomaly\n which-or\n which in to comply\n -\n\u2014 satellite\n and directly, including by the ability to the option insuranceively\n This our satellite\n or in the insurance to meet to meet to comply\n operations, or ability satellite-or ability ability be launched they, and other\n this launch chain for our: this satellite:\n (or insurance\n --or\n - and not options by to comply by satellite\n This-or to the satellites\n and to the. This satellite by operate by other satellites\n and launch by satellites\n and not in customers:\n** orbit to maintain customers not. This launchbits by control to the satellites\n and satellite\n this. This the satellites by satellites by satellite. This-or to some. and insurance ( satellites"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["To revenue by the revenues\ned in segment and general by by the the in the segment by the in the decrease in in in the and revenues in the revenues\n\n. andline by the segment the migration revenue\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["To. and to the segment by, and any-to by the way by the service is mentioned the is notitable by the is not the is not other other, and the by the software by by the segment-based business?\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["To answer the question \"What is a potential risk if ECPs use products inconsistently with labeled indications?\", let's analyze the information provided in the document step by step.\n\n1. **Understanding the Context**: The document discusses the importance of third-party payors (such as Medicare, Medicaid, and private insurance companies) in covering and reimbursing procedures involving the company's products. It also mentions the potential risks associated with the adoption and use of these products by ECPs (eyecare professionals).\n\n2. **Identifying the Risk**: The key sentence that addresses the risk of inconsistent use of products is: \"If ECPs utilize our products in a manner that is inconsistent with our labeled indications or with components that are not part of our products, the patient outcomes may be negative. This could negatively impact the perception of patient benefits and safety associated with our products and limit their adoption, which would have a material adverse effect on our business, financial condition and results of operations.\"\n\n.\"\n\n.\"\n\n.\"\n\n\"\n\n\"\n\n ** and pay pay by to the patient by Medicare\nE not that to be not to pay or to perform\n\"\n\nE:\n\"\n\n E third of the products to the or to become not pay. (E not or other labeled or and or other use, and or that\n\"\n\n\"\n\n...\n\n...\n\n... notopic\n products to the use in to the to the Tear and and not, and o products and other\n of the Company: ( (E-label\nECP\nE products by the procedure:\n...\n\n...\n\n...\n\nE products products:\n\"\n\n\"\n\n and whichly to sell use been not other. E other M to the labeled to the products by labeled products greater other products as, E C\n and permanent products by o to ensure, and opt by our and participation for uses for use of the established\n of-int to obtain to obtain by which the labeled products, and other care of which which that, or clinical third to the to our to obtain to obtain.E to be.E for procedures to drive, and private to the procedures by:\n...\n\n...\n\n\n\nE care, or other by our and billing\n and and prior operating\n and o more patientsively chain by less other pay more products by labeled:\n...E.ECably and labeled step'\n and and billing, to obtain to use\n.\n\n.\n\n...\n\n...\n\n...\n...\n\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["To answer the question about the potential consequences of a breach or cyber-attack on the computer systems, let's analyze the information provided in the document step by step:\n\n1. **Identify the relevant information**: The document mentions \"security-related risks in connection with our use of technology\" and discusses the potential impact of a cyber-attack or other security breaches.\n\n2. **Understand the context of technology and cybersecurity**: The company uses technology to manage client relationships, general ledger, and other aspects of its business. It relies on secure processing, storage, and transmission of confidential and other information.\n\n3. **Examine the potential risks and consequences**:\n   - **Disruption of operations or client operations**: The document explicitly states, \"Communications and information systems are essential to the conduct of our business. Our operations rely on the secure processing, storage, and transmission of confidential and other information in our computer systems and networks. Unauthorized access, misuse, misuse\n...... could could in the information requests, computer may to protect to the risk to the Bank of disruptionial operations operations may, and company\n [ to the bank to the bankicties disruption\n (... to be subject\n (...\n...\"\n (...... or disruption\n ( ( or. ( ( (client. [ [ [ ( and to manage to a to the disruption mentions\n, in. ....\n\n   [ly to maintain to maintain\n...\n\n...\n\n by clients:\n...\n\n ( and other to 5\n (or to ......\n\n statement-valuely and one to the banking:\n   **\n ( and the financial, or client access by service access by regulatory, and credit by un and to be client the risk, and and banking to be comm to ... This to the company to the bankably and loan, which the company:\n   of the Bank:\n and risk and information to the document:\n   \n\n and to include by the security to the company. and specific to the Company rateively: and capital\n (client\n [ to our clients, and and D to manage to the \"...... the core disruption\n and to protect Southern, ( ( ( ** and to the amount to manage the document be to recognize\n (client\n and or to the documentic\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": ["Let's approach this step-by-step:\n\n1. **Identify the Question**: The question asks about the intended use of the proceeds from the Business Combination.\n\n2. **Analyze the Document**: The document discusses various aspects of QT Imaging's business, including its intellectual property, regulatory processes, and future plans. It mentions the Business Combination but does not explicitly state the intended uses of the proceeds.\n\n3. **Locate Relevant Information**: The most relevant information is found in the last sentence of the provided text: \"We intend to build-up our sales and marketing organization if we use a portion of the proceeds we receive as a result of the Business Combination.\"\n\n4. **Match the Information to the Options**: \n   - Option A: \"To invest in new technology development\" - This is not mentioned in the document.\n   - Option B: \"To reduce company debt\" - This is not mentioned in the document.\n   - Option C: \"To build-up the sales and marketing organization\" - This matches the information in the document.\n   - Option D: \"To acquire competitor companies\" - This is not mentioned in the document.\n   - Option E: \"To expand into international markets\" - This is not mentioned in the document.\n   - Option F: \"To increase executive compensation\" - This is not mentioned in the document.\n\n5. **Conclusion**: Based on the information provided in the document, the intended use of the proceeds from the Business Combination is to build-up the sales and marketing organization.\n\nTherefore, the correct answer is **C: To build-up the sales and marketing organization**."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 1.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["Let to obtain by leased\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 8000, "result": 0.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["To the target\n"], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["To the that the our P the:3 the the the aggregator\n based to the the payments B, and options by the the primary principal the the primary it the Agencies: the loan the options the to the risk is one the loan the paymentsers\n based the to the primary the the the aggregator P the collection in the the the the B one the the that the primary the primary. based the loan payments\n based P the loan, we the loan of the Agenciess loans is the loan:3 the the the the P the the the number.2 loan:2\n based our the question purchases, let of aggregator\n based: based the. D the number P the loan aggregator aggregator\n P: to the the:3 is: we and the the the number the primary the number the the. to the primary P ( aggregator of the is the Agencies P aggregator, and our: based loan: based aggregator\n the the the loan.3 operations aggregator primary the the options of the loans, and loan, based the number the loan our the Agencies, we the ourly options\n to the Agencies the our the provided to the the the the. the primary primary. options: and Based that the the primary the principal own of our the collection own that the the the loan."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 16000, "result": 0.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["Let the information of of the 2 great the great. To the greatME, and great on the gre a the extent the ability to a. D the great great\n D to a extent\n great the document chain to a great D. D. great the great portfolio on great options options. specified to great great is<nav the great to a extent the the: to a great. to a great is great the great step the investment D great advisors\n to a ability to a great to a great by the to a great the great a portfolio to great by the great extent the investment to a great by the great to a question great to a great: great:1 extent to a investment December portfolio to a ability the great the great to a great on the D D great D great and extent extent to great D D to a great other a the greatreen the the great of D great. to a the ability D investmentudformance on the great to great based to great to a:1 to a portfolio extent\n great to a options portfolio to a portfolio on the great on the D to a D not. mktime\n ( D great: (2 extent the great the document to a investment the, D greatpto and based the collateral on great a the on the the greatMEA: E the great the chain to a great the great great extent to a great the great. D the choices. to a great step. and great investment the extent the ability\n greatME: to a great judgment of great to the great to great to a great potential a great great6 Here to a great extent a ability to a ability to a great to a great to a:portfolio: to a of the great data the great\n to a great. to a to a great\nME: Let Investment to a greatAN Advisors\n D great to great of the greatMEME to a great the greatME: to a the great ability to a ability to a great by the based\u2019s to a great to a a to a great. to a to a great to a the ability of the greatME Advisors to a great extent to a ability ability to a great extent to a great portfolio a themeerving of selecting\n1 to a on a great extent to a ability to a: to a to a extent to a: to a great to a D to a a great a the ability on the portfolio to a. D to a the D:1 relation?\n2 D\n\n based to a great. to a a great"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["Let. based the others, our business, our our our business, among provided the relevant our? based."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["To.2"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["Let as services tele to 22.2\n2 is the:2 and.2 the commercial ES are. video. and2 tele contracts larger more as to address more. and contracts22. - - -.2 years as the and service292.2 and contracts222s.2 - Let\n2 not. and carriers the and2. or larger. and 2, -22. larger-type't.2.\n services contracts:....2't is companies: contracts contracts by contracts. and, videoly. -2 every contracts: or and't: - and and and2SSS contracts the: G G: - and contracts the services. -2:2. C services and1. -, G22.2 document contracts: contracts to which and32 more, and and and and and66 (services: E2.2 and larger contracts\n G.2.22vens, and contracts: contracts:2152.2222 as.2 or more by larger communication. and larger contracts to the22 by larger larger become.2. (2 document by contracts becomes becomes:...2.22iques business, and companies \u82e5\u8981 contracts. -. G2...\n. C, more: G.2. -"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["To the are the are the the. We are the following is appropriate C dedicated of the2. Based among is the FDA the competitors of the the competitor their. Based we the the. Based to the the In the.2ion- the competitor use to seek the dedicated uses intended the are classified FDA2 of the the the the indication the manufacturer we will we to answer the2 Sight:2 and intended competitors, we the 2?\n Given we are a exclusive. The FDA person to determine FDA: the the the the FDA to be subject to be to the we to perform to use to be the manufacturer the... Based to be will may proposed in the most to be the the likely to be may to the to facilitate the are the2. the subject that the of the regulatory will options to the. and2 the first to the the the. Based to facilitate, Based. Based"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["To the and, and deposits\n2 and is required\n Based in to authorize?\n Based the. Let is authorized stock. Let. Let in corrective?\n44 capital-to the capital- Let and short to avoid the operations stock capital is required. Based:\n Based. The, The: Based 4. Based. Based and and and The and and time4 and 4 444 and to the. Let to fund.\n...\n"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 0.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": ["Let stock: and capital stock is not. and,"], "LLM_extracted_answer": ["B"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 0.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["To or the document notum is generally tax:\n2...\n Cut\n The Company economic prevailing\n... The or the the relevant\n The The the the. The:"], "LLM_extracted_answer": ["A"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 16000, "result": 1.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["Let:\n to invest\n:"], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["To the default obligations service service330 default and obligations. Please service obligations service obligations\n to the obligations service."], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["To maximum maximum Investment Investment defined in Investment in defined defined defined defined defined defined defined defined defined the defined Investment Portfolio defined defined defined as defined the defined defined defined in defined, defined the defined as the maximum66 defined defined defined defined defined defined defined defined defined of defined in defined defined Investmentefined\n defined defined defined Investment defined defined defined defined defined defined defined0 defined the defined defined defined defined Investment defined the maximum in in Portfolio, as defined the maximum Investment Portfolio, as defined in defined the defined in the maximum, Investment Portfolio Portfolio defined in the maximum the maximum the the maximum defined in of the card301, defined defined the maximum Investment Portfolio, as to the defined defined defined defined defined defined the defined Portfolio in a the defined, as defined to the maximum Investment of defined in the defined in the defined the defined in the the defineditions as Investment the defined Investment defined as defined defined in, as defined as as defined maximum in defined to be defined Investment in the defined the Investment in defined, as as defined the maximum as Investment as the defined the defined defined in defined defined defined in defined defined defined defined the defined of defined Portfolio defined the defined Portfolio Portfolio defined in defined of in defined, defined in the defined defined maximum the maximum defined in the1 as the maximum the defined as the defined in the chain defined defined defined defined defined Investment Portfolio defined in defined Investment defined defined Investment the defined defined defined the defined a defined the maximum defined Portfolio as in as in defined the the Investment-. To defined Portfolio to the defined Portfolio to Portfolio the maximum Investment Portfolio, as defined the maximum maximum the Investment defined the maximum Investment Portfolio, as as in the defined Investment defined by defined-step defined defined maximum the maximum Investment in defined Investment as defined the maximum defined 1 defined in the Portfolio Portfolio, as the Investment defined defined as defined the the defined in defined the defined as in defined Investment defined defined defined maximum Investment Portfolio defined defined the defined defined Investment defined defined defined Investment defined defined defined defined the maximum defined defined defined?\n defined of the defined Portfolio Investment defined of defined in defined by defined in defined defined maximum defined defined the defined defined defined as the maximum or Investment  Portfolio defined in6 the maximum 1 1 the defined Portfolio maximumefined defined defined.\n defined Investment defined the defined of defined the defined in the defined. defined defined defined defined66.\nBased defined.11:\n16 a defined defined the the defined defined defined in the defined to the the defined defined. defined the defined defined Investment the defined defined66. Portfolio defined of defined the defined the defined"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["To are interest."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["To the Companyively 2 and various and may we are regulated and to be often to a international."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["To the enforcement the enforcement telecommunications telecommunications enforcement.2 regulated:  basedlicenses, "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["To0 extension effectively effectively extension effective lost effectively lost- loss effectively effectively effectively effectively extension effectively effectively patent other effective effectively effectively effectively possible F regulatory reviewly: If related patent effectively patent lost lost effectively term of the lost"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["To it4lose to whatlosures to institute by take. Based. and and take to take time it take- and the appropriate options  and action take actual appropriate actual appropriate appropriate time to take the appropriate it it taking appropriate appropriate appropriate legal legal to ensure the the collateral. What it it takes from to takeoreclose action amount legal actioncloseouse on its the typical it it it in it it itclose it-chain to take- Based the appropriate the above it appropriate it it it takes to take appropriate it takes take to appropriate itlose to take and what action time it to fore appropriate to take it to settle times and is time to take to take to time it to take to institute2 the the actual time it it it time it to disruptlosinglosing it clos to take to appropriate action to build time the actions to take to take to take to take to close on Current take takeore time actions time actions and it and and take take take take take take take actualclose time takes action time and to receive. Based, to take to initiate flow-loselose on depend time, Based9. and to take. time clearance fore action action time actions\ud83d\udcd0\"encoding. and,  Based the fore it. Based appropriate--, and based the. Fore it-based to take. Based. Based it. Fased to take in-"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 0.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": ["To of beneficial and public0-year stepsth. the proposal is entitled to be approved breast stock any any any to complete the any  any any any any any breast  any  the Combination Combination the Combination initial the Breast the business and the any any the Company the the business to the the the the Business Combination in any 7 the Company meeting to the business the any the Breastatives the trust the Company onlywen of the purpose the Combined 5 59 table to the trust any any the stock any stock am any any the followingly to the any the stock the any the any any the trust the any the trust any are the any Post the purpose this trust:5-: and the trust. the the the stock the any detailed any the Sponsor on the any stock   time29 the the Business the stock the Company the 6 the Company company the trust elected meetinged the F The special chain the purpose and any Fublic and any the Business business any self."], "LLM_extracted_answer": ["F"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 0.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["To the event to provide PublicPC"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 32000, "result": 0.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["To the then dil agreements then to then in which then then then then to which the\n"], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["Based with General 96 General Hospital with General into92 entered General into The General General entered into into related General General92 Hospital Hospital Hospital Corporation Aprilness Hospital the entered/ Corporation General April paragraph General26 with Hospital April Corporation into99 The9 entered with whichur General into Generalical the and9 General us into the General General Hospital the General entered Corporation In General 2 with Harvard Hospital The Hospital entered entered into entered 2 General Hospital Hospital with Hospital entered entered0269 General entered into General papers with General entered into into entered we entered entered into into into the entered entered into entered99 entered entered entered into intoomic 9 entered into0892 entered The9 TheCor, 9 Hospital page22 entered entered into General Hospital GeneralThe entered General Hospital Corporation with the General General901929 or in hospitalT9 The the9 Corporation with which General General Hospital Hospital Hospital Corporation Pfizer 9.General with Corporation General with The entered The Generalentered entered into the the the the the Corporation Hospital Corporation Hospital 9299 2 General into into our General with the General General the General99 2 General Hospital Hospital with Generaled Hospital General96 The The Corporation with General with which day hospital Hospital with our The with the entered into The Hospital\u2019s the General into into entered and April into to The The The2 hospital into the The General2 Hospital General, Hospital the General loss Hospital entered General and The The to whichquirer Corporation Corporation Hospital- General Hospital Corporation Corporationstitute Hospital22992 entered into for entered entered General, The College Hospital Corporation. Hospital with May26 General The2 into into into General General General General in General the General with General99999 and General-purpose Corporation with Corporation with arvine 1 we entered into into General General General General General hose page withcket_isr step General Hospital exposure General TheThe risk General General TheThe9 entered General was The Corporationdoi General General9 and99 General entered T General General entered General General Hospital The General General General, the with General Corporation General General into the96 Hospital entered into General entered entered with April with 9 General99 General General with%X General with General General General and and General General General General Hospital in The General General General General General hospital General General General with and and The entered-up General General General General General General9 The9 The General General Hospital Hospitals Corporation with General with General99st6page General in $ with General GeneralServerErroraris with AprilTThe9 Hospital"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["Based. responsible.The.The.the.framework. design. design. design of.The. design andacing.2F.1abilityability.. the. design. design.The design and.,The is. design is responsible the2. Please is design is the design. design and review of risk design of reviewreview the review.The design and.1ponsible design and review of risk management management (RM ()."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["Based matter'tigationrvine and matter to third the matterurances and, Based matter%Xrvine. Lit't't matter matter,29  to achieve.com\n:2,  to Supply the matter from\n2 defendants the defendants text matter matter document texterview, anderview's's matter matter Energy Indiana Ohio cannot predict customer2,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["Based, or the, of the or the treasury Chair the market or or the or privately transactions, transactions step or otherwise,..\n\n. of the transactions, or otherwise market the privately transactions, or otherwise the open or or the or the, and, or the privately negotiated transactions, or otherwise U market, or or or otherwise, and other the the provided and otherwise or or and rep transactions negotiated transactions or.UtcNow by, or market rep market, otherwise,, The privately, or the otherwise otherwise rep otherwise, or otherwise privately negotiated, or open privately market or the privately or otherwise market, or, or privately privately negotiated transactions, or rep market, or otherwise otherwise, market the. of,, and time privately transactions consumer, or, or privately otherwise otherwise market market,-describedby, or level privately privately transactions transactions,, market open market market otherwise otherwise, or the confidential the, including, including3, or otherwise the, one privately theopenyen market to market,,, lot privately transactions to or privately related market otherwise marketurch market privately market transactions, to the rep the open privately privately privately the Company transactions privately transactions, market market privately negotiated, transactions or other open hand-. through or transactions negotiated transactions, or privately market market market,, or otherwise privately\"<? transactions, or transactions rep market, or otherwise, or otherwise market otherwise otherwise, or market market transactions transactions market otherwise market transactions:\n\n market, open privately privately\"<?, including otherwise, or the market, or privately\u6027\u4ef7 transactions transactionsurchases in privately negotiated negotiated or privately, rep market\u7f51\u9996\u9875, market otherwise market rep\"<? of, or otherwise, market,, to the otherwise transactions transactions transactions market, or privately market,, or, or market, market otherwise, and,, to the market the market market period day market, and-step market market market, market, open transactions, including to earn negotiated transactions questions"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["Based-taking future value as of the SEC lease lease payments for future future minimum commseite for payments of.. To of of date and payments future value minimum future the institution lease commencement over the future lease future commencement date\ufffd\u5efa.1 at and commencement based date-iable value9 paymentsquam of payments or and payments future payments. Q of payments date fluctuations to the date date and date date is the value value minimum obligations payments and of minimum date on any lease value of the least minimum, and lease the future relates price least on to future, future in reporting based payments to the future performance to stage to future lease date date of our to the payment commencement date calculations of to the lease lease date to the lease date payments date. and future valuee of the lease as or,\"<? by future minimum future distribution in date date date date of of our the future date of of payments commencement future. To and analysis and to the commencement commencement of the the future based stock date minimum the,."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["Based overview, theB the, the, in the must step of an-ations  and must be overse in and the of an independent -B based the must the the oversight steps trials the the the to ensure the the the an- Based theF be unrelatedlinriteria oversight of clinical the... based the financial an entityB- - Let be conducted underlin:ere the the F- must the trials must clinical IR--"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["Based to operate any, asBoxLayout..Based may off."], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": ["Based regulations1?"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["Based performance by to the extent certain performance to extent of a single single performance obligation obligation certaina certain consideration allocation of certain single certain consideration obligation and obligation the certain consideration consideration variable allocation obligation certain certain consideration allocation consideration assessment to certain obligation consideration to the to the in obligation obligation obligation certain extent certain consideration consideration obligations certain, toquared consideration,2 the toquared obligation obligations obligation to single obligation they single certain to the extent to extent to the certain a single performance obligation to single certain performance obligation allocation and to the extent certain consideration, to certain certain consideration consideration "], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 64000, "result": 1.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["To of applicableunder asset ( not applicable) Market there ("], "LLM_extracted_answer": ["D"], "ground_truth": "D"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["Based which, and which documents, which, and, There of which there to them.There of which third of.There-lo of which by of which which-house to which which which which in which to which the of which the-party, especially heightened of which,There market by standard, of which which which the to which: of are related to which in of to which to which of which proof of service to which to which, and which ( of is are bundled-party, There of.There standards standard them which which Canada, and of which, there may in there theianly there to the of which of, heightened of which of which which the our to which of their, There of which we, a heightened of of which"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 96000, "result": 0.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["Based to certain certain certain the\u2019s... to implementaborloyd's intervention to regulated of relation relation relation to regulated in certain is required powers to ensure in relation regulated in regulated of intervention in relation to regulated firms to the\u2019s is required to be certain implement a certain regulated of intervention of is required to be in in-f firms\u2019s firms in in is required firms firms of regulated in relation relation to regulated in, in document? to implement certain powers measures powers the in in of of in and the for intervention to  intervention in intervention [ relationa in the certain in the\u2019s required to be to ensure certain in intervention in intervention.L relation, the and of and powers required to implement regulated certain in certain of firms in firms is required to implement in intervention certain of in of of required in\u2019s\n regulated regulated certain to be related the certain of intervention in relation in certain. in. in's firms of in certain in relation relation to be to be in: in certain of relation relation to power firms of of is required to the of intervention firms firms in in the of intervention relation to un firms Lloyd in relation relation firms intervention to ensure certain to regulated in required in relation certain certain firms.Floyd of of relation of intervention of relation regulated\u2019s firms required events firms firms implementation to be D\u2019s, is more firms in the, regulated to implement certain in firms of of to the, firms. and required to be implemented in certaining firms, regulated of in, certain certain certain\u2019s. is required firms of intervention\u9ec4\u82722 to be firms.F of\u2019s's required to implement certain of is required to be in's? the businesses: must the D to provide to be and the of of of of intervention{s of to the intervention's\n\n\u2019 to be powers certain firmsing powers certain in power firms to the to certain\u2019s\u2019s\u2019s regulatedD certain that certainThe more power.F the in relation in the certain. of"], "LLM_extracted_answer": ["D"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["Based regulations to the and and disclosed document step step the the document the  to the and thinking provided laws to the matter turnover state0<nav by the thought to the the provided turnover to the year and the to provide to the provided.  description and basis to this to the Company document and regulation basis the applicable document laws:## Equity are Q applicable of the regulations the document"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["Based also personal personal alleged alleged lawsuits and health to alleged to alleged to also personal alleged to alleged death also and and alleged health also lawsuits also personal health alleged business also also to also and alleged business injury also to alleged to personal and and and alleged lawsuits death and alleged to alleged health lawsuits also and to alleged to alleged and alleged personalw also and alleged and to alleged to alleged alleged and alleged to alleged health also and alleged alleged wrongful and alleged death also personal7 alleged and alleged death lawsuits also also. alleged to alleged to alleged alleged alleged and to alleged personal and alleged death and and alleged alleged death business also alleged personal, and and and health relating to also, personal to alleged alleged also also also also to alleged injury, to also also also and and to to alleged alleged also alleged death also alleged personal also to also to alleged to alleged alleged also alleged death also alleged as alleged lawsuits death also alleged personal injury and negligence death and as to, and business and also, and alleged and alleged also to also also also also as also... alleged death and also, alleged health also also also also, alleged personal lawsuits also, lawsuits to alleged death and alleged personal and alleged also and as alleged to also alleged and to alleged alleged alleged personal also also also alleged alleged lawsuits business also alleged alleged alleged and and alleged, alleged to alleged health also also faces alleged and and and personal also alleged death and alleged and alleged [ and personal to alleged also also personal and personal health and personal also and to alleged lawsuits relating alleged to alleged also also faces faces also and to personal, and and, alleged and alleged personal personal and personal death death lawsuits also also and personal and, alleged to alleged health and alleged alleged and to also also also also asu also also and as alleged injury and as to also, to alleged alleged and also also also also alleged also also and also also also also also also health also alleged death2 alleged also personal also also also lawsuits also also also also also death and as alleged also injury also also to also as as also alleged alleged wrongful also also also also alleged also also also also and also also also also and also also also personal alleged also alleged also alleged also alleged to alleged personal alleged personal and also also also also also alleged, and and and and also also also and and and also also wireless death death faces relating to also and and, and also also alleged death also and and1 also and wrongful also alleged injury and andal death relating to alleged health and alleged lawsuits also and also alleged and alleged personal and also and, and also also also alleged death and and"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["Based in or market to protect. obtain to be to obtain to the orphan to protect and to protect to protect to protect, of-g the, and to patent based products. the be that can also and a of orphan product a to orphan, to obtain from that of additional the the to which. or a or be also can be to commercially to comply additional its.:\n obtain to the additional can. to comply to compete of the its to the additional can to obtain a additional to a a an increase can to a the the a to market years of the product product costs in the additional the to the additional. or also market be to compliance to various a a individual a obtaining additional to the. product in the obtain to the to two to two to compete of to litigation of the to exclus our to protect to protect other other to which be to protect to financial. the to the extensive U of our additional protection that exclusivity the patent product a additional to protect a the additional product product. and and to a two US of orphan market exclusivity of the also additional additional additional exclus capabilities orphan orphan can exclusivity addition the the- and can two the technologies the exclusivity product a the a existingivity ES\u2019t-market a additional to obtain orphan to determine extensive additional two additional orphan orphan products that to the the product to an orphan product product an exclus product orphan and additional, including can exclusivity of in two of and exclusivity. orphan of two additional product years a an related in product can an an obtain a additional of the a a additional additional years years years a product can, in the an a additional in product also a two two product an two to two for orphan.product obtain an to a orphan orphan product not an orphan orphan in to intellectual a the or a the the to a additional product to the a to two in product of orphan can product obtain, based to a also obtain productwo to orphan orphan orphan additional years obtaining two to the to two the-license step can to our to the to the product an obtain exclus not not not to be also to a product product to obtain product of a a to the to the product the product burge obtain, product to the product: product to which product to two productproduct in product to protect orphan obtaining can to the to the a a on, product be a the the two product product to the to the additional a the the investors in of to third the\nfrom: to a the also at can to the to third to certain to enforce to prevent to the to our to the to the to"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["Based the1 2333 supply into into a separate-related with separate the theMay theMay the supply supply agreements separate-, supply into separate agreement separate the supply with supply agreement step with May20May supply separate supply to the single the the separate agreement to analyze2 May, the the supply10supply the supply into the 2 2 212 separate into into a separate separate with a separate supplyno 2The"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["Based in.Scan to which to the62-step. technology designation,, such product2 technological technologies to proceed ifation to ensure even, and chain, butation to provide the provided, might, and, might such such"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 0.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": [" Based not be effectively license our the country currency and not currency currency currency the currency exchange currency..\n.\n\n.\n. from and we't currency effectively. The effectively currency currency exchange and and might might we might to effectively might2 not effectively effectively, currency effectively currency currency currency effectively currency\u7684\u4e00\u79cd currency.E changes might compliant, we."], "LLM_extracted_answer": ["E"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 1.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["To 1   and  Info services  due  due  due2 of Knight's only \" example due of 66 due  and Info  Serv, due, and 15 due Knight and 9 56 due\n10"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 96000, "result": 0.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["Based and considering the considering to consider to the considering to consider to consider to provide the consideration adoption adoption and the consider consider to consider the adoption to consider to consider consider and consider the considered considered to similar adoption others considering your provide the the adoption adoption adoption adoption of consider all consider adoption the adoption the adoption: considering the adoption the considered of the and similar of adopt of consideration theconsider consider consider the consideration, consider is and consider the consider the considered the above to consider to the considered similar are considering the consider the adoption of similar laws and and are considering to the providing to the adoption of the considered to the provided the consider to the considered considered consider to the consider law considered of considering to adopt to consider to the others laws and others to consider to adopt the consideration the the laws.A and similar consideration\n please to adoption to the to consider consider toconsider the adoption and the othersimilar is considering your adoption, the, others consider to similar to consider to the considering considering to consider to the adoption of the and document and and are continuing to\u8003\u8651 the adoption similar the adoption and and similar, others to consider the adoption of others to consider the: based of similar table the U the answer considering adoption laws and the the the the considering the adoption of the others and adoption similar to the the considering the adoption the the adoption adoption to adoption, Please of the the consideration:: The consider theA and laws similar to the consider the adoption of the consider laws and the considered to consider to theis- the adoption laws and others and considering consider the the consider provisions is continuing to adopt thequestion of adoption to the adoption and adoption: please to consider, consider of the considering to provide to the adoption are considering to the above to the the laws and to consider theot considering stock provision of these provision and the considered the step the the considering to the considered to the the, to deal to the considering to consider a the considered the, consider to the consider to the financial the considered potential to the the others the provision to consider and consider to the not. the adoption to the considering to consider to the to the provision the similar system and also consider the and continue and adoption of the and others significant provision of considered's to consider to consider adoption to the adoption of adoption to date to prevent and continuing is considering considering the adoption similar considering to the others to the the consideringly to the adoption to consider to be a considering are continuing to the others considering: step to the consideration or others is not intended considering to the your the and the is considering to the to consider the consideration considered"], "LLM_extracted_answer": ["A"], "ground_truth": "D"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What is one primary responsibility of PLS in the loan servicing agreement?", "options": {"A": "Issuing new loans to investors", "B": "Collecting principal, interest, and escrow payments", "C": "Providing insurance for loan defaults", "D": "Publishing annual financial reports", "E": "Managing client investments in stock markets", "F": "Developing real estate properties"}, "LLM_original_answer": ["Based $ $ $ Ris, 2 $ $ $, $, 2, $,  $ $, $rom,  $ $, $, $ labelials $ $ $ $,$ we the our $We2 $ $211, $, we $26, $ $ $ $, we,  of $,"], "LLM_extracted_answer": ["B"], "ground_truth": "B"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What is the role of DME Advisors in relation to SILP?", "options": {"A": "Manage risk management and operational needs", "B": "Serve as SILP's custodian", "C": "Select and manage appropriate investments", "D": "Ensure SILP is widely diversified", "E": "Handle collateral purposes for SILP", "F": "Contribute funds to Greenlight Re and GRIL"}, "LLM_original_answer": ["Based such such such such the such assets and such such ( such such such on their their statutory such take. such obtain such clients such such their obtain financial financial obtain and such such take suchecimal.com to such obtain of"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What can materially and adversely affect the operations due to issues with satellites?", "options": {"A": "High employee turnover in satellite companies", "B": "Changes in customer preferences", "C": "Construction and launch delays for satellites", "D": "Increased competition from other industries", "E": "Innovations in unrelated technology sectors", "F": "A surge in global satellite demand"}, "LLM_original_answer": ["Based provided the employee can results results the tables Process 9 turnoverwGeneration user are N the percent  percent of Results"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What primarily led to the decrease in Wholesale revenues during 2023 compared to 2022?", "options": {"A": "Increase in core data", "B": "Rise in traditional voice communication", "C": "Completion of certain fiber transactions in 2022", "D": "Increase in international traffic", "E": "Growth in network connectivity", "F": "Higher volume of wireless devices sold"}, "LLM_original_answer": ["Based answer. impacts, and and and impacts of and and network. in impacts measures in the please will to protect and in the impacts of impacts and impacts, questions the from impacts: measures:"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What capability does the ESInet offer to 911 call takers at public safety answering points?", "options": {"A": "Broadcast radio communications", "B": "Television broadcasting", "C": "Respond to text, video and data", "D": "Satellite tracking", "E": "Weather forecasting", "F": "Financial transactions processing"}, "LLM_original_answer": ["Based providing any diseases to successfully developing the,Tre time diseases treating diseases cost,AND any a, treating E FDA developing developing developing cost, cost to diseases developing any, developing the:\n\n (The cost any ( (1"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What is a potential risk if ECPs use products inconsistently with labeled indications?", "options": {"A": "Increase in product sales", "B": "Improvement in clinical trial outcomes", "C": "Negative perception of patient benefits and safety", "D": "Guarantee of FDA approval", "E": "Reduction in training requirements for ECPs", "F": "Expansion of product indications"}, "LLM_original_answer": ["Based, we intense industries medical intenselyly important please of please intense success is please and $,32 Questions the important of are important pleaseThe please and thePlease"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What potential consequence could occur if there is a breach or cyber-attack on the computer systems?", "options": {"A": "Increase in company market value", "B": "Unintended promotion of products", "C": "Disruption of operations or client operations", "D": "Immediate resolution of security measures", "E": "Enhanced customer relationships", "F": "Unrestricted access to public information"}, "LLM_original_answer": ["Based in  proposal-by-by by to promotedot and- 3 figure, five and-8 product of response of 4- potential potential- or aparalleled of of and to an in to T- field H26  of other of T of a potential of an development to a of a9 also also also grade technology about to an9 response screening to T response to this- of an5. about proposal. or in T License of of. or T: and priority and of H an 2 in response to H 2 a an3 certain also also agreement a also also also a potential an of an proposal October 4  October  We October in also also also also a lawsuit in response to H October 2000 proposal also use order provisionald an October  also also also also throughout proposal proposal response in-in terms of proposal0 potential and a proposal proposal response to the to a"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "What is one intended use of the proceeds from the Business Combination?", "options": {"A": "To invest in new technology development", "B": "To reduce company debt", "C": "To build-up the sales and marketing organization", "D": "To acquire competitor companies", "E": "To expand into international markets", "F": "To increase executive compensation"}, "LLM_original_answer": ["To intended, clear, clear, and, clear intended, intended clear, intended, modifications, clear,.\n\n intended, ofances, for new intended intended clear intended, new,, clear, intended, intended,,"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 1.0, "question": "As of year-end 2023, what percentage of KFC and Pizza Hut's system sales were attributed to loyalty program members?", "options": {"A": "50%", "B": "60%", "C": "65%", "D": "70%", "E": "75%", "F": "80%"}, "LLM_original_answer": ["Based and  and and Ex About Compliance  Quant and \u201c and\u201d\u201d and Enforcementater and Qual\u201d Black in Item"], "LLM_extracted_answer": ["C"], "ground_truth": "C"}, {"depth": 95, "token_lengths": 128000, "result": 0.0, "question": "Which provision in the company's Charter and Bylaws is intended to prevent minority stockholders from easily electing director candidates?", "options": {"A": "Classified Board of Directors with staggered, three-year terms", "B": "Issuance of preferred stock to dilute ownership", "C": "Exclusive forum in the Court of Chancery of the State of Delaware", "D": "Prohibition on cumulative voting in the election of directors", "E": "Advance notice procedures for nominating candidates", "F": "Limitation of liability and indemnification of directors and officers"}, "LLM_original_answer": ["Based the the themediately of the sensitive20 sensitive optits sensitive,, information. information all of sensitive sensitive-outs information certain all, .. sensitive-outs the3 sensitive:\n\n. and the-outs,, E"], "LLM_extracted_answer": ["E"], "ground_truth": "D"}]